"Chr","Start","End","Variation_detail","GENEINFO","Gene_refGene","Func_refGene","ExonicFunc_refGene","GeneDetail_refGene","AAChange_refGene","Gene_ensGene","Func_ensGene","ExonicFunc_ensGene","GeneDetail_ensGene","AAChange_ensGene","HGVS","EXOMISER_VARIANT_SCORE","EXOMISER_GENE_PHENO_SCORE(AD)","EXOMISER_GENE_VARIANT_SCORE(AD)","EXOMISER_GENE_COMBINED_SCORE(AD)","EXOMISER_GENE_PHENO_SCORE(AR)","EXOMISER_GENE_VARIANT_SCORE(AR)","EXOMISER_GENE_COMBINED_SCORE(AR)","EXOMISER_GENE_PHENO_SCORE(XD)","EXOMISER_GENE_VARIANT_SCORE(XD)","EXOMISER_GENE_COMBINED_SCORE(XD)","EXOMISER_GENE_PHENO_SCORE(XR)","EXOMISER_GENE_VARIANT_SCORE(XR)","EXOMISER_GENE_COMBINED_SCORE(XR)","EXOMISER_GENE_PHENO_SCORE(MT)","EXOMISER_GENE_VARIANT_SCORE(MT)","EXOMISER_GENE_COMBINED_SCORE(MT)","geneId","geneSymbol","hgncId","hgncSymbol","entrezId","ensemblId","ucscId","combinedScore","priorityScore","variantScore","Diseases","exomiserRank","Genotype","Hom_Het","Depth","Allele_Depth","WT_ratio","CLNSIG","CLIN_exmpt","CLNDN","CLNDISDB","CLNHGVS","CLNREVSTAT","InterVar_automated","InterVar_detail","OMIM_Phenotype","HPO_phenotype","annotation_summary","annotation_description","GO_BP","GO_CC","GO_MF","DO_disease","KEGG_pathway","WIKI_pathway","REACTOME_pathway","BIOCARTA_pathway","HALLMARK_pathway","SpliceAI","Interpro_domain","rmsk","tfbsConsSites","max_maf","1000G_ALL","1000G_EAS","ExAC_ALL","ExAC_EAS","ESP6500siv2_ALL","ESP6500siv2_EA","AF","AF_eas","SIFT_pred","SIFT_score","SIFT4G_pred","SIFT4G_score","Polyphen2_HDIV_pred","Polyphen2_HDIV_score","Polyphen2_HVAR_pred","Polyphen2_HVAR_score","LRT_pred","LRT_score","MutationTaster_pred","MutationTaster_score","MutationAssessor_pred","MutationAssessor_score","FATHMM_pred","FATHMM_score","PROVEAN_pred","PROVEAN_score","VEST4_score","MetaSVM_pred","MetaSVM_score","MetaLR_pred","MetaLR_score","M-CAP_pred","M-CAP_score","REVEL_score","ClinPred_pred","ClinPred_score","CADD_phred","CADD_raw","GERP++_NR","phyloP100way_vertebrate","SiPhy_29way_logOdds"
"chr3","37035012","37035012","C>A","MLH1:4292","MLH1","intron","","NM_000249:c.-27C>A;NM_001258273:c.-20957C>A;NM_001258271:c.-27C>A","","MLH1","intron","","ENST00000536378.5_1:c.-20957C>A;ENST00000673899.1_1:c.-27C>A;ENST00000231790.8_1:c.-27C>A","","MLH1:ENST00000231790.2:c.-27C>A:p.(=)","1","1.0","1.0","0.9981490248863316","","","","","","","","","","","","","ENSG00000076242","MLH1","HGNC:7127","MLH1","4292","ENSG00000076242","uc003cgl.4","0.9981490248863317","1.0","1.0","OMIM:158320 Muir-Torre syndrome-autosomal_dominant;OMIM:276300 Mismatch repair cancer syndrome 1-autosomal_recessive;OMIM:609310 Colorectal cancer, hereditary nonpolyposis, type 2-autosomal_dominant;ORPHA:144 Lynch syndrome-autosomal_dominant;ORPHA:587 Muir-Torre syndrome-autosomal_dominant","1","0/1","Het","181","105,76","0.580110497237569","Pathogenic/Likely_pathogenic","True","Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|not_provided","MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:ORPHA140162,SNOMED_CT:699346009|MedGen:C0009405|MedGen:CN169374|MedGen:CN517202","NC_000003.11:g.37035012C>A","criteria_provided,_multiple_submitters,_no_conflicts","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Torre syndrome(158320)|Mismatch repair cancer syndrome 1(276300)|Colorectal cancer, hereditary nonpolyposis, type 2(609310)","Adenomatous colonic polyposis(HP:0005227)|Adenocarcinoma of the colon(HP:0040276)|Adenocarcinoma of the small intestine(HP:0040274)|Basal cell carcinoma(HP:0002671)|Hypopigmentation of the skin(HP:0001010)|Rhabdomyosarcoma(HP:0002859)|Medulloblastoma(HP:0002885)|Plexiform neurofibroma(HP:0009732)|Agenesis of corpus callosum(HP:0001274)|Gray matter heterotopia(HP:0002282)|Axillary freckling(HP:0000997)|Autosomal recessive inheritance(HP:0000007)|Pleomorphic xanthoastrocytoma(HP:0033682)|Multiple cafe-au-lait spots(HP:0007565)|Glioblastoma multiforme(HP:0012174)|Neuroblastoma(HP:0003006)|Ependymoma(HP:0002888)|Leukemia(HP:0001909)|T-cell lymphoma(HP:0012190)|Oligodendroglioma(HP:0033681)|Autosomal dominant inheritance(HP:0000006)|Colon cancer(HP:0003003)|Hematological neoplasm(HP:0004377)|Adenoma sebaceum(HP:0009720)|Neoplasm of the liver(HP:0002896)|Laryngeal carcinoma(HP:0012118)|Salivary gland neoplasm(HP:0100684)|Colon cancer(HP:0003003)|Malignant genitourinary tract tumor(HP:0006758)|Endometrial carcinoma(HP:0012114)|Breast carcinoma(HP:0003002)|Renal neoplasm(HP:0009726)|Neoplasm of the stomach(HP:0006753)|Malignant genitourinary tract tumor(HP:0006758)|Laryngeal carcinoma(HP:0012118)|Benign genitourinary tract neoplasm(HP:0006778)|Carcinoma(HP:0030731)|Colon cancer(HP:0003003)|Duodenal adenocarcinoma(HP:0006771)|Breast carcinoma(HP:0003002)|Basal cell carcinoma(HP:0002671)|Adenoma sebaceum(HP:0009720)|Sebaceous gland carcinoma(HP:0030410)|Autosomal dominant inheritance(HP:0000006)|Colonic diverticula(HP:0002253)|Benign gastrointestinal tract tumors(HP:0006719)|Hypertonia(HP:0001276)|Basal cell carcinoma(HP:0002671)|Ovarian neoplasm(HP:0100615)|Agnosia(HP:0010524)|Irritability(HP:0000737)|Death in infancy(HP:0001522)|Urinary tract neoplasm(HP:0010786)|Amaurosis fugax(HP:0100576)|Pituitary adenoma(HP:0002893)|Glioblastoma multiforme(HP:0012174)|Hepatocellular carcinoma(HP:0001402)|Benign neoplasm of the central nervous system(HP:0100835)|Seizure(HP:0001250)|Fatigue(HP:0012378)|Migraine(HP:0002076)|Hemiplegia/hemiparesis(HP:0004374)|Neoplasm of the rectum(HP:0100743)|Visual field defect(HP:0001123)|Nausea and vomiting(HP:0002017)|Developmental regression(HP:0002376)|Paresthesia(HP:0003401)|Abdominal pain(HP:0002027)|Depression(HP:0000716)|Memory impairment(HP:0002354)|Anxiety(HP:0000739)|Pancreatic adenocarcinoma(HP:0006725)|Weight loss(HP:0001824)|Neoplasm of the skeletal system(HP:0010622)|Constipation(HP:0002019)|Neoplasm of the thyroid gland(HP:0100031)|Colon cancer(HP:0003003)|Intestinal polyposis(HP:0200008)|Neuroblastoma(HP:0003006)|Abnormal pyramidal sign(HP:0007256)|Dyskinesia(HP:0100660)|Attention deficit hyperactivity disorder(HP:0007018)|Cardiac diverticulum(HP:0100571)|Dysarthria(HP:0001260)|Flexion contracture(HP:0001371)|Gastrointestinal hemorrhage(HP:0002239)|Dysgraphia(HP:0010526)|Gait disturbance(HP:0001288)|Death in early adulthood(HP:0100613)|Malabsorption(HP:0002024)|Increased intracranial pressure(HP:0002516)|Hypotonia(HP:0001252)|Hallucinations(HP:0000738)","The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]","mutL homolog 1","nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289)|resolution of meiotic recombination intermediates(GO:0000712)|mismatch repair(GO:0006298)|mismatch repair(GO:0006298)|double-strand break repair via nonhomologous end joining(GO:0006303)|male meiosis chromosome segregation(GO:0007060)|homologous chromosome pairing at meiosis(GO:0007129)|spermatogenesis(GO:0007283)|intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630)|response to bacterium(GO:0009617)|female meiosis chromosome segregation(GO:0016321)|somatic hypermutation of immunoglobulin genes(GO:0016446)|meiotic metaphase I plate congression(GO:0043060)|meiotic telomere clustering(GO:0045141)|isotype switching(GO:0045190)|negative regulation of mitotic recombination(GO:0045950)|positive regulation of isotype switching to IgA isotypes(GO:0048298)|positive regulation of isotype switching to IgG isotypes(GO:0048304)|oogenesis(GO:0048477)|meiotic spindle midzone assembly(GO:0051257)","synaptonemal complex(GO:0000795)|male germ cell nucleus(GO:0001673)|nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|chromosome(GO:0005694)|chiasma(GO:0005712)|late recombination nodule(GO:0005715)|membrane(GO:0016020)|mismatch repair complex(GO:0032300)|MutLalpha complex(GO:0032389)","chromatin binding(GO:0003682)|single-stranded DNA binding(GO:0003697)|protein binding(GO:0005515)|protein binding(GO:0005515)|ATP binding(GO:0005524)|ATP hydrolysis activity(GO:0016887)|enzyme binding(GO:0019899)|guanine/thymine mispair binding(GO:0032137)|MutSalpha complex binding(GO:0032407)","prostate cancer(DOID:10283)|chronic lymphocytic leukemia(DOID:1040)|sarcoma(DOID:1115)|head and neck cancer(DOID:11934)|leukemia(DOID:1240)|acute leukemia(DOID:12603)|vulva carcinoma(DOID:1294)|colon carcinoma(DOID:1520)|head and neck carcinoma(DOID:1542)|fungal infectious disease(DOID:1564)|cancer(DOID:162)|squamous cell carcinoma(DOID:1749)|melanoma(DOID:1909)|hepatitis(DOID:2237)|syndrome(DOID:225)|breast carcinoma(DOID:3459)|lung non-small cell carcinoma(DOID:3908)|thyroid gland carcinoma(DOID:3963)|thyroid gland papillary carcinoma(DOID:3969)|gastritis(DOID:4029)|alveolar soft part sarcoma(DOID:4239)|renal cell carcinoma(DOID:4450)|gallbladder carcinoma(DOID:4948)|atypical polypoid adenomyoma(DOID:4993)|infertility(DOID:5223)|synovial sarcoma(DOID:5485)|head and neck squamous cell carcinoma(DOID:5520)|hereditary breast ovarian cancer syndrome(DOID:5683)|adenoma(DOID:657)|hepatocellular carcinoma(DOID:684)|embryoma(DOID:4766)|laryngeal squamous cell carcinoma(DOID:2876)|ulcerative colitis(DOID:8577)|Crohn's disease(DOID:8778)|substance dependence(DOID:9973)|ataxia telangiectasia(DOID:12704)|stomach carcinoma(DOID:5517)|colon cancer(DOID:219)|pancreatic cancer(DOID:1793)|pancreatic carcinoma(DOID:4905)|breast ductal carcinoma(DOID:3007)|stomach cancer(DOID:10534)|acute myeloid leukemia(DOID:9119)|endometrial adenocarcinoma(DOID:2870)|skin melanoma(DOID:8923)|acquired immunodeficiency syndrome(DOID:635)|esophageal disease(DOID:6050)|endometrial carcinoma(DOID:2871)|lung cancer(DOID:1324)|adenocarcinoma(DOID:299)|esophagus squamous cell carcinoma(DOID:3748)|cervical squamous cell carcinoma(DOID:3744)|germ cell cancer(DOID:2994)|disease(DOID:4)|mycosis fungoides(DOID:8691)|mucinous adenocarcinoma(DOID:3030)|carcinoma(DOID:305)","Mismatch repair|Pathways in cancer|Colorectal cancer|Endometrial cancer","Wp ovarian infertility genes|Wp dna irdamage and cellular response via atr|Wp dna mismatch repair|Wp chromosomal and microsatellite instability in colorectal cancer|Wp genes involved in male infertility|Wp dna repair pathways full network|Wp p53 transcriptional gene network","Reproduction|Meiosis|Cell cycle|Transcriptional regulation by tp53|Mismatch repair|Diseases of mismatch repair mmr|Tp53 regulates transcription of dna repair genes|Rna polymerase ii transcription|Dna repair|Meiotic recombination|Diseases of dna repair","","E2f targets","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr11","6644241","6644241","C>G","","DCHS1","exonic","nonsynonymous SNV","","DCHS1:NM_003737:exon21:c.G8666C:p.R2889P","DCHS1","exonic","nonsynonymous SNV","","DCHS1:ENST00000299441.5_1:exon21:c.G8666C:p.R2889P","DCHS1:ENST00000299441.3:c.8666G>C:p.(Arg2889Pro)","1","0.5980052585370823","1.0","0.892030509142719","","","","","","","","","","","","","ENSG00000166341","DCHS1","HGNC:13681","DCHS1","8642","ENSG00000166341","uc001mem.3","0.892030509142719","0.5980052585370823","1.0","OMIM:601390 Van Maldergem syndrome 1-autosomal_recessive;OMIM:607829 Mitral valve prolapse 2-autosomal_dominant;ORPHA:314679 Cerebrofacioarticular syndrome-autosomal_recessive","4","0/1","Het","125","69,56","0.552","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Van maldergem syndrome 1(601390)|Mitral valve prolapse 2(607829)","Mitral regurgitation(HP:0001653)|Autosomal dominant inheritance(HP:0000006)|Mitral valve prolapse(HP:0001634)|Age-dependent penetrance(HP:0003831)|Narrow mouth(HP:0000160)|Anal stenosis(HP:0002025)|Caudal appendage(HP:0002825)|Renal hypoplasia(HP:0000089)|Intellectual disability, moderate(HP:0002342)|Cerebellar vermis hypoplasia(HP:0001320)|Gray matter heterotopia(HP:0002282)|Wide nasal bridge(HP:0000431)|Lymphedema(HP:0001004)|Ventriculomegaly(HP:0002119)|Hypoplasia of the corpus callosum(HP:0002079)|Large fontanelles(HP:0000239)|Ataxia(HP:0001251)|Intellectual disability, severe(HP:0010864)|Micrognathia(HP:0000347)|Abnormal heart morphology(HP:0001627)|Abnormal facial shape(HP:0001999)|Global developmental delay(HP:0001263)|Pulmonic stenosis(HP:0001642)|Epicanthus(HP:0000286)|Talipes equinovarus(HP:0001762)|Hypoplasia of the maxilla(HP:0000327)|Microcephaly(HP:0000252)|Osteopenia(HP:0000938)|Conductive hearing impairment(HP:0000405)|Camptodactyly(HP:0012385)|Agenesis of corpus callosum(HP:0001274)|Gastrostomy tube feeding in infancy(HP:0011471)|Hypospadias(HP:0000047)|Microtia(HP:0008551)|Irregular dentition(HP:0040079)|Syndactyly(HP:0001159)|Short stature(HP:0004322)|Tracheomalacia(HP:0002779)|Hypertelorism(HP:0000316)|Blepharophimosis(HP:0000581)|Bilateral choanal atresia/stenosis(HP:0200138)|Self-injurious behavior(HP:0100716)|Infantile muscular hypotonia(HP:0008947)|Dysplastic corpus callosum(HP:0006989)|Anteriorly placed anus(HP:0001545)|Absence of pubertal development(HP:0008197)|Tented upper lip vermilion(HP:0010804)|Short fourth metatarsal(HP:0004689)|Tracheomalacia(HP:0002779)|Subcortical band heterotopia(HP:0032409)|Irregular dentition(HP:0040079)|Feeding difficulties(HP:0011968)|Atresia of the external auditory canal(HP:0000413)|Narrow chest(HP:0000774)|Wide cranial sutures(HP:0010537)|Growth delay(HP:0001510)|Joint laxity(HP:0001388)|Midface retrusion(HP:0011800)|Ptosis(HP:0000508)|Micrognathia(HP:0000347)|Pachygyria(HP:0001302)|Hypertelorism(HP:0000316)|Clinodactyly(HP:0030084)|Autosomal recessive inheritance(HP:0000007)|Malar flattening(HP:0000272)|Hypoplasia of the corpus callosum(HP:0002079)|Renal hypoplasia(HP:0000089)|High palate(HP:0000218)|Wide anterior fontanel(HP:0000260)|Talipes equinovarus(HP:0001762)|Intellectual disability(HP:0001249)|Hypoplasia of the maxilla(HP:0000327)|Sensorineural hearing impairment(HP:0000407)|Periventricular nodular heterotopia(HP:0032388)|Dental malocclusion(HP:0000689)|Microtia(HP:0008551)|Epicanthus(HP:0000286)|Short clavicles(HP:0000894)|Sacral dimple(HP:0000960)|Anteriorly placed anus(HP:0001545)|Narrow forehead(HP:0000341)|Conductive hearing impairment(HP:0000405)|Scoliosis(HP:0002650)|Generalized hypotonia(HP:0001290)|Anal atresia(HP:0002023)|Simplified gyral pattern(HP:0009879)|Blepharophimosis(HP:0000581)|Downturned corners of mouth(HP:0002714)|Short palpebral fissure(HP:0012745)|Skeletal dysplasia(HP:0002652)|Osteopenia(HP:0000938)|Short 4th metacarpal(HP:0010044)|Hypospadias(HP:0000047)|Congenital onset(HP:0003577)|Wide nasal bridge(HP:0000431)|Cutaneous finger syndactyly(HP:0010554)","This gene is a member of the cadherin superfamily whose members encode calcium-dependent cell-cell adhesion molecules. The encoded protein has a signal peptide, 27 cadherin repeat domains and a unique cytoplasmic region. This particular cadherin family member is expressed in fibroblasts but not in melanocytes or keratinocytes. The cell-cell adhesion of fibroblasts is thought to be necessary for wound healing. [provided by RefSeq, Jul 2008]","dachsous cadherin-related 1","cell morphogenesis(GO:0000902)|branching involved in ureteric bud morphogenesis(GO:0001658)|mitral valve formation(GO:0003192)|cell migration involved in endocardial cushion formation(GO:0003273)|cell-cell junction assembly(GO:0007043)|homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156)|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157)|multicellular organism development(GO:0007275)|pattern specification process(GO:0007389)|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339)|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339)|neural tube development(GO:0021915)|neurogenesis(GO:0022008)|adherens junction organization(GO:0034332)|hippo signaling(GO:0035329)|post-anal tail morphogenesis(GO:0036342)|ossification involved in bone maturation(GO:0043931)|digestive tract development(GO:0048565)|condensed mesenchymal cell proliferation(GO:0072137)|protein localization to plasma membrane(GO:0072659)|cochlea development(GO:0090102)|cell-cell adhesion via plasma-membrane adhesion molecules(GO:0098742)","adherens junction(GO:0005912)|membrane(GO:0016020)|integral component of membrane(GO:0016021)|catenin complex(GO:0016342)|apical part of cell(GO:0045177)","calcium ion binding(GO:0005509)|cadherin binding(GO:0045296)","","","","","","","","Cadherin-like","","Score=885;Name=V$MAZR_01","","","","","","","","","","D","0.018","D","0.0","D","1.0","D","0.968","N","0.003","D","1","M","2.44","T","0.43","D","-3.0","0.687","T","-0.783","T","0.244","T","0.021","0.301","D","0.963","27.9","4.026","4.76","6.164","16.513"
"chr7","6017340","6017340","T>C","PMS2:5395","PMS2","exonic","nonsynonymous SNV","","PMS2:NM_000535:exon14:c.A2324G:p.N775S","PMS2","exonic","nonsynonymous SNV","","PMS2:ENST00000382321.5_1:exon10:c.A1121G:p.N374S,PMS2:ENST00000644110.1_1:exon11:c.A2006G:p.N669S,PMS2:ENST00000441476.6_1:exon13:c.A2006G:p.N669S,PMS2:ENST00000642292.1_1:exon13:c.A1919G:p.N640S,PMS2:ENST00000265849.12_1:exon14:c.A2324G:p.N775S,PMS2:ENST00000642456.1_1:exon14:c.A1919G:p.N640S","PMS2:ENST00000265849.7:c.2324A>G:p.(Asn775Ser)","0.9719917","","","","0.8050328386969675","0.7234958559274673","0.8486742167093685","","","","","","","","","","ENSG00000122512","PMS2","HGNC:9122","PMS2","5395","ENSG00000122512","uc003spl.4","0.8486742167093685","0.8050328386969675","0.7234958559274673","OMIM:614337 Colorectal cancer, hereditary nonpolyposis, type 4-autosomal_dominant;OMIM:619101 Mismatch repair cancer syndrome 4-autosomal_recessive;ORPHA:144 Lynch syndrome-autosomal_dominant","11","0/1","Het","172","105,67","0.61046511627907","Benign","False","Endometrial_carcinoma|Lynch_syndrome|Lynch_syndrome_1|Turcot_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_4|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|Breast_and/or_ovarian_cancer|not_provided","Human_Phenotype_Ontology:HP:0012114,MONDO:MONDO:0002447,MedGen:C0476089,OMIM:608089,SNOMED_CT:254878006|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:ORPHA144|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435|MONDO:MONDO:0010159,MedGen:C5399763,OMIM:276300,Orphanet:ORPHA252202,SNOMED_CT:61665008|MONDO:MONDO:0013699,MedGen:C1838333,OMIM:614337|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:ORPHA140162,SNOMED_CT:699346009|MedGen:C0009405|MedGen:CN169374|MedGen:CN221562|MedGen:CN517202","NC_000007.13:g.6017340T>C","reviewed_by_expert_panel","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 1 ; BP7: 0","Colorectal cancer, hereditary nonpolyposis, type 4(614337)|Mismatch repair cancer syndrome 4(619101)","Hereditary nonpolyposis colorectal carcinoma(HP:0006716)|Autosomal dominant inheritance(HP:0000006)|Endometrial carcinoma(HP:0012114)|Ovarian neoplasm(HP:0100615)|Hypertonia(HP:0001276)|Basal cell carcinoma(HP:0002671)|Ovarian neoplasm(HP:0100615)|Agnosia(HP:0010524)|Irritability(HP:0000737)|Death in infancy(HP:0001522)|Urinary tract neoplasm(HP:0010786)|Amaurosis fugax(HP:0100576)|Pituitary adenoma(HP:0002893)|Glioblastoma multiforme(HP:0012174)|Hepatocellular carcinoma(HP:0001402)|Benign neoplasm of the central nervous system(HP:0100835)|Seizure(HP:0001250)|Fatigue(HP:0012378)|Migraine(HP:0002076)|Hemiplegia/hemiparesis(HP:0004374)|Neoplasm of the rectum(HP:0100743)|Visual field defect(HP:0001123)|Nausea and vomiting(HP:0002017)|Developmental regression(HP:0002376)|Paresthesia(HP:0003401)|Abdominal pain(HP:0002027)|Depression(HP:0000716)|Memory impairment(HP:0002354)|Anxiety(HP:0000739)|Pancreatic adenocarcinoma(HP:0006725)|Weight loss(HP:0001824)|Neoplasm of the skeletal system(HP:0010622)|Constipation(HP:0002019)|Neoplasm of the thyroid gland(HP:0100031)|Colon cancer(HP:0003003)|Intestinal polyposis(HP:0200008)|Neuroblastoma(HP:0003006)|Abnormal pyramidal sign(HP:0007256)|Dyskinesia(HP:0100660)|Attention deficit hyperactivity disorder(HP:0007018)|Cardiac diverticulum(HP:0100571)|Dysarthria(HP:0001260)|Flexion contracture(HP:0001371)|Gastrointestinal hemorrhage(HP:0002239)|Dysgraphia(HP:0010526)|Gait disturbance(HP:0001288)|Death in early adulthood(HP:0100613)|Malabsorption(HP:0002024)|Increased intracranial pressure(HP:0002516)|Hypotonia(HP:0001252)|Hallucinations(HP:0000738)|Agenesis of corpus callosum(HP:0001274)|Colon cancer(HP:0003003)|Adenomatous colonic polyposis(HP:0005227)|Gray matter heterotopia(HP:0002282)|Multiple cafe-au-lait spots(HP:0007565)|Non-Hodgkin lymphoma(HP:0012539)|Autosomal recessive inheritance(HP:0000007)|Astrocytoma(HP:0009592)|Glioblastoma multiforme(HP:0012174)","The protein encoded by this gene is a key component of the mismatch repair system that functions to correct DNA mismatches and small insertions and deletions that can occur during DNA replication and homologous recombination. This protein forms heterodimers with the gene product of the mutL homolog 1 (MLH1) gene to form the MutL-alpha heterodimer. The MutL-alpha heterodimer possesses an endonucleolytic activity that is activated following recognition of mismatches and insertion/deletion loops by the MutS-alpha and MutS-beta heterodimers, and is necessary for removal of the mismatched DNA. There is a DQHA(X)2E(X)4E motif found at the C-terminus of the protein encoded by this gene that forms part of the active site of the nuclease. Mutations in this gene have been associated with hereditary nonpolyposis colorectal cancer (HNPCC; also known as Lynch syndrome) and Turcot syndrome. [provided by RefSeq, Apr 2016]","PMS1 homolog 2, mismatch repair system component","mismatch repair(GO:0006298)|mismatch repair(GO:0006298)|mismatch repair(GO:0006298)|mismatch repair(GO:0006298)|response to xenobiotic stimulus(GO:0009410)|somatic hypermutation of immunoglobulin genes(GO:0016446)|nucleic acid phosphodiester bond hydrolysis(GO:0090305)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|mismatch repair complex(GO:0032300)|MutLalpha complex(GO:0032389)|cytoplasmic ribonucleoprotein granule(GO:0036464)","DNA binding(GO:0003677)|single-stranded DNA binding(GO:0003697)|endonuclease activity(GO:0004519)|protein binding(GO:0005515)|ATP binding(GO:0005524)|ATP hydrolysis activity(GO:0016887)|single base insertion or deletion binding(GO:0032138)|MutSalpha complex binding(GO:0032407)","prostate cancer(DOID:10283)|cancer(DOID:162)|syndrome(DOID:225)|primary hyperaldosteronism(DOID:446)|hereditary breast ovarian cancer syndrome(DOID:5683)|ataxia telangiectasia(DOID:12704)|embryoma(DOID:4766)|disease(DOID:4)","Mismatch repair","Wp dna mismatch repair|Wp genes involved in male infertility|Wp dna repair pathways full network","Transcriptional regulation by tp53|Mismatch repair|Diseases of mismatch repair mmr|Tp53 regulates transcription of dna repair genes|Rna polymerase ii transcription|Dna repair|Diseases of dna repair","","E2f targets","SpliceAI>C|PMS2|0.02|0.01|0.00|0.00|5|-20|-1|42","MutL,","","","0.0004","","","0.0004","0.0003","","","0.0003","0","T","0.218","T","0.166","P","0.763","P","0.722","D","0.000","D","1.000","L","1.455","T","-0.97","D","-3.08","0.391","T","-0.566","T","0.402","T","0.025","0.333","T","0.204","23.1","2.769","5.75","4.852","11.180"
"chr11","36511736","36511736","T>C","","TRAF6","exonic","nonsynonymous SNV","","TRAF6:NM_004620:exon7:c.A1221G:p.I407M,TRAF6:NM_145803:exon8:c.A1221G:p.I407M","TRAF6","exonic","nonsynonymous SNV","","TRAF6:ENST00000526995.6_1:exon7:c.A1221G:p.I407M,TRAF6:ENST00000348124.5_1:exon8:c.A1221G:p.I407M","TRAF6:ENST00000348124.5:c.1221A>G:p.(Ile407Met)","0.9984225","0.5424699478427718","0.9984225034713744","0.8205240298727068","","","","","","","","","","","","","ENSG00000175104","TRAF6","HGNC:12036","TRAF6","7189","ENSG00000175104","uc001mws.3","0.8205240298727068","0.5424699478427718","0.9984225034713745","ORPHA:1810 Autosomal dominant hypohidrotic ectodermal dysplasia-autosomal_dominant","12","0/1","Het","144","71,73","0.493055555555556","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","Abnormal fingernail morphology(HP:0001231)|Abnormality of dental morphology(HP:0006482)|Eczema(HP:0000964)|Thick vermilion border(HP:0012471)|Prominent forehead(HP:0011220)|Malignant hyperthermia(HP:0002047)|Thin skin(HP:0000963)|Hypohidrosis(HP:0000966)|Depressed nasal ridge(HP:0000457)|Abnormality of skin pigmentation(HP:0001000)|Premature loss of primary teeth(HP:0006323)|Hypodontia(HP:0000668)|Sparse body hair(HP:0002231)","The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]","TNF receptor associated factor 6","negative regulation of transcription by RNA polymerase II(GO:0000122)|protein polyubiquitination(GO:0000209)|ossification(GO:0001503)|in utero embryonic development(GO:0001701)|neural tube closure(GO:0001843)|stimulatory C-type lectin receptor signaling pathway(GO:0002223)|regulation of immunoglobulin production(GO:0002637)|positive regulation of T cell cytokine production(GO:0002726)|cytoplasmic pattern recognition receptor signaling pathway(GO:0002753)|MyD88-dependent toll-like receptor signaling pathway(GO:0002755)|cellular response to DNA damage stimulus(GO:0006974)|I-kappaB kinase/NF-kappaB signaling(GO:0007249)|activation of NF-kappaB-inducing kinase activity(GO:0007250)|JNK cascade(GO:0007254)|antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886)|osteoclast differentiation(GO:0030316)|positive regulation of protein ubiquitination(GO:0031398)|positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666)|activation of protein kinase activity(GO:0032147)|positive regulation of interleukin-12 production(GO:0032735)|positive regulation of interleukin-2 production(GO:0032743)|positive regulation of interleukin-6 production(GO:0032755)|tumor necrosis factor-mediated signaling pathway(GO:0033209)|Fc-epsilon receptor signaling pathway(GO:0038095)|T-helper 1 type immune response(GO:0042088)|positive regulation of T cell proliferation(GO:0042102)|odontogenesis of dentin-containing tooth(GO:0042475)|regulation of apoptotic process(GO:0042981)|myeloid dendritic cell differentiation(GO:0043011)|regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122)|positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123)|positive regulation of JUN kinase activity(GO:0043507)|positive regulation of JUN kinase activity(GO:0043507)|bone resorption(GO:0045453)|positive regulation of osteoclast differentiation(GO:0045672)|negative regulation of transcription, DNA-templated(GO:0045892)|positive regulation of transcription by RNA polymerase II(GO:0045944)|positive regulation of transcription by RNA polymerase II(GO:0045944)|positive regulation of JNK cascade(GO:0046330)|cell development(GO:0048468)|positive regulation of smooth muscle cell proliferation(GO:0048661)|T cell receptor signaling pathway(GO:0050852)|T cell receptor signaling pathway(GO:0050852)|positive regulation of DNA-binding transcription factor activity(GO:0051091)|positive regulation of NF-kappaB transcription factor activity(GO:0051092)|positive regulation of NF-kappaB transcription factor activity(GO:0051092)|positive regulation of NF-kappaB transcription factor activity(GO:0051092)|protein autoubiquitination(GO:0051865)|protein autoubiquitination(GO:0051865)|protein autoubiquitination(GO:0051865)|interleukin-1-mediated signaling pathway(GO:0070498)|interleukin-1-mediated signaling pathway(GO:0070498)|protein K63-linked ubiquitination(GO:0070534)|protein K63-linked ubiquitination(GO:0070534)|protein K63-linked ubiquitination(GO:0070534)|response to interleukin-1(GO:0070555)|cellular response to lipopolysaccharide(GO:0071222)|cellular response to cytokine stimulus(GO:0071345)|interleukin-17-mediated signaling pathway(GO:0097400)|positive regulation of NIK/NF-kappaB signaling(GO:1901224)|positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996)|positive regulation of transcription regulatory region DNA binding(GO:2000679)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|lipid droplet(GO:0005811)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|cell cortex(GO:0005938)|cytoplasmic side of plasma membrane(GO:0009898)|endosome membrane(GO:0010008)|protein-containing complex(GO:0032991)|CD40 receptor complex(GO:0035631)|perinuclear region of cytoplasm(GO:0048471)|plasma membrane signaling receptor complex(GO:0098802)","ubiquitin-protein transferase activity(GO:0004842)|ubiquitin-protein transferase activity(GO:0004842)|tumor necrosis factor receptor binding(GO:0005164)|protein binding(GO:0005515)|zinc ion binding(GO:0008270)|protein kinase binding(GO:0019901)|mitogen-activated protein kinase kinase kinase binding(GO:0031435)|ubiquitin conjugating enzyme binding(GO:0031624)|ubiquitin protein ligase binding(GO:0031625)|thioesterase binding(GO:0031996)|tumor necrosis factor receptor superfamily binding(GO:0032813)|identical protein binding(GO:0042802)|histone deacetylase binding(GO:0042826)|protein kinase B binding(GO:0043422)|protein N-terminus binding(GO:0047485)|ubiquitin protein ligase activity(GO:0061630)|ubiquitin protein ligase activity(GO:0061630)","osteoporosis(DOID:11476)|Parkinson's disease(DOID:14330)","Mapk signaling pathway|Ubiquitin mediated proteolysis|Endocytosis|Toll like receptor signaling pathway|Nod like receptor signaling pathway|Rig i like receptor signaling pathway|Neurotrophin signaling pathway|Leishmania infection|Pathways in cancer|Small cell lung cancer","Wp oxidative damage|Wp il1 signaling pathway|Wp mirnas involvement in the immune response in sepsis|Wp interleukin1 induced activation of nfkappab|Wp ebv lmp1 signaling|Wp melatonin metabolism and effects|Wp tgfbeta signaling pathway|Wp tolllike receptor signaling pathway|Wp photodynamic therapyinduced ap1 survival signaling|Wp simplified depiction of myd88 distinct inputoutput pathway|Wp photodynamic therapyinduced nfkb survival signaling|Wp structural pathway of interleukin 1 il1|Wp apoe and mir146 in inflammation and atherosclerosis|Wp mapk and nfkb signalling pathways inhibited by yersinia yopj|Wp regulation of tolllike receptor signaling pathway|Wp il17 signaling pathway|Wp tlr4 signaling and tolerance|Wp tolllike receptor signaling related to myd88|Wp novel intracellular components of rigilike receptor rlr pathway|Wp mapk signaling pathway|Wp dna irdouble strand breaks dsbs and cellular response via atm|Wp apoptosis modulation and signaling|Wp ranklrank receptor activator of nfkb ligand signaling pathway|Wp brainderived neurotrophic factor bdnf signaling pathway|Wp ltf danger signal response pathway|Wp tcell antigen receptor tcr signaling pathway|Wp fibrin complement receptor 3 signaling pathway|Wp epithelial to mesenchymal transition in colorectal cancer|Wp interactions between immune cells and micrornas in tumor microenvironment|Wp hepatitis b infection|Wp signal transduction through il1r|Wp il18 signaling pathway|Wp small cell lung cancer|Wp type i interferon induction and signaling during sarscov2 infection|Wp autosomal recessive osteopetrosis pathways|Wp hostpathogen interaction of human corona viruses interferon induction|Wp 16p112 proximal deletion syndrome|Wp sarscov2 mitochondrial interactions|Wp sarscov2 innate immunity evasion and cellspecific immune response","Cytokine signaling in immune system|Adaptive immune system|Myd88 independent tlr4 cascade|Toll like receptor 9 tlr9 cascade|Toll like receptor tlr1 tlr2 cascade|Innate immune system|Nod1 2 signaling pathway|Nucleotide binding domain leucine rich repeat containing receptor nlr signaling pathways|Toll like receptor cascades|Ticam1 rip1 mediated ikk complex recruitment|Ddx58 ifih1 mediated induction of interferon alpha beta|P75ntr signals via nf kb|Regulated proteolysis of p75ntr|P75 ntr receptor mediated signalling|Negative regulation of the pi3k akt network|Tcr signaling|Cell death signalling via nrage nrif and nade|Nrif signals cell death from the nucleus|P75ntr recruits signalling complexes|Nf kb is activated and signals survival|Fc epsilon receptor fceri signaling|Fceri mediated nf kb activation|Tak1 activates nfkb by phosphorylation and activation of ikks complex|Interleukin 1 family signaling|Interleukin 17 signaling|Signaling by interleukins|Activated tak1 mediates p38 mapk activation|Jnk c jun kinases phosphorylation and activation mediated by activated human tak1|Clec7a dectin 1 signaling|C type lectin receptors clrs|Deubiquitination|Ub specific processing proteases|Ovarian tumor domain proteases|Post translational protein modification|Death receptor signalling|Intracellular signaling by second messengers|Ticam1 traf6 dependent induction of tak1 complex|Interleukin 1 signaling|Traf6 mediated irf7 activation|Traf6 mediated nf kb activation|Irak1 recruits ikk complex|Ikk complex recruitment mediated by rip1|Irak2 mediated activation of tak1 complex|Traf6 mediated induction of tak1 complex within tlr4 complex|Alpha protein kinase 1 signaling pathway|Traf6 mediated irf7 activation in tlr7 8 or 9 signaling","Rela pathway|Rankl pathway|Cd40 pathway|Nfkb pathway|Il1r pathway|Tall1 pathway|Toll pathway","","","MATH/TRAF","","","","","","","","","","","","D","0.004","D","0.003","P","0.937","P","0.831","D","0.000","D","1.000","L","1.71","T","0.93","N","-1.32","0.698","T","-0.904","T","0.139","D","0.034","0.298","D","0.902","22.6","2.548","5.52","-0.077","8.733"
"chr17","72889676","72889676","->GGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATC","","FADS6","exonic","nonframeshift insertion","","FADS6:NM_178128:exon1:c.17_18insGATGGAACCTACGGAGCCCATGGAACCTACGGAGCCCATGGAACCTACGGAGCC:p.P15_A16insTEPMEPTEPMEPTEPMEP","FADS6","exonic","nonframeshift insertion","","FADS6:ENST00000612771.5_1:exon1:c.17_18insGATGGAACCTACGGAGCCCATGGAACCTACGGAGCCCATGGAACCTACGGAGCC:p.P15_A16insTEPMEPTEPMEPTEPMEP","FADS6:ENST00000310226.6:c.17_18insGATGGAACCTACGGAGCCCATGGAACCTACGGAGCCCATGGAACCTACGGAGCC:p.(Pro15_Ala16insThrGluProMetGluProThrGluProMetGluProThrGluProMetGluPro)","0.85","","","","0.6490214736686337","0.8500000238418579","0.7797772756499494","","","","","","","","","","ENSG00000172782","FADS6","HGNC:30459","FADS6","283985","ENSG00000172782","uc060jrm.1","0.7797772756499494","0.6490214736686337","0.8500000238418579","","16","1/1","Hom","93","1,92","0.010752688172043","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","fatty acid desaturase 6","lipid metabolic process(GO:0006629)|fatty acid biosynthetic process(GO:0006633)","integral component of membrane(GO:0016021)","protein binding(GO:0005515)|oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717)","","","","","","","SpliceAI>GGGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATC|FADS6|0.00|0.00|0.00|0.00|22|29|-43|22","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr22","25024072","25024072","G>T","","GGT1","exonic","nonsynonymous SNV","","GGT1:NM_001288833:exon14:c.G1361T:p.C454F,GGT1:NM_013430:exon14:c.G1361T:p.C454F,GGT1:NM_013421:exon15:c.G1361T:p.C454F","GGT1","exonic","nonsynonymous SNV","","GGT1:ENST00000403838.5_1:exon3:c.G329T:p.C110F,GGT1:ENST00000404223.5_1:exon3:c.G329T:p.C110F,GGT1:ENST00000404920.1_1:exon3:c.G329T:p.C110F,GGT1:ENST00000401885.5_1:exon4:c.G329T:p.C110F,GGT1:ENST00000404532.5_1:exon4:c.G329T:p.C110F,GGT1:ENST00000400382.6_1:exon14:c.G1361T:p.C454F,GGT1:ENST00000400380.5_1:exon15:c.G1361T:p.C454F","GGT1:ENST00000248923.4:c.1361G>T:p.(Cys454Phe)","0.999907","0.2581529933959245","0.9999070167541504","0.1943795446427941","0.5163059867918491","0.9960154592990876","0.7730886790393326","","","","","","","","","","ENSG00000100031","GGT1","HGNC:4250","GGT1","2678","ENSG00000100031","uc003aan.2","0.7730886790393326","0.5163059867918491","0.9960154592990875","OMIM:231950 ?Glutathioninuria-autosomal_recessive","17","0/1","Het","319","238,81","0.746081504702194","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Glutathionuria(231950)","Strabismus(HP:0000486)|Tremor(HP:0001337)|Intellectual disability(HP:0001249)|Autosomal recessive inheritance(HP:0000007)|Abnormality of metabolism/homeostasis(HP:0001939)","The enzyme encoded by this gene is a type I gamma-glutamyltransferase that catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors. The enzyme is composed of a heavy chain and a light chain, which are derived from a single precursor protein. It is expressed in tissues involved in absorption and secretion and may contribute to the etiology of diabetes and other metabolic disorders. Multiple alternatively spliced variants have been identified. There are a number of related genes present on chromosomes 20 and 22, and putative pseudogenes for this gene on chromosomes 2, 13, and 22. [provided by RefSeq, Jan 2014]","gamma-glutamyltransferase 1","regulation of immune system process(GO:0002682)|regulation of immune system process(GO:0002682)|translation(GO:0006412)|proteolysis(GO:0006508)|cellular amino acid metabolic process(GO:0006520)|glutamate metabolic process(GO:0006536)|fatty acid metabolic process(GO:0006631)|leukotriene metabolic process(GO:0006691)|glutathione biosynthetic process(GO:0006750)|glutathione catabolic process(GO:0006751)|glutathione catabolic process(GO:0006751)|spermatogenesis(GO:0007283)|spermatogenesis(GO:0007283)|cysteine biosynthetic process(GO:0019344)|peptide modification(GO:0031179)|zymogen activation(GO:0031638)|response to estradiol(GO:0032355)|response to lipopolysaccharide(GO:0032496)|response to tumor necrosis factor(GO:0034612)|regulation of inflammatory response(GO:0050727)|regulation of inflammatory response(GO:0050727)|leukotriene D4 biosynthetic process(GO:1901750)|leukotriene D4 biosynthetic process(GO:1901750)","extracellular space(GO:0005615)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extracellular exosome(GO:0070062)","peptidyltransferase activity(GO:0000048)|peptidyltransferase activity(GO:0000048)|leukotriene-C(4) hydrolase(GO:0002951)|leukotriene-C(4) hydrolase(GO:0002951)|protein binding(GO:0005515)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|hypoglycin A gamma-glutamyl transpeptidase activity(GO:0102953)|leukotriene C4 gamma-glutamyl transferase activity(GO:0103068)","glucose intolerance(DOID:10603)|hypertension(DOID:10763)|heart disease(DOID:114)|myotonic dystrophy type 1(DOID:11722)|leukemia(DOID:1240)|colon carcinoma(DOID:1520)|cancer(DOID:162)|atherosclerosis(DOID:1936)|hepatitis(DOID:2237)|syndrome(DOID:225)|coronary artery disease(DOID:3393)|liver disease(DOID:409)|kidney disease(DOID:557)|aortic valve disease(DOID:62)|hepatocellular carcinoma(DOID:684)|fatty liver disease(DOID:9452)|obesity(DOID:9970)","Arachidonic acid metabolism|Taurine and hypotaurine metabolism|Selenoamino acid metabolism|Glutathione metabolism","Wp eicosanoid synthesis|Wp selenium micronutrient network|Wp glutathione metabolism|Wp nuclear receptors metapathway|Wp nrf2 pathway|Wp gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases|Wp vitamin dsensitive calcium signaling in depression","Phase ii conjugation of compounds|Glutathione conjugation|Glutathione synthesis and recycling|Biological oxidations|Synthesis of leukotrienes lt and eoxins ex|Arachidonic acid metabolism|Aflatoxin activation and detoxification|Metabolism of lipids|Metabolic disorders of biological oxidation enzymes|Infectious disease|Diseases of metabolism|Fatty acid metabolism|Leishmania infection|Anti inflammatory response favouring leishmania parasite infection|Ltc4 cysltr mediated il4 production","","","",".;.;.;.;.;.;.;.;.","","","","","","","","","","","","D","0.003","D","0.014","B","0.036","B","0.031","D","0.000","D","1.000","M","2.64","T","3.3","D","-5.75","0.797","T","-1.049","T","0.035","T","0.016","0.293","D","0.975","22.1","2.331","2.79","6.106","13.769"
"chr22","25023441","25023441","C>T","","GGT1","exonic","nonsynonymous SNV","","GGT1:NM_001288833:exon12:c.C1063T:p.R355W,GGT1:NM_013430:exon12:c.C1063T:p.R355W,GGT1:NM_013421:exon13:c.C1063T:p.R355W","GGT1","exonic","nonsynonymous SNV","","GGT1:ENST00000403838.5_1:exon1:c.C31T:p.R11W,GGT1:ENST00000404223.5_1:exon1:c.C31T:p.R11W,GGT1:ENST00000404920.1_1:exon1:c.C31T:p.R11W,GGT1:ENST00000401885.5_1:exon2:c.C31T:p.R11W,GGT1:ENST00000404532.5_1:exon2:c.C31T:p.R11W,GGT1:ENST00000400382.6_1:exon12:c.C1063T:p.R355W,GGT1:ENST00000400380.5_1:exon13:c.C1063T:p.R355W","GGT1:ENST00000248923.4:c.1063C>T:p.(Arg355Trp)","0.9921239","","","","0.5163059867918491","0.9960154592990876","0.7730886790393326","","","","","","","","","","ENSG00000100031","GGT1","HGNC:4250","GGT1","2678","ENSG00000100031","uc003aan.2","0.7730886790393326","0.5163059867918491","0.9960154592990875","OMIM:231950 ?Glutathioninuria-autosomal_recessive","18","0/1","Het","250","198,52","0.792","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Glutathionuria(231950)","Strabismus(HP:0000486)|Tremor(HP:0001337)|Intellectual disability(HP:0001249)|Autosomal recessive inheritance(HP:0000007)|Abnormality of metabolism/homeostasis(HP:0001939)","The enzyme encoded by this gene is a type I gamma-glutamyltransferase that catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors. The enzyme is composed of a heavy chain and a light chain, which are derived from a single precursor protein. It is expressed in tissues involved in absorption and secretion and may contribute to the etiology of diabetes and other metabolic disorders. Multiple alternatively spliced variants have been identified. There are a number of related genes present on chromosomes 20 and 22, and putative pseudogenes for this gene on chromosomes 2, 13, and 22. [provided by RefSeq, Jan 2014]","gamma-glutamyltransferase 1","regulation of immune system process(GO:0002682)|regulation of immune system process(GO:0002682)|translation(GO:0006412)|proteolysis(GO:0006508)|cellular amino acid metabolic process(GO:0006520)|glutamate metabolic process(GO:0006536)|fatty acid metabolic process(GO:0006631)|leukotriene metabolic process(GO:0006691)|glutathione biosynthetic process(GO:0006750)|glutathione catabolic process(GO:0006751)|glutathione catabolic process(GO:0006751)|spermatogenesis(GO:0007283)|spermatogenesis(GO:0007283)|cysteine biosynthetic process(GO:0019344)|peptide modification(GO:0031179)|zymogen activation(GO:0031638)|response to estradiol(GO:0032355)|response to lipopolysaccharide(GO:0032496)|response to tumor necrosis factor(GO:0034612)|regulation of inflammatory response(GO:0050727)|regulation of inflammatory response(GO:0050727)|leukotriene D4 biosynthetic process(GO:1901750)|leukotriene D4 biosynthetic process(GO:1901750)","extracellular space(GO:0005615)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extracellular exosome(GO:0070062)","peptidyltransferase activity(GO:0000048)|peptidyltransferase activity(GO:0000048)|leukotriene-C(4) hydrolase(GO:0002951)|leukotriene-C(4) hydrolase(GO:0002951)|protein binding(GO:0005515)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|hypoglycin A gamma-glutamyl transpeptidase activity(GO:0102953)|leukotriene C4 gamma-glutamyl transferase activity(GO:0103068)","glucose intolerance(DOID:10603)|hypertension(DOID:10763)|heart disease(DOID:114)|myotonic dystrophy type 1(DOID:11722)|leukemia(DOID:1240)|colon carcinoma(DOID:1520)|cancer(DOID:162)|atherosclerosis(DOID:1936)|hepatitis(DOID:2237)|syndrome(DOID:225)|coronary artery disease(DOID:3393)|liver disease(DOID:409)|kidney disease(DOID:557)|aortic valve disease(DOID:62)|hepatocellular carcinoma(DOID:684)|fatty liver disease(DOID:9452)|obesity(DOID:9970)","Arachidonic acid metabolism|Taurine and hypotaurine metabolism|Selenoamino acid metabolism|Glutathione metabolism","Wp eicosanoid synthesis|Wp selenium micronutrient network|Wp glutathione metabolism|Wp nuclear receptors metapathway|Wp nrf2 pathway|Wp gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases|Wp vitamin dsensitive calcium signaling in depression","Phase ii conjugation of compounds|Glutathione conjugation|Glutathione synthesis and recycling|Biological oxidations|Synthesis of leukotrienes lt and eoxins ex|Arachidonic acid metabolism|Aflatoxin activation and detoxification|Metabolism of lipids|Metabolic disorders of biological oxidation enzymes|Infectious disease|Diseases of metabolism|Fatty acid metabolism|Leishmania infection|Anti inflammatory response favouring leishmania parasite infection|Ltc4 cysltr mediated il4 production","","","",".;.;.;.;.;.;.;.;.","","","0.00005438","","","0.","0.0001","","","1.596e-05","5.438e-05","D","0.013","D","0.027","D","0.966","P","0.716","D","0.000","D","0.945","M","3.135","T","3.03","D","-7.64","0.57","T","-1.118","T","0.044","T","0.006","0.130","D","0.908","23.2","2.830","3.4","1.073","5.176"
"chr22","25023540","25023540","G>A","","GGT1","exonic","nonsynonymous SNV","","GGT1:NM_001288833:exon12:c.G1162A:p.A388T,GGT1:NM_013430:exon12:c.G1162A:p.A388T,GGT1:NM_013421:exon13:c.G1162A:p.A388T","GGT1","exonic","nonsynonymous SNV","","GGT1:ENST00000403838.5_1:exon1:c.G130A:p.A44T,GGT1:ENST00000404223.5_1:exon1:c.G130A:p.A44T,GGT1:ENST00000404920.1_1:exon1:c.G130A:p.A44T,GGT1:ENST00000401885.5_1:exon2:c.G130A:p.A44T,GGT1:ENST00000404532.5_1:exon2:c.G130A:p.A44T,GGT1:ENST00000400382.6_1:exon12:c.G1162A:p.A388T,GGT1:ENST00000400380.5_1:exon13:c.G1162A:p.A388T","GGT1:ENST00000248923.4:c.1162G>A:p.(Ala388Thr)","0.96691173","","","","","","","","","","","","","","","","ENSG00000100031","GGT1","HGNC:4250","GGT1","2678","ENSG00000100031","uc003aan.2","0.7730886790393326","0.5163059867918491","0.9960154592990875","OMIM:231950 ?Glutathioninuria-autosomal_recessive","19","0/1","Het","263","227,36","0.863117870722434","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Glutathionuria(231950)","Strabismus(HP:0000486)|Tremor(HP:0001337)|Intellectual disability(HP:0001249)|Autosomal recessive inheritance(HP:0000007)|Abnormality of metabolism/homeostasis(HP:0001939)","The enzyme encoded by this gene is a type I gamma-glutamyltransferase that catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors. The enzyme is composed of a heavy chain and a light chain, which are derived from a single precursor protein. It is expressed in tissues involved in absorption and secretion and may contribute to the etiology of diabetes and other metabolic disorders. Multiple alternatively spliced variants have been identified. There are a number of related genes present on chromosomes 20 and 22, and putative pseudogenes for this gene on chromosomes 2, 13, and 22. [provided by RefSeq, Jan 2014]","gamma-glutamyltransferase 1","regulation of immune system process(GO:0002682)|regulation of immune system process(GO:0002682)|translation(GO:0006412)|proteolysis(GO:0006508)|cellular amino acid metabolic process(GO:0006520)|glutamate metabolic process(GO:0006536)|fatty acid metabolic process(GO:0006631)|leukotriene metabolic process(GO:0006691)|glutathione biosynthetic process(GO:0006750)|glutathione catabolic process(GO:0006751)|glutathione catabolic process(GO:0006751)|spermatogenesis(GO:0007283)|spermatogenesis(GO:0007283)|cysteine biosynthetic process(GO:0019344)|peptide modification(GO:0031179)|zymogen activation(GO:0031638)|response to estradiol(GO:0032355)|response to lipopolysaccharide(GO:0032496)|response to tumor necrosis factor(GO:0034612)|regulation of inflammatory response(GO:0050727)|regulation of inflammatory response(GO:0050727)|leukotriene D4 biosynthetic process(GO:1901750)|leukotriene D4 biosynthetic process(GO:1901750)","extracellular space(GO:0005615)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extracellular exosome(GO:0070062)","peptidyltransferase activity(GO:0000048)|peptidyltransferase activity(GO:0000048)|leukotriene-C(4) hydrolase(GO:0002951)|leukotriene-C(4) hydrolase(GO:0002951)|protein binding(GO:0005515)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|hypoglycin A gamma-glutamyl transpeptidase activity(GO:0102953)|leukotriene C4 gamma-glutamyl transferase activity(GO:0103068)","glucose intolerance(DOID:10603)|hypertension(DOID:10763)|heart disease(DOID:114)|myotonic dystrophy type 1(DOID:11722)|leukemia(DOID:1240)|colon carcinoma(DOID:1520)|cancer(DOID:162)|atherosclerosis(DOID:1936)|hepatitis(DOID:2237)|syndrome(DOID:225)|coronary artery disease(DOID:3393)|liver disease(DOID:409)|kidney disease(DOID:557)|aortic valve disease(DOID:62)|hepatocellular carcinoma(DOID:684)|fatty liver disease(DOID:9452)|obesity(DOID:9970)","Arachidonic acid metabolism|Taurine and hypotaurine metabolism|Selenoamino acid metabolism|Glutathione metabolism","Wp eicosanoid synthesis|Wp selenium micronutrient network|Wp glutathione metabolism|Wp nuclear receptors metapathway|Wp nrf2 pathway|Wp gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases|Wp vitamin dsensitive calcium signaling in depression","Phase ii conjugation of compounds|Glutathione conjugation|Glutathione synthesis and recycling|Biological oxidations|Synthesis of leukotrienes lt and eoxins ex|Arachidonic acid metabolism|Aflatoxin activation and detoxification|Metabolism of lipids|Metabolic disorders of biological oxidation enzymes|Infectious disease|Diseases of metabolism|Fatty acid metabolism|Leishmania infection|Anti inflammatory response favouring leishmania parasite infection|Ltc4 cysltr mediated il4 production","","","SpliceAI>A|GGT1|0.00|0.00|0.00|0.00|4|32|-11|17",".;.;.;.;.;.;.;.;.","","","0.00002686","","","0.","0.","","","2.686e-05","0","T","0.066","T","0.11","B","0.293","B","0.103","D","0.000","D","0.881","M","2.325","T","3.26","N","-2.1","0.609","T","-1.063","T","0.029","T","0.004","0.218","T","0.257","13.98","1.084","3.36","3.592","11.226"
"chr22","25023513","25023513","G>A","","GGT1","exonic","nonsynonymous SNV","","GGT1:NM_001288833:exon12:c.G1135A:p.G379R,GGT1:NM_013430:exon12:c.G1135A:p.G379R,GGT1:NM_013421:exon13:c.G1135A:p.G379R","GGT1","exonic","nonsynonymous SNV","","GGT1:ENST00000403838.5_1:exon1:c.G103A:p.G35R,GGT1:ENST00000404223.5_1:exon1:c.G103A:p.G35R,GGT1:ENST00000404920.1_1:exon1:c.G103A:p.G35R,GGT1:ENST00000401885.5_1:exon2:c.G103A:p.G35R,GGT1:ENST00000404532.5_1:exon2:c.G103A:p.G35R,GGT1:ENST00000400382.6_1:exon12:c.G1135A:p.G379R,GGT1:ENST00000400380.5_1:exon13:c.G1135A:p.G379R","GGT1:ENST00000248923.4:c.1135G>A:p.(Gly379Arg)","0.8612094","","","","","","","","","","","","","","","","ENSG00000100031","GGT1","HGNC:4250","GGT1","2678","ENSG00000100031","uc003aan.2","0.7730886790393326","0.5163059867918491","0.9960154592990875","OMIM:231950 ?Glutathioninuria-autosomal_recessive","20","0/1","Het","295","233,62","0.789830508474576","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Glutathionuria(231950)","Strabismus(HP:0000486)|Tremor(HP:0001337)|Intellectual disability(HP:0001249)|Autosomal recessive inheritance(HP:0000007)|Abnormality of metabolism/homeostasis(HP:0001939)","The enzyme encoded by this gene is a type I gamma-glutamyltransferase that catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors. The enzyme is composed of a heavy chain and a light chain, which are derived from a single precursor protein. It is expressed in tissues involved in absorption and secretion and may contribute to the etiology of diabetes and other metabolic disorders. Multiple alternatively spliced variants have been identified. There are a number of related genes present on chromosomes 20 and 22, and putative pseudogenes for this gene on chromosomes 2, 13, and 22. [provided by RefSeq, Jan 2014]","gamma-glutamyltransferase 1","regulation of immune system process(GO:0002682)|regulation of immune system process(GO:0002682)|translation(GO:0006412)|proteolysis(GO:0006508)|cellular amino acid metabolic process(GO:0006520)|glutamate metabolic process(GO:0006536)|fatty acid metabolic process(GO:0006631)|leukotriene metabolic process(GO:0006691)|glutathione biosynthetic process(GO:0006750)|glutathione catabolic process(GO:0006751)|glutathione catabolic process(GO:0006751)|spermatogenesis(GO:0007283)|spermatogenesis(GO:0007283)|cysteine biosynthetic process(GO:0019344)|peptide modification(GO:0031179)|zymogen activation(GO:0031638)|response to estradiol(GO:0032355)|response to lipopolysaccharide(GO:0032496)|response to tumor necrosis factor(GO:0034612)|regulation of inflammatory response(GO:0050727)|regulation of inflammatory response(GO:0050727)|leukotriene D4 biosynthetic process(GO:1901750)|leukotriene D4 biosynthetic process(GO:1901750)","extracellular space(GO:0005615)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extracellular exosome(GO:0070062)","peptidyltransferase activity(GO:0000048)|peptidyltransferase activity(GO:0000048)|leukotriene-C(4) hydrolase(GO:0002951)|leukotriene-C(4) hydrolase(GO:0002951)|protein binding(GO:0005515)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|hypoglycin A gamma-glutamyl transpeptidase activity(GO:0102953)|leukotriene C4 gamma-glutamyl transferase activity(GO:0103068)","glucose intolerance(DOID:10603)|hypertension(DOID:10763)|heart disease(DOID:114)|myotonic dystrophy type 1(DOID:11722)|leukemia(DOID:1240)|colon carcinoma(DOID:1520)|cancer(DOID:162)|atherosclerosis(DOID:1936)|hepatitis(DOID:2237)|syndrome(DOID:225)|coronary artery disease(DOID:3393)|liver disease(DOID:409)|kidney disease(DOID:557)|aortic valve disease(DOID:62)|hepatocellular carcinoma(DOID:684)|fatty liver disease(DOID:9452)|obesity(DOID:9970)","Arachidonic acid metabolism|Taurine and hypotaurine metabolism|Selenoamino acid metabolism|Glutathione metabolism","Wp eicosanoid synthesis|Wp selenium micronutrient network|Wp glutathione metabolism|Wp nuclear receptors metapathway|Wp nrf2 pathway|Wp gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases|Wp vitamin dsensitive calcium signaling in depression","Phase ii conjugation of compounds|Glutathione conjugation|Glutathione synthesis and recycling|Biological oxidations|Synthesis of leukotrienes lt and eoxins ex|Arachidonic acid metabolism|Aflatoxin activation and detoxification|Metabolism of lipids|Metabolic disorders of biological oxidation enzymes|Infectious disease|Diseases of metabolism|Fatty acid metabolism|Leishmania infection|Anti inflammatory response favouring leishmania parasite infection|Ltc4 cysltr mediated il4 production","","","SpliceAI>A|GGT1|0.00|0.01|0.00|0.00|2|-24|39|46",".;.;.;.;.;.;.;.;.","","","0.00002824","","","0.0001","0.","","","2.824e-05","0","T","0.234","T","0.541","B","0.002","B","0.005","N","0.002","N","1.000","N","0.325","T","3.14","N","-1.59","0.383","T","-1.022","T","0.018","T","0.004","0.125","T","0.046","14.89","1.244","3.54","2.985","10.861"
"chr22","25023471","25023471","C>A","","GGT1","exonic","nonsynonymous SNV","","GGT1:NM_001288833:exon12:c.C1093A:p.P365T,GGT1:NM_013430:exon12:c.C1093A:p.P365T,GGT1:NM_013421:exon13:c.C1093A:p.P365T","GGT1","exonic","nonsynonymous SNV","","GGT1:ENST00000403838.5_1:exon1:c.C61A:p.P21T,GGT1:ENST00000404223.5_1:exon1:c.C61A:p.P21T,GGT1:ENST00000404920.1_1:exon1:c.C61A:p.P21T,GGT1:ENST00000401885.5_1:exon2:c.C61A:p.P21T,GGT1:ENST00000404532.5_1:exon2:c.C61A:p.P21T,GGT1:ENST00000400382.6_1:exon12:c.C1093A:p.P365T,GGT1:ENST00000400380.5_1:exon13:c.C1093A:p.P365T","GGT1:ENST00000248923.4:c.1093C>A:p.(Pro365Thr)","0.846","","","","","","","","","","","","","","","","ENSG00000100031","GGT1","HGNC:4250","GGT1","2678","ENSG00000100031","uc003aan.2","0.7730886790393326","0.5163059867918491","0.9960154592990875","OMIM:231950 ?Glutathioninuria-autosomal_recessive","21","0/1","Het","289","231,58","0.799307958477509","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Glutathionuria(231950)","Strabismus(HP:0000486)|Tremor(HP:0001337)|Intellectual disability(HP:0001249)|Autosomal recessive inheritance(HP:0000007)|Abnormality of metabolism/homeostasis(HP:0001939)","The enzyme encoded by this gene is a type I gamma-glutamyltransferase that catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors. The enzyme is composed of a heavy chain and a light chain, which are derived from a single precursor protein. It is expressed in tissues involved in absorption and secretion and may contribute to the etiology of diabetes and other metabolic disorders. Multiple alternatively spliced variants have been identified. There are a number of related genes present on chromosomes 20 and 22, and putative pseudogenes for this gene on chromosomes 2, 13, and 22. [provided by RefSeq, Jan 2014]","gamma-glutamyltransferase 1","regulation of immune system process(GO:0002682)|regulation of immune system process(GO:0002682)|translation(GO:0006412)|proteolysis(GO:0006508)|cellular amino acid metabolic process(GO:0006520)|glutamate metabolic process(GO:0006536)|fatty acid metabolic process(GO:0006631)|leukotriene metabolic process(GO:0006691)|glutathione biosynthetic process(GO:0006750)|glutathione catabolic process(GO:0006751)|glutathione catabolic process(GO:0006751)|spermatogenesis(GO:0007283)|spermatogenesis(GO:0007283)|cysteine biosynthetic process(GO:0019344)|peptide modification(GO:0031179)|zymogen activation(GO:0031638)|response to estradiol(GO:0032355)|response to lipopolysaccharide(GO:0032496)|response to tumor necrosis factor(GO:0034612)|regulation of inflammatory response(GO:0050727)|regulation of inflammatory response(GO:0050727)|leukotriene D4 biosynthetic process(GO:1901750)|leukotriene D4 biosynthetic process(GO:1901750)","extracellular space(GO:0005615)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extracellular exosome(GO:0070062)","peptidyltransferase activity(GO:0000048)|peptidyltransferase activity(GO:0000048)|leukotriene-C(4) hydrolase(GO:0002951)|leukotriene-C(4) hydrolase(GO:0002951)|protein binding(GO:0005515)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|hypoglycin A gamma-glutamyl transpeptidase activity(GO:0102953)|leukotriene C4 gamma-glutamyl transferase activity(GO:0103068)","glucose intolerance(DOID:10603)|hypertension(DOID:10763)|heart disease(DOID:114)|myotonic dystrophy type 1(DOID:11722)|leukemia(DOID:1240)|colon carcinoma(DOID:1520)|cancer(DOID:162)|atherosclerosis(DOID:1936)|hepatitis(DOID:2237)|syndrome(DOID:225)|coronary artery disease(DOID:3393)|liver disease(DOID:409)|kidney disease(DOID:557)|aortic valve disease(DOID:62)|hepatocellular carcinoma(DOID:684)|fatty liver disease(DOID:9452)|obesity(DOID:9970)","Arachidonic acid metabolism|Taurine and hypotaurine metabolism|Selenoamino acid metabolism|Glutathione metabolism","Wp eicosanoid synthesis|Wp selenium micronutrient network|Wp glutathione metabolism|Wp nuclear receptors metapathway|Wp nrf2 pathway|Wp gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases|Wp vitamin dsensitive calcium signaling in depression","Phase ii conjugation of compounds|Glutathione conjugation|Glutathione synthesis and recycling|Biological oxidations|Synthesis of leukotrienes lt and eoxins ex|Arachidonic acid metabolism|Aflatoxin activation and detoxification|Metabolism of lipids|Metabolic disorders of biological oxidation enzymes|Infectious disease|Diseases of metabolism|Fatty acid metabolism|Leishmania infection|Anti inflammatory response favouring leishmania parasite infection|Ltc4 cysltr mediated il4 production","","","",".;.;.;.;.;.;.;.;.","","","","","","","","","","","","T","0.497","T","0.674","B","0.175","B","0.062","D","0.000","N","0.536","L","1.88","T","3.26","N","-1.28","0.354","T","-1.043","T","0.019","T","0.006","0.109","T","0.248","10.61","0.635","3.54","2.341","12.601"
"chr22","25023537","25023537","G>A","","GGT1","exonic","nonsynonymous SNV","","GGT1:NM_001288833:exon12:c.G1159A:p.V387I,GGT1:NM_013430:exon12:c.G1159A:p.V387I,GGT1:NM_013421:exon13:c.G1159A:p.V387I","GGT1","exonic","nonsynonymous SNV","","GGT1:ENST00000403838.5_1:exon1:c.G127A:p.V43I,GGT1:ENST00000404223.5_1:exon1:c.G127A:p.V43I,GGT1:ENST00000404920.1_1:exon1:c.G127A:p.V43I,GGT1:ENST00000401885.5_1:exon2:c.G127A:p.V43I,GGT1:ENST00000404532.5_1:exon2:c.G127A:p.V43I,GGT1:ENST00000400382.6_1:exon12:c.G1159A:p.V387I,GGT1:ENST00000400380.5_1:exon13:c.G1159A:p.V387I","GGT1:ENST00000248923.4:c.1159G>A:p.(Val387Ile)","0.785006","","","","","","","","","","","","","","","","ENSG00000100031","GGT1","HGNC:4250","GGT1","2678","ENSG00000100031","uc003aan.2","0.7730886790393326","0.5163059867918491","0.9960154592990875","OMIM:231950 ?Glutathioninuria-autosomal_recessive","24","0/1","Het","266","228,38","0.857142857142857","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Glutathionuria(231950)","Strabismus(HP:0000486)|Tremor(HP:0001337)|Intellectual disability(HP:0001249)|Autosomal recessive inheritance(HP:0000007)|Abnormality of metabolism/homeostasis(HP:0001939)","The enzyme encoded by this gene is a type I gamma-glutamyltransferase that catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors. The enzyme is composed of a heavy chain and a light chain, which are derived from a single precursor protein. It is expressed in tissues involved in absorption and secretion and may contribute to the etiology of diabetes and other metabolic disorders. Multiple alternatively spliced variants have been identified. There are a number of related genes present on chromosomes 20 and 22, and putative pseudogenes for this gene on chromosomes 2, 13, and 22. [provided by RefSeq, Jan 2014]","gamma-glutamyltransferase 1","regulation of immune system process(GO:0002682)|regulation of immune system process(GO:0002682)|translation(GO:0006412)|proteolysis(GO:0006508)|cellular amino acid metabolic process(GO:0006520)|glutamate metabolic process(GO:0006536)|fatty acid metabolic process(GO:0006631)|leukotriene metabolic process(GO:0006691)|glutathione biosynthetic process(GO:0006750)|glutathione catabolic process(GO:0006751)|glutathione catabolic process(GO:0006751)|spermatogenesis(GO:0007283)|spermatogenesis(GO:0007283)|cysteine biosynthetic process(GO:0019344)|peptide modification(GO:0031179)|zymogen activation(GO:0031638)|response to estradiol(GO:0032355)|response to lipopolysaccharide(GO:0032496)|response to tumor necrosis factor(GO:0034612)|regulation of inflammatory response(GO:0050727)|regulation of inflammatory response(GO:0050727)|leukotriene D4 biosynthetic process(GO:1901750)|leukotriene D4 biosynthetic process(GO:1901750)","extracellular space(GO:0005615)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extracellular exosome(GO:0070062)","peptidyltransferase activity(GO:0000048)|peptidyltransferase activity(GO:0000048)|leukotriene-C(4) hydrolase(GO:0002951)|leukotriene-C(4) hydrolase(GO:0002951)|protein binding(GO:0005515)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|hypoglycin A gamma-glutamyl transpeptidase activity(GO:0102953)|leukotriene C4 gamma-glutamyl transferase activity(GO:0103068)","glucose intolerance(DOID:10603)|hypertension(DOID:10763)|heart disease(DOID:114)|myotonic dystrophy type 1(DOID:11722)|leukemia(DOID:1240)|colon carcinoma(DOID:1520)|cancer(DOID:162)|atherosclerosis(DOID:1936)|hepatitis(DOID:2237)|syndrome(DOID:225)|coronary artery disease(DOID:3393)|liver disease(DOID:409)|kidney disease(DOID:557)|aortic valve disease(DOID:62)|hepatocellular carcinoma(DOID:684)|fatty liver disease(DOID:9452)|obesity(DOID:9970)","Arachidonic acid metabolism|Taurine and hypotaurine metabolism|Selenoamino acid metabolism|Glutathione metabolism","Wp eicosanoid synthesis|Wp selenium micronutrient network|Wp glutathione metabolism|Wp nuclear receptors metapathway|Wp nrf2 pathway|Wp gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases|Wp vitamin dsensitive calcium signaling in depression","Phase ii conjugation of compounds|Glutathione conjugation|Glutathione synthesis and recycling|Biological oxidations|Synthesis of leukotrienes lt and eoxins ex|Arachidonic acid metabolism|Aflatoxin activation and detoxification|Metabolism of lipids|Metabolic disorders of biological oxidation enzymes|Infectious disease|Diseases of metabolism|Fatty acid metabolism|Leishmania infection|Anti inflammatory response favouring leishmania parasite infection|Ltc4 cysltr mediated il4 production","","","SpliceAI>A|GGT1|0.00|0.00|0.00|0.00|7|-48|22|20",".;.;.;.;.;.;.;.;.","","","0.00004247","","","0.0001","0.","","","4.247e-05","0","T","0.486","T","0.47","B","0.015","B","0.006","N","0.001","D","0.678","L","1.055","T","3.19","N","-0.06","0.233","T","-1.021","T","0.016","T","0.004","0.039","T","0.010","4.640","0.123","3.36","2.583","8.905"
"chr22","25023459","25023459","G>A","","GGT1","exonic","nonsynonymous SNV","","GGT1:NM_001288833:exon12:c.G1081A:p.D361N,GGT1:NM_013430:exon12:c.G1081A:p.D361N,GGT1:NM_013421:exon13:c.G1081A:p.D361N","GGT1","exonic","nonsynonymous SNV","","GGT1:ENST00000403838.5_1:exon1:c.G49A:p.D17N,GGT1:ENST00000404223.5_1:exon1:c.G49A:p.D17N,GGT1:ENST00000404920.1_1:exon1:c.G49A:p.D17N,GGT1:ENST00000401885.5_1:exon2:c.G49A:p.D17N,GGT1:ENST00000404532.5_1:exon2:c.G49A:p.D17N,GGT1:ENST00000400382.6_1:exon12:c.G1081A:p.D361N,GGT1:ENST00000400380.5_1:exon13:c.G1081A:p.D361N","GGT1:ENST00000248923.4:c.1081G>A:p.(Asp361Asn)","0.6926669","","","","","","","","","","","","","","","","ENSG00000100031","GGT1","HGNC:4250","GGT1","2678","ENSG00000100031","uc003aan.2","0.7730886790393326","0.5163059867918491","0.9960154592990875","OMIM:231950 ?Glutathioninuria-autosomal_recessive","25","0/1","Het","277","219,58","0.790613718411552","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Glutathionuria(231950)","Strabismus(HP:0000486)|Tremor(HP:0001337)|Intellectual disability(HP:0001249)|Autosomal recessive inheritance(HP:0000007)|Abnormality of metabolism/homeostasis(HP:0001939)","The enzyme encoded by this gene is a type I gamma-glutamyltransferase that catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors. The enzyme is composed of a heavy chain and a light chain, which are derived from a single precursor protein. It is expressed in tissues involved in absorption and secretion and may contribute to the etiology of diabetes and other metabolic disorders. Multiple alternatively spliced variants have been identified. There are a number of related genes present on chromosomes 20 and 22, and putative pseudogenes for this gene on chromosomes 2, 13, and 22. [provided by RefSeq, Jan 2014]","gamma-glutamyltransferase 1","regulation of immune system process(GO:0002682)|regulation of immune system process(GO:0002682)|translation(GO:0006412)|proteolysis(GO:0006508)|cellular amino acid metabolic process(GO:0006520)|glutamate metabolic process(GO:0006536)|fatty acid metabolic process(GO:0006631)|leukotriene metabolic process(GO:0006691)|glutathione biosynthetic process(GO:0006750)|glutathione catabolic process(GO:0006751)|glutathione catabolic process(GO:0006751)|spermatogenesis(GO:0007283)|spermatogenesis(GO:0007283)|cysteine biosynthetic process(GO:0019344)|peptide modification(GO:0031179)|zymogen activation(GO:0031638)|response to estradiol(GO:0032355)|response to lipopolysaccharide(GO:0032496)|response to tumor necrosis factor(GO:0034612)|regulation of inflammatory response(GO:0050727)|regulation of inflammatory response(GO:0050727)|leukotriene D4 biosynthetic process(GO:1901750)|leukotriene D4 biosynthetic process(GO:1901750)","extracellular space(GO:0005615)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extracellular exosome(GO:0070062)","peptidyltransferase activity(GO:0000048)|peptidyltransferase activity(GO:0000048)|leukotriene-C(4) hydrolase(GO:0002951)|leukotriene-C(4) hydrolase(GO:0002951)|protein binding(GO:0005515)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|glutathione hydrolase activity(GO:0036374)|hypoglycin A gamma-glutamyl transpeptidase activity(GO:0102953)|leukotriene C4 gamma-glutamyl transferase activity(GO:0103068)","glucose intolerance(DOID:10603)|hypertension(DOID:10763)|heart disease(DOID:114)|myotonic dystrophy type 1(DOID:11722)|leukemia(DOID:1240)|colon carcinoma(DOID:1520)|cancer(DOID:162)|atherosclerosis(DOID:1936)|hepatitis(DOID:2237)|syndrome(DOID:225)|coronary artery disease(DOID:3393)|liver disease(DOID:409)|kidney disease(DOID:557)|aortic valve disease(DOID:62)|hepatocellular carcinoma(DOID:684)|fatty liver disease(DOID:9452)|obesity(DOID:9970)","Arachidonic acid metabolism|Taurine and hypotaurine metabolism|Selenoamino acid metabolism|Glutathione metabolism","Wp eicosanoid synthesis|Wp selenium micronutrient network|Wp glutathione metabolism|Wp nuclear receptors metapathway|Wp nrf2 pathway|Wp gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases|Wp vitamin dsensitive calcium signaling in depression","Phase ii conjugation of compounds|Glutathione conjugation|Glutathione synthesis and recycling|Biological oxidations|Synthesis of leukotrienes lt and eoxins ex|Arachidonic acid metabolism|Aflatoxin activation and detoxification|Metabolism of lipids|Metabolic disorders of biological oxidation enzymes|Infectious disease|Diseases of metabolism|Fatty acid metabolism|Leishmania infection|Anti inflammatory response favouring leishmania parasite infection|Ltc4 cysltr mediated il4 production","","","",".;.;.;.;.;.;.;.;.","","","0.00001214","","","0.","","","","1.214e-05","0","T","0.606","T","0.839","B","0.001","B","0.002","N","0.013","N","0.973","N","0.18","T","3.35","N","-0.24","0.203","T","-0.919","T","0.007","T","0.003","0.030","T","0.021","8.341","0.395","3.4","0.434","8.953"
"chr2","239170917","239170917","T>C","","PER2","exonic","nonsynonymous SNV","","PER2:NM_022817:exon11:c.A1222G:p.I408V","PER2","exonic","nonsynonymous SNV","","PER2:ENST00000254657.8_1:exon11:c.A1222G:p.I408V","PER2:ENST00000254657.3:c.1222A>G:p.(Ile408Val)","0.9979387","0.5077309599146247","0.9979386925697328","0.7603070953317407","","","","","","","","","","","","","ENSG00000132326","PER2","HGNC:8846","PER2","8864","ENSG00000132326","uc002vyc.4","0.7603070953317407","0.5077309599146247","0.9979386925697327","OMIM:604348 ?Advanced sleep phase syndrome, familial, 1-autosomal_dominant","27","0/1","Het","75","42,33","0.56","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Advanced sleep phase syndrome, familial, 1(604348)","Early chronotype(HP:0031873)|Sleep-wake cycle disturbance(HP:0006979)|Autosomal dominant inheritance(HP:0000006)|Depression(HP:0000716)","This gene is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Genes in this family encode components of the circadian rhythms of locomotor activity, metabolism, and behavior. This gene is upregulated by CLOCK/ARNTL heterodimers but then represses this upregulation in a feedback loop using PER/CRY heterodimers to interact with CLOCK/ARNTL. Polymorphisms in this gene may increase the risk of getting certain cancers and have been linked to sleep disorders. [provided by RefSeq, Jan 2014]","period circadian regulator 2","negative regulation of transcription by RNA polymerase II(GO:0000122)|negative regulation of transcription by RNA polymerase II(GO:0000122)|response to ischemia(GO:0002931)|glycogen biosynthetic process(GO:0005978)|gluconeogenesis(GO:0006094)|fatty acid metabolic process(GO:0006631)|circadian rhythm(GO:0007623)|regulation of vasoconstriction(GO:0019229)|lactate biosynthetic process(GO:0019249)|negative regulation of protein ubiquitination(GO:0031397)|circadian regulation of gene expression(GO:0032922)|circadian regulation of gene expression(GO:0032922)|regulation of circadian rhythm(GO:0042752)|negative regulation of circadian rhythm(GO:0042754)|entrainment of circadian clock by photoperiod(GO:0043153)|negative regulation of transcription, DNA-templated(GO:0045892)|positive regulation of transcription, DNA-templated(GO:0045893)|regulation of neurogenesis(GO:0050767)|regulation of insulin secretion(GO:0050796)|white fat cell differentiation(GO:0050872)|regulation of cell cycle(GO:0051726)|regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946)|negative regulation of fat cell proliferation(GO:0070345)|histone H3 deacetylation(GO:0070932)|circadian regulation of translation(GO:0097167)|positive regulation of cold-induced thermogenesis(GO:0120162)|negative regulation of transcription regulatory region DNA binding(GO:2000678)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleolus(GO:0005730)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|perinuclear region of cytoplasm(GO:0048471)","transcription cis-regulatory region binding(GO:0000976)|transcription cis-regulatory region binding(GO:0000976)|transcription corepressor binding(GO:0001222)|transcription coactivator activity(GO:0003713)|protein binding(GO:0005515)","chronic lymphocytic leukemia(DOID:1040)|leukemia(DOID:1240)|cancer(DOID:162)|bipolar disorder(DOID:3312)|hepatocellular carcinoma(DOID:684)|disease(DOID:4)|acute myeloid leukemia(DOID:9119)","Circadian rhythm mammal","Wp melatonin metabolism and effects|Wp exerciseinduced circadian regulation|Wp circadian rhythm related genes","Circadian clock","","","","PAS","","","","","","","","","","","","T","0.387","T","0.668","B","0.01","B","0.074","N","0.000","D","0.998","N","-0.125","T","2.72","N","-0.37","0.237","T","-0.937","T","0.012","T","0.006","0.123","T","0.331","13.28","0.979","4.66","0.171","8.795"
"chr16","2156949","2156949","C>A","","PKD1","exonic","nonsynonymous SNV","","PKD1:NM_000296:exon17:c.G7066T:p.V2356L,PKD1:NM_001009944:exon17:c.G7066T:p.V2356L","PKD1","exonic","nonsynonymous SNV","","PKD1:ENST00000262304.9_1:exon17:c.G7066T:p.V2356L,PKD1:ENST00000423118.5_1:exon17:c.G7066T:p.V2356L","PKD1:ENST00000262304.4:c.7066G>T:p.(Val2356Leu)","0.999999","0.5056022353716056","0.9999989867210388","0.7597224007335641","","","","","","","","","","","","","ENSG00000008710","PKD1","HGNC:9008","PKD1","5310","ENSG00000008710","uc002cos.1","0.7597224007335641","0.5056022353716056","0.9999989867210388","OMIM:173900 Polycystic kidney disease 1-autosomal_dominant;ORPHA:730 Autosomal dominant polycystic kidney disease-autosomal_dominant","28","0/1","Het","372","333,39","0.895161290322581","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Polycystic kidney disease 1 with or without polycystic liver disease(173900)","Mitral valve prolapse(HP:0001634)|Autosomal dominant inheritance(HP:0000006)|Hypertension(HP:0000822)|Cerebral berry aneurysm(HP:0007029)|Polycystic kidney dysplasia(HP:0000113)|Hepatic cysts(HP:0001407)|Colonic diverticula(HP:0002253)|Renal insufficiency(HP:0000083)|Mitral regurgitation(HP:0001653)|Recurrent urinary tract infections(HP:0000010)|Mitral valve prolapse(HP:0001634)|Aortic root aneurysm(HP:0002616)|Pituitary growth hormone cell adenoma(HP:0011760)|Hypertension(HP:0000822)|Nephrolithiasis(HP:0000787)|Enlarged kidney(HP:0000105)|Reduced sperm motility(HP:0012207)|Pain(HP:0012531)|Stage 5 chronic kidney disease(HP:0003774)|Arachnoid cyst(HP:0100702)|Decreased glomerular filtration rate(HP:0012213)|Pancreatic cysts(HP:0001737)|Hematuria(HP:0000790)|Polycystic liver disease(HP:0006557)|Pyelonephritis(HP:0012330)|Hepatic cysts(HP:0001407)|Elevated circulating creatinine concentration(HP:0003259)|Abnormal urinary electrolyte concentration(HP:0012591)|Albuminuria(HP:0012592)|Renal cyst(HP:0000107)|Dilatation of the cerebral artery(HP:0004944)","This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]","polycystin 1, transient receptor potential channel interacting","cartilage condensation(GO:0001502)|in utero embryonic development(GO:0001701)|kidney development(GO:0001822)|liver development(GO:0001889)|embryonic placenta development(GO:0001892)|protein export from nucleus(GO:0006611)|homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156)|cell-matrix adhesion(GO:0007160)|calcium-independent cell-matrix adhesion(GO:0007161)|positive regulation of cytosolic calcium ion concentration(GO:0007204)|receptor signaling pathway via JAK-STAT(GO:0007259)|heart development(GO:0007507)|anatomical structure morphogenesis(GO:0009653)|Wnt signaling pathway(GO:0016055)|peptidyl-serine phosphorylation(GO:0018105)|spinal cord development(GO:0021510)|neural tube development(GO:0021915)|establishment of cell polarity(GO:0030010)|regulation of cell adhesion(GO:0030155)|positive regulation of protein binding(GO:0032092)|response to fluid shear stress(GO:0034405)|lymph vessel morphogenesis(GO:0036303)|cytoplasmic sequestering of transcription factor(GO:0042994)|skin development(GO:0043588)|positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737)|positive regulation of transcription by RNA polymerase II(GO:0045944)|digestive tract development(GO:0048565)|branching morphogenesis of an epithelial tube(GO:0048754)|genitalia development(GO:0048806)|detection of mechanical stimulus(GO:0050982)|cartilage development(GO:0051216)|protein heterotetramerization(GO:0051290)|regulation of cell cycle(GO:0051726)|regulation of mitotic spindle organization(GO:0060236)|lung epithelium development(GO:0060428)|placenta blood vessel development(GO:0060674)|regulation of proteasomal protein catabolic process(GO:0061136)|calcium ion transmembrane transport(GO:0070588)|mesonephric tubule development(GO:0072164)|mesonephric duct development(GO:0072177)|metanephric collecting duct development(GO:0072205)|metanephric ascending thin limb development(GO:0072218)|metanephric proximal tubule development(GO:0072237)|metanephric distal tubule morphogenesis(GO:0072287)|cell-cell signaling by wnt(GO:0198738)|regulation of G1/S transition of mitotic cell cycle(GO:2000045)","Golgi membrane(GO:0000139)|polycystin complex(GO:0002133)|nucleus(GO:0005634)|cytoplasm(GO:0005737)|endoplasmic reticulum(GO:0005783)|Golgi apparatus(GO:0005794)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|cilium(GO:0005929)|cilium(GO:0005929)|cell surface(GO:0009986)|integral component of membrane(GO:0016021)|basolateral plasma membrane(GO:0016323)|lateral plasma membrane(GO:0016328)|Golgi-associated vesicle membrane(GO:0030660)|motile cilium(GO:0031514)|cation channel complex(GO:0034703)|calcium channel complex(GO:0034704)|ciliary membrane(GO:0060170)|extracellular exosome(GO:0070062)|extracellular exosome(GO:0070062)","calcium channel activity(GO:0005262)|calcium channel activity(GO:0005262)|protein binding(GO:0005515)|protein kinase binding(GO:0019901)|protein domain specific binding(GO:0019904)|carbohydrate binding(GO:0030246)|Wnt-activated receptor activity(GO:0042813)|transmembrane transporter binding(GO:0044325)","tuberous sclerosis(DOID:13515)|cancer(DOID:162)|kidney disease(DOID:557)|dysostosis(DOID:1934)|disease(DOID:4)|stomach cancer(DOID:10534)","","Wp gpr40 pathway|Wp simplified interaction map between loxl4 and oxidative stress pathway|Wp epithelial to mesenchymal transition in colorectal cancer|Wp ciliopathies","Organelle biogenesis and maintenance|Cilium assembly|Vxpx cargo targeting to cilium|Cargo trafficking to the periciliary membrane","","Apical junction","","PKD/REJ-like","","","","","","","","","","","","D","0.017","D","0.018","D","1.0","D","0.996","D","0.000","D","1.000","M","2.76","T","-0.59","N","-1.94","0.605","D","0.112","D","0.553","D","0.632","0.529","D","0.982","33","5.389","4.61","7.494","18.063"
"chr1","111963935","111963935","T>C","","OVGP1","exonic","nonsynonymous SNV","","OVGP1:NM_002557:exon8:c.A866G:p.K289R","OVGP1","exonic","nonsynonymous SNV","","OVGP1:ENST00000369732.4_1:exon8:c.A866G:p.K289R","OVGP1:ENST00000369732.3:c.866A>G:p.(Lys289Arg)","0.991383","0.5127593772485852","0.9913830161094666","0.758857456796118","","","","","","","","","","","","","ENSG00000085465","OVGP1","HGNC:8524","OVGP1","5016","ENSG00000085465","uc001eba.4","0.758857456796118","0.5127593772485852","0.9913830161094666","","29","0/1","Het","132","60,72","0.454545454545455","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a large, carbohydrate-rich, epithelial glycoprotein with numerous O-glycosylation sites located within threonine, serine, and proline-rich tandem repeats. The gene is similar to members of the mucin and the glycosyl hydrolase 18 gene families. Regulation of expression may be estrogen-dependent. Gene expression and protein secretion occur during late follicular development through early cleavage-stage embryonic development. The protein is secreted from non-ciliated oviductal epithelial cells and associates with ovulated oocytes, blastomeres, and spermatozoan acrosomal regions. [provided by RefSeq, Jul 2008]","oviductal glycoprotein 1","carbohydrate metabolic process(GO:0005975)|chitin catabolic process(GO:0006032)|single fertilization(GO:0007338)|female pregnancy(GO:0007565)|negative regulation of binding of sperm to zona pellucida(GO:2000360)","extracellular region(GO:0005576)|cytosol(GO:0005829)|microtubule cytoskeleton(GO:0015630)|transport vesicle(GO:0030133)|egg coat(GO:0035805)|intracellular membrane-bounded organelle(GO:0043231)|perivitelline space(GO:0098595)","chitinase activity(GO:0004568)|chitin binding(GO:0008061)","cancer(DOID:162)|laryngitis(DOID:3437)|endometrial carcinoma(DOID:2871)","","","Fertilization|Reproduction|Interaction with cumulus cells and the zona pellucida","","","","Glycoside","","","0.00003608","","","0.","0.0003","","","3.608e-05","0.0005","T","0.132","T","0.341","B","0.295","B","0.356","N","0.017","D","1","L","1.785","T","0.98","N","-1.34","0.226","T","-1.073","T","0.080","T","0.009","0.054","T","0.190","23.6","3.002","5.08","5.251","11.141"
"chr17","45214523","45214523","A>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon13:c.T1725G:p.N575K,CDC27:NM_001114091:exon14:c.T1926G:p.N642K,CDC27:NM_001256:exon14:c.T1908G:p.N636K,CDC27:NM_001293089:exon14:c.T1905G:p.N635K","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon14:c.T1908G:p.N636K,CDC27:ENST00000527547.5_1:exon14:c.T1905G:p.N635K,CDC27:ENST00000531206.5_1:exon14:c.T1926G:p.N642K","CDC27:ENST00000066544.3:c.1908T>G:p.(Asn636Lys)","1","0.5037623471580446","1.0","0.7562156852775339","0.5037623471580446","1.0","0.7562156852775339","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","30","0/1","Het","317","50,267","0.157728706624606","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","Score=858;Name=V$OCT1_07","0","","","","","","","0","0","T","0.058","T","0.058","P","0.827","P","0.521","D","0.000","D","1","M","2.865","T","0.27","D","-4.51","0.668","T","-0.482","T","0.287","D","0.048","0.356","D","0.996","24.2","3.249","5.98","3.049","10.485"
"chr17","45214614","45214614","A>-","","CDC27","exonic","frameshift deletion","","CDC27:NM_001293091:exon13:c.1634delT:p.L545Hfs*2,CDC27:NM_001114091:exon14:c.1835delT:p.L612Hfs*2,CDC27:NM_001256:exon14:c.1817delT:p.L606Hfs*2,CDC27:NM_001293089:exon14:c.1814delT:p.L605Hfs*2","CDC27","exonic","frameshift deletion","","CDC27:ENST00000066544.8_1:exon14:c.1817delT:p.L606Hfs*2,CDC27:ENST00000527547.5_1:exon14:c.1814delT:p.L605Hfs*2,CDC27:ENST00000531206.5_1:exon14:c.1835delT:p.L612Hfs*2","CDC27:ENST00000066544.3:c.1817del:p.(Leu606Hisfs*2)","1","","","","0.5037623471580446","1.0","0.7562156852775339","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","31","0/1","Het","262","81,181","0.309160305343511","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","","","Score=721;Name=V$SRF_01","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","45214617","45214617","->C","","CDC27","exonic","frameshift insertion","","CDC27:NM_001293091:exon13:c.1630_1631insG:p.T544Sfs*6,CDC27:NM_001114091:exon14:c.1831_1832insG:p.T611Sfs*6,CDC27:NM_001256:exon14:c.1813_1814insG:p.T605Sfs*6,CDC27:NM_001293089:exon14:c.1810_1811insG:p.T604Sfs*6","CDC27","exonic","frameshift insertion","","CDC27:ENST00000066544.8_1:exon14:c.1813_1814insG:p.T605Sfs*6,CDC27:ENST00000527547.5_1:exon14:c.1810_1811insG:p.T604Sfs*6,CDC27:ENST00000531206.5_1:exon14:c.1831_1832insG:p.T611Sfs*6","CDC27:ENST00000446365.2:c.1630_1631insG:p.(Thr544Serfs*6)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","32","0/1","Het","249","82,167","0.329317269076305","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","","","Score=721;Name=V$SRF_01","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","45214633","45214633","A>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon13:c.T1615G:p.Y539D,CDC27:NM_001114091:exon14:c.T1816G:p.Y606D,CDC27:NM_001256:exon14:c.T1798G:p.Y600D,CDC27:NM_001293089:exon14:c.T1795G:p.Y599D","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon14:c.T1798G:p.Y600D,CDC27:ENST00000527547.5_1:exon14:c.T1795G:p.Y599D,CDC27:ENST00000531206.5_1:exon14:c.T1816G:p.Y606D","CDC27:ENST00000066544.3:c.1798T>G:p.(Tyr600Asp)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","33","0/1","Het","222","79,143","0.355855855855856","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","","","","","","","","","","","D","0.0","D","0.001","B","0.001","B","0.004","D","0.000","D","1.000","L","1.87","T","1.27","D","-5.13","0.689","T","-0.847","T","0.185","D","0.028","0.424","D","0.976","25.4","3.616","5.81","7.515","14.108"
"chr17","45214648","45214648","G>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon13:c.C1600G:p.Q534E,CDC27:NM_001114091:exon14:c.C1801G:p.Q601E,CDC27:NM_001256:exon14:c.C1783G:p.Q595E,CDC27:NM_001293089:exon14:c.C1780G:p.Q594E","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon14:c.C1783G:p.Q595E,CDC27:ENST00000527547.5_1:exon14:c.C1780G:p.Q594E,CDC27:ENST00000531206.5_1:exon14:c.C1801G:p.Q601E","CDC27:ENST00000066544.3:c.1783C>G:p.(Gln595Glu)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","34","0/1","Het","173","70,103","0.404624277456647","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","","","","","","","","","","","D","0.0","D","0.0","D","0.96","P","0.647","D","0.000","D","1","M","2.665","T","1.33","D","-2.64","0.549","T","-0.520","T","0.248","D","0.027","0.315","D","0.978","25.0","3.502","5.81","8.161","13.879"
"chr17","45214651","45214651","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon13:c.A1597C:p.I533L,CDC27:NM_001114091:exon14:c.A1798C:p.I600L,CDC27:NM_001256:exon14:c.A1780C:p.I594L,CDC27:NM_001293089:exon14:c.A1777C:p.I593L","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon14:c.A1780C:p.I594L,CDC27:ENST00000527547.5_1:exon14:c.A1777C:p.I593L,CDC27:ENST00000531206.5_1:exon14:c.A1798C:p.I600L","CDC27:ENST00000066544.3:c.1780A>C:p.(Ile594Leu)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","35","0/1","Het","168","70,98","0.416666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","","","","","","","","","","","D","0.011","T","0.352","B","0.149","B","0.101","D","0.000","D","1","N","0.595","T","1.23","N","-1.36","0.636","T","-1.019","T","0.085","T","0.012","0.089","D","0.535","24.7","3.427","5.81","5.084","14.108"
"chr17","45214654","45214654","C>T","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon13:c.G1594A:p.A532T,CDC27:NM_001114091:exon14:c.G1795A:p.A599T,CDC27:NM_001256:exon14:c.G1777A:p.A593T,CDC27:NM_001293089:exon14:c.G1774A:p.A592T","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon14:c.G1777A:p.A593T,CDC27:ENST00000527547.5_1:exon14:c.G1774A:p.A592T,CDC27:ENST00000531206.5_1:exon14:c.G1795A:p.A599T","CDC27:ENST00000066544.3:c.1777G>A:p.(Ala593Thr)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","36","0/1","Het","155","69,86","0.445161290322581","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","SpliceAI>T|CDC27|0.00|0.00|0.00|0.00|3|-1|-8|0","Tetratricopeptide","","","0","","","0.","0.","","","0","0","D","0.0","D","0.0","D","0.982","D","0.931","D","0.000","D","1","H","4.24","T","0.5","D","-3.61","0.721","D","0.834","D","0.801","D","0.186","0.563","D","0.999","31","4.373","5.81","6.180","17.563"
"chr17","45214669","45214669","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon13:c.A1579C:p.K527Q,CDC27:NM_001114091:exon14:c.A1780C:p.K594Q,CDC27:NM_001256:exon14:c.A1762C:p.K588Q,CDC27:NM_001293089:exon14:c.A1759C:p.K587Q","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon14:c.A1762C:p.K588Q,CDC27:ENST00000527547.5_1:exon14:c.A1759C:p.K587Q,CDC27:ENST00000531206.5_1:exon14:c.A1780C:p.K594Q","CDC27:ENST00000066544.3:c.1762A>C:p.(Lys588Gln)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","37","0/1","Het","126","69,57","0.547619047619048","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","Score=853;Name=V$NKX61_01","","","","","","","","","","D","0.0","D","0.009","D","0.997","P","0.895","D","0.000","D","1","M","2.405","T","1.16","D","-3.38","0.567","T","-0.260","T","0.383","D","0.029","0.328","D","0.995","29.5","4.205","5.81","6.286","14.108"
"chr17","45214699","45214699","T>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon13:c.A1549G:p.S517G,CDC27:NM_001114091:exon14:c.A1750G:p.S584G,CDC27:NM_001256:exon14:c.A1732G:p.S578G,CDC27:NM_001293089:exon14:c.A1729G:p.S577G","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon14:c.A1732G:p.S578G,CDC27:ENST00000527547.5_1:exon14:c.A1729G:p.S577G,CDC27:ENST00000531206.5_1:exon14:c.A1750G:p.S584G","CDC27:ENST00000066544.3:c.1732A>G:p.(Ser578Gly)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","38","0/1","Het","76","61,15","0.802631578947368","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","SpliceAI>C|CDC27|0.01|0.00|0.00|0.00|27|-42|0|27","Tetratricopeptide","","","0","","","","","","","0","0","D","0.009","D","0.016","P","0.528","B","0.385","D","0.000","D","1","H","4.23","T","1.16","D","-3.41","0.595","T","-0.499","T","0.206","D","0.031","0.412","D","0.994","25.0","3.517","5.81","6.286","14.108"
"chr17","45216169","45216169","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon12:c.A1457C:p.Q486P,CDC27:NM_001114091:exon13:c.A1658C:p.Q553P,CDC27:NM_001256:exon13:c.A1640C:p.Q547P,CDC27:NM_001293089:exon13:c.A1637C:p.Q546P","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon13:c.A1640C:p.Q547P,CDC27:ENST00000527547.5_1:exon13:c.A1637C:p.Q546P,CDC27:ENST00000531206.5_1:exon13:c.A1658C:p.Q553P","CDC27:ENST00000066544.3:c.1640A>C:p.(Gln547Pro)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","39","0/1","Het","70","56,14","0.8","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","","","","","","","","","","","D","0.005","D","0.007","D","1.0","D","0.976","D","0.000","D","1","M","2.35","T","-0.47","D","-4.28","0.835","D","0.093","D","0.516","D","0.114","0.723","D","0.994","28.2","4.062","5.57","7.674","13.695"
"chr17","45216172","45216172","A>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon12:c.T1454C:p.L485P,CDC27:NM_001114091:exon13:c.T1655C:p.L552P,CDC27:NM_001256:exon13:c.T1637C:p.L546P,CDC27:NM_001293089:exon13:c.T1634C:p.L545P","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon13:c.T1637C:p.L546P,CDC27:ENST00000527547.5_1:exon13:c.T1634C:p.L545P,CDC27:ENST00000531206.5_1:exon13:c.T1655C:p.L552P","CDC27:ENST00000066544.3:c.1637T>C:p.(Leu546Pro)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","40","0/1","Het","64","50,14","0.78125","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","","","","","","","","","","","D","0.001","D","0.004","D","1.0","D","0.987","D","0.000","D","1","M","2.57","T","-0.89","D","-5.69","0.917","D","0.345","D","0.608","D","0.331","0.861","D","0.997","31","4.297","5.57","8.947","13.695"
"chr17","45221298","45221298","A>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon9:c.T938C:p.L313P,CDC27:NM_001114091:exon10:c.T1139C:p.L380P,CDC27:NM_001256:exon10:c.T1121C:p.L374P,CDC27:NM_001293089:exon10:c.T1121C:p.L374P","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon10:c.T1121C:p.L374P,CDC27:ENST00000527547.5_1:exon10:c.T1121C:p.L374P,CDC27:ENST00000531206.5_1:exon10:c.T1139C:p.L380P","CDC27:ENST00000066544.3:c.1121T>C:p.(Leu374Pro)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","41","0/1","Het","166","48,118","0.289156626506024","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","Score=774;Name=V$STAT5A_02","","","","","","","","","","T","0.139","T","0.308","B","0.001","B","0.001","D","0.000","D","1","N","-0.46","T","-0.16","N","-0.42","0.341","T","-0.982","T","0.132","T","0.022","0.209","D","0.902","22.7","2.560","5.59","5.733","13.704"
"chr17","45221350","45221350","->TTGTGTTTTTGCAAGGACTGGAGTTACCTTTCGGCTCTTTCCCCTCTGCGAGAAGACAG","","CDC27","splicing","","NM_001114091:exon10:c.1089-2->CTGTCTTCTCGCAGAGGGGAAAGAGCCGAAAGGTAACTCCAGTCCTTGCAAAAACACAA;NM_001256:exon10:c.1071-2->CTGTCTTCTCGCAGAGGGGAAAGAGCCGAAAGGTAACTCCAGTCCTTGCAAAAACACAA;NM_001293089:exon10:c.1071-2->CTGTCTTCTCGCAGAGGGGAAAGAGCCGAAAGGTAACTCCAGTCCTTGCAAAAACACAA;NM_001293091:exon9:c.888-2->CTGTCTTCTCGCAGAGGGGAAAGAGCCGAAAGGTAACTCCAGTCCTTGCAAAAACACAA","","CDC27","splicing","","ENST00000066544.8_1:exon10:c.1071-2->CTGTCTTCTCGCAGAGGGGAAAGAGCCGAAAGGTAACTCCAGTCCTTGCAAAAACACAA;ENST00000531206.5_1:exon10:c.1089-2->CTGTCTTCTCGCAGAGGGGAAAGAGCCGAAAGGTAACTCCAGTCCTTGCAAAAACACAA;ENST00000527547.5_1:exon10:c.1071-2->CTGTCTTCTCGCAGAGGGGAAAGAGCCGAAAGGTAACTCCAGTCCTTGCAAAAACACAA","","CDC27:ENST00000066544.3:c.1071-3_1071-2insCTGTCTTCTCGCAGAGGGGAAAGAGCCGAAAGGTAACTCCAGTCCTTGCAAAAACACAA:p.?","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","42","0/1","Het","112","28,84","0.25","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","45232087","45232087","->AC","","CDC27","exonic","frameshift insertion","","CDC27:NM_001293091:exon7:c.724_725insGT:p.N242Sfs*6,CDC27:NM_001114091:exon8:c.907_908insGT:p.N303Sfs*6,CDC27:NM_001256:exon8:c.907_908insGT:p.N303Sfs*6,CDC27:NM_001293089:exon8:c.907_908insGT:p.N303Sfs*6","CDC27","exonic","frameshift insertion","","CDC27:ENST00000066544.8_1:exon8:c.907_908insGT:p.N303Sfs*6,CDC27:ENST00000527547.5_1:exon8:c.907_908insGT:p.N303Sfs*6,CDC27:ENST00000531206.5_1:exon8:c.907_908insGT:p.N303Sfs*6","CDC27:ENST00000066544.3:c.907_908insGT:p.(Asn303Serfs*6)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","43","0/1","Het","55","48,7","0.872727272727273","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","45232102","45232102","A>C","","CDC27","exonic","stopgain","","CDC27:NM_001293091:exon7:c.T710G:p.L237X,CDC27:NM_001114091:exon8:c.T893G:p.L298X,CDC27:NM_001256:exon8:c.T893G:p.L298X,CDC27:NM_001293089:exon8:c.T893G:p.L298X","CDC27","exonic","stopgain","","CDC27:ENST00000066544.8_1:exon8:c.T893G:p.L298X,CDC27:ENST00000527547.5_1:exon8:c.T893G:p.L298X,CDC27:ENST00000531206.5_1:exon8:c.T893G:p.L298X","CDC27:ENST00000066544.3:c.893T>G:p.(Leu298*)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","44","0/1","Het","46","39,7","0.847826086956522","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","Score=806;Name=V$RSRFC4_01","","","","","","","","","","","","","","","","","","D","0.000","A","1","","","","","","","0.859","","","","","","","","","","36","6.891","5.92","6.753","14.323"
"chr17","45234343","45234343","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon6:c.A595C:p.N199H,CDC27:NM_001114091:exon7:c.A778C:p.N260H,CDC27:NM_001256:exon7:c.A778C:p.N260H,CDC27:NM_001293089:exon7:c.A778C:p.N260H","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon7:c.A778C:p.N260H,CDC27:ENST00000527547.5_1:exon7:c.A778C:p.N260H,CDC27:ENST00000531206.5_1:exon7:c.A778C:p.N260H","CDC27:ENST00000066544.3:c.778A>C:p.(Asn260His)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","45","0/1","Het","65","32,33","0.492307692307692","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","SpliceAI>G|CDC27|0.16|0.00|0.00|0.00|6|7|7|6",".;.;.;.","","Score=883;Name=V$FOXJ2_01","","","","","","","","","","T","0.053","T","0.125","P","0.913","B","0.339","D","0.000","D","1","M","2.015","T","-0.24","N","-0.83","0.796","T","-0.742","T","0.207","D","0.040","0.233","D","0.808","24.5","3.339","5.64","7.504","13.818"
"chr17","45234360","45234360","A>C","","CDC27","exonic","stopgain","","CDC27:NM_001293091:exon6:c.T578G:p.L193X,CDC27:NM_001114091:exon7:c.T761G:p.L254X,CDC27:NM_001256:exon7:c.T761G:p.L254X,CDC27:NM_001293089:exon7:c.T761G:p.L254X","CDC27","exonic","stopgain","","CDC27:ENST00000066544.8_1:exon7:c.T761G:p.L254X,CDC27:ENST00000527547.5_1:exon7:c.T761G:p.L254X,CDC27:ENST00000531206.5_1:exon7:c.T761G:p.L254X","CDC27:ENST00000066544.3:c.761T>G:p.(Leu254*)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","46","0/1","Het","58","25,33","0.431034482758621","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","SpliceAI>C|CDC27|0.01|0.40|0.00|0.00|48|-11|-10|-11",".;.;.","","","","","","","","","","","","","","","","","","","","N","0.018","A","1","","","","","","","0.867","","","","","","","","","","37","7.088","5.64","8.745","13.818"
"chr17","45234663","45234663","A>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.T380G:p.V127G,CDC27:NM_001114091:exon6:c.T563G:p.V188G,CDC27:NM_001256:exon6:c.T563G:p.V188G,CDC27:NM_001293089:exon6:c.T563G:p.V188G","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.T563G:p.V188G,CDC27:ENST00000527547.5_1:exon6:c.T563G:p.V188G,CDC27:ENST00000531206.5_1:exon6:c.T563G:p.V188G","CDC27:ENST00000066544.3:c.563T>G:p.(Val188Gly)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","47","0/1","Het","76","43,33","0.565789473684211","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","","","","","","","","","","T","0.3","T","0.331","B","0.0","B","0.001","N","0.005","D","1","L","1.355","T","-0.33","N","-0.59","0.618","T","-0.958","T","0.133","T","0.011","0.267","D","0.715","21.2","2.174","5.39","6.387","13.376"
"chr17","45234721","45234721","T>A","","CDC27","exonic","stopgain","","CDC27:NM_001293091:exon5:c.A322T:p.K108X,CDC27:NM_001114091:exon6:c.A505T:p.K169X,CDC27:NM_001256:exon6:c.A505T:p.K169X,CDC27:NM_001293089:exon6:c.A505T:p.K169X","CDC27","exonic","stopgain","","CDC27:ENST00000066544.8_1:exon6:c.A505T:p.K169X,CDC27:ENST00000527547.5_1:exon6:c.A505T:p.K169X,CDC27:ENST00000531206.5_1:exon6:c.A505T:p.K169X","CDC27:ENST00000066544.3:c.505A>T:p.(Lys169*)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","48","0/1","Het","44","18,26","0.409090909090909","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","Score=890;Name=V$HNF3B_01","","","","","","","","","","","","","","","","","","D","0.000","A","1","","","","","","","0.761","","","","","","","","","","36","6.560","5.39","7.128","13.376"
"chr17","45249365","45249365","C>T","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001114091:exon3:c.G169A:p.A57T,CDC27:NM_001256:exon3:c.G169A:p.A57T,CDC27:NM_001293089:exon3:c.G169A:p.A57T","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon3:c.G169A:p.A57T,CDC27:ENST00000527547.5_1:exon3:c.G169A:p.A57T,CDC27:ENST00000531206.5_1:exon3:c.G169A:p.A57T","CDC27:ENST00000066544.3:c.169G>A:p.(Ala57Thr)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","49","0/1","Het","43","25,18","0.581395348837209","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","0","","","","","","","0","0","T","0.085","T","0.168","D","0.982","P","0.758","D","0.000","D","1","M","2.52","D","-2.2","N","-2.37","0.873","D","0.378","D","0.667","D","0.109","0.839","D","0.981","26.0","3.742","5.69","7.905","17.289"
"chr17","45249391","45249391","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001114091:exon3:c.A143C:p.Y48S,CDC27:NM_001256:exon3:c.A143C:p.Y48S,CDC27:NM_001293089:exon3:c.A143C:p.Y48S","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon3:c.A143C:p.Y48S,CDC27:ENST00000527547.5_1:exon3:c.A143C:p.Y48S,CDC27:ENST00000531206.5_1:exon3:c.A143C:p.Y48S","CDC27:ENST00000066544.3:c.143A>C:p.(Tyr48Ser)","1","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","50","0/1","Het","40","24,16","0.6","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","Name=L4","","","","","","","","","","","D","0.0","D","0.017","D","0.997","D","0.942","D","0.000","D","1","M","2.29","T","-0.95","D","-7.9","0.933","D","0.137","D","0.552","D","0.138","0.799","D","0.999","32","4.484","5.69","8.017","13.883"
"chr17","45232151","45232151","A>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon7:c.T661G:p.F221V,CDC27:NM_001114091:exon8:c.T844G:p.F282V,CDC27:NM_001256:exon8:c.T844G:p.F282V,CDC27:NM_001293089:exon8:c.T844G:p.F282V","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon8:c.T844G:p.F282V,CDC27:ENST00000527547.5_1:exon8:c.T844G:p.F282V,CDC27:ENST00000531206.5_1:exon8:c.T844G:p.F282V","CDC27:ENST00000066544.3:c.844T>G:p.(Phe282Val)","0.999999","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","51","0/1","Het","30","27,3","0.9","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","","","","","","","","","","","D","0.002","D","0.008","D","1.0","D","0.977","D","0.000","D","1.000","M","2.445","T","-0.47","D","-4.1","0.811","T","-0.318","T","0.398","D","0.032","0.408","D","0.996","29.5","4.203","5.92","6.753","14.323"
"chr17","45216132","45216132","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon12:c.A1494C:p.L498F,CDC27:NM_001114091:exon13:c.A1695C:p.L565F,CDC27:NM_001256:exon13:c.A1677C:p.L559F,CDC27:NM_001293089:exon13:c.A1674C:p.L558F","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon13:c.A1677C:p.L559F,CDC27:ENST00000527547.5_1:exon13:c.A1674C:p.L558F,CDC27:ENST00000531206.5_1:exon13:c.A1695C:p.L565F","CDC27:ENST00000066544.3:c.1677A>C:p.(Leu559Phe)","0.999998","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","52","0/1","Het","91","77,14","0.846153846153846","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","","","","","","","","","","","D","0.005","D","0.026","D","1.0","D","0.984","D","0.000","D","1.000","M","1.955","T","-0.96","D","-3.28","0.844","D","0.103","D","0.531","D","0.116","0.559","D","0.977","26.4","3.822","5.72","2.237","8.487"
"chr17","45232093","45232093","T>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon7:c.A719G:p.Y240C,CDC27:NM_001114091:exon8:c.A902G:p.Y301C,CDC27:NM_001256:exon8:c.A902G:p.Y301C,CDC27:NM_001293089:exon8:c.A902G:p.Y301C","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon8:c.A902G:p.Y301C,CDC27:ENST00000527547.5_1:exon8:c.A902G:p.Y301C,CDC27:ENST00000531206.5_1:exon8:c.A902G:p.Y301C","CDC27:ENST00000066544.3:c.902A>G:p.(Tyr301Cys)","0.999998","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","53","0/1","Het","52","45,7","0.865384615384615","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","Score=804;Name=V$MEF2_03","","","","","","","","","","T","0.107","T","0.175","B","0.0","B","0.0","D","0.000","D","1.000","L","1.79","T","-0.25","N","-1.26","0.683","T","-0.923","T","0.164","T","0.007","0.346","D","0.564","22.7","2.597","5.92","3.079","14.323"
"chr17","45232109","45232109","A>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon7:c.T703C:p.S235P,CDC27:NM_001114091:exon8:c.T886C:p.S296P,CDC27:NM_001256:exon8:c.T886C:p.S296P,CDC27:NM_001293089:exon8:c.T886C:p.S296P","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon8:c.T886C:p.S296P,CDC27:ENST00000527547.5_1:exon8:c.T886C:p.S296P,CDC27:ENST00000531206.5_1:exon8:c.T886C:p.S296P","CDC27:ENST00000066544.3:c.886T>C:p.(Ser296Pro)","0.999998","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","54","0/1","Het","45","38,7","0.844444444444444","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","Score=891;Name=V$CDPCR3HD_01","","","","","","","","","","D","0.009","D","0.035","B","0.229","B","0.047","D","0.000","D","1.000","L","1.59","T","-0.39","N","-0.79","0.882","T","-0.839","T","0.153","T","0.017","0.280","D","0.788","24.3","3.301","5.92","6.753","14.323"
"chr17","45234706","45234706","G>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.C337G:p.Q113E,CDC27:NM_001114091:exon6:c.C520G:p.Q174E,CDC27:NM_001256:exon6:c.C520G:p.Q174E,CDC27:NM_001293089:exon6:c.C520G:p.Q174E","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.C520G:p.Q174E,CDC27:ENST00000527547.5_1:exon6:c.C520G:p.Q174E,CDC27:ENST00000531206.5_1:exon6:c.C520G:p.Q174E","CDC27:ENST00000066544.3:c.520C>G:p.(Gln174Glu)","0.999997","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","55","0/1","Het","55","26,29","0.472727272727273","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","","","","","","","","","","T","0.362","T","0.705","B","0.003","B","0.002","D","0.000","D","1.000","L","1.67","T","-0.19","N","0.42","0.647","T","-0.964","T","0.121","T","0.011","0.184","D","0.818","19.11","1.921","5.39","8.912","16.664"
"chr17","45234403","45234403","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon6:c.A535C:p.I179L,CDC27:NM_001114091:exon7:c.A718C:p.I240L,CDC27:NM_001256:exon7:c.A718C:p.I240L,CDC27:NM_001293089:exon7:c.A718C:p.I240L","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon7:c.A718C:p.I240L,CDC27:ENST00000527547.5_1:exon7:c.A718C:p.I240L,CDC27:ENST00000531206.5_1:exon7:c.A718C:p.I240L","CDC27:ENST00000066544.3:c.718A>C:p.(Ile240Leu)","0.999996","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","56","0/1","Het","46","13,33","0.282608695652174","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","Score=866;Name=V$TST1_01","0","","","","","","","0","0","T","0.513","T","0.938","B","0.003","B","0.002","D","0.000","D","1.000","L","1.255","T","-0.23","N","-0.24","0.613","T","-0.937","T","0.148","T","0.013","0.252","D","0.655","22.0","2.308","5.44","7.500","13.444"
"chr17","45234685","45234685","G>A","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.C358T:p.P120S,CDC27:NM_001114091:exon6:c.C541T:p.P181S,CDC27:NM_001256:exon6:c.C541T:p.P181S,CDC27:NM_001293089:exon6:c.C541T:p.P181S","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.C541T:p.P181S,CDC27:ENST00000527547.5_1:exon6:c.C541T:p.P181S,CDC27:ENST00000531206.5_1:exon6:c.C541T:p.P181S","CDC27:ENST00000066544.3:c.541C>T:p.(Pro181Ser)","0.999996","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","57","0/1","Het","66","36,30","0.545454545454545","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","","","","","","","","","","T","0.738","T","0.772","B","0.001","B","0.001","D","0.000","D","1.000","N","0.06","T","-0.23","N","0.65","0.207","T","-0.917","T","0.160","T","0.006","0.184","D","0.539","19.55","1.977","5.39","4.722","16.664"
"chr17","45214592","45214592","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon13:c.A1656C:p.L552F,CDC27:NM_001114091:exon14:c.A1857C:p.L619F,CDC27:NM_001256:exon14:c.A1839C:p.L613F,CDC27:NM_001293089:exon14:c.A1836C:p.L612F","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon14:c.A1839C:p.L613F,CDC27:ENST00000527547.5_1:exon14:c.A1836C:p.L612F,CDC27:ENST00000531206.5_1:exon14:c.A1857C:p.L619F","CDC27:ENST00000066544.3:c.1839A>C:p.(Leu613Phe)","0.999994","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","58","0/1","Het","304","78,226","0.256578947368421","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","","","","","","","","","","","D","0.009","T","0.299","B","0.036","B","0.079","D","0.000","D","1.000","M","1.955","T","0.2","N","-1.61","0.489","T","-0.983","T","0.164","T","0.021","0.216","T","0.392","21.1","2.160","5.81","-0.045","8.242"
"chr17","45234702","45234702","T>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.A341G:p.N114S,CDC27:NM_001114091:exon6:c.A524G:p.N175S,CDC27:NM_001256:exon6:c.A524G:p.N175S,CDC27:NM_001293089:exon6:c.A524G:p.N175S","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.A524G:p.N175S,CDC27:ENST00000527547.5_1:exon6:c.A524G:p.N175S,CDC27:ENST00000531206.5_1:exon6:c.A524G:p.N175S","CDC27:ENST00000066544.3:c.524A>G:p.(Asn175Ser)","0.99999","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","59","0/1","Het","57","28,29","0.491228070175439","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","","","","","","","","","","T","0.364","T","1.0","B","0.001","B","0.004","D","0.000","D","1.000","L","1.7","T","-0.33","N","-1.0","0.534","T","-0.944","T","0.146","T","0.009","0.047","D","0.778","21.5","2.213","5.39","5.381","13.376"
"chr17","45234654","45234654","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.A389C:p.H130P,CDC27:NM_001114091:exon6:c.A572C:p.H191P,CDC27:NM_001256:exon6:c.A572C:p.H191P,CDC27:NM_001293089:exon6:c.A572C:p.H191P","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.A572C:p.H191P,CDC27:ENST00000527547.5_1:exon6:c.A572C:p.H191P,CDC27:ENST00000531206.5_1:exon6:c.A572C:p.H191P","CDC27:ENST00000066544.3:c.572A>C:p.(His191Pro)","0.999982","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","60","0/1","Het","77","44,33","0.571428571428571","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","","","","","","","","","","T","0.112","T","0.391","B","0.347","B","0.043","D","0.000","D","1.000","L","1.155","T","-0.18","N","-0.47","0.706","T","-0.957","T","0.111","T","0.016","0.241","D","0.736","22.2","2.343","5.39","7.128","13.376"
"chr17","45221273","45221273","A>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon9:c.T963G:p.F321L,CDC27:NM_001114091:exon10:c.T1164G:p.F388L,CDC27:NM_001256:exon10:c.T1146G:p.F382L,CDC27:NM_001293089:exon10:c.T1146G:p.F382L","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon10:c.T1146G:p.F382L,CDC27:ENST00000527547.5_1:exon10:c.T1146G:p.F382L,CDC27:ENST00000531206.5_1:exon10:c.T1164G:p.F388L","CDC27:ENST00000066544.3:c.1146T>G:p.(Phe382Leu)","0.999962","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","61","0/1","Het","158","49,109","0.310126582278481","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","","","","","","","","","","","T","0.052","D","0.034","P","0.818","B","0.254","D","0.000","D","1.000","L","1.845","T","-0.56","D","-3.78","0.679","T","-0.659","T","0.285","D","0.078","0.410","D","0.994","22.8","2.603","5.59","0.991","9.883"
"chr17","45214600","45214600","A>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon13:c.T1648C:p.F550L,CDC27:NM_001114091:exon14:c.T1849C:p.F617L,CDC27:NM_001256:exon14:c.T1831C:p.F611L,CDC27:NM_001293089:exon14:c.T1828C:p.F610L","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon14:c.T1831C:p.F611L,CDC27:ENST00000527547.5_1:exon14:c.T1828C:p.F610L,CDC27:ENST00000531206.5_1:exon14:c.T1849C:p.F617L","CDC27:ENST00000066544.3:c.1831T>C:p.(Phe611Leu)","0.99982","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","62","0/1","Het","295","79,216","0.267796610169492","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","","","","","","","","","","","T","0.456","T","0.418","B","0.001","B","0.002","D","0.000","D","1.000","N","-0.345","T","0.44","N","-2.43","0.499","T","-1.028","T","0.074","T","0.012","0.200","D","0.531","23.2","2.830","5.81","5.137","14.108"
"chr17","45216162","45216162","A>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon12:c.T1464G:p.D488E,CDC27:NM_001114091:exon13:c.T1665G:p.D555E,CDC27:NM_001256:exon13:c.T1647G:p.D549E,CDC27:NM_001293089:exon13:c.T1644G:p.D548E","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon13:c.T1647G:p.D549E,CDC27:ENST00000527547.5_1:exon13:c.T1644G:p.D548E,CDC27:ENST00000531206.5_1:exon13:c.T1665G:p.D555E","CDC27:ENST00000066544.3:c.1647T>G:p.(Asp549Glu)","0.999577","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","63","0/1","Het","73","59,14","0.808219178082192","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","Tetratricopeptide","","","","","","","","","","","","T","1.0","T","1.0","B","0.052","B","0.021","D","0.000","D","1.000","N","-0.765","T","-0.14","N","0.42","0.757","T","-0.976","T","0.061","T","0.016","0.338","T","0.168","14.34","1.145","5.57","1.470","9.464"
"chr17","45234720","45234720","T>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.A323G:p.K108R,CDC27:NM_001114091:exon6:c.A506G:p.K169R,CDC27:NM_001256:exon6:c.A506G:p.K169R,CDC27:NM_001293089:exon6:c.A506G:p.K169R","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.A506G:p.K169R,CDC27:ENST00000527547.5_1:exon6:c.A506G:p.K169R,CDC27:ENST00000531206.5_1:exon6:c.A506G:p.K169R","CDC27:ENST00000066544.3:c.506A>G:p.(Lys169Arg)","0.998578","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","64","0/1","Het","45","19,26","0.422222222222222","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","Score=890;Name=V$HNF3B_01","","","","","","","","","","T","0.139","T","0.215","B","0.001","B","0.003","D","0.000","D","0.999","N","-0.365","T","-0.32","N","-0.46","0.303","T","-0.976","T","0.110","T","0.006","0.065","D","0.884","21.8","2.253","5.39","4.252","13.376"
"chr17","45234680","45234680","G>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.C363G:p.N121K,CDC27:NM_001114091:exon6:c.C546G:p.N182K,CDC27:NM_001256:exon6:c.C546G:p.N182K,CDC27:NM_001293089:exon6:c.C546G:p.N182K","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.C546G:p.N182K,CDC27:ENST00000527547.5_1:exon6:c.C546G:p.N182K,CDC27:ENST00000531206.5_1:exon6:c.C546G:p.N182K","CDC27:ENST00000066544.3:c.546C>G:p.(Asn182Lys)","0.997774","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","65","0/1","Het","67","37,30","0.552238805970149","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","SpliceAI>C|CDC27|0.01|0.00|0.00|0.00|23|-42|1|-15",".;.;.;.","","","","","","","","","","","","T","0.201","T","0.928","B","0.0","B","0.0","D","0.000","D","0.996","N","0","T","-0.27","N","-0.66","0.386","T","-1.048","T","0.119","T","0.010","0.203","T","0.267","16.97","1.619","5.39","3.937","10.054"
"chr17","45234298","45234298","G>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon6:c.C640G:p.L214V,CDC27:NM_001114091:exon7:c.C823G:p.L275V,CDC27:NM_001256:exon7:c.C823G:p.L275V,CDC27:NM_001293089:exon7:c.C823G:p.L275V","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon7:c.C823G:p.L275V,CDC27:ENST00000527547.5_1:exon7:c.C823G:p.L275V,CDC27:ENST00000531206.5_1:exon7:c.C823G:p.L275V","CDC27:ENST00000066544.3:c.823C>G:p.(Leu275Val)","0.9974752","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","66","0/1","Het","79","60,19","0.759493670886076","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","SpliceAI>C|CDC27|0.00|0.00|0.01|0.00|22|2|-19|30",".;.;.;.","","Score=863;Name=V$S8_01","0.00002427","","","","","","","2.427e-05","0","T","0.08","T","0.436","P","0.948","P","0.533","D","0.000","D","1","M","1.995","T","-0.27","N","-0.53","0.621","T","-0.646","T","0.324","D","0.027","0.206","D","0.560","25.1","3.525","5.64","4.947","17.208"
"chr17","45229253","45229253","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon8:c.A806C:p.K269T,CDC27:NM_001114091:exon9:c.A1007C:p.K336T,CDC27:NM_001256:exon9:c.A989C:p.K330T,CDC27:NM_001293089:exon9:c.A989C:p.K330T","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon9:c.A989C:p.K330T,CDC27:ENST00000527547.5_1:exon9:c.A989C:p.K330T,CDC27:ENST00000531206.5_1:exon9:c.A1007C:p.K336T","CDC27:ENST00000066544.3:c.989A>C:p.(Lys330Thr)","0.9973995","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","67","0/1","Het","67","61,6","0.91044776119403","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","","0.000008113","","","","","","","8.113e-06","0","D","0.037","T","0.21","P","0.826","B","0.341","D","0.000","D","1.000","M","2.045","T","-0.39","N","-1.49","0.699","T","-0.793","T","0.212","T","0.025","0.384","T","0.409","24.8","3.448","5.51","7.085","13.623"
"chr17","45229254","45229254","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon8:c.A805C:p.K269Q,CDC27:NM_001114091:exon9:c.A1006C:p.K336Q,CDC27:NM_001256:exon9:c.A988C:p.K330Q,CDC27:NM_001293089:exon9:c.A988C:p.K330Q","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon9:c.A988C:p.K330Q,CDC27:ENST00000527547.5_1:exon9:c.A988C:p.K330Q,CDC27:ENST00000531206.5_1:exon9:c.A1006C:p.K336Q","CDC27:ENST00000066544.3:c.988A>C:p.(Lys330Gln)","0.99738455","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","68","0/1","Het","68","62,6","0.911764705882353","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","","0.000004055","","","","","","","4.055e-06","0","D","0.017","T","0.296","P","0.675","B","0.158","D","0.000","D","1.000","L","1.355","T","-0.37","N","-1.19","0.727","T","-0.793","T","0.212","T","0.022","0.231","T","0.319","24.0","3.173","5.51","5.801","13.623"
"chr17","45232088","45232088","T>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon7:c.A724G:p.N242D,CDC27:NM_001114091:exon8:c.A907G:p.N303D,CDC27:NM_001256:exon8:c.A907G:p.N303D,CDC27:NM_001293089:exon8:c.A907G:p.N303D","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon8:c.A907G:p.N303D,CDC27:ENST00000527547.5_1:exon8:c.A907G:p.N303D,CDC27:ENST00000531206.5_1:exon8:c.A907G:p.N303D","CDC27:ENST00000066544.3:c.907A>G:p.(Asn303Asp)","0.996494","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","69","0/1","Het","55","48,7","0.872727272727273","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","","","","","","","","","","","T","0.462","T","0.622","B","0.0","B","0.001","N","0.001","D","0.971","L","1.1","T","-0.24","N","-0.73","0.721","T","-0.905","T","0.131","T","0.010","0.094","T","0.429","21.6","2.233","5.92","3.892","12.763"
"chr17","45219332","45219332","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon11:c.A1255C:p.N419H,CDC27:NM_001114091:exon12:c.A1456C:p.N486H,CDC27:NM_001256:exon12:c.A1438C:p.N480H,CDC27:NM_001293089:exon12:c.A1435C:p.N479H","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon12:c.A1438C:p.N480H,CDC27:ENST00000527547.5_1:exon12:c.A1435C:p.N479H,CDC27:ENST00000531206.5_1:exon12:c.A1456C:p.N486H","CDC27:ENST00000066544.3:c.1438A>C:p.(Asn480His)","0.9923097","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","70","0/1","Het","54","38,16","0.703703703703704","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","SpliceAI>G|CDC27|0.00|0.00|0.00|0.00|-10|23|24|9",".;.;.","","Score=807;Name=V$MEIS1AHOXA9_01","0.0009","","","0.0008","0.0009","","","0.0002","0.0005","D","0.024","D","0.043","D","0.985","P","0.669","D","0.000","D","1","L","1.65","T","-0.79","N","-1.15","0.779","T","-0.076","T","0.469","D","0.028","0.364","T","0.044","24.8","3.456","5.92","7.945","14.316"
"chr17","45234678","45234678","G>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.C365G:p.S122C,CDC27:NM_001114091:exon6:c.C548G:p.S183C,CDC27:NM_001256:exon6:c.C548G:p.S183C,CDC27:NM_001293089:exon6:c.C548G:p.S183C","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.C548G:p.S183C,CDC27:ENST00000527547.5_1:exon6:c.C548G:p.S183C,CDC27:ENST00000531206.5_1:exon6:c.C548G:p.S183C","CDC27:ENST00000066544.3:c.548C>G:p.(Ser183Cys)","0.959","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","71","0/1","Het","68","37,31","0.544117647058823","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","","","","","","","","","","D","0.046","T","0.06","B","0.0","B","0.0","N","0.029","D","0.832","N","-0.345","T","-0.39","N","-1.01","0.468","T","-0.805","T","0.173","T","0.013","0.163","D","0.619","22.3","2.401","5.39","5.828","16.664"
"chr17","45221286","45221286","C>T","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon9:c.G950A:p.S317N,CDC27:NM_001114091:exon10:c.G1151A:p.S384N,CDC27:NM_001256:exon10:c.G1133A:p.S378N,CDC27:NM_001293089:exon10:c.G1133A:p.S378N","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon10:c.G1133A:p.S378N,CDC27:ENST00000527547.5_1:exon10:c.G1133A:p.S378N,CDC27:ENST00000531206.5_1:exon10:c.G1151A:p.S384N","CDC27:ENST00000066544.3:c.1133G>A:p.(Ser378Asn)","0.9562714","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","72","0/1","Het","168","50,118","0.297619047619048","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","SpliceAI>T|CDC27|0.00|0.00|0.00|0.00|-19|49|50|-37",".;.;.","","","0.0009","","","0.0003","0.0004","","","0.0009","0.0007","D","0.0","D","0.012","D","0.993","P","0.706","D","0.000","D","1","M","2.49","D","-1.58","N","-2.42","0.629","D","0.475","D","0.694","D","0.102","0.518","T","0.088","28.0","4.039","5.59","7.624","17.070"
"chr17","45234658","45234658","T>G","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.A385C:p.N129H,CDC27:NM_001114091:exon6:c.A568C:p.N190H,CDC27:NM_001256:exon6:c.A568C:p.N190H,CDC27:NM_001293089:exon6:c.A568C:p.N190H","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.A568C:p.N190H,CDC27:ENST00000527547.5_1:exon6:c.A568C:p.N190H,CDC27:ENST00000531206.5_1:exon6:c.A568C:p.N190H","CDC27:ENST00000066544.3:c.568A>C:p.(Asn190His)","0.9521868","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","73","0/1","Het","77","44,33","0.571428571428571","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","0.000003978","","","0.","0.","","","3.978e-06","0","T","0.073","T","0.229","B","0.005","B","0.004","D","0.001","D","0.921","L","1.355","T","-0.36","N","-1.22","0.597","T","-0.812","T","0.148","T","0.018","0.072","D","0.576","23.1","2.774","5.39","5.151","13.376"
"chr17","45221318","45221318","A>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon9:c.T918G:p.I306M,CDC27:NM_001114091:exon10:c.T1119G:p.I373M,CDC27:NM_001256:exon10:c.T1101G:p.I367M,CDC27:NM_001293089:exon10:c.T1101G:p.I367M","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon10:c.T1101G:p.I367M,CDC27:ENST00000527547.5_1:exon10:c.T1101G:p.I367M,CDC27:ENST00000531206.5_1:exon10:c.T1119G:p.I373M","CDC27:ENST00000066544.3:c.1101T>G:p.(Ile367Met)","0.9264591","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","74","0/1","Het","158","41,117","0.259493670886076","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","SpliceAI>C|CDC27|0.00|0.00|0.00|0.00|17|-30|17|18",".;.;.","","","0.0014","","","0.0002","0.","","","0.0014","0.0007","T","0.101","T","0.207","B","0.019","B","0.004","D","0.000","D","1.000","N","0.205","T","-0.18","N","-0.37","0.24","T","-1.024","T","0.117","T","0.009","0.257","T","0.007","16.96","1.617","5.29","1.906","3.088"
"chr17","45221346","45221346","->CCC","","CDC27","exonic","nonframeshift insertion","","CDC27:NM_001293091:exon9:c.889_890insGGG:p.T297delinsRA,CDC27:NM_001114091:exon10:c.1090_1091insGGG:p.T364delinsRA,CDC27:NM_001256:exon10:c.1072_1073insGGG:p.T358delinsRA,CDC27:NM_001293089:exon10:c.1072_1073insGGG:p.T358delinsRA","CDC27","exonic","nonframeshift insertion","","CDC27:ENST00000066544.8_1:exon10:c.1072_1073insGGG:p.T358delinsRA,CDC27:ENST00000527547.5_1:exon10:c.1072_1073insGGG:p.T358delinsRA,CDC27:ENST00000531206.5_1:exon10:c.1090_1091insGGG:p.T364delinsRA","CDC27:ENST00000066544.3:c.1072_1073insGGG:p.(Thr358delinsArgAla)","0.85","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","76","0/1","Het","121","28,93","0.231404958677686","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","45221347","45221347","->TGTCGGCGGACCAGA","","CDC27","exonic","nonframeshift insertion","","CDC27:NM_001293091:exon9:c.888_889insTCTGGTCCGCCGACA:p.S296_T297insSGPPT,CDC27:NM_001114091:exon10:c.1089_1090insTCTGGTCCGCCGACA:p.S363_T364insSGPPT,CDC27:NM_001256:exon10:c.1071_1072insTCTGGTCCGCCGACA:p.S357_T358insSGPPT,CDC27:NM_001293089:exon10:c.1071_1072insTCTGGTCCGCCGACA:p.S357_T358insSGPPT","CDC27","exonic","nonframeshift insertion","","CDC27:ENST00000066544.8_1:exon10:c.1071_1072insTCTGGTCCGCCGACA:p.S357_T358insSGPPT,CDC27:ENST00000527547.5_1:exon10:c.1071_1072insTCTGGTCCGCCGACA:p.S357_T358insSGPPT,CDC27:ENST00000531206.5_1:exon10:c.1089_1090insTCTGGTCCGCCGACA:p.S363_T364insSGPPT","CDC27:ENST00000066544.3:c.1071_1072insTCTGGTCCGCCGACA:p.(Ser357_Thr358insSerGlyProProThr)","0.85","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","77","0/1","Het","119","28,91","0.235294117647059","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","45232085","45232085","->CTC","","CDC27","exonic","nonframeshift insertion","","CDC27:NM_001293091:exon7:c.726_727insGAG:p.N242_T243insE,CDC27:NM_001114091:exon8:c.909_910insGAG:p.N303_T304insE,CDC27:NM_001256:exon8:c.909_910insGAG:p.N303_T304insE,CDC27:NM_001293089:exon8:c.909_910insGAG:p.N303_T304insE","CDC27","exonic","nonframeshift insertion","","CDC27:ENST00000066544.8_1:exon8:c.909_910insGAG:p.N303_T304insE,CDC27:ENST00000527547.5_1:exon8:c.909_910insGAG:p.N303_T304insE,CDC27:ENST00000531206.5_1:exon8:c.909_910insGAG:p.N303_T304insE","CDC27:ENST00000066544.3:c.909_910insGAG:p.(Asn303_Thr304insGlu)","0.85","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","78","0/1","Het","55","48,7","0.872727272727273","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","45234673","45234673","->GGC","","CDC27","exonic","nonframeshift insertion","","CDC27:NM_001293091:exon5:c.369_370insGCC:p.C123_T124insA,CDC27:NM_001114091:exon6:c.552_553insGCC:p.C184_T185insA,CDC27:NM_001256:exon6:c.552_553insGCC:p.C184_T185insA,CDC27:NM_001293089:exon6:c.552_553insGCC:p.C184_T185insA","CDC27","exonic","nonframeshift insertion","","CDC27:ENST00000066544.8_1:exon6:c.552_553insGCC:p.C184_T185insA,CDC27:ENST00000527547.5_1:exon6:c.552_553insGCC:p.C184_T185insA,CDC27:ENST00000531206.5_1:exon6:c.552_553insGCC:p.C184_T185insA","CDC27:ENST00000066544.3:c.552_553insGCC:p.(Cys184_Thr185insAla)","0.85","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","79","0/1","Het","70","37,33","0.528571428571429","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","45234665","45234665","T>A","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.A378T:p.Q126H,CDC27:NM_001114091:exon6:c.A561T:p.Q187H,CDC27:NM_001256:exon6:c.A561T:p.Q187H,CDC27:NM_001293089:exon6:c.A561T:p.Q187H","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.A561T:p.Q187H,CDC27:ENST00000527547.5_1:exon6:c.A561T:p.Q187H,CDC27:ENST00000531206.5_1:exon6:c.A561T:p.Q187H","CDC27:ENST00000066544.3:c.561A>T:p.(Gln187His)","0.66499996","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","81","0/1","Het","76","43,33","0.565789473684211","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","","","","","","","","","","T","0.345","T","0.152","B","0.0","B","0.0","N","0.075","N","0.973","N","0","T","-0.23","N","-0.51","0.211","T","-0.991","T","0.132","T","0.012","0.146","T","0.174","20.8","2.126","5.39","1.529","9.588"
"chr17","45234666","45234666","T>A","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon5:c.A377T:p.Q126L,CDC27:NM_001114091:exon6:c.A560T:p.Q187L,CDC27:NM_001256:exon6:c.A560T:p.Q187L,CDC27:NM_001293089:exon6:c.A560T:p.Q187L","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon6:c.A560T:p.Q187L,CDC27:ENST00000527547.5_1:exon6:c.A560T:p.Q187L,CDC27:ENST00000531206.5_1:exon6:c.A560T:p.Q187L","CDC27:ENST00000066544.3:c.560A>T:p.(Gln187Leu)","0.458","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","82","0/1","Het","76","43,33","0.565789473684211","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.;.","","","","","","","","","","","","T","0.557","T","0.316","B","0.0","B","0.0","N","0.075","N","0.996","N","0.69","T","-0.17","N","-0.14","0.136","T","-1.029","T","0.124","T","0.019","0.316","T","0.150","17.12","1.644","5.39","3.745","4.832"
"chr17","45221317","45221317","T>C","","CDC27","exonic","nonsynonymous SNV","","CDC27:NM_001293091:exon9:c.A919G:p.T307A,CDC27:NM_001114091:exon10:c.A1120G:p.T374A,CDC27:NM_001256:exon10:c.A1102G:p.T368A,CDC27:NM_001293089:exon10:c.A1102G:p.T368A","CDC27","exonic","nonsynonymous SNV","","CDC27:ENST00000066544.8_1:exon10:c.A1102G:p.T368A,CDC27:ENST00000527547.5_1:exon10:c.A1102G:p.T368A,CDC27:ENST00000531206.5_1:exon10:c.A1120G:p.T374A","CDC27:ENST00000066544.3:c.1102A>G:p.(Thr368Ala)","0.144","","","","","","","","","","","","","","","","ENSG00000004897","CDC27","HGNC:1728","CDC27","996","ENSG00000004897","uc002ild.5","0.7562156852775339","0.5037623471580446","1.0","","83","0/1","Het","158","73,85","0.462025316455696","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene shares strong similarity with Saccharomyces cerevisiae protein Cdc27, and the gene product of Schizosaccharomyces pombe nuc 2. This protein is a component of the anaphase-promoting complex (APC), which is composed of eight protein subunits and is highly conserved in eukaryotic cells. This complex catalyzes the formation of cyclin B-ubiquitin conjugate, which is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. The protein encoded by this gene and three other members of the APC complex contain tetratricopeptide (TPR) repeats, which are important for protein-protein interactions. This protein was shown to interact with mitotic checkpoint proteins including Mad2, p55CDC and BUBR1, and it may thus be involved in controlling the timing of mitosis. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 22 and Y. [provided by RefSeq, May 2014]","cell division cycle 27","metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|metaphase/anaphase transition of mitotic cell cycle(GO:0007091)|protein ubiquitination(GO:0016567)|anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of mitotic metaphase/anaphase transition(GO:0045842)|cell division(GO:0051301)|protein K11-linked ubiquitination(GO:0070979)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|anaphase-promoting complex(GO:0005680)|anaphase-promoting complex(GO:0005680)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|spindle(GO:0005819)|cytosol(GO:0005829)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)|protein phosphatase binding(GO:0019903)","hereditary breast ovarian cancer syndrome(DOID:5683)","Cell cycle|Oocyte meiosis|Ubiquitin mediated proteolysis|Progesterone mediated oocyte maturation","Wp cell cycle","Adaptive immune system|Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components|Cell cycle|Apc c cdc20 mediated degradation of cyclin b|Apc c mediated degradation of cell cycle proteins|Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1|Conversion from apc c cdc20 to apc c cdh1 in late anaphase|Phosphorylation of the apc c|Apc cdc20 mediated degradation of nek2a|Separation of sister chromatids|Mitotic metaphase and anaphase|Senescence associated secretory phenotype sasp|Cellular senescence|M phase|Switching of origins to a post replicative state|S phase|Cell cycle mitotic|Dna replication|Mitotic spindle checkpoint|Cell cycle checkpoints|Rna polymerase ii transcription|Transcriptional regulation by ventx|Cellular responses to external stimuli|Diseases of mitotic cell cycle|Aberrant regulation of mitotic exit in cancer due to rb1 defects|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Mitotic spindle|G2m checkpoint|Heme metabolism","",".;.;.","","","0","","","","","","","0","0","T","1.0","T","0.81","B","0.0","B","0.0","N","0.000","N","0.984","N","-0.895","T","-0.17","N","-0.08","0.047","T","-1.029","T","0.072","T","0.007","0.205","T","0.177","10.43","0.614","5.29","3.108","7.021"
"chr9","70177470","70177470","C>T","","FOXD4L5","exonic","nonsynonymous SNV","","FOXD4L5:NM_001126334:exon1:c.G514A:p.E172K","FOXD4L5","exonic","nonsynonymous SNV","","FOXD4L5:ENST00000377420.1_1:exon1:c.G514A:p.E172K","FOXD4L5:ENST00000377420.1:c.514G>A:p.(Glu172Lys)","0.999993","0.503326102392748","0.9999930262565612","0.755366919337717","","","","","","","","","","","","","ENSG00000204779","FOXD4L5","HGNC:18522","FOXD4L5","653427","ENSG00000204779","uc010moc.3","0.755366919337717","0.503326102392748","0.9999930262565613","","84","0/1","Het","21","15,6","0.714285714285714","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","forkhead box D4 like 5","regulation of transcription by RNA polymerase II(GO:0006357)|anatomical structure morphogenesis(GO:0009653)|cell differentiation(GO:0030154)","chromatin(GO:0000785)|nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)","","","","","","","","Fork","","","","","","","","","","","","D","0.015","D","0.0","D","0.998","D","0.955","U","0.001","D","1.000","L","1.71","D","-3.7","D","-3.86","0.399","D","0.705","D","0.858","D","0.337","0.479","D","0.984","21.5","2.212","","4.446","7.667"
"chr17","79082790","79082790","A>G","","BAIAP2","exonic","nonsynonymous SNV","","BAIAP2:NM_017450:exon14:c.A1558G:p.T520A","BAIAP2","exonic","nonsynonymous SNV","","BAIAP2:ENST00000321280.11_1:exon14:c.A1558G:p.T520A","BAIAP2:ENST00000321280.7:c.1558A>G:p.(Thr520Ala)","1","0.5025068607646972","1.0","0.7538018042963273","","","","","","","","","","","","","ENSG00000175866","BAIAP2","HGNC:947","BAIAP2","10458","ENSG00000175866","uc002jzg.3","0.7538018042963273","0.5025068607646972","1.0","","85","0/1","Het","9","5,4","0.555555555555556","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene has been identified as a brain-specific angiogenesis inhibitor (BAI1)-binding protein. This adaptor protein links membrane bound G-proteins to cytoplasmic effector proteins. This protein functions as an insulin receptor tyrosine kinase substrate and suggests a role for insulin in the central nervous system. It also associates with a downstream effector of Rho small G proteins, which is associated with the formation of stress fibers and cytokinesis. This protein is involved in lamellipodia and filopodia formation in motile cells and may affect neuronal growth-cone guidance. This protein has also been identified as interacting with the dentatorubral-pallidoluysian atrophy gene, which is associated with an autosomal dominant neurodegenerative disease. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Jan 2009]","BAR/IMD domain containing adaptor protein 2","plasma membrane organization(GO:0007009)|axonogenesis(GO:0007409)|brain development(GO:0007420)|insulin receptor signaling pathway(GO:0008286)|regulation of cell shape(GO:0008360)|response to bacterium(GO:0009617)|dendrite development(GO:0016358)|positive regulation of actin filament polymerization(GO:0030838)|regulation of actin cytoskeleton organization(GO:0032956)|protein localization to synapse(GO:0035418)|regulation of synaptic plasticity(GO:0048167)|actin filament bundle assembly(GO:0051017)|actin filament bundle assembly(GO:0051017)|actin crosslink formation(GO:0051764)|actin crosslink formation(GO:0051764)|positive regulation of dendritic spine morphogenesis(GO:0061003)|cellular response to epidermal growth factor stimulus(GO:0071364)|cell-cell adhesion(GO:0098609)|modification of synaptic structure, modulating synaptic transmission(GO:0099564)|cellular response to L-glutamate(GO:1905232)|regulation of modification of postsynaptic actin cytoskeleton(GO:1905274)|positive regulation of actin cytoskeleton reorganization(GO:2000251)|positive regulation of excitatory postsynaptic potential(GO:2000463)","ruffle(GO:0001726)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|rough endoplasmic reticulum(GO:0005791)|Golgi apparatus(GO:0005794)|cytosol(GO:0005829)|cytosol(GO:0005829)|cytosol(GO:0005829)|microtubule(GO:0005874)|plasma membrane(GO:0005886)|adherens junction(GO:0005912)|actin cytoskeleton(GO:0015629)|lamellipodium(GO:0030027)|secretory granule(GO:0030141)|filopodium(GO:0030175)|neuronal cell body(GO:0043025)|dendritic shaft(GO:0043198)|neuron projection terminus(GO:0044306)|excitatory synapse(GO:0060076)|neuron projection branch point(GO:0061845)|dendritic spine cytoplasm(GO:0061846)|extracellular exosome(GO:0070062)|synaptic membrane(GO:0097060)|Schaffer collateral - CA1 synapse(GO:0098685)|glutamatergic synapse(GO:0098978)|postsynaptic density, intracellular component(GO:0099092)|presynaptic cytosol(GO:0099523)|postsynaptic cytosol(GO:0099524)","transcription coregulator binding(GO:0001221)|protein binding(GO:0005515)|protein C-terminus binding(GO:0008022)|cytoskeletal anchor activity(GO:0008093)|PDZ domain binding(GO:0030165)|identical protein binding(GO:0042802)|proline-rich region binding(GO:0070064)|scaffold protein binding(GO:0097110)|cadherin binding involved in cell-cell adhesion(GO:0098641)","autistic disorder(DOID:12849)|cancer(DOID:162)","Adherens junction|Regulation of actin cytoskeleton","Wp regulation of actin cytoskeleton","Innate immune system|Signaling by vegf|Rho gtpase effectors|Fcgamma receptor fcgr dependent phagocytosis|Infectious disease|Rho gtpases activate wasps and waves|Signaling by receptor tyrosine kinases|Rho gtpase cycle|Cdc42 gtpase cycle|Rac1 gtpase cycle|Rac3 gtpase cycle|Leishmania infection|Parasite infection|Signaling by rho gtpases miro gtpases and rhobtb3","Rho pathway","Apical junction|P53 pathway","","","","Score=696;Name=V$BRACH_01","","","","","","","","","","D","0.0","D","0.0","D","0.99","D","0.971","","","D","0.502","","","T","1.38","N","-0.59","0.411","T","-0.970","T","0.141","D","0.031","0.102","D","0.870","21.6","2.224","3.78","5.034","12.689"
"chr6","25492246","25492246","C>G","","LRRC16A","exonic","nonsynonymous SNV","","LRRC16A:NM_001173977:exon15:c.C1214G:p.S405C,LRRC16A:NM_017640:exon15:c.C1214G:p.S405C","CARMIL1","exonic","nonsynonymous SNV","","CARMIL1:ENST00000329474.7_1:exon15:c.C1214G:p.S405C","CARMIL1:ENST00000329474.6:c.1214C>G:p.(Ser405Cys)","1","0.5016052331775427","1.0","0.7520583750825975","","","","","","","","","","","","","ENSG00000079691","CARMIL1","HGNC:21581","CARMIL1","55604","ENSG00000079691","uc011djw.2","0.7520583750825975","0.5016052331775427","1.0","","86","0/1","Het","63","31,32","0.492063492063492","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","capping protein regulator and myosin 1 linker 1","actin filament organization(GO:0007015)|cell migration(GO:0016477)|lamellipodium assembly(GO:0030032)|positive regulation of cell migration(GO:0030335)|positive regulation of cell migration(GO:0030335)|positive regulation of actin filament polymerization(GO:0030838)|ruffle organization(GO:0031529)|macropinocytosis(GO:0044351)|urate metabolic process(GO:0046415)|positive regulation of stress fiber assembly(GO:0051496)|barbed-end actin filament uncapping(GO:0051638)|actin filament network formation(GO:0051639)|positive regulation of substrate adhesion-dependent cell spreading(GO:1900026)|positive regulation of lamellipodium organization(GO:1902745)|negative regulation of barbed-end actin filament capping(GO:2000813)","nucleoplasm(GO:0005654)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|nuclear speck(GO:0016607)|lamellipodium(GO:0030027)|cell leading edge(GO:0031252)|filamentous actin(GO:0031941)|macropinosome(GO:0044354)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)|protein-containing complex binding(GO:0044877)","","","","Hemostasis|Factors involved in megakaryocyte development and platelet production","","","","","","Score=872;Name=V$EVI1_02","","","","","","","","","","D","0.001","D","0.002","D","0.999","D","0.944","D","0.000","D","1","","","T","0.47","D","-4.01","0.747","D","0.053","T","0.435","D","0.068","0.391","D","0.994","27.7","3.996","5.48","6.782","19.724"
"chr2","165381543","165381543","C>A","","GRB14","exonic","nonsynonymous SNV","","GRB14:NM_001303422:exon4:c.G388T:p.G130C,GRB14:NM_004490:exon5:c.G649T:p.G217C","GRB14","exonic","nonsynonymous SNV","","GRB14:ENST00000263915.8_1:exon5:c.G649T:p.G217C","GRB14:ENST00000263915.3:c.649G>T:p.(Gly217Cys)","1","0.5013781691668555","1.0","0.7516180113302331","","","","","","","","","","","","","ENSG00000115290","GRB14","HGNC:4565","GRB14","2888","ENSG00000115290","uc002ucl.4","0.7516180113302331","0.5013781691668555","1.0","","88","0/1","Het","47","27,20","0.574468085106383","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The product of this gene belongs to a small family of adapter proteins that are known to interact with a number of receptor tyrosine kinases and signaling molecules. This gene encodes a growth factor receptor-binding protein that interacts with insulin receptors and insulin-like growth-factor receptors. This protein likely has an inhibitory effect on receptor tyrosine kinase signaling and, in particular, on insulin receptor signaling. This gene may play a role in signaling pathways that regulate growth and metabolism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]","growth factor receptor bound protein 14","signal transduction(GO:0007165)|insulin receptor signaling pathway(GO:0008286)|negative regulation of insulin receptor signaling pathway(GO:0046627)|negative regulation of insulin receptor signaling pathway(GO:0046627)","cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|endosome membrane(GO:0010008)|intracellular membrane-bounded organelle(GO:0043231)","protein binding(GO:0005515)|protein-macromolecule adaptor activity(GO:0030674)|receptor tyrosine kinase binding(GO:0030971)","","","Wp rac1pak1p38mmp2 pathway|Wp insulin signaling","Hemostasis|Cell surface interactions at the vascular wall|Tie2 signaling","","","",".;.","","","","","","","","","","","","D","0.003","T","0.1","D","0.991","P","0.827","D","0.000","D","1","M","2.22","T","1.83","D","-4.73","0.386","T","-0.852","T","0.182","T","0.016","0.197","D","0.991","29.9","4.258","6.01","5.787","20.514"
"chr6","76599857","76599857","->A","MYO6:4646","MYO6","exonic","frameshift insertion","","MYO6:NM_001300899:exon26:c.2743dupA:p.Q918Tfs*24,MYO6:NM_004999:exon26:c.2743dupA:p.Q918Tfs*24","MYO6","exonic","frameshift insertion","","MYO6:ENST00000615563.4_1:exon25:c.2743dupA:p.Q918Tfs*24,MYO6:ENST00000672093.1_1:exon25:c.2743dupA:p.Q918Tfs*24,MYO6:ENST00000369975.6_1:exon26:c.2743dupA:p.Q918Tfs*24,MYO6:ENST00000369977.8_1:exon26:c.2743dupA:p.Q918Tfs*24,MYO6:ENST00000369981.7_1:exon26:c.2743dupA:p.Q918Tfs*24,MYO6:ENST00000369985.9_1:exon26:c.2743dupA:p.Q918Tfs*24,MYO6:ENST00000664640.1_1:exon26:c.2743dupA:p.Q918Tfs*24","MYO6:ENST00000369975.1:c.2751dup:p.(Gln918Thrfs*24)","1","0.501363520976156","1.0","0.7515895849262796","0.501363520976156","0.5017351361457258","0.0302113140411536","","","","","","","","","","ENSG00000196586","MYO6","HGNC:7605","MYO6","4646","ENSG00000196586","uc003pih.2","0.7515895849262796","0.501363520976156","1.0","OMIM:606346 Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy-autosomal_dominant;OMIM:607821 Deafness, autosomal recessive 37-autosomal_recessive","89","0/1","Het","36","28,8","0.777777777777778","Uncertain_significance","False","Essential_tremor|Nonsyndromic_genetic_hearing_loss|not_specified|not_provided","MONDO:MONDO:0003233,MedGen:C0270736,OMIM:PS190300,SNOMED_CT:192839001|MONDO:MONDO:0019497,MedGen:CN043648,Orphanet:ORPHA87884|MedGen:CN169374|MedGen:CN517202","NC_000006.11:g.76599866dup","reviewed_by_expert_panel","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Deafness, autosomal dominant 22(606346)|Deafness, autosomal recessive 37(607821)","Autosomal recessive inheritance(HP:0000007)|Bilateral sensorineural hearing impairment(HP:0008619)|Rod-cone dystrophy(HP:0000510)|Congenital stationary night blindness(HP:0007642)|Vestibular dysfunction(HP:0001751)|Progressive sensorineural hearing impairment(HP:0000408)|Autosomal dominant inheritance(HP:0000006)","This gene encodes a reverse-direction motor protein that moves toward the minus end of actin filaments and plays a role in intracellular vesicle and organelle transport. The protein consists of a motor domain containing an ATP- and an actin-binding site and a globular tail which interacts with other proteins. This protein maintains the structural integrity of inner ear hair cells and mutations in this gene cause non-syndromic autosomal dominant and recessive hearing loss. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]","myosin VI","intracellular protein transport(GO:0006886)|endocytosis(GO:0006897)|endocytosis(GO:0006897)|endocytosis(GO:0006897)|actin filament organization(GO:0007015)|sensory perception of sound(GO:0007605)|response to xenobiotic stimulus(GO:0009410)|actin filament-based movement(GO:0030048)|actin filament-based movement(GO:0030048)|vesicle transport along actin filament(GO:0030050)|DNA damage response, signal transduction by p53 class mediator(GO:0030330)|inner ear morphogenesis(GO:0042472)|inner ear auditory receptor cell differentiation(GO:0042491)|positive regulation of transcription by RNA polymerase II(GO:0045944)|regulation of secretion(GO:0051046)","ruffle(GO:0001726)|ruffle(GO:0001726)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|lysosomal membrane(GO:0005765)|Golgi apparatus(GO:0005794)|cytosol(GO:0005829)|actin filament(GO:0005884)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|microvillus(GO:0005902)|clathrin-coated pit(GO:0005905)|cell cortex(GO:0005938)|actin cytoskeleton(GO:0015629)|membrane(GO:0016020)|unconventional myosin complex(GO:0016461)|RNA polymerase II, holoenzyme(GO:0016591)|endocytic vesicle(GO:0030139)|endocytic vesicle(GO:0030139)|filopodium(GO:0030175)|clathrin-coated vesicle membrane(GO:0030665)|cytoplasmic vesicle(GO:0031410)|filamentous actin(GO:0031941)|nuclear membrane(GO:0031965)|vesicle(GO:0031982)|ruffle membrane(GO:0032587)|apical part of cell(GO:0045177)|clathrin-coated endocytic vesicle(GO:0045334)|perinuclear region of cytoplasm(GO:0048471)|perinuclear region of cytoplasm(GO:0048471)|extracellular exosome(GO:0070062)","microfilament motor activity(GO:0000146)|cytoskeletal motor activity(GO:0003774)|actin binding(GO:0003779)|protein binding(GO:0005515)|calmodulin binding(GO:0005516)|calmodulin binding(GO:0005516)|ATP binding(GO:0005524)|ADP binding(GO:0043531)|actin filament binding(GO:0051015)|actin filament binding(GO:0051015)|actin filament binding(GO:0051015)|minus-end directed microfilament motor activity(GO:0060001)","cancer(DOID:162)|ovarian carcinoma(DOID:4001)|prostate cancer(DOID:10283)","","Wp vegfavegfr2 signaling pathway|Wp joubert syndrome","Neurotransmitter receptors and postsynaptic signal transmission|Transmission across chemical synapses|Neuronal system|Gap junction trafficking and regulation|Gap junction degradation|Membrane trafficking|Trafficking of ampa receptors|Vesicle mediated transport|Rho gtpase cycle|Rhobtb2 gtpase cycle|Rhou gtpase cycle|Rhobtb1 gtpase cycle|Rhobtb gtpase cycle|Signaling by rho gtpases miro gtpases and rhobtb3","","","SpliceAI>GA|MYO6|0.00|0.00|0.00|0.00|0|1|40|1","","","","0.0044","0.0036","","0.0044","0.003","0.0032","0.0038","0.0004","0.0001","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr6","76627959","76627959","T>C","MYO6:4646","MYO6","UTR3","","NM_001300899:c.*3230T>C;NM_004999:c.*3230T>C","","MYO6","UTR3","","ENST00000369981.7_1:c.*3230T>C;ENST00000369977.8_1:c.*3230T>C;ENST00000369985.9_1:c.*3230T>C;ENST00000664640.1_1:c.*3230T>C","","MYO6:ENST00000369981.3:c.*3230T>C:p.(=)","0.0034702723","","","","0.501363520976156","0.5017351361457258","0.0302113140411536","","","","","","","","","","ENSG00000196586","MYO6","HGNC:7605","MYO6","4646","ENSG00000196586","uc003pih.2","0.7515895849262796","0.501363520976156","1.0","OMIM:606346 Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy-autosomal_dominant;OMIM:607821 Deafness, autosomal recessive 37-autosomal_recessive","90","0/1","Het","26","17,9","0.653846153846154","Conflicting_interpretations_of_pathogenicity","True","Autosomal_dominant_nonsyndromic_hearing_loss_22|Autosomal_recessive_nonsyndromic_hearing_loss_37","MONDO:MONDO:0011660,MedGen:C2931767,OMIM:606346|MONDO:MONDO:0011912,MedGen:C1843028,OMIM:607821","NC_000006.11:g.76627959T>C","criteria_provided,_conflicting_interpretations","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Deafness, autosomal dominant 22(606346)|Deafness, autosomal recessive 37(607821)","Autosomal recessive inheritance(HP:0000007)|Bilateral sensorineural hearing impairment(HP:0008619)|Rod-cone dystrophy(HP:0000510)|Congenital stationary night blindness(HP:0007642)|Vestibular dysfunction(HP:0001751)|Progressive sensorineural hearing impairment(HP:0000408)|Autosomal dominant inheritance(HP:0000006)","This gene encodes a reverse-direction motor protein that moves toward the minus end of actin filaments and plays a role in intracellular vesicle and organelle transport. The protein consists of a motor domain containing an ATP- and an actin-binding site and a globular tail which interacts with other proteins. This protein maintains the structural integrity of inner ear hair cells and mutations in this gene cause non-syndromic autosomal dominant and recessive hearing loss. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]","myosin VI","intracellular protein transport(GO:0006886)|endocytosis(GO:0006897)|endocytosis(GO:0006897)|endocytosis(GO:0006897)|actin filament organization(GO:0007015)|sensory perception of sound(GO:0007605)|response to xenobiotic stimulus(GO:0009410)|actin filament-based movement(GO:0030048)|actin filament-based movement(GO:0030048)|vesicle transport along actin filament(GO:0030050)|DNA damage response, signal transduction by p53 class mediator(GO:0030330)|inner ear morphogenesis(GO:0042472)|inner ear auditory receptor cell differentiation(GO:0042491)|positive regulation of transcription by RNA polymerase II(GO:0045944)|regulation of secretion(GO:0051046)","ruffle(GO:0001726)|ruffle(GO:0001726)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|lysosomal membrane(GO:0005765)|Golgi apparatus(GO:0005794)|cytosol(GO:0005829)|actin filament(GO:0005884)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|microvillus(GO:0005902)|clathrin-coated pit(GO:0005905)|cell cortex(GO:0005938)|actin cytoskeleton(GO:0015629)|membrane(GO:0016020)|unconventional myosin complex(GO:0016461)|RNA polymerase II, holoenzyme(GO:0016591)|endocytic vesicle(GO:0030139)|endocytic vesicle(GO:0030139)|filopodium(GO:0030175)|clathrin-coated vesicle membrane(GO:0030665)|cytoplasmic vesicle(GO:0031410)|filamentous actin(GO:0031941)|nuclear membrane(GO:0031965)|vesicle(GO:0031982)|ruffle membrane(GO:0032587)|apical part of cell(GO:0045177)|clathrin-coated endocytic vesicle(GO:0045334)|perinuclear region of cytoplasm(GO:0048471)|perinuclear region of cytoplasm(GO:0048471)|extracellular exosome(GO:0070062)","microfilament motor activity(GO:0000146)|cytoskeletal motor activity(GO:0003774)|actin binding(GO:0003779)|protein binding(GO:0005515)|calmodulin binding(GO:0005516)|calmodulin binding(GO:0005516)|ATP binding(GO:0005524)|ADP binding(GO:0043531)|actin filament binding(GO:0051015)|actin filament binding(GO:0051015)|actin filament binding(GO:0051015)|minus-end directed microfilament motor activity(GO:0060001)","cancer(DOID:162)|ovarian carcinoma(DOID:4001)|prostate cancer(DOID:10283)","","Wp vegfavegfr2 signaling pathway|Wp joubert syndrome","Neurotransmitter receptors and postsynaptic signal transmission|Transmission across chemical synapses|Neuronal system|Gap junction trafficking and regulation|Gap junction degradation|Membrane trafficking|Trafficking of ampa receptors|Vesicle mediated transport|Rho gtpase cycle|Rhobtb2 gtpase cycle|Rhou gtpase cycle|Rhobtb1 gtpase cycle|Rhobtb gtpase cycle|Signaling by rho gtpases miro gtpases and rhobtb3","","","","","","","0.002","0.0004","0.002","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr13","21734127","21734127","->ACTTTTTTCCAACTGCTGGATGATGGGGCTGGGAGTGGCAAAAACATTATCATTGAGCCTGGATTCTG","","SKA3","splicing","","NM_145061:exon6:c.830-1->CAGAATCCAGGCTCAATGATAATGTTTTTGCCACTCCCAGCCCCATCATCCAGCAGTTGGAAAAAAGT;NM_001166017:exon6:c.830-1->CAGAATCCAGGCTCAATGATAATGTTTTTGCCACTCCCAGCCCCATCATCCAGCAGTTGGAAAAAAGT","","SKA3","splicing","","ENST00000400018.7_1:exon6:c.830-1->CAGAATCCAGGCTCAATGATAATGTTTTTGCCACTCCCAGCCCCATCATCCAGCAGTTGGAAAAAAGT;ENST00000314759.6_1:exon6:c.830-1->CAGAATCCAGGCTCAATGATAATGTTTTTGCCACTCCCAGCCCCATCATCCAGCAGTTGGAAAAAAGT","","SKA3:ENST00000314759.5:c.830-2_830-1insCAGAATCCAGGCTCAATGATAATGTTTTTGCCACTCCCAGCCCCATCATCCAGCAGTTGGAAAAAAGT:p.?","1","0.5010461914353073","1.0","0.7509732379927391","0.5010461914353073","0.8817868232727051","0.5045404483820474","","","","","","","","","","ENSG00000165480","SKA3","HGNC:20262","SKA3","221150","ENSG00000165480","uc001unt.3","0.7509732379927391","0.5010461914353073","1.0","","92","0/1","Het","127","105,22","0.826771653543307","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a component of the spindle and kinetochore-associated protein complex that regulates microtubule attachment to the kinetochores during mitosis. The encoded protein localizes to the outer kinetechore and may be required for normal chromosome segregation and cell division. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]","spindle and kinetochore associated complex subunit 3","mitotic cell cycle(GO:0000278)|mitotic cell cycle(GO:0000278)|chromosome segregation(GO:0007059)|chromosome segregation(GO:0007059)|regulation of microtubule polymerization or depolymerization(GO:0031110)|cell division(GO:0051301)","kinetochore(GO:0000776)|outer kinetochore(GO:0000940)|outer kinetochore(GO:0000940)|centrosome(GO:0005813)|cytosol(GO:0005829)|spindle microtubule(GO:0005876)|spindle microtubule(GO:0005876)|mitotic spindle(GO:0072686)","protein binding(GO:0005515)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","44684481","44684481","A>G","","ZNF197","exonic","nonsynonymous SNV","","ZNF197:NM_006991:exon6:c.A1859G:p.K620R","ZNF197","exonic","nonsynonymous SNV","","ZNF197:ENST00000396058.1_1:exon5:c.A1859G:p.K620R,ZNF197:ENST00000344387.9_1:exon6:c.A1859G:p.K620R","ZNF197:ENST00000344387.4:c.1859A>G:p.(Lys620Arg)","1","0.5008105388842523","1.0","0.7505148708275914","","","","","","","","","","","","","ENSG00000186448","ZNF197","HGNC:12988","ZNF197","10168","ENSG00000186448","uc003cnm.4","0.7505148708275914","0.5008105388842523","1.0","","94","0/1","Het","120","73,47","0.608333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene product belongs to the zinc finger protein superfamily, members of which are regulatory proteins characterized by nucleic acid-binding zinc finger domains. The encoded protein contains 20 tandemly arrayed C2H2-type zinc fingers, a Kruppel-associated box (KRAB) domain, and a SCAN box. This transcript turns over rapidly and contains 3' UTR AUUUA motifs, which are often a hallmark of rapid turnover. It is overexpressed in some thyroid papillary carcinomas. This gene is located in a cluster of zinc finger genes at 3p21. Naturally-occurring readthrough transcription is observed between this gene and the upstream zinc finger protein 660 gene and is represented by GeneID:110354863. [provided by RefSeq, May 2017]","zinc finger protein 197","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.038","T","0.081","B","0.271","B","0.333","U","0.003","D","0.599","N","0.68","T","1.83","N","-2.08","0.194","T","-0.894","T","0.079","T","0.008","0.078","D","0.667","23.3","2.898","4.5","1.776","12.071"
"chr19","55665480","55665480","->AG","","TNNI3","exonic","unknown","","UNKNOWN","TNNI3","exonic","frameshift insertion","","TNNI3:ENST00000588882.1_1:exon4:c.391_392insCT:p.Q131Pfs*22,TNNI3:ENST00000344887.10_1:exon7:c.466_467insCT:p.Q156Pfs*22,TNNI3:ENST00000665070.1_1:exon7:c.499_500insCT:p.Q167Pfs*22","TNNI3:ENST00000344887.5:c.466_467insCT:p.(Gln156Profs*22)","1","0.5003303794073872","1.0","0.749579172315689","","","","","","","","","","","","","ENSG00000129991","TNNI3","HGNC:11947","TNNI3","7137","ENSG00000129991","uc002qjg.5","0.749579172315689","0.5003303794073872","1.0","OMIM:115210 Cardiomyopathy, familial restrictive, 1-autosomal_dominant;OMIM:611880 ?Cardiomyopathy, dilated, 2A-autosomal_recessive;OMIM:613286 Cardiomyopathy, dilated, 1FF-unknown;OMIM:613690 Cardiomyopathy, hypertrophic, 7-autosomal_dominant;ORPHA:154 Familial isolated dilated cardiomyopathy-autosomal_recessive;ORPHA:154 Familial isolated dilated cardiomyopathy-autosomal_dominant_and_recessive;ORPHA:75249 Familial isolated restrictive cardiomyopathy-autosomal_dominant","95","0/1","Het","86","45,41","0.523255813953488","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Cardiomyopathy, familial restrictive, 1(115210)|Cardiomyopathy, dilated, 2a(611880)|Cardiomyopathy, dilated, 1ff(613286)|Cardiomyopathy, familial hypertrophic, 7(613690)","Ventricular hypertrophy(HP:0001714)|Heterogeneous(HP:0001425)|Atrial fibrillation(HP:0005110)|Autosomal dominant inheritance(HP:0000006)|Cardiomyopathy(HP:0001638)|Congestive heart failure(HP:0001635)|Dilated cardiomyopathy(HP:0001644)|Young adult onset(HP:0011462)|Juvenile onset(HP:0003621)|Autosomal recessive inheritance(HP:0000007)|Sudden cardiac death(HP:0001645)|Left atrial enlargement(HP:0031295)|Autosomal dominant inheritance(HP:0000006)|Restrictive cardiomyopathy(HP:0001723)|Left ventricular hypertrophy(HP:0001712)|Ventriculomegaly(HP:0002119)|Tricuspid regurgitation(HP:0005180)|Stroke(HP:0001297)|Hypertrophic cardiomyopathy(HP:0001639)|Recurrent respiratory infections(HP:0002205)|Syncope(HP:0001279)|Hepatomegaly(HP:0002240)|Abnormal left ventricular function(HP:0005162)|Postnatal growth retardation(HP:0008897)|Right atrial enlargement(HP:0030718)|Pulmonary venous hypertension(HP:0030950)|Orthopnea(HP:0012764)|Pulmonary edema(HP:0100598)|Thromboembolism(HP:0001907)|Left atrial enlargement(HP:0031295)|Peripheral edema(HP:0012398)|Atrial fibrillation(HP:0005110)|Mitral regurgitation(HP:0001653)|Interstitial cardiac fibrosis(HP:0031329)|Dilated cardiomyopathy(HP:0001644)|Palmoplantar keratoderma(HP:0000982)|Elevated circulating creatine kinase concentration(HP:0003236)|Lipoatrophy(HP:0100578)|Abnormality of neutrophils(HP:0001874)|Myopathy(HP:0003198)|EMG abnormality(HP:0003457)|Dilated cardiomyopathy(HP:0001644)|Sensorineural hearing impairment(HP:0000407)","Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19. [provided by RefSeq, Aug 2020]","troponin I3, cardiac type","vasculogenesis(GO:0001570)|regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980)|skeletal muscle contraction(GO:0003009)|cellular calcium ion homeostasis(GO:0006874)|muscle contraction(GO:0006936)|regulation of smooth muscle contraction(GO:0006940)|heart development(GO:0007507)|regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882)|negative regulation of ATPase activity(GO:0032780)|negative regulation of ATPase activity(GO:0032780)|ventricular cardiac muscle tissue morphogenesis(GO:0055010)|heart contraction(GO:0060047)|cardiac muscle contraction(GO:0060048)|cardiac muscle contraction(GO:0060048)","cytosol(GO:0005829)|troponin complex(GO:0005861)|troponin complex(GO:0005861)|sarcomere(GO:0030017)|cardiac myofibril(GO:0097512)|cardiac Troponin complex(GO:1990584)","actin binding(GO:0003779)|protein binding(GO:0005515)|calcium channel inhibitor activity(GO:0019855)|protein kinase binding(GO:0019901)|protein domain specific binding(GO:0019904)|troponin C binding(GO:0030172)|troponin T binding(GO:0031014)|metal ion binding(GO:0046872)|calcium-dependent protein binding(GO:0048306)|actin filament binding(GO:0051015)","thalassemia(DOID:10241)|endocarditis(DOID:10314)|hypertrophic cardiomyopathy(DOID:11984)|dilated cardiomyopathy(DOID:12930)|diabetic ketoacidosis(DOID:1837)|syndrome(DOID:225)|ischemia(DOID:326)|restrictive cardiomyopathy(DOID:397)|myocardial infarction(DOID:5844)|congestive heart failure(DOID:6000)|acute myocardial infarction(DOID:9408)|pulmonary embolism(DOID:9477)|myocardial stunning(DOID:9767)","Cardiac muscle contraction|Hypertrophic cardiomyopathy hcm|Dilated cardiomyopathy","Wp striated muscle contraction pathway|Wp cardiac progenitor differentiation","Striated muscle contraction|Muscle contraction|Cardiac conduction|Ion homeostasis","","Spermatogenesis|Kras signaling dn","","","","Score=719;Name=V$HOX13_01","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr12","104378698","104378698","->AGGATGCAAAGAAGATGGCTGTTAAGGAA","","TDG","exonic","frameshift insertion","","TDG:NM_003211:exon8:c.964_965insAGGATGCAAAGAAGATGGCTGTTAAGGAA:p.E332Rfs*42","TDG","exonic","frameshift insertion","","TDG:ENST00000544861.5_1:exon7:c.535_536insAGGATGCAAAGAAGATGGCTGTTAAGGAA:p.E189Rfs*42,TDG:ENST00000392872.8_1:exon8:c.964_965insAGGATGCAAAGAAGATGGCTGTTAAGGAA:p.E332Rfs*42,TDG:ENST00000266775.13_1:exon9:c.952_953insAGGATGCAAAGAAGATGGCTGTTAAGGAA:p.E328Rfs*42","TDG:ENST00000266775.9:c.952_952+1insAGGATGCAAAGAAGATGGCTGTTAAGGAA:p.?","1","0.500308310467517","1.0","0.7495361099074891","0.500308310467517","0.9954939186573027","0.7416872774117667","","","","","","","","","","ENSG00000139372","TDG","HGNC:11700","TDG","6996","ENSG00000139372","uc001tkg.4","0.7495361099074891","0.500308310467517","1.0","","96","0/1","Het","54","42,12","0.777777777777778","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene belongs to the TDG/mug DNA glycosylase family. Thymine-DNA glycosylase (TDG) removes thymine moieties from G/T mismatches by hydrolyzing the carbon-nitrogen bond between the sugar-phosphate backbone of DNA and the mispaired thymine. With lower activity, this enzyme also removes thymine from C/T and T/T mispairings. TDG can also remove uracil and 5-bromouracil from mispairings with guanine. This enzyme plays a central role in cellular defense against genetic mutation caused by the spontaneous deamination of 5-methylcytosine and cytosine. This gene may have a pseudogene in the p arm of chromosome 12. [provided by RefSeq, Jul 2008]","thymine DNA glycosylase","negative regulation of transcription by RNA polymerase II(GO:0000122)|base-excision repair(GO:0006284)|base-excision repair, AP site formation(GO:0006285)|base-excision repair, AP site formation(GO:0006285)|base-excision repair, AP site formation(GO:0006285)|mismatch repair(GO:0006298)|chromatin organization(GO:0006325)|oxidative DNA demethylation(GO:0035511)|regulation of gene expression, epigenetic(GO:0040029)|depyrimidination(GO:0045008)|regulation of embryonic development(GO:0045995)|DNA demethylation(GO:0080111)|regulation of DNA N-glycosylase activity(GO:1902544)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|plasma membrane(GO:0005886)","magnesium ion binding(GO:0000287)|DNA binding(GO:0003677)|damaged DNA binding(GO:0003684)|double-stranded DNA binding(GO:0003690)|uracil DNA N-glycosylase activity(GO:0004844)|uracil DNA N-glycosylase activity(GO:0004844)|protein binding(GO:0005515)|ATP binding(GO:0005524)|pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263)|pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263)|pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263)|DNA N-glycosylase activity(GO:0019104)|DNA N-glycosylase activity(GO:0019104)|protein domain specific binding(GO:0019904)|mismatched DNA binding(GO:0030983)|sodium ion binding(GO:0031402)|chloride ion binding(GO:0031404)|SUMO binding(GO:0032183)|protein homodimerization activity(GO:0042803)|protein self-association(GO:0043621)|G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739)|DNA-binding transcription factor binding(GO:0140297)","","Base excision repair","Wp cytosine methylation|Wp fluoropyrimidine activity|Wp base excision repair|Wp dna repair pathways full network","Displacement of dna glycosylase by apex1|Epigenetic regulation of gene expression|Sumoylation|Sumoylation of dna damage response and repair proteins|Post translational protein modification|Base excision repair|Dna repair|Base excision repair ap site formation|Resolution of abasic sites ap sites","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr12","104379508","104379508","->GGAGTTAAGAGGAGAATC","","TDG","splicing","","NM_003211:exon9:c.1090+2->GGAGTTAAGAGGAGAATC","","TDG","splicing","","ENST00000266775.13_1:exon10:c.1078+2->GGAGTTAAGAGGAGAATC;ENST00000544861.5_1:exon8:c.661+2->GGAGTTAAGAGGAGAATC;ENST00000392872.8_1:exon9:c.1090+2->GGAGTTAAGAGGAGAATC","","TDG:ENST00000266775.9:c.1078+2_1078+3insGGAGTTAAGAGGAGAATC:p.?","0.99098784","","","","0.500308310467517","0.9954939186573027","0.7416872774117667","","","","","","","","","","ENSG00000139372","TDG","HGNC:11700","TDG","6996","ENSG00000139372","uc001tkg.4","0.7495361099074891","0.500308310467517","1.0","","97","0/1","Het","116","108,8","0.931034482758621","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","The protein encoded by this gene belongs to the TDG/mug DNA glycosylase family. Thymine-DNA glycosylase (TDG) removes thymine moieties from G/T mismatches by hydrolyzing the carbon-nitrogen bond between the sugar-phosphate backbone of DNA and the mispaired thymine. With lower activity, this enzyme also removes thymine from C/T and T/T mispairings. TDG can also remove uracil and 5-bromouracil from mispairings with guanine. This enzyme plays a central role in cellular defense against genetic mutation caused by the spontaneous deamination of 5-methylcytosine and cytosine. This gene may have a pseudogene in the p arm of chromosome 12. [provided by RefSeq, Jul 2008]","thymine DNA glycosylase","negative regulation of transcription by RNA polymerase II(GO:0000122)|base-excision repair(GO:0006284)|base-excision repair, AP site formation(GO:0006285)|base-excision repair, AP site formation(GO:0006285)|base-excision repair, AP site formation(GO:0006285)|mismatch repair(GO:0006298)|chromatin organization(GO:0006325)|oxidative DNA demethylation(GO:0035511)|regulation of gene expression, epigenetic(GO:0040029)|depyrimidination(GO:0045008)|regulation of embryonic development(GO:0045995)|DNA demethylation(GO:0080111)|regulation of DNA N-glycosylase activity(GO:1902544)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|plasma membrane(GO:0005886)","magnesium ion binding(GO:0000287)|DNA binding(GO:0003677)|damaged DNA binding(GO:0003684)|double-stranded DNA binding(GO:0003690)|uracil DNA N-glycosylase activity(GO:0004844)|uracil DNA N-glycosylase activity(GO:0004844)|protein binding(GO:0005515)|ATP binding(GO:0005524)|pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263)|pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263)|pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263)|DNA N-glycosylase activity(GO:0019104)|DNA N-glycosylase activity(GO:0019104)|protein domain specific binding(GO:0019904)|mismatched DNA binding(GO:0030983)|sodium ion binding(GO:0031402)|chloride ion binding(GO:0031404)|SUMO binding(GO:0032183)|protein homodimerization activity(GO:0042803)|protein self-association(GO:0043621)|G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739)|DNA-binding transcription factor binding(GO:0140297)","","Base excision repair","Wp cytosine methylation|Wp fluoropyrimidine activity|Wp base excision repair|Wp dna repair pathways full network","Displacement of dna glycosylase by apex1|Epigenetic regulation of gene expression|Sumoylation|Sumoylation of dna damage response and repair proteins|Post translational protein modification|Base excision repair|Dna repair|Base excision repair ap site formation|Resolution of abasic sites ap sites","","","","","","Score=859;Name=V$NKX3A_01","0.00005582","","","0.0021","","","","0.0003","5.582e-05","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","9012898","9012898","G>-","","MUC16","exonic","frameshift deletion","","MUC16:NM_024690:exon34:c.38546delC:p.S12849Lfs*61","MUC16","exonic","frameshift deletion","","MUC16:ENST00000397910.8_1:exon34:c.38546delC:p.S12849Lfs*61","MUC16:ENST00000397910.4:c.38546del:p.(Ser12849Leufs*61)","1","0.5002122062869603","1.0","0.7493485274506263","0.5002122062869603","0.9414241909980774","0.6358025005299318","","","","","","","","","","ENSG00000181143","MUC16","HGNC:15582","MUC16","94025","ENSG00000181143","uc002mkp.3","0.7493485274506263","0.5002122062869603","1.0","","98","0/1","Het","36","31,5","0.861111111111111","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes. [provided by RefSeq, May 2017]","mucin 16, cell surface associated","cell adhesion(GO:0007155)","Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extrinsic component of membrane(GO:0019898)|vesicle(GO:0031982)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)","pre-eclampsia(DOID:10591)|nephrotic syndrome(DOID:1184)|hypertrophic cardiomyopathy(DOID:11984)|leukemia(DOID:1240)|Sjogren's syndrome(DOID:12894)|cancer(DOID:162)|aortic valve stenosis(DOID:1712)|squamous cell carcinoma(DOID:1749)|hepatitis(DOID:2237)|syndrome(DOID:225)|chronic obstructive pulmonary disease(DOID:3083)|breast carcinoma(DOID:3459)|tuberculosis(DOID:399)|ovarian carcinoma(DOID:4001)|renal cell carcinoma(DOID:4450)|large cell carcinoma(DOID:4552)|liver cirrhosis(DOID:5082)|congestive heart failure(DOID:6000)","","","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","gnomad>TRUE;SpliceAI>A|MUC16|0.99|0.98|0.00|0.00|0|1|0|1","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","9000169","9000169","C>T","","MUC16","exonic","nonsynonymous SNV","","MUC16:NM_024690:exon55:c.G40588A:p.G13530S","MUC16","exonic","nonsynonymous SNV","","MUC16:ENST00000397910.8_1:exon55:c.G40588A:p.G13530S","MUC16:ENST00000380951.5:c.511G>A:p.(Gly171Ser)","0.8828484","","","","0.5002122062869603","0.9414241909980774","0.6358025005299318","","","","","","","","","","ENSG00000181143","MUC16","HGNC:15582","MUC16","94025","ENSG00000181143","uc002mkp.3","0.7493485274506263","0.5002122062869603","1.0","","99","0/1","Het","74","61,13","0.824324324324324","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes. [provided by RefSeq, May 2017]","mucin 16, cell surface associated","cell adhesion(GO:0007155)","Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extrinsic component of membrane(GO:0019898)|vesicle(GO:0031982)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)","pre-eclampsia(DOID:10591)|nephrotic syndrome(DOID:1184)|hypertrophic cardiomyopathy(DOID:11984)|leukemia(DOID:1240)|Sjogren's syndrome(DOID:12894)|cancer(DOID:162)|aortic valve stenosis(DOID:1712)|squamous cell carcinoma(DOID:1749)|hepatitis(DOID:2237)|syndrome(DOID:225)|chronic obstructive pulmonary disease(DOID:3083)|breast carcinoma(DOID:3459)|tuberculosis(DOID:399)|ovarian carcinoma(DOID:4001)|renal cell carcinoma(DOID:4450)|large cell carcinoma(DOID:4552)|liver cirrhosis(DOID:5082)|congestive heart failure(DOID:6000)","","","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","SpliceAI>T|MUC16|0.01|0.06|0.00|0.11|-2|40|45|-22","SEA","","","","","","","","","","","","T","0.053","D","0.037","","","","","","","N","1","","","T","1.09","N","-1.81","0.218","T","-0.602","T","0.239","T","0.023","0.201","D","0.505","22.7","2.574","2.9","0.131","5.125"
"chr19","9015374","9015374","C>T","","MUC16","exonic","nonsynonymous SNV","","MUC16:NM_024690:exon30:c.G38214A:p.M12738I","MUC16","exonic","nonsynonymous SNV","","MUC16:ENST00000397910.8_1:exon30:c.G38214A:p.M12738I","MUC16:ENST00000397910.4:c.38214G>A:p.(Met12738Ile)","0.6986007","","","","","","","","","","","","","","","","ENSG00000181143","MUC16","HGNC:15582","MUC16","94025","ENSG00000181143","uc002mkp.3","0.7493485274506263","0.5002122062869603","1.0","","100","0/1","Het","100","90,10","0.9","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes. [provided by RefSeq, May 2017]","mucin 16, cell surface associated","cell adhesion(GO:0007155)","Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extrinsic component of membrane(GO:0019898)|vesicle(GO:0031982)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)","pre-eclampsia(DOID:10591)|nephrotic syndrome(DOID:1184)|hypertrophic cardiomyopathy(DOID:11984)|leukemia(DOID:1240)|Sjogren's syndrome(DOID:12894)|cancer(DOID:162)|aortic valve stenosis(DOID:1712)|squamous cell carcinoma(DOID:1749)|hepatitis(DOID:2237)|syndrome(DOID:225)|chronic obstructive pulmonary disease(DOID:3083)|breast carcinoma(DOID:3459)|tuberculosis(DOID:399)|ovarian carcinoma(DOID:4001)|renal cell carcinoma(DOID:4450)|large cell carcinoma(DOID:4552)|liver cirrhosis(DOID:5082)|congestive heart failure(DOID:6000)","","","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","","SEA","","","0","","","0.","0.","","","0","0","T","0.151","D","0.024","","","","","","","N","1","","","T","1.62","N","-0.23","0.22","T","-1.043","T","0.037","T","0.002","0.030","T","0.043","7.627","0.333","2.82","-0.017","4.812"
"chr19","9000187","9000187","C>T","","MUC16","exonic","nonsynonymous SNV","","MUC16:NM_024690:exon55:c.G40570A:p.V13524I","MUC16","exonic","nonsynonymous SNV","","MUC16:ENST00000397910.8_1:exon55:c.G40570A:p.V13524I","MUC16:ENST00000380951.5:c.493G>A:p.(Val165Ile)","0.2858783","","","","","","","","","","","","","","","","ENSG00000181143","MUC16","HGNC:15582","MUC16","94025","ENSG00000181143","uc002mkp.3","0.7493485274506263","0.5002122062869603","1.0","","101","0/1","Het","81","63,18","0.777777777777778","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes. [provided by RefSeq, May 2017]","mucin 16, cell surface associated","cell adhesion(GO:0007155)","Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|extrinsic component of membrane(GO:0019898)|vesicle(GO:0031982)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)","pre-eclampsia(DOID:10591)|nephrotic syndrome(DOID:1184)|hypertrophic cardiomyopathy(DOID:11984)|leukemia(DOID:1240)|Sjogren's syndrome(DOID:12894)|cancer(DOID:162)|aortic valve stenosis(DOID:1712)|squamous cell carcinoma(DOID:1749)|hepatitis(DOID:2237)|syndrome(DOID:225)|chronic obstructive pulmonary disease(DOID:3083)|breast carcinoma(DOID:3459)|tuberculosis(DOID:399)|ovarian carcinoma(DOID:4001)|renal cell carcinoma(DOID:4450)|large cell carcinoma(DOID:4552)|liver cirrhosis(DOID:5082)|congestive heart failure(DOID:6000)","","","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","SpliceAI>T|MUC16|0.01|0.00|0.01|0.00|22|9|-40|1","SEA","","","","","","","","","","","","T","0.691","T","0.225","","","","","","","N","1","","","T","2.0","N","-0.2","0.12","T","-0.978","T","0.056","T","0.004","0.058","T","0.105","12.33","0.849","2.9","-2.811","0.777"
"chr1","16560112","16560112","G>C","","RSG1","exonic","nonsynonymous SNV","","RSG1:NM_030907:exon2:c.C260G:p.T87S","CPLANE2","exonic","nonsynonymous SNV","","CPLANE2:ENST00000375599.8_1:exon2:c.C260G:p.T87S","CPLANE2:ENST00000375599.3:c.260C>G:p.(Thr87Ser)","1","0.5001946895499714","1.0","0.7493143270600574","","","","","","","","","","","","","ENSG00000132881","CPLANE2","HGNC:28127","CPLANE2","79363","ENSG00000132881","uc001ayd.4","0.7493143270600574","0.5001946895499714","1.0","","102","0/1","Het","94","45,49","0.478723404255319","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ciliogenesis and planar polarity effector 2","exocytosis(GO:0006887)|protein transport(GO:0015031)|regulation of exocytosis(GO:0017157)|regulation of vesicle fusion(GO:0031338)|cellular protein localization(GO:0034613)|cilium assembly(GO:0060271)","cytoplasm(GO:0005737)|ciliary basal body(GO:0036064)","GTPase activity(GO:0003924)|protein binding(GO:0005515)|GTP binding(GO:0005525)","","","Wp genes related to primary cilium development based on crispr","","","","","","","","","","","","","","","","","D","0.0","D","0.0","P","0.535","B","0.367","D","0.000","D","1","","","T","-1.48","D","-2.85","0.918","D","0.066","D","0.520","D","0.044","0.694","D","0.985","23.4","2.948","5.4","8.930","16.708"
"chr6","10704998","10704998","G>T","","PAK1IP1","exonic","nonsynonymous SNV","","PAK1IP1:NM_017906:exon7:c.G661T:p.A221S","PAK1IP1","exonic","nonsynonymous SNV","","PAK1IP1:ENST00000379568.4_1:exon7:c.G661T:p.A221S","PAK1IP1:ENST00000379568.3:c.661G>T:p.(Ala221Ser)","0.999998","0.500159586124937","0.9999979734420776","0.7492422836724737","","","","","","","","","","","","","ENSG00000111845","PAK1IP1","HGNC:20882","PAK1IP1","55003","ENSG00000111845","uc003mzg.4","0.7492422836724737","0.500159586124937","0.9999979734420776","","103","0/1","Het","148","80,68","0.540540540540541","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","PAK1 interacting protein 1","cell population proliferation(GO:0008283)|negative regulation of signal transduction(GO:0009968)|ribosomal large subunit biogenesis(GO:0042273)|roof of mouth development(GO:0060021)|regulation of signal transduction by p53 class mediator(GO:1901796)","nucleolus(GO:0005730)","protein binding(GO:0005515)","","","","","","","","WD40-repeat-containing","","","","","","","","","","","","D","0.02","T","0.05","P","0.876","P","0.464","D","0.000","D","1.000","M","3.005","T","1.21","N","-1.8","0.658","T","-0.955","T","0.105","T","0.014","0.199","D","0.955","27.6","3.993","5.48","7.258","16.842"
"chr16","70896016","70896016","A>-","","HYDIN","exonic","frameshift deletion","","HYDIN:NM_001270974:exon69:c.11712delT:p.Q3905Rfs*5","HYDIN","exonic","frameshift deletion","","HYDIN:ENST00000393567.7_1:exon69:c.11712delT:p.Q3905Rfs*5","HYDIN:ENST00000393567.2:c.11712del:p.(Ile3904Ilefs*6)","1","0.2500741871335776","1.0","0.1816926671190891","0.5001483742671553","1.0","0.7492238842570191","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","104","0/1","Het","207","96,111","0.463768115942029","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr16","71098649","71098649","T>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001198542:exon16:c.A2251G:p.N751D,HYDIN:NM_001198543:exon16:c.A2221G:p.N741D,HYDIN:NM_001270974:exon16:c.A2170G:p.N724D,HYDIN:NM_017558:exon16:c.A2170G:p.N724D","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000321489.9_1:exon16:c.A2170G:p.N724D,HYDIN:ENST00000393567.7_1:exon16:c.A2170G:p.N724D,HYDIN:ENST00000538248.5_1:exon16:c.A2251G:p.N751D,HYDIN:ENST00000541601.5_1:exon16:c.A2221G:p.N741D","HYDIN:ENST00000321489.5:c.2170A>G:p.(Asn724Asp)","1","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","106","0/1","Het","245","144,101","0.587755102040816","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","",".;.;.;.","","","","","","","","","","","","D","0.0","D","0.0","D","1.0","D","1.0","U","0.004","D","0.971","M","3.265","T","3.0","D","-4.43","0.948","T","-0.954","T","0.101","D","0.099","0.271","D","0.998","25.2","3.551","4.8","5.818","13.389"
"chr16","71122408","71122408","C>T","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001198542:exon12:c.G1547A:p.G516D,HYDIN:NM_001198543:exon12:c.G1517A:p.G506D,HYDIN:NM_001270974:exon12:c.G1466A:p.G489D,HYDIN:NM_017558:exon12:c.G1466A:p.G489D","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000288168.14_1:exon12:c.G1517A:p.G506D,HYDIN:ENST00000321489.9_1:exon12:c.G1466A:p.G489D,HYDIN:ENST00000393567.7_1:exon12:c.G1466A:p.G489D,HYDIN:ENST00000538248.5_1:exon12:c.G1547A:p.G516D,HYDIN:ENST00000541601.5_1:exon12:c.G1517A:p.G506D","HYDIN:ENST00000288168.10:c.1517G>A:p.(Gly506Asp)","0.999923","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","107","0/1","Het","35","23,12","0.657142857142857","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","",".;.;.;.;.","","","","","","","","","","","","D","0.006","D","0.009","D","1.0","D","0.994","U","0.005","D","1.000","M","2.73","T","4.47","D","-5.62","0.51","T","-0.726","T","0.183","D","0.044","0.334","D","0.988","24.0","3.187","5.22","5.476","18.433"
"chr16","70926334","70926334","G>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon56:c.C9347G:p.T3116R","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon56:c.C9347G:p.T3116R","HYDIN:ENST00000393567.2:c.9347C>G:p.(Thr3116Arg)","0.996","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","108","0/1","Het","176","138,38","0.784090909090909","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","D","0.004","","","","","","","U","0.340","D","0.597","M","2.745","T","5.45","D","-3.34","0.415","T","-0.621","T","0.006","D","0.065","0.160","D","0.908","23.4","2.934","4.86","2.023","10.767"
"chr16","70896033","70896033","C>T","HYDIN:54768","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon69:c.G11695A:p.V3899M","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon69:c.G11695A:p.V3899M","HYDIN:ENST00000393567.2:c.11695G>A:p.(Val3899Met)","0.99411947","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","109","0/1","Het","213","162,51","0.76056338028169","Uncertain_significance","False","Primary_ciliary_dyskinesia_5","MONDO:MONDO:0012088,MedGen:C1837615,OMIM:608647","NC_000016.9:g.70896033C>T","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","0.000008048","","","","","","","8.048e-06","0","D","0.005","","","","","","","U","0.197","P","0.955","M","2.44","T","5.28","N","-2.17","0.296","T","-1.053","T","0.012","T","0.024","0.140","D","0.759","22.1","2.314","5.97","2.053","4.922"
"chr16","70917855","70917855","A>G","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon59:c.T9947C:p.L3316P","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon59:c.T9947C:p.L3316P","HYDIN:ENST00000393567.2:c.9947T>C:p.(Leu3316Pro)","0.994072","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","110","0/1","Het","223","118,105","0.52914798206278","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","1.0","","","","","","","N","0.005","D","0.994","N","-2.72","T","5.73","N","6.25","0.146","T","-0.976","T","0.001","T","0.014","0.107","T","0.054","15.18","1.298","5.01","2.841","7.613"
"chr16","70972620","70972620","G>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon44:c.C6892G:p.R2298G","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon44:c.C6892G:p.R2298G","HYDIN:ENST00000393567.2:c.6892C>G:p.(Arg2298Gly)","0.983","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","111","0/1","Het","166","83,83","0.5","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","D","0.017","","","","","","","U","0.005","D","0.954","M","2.585","T","5.45","D","-3.33","0.788","T","-0.729","T","0.010","D","0.045","0.236","D","0.987","29.5","4.199","5.6","4.819","19.268"
"chr16","70989335","70989335","G>A","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon40:c.C6259T:p.R2087C","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon40:c.C6259T:p.R2087C","HYDIN:ENST00000393567.2:c.6259C>T:p.(Arg2087Cys)","0.98204064","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","112","0/1","Het","230","126,104","0.547826086956522","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","Hydin","","","0.00001605","0.0004","0.002","","","","","1.605e-05","0.0002","D","0.001","","","","","","","U","0.006","D","1.000","M","2.72","T","0.97","D","-5.7","0.766","T","-0.588","T","0.247","D","0.078","0.251","D","0.945","26.4","3.822","4.66","2.868","12.591"
"chr16","70884524","70884524","C>G","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon74:c.G12478C:p.E4160Q","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon74:c.G12478C:p.E4160Q","HYDIN:ENST00000393567.2:c.12478G>C:p.(Glu4160Gln)","0.971","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","113","0/1","Het","79","42,37","0.531645569620253","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","D","0.029","","","","","","","U","0.005","N","0.929","M","2.12","T","5.14","N","-2.49","0.357","T","-0.814","T","0.016","T","0.014","0.132","D","0.979","23.7","3.039","5.56","3.520","16.088"
"chr16","70902559","70902559","C>T","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon66:c.G11224A:p.V3742I","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon66:c.G11224A:p.V3742I","HYDIN:ENST00000393567.2:c.11224G>A:p.(Val3742Ile)","0.944","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","114","0/1","Het","222","129,93","0.581081081081081","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","Score=795;Name=V$OLF1_01","","","","","","","","","","T","0.056","","","","","","","U","0.010","N","0.896","L","1.725","T","5.48","N","-0.61","0.214","T","-0.632","T","0.004","T","0.018","0.084","D","0.827","18.15","1.794","5.03","1.453","9.221"
"chr16","70954704","70954718","GCGCTCCTTCTCCGT>-","","HYDIN","exonic","nonframeshift deletion","","HYDIN:NM_001270974:exon46:c.7561_7575del:p.T2521_R2525del","HYDIN","exonic","nonframeshift deletion","","HYDIN:ENST00000393567.7_1:exon46:c.7561_7575del:p.T2521_R2525del","HYDIN:ENST00000393567.2:c.7561_7575del:p.(Thr2521_Arg2525del)","0.85","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","115","0/1","Het","314","166,148","0.528662420382166","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","Name=C-rich","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr16","70894087","70894087","T>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon71:c.A12013G:p.T4005A","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon71:c.A12013G:p.T4005A","HYDIN:ENST00000393567.2:c.12013A>G:p.(Thr4005Ala)","0.8490587","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","116","0/1","Het","224","181,43","0.808035714285714","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","0.00001256","","","","","","","1.256e-05","0","T","0.051","","","","","","","U","0.005","D","0.937","M","3.385","T","4.42","D","-4.22","0.641","T","-1.165","T","0.033","D","0.054","0.226","D","0.951","25.0","3.518","5.51","6.270","15.259"
"chr16","71101200","71101200","T>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001198542:exon15:c.A2149G:p.T717A,HYDIN:NM_001198543:exon15:c.A2119G:p.T707A,HYDIN:NM_001270974:exon15:c.A2068G:p.T690A,HYDIN:NM_017558:exon15:c.A2068G:p.T690A","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000288168.14_1:exon15:c.A2119G:p.T707A,HYDIN:ENST00000321489.9_1:exon15:c.A2068G:p.T690A,HYDIN:ENST00000393567.7_1:exon15:c.A2068G:p.T690A,HYDIN:ENST00000538248.5_1:exon15:c.A2149G:p.T717A,HYDIN:ENST00000541601.5_1:exon15:c.A2119G:p.T707A","HYDIN:ENST00000288168.10:c.2119A>G:p.(Thr707Ala)","0.8241739","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","117","0/1","Het","94","51,43","0.542553191489362","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","SpliceAI>C|HYDIN|0.00|0.00|0.00|0.00|-4|-22|-4|19",".;.;.;.;.","","","0.0009","","","0.0002","0.0002","","","0.0005","0.0009","D","0.033","D","0.03","P","0.767","P","0.491","U","0.005","D","0.947","L","1.845","T","3.2","N","-2.18","0.62","T","-1.041","T","0.060","T","0.018","0.082","T","0.036","24.9","3.476","4.99","3.390","13.749"
"chr16","71054178","71054178","T>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon22:c.A3229G:p.I1077V","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon22:c.A3229G:p.I1077V","HYDIN:ENST00000393567.2:c.3229A>G:p.(Ile1077Val)","0.7548145","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","122","0/1","Het","173","97,76","0.560693641618497","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","0.00004042","0.0004","","0.0001","0.","","","4.042e-05","0","T","0.241","","","","","","","U","0.853","N","1.000","M","2.62","T","3.31","N","-0.51","0.11","T","-0.988","T","0.016","T","0.004","0.032","T","0.023","8.485","0.408","4.61","-0.230","1.430"
"chr16","70954945","70954945","T>A","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon46:c.A7334T:p.N2445I","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon46:c.A7334T:p.N2445I","HYDIN:ENST00000393567.2:c.7334A>T:p.(Asn2445Ile)","0.68200004","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","123","0/1","Het","328","172,156","0.524390243902439","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","0.318","","","","","","","N","0.531","N","1","N","-0.69","T","5.61","N","2.26","0.11","T","-0.903","T","0.002","T","0.010","0.170","D","0.568","13.49","1.010","5.89","2.513","6.542"
"chr16","70897039","70897039","C>G","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon68:c.G11518C:p.V3840L","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon68:c.G11518C:p.V3840L","HYDIN:ENST00000393567.2:c.11518G>C:p.(Val3840Leu)","0.64100003","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","124","0/1","Het","53","33,20","0.622641509433962","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","0.359","","","","","","","U","0.893","N","1","N","0.72","T","5.6","N","-0.72","0.048","T","-0.897","T","0.002","T","0.009","0.029","T","0.053","0.747","-0.194","5.36","-0.472","8.987"
"chr16","70896122","70896122","A>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon69:c.T11606G:p.M3869R","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon69:c.T11606G:p.M3869R","HYDIN:ENST00000393567.2:c.11606T>G:p.(Met3869Arg)","0.61304045","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","125","0/1","Het","147","108,39","0.73469387755102","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","0.386","","","","","","","","","N","1","N","-0.28","T","5.7","N","-0.56","0.163","T","-0.926","T","0.001","T","0.005","0.028","T","0.033","5.040","0.148","4.14","0.320","1.643"
"chr16","70954691","70954691","T>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon46:c.A7588G:p.K2530E","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon46:c.A7588G:p.K2530E","HYDIN:ENST00000393567.2:c.7588A>G:p.(Lys2530Glu)","0.566971","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","127","0/1","Het","334","278,56","0.832335329341317","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","Name=C-rich","","","","","","","","","","","T","0.433","","","","","","","","","N","1.000","L","1.845","T","5.27","N","-1.54","0.274","T","-0.365","T","0.003","T","0.015","0.137","D","0.734","21.5","2.216","5.89","1.684","11.628"
"chr16","70902568","70902568","C>T","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon66:c.G11215A:p.A3739T","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon66:c.G11215A:p.A3739T","HYDIN:ENST00000393567.2:c.11215G>A:p.(Ala3739Thr)","0.528","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","128","0/1","Het","229","134,95","0.585152838427948","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","Score=795;Name=V$OLF1_01","","","","","","","","","","T","0.472","","","","","","","U","0.109","N","1.000","M","2.015","T","5.57","N","-1.04","0.095","T","-0.804","T","0.004","T","0.009","0.044","D","0.652","18.47","1.836","5.03","0.392","7.019"
"chr16","70954513","70954513","T>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon46:c.A7766G:p.K2589R","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon46:c.A7766G:p.K2589R","HYDIN:ENST00000393567.2:c.7766A>G:p.(Lys2589Arg)","0.5099478","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","129","0/1","Het","121","64,57","0.528925619834711","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","0.49","","","","","","","N","0.362","N","1.000","N","0.345","T","5.42","N","-0.57","0.085","T","-0.905","T","0.002","T","0.016","0.134","T","0.031","0.077","-0.520","5.89","-1.067","20.876"
"chr16","70954571","70954571","C>T","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon46:c.G7708A:p.D2570N","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon46:c.G7708A:p.D2570N","HYDIN:ENST00000393567.2:c.7708G>A:p.(Asp2570Asn)","0.464","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","130","0/1","Het","214","125,89","0.58411214953271","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","0.536","","","","","","","N","0.062","N","1","N","-1.79","T","5.62","N","0.64","0.038","T","-0.944","T","0.001","T","0.007","0.100","T","0.089","13.58","1.022","5.89","1.372","3.169"
"chr16","70989299","70989299","C>T","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon40:c.G6295A:p.V2099M","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon40:c.G6295A:p.V2099M","HYDIN:ENST00000393567.2:c.6295G>A:p.(Val2099Met)","0.3118652","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","131","0/1","Het","161","88,73","0.546583850931677","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","Hydin","","","","","","","","","","","","T","0.688","","","","","","","N","0.498","N","1.000","N","-2.075","T","1.95","N","0.92","0.066","T","-1.014","T","0.011","T","0.007","0.080","D","0.764","14.26","1.131","4.66","0.601","2.189"
"chr16","70954606","70954606","C>T","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon46:c.G7673A:p.G2558E","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon46:c.G7673A:p.G2558E","HYDIN:ENST00000393567.2:c.7673G>A:p.(Gly2558Glu)","0.18199998","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","132","0/1","Het","259","148,111","0.571428571428571","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","Name=C-rich","","","","","","","","","","","T","0.818","","","","","","","U","0.295","N","0.849","M","2.135","T","5.57","N","-0.93","0.213","T","-0.716","T","0.005","T","0.020","0.238","T","0.388","18.71","1.867","5.89","1.891","13.071"
"chr16","70942688","70942688","A>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon48:c.T8081G:p.I2694S","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon48:c.T8081G:p.I2694S","HYDIN:ENST00000393567.2:c.8081T>G:p.(Ile2694Ser)","0.143","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","133","0/1","Het","345","180,165","0.521739130434783","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","0.857","","","","","","","U","0.350","N","1","N","-1.15","T","5.76","N","2.31","0.201","T","-0.939","T","0.001","T","0.006","0.070","T","0.053","2.234","-0.027","5.49","0.787","1.103"
"chr16","70954774","70954774","A>G","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon46:c.T7505C:p.L2502S","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon46:c.T7505C:p.L2502S","HYDIN:ENST00000393567.2:c.7505T>C:p.(Leu2502Ser)","0.10500002","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","134","0/1","Het","291","148,143","0.508591065292096","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","Score=862;Name=V$HAND1E47_01","","","","","","","","","","T","0.895","","","","","","","N","0.916","N","1.000","N","-2.44","T","5.83","N","2.06","0.106","T","-0.985","T","0.001","T","0.012","0.193","T","0.203","17.00","1.624","5.89","5.504","13.270"
"chr16","70894024","70894024","C>T","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon71:c.G12076A:p.A4026T","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon71:c.G12076A:p.A4026T","HYDIN:ENST00000393567.2:c.12076G>A:p.(Ala4026Thr)","0.102818914","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","135","0/1","Het","225","171,54","0.76","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","0.897","","","","","","","U","0.006","N","0.805","L","1.76","T","5.45","N","-1.07","0.132","T","-0.674","T","0.003","T","0.023","0.037","D","0.768","21.5","2.208","5.51","1.133","8.319"
"chr16","71026076","71026076","C>G","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon24:c.G3682C:p.V1228L","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon24:c.G3682C:p.V1228L","HYDIN:ENST00000393567.2:c.3682G>C:p.(Val1228Leu)","0.046000004","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","136","0/1","Het","330","155,175","0.46969696969697","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","0.954","","","","","","","N","0.432","N","1","N","-1.43","T","5.71","N","0.7","0.021","T","-0.925","T","0.003","T","0.007","0.008","T","0.036","0.042","-0.602","5.07","-0.793","3.215"
"chr16","70917931","70917931","C>G","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon59:c.G9871C:p.A3291P","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon59:c.G9871C:p.A3291P","HYDIN:ENST00000393567.2:c.9871G>C:p.(Ala3291Pro)","0","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","137","0/1","Het","335","176,159","0.525373134328358","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","","","","","","","","","","T","1.0","","","","","","","N","0.005","N","0.999","N","-2.28","T","5.56","N","2.02","0.113","T","-0.605","T","0.001","D","0.030","0.141","T","0.188","18.69","1.865","5.01","2.022","15.221"
"chr16","70975565","70975565","T>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon43:c.A6827G:p.Q2276R","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon43:c.A6827G:p.Q2276R","HYDIN:ENST00000393567.2:c.6827A>G:p.(Gln2276Arg)","0","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","138","0/1","Het","104","74,30","0.711538461538462","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","Score=808;Name=V$COMP1_01,V$PPARG_03","","","","","","","","","","T","1.0","","","","","","","U","0.129","N","0.999","L","1.445","T","5.8","N","0.59","0.135","T","-0.931","T","0.002","T","0.009","0.119","T","0.107","17.05","1.632","5.32","0.129","7.594"
"chr16","70975667","70975667","T>C","","HYDIN","exonic","nonsynonymous SNV","","HYDIN:NM_001270974:exon43:c.A6725G:p.Q2242R","HYDIN","exonic","nonsynonymous SNV","","HYDIN:ENST00000393567.7_1:exon43:c.A6725G:p.Q2242R","HYDIN:ENST00000393567.2:c.6725A>G:p.(Gln2242Arg)","0","","","","","","","","","","","","","","","","ENSG00000157423","HYDIN","HGNC:19368","HYDIN","54768","ENSG00000157423","uc021tkq.3","0.7492238842570191","0.5001483742671553","1.0","OMIM:608647 Ciliary dyskinesia, primary, 5-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_recessive","139","0/1","Het","182","96,86","0.527472527472527","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ciliary dyskinesia, primary, 5(608647)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Bronchiectasis(HP:0002110)|Ciliary dyskinesia(HP:0012265)|Autosomal recessive inheritance(HP:0000007)|Recurrent otitis media(HP:0000403)|Rhinitis(HP:0012384)|Recurrent bronchitis(HP:0002837)|Nasal polyposis(HP:0100582)|Recurrent sinusitis(HP:0011108)|Respiratory insufficiency due to defective ciliary clearance(HP:0200073)|Infantile onset(HP:0003593)","This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]","HYDIN axonemal central pair apparatus protein","epithelial cell development(GO:0002064)|cilium movement(GO:0003341)|ventricular system development(GO:0021591)|trachea development(GO:0060438)|axonemal central apparatus assembly(GO:1904158)","axonemal central apparatus(GO:1990716)|axonemal central pair projection(GO:1990718)","","","","Wp ciliopathies","","","","","","","","0.0077","","","","","","","0.0026","0.0077","T","1.0","","","","","","","N","0.008","N","1","N","-2.535","T","1.83","N","0.95","0.075","T","-0.944","T","0.011","T","0.003","0.055","T","0.004","0.305","-0.327","5.32","0.561","7.931"
"chr12","123892186","123892186","T>C","","KMT5A","exonic","nonsynonymous SNV","","KMT5A:NM_020382:exon8:c.T995C:p.L332P","KMT5A","exonic","nonsynonymous SNV","","KMT5A:ENST00000330479.8_1:exon8:c.T905C:p.L302P,KMT5A:ENST00000402868.8_1:exon8:c.T995C:p.L332P","KMT5A:ENST00000330479.4:c.995T>C:p.(Leu332Pro)","1","0.5001109654331231","1.0","0.7491508177977161","0.5001109654331231","0.9999989867210388","0.7491490690189555","","","","","","","","","","ENSG00000183955","KMT5A","HGNC:29489","KMT5A","387893","ENSG00000183955","uc001uew.4","0.7491508177977161","0.5001109654331231","1.0","","140","0/1","Het","513","325,188","0.633528265107212","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a protein-lysine N-methyltransferase that can monomethylate Lys-20 of histone H4 to effect transcriptional repression of some genes. The encoded protein is required for cell proliferation and plays a role in chromatin condensation. [provided by RefSeq, May 2016]","lysine methyltransferase 5A","negative regulation of transcription by RNA polymerase II(GO:0000122)|mitotic chromosome condensation(GO:0007076)|peptidyl-lysine monomethylation(GO:0018026)|histone H4-K20 methylation(GO:0034770)|regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516)|negative regulation of transcription, DNA-templated(GO:0045892)|cell division(GO:0051301)|regulation of signal transduction by p53 class mediator(GO:1901796)","nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|chromosome(GO:0005694)|cytosol(GO:0005829)","p53 binding(GO:0002039)|transcription corepressor activity(GO:0003714)|protein binding(GO:0005515)|lysine N-methyltransferase activity(GO:0016278)|protein-lysine N-methyltransferase activity(GO:0016279)|histone-lysine N-methyltransferase activity(GO:0018024)|histone-lysine N-methyltransferase activity(GO:0018024)|histone methyltransferase activity (H4-K20 specific)(GO:0042799)","cancer(DOID:162)","Lysine degradation","Wp histone modifications","Cell cycle|Condensation of prophase chromosomes|Pkmts methylate histone lysines|Chromatin modifying enzymes|Transcriptional regulation by tp53|Regulation of tp53 activity|Regulation of tp53 activity through methylation|Mitotic prophase|M phase|Cell cycle mitotic|Rna polymerase ii transcription","","G2m checkpoint|Fatty acid metabolism","","SET","","","","","","","","","","","","D","0.014","D","0.001","D","1.0","D","0.999","D","0.000","D","1","","","D","-2.42","D","-6.36","0.976","D","1.075","D","0.906","D","0.493","0.954","D","0.999","31","4.315","5.12","8.017","15.232"
"chr12","123889492","123889492","A>C","","KMT5A","exonic","nonsynonymous SNV","","KMT5A:NM_020382:exon7:c.A719C:p.D240A","KMT5A","exonic","nonsynonymous SNV","","KMT5A:ENST00000330479.8_1:exon7:c.A629C:p.D210A,KMT5A:ENST00000402868.8_1:exon7:c.A719C:p.D240A","KMT5A:ENST00000330479.4:c.719A>C:p.(Asp240Ala)","0.999998","","","","0.5001109654331231","0.9999989867210388","0.7491490690189555","","","","","","","","","","ENSG00000183955","KMT5A","HGNC:29489","KMT5A","387893","ENSG00000183955","uc001uew.4","0.7491508177977161","0.5001109654331231","1.0","","141","0/1","Het","117","97,20","0.829059829059829","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a protein-lysine N-methyltransferase that can monomethylate Lys-20 of histone H4 to effect transcriptional repression of some genes. The encoded protein is required for cell proliferation and plays a role in chromatin condensation. [provided by RefSeq, May 2016]","lysine methyltransferase 5A","negative regulation of transcription by RNA polymerase II(GO:0000122)|mitotic chromosome condensation(GO:0007076)|peptidyl-lysine monomethylation(GO:0018026)|histone H4-K20 methylation(GO:0034770)|regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516)|negative regulation of transcription, DNA-templated(GO:0045892)|cell division(GO:0051301)|regulation of signal transduction by p53 class mediator(GO:1901796)","nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|chromosome(GO:0005694)|cytosol(GO:0005829)","p53 binding(GO:0002039)|transcription corepressor activity(GO:0003714)|protein binding(GO:0005515)|lysine N-methyltransferase activity(GO:0016278)|protein-lysine N-methyltransferase activity(GO:0016279)|histone-lysine N-methyltransferase activity(GO:0018024)|histone-lysine N-methyltransferase activity(GO:0018024)|histone methyltransferase activity (H4-K20 specific)(GO:0042799)","cancer(DOID:162)","Lysine degradation","Wp histone modifications","Cell cycle|Condensation of prophase chromosomes|Pkmts methylate histone lysines|Chromatin modifying enzymes|Transcriptional regulation by tp53|Regulation of tp53 activity|Regulation of tp53 activity through methylation|Mitotic prophase|M phase|Cell cycle mitotic|Rna polymerase ii transcription","","G2m checkpoint|Fatty acid metabolism","","SET","","","","","","","","","","","","D","0.031","D","0.01","B","0.027","B","0.03","D","0.001","D","1.000","","","T","-1.47","D","-5.35","0.482","T","-0.230","T","0.385","D","0.051","0.574","D","0.968","24.7","3.429","5.16","7.508","15.303"
"chr12","123892095","123892095","T>C","","KMT5A","exonic","nonsynonymous SNV","","KMT5A:NM_020382:exon8:c.T904C:p.C302R","KMT5A","exonic","nonsynonymous SNV","","KMT5A:ENST00000330479.8_1:exon8:c.T814C:p.C272R,KMT5A:ENST00000402868.8_1:exon8:c.T904C:p.C302R","KMT5A:ENST00000330479.4:c.904T>C:p.(Cys302Arg)","0.9997969","","","","","","","","","","","","","","","","ENSG00000183955","KMT5A","HGNC:29489","KMT5A","387893","ENSG00000183955","uc001uew.4","0.7491508177977161","0.5001109654331231","1.0","","142","0/1","Het","341","236,105","0.69208211143695","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a protein-lysine N-methyltransferase that can monomethylate Lys-20 of histone H4 to effect transcriptional repression of some genes. The encoded protein is required for cell proliferation and plays a role in chromatin condensation. [provided by RefSeq, May 2016]","lysine methyltransferase 5A","negative regulation of transcription by RNA polymerase II(GO:0000122)|mitotic chromosome condensation(GO:0007076)|peptidyl-lysine monomethylation(GO:0018026)|histone H4-K20 methylation(GO:0034770)|regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516)|negative regulation of transcription, DNA-templated(GO:0045892)|cell division(GO:0051301)|regulation of signal transduction by p53 class mediator(GO:1901796)","nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|chromosome(GO:0005694)|cytosol(GO:0005829)","p53 binding(GO:0002039)|transcription corepressor activity(GO:0003714)|protein binding(GO:0005515)|lysine N-methyltransferase activity(GO:0016278)|protein-lysine N-methyltransferase activity(GO:0016279)|histone-lysine N-methyltransferase activity(GO:0018024)|histone-lysine N-methyltransferase activity(GO:0018024)|histone methyltransferase activity (H4-K20 specific)(GO:0042799)","cancer(DOID:162)","Lysine degradation","Wp histone modifications","Cell cycle|Condensation of prophase chromosomes|Pkmts methylate histone lysines|Chromatin modifying enzymes|Transcriptional regulation by tp53|Regulation of tp53 activity|Regulation of tp53 activity through methylation|Mitotic prophase|M phase|Cell cycle mitotic|Rna polymerase ii transcription","","G2m checkpoint|Fatty acid metabolism","SpliceAI>C|SETD8|0.00|0.00|0.00|0.00|-4|-23|-4|0","SET","","Score=866;Name=V$IK1_01","0.000003982","","","0.","0.","","","3.982e-06","0","T","0.611","T","0.649","B","0.004","B","0.007","N","0.002","D","1","","","T","-1.37","D","-3.18","0.509","T","-0.746","T","0.209","D","0.053","0.429","D","0.631","22.8","2.618","5.12","6.261","15.232"
"chr12","58220823","58220823","C>T","","CTDSP2","exonic","nonsynonymous SNV","","CTDSP2:NM_005730:exon4:c.G310A:p.V104M","CTDSP2","exonic","nonsynonymous SNV","","CTDSP2:ENST00000398073.7_1:exon4:c.G310A:p.V104M","CTDSP2:ENST00000398073.2:c.310G>A:p.(Val104Met)","1","0.5001013855508063","1.0","0.749132104216018","0.5001013855508063","1.0","0.749132104216018","","","","","","","","","","ENSG00000175215","CTDSP2","HGNC:17077","CTDSP2","10106","ENSG00000175215","uc001sqm.4","0.749132104216018","0.5001013855508063","1.0","","154","0/1","Het","95","75,20","0.789473684210526","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","CTD small phosphatase 2","negative regulation of protein phosphorylation(GO:0001933)|protein dephosphorylation(GO:0006470)|negative regulation of G1/S transition of mitotic cell cycle(GO:2000134)","nucleoplasm(GO:0005654)","phosphoprotein phosphatase activity(GO:0004721)|protein binding(GO:0005515)|RNA polymerase II CTD heptapeptide repeat phosphatase activity(GO:0008420)|RNA polymerase II CTD heptapeptide repeat phosphatase activity(GO:0008420)|metal ion binding(GO:0046872)|protein serine phosphatase activity(GO:0106306)|protein threonine phosphatase activity(GO:0106307)","","","","Ire1alpha activates chaperones|Unfolded protein response upr","","","","FCP1","","","","","","","","","","","","T","0.233","T","0.119","P","0.5","B","0.316","D","0.000","D","1.000","N","0.72","T","2.0","N","-0.96","0.539","T","-1.137","T","0.053","T","0.010","0.072","D","0.689","22.7","2.551","4.92","4.956","10.932"
"chr12","58220841","58220841","C>T","","CTDSP2","exonic","nonsynonymous SNV","","CTDSP2:NM_005730:exon4:c.G292A:p.D98N","CTDSP2","exonic","nonsynonymous SNV","","CTDSP2:ENST00000398073.7_1:exon4:c.G292A:p.D98N","CTDSP2:ENST00000398073.2:c.292G>A:p.(Asp98Asn)","1","","","","0.5001013855508063","1.0","0.749132104216018","","","","","","","","","","ENSG00000175215","CTDSP2","HGNC:17077","CTDSP2","10106","ENSG00000175215","uc001sqm.4","0.749132104216018","0.5001013855508063","1.0","","155","0/1","Het","98","79,19","0.806122448979592","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","CTD small phosphatase 2","negative regulation of protein phosphorylation(GO:0001933)|protein dephosphorylation(GO:0006470)|negative regulation of G1/S transition of mitotic cell cycle(GO:2000134)","nucleoplasm(GO:0005654)","phosphoprotein phosphatase activity(GO:0004721)|protein binding(GO:0005515)|RNA polymerase II CTD heptapeptide repeat phosphatase activity(GO:0008420)|RNA polymerase II CTD heptapeptide repeat phosphatase activity(GO:0008420)|metal ion binding(GO:0046872)|protein serine phosphatase activity(GO:0106306)|protein threonine phosphatase activity(GO:0106307)","","","","Ire1alpha activates chaperones|Unfolded protein response upr","","","","FCP1","","","","","","","","","","","","T","0.063","T","0.181","P","0.94","P","0.792","D","0.000","D","1","M","2.315","T","2.38","D","-4.71","0.671","T","-0.271","T","0.403","T","0.016","0.241","D","0.988","27.3","3.949","4.92","6.061","17.399"
"chr12","58220844","58220844","C>T","","CTDSP2","exonic","nonsynonymous SNV","","CTDSP2:NM_005730:exon4:c.G289A:p.E97K","CTDSP2","exonic","nonsynonymous SNV","","CTDSP2:ENST00000398073.7_1:exon4:c.G289A:p.E97K","CTDSP2:ENST00000398073.2:c.289G>A:p.(Glu97Lys)","0.9991779","","","","","","","","","","","","","","","","ENSG00000175215","CTDSP2","HGNC:17077","CTDSP2","10106","ENSG00000175215","uc001sqm.4","0.749132104216018","0.5001013855508063","1.0","","156","0/1","Het","97","81,16","0.835051546391753","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","CTD small phosphatase 2","negative regulation of protein phosphorylation(GO:0001933)|protein dephosphorylation(GO:0006470)|negative regulation of G1/S transition of mitotic cell cycle(GO:2000134)","nucleoplasm(GO:0005654)","phosphoprotein phosphatase activity(GO:0004721)|protein binding(GO:0005515)|RNA polymerase II CTD heptapeptide repeat phosphatase activity(GO:0008420)|RNA polymerase II CTD heptapeptide repeat phosphatase activity(GO:0008420)|metal ion binding(GO:0046872)|protein serine phosphatase activity(GO:0106306)|protein threonine phosphatase activity(GO:0106307)","","","","Ire1alpha activates chaperones|Unfolded protein response upr","","","","FCP1","","","0.000004013","","","0.","0.","","","4.013e-06","0","T","0.585","T","0.922","B","0.0","B","0.0","D","0.000","D","1","N","0.57","T","2.35","N","-0.2","0.271","T","-1.090","T","0.090","T","0.007","0.093","T","0.147","21.6","2.221","4.92","0.593","9.216"
"chr12","58220816","58220816","A>G","","CTDSP2","exonic","nonsynonymous SNV","","CTDSP2:NM_005730:exon4:c.T317C:p.I106T","CTDSP2","exonic","nonsynonymous SNV","","CTDSP2:ENST00000398073.7_1:exon4:c.T317C:p.I106T","CTDSP2:ENST00000398073.2:c.317T>C:p.(Ile106Thr)","0.9991122","","","","","","","","","","","","","","","","ENSG00000175215","CTDSP2","HGNC:17077","CTDSP2","10106","ENSG00000175215","uc001sqm.4","0.749132104216018","0.5001013855508063","1.0","","157","0/1","Het","92","70,22","0.760869565217391","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","CTD small phosphatase 2","negative regulation of protein phosphorylation(GO:0001933)|protein dephosphorylation(GO:0006470)|negative regulation of G1/S transition of mitotic cell cycle(GO:2000134)","nucleoplasm(GO:0005654)","phosphoprotein phosphatase activity(GO:0004721)|protein binding(GO:0005515)|RNA polymerase II CTD heptapeptide repeat phosphatase activity(GO:0008420)|RNA polymerase II CTD heptapeptide repeat phosphatase activity(GO:0008420)|metal ion binding(GO:0046872)|protein serine phosphatase activity(GO:0106306)|protein threonine phosphatase activity(GO:0106307)","","","","Ire1alpha activates chaperones|Unfolded protein response upr","","","SpliceAI>G|CTDSP2|0.00|0.00|0.00|0.00|-28|39|37|-37","FCP1","","","0.000008022","","","0.","0.","","","8.022e-06","0","D","0.001","T","0.066","P","0.845","P","0.766","D","0.000","D","1","M","2.57","T","2.18","D","-4.81","0.964","T","-0.733","T","0.155","D","0.059","0.732","D","0.984","24.5","3.351","4.92","9.189","13.953"
"chr3","48691428","48691428","C>G","","CELSR3","exonic","nonsynonymous SNV","","CELSR3:NM_001407:exon8:c.G5161C:p.A1721P","CELSR3","exonic","nonsynonymous SNV","","CELSR3:ENST00000164024.5_1:exon8:c.G5161C:p.A1721P","CELSR3:ENST00000164024.4:c.5161G>C:p.(Ala1721Pro)","0.9999488","0.5001022117212415","0.999948799610138","0.7490453391992797","","","","","","","","","","","","","ENSG00000008300","CELSR3","HGNC:3230","CELSR3","1951","ENSG00000008300","uc003cul.4","0.7490453391992797","0.5001022117212415","0.9999487996101379","","158","0/1","Het","100","56,44","0.56","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene belongs to the flamingo subfamily, which is included in the cadherin superfamily. The flamingo cadherins consist of nonclassic-type cadherins that do not interact with catenins. They are plasma membrane proteins containing seven epidermal growth factor-like repeats, nine cadherin domains and two laminin A G-type repeats in their ectodomain. They also have seven transmembrane domains, a characteristic feature of their subfamily. The encoded protein may be involved in the regulation of contact-dependent neurite growth and may play a role in tumor formation. [provided by RefSeq, Jun 2013]","cadherin EGF LAG seven-pass G-type receptor 3","homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156)|G protein-coupled receptor signaling pathway(GO:0007186)|Wnt signaling pathway, planar cell polarity pathway(GO:0060071)|cell-cell adhesion(GO:0098609)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)","G protein-coupled receptor activity(GO:0004930)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)","","","Wp gpcrs other","","","","","","","","","","","","","","","","","D","0.045","D","0.005","D","0.997","D","0.943","","","D","1","L","1.755","T","-1.06","D","-3.59","0.578","D","0.026","D","0.554","D","0.084","0.591","D","0.973","32","4.420","5.25","7.530","19.204"
"chr7","151927023","151927023","G>C","KMT2C:58508","KMT2C","exonic","stopgain","","KMT2C:NM_170606:exon18:c.C2961G:p.Y987X","KMT2C","exonic","stopgain","","KMT2C:ENST00000679882.1_1:exon17:c.C2841G:p.Y947X,KMT2C:ENST00000262189.11_1:exon18:c.C2961G:p.Y987X,KMT2C:ENST00000682283.1_1:exon18:c.C2961G:p.Y987X,KMT2C:ENST00000683490.1_1:exon18:c.C2961G:p.Y987X,KMT2C:ENST00000684550.1_1:exon18:c.C2961G:p.Y987X","KMT2C:ENST00000262189.6:c.2961C>G:p.(Tyr987*)","1","0.5000553554164071","1.0","0.7490421748517401","0.2500276777082035","0.9999944865703584","0.1816132738169102","","","","","","","","","","ENSG00000055609","KMT2C","HGNC:13726","KMT2C","58508","ENSG00000055609","","0.7490421748517401","0.5000553554164071","1.0","OMIM:617768 Kleefstra syndrome 2-autosomal_dominant;ORPHA:261652 Kleefstra syndrome due to a point mutation-autosomal_dominant","159","0/1","Het","364","308,56","0.846153846153846","Conflicting_interpretations_of_pathogenicity","True","Global_developmental_delay|Cerebellar_atrophy|Kleefstra_syndrome_2","Human_Phenotype_Ontology:HP:0000754,Human_Phenotype_Ontology:HP:0001255,Human_Phenotype_Ontology:HP:0001263,Human_Phenotype_Ontology:HP:0001277,Human_Phenotype_Ontology:HP:0001292,Human_Phenotype_Ontology:HP:0002433,Human_Phenotype_Ontology:HP:0002473,Human_Phenotype_Ontology:HP:0002532,Human_Phenotype_Ontology:HP:0006793,Human_Phenotype_Ontology:HP:0006867,Human_Phenotype_Ontology:HP:0006885,Human_Phenotype_Ontology:HP:0006935,Human_Phenotype_Ontology:HP:0007005,Human_Phenotype_Ontology:HP:0007094,Human_Phenotype_Ontology:HP:0007106,Human_Phenotype_Ontology:HP:0007174,Human_Phenotype_Ontology:HP:0007224,Human_Phenotype_Ontology:HP:0007228,Human_Phenotype_Ontology:HP:0007342,MedGen:C0557874|Human_Phenotype_Ontology:HP:0001272,Human_Phenotype_Ontology:HP:0002364,Human_Phenotype_Ontology:HP:0006839,Human_Phenotype_Ontology:HP:0007072,Human_Phenotype_Ontology:HP:0007203,MedGen:C0740279|MONDO:MONDO:0054701,MedGen:C4540395,OMIM:617768","NC_000007.13:g.151927023G>C","criteria_provided,_conflicting_interpretations","Pathogenic","PVS1: 1 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Kleefstra syndrome 2(617768)","Intellectual disability(HP:0001249)|Plagiocephaly(HP:0001357)|Kyphosis(HP:0002808)|Thick eyebrow(HP:0000574)|Hypotonia(HP:0001252)|Growth delay(HP:0001510)|Autosomal dominant inheritance(HP:0000006)|Midface retrusion(HP:0011800)|Microcephaly(HP:0000252)|Scoliosis(HP:0002650)|Delayed speech and language development(HP:0000750)|Seizure(HP:0001250)|Autosomal dominant germline de novo mutation(HP:0025352)|Everted lower lip vermilion(HP:0000232)|Generalized hypotonia(HP:0001290)|Everted lower lip vermilion(HP:0000232)|Self-injurious behavior(HP:0100716)|Abnormal facial shape(HP:0001999)|Global developmental delay(HP:0001263)|Bifid uvula(HP:0000193)|Autistic behavior(HP:0000729)|Hearing impairment(HP:0000365)|Anal atresia(HP:0002023)|Precocious puberty(HP:0000826)|Large for gestational age(HP:0001520)|Hypotonia(HP:0001252)|Seizure(HP:0001250)|Brachycephaly(HP:0000248)|Intellectual disability(HP:0001249)|Global developmental delay(HP:0001263)|Failure to thrive(HP:0001508)|Midface retrusion(HP:0011800)|Gastroesophageal reflux(HP:0002020)|Cerebellar hypoplasia(HP:0001321)|Abnormal facial shape(HP:0001999)|Abnormal shape of the palpebral fissure(HP:0200005)|Abnormality of the kidney(HP:0000077)|Abnormality of the genital system(HP:0000078)|Ventriculomegaly(HP:0002119)|Hyperextensible skin(HP:0000974)|Thick lower lip vermilion(HP:0000179)|Tapered finger(HP:0001182)|Umbilical hernia(HP:0001537)|Moderate receptive language delay(HP:0011351)|Hypoplasia of the corpus callosum(HP:0002079)|Natal tooth(HP:0000695)|Developmental cataract(HP:0000519)|Recurrent infections(HP:0002719)|Autistic behavior(HP:0000729)|Inguinal hernia(HP:0000023)|Severe expressive language delay(HP:0006863)|Microcephaly(HP:0000252)|Tracheomalacia(HP:0002779)|Plagiocephaly(HP:0001357)|Delayed gross motor development(HP:0002194)|Short stature(HP:0004322)|Gliosis(HP:0002171)|Brain imaging abnormality(HP:0410263)|Vesicoureteral reflux(HP:0000076)|Self-injurious behavior(HP:0100716)|Abnormal heart morphology(HP:0001627)|Uplifted earlobe(HP:0009909)|Overgrowth(HP:0001548)|Hypermetropia(HP:0000540)","This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]","lysine methyltransferase 2C","positive regulation of transcription by RNA polymerase II(GO:0045944)|histone H3-K4 monomethylation(GO:0097692)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|histone methyltransferase complex(GO:0035097)|MLL3/4 complex(GO:0044666)|MLL3/4 complex(GO:0044666)","DNA binding(GO:0003677)|transcription coactivator activity(GO:0003713)|RNA binding(GO:0003723)|protein binding(GO:0005515)|acyltransferase activity(GO:0016746)|histone methyltransferase activity(GO:0042054)|histone binding(GO:0042393)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|metal ion binding(GO:0046872)","","","Wp histone modifications|Wp pathways affected in adenoid cystic carcinoma|Wp 16p112 proximal deletion syndrome","Developmental biology|Pkmts methylate histone lysines|Chromatin modifying enzymes|Activation of anterior hox genes in hindbrain development during early embryogenesis|Rna polymerase ii transcription|Transcriptional regulation by runx1|Runx1 regulates genes involved in megakaryocyte differentiation and platelet function","","","","Zinc","","Score=897;Name=V$AP1_Q2","","","","","","","","","","","","","","","","","","U","0.002","A","1","","","","","","","0.71","","","","","","","","D","0.998","36","6.795","4.67","3.613","11.250"
"chr7","151935871","151935871","C>A","KMT2C:58508","KMT2C","exonic","nonsynonymous SNV","","KMT2C:NM_170606:exon15:c.G2573T:p.W858L","KMT2C","exonic","nonsynonymous SNV","","KMT2C:ENST00000262189.11_1:exon15:c.G2573T:p.W858L,KMT2C:ENST00000682283.1_1:exon15:c.G2573T:p.W858L,KMT2C:ENST00000683490.1_1:exon15:c.G2573T:p.W858L,KMT2C:ENST00000684550.1_1:exon15:c.G2573T:p.W858L","KMT2C:ENST00000262189.6:c.2573G>T:p.(Trp858Leu)","0.999989","","","","0.2500276777082035","0.9999944865703584","0.1816132738169102","","","","","","","","","","ENSG00000055609","KMT2C","HGNC:13726","KMT2C","58508","ENSG00000055609","","0.7490421748517401","0.5000553554164071","1.0","OMIM:617768 Kleefstra syndrome 2-autosomal_dominant;ORPHA:261652 Kleefstra syndrome due to a point mutation-autosomal_dominant","160","0/1","Het","119","105,14","0.882352941176471","Uncertain_significance","False","not_specified","MedGen:CN169374","NC_000007.13:g.151935871C>A","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Kleefstra syndrome 2(617768)","Intellectual disability(HP:0001249)|Plagiocephaly(HP:0001357)|Kyphosis(HP:0002808)|Thick eyebrow(HP:0000574)|Hypotonia(HP:0001252)|Growth delay(HP:0001510)|Autosomal dominant inheritance(HP:0000006)|Midface retrusion(HP:0011800)|Microcephaly(HP:0000252)|Scoliosis(HP:0002650)|Delayed speech and language development(HP:0000750)|Seizure(HP:0001250)|Autosomal dominant germline de novo mutation(HP:0025352)|Everted lower lip vermilion(HP:0000232)|Generalized hypotonia(HP:0001290)|Everted lower lip vermilion(HP:0000232)|Self-injurious behavior(HP:0100716)|Abnormal facial shape(HP:0001999)|Global developmental delay(HP:0001263)|Bifid uvula(HP:0000193)|Autistic behavior(HP:0000729)|Hearing impairment(HP:0000365)|Anal atresia(HP:0002023)|Precocious puberty(HP:0000826)|Large for gestational age(HP:0001520)|Hypotonia(HP:0001252)|Seizure(HP:0001250)|Brachycephaly(HP:0000248)|Intellectual disability(HP:0001249)|Global developmental delay(HP:0001263)|Failure to thrive(HP:0001508)|Midface retrusion(HP:0011800)|Gastroesophageal reflux(HP:0002020)|Cerebellar hypoplasia(HP:0001321)|Abnormal facial shape(HP:0001999)|Abnormal shape of the palpebral fissure(HP:0200005)|Abnormality of the kidney(HP:0000077)|Abnormality of the genital system(HP:0000078)|Ventriculomegaly(HP:0002119)|Hyperextensible skin(HP:0000974)|Thick lower lip vermilion(HP:0000179)|Tapered finger(HP:0001182)|Umbilical hernia(HP:0001537)|Moderate receptive language delay(HP:0011351)|Hypoplasia of the corpus callosum(HP:0002079)|Natal tooth(HP:0000695)|Developmental cataract(HP:0000519)|Recurrent infections(HP:0002719)|Autistic behavior(HP:0000729)|Inguinal hernia(HP:0000023)|Severe expressive language delay(HP:0006863)|Microcephaly(HP:0000252)|Tracheomalacia(HP:0002779)|Plagiocephaly(HP:0001357)|Delayed gross motor development(HP:0002194)|Short stature(HP:0004322)|Gliosis(HP:0002171)|Brain imaging abnormality(HP:0410263)|Vesicoureteral reflux(HP:0000076)|Self-injurious behavior(HP:0100716)|Abnormal heart morphology(HP:0001627)|Uplifted earlobe(HP:0009909)|Overgrowth(HP:0001548)|Hypermetropia(HP:0000540)","This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]","lysine methyltransferase 2C","positive regulation of transcription by RNA polymerase II(GO:0045944)|histone H3-K4 monomethylation(GO:0097692)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|histone methyltransferase complex(GO:0035097)|MLL3/4 complex(GO:0044666)|MLL3/4 complex(GO:0044666)","DNA binding(GO:0003677)|transcription coactivator activity(GO:0003713)|RNA binding(GO:0003723)|protein binding(GO:0005515)|acyltransferase activity(GO:0016746)|histone methyltransferase activity(GO:0042054)|histone binding(GO:0042393)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|metal ion binding(GO:0046872)","","","Wp histone modifications|Wp pathways affected in adenoid cystic carcinoma|Wp 16p112 proximal deletion syndrome","Developmental biology|Pkmts methylate histone lysines|Chromatin modifying enzymes|Activation of anterior hox genes in hindbrain development during early embryogenesis|Rna polymerase ii transcription|Transcriptional regulation by runx1|Runx1 regulates genes involved in megakaryocyte differentiation and platelet function","","","",".;.","","","","","","","","","","","","D","0.006","","","D","1.0","D","0.996","D","0.001","D","1.000","M","1.95","D","-2.06","D","-4.86","0.747","D","0.125","D","0.702","D","0.052","0.518","D","0.964","27.0","3.912","5.53","7.309","19.826"
"chr7","151935799","151935799","A>G","","KMT2C","exonic","nonsynonymous SNV","","KMT2C:NM_170606:exon15:c.T2645C:p.I882T","KMT2C","exonic","nonsynonymous SNV","","KMT2C:ENST00000262189.11_1:exon15:c.T2645C:p.I882T,KMT2C:ENST00000682283.1_1:exon15:c.T2645C:p.I882T,KMT2C:ENST00000683490.1_1:exon15:c.T2645C:p.I882T,KMT2C:ENST00000684550.1_1:exon15:c.T2645C:p.I882T","KMT2C:ENST00000262189.6:c.2645T>C:p.(Ile882Thr)","0.9992859","","","","","","","","","","","","","","","","ENSG00000055609","KMT2C","HGNC:13726","KMT2C","58508","ENSG00000055609","","0.7490421748517401","0.5000553554164071","1.0","OMIM:617768 Kleefstra syndrome 2-autosomal_dominant;ORPHA:261652 Kleefstra syndrome due to a point mutation-autosomal_dominant","161","0/1","Het","142","126,16","0.887323943661972","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Kleefstra syndrome 2(617768)","Intellectual disability(HP:0001249)|Plagiocephaly(HP:0001357)|Kyphosis(HP:0002808)|Thick eyebrow(HP:0000574)|Hypotonia(HP:0001252)|Growth delay(HP:0001510)|Autosomal dominant inheritance(HP:0000006)|Midface retrusion(HP:0011800)|Microcephaly(HP:0000252)|Scoliosis(HP:0002650)|Delayed speech and language development(HP:0000750)|Seizure(HP:0001250)|Autosomal dominant germline de novo mutation(HP:0025352)|Everted lower lip vermilion(HP:0000232)|Generalized hypotonia(HP:0001290)|Everted lower lip vermilion(HP:0000232)|Self-injurious behavior(HP:0100716)|Abnormal facial shape(HP:0001999)|Global developmental delay(HP:0001263)|Bifid uvula(HP:0000193)|Autistic behavior(HP:0000729)|Hearing impairment(HP:0000365)|Anal atresia(HP:0002023)|Precocious puberty(HP:0000826)|Large for gestational age(HP:0001520)|Hypotonia(HP:0001252)|Seizure(HP:0001250)|Brachycephaly(HP:0000248)|Intellectual disability(HP:0001249)|Global developmental delay(HP:0001263)|Failure to thrive(HP:0001508)|Midface retrusion(HP:0011800)|Gastroesophageal reflux(HP:0002020)|Cerebellar hypoplasia(HP:0001321)|Abnormal facial shape(HP:0001999)|Abnormal shape of the palpebral fissure(HP:0200005)|Abnormality of the kidney(HP:0000077)|Abnormality of the genital system(HP:0000078)|Ventriculomegaly(HP:0002119)|Hyperextensible skin(HP:0000974)|Thick lower lip vermilion(HP:0000179)|Tapered finger(HP:0001182)|Umbilical hernia(HP:0001537)|Moderate receptive language delay(HP:0011351)|Hypoplasia of the corpus callosum(HP:0002079)|Natal tooth(HP:0000695)|Developmental cataract(HP:0000519)|Recurrent infections(HP:0002719)|Autistic behavior(HP:0000729)|Inguinal hernia(HP:0000023)|Severe expressive language delay(HP:0006863)|Microcephaly(HP:0000252)|Tracheomalacia(HP:0002779)|Plagiocephaly(HP:0001357)|Delayed gross motor development(HP:0002194)|Short stature(HP:0004322)|Gliosis(HP:0002171)|Brain imaging abnormality(HP:0410263)|Vesicoureteral reflux(HP:0000076)|Self-injurious behavior(HP:0100716)|Abnormal heart morphology(HP:0001627)|Uplifted earlobe(HP:0009909)|Overgrowth(HP:0001548)|Hypermetropia(HP:0000540)","This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]","lysine methyltransferase 2C","positive regulation of transcription by RNA polymerase II(GO:0045944)|histone H3-K4 monomethylation(GO:0097692)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|histone methyltransferase complex(GO:0035097)|MLL3/4 complex(GO:0044666)|MLL3/4 complex(GO:0044666)","DNA binding(GO:0003677)|transcription coactivator activity(GO:0003713)|RNA binding(GO:0003723)|protein binding(GO:0005515)|acyltransferase activity(GO:0016746)|histone methyltransferase activity(GO:0042054)|histone binding(GO:0042393)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|metal ion binding(GO:0046872)","","","Wp histone modifications|Wp pathways affected in adenoid cystic carcinoma|Wp 16p112 proximal deletion syndrome","Developmental biology|Pkmts methylate histone lysines|Chromatin modifying enzymes|Activation of anterior hox genes in hindbrain development during early embryogenesis|Rna polymerase ii transcription|Transcriptional regulation by runx1|Runx1 regulates genes involved in megakaryocyte differentiation and platelet function","","","",".;.","","Score=740;Name=V$MEF2_04","","","","","","","","","","D","0.001","","","D","0.993","P","0.796","D","0.000","D","0.999","L","1.935","D","-2.01","D","-3.08","0.714","D","0.339","D","0.620","D","0.078","0.559","D","0.983","26.4","3.819","5.53","8.633","15.955"
"chr7","151927067","151927067","T>C","","KMT2C","exonic","nonsynonymous SNV","","KMT2C:NM_170606:exon18:c.A2917G:p.R973G","KMT2C","exonic","nonsynonymous SNV","","KMT2C:ENST00000679882.1_1:exon17:c.A2797G:p.R933G,KMT2C:ENST00000262189.11_1:exon18:c.A2917G:p.R973G,KMT2C:ENST00000682283.1_1:exon18:c.A2917G:p.R973G,KMT2C:ENST00000683490.1_1:exon18:c.A2917G:p.R973G,KMT2C:ENST00000684550.1_1:exon18:c.A2917G:p.R973G","KMT2C:ENST00000262189.6:c.2917A>G:p.(Arg973Gly)","0.994","","","","","","","","","","","","","","","","ENSG00000055609","KMT2C","HGNC:13726","KMT2C","58508","ENSG00000055609","","0.7490421748517401","0.5000553554164071","1.0","OMIM:617768 Kleefstra syndrome 2-autosomal_dominant;ORPHA:261652 Kleefstra syndrome due to a point mutation-autosomal_dominant","162","0/1","Het","419","351,68","0.837708830548926","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Kleefstra syndrome 2(617768)","Intellectual disability(HP:0001249)|Plagiocephaly(HP:0001357)|Kyphosis(HP:0002808)|Thick eyebrow(HP:0000574)|Hypotonia(HP:0001252)|Growth delay(HP:0001510)|Autosomal dominant inheritance(HP:0000006)|Midface retrusion(HP:0011800)|Microcephaly(HP:0000252)|Scoliosis(HP:0002650)|Delayed speech and language development(HP:0000750)|Seizure(HP:0001250)|Autosomal dominant germline de novo mutation(HP:0025352)|Everted lower lip vermilion(HP:0000232)|Generalized hypotonia(HP:0001290)|Everted lower lip vermilion(HP:0000232)|Self-injurious behavior(HP:0100716)|Abnormal facial shape(HP:0001999)|Global developmental delay(HP:0001263)|Bifid uvula(HP:0000193)|Autistic behavior(HP:0000729)|Hearing impairment(HP:0000365)|Anal atresia(HP:0002023)|Precocious puberty(HP:0000826)|Large for gestational age(HP:0001520)|Hypotonia(HP:0001252)|Seizure(HP:0001250)|Brachycephaly(HP:0000248)|Intellectual disability(HP:0001249)|Global developmental delay(HP:0001263)|Failure to thrive(HP:0001508)|Midface retrusion(HP:0011800)|Gastroesophageal reflux(HP:0002020)|Cerebellar hypoplasia(HP:0001321)|Abnormal facial shape(HP:0001999)|Abnormal shape of the palpebral fissure(HP:0200005)|Abnormality of the kidney(HP:0000077)|Abnormality of the genital system(HP:0000078)|Ventriculomegaly(HP:0002119)|Hyperextensible skin(HP:0000974)|Thick lower lip vermilion(HP:0000179)|Tapered finger(HP:0001182)|Umbilical hernia(HP:0001537)|Moderate receptive language delay(HP:0011351)|Hypoplasia of the corpus callosum(HP:0002079)|Natal tooth(HP:0000695)|Developmental cataract(HP:0000519)|Recurrent infections(HP:0002719)|Autistic behavior(HP:0000729)|Inguinal hernia(HP:0000023)|Severe expressive language delay(HP:0006863)|Microcephaly(HP:0000252)|Tracheomalacia(HP:0002779)|Plagiocephaly(HP:0001357)|Delayed gross motor development(HP:0002194)|Short stature(HP:0004322)|Gliosis(HP:0002171)|Brain imaging abnormality(HP:0410263)|Vesicoureteral reflux(HP:0000076)|Self-injurious behavior(HP:0100716)|Abnormal heart morphology(HP:0001627)|Uplifted earlobe(HP:0009909)|Overgrowth(HP:0001548)|Hypermetropia(HP:0000540)","This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]","lysine methyltransferase 2C","positive regulation of transcription by RNA polymerase II(GO:0045944)|histone H3-K4 monomethylation(GO:0097692)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|histone methyltransferase complex(GO:0035097)|MLL3/4 complex(GO:0044666)|MLL3/4 complex(GO:0044666)","DNA binding(GO:0003677)|transcription coactivator activity(GO:0003713)|RNA binding(GO:0003723)|protein binding(GO:0005515)|acyltransferase activity(GO:0016746)|histone methyltransferase activity(GO:0042054)|histone binding(GO:0042393)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|metal ion binding(GO:0046872)","","","Wp histone modifications|Wp pathways affected in adenoid cystic carcinoma|Wp 16p112 proximal deletion syndrome","Developmental biology|Pkmts methylate histone lysines|Chromatin modifying enzymes|Activation of anterior hox genes in hindbrain development during early embryogenesis|Rna polymerase ii transcription|Transcriptional regulation by runx1|Runx1 regulates genes involved in megakaryocyte differentiation and platelet function","","","","Zinc","","","","","","","","","","","","D","0.023","","","D","0.997","D","0.994","U","0.000","D","0.986","M","2.175","D","-2.26","D","-4.33","0.935","D","0.226","D","0.662","D","0.133","0.686","D","0.987","24.2","3.267","4.67","1.088","13.311"
"chr7","151935866","151935866","G>A","KMT2C:58508","KMT2C","exonic","nonsynonymous SNV","","KMT2C:NM_170606:exon15:c.C2578T:p.P860S","KMT2C","exonic","nonsynonymous SNV","","KMT2C:ENST00000262189.11_1:exon15:c.C2578T:p.P860S,KMT2C:ENST00000682283.1_1:exon15:c.C2578T:p.P860S,KMT2C:ENST00000683490.1_1:exon15:c.C2578T:p.P860S,KMT2C:ENST00000684550.1_1:exon15:c.C2578T:p.P860S","KMT2C:ENST00000262189.6:c.2578C>T:p.(Pro860Ser)","0.977932","","","","","","","","","","","","","","","","ENSG00000055609","KMT2C","HGNC:13726","KMT2C","58508","ENSG00000055609","","0.7490421748517401","0.5000553554164071","1.0","OMIM:617768 Kleefstra syndrome 2-autosomal_dominant;ORPHA:261652 Kleefstra syndrome due to a point mutation-autosomal_dominant","163","0/1","Het","118","104,14","0.88135593220339","Uncertain_significance","False","not_specified","MedGen:CN169374","NC_000007.13:g.151935866G>A","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Kleefstra syndrome 2(617768)","Intellectual disability(HP:0001249)|Plagiocephaly(HP:0001357)|Kyphosis(HP:0002808)|Thick eyebrow(HP:0000574)|Hypotonia(HP:0001252)|Growth delay(HP:0001510)|Autosomal dominant inheritance(HP:0000006)|Midface retrusion(HP:0011800)|Microcephaly(HP:0000252)|Scoliosis(HP:0002650)|Delayed speech and language development(HP:0000750)|Seizure(HP:0001250)|Autosomal dominant germline de novo mutation(HP:0025352)|Everted lower lip vermilion(HP:0000232)|Generalized hypotonia(HP:0001290)|Everted lower lip vermilion(HP:0000232)|Self-injurious behavior(HP:0100716)|Abnormal facial shape(HP:0001999)|Global developmental delay(HP:0001263)|Bifid uvula(HP:0000193)|Autistic behavior(HP:0000729)|Hearing impairment(HP:0000365)|Anal atresia(HP:0002023)|Precocious puberty(HP:0000826)|Large for gestational age(HP:0001520)|Hypotonia(HP:0001252)|Seizure(HP:0001250)|Brachycephaly(HP:0000248)|Intellectual disability(HP:0001249)|Global developmental delay(HP:0001263)|Failure to thrive(HP:0001508)|Midface retrusion(HP:0011800)|Gastroesophageal reflux(HP:0002020)|Cerebellar hypoplasia(HP:0001321)|Abnormal facial shape(HP:0001999)|Abnormal shape of the palpebral fissure(HP:0200005)|Abnormality of the kidney(HP:0000077)|Abnormality of the genital system(HP:0000078)|Ventriculomegaly(HP:0002119)|Hyperextensible skin(HP:0000974)|Thick lower lip vermilion(HP:0000179)|Tapered finger(HP:0001182)|Umbilical hernia(HP:0001537)|Moderate receptive language delay(HP:0011351)|Hypoplasia of the corpus callosum(HP:0002079)|Natal tooth(HP:0000695)|Developmental cataract(HP:0000519)|Recurrent infections(HP:0002719)|Autistic behavior(HP:0000729)|Inguinal hernia(HP:0000023)|Severe expressive language delay(HP:0006863)|Microcephaly(HP:0000252)|Tracheomalacia(HP:0002779)|Plagiocephaly(HP:0001357)|Delayed gross motor development(HP:0002194)|Short stature(HP:0004322)|Gliosis(HP:0002171)|Brain imaging abnormality(HP:0410263)|Vesicoureteral reflux(HP:0000076)|Self-injurious behavior(HP:0100716)|Abnormal heart morphology(HP:0001627)|Uplifted earlobe(HP:0009909)|Overgrowth(HP:0001548)|Hypermetropia(HP:0000540)","This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]","lysine methyltransferase 2C","positive regulation of transcription by RNA polymerase II(GO:0045944)|histone H3-K4 monomethylation(GO:0097692)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|histone methyltransferase complex(GO:0035097)|MLL3/4 complex(GO:0044666)|MLL3/4 complex(GO:0044666)","DNA binding(GO:0003677)|transcription coactivator activity(GO:0003713)|RNA binding(GO:0003723)|protein binding(GO:0005515)|acyltransferase activity(GO:0016746)|histone methyltransferase activity(GO:0042054)|histone binding(GO:0042393)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|histone methyltransferase activity (H3-K4 specific)(GO:0042800)|metal ion binding(GO:0046872)","","","Wp histone modifications|Wp pathways affected in adenoid cystic carcinoma|Wp 16p112 proximal deletion syndrome","Developmental biology|Pkmts methylate histone lysines|Chromatin modifying enzymes|Activation of anterior hox genes in hindbrain development during early embryogenesis|Rna polymerase ii transcription|Transcriptional regulation by runx1|Runx1 regulates genes involved in megakaryocyte differentiation and platelet function","","","",".;.","","","","","","","","","","","","D","0.031","","","P","0.647","B","0.131","D","0.001","D","0.978","L","1.01","D","-1.77","D","-3.02","0.531","T","-0.485","T","0.355","T","0.018","0.296","D","0.906","19.29","1.943","5.53","6.188","12.706"
"chr14","53150581","53150581","A>C","","ERO1A","exonic","nonsynonymous SNV","","ERO1A:NM_014584:exon2:c.T159G:p.I53M","ERO1A","exonic","nonsynonymous SNV","","ERO1A:ENST00000395686.8_1:exon2:c.T159G:p.I53M,ERO1A:ENST00000629528.2_1:exon2:c.T159G:p.I53M","ERO1A:ENST00000395686.3:c.159T>G:p.(Ile53Met)","0.999999","0.5000540117034689","0.9999989867210388","0.7490378000146856","","","","","","","","","","","","","ENSG00000197930","ERO1A","HGNC:13280","ERO1A","30001","ENSG00000197930","","0.7490378000146856","0.5000540117034689","0.9999989867210388","","164","0/1","Het","63","39,24","0.619047619047619","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","endoplasmic reticulum oxidoreductase 1 alpha","protein folding(GO:0006457)|cellular protein modification process(GO:0006464)|response to oxidative stress(GO:0006979)|response to temperature stimulus(GO:0009266)|animal organ senescence(GO:0010260)|peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401)|protein maturation by protein folding(GO:0022417)|extracellular matrix organization(GO:0030198)|endoplasmic reticulum unfolded protein response(GO:0030968)|protein folding in endoplasmic reticulum(GO:0034975)|response to endoplasmic reticulum stress(GO:0034976)|cell redox homeostasis(GO:0045454)|brown fat cell differentiation(GO:0050873)|chaperone cofactor-dependent protein refolding(GO:0051085)|release of sequestered calcium ion into cytosol(GO:0051209)|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059)|cellular response to hypoxia(GO:0071456)","endoplasmic reticulum(GO:0005783)|endoplasmic reticulum lumen(GO:0005788)|endoplasmic reticulum membrane(GO:0005789)|membrane(GO:0016020)|dendrite(GO:0030425)|intracellular membrane-bounded organelle(GO:0043231)","protein binding(GO:0005515)|protein-disulfide reductase activity(GO:0015035)|disulfide oxidoreductase activity(GO:0015036)|oxidoreductase activity(GO:0016491)|thiol oxidase activity(GO:0016972)|FAD binding(GO:0071949)","","Vibrio cholerae infection","","Insulin processing|Peptide hormone metabolism|Detoxification of reactive oxygen species|Cellular responses to external stimuli|Cellular response to chemical stress","","Hypoxia|Unfolded protein response|Mtorc1 signaling|Glycolysis|Kras signaling up","",".;.","","Score=871;Name=V$CDP_02","","","","","","","","","","D","0.002","D","0.003","D","0.999","D","0.977","D","0.000","D","1.000","L","1.935","T","0.45","N","-2.17","0.808","T","-0.555","T","0.291","D","0.054","0.377","D","0.918","23.1","2.799","5.54","-0.223","9.573"
"chr14","92537354","92537354","->TGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG","","ATXN3","exonic","frameshift insertion","","ATXN3:NM_001164782:exon2:c.67_68insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G23Afs*71,ATXN3:NM_001164774:exon3:c.232_233insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G78Afs*71,ATXN3:NM_001164777:exon3:c.112_113insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G38Afs*71,ATXN3:NM_001164776:exon4:c.277_278insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G93Afs*71,ATXN3:NM_001164778:exon6:c.430_431insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G144Afs*71,ATXN3:NM_001164779:exon6:c.552_553insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G185Qfs*39,ATXN3:NM_001164780:exon7:c.378_379insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G127Qfs*39,ATXN3:NM_001127697:exon8:c.762_763insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G255Qfs*39,ATXN3:NM_001164781:exon8:c.705_706insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G236Qfs*39,ATXN3:NM_001127696:exon9:c.870_871insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G291Qfs*39,ATXN3:NM_030660:exon9:c.750_751insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G251Qfs*39,ATXN3:NM_004993:exon10:c.915_916insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G306Qfs*39","ATXN3","exonic","frameshift insertion","","ATXN3:ENST00000502250.5_1:exon7:c.378_379insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G127Qfs*39,ATXN3:ENST00000393287.9_1:exon8:c.762_763insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G255Qfs*39,ATXN3:ENST00000429774.6_1:exon8:c.705_706insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G236Qfs*39,ATXN3:ENST00000340660.10_1:exon9:c.750_751insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G251Qfs*39,ATXN3:ENST00000503767.5_1:exon9:c.870_871insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G291Qfs*39,ATXN3:ENST00000532032.5_1:exon10:c.915_916insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G306Qfs*39,ATXN3:ENST00000644486.2_1:exon10:c.915_916insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G306Qfs*39,ATXN3:ENST00000545170.5_1:exon11:c.942_943insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G315Qfs*39,ATXN3:ENST00000620536.4_1:exon12:c.942_943insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.G315Qfs*24","ATXN3:ENST00000340660.6:c.750_751insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.(Gly251Glnfs*39)","1","0.5000506967408","1.0","0.7490330719733062","","","","","","","","","","","","","ENSG00000066427","ATXN3","HGNC:7106","ATXN3","4287","ENSG00000066427","uc001yac.5","0.7490330719733062","0.5000506967408","1.0","OMIM:109150 Machado-Joseph disease-autosomal_dominant","165","0/1","Het","13","8,5","0.615384615384615","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Joseph disease(109150)","Supranuclear ophthalmoplegia(HP:0000623)|Urinary bladder sphincter dysfunction(HP:0002839)|Dilated fourth ventricle(HP:0002198)|Impaired horizontal smooth pursuit(HP:0001151)|Absent Achilles reflex(HP:0003438)|Distal amyotrophy(HP:0003693)|Dysmetric saccades(HP:0000641)|Abnormal autonomic nervous system physiology(HP:0012332)|Chronic pain(HP:0012532)|Ataxia(HP:0001251)|Gliosis(HP:0002171)|Bradykinesia(HP:0002067)|Gaze-evoked nystagmus(HP:0000640)|Dysphagia(HP:0002015)|Truncal ataxia(HP:0002078)|Fasciculations(HP:0002380)|Dystonia(HP:0001332)|Autosomal dominant inheritance(HP:0000006)|Cerebellar atrophy(HP:0001272)|Postural instability(HP:0002172)|Impaired vibratory sensation(HP:0002495)|Diplopia(HP:0000651)|Dementia(HP:0000726)|Proptosis(HP:0000520)|Genetic anticipation(HP:0003743)|Rigidity(HP:0002063)|Babinski sign(HP:0003487)|Ptosis(HP:0000508)|Progressive cerebellar ataxia(HP:0002073)|Facial-lingual fasciculations(HP:0007089)|External ophthalmoplegia(HP:0000544)|Limb ataxia(HP:0002070)|Parkinsonism(HP:0001300)|Spinocerebellar tract degeneration(HP:0002503)|Spasticity(HP:0001257)|Progressive(HP:0003676)|Abnormal electrooculogram(HP:0030454)|Muscle spasm(HP:0003394)|Dysarthria(HP:0001260)|Dysarthria(HP:0001260)|Vestibular dysfunction(HP:0001751)|Proptosis(HP:0000520)|Spinocerebellar tract degeneration(HP:0002503)|Supranuclear ophthalmoplegia(HP:0000623)|Muscle spasm(HP:0003394)|Progressive external ophthalmoplegia(HP:0000590)|Sleep disturbance(HP:0002360)|Memory impairment(HP:0002354)|Neurogenic bladder(HP:0000011)|Distal lower limb amyotrophy(HP:0008944)|Delayed speech and language development(HP:0000750)|Degeneration of the striatum(HP:0040140)|Clumsiness(HP:0002312)|Cerebellar atrophy(HP:0001272)|Facial-lingual fasciculations(HP:0007089)|Dilated fourth ventricle(HP:0002198)|Dysphagia(HP:0002015)|Peripheral neuropathy(HP:0009830)|Abnormality of extrapyramidal motor function(HP:0002071)|Diplopia(HP:0000651)|Progressive cerebellar ataxia(HP:0002073)|Dystonia(HP:0001332)|Vocal cord paralysis(HP:0001605)|Progressive gait ataxia(HP:0007240)|Gaze-evoked nystagmus(HP:0000640)|Hyperreflexia(HP:0001347)|Abnormality of temperature regulation(HP:0004370)|Spasticity(HP:0001257)|Babinski sign(HP:0003487)|Substantia nigra gliosis(HP:0011960)|Sleep disturbance(HP:0002360)|Progressive gait ataxia(HP:0007240)|Memory impairment(HP:0002354)|Spasticity(HP:0001257)|Dilated fourth ventricle(HP:0002198)|Degeneration of the striatum(HP:0040140)|Delayed speech and language development(HP:0000750)|Abnormality of extrapyramidal motor function(HP:0002071)|Dysphagia(HP:0002015)|Progressive external ophthalmoplegia(HP:0000590)|Muscle spasm(HP:0003394)|Substantia nigra gliosis(HP:0011960)|Abnormality of temperature regulation(HP:0004370)|Dysarthria(HP:0001260)|Distal lower limb amyotrophy(HP:0008944)|Vestibular dysfunction(HP:0001751)|Facial-lingual fasciculations(HP:0007089)|Peripheral neuropathy(HP:0009830)|Supranuclear ophthalmoplegia(HP:0000623)|Vocal cord paralysis(HP:0001605)|Babinski sign(HP:0003487)|Dystonia(HP:0001332)|Clumsiness(HP:0002312)|Progressive cerebellar ataxia(HP:0002073)|Proptosis(HP:0000520)|Spinocerebellar tract degeneration(HP:0002503)|Neurogenic bladder(HP:0000011)|Cerebellar atrophy(HP:0001272)|Diplopia(HP:0000651)|Hyperreflexia(HP:0001347)|Gaze-evoked nystagmus(HP:0000640)|Abnormality of temperature regulation(HP:0004370)|Proptosis(HP:0000520)|Facial-lingual fasciculations(HP:0007089)|Progressive gait ataxia(HP:0007240)|Progressive cerebellar ataxia(HP:0002073)|Delayed speech and language development(HP:0000750)|Cerebellar atrophy(HP:0001272)|Distal muscle weakness(HP:0002460)|Vestibular dysfunction(HP:0001751)|Degeneration of the striatum(HP:0040140)|Distal lower limb amyotrophy(HP:0008944)|Substantia nigra gliosis(HP:0011960)|Supranuclear ophthalmoplegia(HP:0000623)|Dysarthria(HP:0001260)|Clumsiness(HP:0002312)|Dysphagia(HP:0002015)|EMG abnormality(HP:0003457)|Abnormal lower motor neuron morphology(HP:0002366)|Progressive external ophthalmoplegia(HP:0000590)|Dilated fourth ventricle(HP:0002198)|Sleep disturbance(HP:0002360)|Dystonia(HP:0001332)|Degeneration of anterior horn cells(HP:0002398)|Vocal cord paralysis(HP:0001605)|Gaze-evoked nystagmus(HP:0000640)|Diplopia(HP:0000651)|Memory impairment(HP:0002354)|Babinski sign(HP:0003487)|Spasticity(HP:0001257)|Muscle spasm(HP:0003394)|Abnormality of extrapyramidal motor function(HP:0002071)|Spinocerebellar tract degeneration(HP:0002503)|Hyperreflexia(HP:0001347)|Peripheral axonal neuropathy(HP:0003477)|Neurogenic bladder(HP:0000011)","Machado-Joseph disease, also known as spinocerebellar ataxia-3, is an autosomal dominant neurologic disorder. The protein encoded by this gene contains (CAG)n repeats in the coding region, and the expansion of these repeats from the normal 12-44 to 52-86 is one cause of Machado-Joseph disease. There is a negative correlation between the age of onset and CAG repeat numbers. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2016]","ataxin 3","microtubule cytoskeleton organization(GO:0000226)|nucleotide-excision repair(GO:0006289)|ubiquitin-dependent protein catabolic process(GO:0006511)|protein quality control for misfolded or incompletely synthesized proteins(GO:0006515)|chemical synaptic transmission(GO:0007268)|nervous system development(GO:0007399)|regulation of cell-substrate adhesion(GO:0010810)|protein deubiquitination(GO:0016579)|protein deubiquitination(GO:0016579)|protein deubiquitination(GO:0016579)|actin cytoskeleton organization(GO:0030036)|cellular response to heat(GO:0034605)|monoubiquitinated protein deubiquitination(GO:0035520)|proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161)|intermediate filament cytoskeleton organization(GO:0045104)|protein K63-linked deubiquitination(GO:0070536)|protein K48-linked deubiquitination(GO:0071108)|cellular response to misfolded protein(GO:0071218)|positive regulation of ERAD pathway(GO:1904294)|protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|nucleolus(GO:0005730)|cytoplasm(GO:0005737)|mitochondrial matrix(GO:0005759)|endoplasmic reticulum membrane(GO:0005789)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|nuclear matrix(GO:0016363)|mitochondrial membrane(GO:0031966)|nuclear inclusion body(GO:0042405)|synapse(GO:0045202)","thiol-dependent deubiquitinase(GO:0004843)|thiol-dependent deubiquitinase(GO:0004843)|thiol-dependent deubiquitinase(GO:0004843)|protein binding(GO:0005515)|ubiquitin protein ligase binding(GO:0031625)|ubiquitin protein ligase binding(GO:0031625)|ATPase binding(GO:0051117)|Lys63-specific deubiquitinase activity(GO:0061578)|Lys48-specific deubiquitinase activity(GO:1990380)","Parkinson's disease(DOID:14330)|Machado-Joseph disease(DOID:1440)|autosomal dominant cerebellar ataxia(DOID:1441)|dystonia(DOID:543)|neuroblastoma(DOID:769)|disease(DOID:4)","","","Deubiquitination|Josephin domain dubs|Post translational protein modification|Rna polymerase ii transcription|Foxo mediated transcription|Foxo mediated transcription of oxidative stress metabolic and neuronal genes","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr11","4080605","4080605","G>A","","STIM1","exonic","nonsynonymous SNV","","STIM1:NM_001277961:exon5:c.G592A:p.V198M,STIM1:NM_001277962:exon5:c.G592A:p.V198M,STIM1:NM_003156:exon5:c.G592A:p.V198M","STIM1","exonic","nonsynonymous SNV","","STIM1:ENST00000533977.5_1:exon2:c.G73A:p.V25M,STIM1:ENST00000300737.8_1:exon5:c.G592A:p.V198M,STIM1:ENST00000526596.2_1:exon5:c.G592A:p.V198M,STIM1:ENST00000527651.5_1:exon5:c.G592A:p.V198M,STIM1:ENST00000616714.4_1:exon5:c.G592A:p.V198M","STIM1:ENST00000300737.4:c.592G>A:p.(Val198Met)","0.99979645","0.5002087400789605","0.999796450138092","0.7489904764512743","","","","","","","","","","","","","ENSG00000167323","STIM1","HGNC:11386","STIM1","6786","ENSG00000167323","uc001lyv.3","0.7489904764512743","0.5002087400789605","0.999796450138092","OMIM:160565 Myopathy, tubular aggregate, 1-autosomal_dominant;OMIM:185070 Stormorken syndrome-autosomal_dominant;OMIM:612783 Immunodeficiency 10-autosomal_recessive;ORPHA:2593 Tubular aggregate myopathy-autosomal_dominant;ORPHA:3204 Stormorken-Sjaastad-Langslet syndrome-autosomal_dominant","166","0/1","Het","139","82,57","0.589928057553957","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Myopathy, tubular aggregate, 1(160565)|Stormorken syndrome(185070)|Immunodeficiency 10(612783)","Elevated circulating creatine kinase concentration(HP:0003236)|Myalgia(HP:0003326)|Hypotelorism(HP:0000601)|Increased muscle fatiguability(HP:0003750)|Asplenia(HP:0001746)|Short stature(HP:0004322)|Myopathy(HP:0003198)|Epistaxis(HP:0000421)|Stroke-like episode(HP:0002401)|Autosomal dominant inheritance(HP:0000006)|Anemia(HP:0001903)|Proximal muscle weakness(HP:0003701)|Migraine(HP:0002076)|Abnormal bleeding(HP:0001892)|Deeply set eye(HP:0000490)|Howell-Jolly bodies(HP:0032550)|Ichthyosis(HP:0008064)|Thrombocytopenia(HP:0001873)|Progressive(HP:0003676)|Dyslexia(HP:0010522)|Prominent nose(HP:0000448)|Miosis(HP:0000616)|Increased variability in muscle fiber diameter(HP:0003557)|Type 2 muscle fiber atrophy(HP:0003554)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Myalgia(HP:0003326)|Muscle spasm(HP:0003394)|Fatiguable weakness of proximal limb muscles(HP:0030200)|Muscle fiber tubular inclusions(HP:0100301)|EMG: myopathic abnormalities(HP:0003458)|Amelogenesis imperfecta(HP:0000705)|Autoimmune hemolytic anemia(HP:0001890)|Myopathy(HP:0003198)|Hypoplasia of the iris(HP:0007676)|Autosomal recessive inheritance(HP:0000007)|Recurrent infections(HP:0002719)|Immunodeficiency(HP:0002721)|Kaposi's sarcoma(HP:0100726)|Hypohidrosis(HP:0000966)|Recurrent fever(HP:0001954)|Recurrent bacterial infections(HP:0002718)|Thrombocytopenia(HP:0001873)|Lymphadenopathy(HP:0002716)|Hypotonia(HP:0001252)|Nail dysplasia(HP:0002164)|Variable expressivity(HP:0003828)|High forehead(HP:0000348)|Abnormality of coagulation(HP:0001928)|Abnormality of the musculature(HP:0003011)|Purpura(HP:0000979)|Abnormal thrombocyte morphology(HP:0001872)|Anemia(HP:0001903)|Neurological speech impairment(HP:0002167)|Ichthyosis(HP:0008064)|Miosis(HP:0000616)|Short stature(HP:0004322)|Asplenia(HP:0001746)|Deeply set eye(HP:0000490)|Abnormal pupil morphology(HP:0000615)|Myopathy(HP:0003198)|Proximal muscle weakness(HP:0003701)|Proximal amyotrophy(HP:0007126)|Weakness of the intrinsic hand muscles(HP:0009005)|Exercise-induced myalgia(HP:0003738)|External ophthalmoplegia(HP:0000544)|Frequent falls(HP:0002359)|Nyctalopia(HP:0000662)|Flexion contracture(HP:0001371)|Adult onset(HP:0003581)|Muscle spasm(HP:0003394)|Type 2 muscle fiber atrophy(HP:0003554)|Slowly progressive(HP:0003677)|Increased variability in muscle fiber diameter(HP:0003557)|Areflexia of lower limbs(HP:0002522)|Difficulty running(HP:0009046)|Respiratory insufficiency(HP:0002093)|Hyporeflexia of lower limbs(HP:0002600)|Easy fatigability(HP:0003388)|Autosomal dominant inheritance(HP:0000006)|Elevated circulating creatine kinase concentration(HP:0003236)|Muscle stiffness(HP:0003552)","This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]","stromal interaction molecule 1","store-operated calcium entry(GO:0002115)|store-operated calcium entry(GO:0002115)|detection of calcium ion(GO:0005513)|cellular calcium ion homeostasis(GO:0006874)|activation of store-operated calcium channel activity(GO:0032237)|activation of store-operated calcium channel activity(GO:0032237)|positive regulation of adenylate cyclase activity(GO:0045762)|positive regulation of angiogenesis(GO:0045766)|regulation of calcium ion transport(GO:0051924)|enamel mineralization(GO:0070166)|regulation of store-operated calcium entry(GO:2001256)","endoplasmic reticulum(GO:0005783)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum membrane(GO:0005789)|microtubule(GO:0005874)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|integral component of endoplasmic reticulum membrane(GO:0030176)|cortical endoplasmic reticulum(GO:0032541)|cortical endoplasmic reticulum(GO:0032541)|sarcoplasmic reticulum membrane(GO:0033017)|plasma membrane raft(GO:0044853)","protease binding(GO:0002020)|calcium channel regulator activity(GO:0005246)|calcium channel regulator activity(GO:0005246)|calcium channel regulator activity(GO:0005246)|calcium ion binding(GO:0005509)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|identical protein binding(GO:0042802)|microtubule plus-end binding(GO:0051010)","T cell deficiency(DOID:11200)|thrombocytopenia(DOID:1588)|cancer(DOID:162)|syndrome(DOID:225)|anemia(DOID:2355)|hemolytic anemia(DOID:583)|primary immunodeficiency disease(DOID:612)|autoimmune hemolytic anemia(DOID:718)","","Wp camkk2 pathway","Hemostasis|Adaptive immune system|Elevation of cytosolic ca2 levels|Muscle contraction|Platelet homeostasis|Platelet calcium homeostasis|Cardiac conduction|Ion homeostasis|Antigen activates b cell receptor bcr leading to generation of second messengers|Signaling by the b cell receptor bcr","","","","Sterile","","","0","","","0.","0.","","","","","D","0.001","D","0.002","D","0.995","P","0.843","D","0.000","D","1","M","3.105","T","0.86","D","-2.59","0.873","D","0.136","D","0.569","D","0.105","0.486","D","0.968","28.1","4.052","5.87","9.892","17.697"
"chr8","53025894","53025894","G>A","","ST18","exonic","nonsynonymous SNV","","ST18:NM_014682:exon26:c.C3008T:p.P1003L","ST18","exonic","nonsynonymous SNV","","ST18:ENST00000276480.11_1:exon26:c.C3008T:p.P1003L","ST18:ENST00000276480.7:c.3008C>T:p.(Pro1003Leu)","1","0.5000246458803304","1.0","0.7489821655168655","","","","","","","","","","","","","ENSG00000147488","ST18","HGNC:18695","ST18","9705","ENSG00000147488","uc003xra.3","0.7489821655168655","0.5000246458803304","1.0","","167","0/1","Het","76","43,33","0.565789473684211","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ST18 C2H2C-type zinc finger transcription factor","regulation of transcription by RNA polymerase II(GO:0006357)|negative regulation of cell population proliferation(GO:0008285)|tumor necrosis factor-mediated signaling pathway(GO:0033209)|positive regulation of transcription by RNA polymerase II(GO:0045944)|interleukin-6-mediated signaling pathway(GO:0070102)|interleukin-1-mediated signaling pathway(GO:0070498)|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269)","chromatin(GO:0000785)|nucleus(GO:0005634)|nucleus(GO:0005634)|protein-DNA complex(GO:0032993)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|zinc ion binding(GO:0008270)","cancer(DOID:162)","","","","","","","","","Score=924;Name=V$GATA_C","","","","","","","","","","D","0.0","D","0.0","D","1.0","D","0.998","D","0.000","D","1","M","2.38","T","0.36","D","-7.74","0.705","T","-0.354","T","0.369","D","0.059","0.576","D","0.999","31","4.377","5.97","10.003","20.417"
"chr2","95691550","95691550","G>A","","MAL","exonic","nonsynonymous SNV","","MAL:NM_002371:exon1:c.G13A:p.A5T,MAL:NM_022438:exon1:c.G13A:p.A5T,MAL:NM_022439:exon1:c.G13A:p.A5T,MAL:NM_022440:exon1:c.G13A:p.A5T","MAL","exonic","nonsynonymous SNV","","MAL:ENST00000309988.9_1:exon1:c.G13A:p.A5T,MAL:ENST00000349807.3_1:exon1:c.G13A:p.A5T,MAL:ENST00000353004.7_1:exon1:c.G13A:p.A5T,MAL:ENST00000354078.7_1:exon1:c.G13A:p.A5T","MAL:ENST00000309988.4:c.13G>A:p.(Ala5Thr)","1","0.5000213800030906","1.0","0.7489757831229722","","","","","","","","","","","","","ENSG00000172005","MAL","HGNC:6817","MAL","4118","ENSG00000172005","uc002stx.3","0.7489757831229722","0.5000213800030906","1.0","","168","0/1","Het","197","104,93","0.527918781725888","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a highly hydrophobic integral membrane protein belonging to the MAL family of proteolipids. The protein has been localized to the endoplasmic reticulum of T-cells and is a candidate linker protein in T-cell signal transduction. In addition, this proteolipid is localized in compact myelin of cells in the nervous system and has been implicated in myelin biogenesis and/or function. The protein plays a role in the formation, stabilization and maintenance of glycosphingolipid-enriched membrane microdomains. Down-regulation of this gene has been associated with a variety of human epithelial malignancies. Alternative splicing produces four transcript variants which vary from each other by the presence or absence of alternatively spliced exons 2 and 3. [provided by RefSeq, May 2012]","mal, T cell differentiation protein","membrane raft polarization(GO:0001766)|apoptotic process(GO:0006915)|central nervous system development(GO:0007417)|cell differentiation(GO:0030154)|myelination(GO:0042552)|myelination(GO:0042552)|myelination(GO:0042552)|apical protein localization(GO:0045176)","endoplasmic reticulum(GO:0005783)|integral component of membrane(GO:0016021)|apical plasma membrane(GO:0016324)|extrinsic component of membrane(GO:0019898)|membrane raft(GO:0045121)","protein binding(GO:0005515)|lipid binding(GO:0008289)|peptidase activator activity involved in apoptotic process(GO:0016505)|structural constituent of myelin sheath(GO:0019911)|structural constituent of myelin sheath(GO:0019911)","head and neck cancer(DOID:11934)|head and neck carcinoma(DOID:1542)|cancer(DOID:162)|squamous cell carcinoma(DOID:1749)|adenoma(DOID:657)|disease(DOID:4)|prostate cancer(DOID:10283)|rheumatoid arthritis(DOID:7148)|carcinoma(DOID:305)|esophagus squamous cell carcinoma(DOID:3748)","","","","Mal pathway","Apical surface","",".;.;.;.","","Score=768;Name=V$PAX5_01","","","","","","","","","","T","0.298","T","0.454","P","0.635","B","0.07","N","0.127","D","0.822","L","0.835","T","0.87","N","0.05","0.336","T","-1.053","T","0.061","D","0.057","0.018","T","0.209","19.73","1.999","4.17","1.844","7.715"
"chr5","122495312","122495312","G>A","","PRDM6","exonic","nonsynonymous SNV","","PRDM6:NM_001136239:exon5:c.G1133A:p.C378Y","PRDM6","exonic","nonsynonymous SNV","","PRDM6:ENST00000407847.5_1:exon5:c.G1133A:p.C378Y","PRDM6:ENST00000407847.4:c.1133G>A:p.(Cys378Tyr)","1","0.5000201696966542","1.0","0.7489734178344669","","","","","","","","","","","","","ENSG00000061455","PRDM6","HGNC:9350","PRDM6","93166","ENSG00000061455","uc003kti.4","0.7489734178344669","0.5000201696966542","1.0","OMIM:617039 Patent ductus arteriosus 3-autosomal_dominant","169","0/1","Het","50","24,26","0.48","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Patent ductus arteriosus 3(617039)","Autosomal dominant inheritance(HP:0000006)|Patent ductus arteriosus(HP:0001643)","The protein encoded by this gene is a transcriptional repressor and a member of the PRDM family. Family members contain a PR domain and multiple zinc-finger domains. The encoded protein is involved in regulation of vascular smooth muscle cells (VSMC) contractile proteins. Mutations in this gene result in patent ductus arteriosus 3 (PDA3). [provided by RefSeq, Apr 2017]","PR/SET domain 6","negative regulation of transcription by RNA polymerase II(GO:0000122)|regulation of gene expression(GO:0010468)|histone methylation(GO:0016571)|neurogenesis(GO:0022008)|negative regulation of smooth muscle cell differentiation(GO:0051151)","nucleus(GO:0005634)","protein binding(GO:0005515)|histone methyltransferase activity(GO:0042054)|identical protein binding(GO:0042802)|metal ion binding(GO:0046872)","","","","","","","","","","Score=836;Name=V$CHOP_01","","","","","","","","","","T","0.079","D","0.008","D","0.987","P","0.737","D","0.000","D","1","N","0.695","T","3.08","N","-0.85","0.818","T","-1.031","T","0.031","T","0.014","0.371","D","0.675","24.6","3.385","6.04","8.113","18.760"
"chr15","62939564","62939564","A>G","","TLN2","exonic","nonsynonymous SNV","","TLN2:NM_015059:exon1:c.A55G:p.M19V","TLN2","exonic","nonsynonymous SNV","","TLN2:ENST00000561311.5_1:exon3:c.A55G:p.M19V","TLN2:ENST00000306829.6:c.55A>G:p.(Met19Val)","0.99989766","0.5001102159876609","0.9998976588249208","0.7489726855571572","","","","","","","","","","","","","ENSG00000171914","TLN2","HGNC:15447","TLN2","83660","ENSG00000171914","uc002alb.5","0.7489726855571572","0.5001102159876609","0.9998976588249207","","170","0/1","Het","199","105,94","0.527638190954774","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein related to talin 1, a cytoskeletal protein that plays a significant role in the assembly of actin filaments and in spreading and migration of various cell types, including fibroblasts and osteoclasts. This protein has a different pattern of expression compared to talin 1 but, like talin 1, is thought to associate with unique transmembrane receptors to form novel linkages between extracellular matrices and the actin cytoskeleton. [provided by RefSeq, Jul 2008]","talin 2","cytoskeleton organization(GO:0007010)|cell-cell junction assembly(GO:0007043)|cell adhesion(GO:0007155)|cell-cell adhesion(GO:0098609)","ruffle(GO:0001726)|cytoplasm(GO:0005737)|plasma membrane(GO:0005886)|focal adhesion(GO:0005925)|focal adhesion(GO:0005925)|actin cytoskeleton(GO:0015629)|synapse(GO:0045202)","actin binding(GO:0003779)|integrin binding(GO:0005178)|structural molecule activity(GO:0005198)|structural constituent of cytoskeleton(GO:0005200)|protein binding(GO:0005515)|actin filament binding(GO:0051015)","epilepsy(DOID:1826)|temporal lobe epilepsy(DOID:3328)","Focal adhesion","Wp focal adhesion","","","","","Talin,","","","","","","","","","","","","D","0.006","D","0.015","D","0.98","D","0.968","D","0.000","D","1","M","2.475","T","-0.45","N","-1.5","0.906","D","0.101","D","0.505","D","0.181","0.614","D","0.930","25.2","3.550","5.5","9.315","15.081"
"chr7","927016","927016","C>G","","GET4","exonic","nonsynonymous SNV","","GET4:NM_015949:exon4:c.C326G:p.A109G","GET4","exonic","nonsynonymous SNV","","GET4:ENST00000407192.5_1:exon3:c.C167G:p.A56G,GET4:ENST00000265857.8_1:exon4:c.C326G:p.A109G","GET4:ENST00000265857.3:c.326C>G:p.(Ala109Gly)","0.999999","0.5000119679434647","0.9999989867210388","0.7489556391729886","","","","","","","","","","","","","ENSG00000239857","GET4","HGNC:21690","GET4","51608","ENSG00000239857","uc003sjl.2","0.7489556391729886","0.5000119679434647","0.9999989867210388","","171","0/1","Het","50","37,13","0.74","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","guided entry of tail-anchored proteins factor 4","protein insertion into ER membrane(GO:0045048)|cytoplasmic sequestering of protein(GO:0051220)|tail-anchored membrane protein insertion into ER membrane(GO:0071816)|tail-anchored membrane protein insertion into ER membrane(GO:0071816)|maintenance of unfolded protein involved in ERAD pathway(GO:1904378)","nucleoplasm(GO:0005654)|chromosome(GO:0005694)|nucleolus(GO:0005730)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytosol(GO:0005829)|BAT3 complex(GO:0071818)|BAT3 complex(GO:0071818)","protein binding(GO:0005515)|chaperone binding(GO:0051087)","","","","Protein localization|Insertion of tail anchored proteins into the endoplasmic reticulum membrane","","","",".;.;.;.;.","","","","","","","","","","","","T","0.197","T","0.28","B","0.003","B","0.011","D","0.000","D","1.000","L","0.98","T","-1.34","N","-1.19","0.471","T","-0.773","T","0.271","D","0.033","0.254","D","0.532","18.13","1.790","5.15","4.749","14.748"
"chr7","144059763","144059763","->TGGAGGCTGAGGAGGCCCAGCG","","ARHGEF5","exonic","frameshift insertion","","ARHGEF5:NM_005435:exon2:c.1_2insTGGAGGCTGAGGAGGCCCAGCG:p.A10Gfs*2","ARHGEF5","exonic","frameshift insertion","","ARHGEF5:ENST00000056217.10_1:exon2:c.1_2insTGGAGGCTGAGGAGGCCCAGCG:p.A10Gfs*2","ARHGEF5:ENST00000056217.5:c.7_28dup:p.(Ala10Glyfs*2)","1","0.5000068467625169","1.0","0.7489473799921119","","","","","","","","","","","","","ENSG00000050327","ARHGEF5","HGNC:13209","ARHGEF5","7984","ENSG00000050327","uc003wel.4","0.7489473799921119","0.5000068467625169","1.0","","172","0/1","Het","256","195,61","0.76171875","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Rho GTPases play a fundamental role in numerous cellular processes initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. This protein may be involved in the control of cytoskeletal organization. [provided by RefSeq, Jul 2008]","Rho guanine nucleotide exchange factor 5","regulation of actin cytoskeleton organization(GO:0032956)|intracellular signal transduction(GO:0035556)|regulation of GTPase activity(GO:0043087)|positive regulation of JUN kinase activity(GO:0043507)|regulation of small GTPase mediated signal transduction(GO:0051056)|positive regulation of DNA-binding transcription factor activity(GO:0051091)|regulation of cytoskeleton organization(GO:0051493)|positive regulation of stress fiber assembly(GO:0051496)|regulation of ERK1 and ERK2 cascade(GO:0070372)|activation of GTPase activity(GO:0090630)|positive regulation of protein import(GO:1904591)","podosome(GO:0002102)|nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|cell junction(GO:0030054)|cell projection(GO:0042995)|cell periphery(GO:0071944)","guanyl-nucleotide exchange factor activity(GO:0005085)|guanyl-nucleotide exchange factor activity(GO:0005085)|protein binding(GO:0005515)|GTP binding(GO:0005525)|lipid binding(GO:0008289)","allergic disease(DOID:1205)|hepatocellular carcinoma(DOID:684)","","","Nrage signals death through jnk|P75 ntr receptor mediated signalling|Cell death signalling via nrage nrif and nade|Signaling by gpcr|G alpha 12 13 signalling events|Death receptor signalling|Rhoa gtpase cycle|Rho gtpase cycle|Rhob gtpase cycle|Rhoc gtpase cycle|Cdc42 gtpase cycle|Rac1 gtpase cycle|Rhog gtpase cycle|Signaling by rho gtpases miro gtpases and rhobtb3","Rho pathway","","SpliceAI>ATGGAGGCTGAGGAGGCCCAGCG|ARHGEF5|0.00|0.10|0.00|0.00|0|-12|-12|6","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr1","65886412","65886412","C>G","","LEPROT","exonic","nonsynonymous SNV","","LEPROT:NM_001198683:exon1:c.C5G:p.A2G,LEPROT:NM_017526:exon1:c.C5G:p.A2G","LEPROT","exonic","nonsynonymous SNV","","LEPROT:ENST00000371065.9_1:exon1:c.C5G:p.A2G,LEPROT:ENST00000475108.5_1:exon1:c.C5G:p.A2G,LEPROT:ENST00000484243.1_1:exon1:c.C5G:p.A2G,LEPROT:ENST00000488747.5_1:exon1:c.C5G:p.A2G","LEPROT:ENST00000371065.4:c.5C>G:p.(Ala2Gly)","1","0.5000027094258712","1.0","0.7489392937713325","","","","","","","","","","","","","ENSG00000213625","LEPROT","HGNC:29477","LEPROT","54741","ENSG00000213625","uc001dcf.4","0.7489392937713325","0.5000027094258712","1.0","","173","0/1","Het","81","58,23","0.716049382716049","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","LEPROT is associated with the Golgi complex and endosomes and has a role in cell surface expression of growth hormone receptor (GHR; MIM 600946) and leptin receptor (OBR, or LEPR; MIM 601007), thereby altering receptor-mediated cell signaling (Couturier et al., 2007 [PubMed 18042720]; Touvier et al., 2009 [PubMed 19907080]).[supplied by OMIM, Jul 2010]","leptin receptor overlapping transcript","late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511)|negative regulation of receptor signaling pathway via JAK-STAT(GO:0046426)|negative regulation of growth hormone receptor signaling pathway(GO:0060400)|negative regulation of growth hormone receptor signaling pathway(GO:0060400)|positive regulation of protein targeting to mitochondrion(GO:1903955)|negative regulation of protein localization to cell surface(GO:2000009)","Golgi membrane(GO:0000139)|endosome(GO:0005768)|endosome(GO:0005768)|Golgi apparatus(GO:0005794)|endosome membrane(GO:0010008)|integral component of membrane(GO:0016021)","signaling receptor binding(GO:0005102)|protein binding(GO:0005515)","","","","","","","",".;.;.;.","","","","","","","","","","","","T","0.118","T","0.357","D","0.992","D","0.982","U","0.102","D","1","M","2.24","","","N","-2.23","0.272","T","-0.461","T","0.284","D","0.505","0.130","D","0.910","32","4.505","4.14","1.708","12.679"
"chr1","117142868","117142868","C>T","IGSF3:3321","IGSF3","exonic","stopgain","","IGSF3:NM_001007237:exon7:c.G1724A:p.W575X,IGSF3:NM_001542:exon7:c.G1784A:p.W595X","IGSF3","exonic","stopgain","","IGSF3:ENST00000318837.6_1:exon7:c.G1784A:p.W595X,IGSF3:ENST00000369486.8_1:exon7:c.G1724A:p.W575X,IGSF3:ENST00000369483.5_1:exon8:c.G1784A:p.W595X","IGSF3:ENST00000318837.6:c.1784G>A:p.(Trp595*)","1","0.2500001354960659","1.0","0.1815782512890134","0.5000002709921318","1.0","0.7489345278915479","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","174","0/1","Het","350","191,159","0.545714285714286","Pathogenic","True","not_provided","MedGen:CN517202","NC_000001.10:g.117142868C>T","criteria_provided,_single_submitter","Pathogenic","PVS1: 1 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin","","","0.00000398","","","","","","","3.98e-06","0","","","","","","","","","D","0.001","A","1","","","","","","","0.404","","","","","","","","","","41","8.071","4.57","4.253","14.899"
"chr1","117156459","117156459","C>T","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001542:exon3:c.G760A:p.D254N,IGSF3:NM_001007237:exon4:c.G760A:p.D254N","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon3:c.G760A:p.D254N,IGSF3:ENST00000369483.5_1:exon4:c.G760A:p.D254N,IGSF3:ENST00000369486.8_1:exon4:c.G760A:p.D254N","IGSF3:ENST00000318837.6:c.760G>A:p.(Asp254Asn)","1","","","","0.5000002709921318","1.0","0.7489345278915479","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","175","0/1","Het","187","100,87","0.53475935828877","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin","","","","","","","","","","","","D","0.006","D","0.0","D","0.999","D","0.997","D","0.000","D","1","M","3.225","T","1.89","D","-4.96","0.875","T","-1.002","T","0.112","D","0.050","0.324","D","0.998","28.1","4.043","4.77","7.565","15.327"
"chr1","117156584","117156584","T>C","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001542:exon3:c.A635G:p.Q212R,IGSF3:NM_001007237:exon4:c.A635G:p.Q212R","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon3:c.A635G:p.Q212R,IGSF3:ENST00000369483.5_1:exon4:c.A635G:p.Q212R,IGSF3:ENST00000369486.8_1:exon4:c.A635G:p.Q212R","IGSF3:ENST00000318837.6:c.635A>G:p.(Gln212Arg)","0.9998564","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","176","0/1","Het","157","106,51","0.67515923566879","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin","","Score=902;Name=V$OCT1_02","0.000003982","","","0.","0.","","","3.982e-06","0","T","0.139","D","0.02","P","0.453","P","0.485","D","0.000","D","1.000","M","2.105","T","-0.1","D","-2.57","0.632","T","-0.888","T","0.140","D","0.029","0.157","D","0.773","22.9","2.663","4.9","4.833","9.041"
"chr1","117156585","117156585","G>A","","IGSF3","exonic","stopgain","","IGSF3:NM_001542:exon3:c.C634T:p.Q212X,IGSF3:NM_001007237:exon4:c.C634T:p.Q212X","IGSF3","exonic","stopgain","","IGSF3:ENST00000318837.6_1:exon3:c.C634T:p.Q212X,IGSF3:ENST00000369483.5_1:exon4:c.C634T:p.Q212X,IGSF3:ENST00000369486.8_1:exon4:c.C634T:p.Q212X","IGSF3:ENST00000318837.6:c.634C>T:p.(Gln212*)","0.9997961","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","177","0/1","Het","157","106,51","0.67515923566879","","","","","","","Pathogenic","PVS1: 1 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin","","Score=902;Name=V$OCT1_02","0.000003982","","","0.","0.","","","3.982e-06","0","","","","","","","","","D","0.000","A","1","","","","","","","0.378","","","","","","","","","","37","7.102","4.9","7.803","15.611"
"chr1","117146504","117146504","G>A","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001007237:exon6:c.C1366T:p.R456C,IGSF3:NM_001542:exon6:c.C1426T:p.R476C","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon6:c.C1426T:p.R476C,IGSF3:ENST00000369486.8_1:exon6:c.C1366T:p.R456C,IGSF3:ENST00000369483.5_1:exon7:c.C1426T:p.R476C","IGSF3:ENST00000318837.6:c.1426C>T:p.(Arg476Cys)","0.9997558","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","178","0/1","Het","221","140,81","0.633484162895928","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","SpliceAI>A|IGSF3|0.00|0.00|0.00|0.00|-25|18|-25|-48",".;Immunoglobulin-like","","","0.000007985","","","0.","0.","","","7.985e-06","0","D","0.007","D","0.013","D","1.0","D","0.985","D","0.000","D","1","M","2.005","T","-0.18","N","-2.47","0.756","T","-0.584","T","0.246","D","0.085","0.385","D","0.809","32","4.436","5.27","3.994","14.260"
"chr1","117158909","117158909","C>T","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001542:exon2:c.G214A:p.V72I,IGSF3:NM_001007237:exon3:c.G214A:p.V72I","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon2:c.G214A:p.V72I,IGSF3:ENST00000369483.5_1:exon3:c.G214A:p.V72I,IGSF3:ENST00000369486.8_1:exon3:c.G214A:p.V72I","IGSF3:ENST00000318837.6:c.214G>A:p.(Val72Ile)","0.9992381","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","179","0/1","Het","171","150,21","0.87719298245614","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin","","","0.00001241","","","0.","0.","","","1.241e-05","0","T","0.831","T","0.616","B","0.198","B","0.06","N","0.000","D","1.000","N","0.45","T","4.35","N","0.12","0.071","T","-0.955","T","0.001","T","0.009","0.034","T","0.327","16.98","1.621","4.79","1.213","9.037"
"chr1","117142700","117142700","C>A","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001007237:exon7:c.G1892T:p.S631I,IGSF3:NM_001542:exon7:c.G1952T:p.S651I","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon7:c.G1952T:p.S651I,IGSF3:ENST00000369486.8_1:exon7:c.G1892T:p.S631I,IGSF3:ENST00000369483.5_1:exon8:c.G1952T:p.S651I","IGSF3:ENST00000318837.6:c.1952G>T:p.(Ser651Ile)","0.9989785","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","180","0/1","Het","390","244,146","0.625641025641026","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin","","Score=842;Name=V$EGR1_01","0.00002808","","","0.0016","0.0016","","","2.808e-05","0","T","0.231","T","0.508","P","0.708","P","0.554","N","0.004","D","1.000","L","1.905","T","2.75","N","-1.07","0.918","T","-1.117","T","0.030","T","0.014","0.243","T","0.275","24.5","3.336","4.8","5.811","10.555"
"chr1","117146563","117146563","G>A","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001007237:exon6:c.C1307T:p.T436M,IGSF3:NM_001542:exon6:c.C1367T:p.T456M","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon6:c.C1367T:p.T456M,IGSF3:ENST00000369486.8_1:exon6:c.C1307T:p.T436M,IGSF3:ENST00000369483.5_1:exon7:c.C1367T:p.T456M","IGSF3:ENST00000318837.6:c.1367C>T:p.(Thr456Met)","0.9970204","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","181","0/1","Het","218","140,78","0.642201834862385","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","SpliceAI>A|IGSF3|0.00|0.00|0.00|0.00|-41|8|-5|8",".;Immunoglobulin-like","","","0.00001999","","","0.","0.","","","1.999e-05","0","T","0.052","T","0.092","P","0.583","B","0.102","D","0.001","D","0.998","L","1.39","T","4.2","N","-1.2","0.28","T","-0.468","T","0.003","T","0.010","0.137","T","0.257","23.0","2.716","5.27","2.776","14.260"
"chr1","117146592","117146592","C>G","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001007237:exon6:c.G1278C:p.E426D,IGSF3:NM_001542:exon6:c.G1338C:p.E446D","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon6:c.G1338C:p.E446D,IGSF3:ENST00000369486.8_1:exon6:c.G1278C:p.E426D,IGSF3:ENST00000369483.5_1:exon7:c.G1338C:p.E446D","IGSF3:ENST00000318837.6:c.1338G>C:p.(Glu446Asp)","0.995157","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","182","0/1","Het","189","134,55","0.708994708994709","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin-like","","","","","","","","","","","","T","0.309","T","0.479","B","0.0","B","0.002","N","0.000","D","0.995","N","0.55","T","4.13","N","-1.66","0.231","T","-0.880","T","0.003","T","0.006","0.145","T","0.341","15.58","1.374","5.09","0.727","11.643"
"chr1","117146585","117146585","G>A","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001007237:exon6:c.C1285T:p.R429C,IGSF3:NM_001542:exon6:c.C1345T:p.R449C","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon6:c.C1345T:p.R449C,IGSF3:ENST00000369486.8_1:exon6:c.C1285T:p.R429C,IGSF3:ENST00000369483.5_1:exon7:c.C1345T:p.R449C","IGSF3:ENST00000318837.6:c.1345C>T:p.(Arg449Cys)","0.99513125","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","183","0/1","Het","204","169,35","0.82843137254902","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin-like","","","0.00000804","","","","","","","8.04e-06","0","D","0.05","T","0.147","P","0.912","P","0.471","N","0.004","D","0.996","L","1.39","T","4.16","N","-1.2","0.53","T","-0.761","T","0.009","T","0.012","0.123","D","0.915","29.3","4.185","5.09","7.415","13.858"
"chr1","117158972","117158972","A>G","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001542:exon2:c.T151C:p.S51P,IGSF3:NM_001007237:exon3:c.T151C:p.S51P","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon2:c.T151C:p.S51P,IGSF3:ENST00000369483.5_1:exon3:c.T151C:p.S51P,IGSF3:ENST00000369486.8_1:exon3:c.T151C:p.S51P","IGSF3:ENST00000318837.6:c.151T>C:p.(Ser51Pro)","0.995","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","184","0/1","Het","152","113,39","0.743421052631579","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin","","","0","","","0.","0.","","","0","0","D","0.005","D","0.023","B","0.023","B","0.035","N","0.785","N","1","M","2.195","T","-0.17","D","-3.9","0.148","T","-0.828","T","0.135","D","0.044","0.264","D","0.558","9.173","0.476","4.65","-0.270","16.775"
"chr1","117150736","117150736","C>G","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001542:exon4:c.G1050C:p.K350N,IGSF3:NM_001007237:exon5:c.G1050C:p.K350N","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon4:c.G1050C:p.K350N,IGSF3:ENST00000369483.5_1:exon5:c.G1050C:p.K350N,IGSF3:ENST00000369486.8_1:exon5:c.G1050C:p.K350N","IGSF3:ENST00000318837.6:c.1050G>C:p.(Lys350Asn)","0.98356664","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","185","0/1","Het","143","119,24","0.832167832167832","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin-like","","","0.000007963","","","","","","","7.963e-06","0","D","0.016","T","0.145","B","0.002","B","0.009","D","0.000","N","0.955","N","0.695","T","-0.22","N","-1.35","0.641","T","-1.150","T","0.069","T","0.024","0.090","T","0.061","1.653","-0.075","4.67","-0.700","19.832"
"chr1","117146629","117146629","T>C","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001007237:exon6:c.A1241G:p.E414G,IGSF3:NM_001542:exon6:c.A1301G:p.E434G","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon6:c.A1301G:p.E434G,IGSF3:ENST00000369486.8_1:exon6:c.A1241G:p.E414G,IGSF3:ENST00000369483.5_1:exon7:c.A1301G:p.E434G","IGSF3:ENST00000318837.6:c.1301A>G:p.(Glu434Gly)","0.973426","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","186","0/1","Het","140","117,23","0.835714285714286","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin-like","","","","","","","","","","","","T","0.124","T","0.315","B","0.127","B","0.075","N","0.002","D","0.973","L","1.1","T","4.0","N","-1.53","0.57","T","-0.646","T","0.005","T","0.011","0.093","D","0.685","23.6","2.999","4.89","4.810","10.815"
"chr1","117142736","117142736","A>G","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001007237:exon7:c.T1856C:p.I619T,IGSF3:NM_001542:exon7:c.T1916C:p.I639T","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon7:c.T1916C:p.I639T,IGSF3:ENST00000369486.8_1:exon7:c.T1856C:p.I619T,IGSF3:ENST00000369483.5_1:exon8:c.T1916C:p.I639T","IGSF3:ENST00000318837.6:c.1916T>C:p.(Ile639Thr)","0.9458729","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","187","0/1","Het","400","229,171","0.5725","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","SpliceAI>G|IGSF3|0.00|0.00|0.00|0.00|-37|-8|47|30",".;Immunoglobulin","","","0.002","0.002","0.001","0.0005","0.0007","","","0.0004","0.0004","D","0.002","D","0.009","B","0.162","B","0.069","D","0.000","D","1.000","L","1.525","T","2.44","D","-3.31","0.73","T","-1.039","T","0.016","T","0.009","0.237","T","0.079","23.7","3.051","4.8","8.702","12.336"
"chr1","117158898","117158898","C>T","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001542:exon2:c.G225A:p.M75I,IGSF3:NM_001007237:exon3:c.G225A:p.M75I","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon2:c.G225A:p.M75I,IGSF3:ENST00000369483.5_1:exon3:c.G225A:p.M75I,IGSF3:ENST00000369486.8_1:exon3:c.G225A:p.M75I","IGSF3:ENST00000318837.6:c.225G>A:p.(Met75Ile)","0.78499997","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","189","0/1","Het","167","150,17","0.898203592814371","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","",".;Immunoglobulin","","","","","","","","","","","","T","0.217","T","0.453","B","0.0","B","0.001","N","0.557","N","1.000","N","0.55","T","-0.12","N","-1.21","0.106","T","-1.048","T","0.043","T","0.010","0.046","T","0.097","16.95","1.616","4.79","0.058","6.805"
"chr1","117156600","117156600","T>C","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001542:exon3:c.A619G:p.S207G,IGSF3:NM_001007237:exon4:c.A619G:p.S207G","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon3:c.A619G:p.S207G,IGSF3:ENST00000369483.5_1:exon4:c.A619G:p.S207G,IGSF3:ENST00000369486.8_1:exon4:c.A619G:p.S207G","IGSF3:ENST00000318837.6:c.619A>G:p.(Ser207Gly)","0.7279894","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","190","0/1","Het","152","111,41","0.730263157894737","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","SpliceAI>C|IGSF3|0.02|0.06|0.00|0.00|-5|-2|-35|-2",".;Immunoglobulin","","","0.00001194","","","0.","0.","","","1.194e-05","0","T","1.0","T","1.0","B","0.001","B","0.004","D","0.000","D","0.729","N","-1.84","T","2.35","N","5.05","0.161","T","-0.907","T","0.003","T","0.007","0.083","T","0.013","12.89","0.923","5.02","3.744","6.441"
"chr1","117142869","117142869","A>G","","IGSF3","exonic","nonsynonymous SNV","","IGSF3:NM_001007237:exon7:c.T1723C:p.W575R,IGSF3:NM_001542:exon7:c.T1783C:p.W595R","IGSF3","exonic","nonsynonymous SNV","","IGSF3:ENST00000318837.6_1:exon7:c.T1783C:p.W595R,IGSF3:ENST00000369486.8_1:exon7:c.T1723C:p.W575R,IGSF3:ENST00000369483.5_1:exon8:c.T1783C:p.W595R","IGSF3:ENST00000318837.6:c.1783T>C:p.(Trp595Arg)","0.15066534","","","","","","","","","","","","","","","","ENSG00000143061","IGSF3","HGNC:5950","IGSF3","3321","ENSG00000143061","uc057jsm.1","0.7489345278915479","0.5000002709921318","1.0","OMIM:149700 ?Lacrimal duct defect-autosomal_recessive","193","0/1","Het","346","187,159","0.540462427745665","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Lacrimal duct defect(149700)","Sinusitis(HP:0000246)|Dacryocystitis(HP:0000620)|Lacrimal duct atresia(HP:0000564)|Dacryocystocele(HP:0030752)|Conjunctivitis(HP:0000509)|Epiphora(HP:0009926)|Autosomal recessive inheritance(HP:0000007)|Periorbital edema(HP:0100539)","The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). [provided by RefSeq, Jun 2016]","immunoglobulin superfamily member 3","lacrimal gland development(GO:0032808)","cell surface(GO:0009986)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","Heme metabolism","SpliceAI>G|IGSF3|0.00|0.02|0.00|0.00|-33|27|-35|35",".;Immunoglobulin","","","0.00005437","","","0.","0.","0.0001","0.0001","2.786e-05","5.437e-05","T","0.849","T","0.808","B","0.0","B","0.001","N","0.001","N","0.998","N","0.235","T","2.78","N","1.01","0.256","T","-0.932","T","0.003","T","0.003","0.039","T","0.016","4.282","0.101","4.57","1.012","2.893"
"chr2","95542416","95542416","A>G","","TEKT4","exonic","nonsynonymous SNV","","TEKT4:NM_001286559:exon6:c.A664G:p.I222V,TEKT4:NM_144705:exon6:c.A1210G:p.I404V","TEKT4","exonic","nonsynonymous SNV","","TEKT4:ENST00000295201.5_1:exon6:c.A1210G:p.I404V","TEKT4:ENST00000295201.4:c.1210A>G:p.(Ile404Val)","0.999993","0.5000048851748033","0.9999930262565612","0.7489315036982322","0.5000048851748033","0.8166687190532684","0.3564756636284133","","","","","","","","","","ENSG00000163060","TEKT4","HGNC:31012","TEKT4","150483","ENSG00000163060","uc002stw.3","0.7489315036982322","0.5000048851748033","0.9999930262565613","","194","0/1","Het","284","261,23","0.919014084507042","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","tektin 4","cilium assembly(GO:0060271)|cilium movement involved in cell motility(GO:0060294)","nucleus(GO:0005634)|microtubule cytoskeleton(GO:0015630)|sperm flagellum(GO:0036126)","protein binding(GO:0005515)","","","","","","","SpliceAI>G|TEKT4|0.00|0.00|0.00|0.00|39|20|-19|40","","","","0","","","","","","","0","0","D","0.014","D","0.044","D","0.967","P","0.77","D","0.000","D","1.000","M","2.465","T","3.8","N","-0.93","0.355","T","-1.154","T","0.035","T","0.004","0.186","D","0.773","22.8","2.605","2.43","2.475","8.354"
"chr16","1268220","1268220","G>A","","CACNA1H","exonic","nonsynonymous SNV","","CACNA1H:NM_001005407:exon32:c.G5438A:p.R1813H,CACNA1H:NM_021098:exon33:c.G5456A:p.R1819H","CACNA1H","exonic","nonsynonymous SNV","","CACNA1H:ENST00000565831.6_1:exon31:c.G5438A:p.R1813H,CACNA1H:ENST00000358590.8_1:exon32:c.G5438A:p.R1813H,CACNA1H:ENST00000348261.11_1:exon33:c.G5456A:p.R1819H,CACNA1H:ENST00000638323.1_1:exon33:c.G5417A:p.R1806H","CACNA1H:ENST00000348261.5:c.5456G>A:p.(Arg1819His)","0.9998447","0.5000460469782411","0.9998446702957152","0.7487557240313847","","","","","","","","","","","","","ENSG00000196557","CACNA1H","HGNC:1395","CACNA1H","8912","ENSG00000196557","uc002cks.4","0.7487557240313847","0.5000460469782411","0.9998446702957153","OMIM:617027 Hyperaldosteronism, familial, type IV-autosomal_dominant;ORPHA:64280 Childhood absence epilepsy-autosomal_dominant","198","0/1","Het","113","57,56","0.504424778761062","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Epilepsy, childhood absence, susceptibility to, 6(611942)|Hyperaldosteronism, familial, type iv(617027)","Hypertension(HP:0000822)|Autosomal dominant inheritance(HP:0000006)|Anxiety(HP:0000739)|Jerky head movements(HP:0006961)|Typical absence seizure(HP:0011147)|Febrile seizure (within the age range of 3 months to 6 years)(HP:0002373)|Hyperventilation(HP:0002883)|Impaired visuospatial constructive cognition(HP:0010794)|Bilateral tonic-clonic seizure(HP:0002069)|Punding(HP:0030218)|Urinary incontinence(HP:0000020)|Low self esteem(HP:0031469)|Myoclonic absence seizure(HP:0011150)|Uncontrolled eye movements(HP:0007738)|EEG with spike-wave complexes (2.5-3.5 Hz)(HP:0010848)|Abnormal social behavior(HP:0012433)|Intellectual disability(HP:0001249)|Limb myoclonus(HP:0045084)|Dyslexia(HP:0010522)|Attention deficit hyperactivity disorder(HP:0007018)|Pallor(HP:0000980)|Depression(HP:0000716)","This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]","calcium voltage-gated channel subunit alpha1 H","muscle contraction(GO:0006936)|muscle organ development(GO:0007517)|myoblast fusion(GO:0007520)|regulation of heart contraction(GO:0008016)|neuronal action potential(GO:0019228)|aldosterone biosynthetic process(GO:0032342)|cellular response to hormone stimulus(GO:0032870)|cortisol biosynthetic process(GO:0034651)|regulation of ion transmembrane transport(GO:0034765)|sodium ion transmembrane transport(GO:0035725)|cellular response to potassium ion(GO:0035865)|regulation of membrane potential(GO:0042391)|positive regulation of calcium ion-dependent exocytosis(GO:0045956)|calcium ion import(GO:0070509)|calcium ion import(GO:0070509)|calcium ion transmembrane transport(GO:0070588)|membrane depolarization during action potential(GO:0086010)|inorganic cation transmembrane transport(GO:0098662)|positive regulation of acrosome reaction(GO:2000344)","voltage-gated sodium channel complex(GO:0001518)|integral component of plasma membrane(GO:0005887)|voltage-gated calcium channel complex(GO:0005891)|integral component of membrane(GO:0016021)|neuron projection(GO:0043005)","voltage-gated ion channel activity(GO:0005244)|voltage-gated sodium channel activity(GO:0005248)|protein binding(GO:0005515)|low voltage-gated calcium channel activity(GO:0008332)|low voltage-gated calcium channel activity(GO:0008332)|metal ion binding(GO:0046872)|scaffold protein binding(GO:0097110)","autistic disorder(DOID:12849)|cancer(DOID:162)|childhood absence epilepsy(DOID:1825)|epilepsy(DOID:1826)|idiopathic generalized epilepsy(DOID:1827)|prostate cancer(DOID:10283)|atrial heart septal defect(DOID:1882)|disease(DOID:4)|syndrome(DOID:225)","Mapk signaling pathway|Calcium signaling pathway","Wp corticotropinreleasing hormone signaling pathway|Wp mapk signaling pathway","Developmental biology|Ncam signaling for neurite out growth|Ncam1 interactions|Nervous system development","","Myogenesis|Glycolysis","SpliceAI>A|CACNA1H|0.00|0.00|0.00|0.00|-26|-5|11|-1","Ion","","","","","","","","","","","","D","0.001","D","0.001","D","1.0","D","0.991","D","0.000","D","1.000","M","2.905","D","-4.4","D","-4.8","0.667","D","1.086","D","0.942","D","0.834","0.809","D","0.999","26.6","3.857","4.3","7.829","16.260"
"chr19","14551121","14551121","C>T","","PKN1","exonic","nonsynonymous SNV","","PKN1:NM_213560:exon1:c.C19T:p.P7S","PKN1","exonic","nonsynonymous SNV","","PKN1:ENST00000342216.8_1:exon1:c.C19T:p.P7S","PKN1:ENST00000342216.4:c.19C>T:p.(Pro7Ser)","0.9996968","0.5001399050670443","0.9996967911720276","0.748683763894559","","","","","","","","","","","","","ENSG00000123143","PKN1","HGNC:9405","PKN1","5585","ENSG00000123143","uc002myp.4","0.748683763894559","0.5001399050670443","0.9996967911720276","","199","0/1","Het","62","39,23","0.629032258064516","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene belongs to the protein kinase C superfamily. This kinase is activated by Rho family of small G proteins and may mediate the Rho-dependent signaling pathway. This kinase can be activated by phospholipids and by limited proteolysis. The 3-phosphoinositide dependent protein kinase-1 (PDPK1/PDK1) is reported to phosphorylate this kinase, which may mediate insulin signals to the actin cytoskeleton. The proteolytic activation of this kinase by caspase-3 or related proteases during apoptosis suggests its role in signal transduction related to apoptosis. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]","protein kinase N1","B cell homeostasis(GO:0001782)|B cell apoptotic process(GO:0001783)|regulation of germinal center formation(GO:0002634)|regulation of immunoglobulin production(GO:0002637)|renal system process(GO:0003014)|regulation of transcription by RNA polymerase II(GO:0006357)|regulation of transcription by RNA polymerase II(GO:0006357)|protein phosphorylation(GO:0006468)|negative regulation of protein kinase activity(GO:0006469)|hyperosmotic response(GO:0006972)|signal transduction(GO:0007165)|epithelial cell migration(GO:0010631)|peptidyl-serine phosphorylation(GO:0018105)|negative regulation of B cell proliferation(GO:0030889)|histone H3-T11 phosphorylation(GO:0035407)|intracellular signal transduction(GO:0035556)|positive regulation of transcription, DNA-templated(GO:0045893)|spleen development(GO:0048536)|regulation of androgen receptor signaling pathway(GO:0060765)|regulation of cell motility(GO:2000145)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|endosome(GO:0005768)|cytosol(GO:0005829)|midbody(GO:0030496)|cleavage furrow(GO:0032154)|protein-containing complex(GO:0032991)","chromatin binding(GO:0003682)|protein kinase activity(GO:0004672)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein kinase C activity(GO:0004697)|protein kinase C activity(GO:0004697)|calcium-dependent protein kinase C activity(GO:0004698)|protein kinase C binding(GO:0005080)|protein binding(GO:0005515)|ATP binding(GO:0005524)|nuclear receptor coactivator activity(GO:0030374)|nuclear receptor coactivator activity(GO:0030374)|small GTPase binding(GO:0031267)|histone kinase activity (H3-T11 specific)(GO:0035402)|histone binding(GO:0042393)|histone deacetylase binding(GO:0042826)|androgen receptor binding(GO:0050681)|protein serine kinase activity(GO:0106310)","lateral sclerosis(DOID:230)|amyotrophic lateral sclerosis(DOID:332)","","Wp g13 signaling pathway|Wp apoptosisrelated network due to altered notch3 in ovarian cancer|Wp pi3kakt signaling pathway|Wp il18 signaling pathway","Rho gtpase effectors|Rho gtpases activate pkns|Activated pkn1 stimulates transcription of ar androgen receptor regulated genes klk2 and klk3|Rhoa gtpase cycle|Rho gtpase cycle|Rhob gtpase cycle|Rhoc gtpase cycle|Rac1 gtpase cycle|Signaling by rho gtpases miro gtpases and rhobtb3","Myosin pathway|Akapcentrosome pathway","","","","","","0.000008861","","","","","","","8.861e-06","0","T","0.129","D","0.042","D","0.996","D","0.986","U","0.652","D","0.803","","","T","-0.05","N","-0.25","0.191","T","-0.505","T","0.437","D","0.633","0.167","D","0.708","22.3","2.385","4.74","0.859","13.217"
"chr1","36904401","36904401","C>T","","OSCP1","exonic","nonsynonymous SNV","","OSCP1:NM_145047:exon2:c.G223A:p.A75T,OSCP1:NM_206837:exon2:c.G223A:p.A75T","OSCP1","exonic","nonsynonymous SNV","","OSCP1:ENST00000235532.9_1:exon2:c.G223A:p.A75T,OSCP1:ENST00000354267.3_1:exon2:c.G223A:p.A75T,OSCP1:ENST00000433045.6_1:exon2:c.G88A:p.A30T,OSCP1:ENST00000356637.9_1:exon3:c.G253A:p.A85T","OSCP1:ENST00000235532.5:c.223G>A:p.(Ala75Thr)","0.99979687","0.5000154113822646","0.9997968673706056","0.7486132043049422","","","","","","","","","","","","","ENSG00000116885","OSCP1","HGNC:29971","OSCP1","127700","ENSG00000116885","uc001caq.4","0.7486132043049422","0.5000154113822646","0.9997968673706055","","200","0/1","Het","95","53,42","0.557894736842105","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","organic solute carrier partner 1","transport(GO:0006810)|xenobiotic detoxification by transmembrane export across the plasma membrane(GO:1990961)","cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|plasma membrane(GO:0005886)|basal plasma membrane(GO:0009925)","transmembrane transporter activity(GO:0022857)","cancer(DOID:162)","","","","","","",".;.;.;.;.","","Score=703;Name=V$HOX13_01","0.000003985","","","0.","0.","","","3.985e-06","0","D","0.005","D","0.037","P","0.936","P","0.773","D","0.000","D","1","M","2.025","T","1.28","D","-2.53","0.909","T","-0.802","T","0.205","T","0.021","0.349","D","0.910","28.0","4.034","5.88","7.568","19.211"
"chrX","119037548","119037548","C>T","","AKAP14","exonic","nonsynonymous SNV","","AKAP14:NM_001008534:exon4:c.C260T:p.S87L,AKAP14:NM_001008535:exon4:c.C260T:p.S87L,AKAP14:NM_178813:exon4:c.C260T:p.S87L","AKAP14","exonic","nonsynonymous SNV","","AKAP14:ENST00000334356.2_1:exon3:c.C260T:p.S87L,AKAP14:ENST00000371422.5_1:exon3:c.C260T:p.S87L,AKAP14:ENST00000371425.8_1:exon4:c.C260T:p.S87L,AKAP14:ENST00000371431.8_1:exon4:c.C260T:p.S87L","AKAP14:ENST00000334356.2:c.260C>T:p.(Ser87Leu)","0.9996588","","","","","","","0.5000088183660409","0.9996588230133056","0.748361639685903","0.5000088183660409","0.9996588230133056","0.748361639685903","","","","ENSG00000186471","AKAP14","HGNC:24061","AKAP14","158798","ENSG00000186471","uc004ese.4","0.748361639685903","0.5000088183660409","0.9996588230133057","","201","0/1","Het","34","21,13","0.617647058823529","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins, which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. The protein anchors PKA in ciliary axonemes and, in this way, may play a role in regulating ciliary beat frequency. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]","A-kinase anchoring protein 14","biological_process(GO:0008150)","axoneme(GO:0005930)|cAMP-dependent protein kinase complex(GO:0005952)|cAMP-dependent protein kinase complex(GO:0005952)","protein binding(GO:0005515)|protein kinase A regulatory subunit binding(GO:0034237)|protein kinase A regulatory subunit binding(GO:0034237)","","","","","","","",".;.;.;.","","","0.000005487","","","0.","0.","","","5.487e-06","0","D","0.007","D","0.009","B","0.223","B","0.019","N","0.488","N","1","L","0.895","","","N","-1.91","0.082","T","-1.026","T","0.051","T","0.002","0.027","T","0.048","0.398","-0.288","4.01","-1.325","7.005"
"chr15","64275858","64275858","C>T","","DAPK2","exonic","nonsynonymous SNV","","DAPK2:NM_014326:exon3:c.G188A:p.R63Q","DAPK2","exonic","nonsynonymous SNV","","DAPK2:ENST00000261891.7_1:exon2:c.G188A:p.R63Q,DAPK2:ENST00000558069.5_1:exon2:c.G188A:p.R63Q,DAPK2:ENST00000457488.5_1:exon3:c.G188A:p.R63Q,DAPK2:ENST00000612884.4_1:exon3:c.G188A:p.R63Q","DAPK2:ENST00000261891.3:c.188G>A:p.(Arg63Gln)","0.99954855","0.5000021632886273","0.9995485544204712","0.7481578524746632","","","","","","","","","","","","","ENSG00000035664","DAPK2","HGNC:2675","DAPK2","23604","ENSG00000035664","uc002amr.4","0.7481578524746632","0.5000021632886273","0.9995485544204712","","202","0/1","Het","167","80,87","0.479041916167665","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that belongs to the serine/threonine protein kinase family. This protein contains a N-terminal protein kinase domain followed by a conserved calmodulin-binding domain with significant similarity to that of death-associated protein kinase 1 (DAPK1), a positive regulator of programmed cell death. Overexpression of this gene was shown to induce cell apoptosis.  It uses multiple polyadenylation sites. [provided by RefSeq, Jul 2008]","death associated protein kinase 2","protein phosphorylation(GO:0006468)|apoptotic process(GO:0006915)|regulation of autophagy(GO:0010506)|intracellular signal transduction(GO:0035556)|intracellular signal transduction(GO:0035556)|regulation of apoptotic process(GO:0042981)|positive regulation of apoptotic process(GO:0043065)|anoikis(GO:0043276)|protein autophosphorylation(GO:0046777)|positive regulation of neutrophil chemotaxis(GO:0090023)|positive regulation of eosinophil chemotaxis(GO:2000424)|regulation of intrinsic apoptotic signaling pathway(GO:2001242)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|Golgi apparatus(GO:0005794)|cytoplasmic vesicle(GO:0031410)|autophagosome lumen(GO:0034423)|intracellular membrane-bounded organelle(GO:0043231)","protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein binding(GO:0005515)|calmodulin binding(GO:0005516)|ATP binding(GO:0005524)|identical protein binding(GO:0042802)|protein serine kinase activity(GO:0106310)","cancer(DOID:162)","Pathways in cancer|Bladder cancer","Wp bladder cancer","Apoptosis|Caspase activation via dependence receptors in the absence of ligand|Caspase activation via extrinsic apoptotic signalling pathway|Programmed cell death","","Myogenesis","SpliceAI>T|DAPK2|0.00|0.00|0.00|0.03|-2|-13|-5|-34","Protein","","Score=681;Name=V$P53_01","0.000003997","","","","","","","3.997e-06","0","D","0.04","D","0.037","D","0.987","P","0.536","N","0.004","D","1.000","N","0.49","T","-0.07","D","-3.62","0.516","T","-0.681","T","0.196","D","0.064","0.240","D","0.860","22.2","2.358","5.31","3.971","15.121"
"chr10","132915100","132915100","G>A","","TCERG1L","exonic","nonsynonymous SNV","","TCERG1L:NM_174937:exon9:c.C1357T:p.R453C","TCERG1L","exonic","nonsynonymous SNV","","TCERG1L:ENST00000368642.4_1:exon9:c.C1357T:p.R453C","TCERG1L:ENST00000368642.4:c.1357C>T:p.(Arg453Cys)","0.999539","0.500004215592071","0.9995390176773072","0.7481453694193929","","","","","","","","","","","","","ENSG00000176769","TCERG1L","HGNC:23533","TCERG1L","256536","ENSG00000176769","uc001lkp.4","0.7481453694193929","0.500004215592071","0.9995390176773071","","203","0/1","Het","149","66,83","0.442953020134228","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","transcription elongation regulator 1 like","regulation of transcription, DNA-templated(GO:0006355)","nucleus(GO:0005634)","transcription coregulator activity(GO:0003712)|RNA polymerase binding(GO:0070063)","","","","","","","SpliceAI>A|TCERG1L|0.00|0.00|0.00|0.00|3|21|2|-38","FF","","Score=852;Name=V$AHRARNT_01","0","","","0.","0.","","","0","0","D","0.026","D","0.0","D","1.0","D","0.998","D","0.000","D","1","L","1.93","T","1.6","D","-6.01","0.753","T","-0.956","T","0.147","T","0.013","0.228","D","0.993","24.1","3.200","4.18","0.654","8.882"
"chr12","56351044","56351044","G>T","","PMEL","exonic","nonsynonymous SNV","","PMEL:NM_001200053:exon4:c.C785A:p.T262N,PMEL:NM_001200054:exon6:c.C1043A:p.T348N,PMEL:NM_006928:exon7:c.C1043A:p.T348N","PMEL","exonic","nonsynonymous SNV","","PMEL:ENST00000550464.5_1:exon4:c.C785A:p.T262N,PMEL:ENST00000449260.6_1:exon6:c.C1043A:p.T348N,PMEL:ENST00000548747.6_1:exon6:c.C1043A:p.T348N,PMEL:ENST00000548493.5_1:exon7:c.C1043A:p.T348N,PMEL:ENST00000552882.5_1:exon7:c.C1043A:p.T348N","PMEL:ENST00000360714.4:c.1043C>A:p.(Thr348Asn)","0.99921304","0.5000974370559561","0.9992130398750304","0.747763670910765","","","","","","","","","","","","","ENSG00000185664","PMEL","HGNC:10880","PMEL","6490","ENSG00000185664","uc001sip.4","0.747763670910765","0.5000974370559561","0.9992130398750305","","204","0/1","Het","94","58,36","0.617021276595745","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a melanocyte-specific type I transmembrane glycoprotein. The encoded protein is enriched in melanosomes, which are the melanin-producing organelles in melanocytes, and plays an essential role in the structural organization of premelanosomes. This protein is involved in generating internal matrix fibers that define the transition from Stage I to Stage II melanosomes. This protein undergoes a complex pattern of prosttranslational processing and modification that is essential to the proper functioning of the protein. A secreted form of this protein that is released by proteolytic ectodomain shedding may be used as a melanoma-specific serum marker. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011]","premelanosome protein","melanosome organization(GO:0032438)|melanosome organization(GO:0032438)|melanin biosynthetic process(GO:0042438)","extracellular region(GO:0005576)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum membrane(GO:0005789)|Golgi apparatus(GO:0005794)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|multivesicular body membrane(GO:0032585)|melanosome(GO:0042470)|melanosome(GO:0042470)","protein binding(GO:0005515)|identical protein binding(GO:0042802)","vitiligo(DOID:12306)|melanoma(DOID:1909)|disease(DOID:4)","","","","","","",".;.;.;.;.;.;.;.","","","0.00005437","","","","","","","3.983e-06","5.437e-05","D","0.012","T","0.062","D","0.997","P","0.895","N","0.025","D","1","M","2.565","T","3.05","N","-1.39","0.11","T","-1.006","T","0.132","D","0.025","0.066","T","0.456","21.9","2.276","5.66","2.031","7.928"
"chr17","73566284","73566284","A>G","","LLGL2","exonic","nonsynonymous SNV","","LLGL2:NM_001031803:exon15:c.A1822G:p.S608G,LLGL2:NM_004524:exon15:c.A1822G:p.S608G","LLGL2","exonic","nonsynonymous SNV","","LLGL2:ENST00000167462.9_1:exon15:c.A1822G:p.S608G,LLGL2:ENST00000392550.8_1:exon15:c.A1822G:p.S608G,LLGL2:ENST00000577200.5_1:exon15:c.A1822G:p.S608G","LLGL2:ENST00000167462.5:c.1822A>G:p.(Ser608Gly)","0.99909","0.5002016974176513","0.999090015888214","0.7477549769615568","","","","","","","","","","","","","ENSG00000073350","LLGL2","HGNC:6629","LLGL2","3993","ENSG00000073350","uc002joh.4","0.7477549769615568","0.5002016974176513","0.9990900158882141","","205","0/1","Het","193","103,90","0.533678756476684","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The lethal (2) giant larvae protein of Drosophila plays a role in asymmetric cell division, epithelial cell polarity, and cell migration. This human gene encodes a protein similar to lethal (2) giant larvae of Drosophila. In fly, the protein's ability to localize cell fate determinants is regulated by the atypical protein kinase C (aPKC). In human, this protein interacts with aPKC-containing complexes and is cortically localized in mitotic cells. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]","LLGL scribble cell polarity complex component 2","exocytosis(GO:0006887)|regulation of Notch signaling pathway(GO:0008593)|leucine transport(GO:0015820)|cortical actin cytoskeleton organization(GO:0030866)|regulation of establishment or maintenance of cell polarity(GO:0032878)|regulation of establishment or maintenance of cell polarity(GO:0032878)|regulation of protein secretion(GO:0050708)|regulation of catalytic activity(GO:0050790)|establishment of spindle orientation(GO:0051294)|cell division(GO:0051301)","cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|cortical actin cytoskeleton(GO:0030864)|intracellular membrane-bounded organelle(GO:0043231)","GTPase activator activity(GO:0005096)|protein binding(GO:0005515)|PDZ domain binding(GO:0030165)|myosin II binding(GO:0045159)","pancreatic ductal adenocarcinoma(DOID:3498)|pancreatic adenocarcinoma(DOID:4074)","Tight junction","","","","Estrogen response late","",".;.;.","","Score=824;Name=V$HNF4_01","","","","","","","","","","T","0.162","T","0.216","B","0.166","B","0.169","D","0.000","D","0.999","M","2.115","T","0.74","N","-2.36","0.804","T","-0.789","T","0.227","D","0.046","0.302","D","0.718","22.5","2.464","5.19","9.253","11.160"
"chr3","45817401","45817401","G>C","","SLC6A20","exonic","nonsynonymous SNV","","SLC6A20:NM_020208:exon4:c.C434G:p.T145R,SLC6A20:NM_022405:exon4:c.C434G:p.T145R","SLC6A20","exonic","nonsynonymous SNV","","SLC6A20:ENST00000353278.8_1:exon4:c.C434G:p.T145R,SLC6A20:ENST00000358525.9_1:exon4:c.C434G:p.T145R,SLC6A20:ENST00000456124.6_1:exon4:c.C434G:p.T145R","SLC6A20:ENST00000353278.4:c.434C>G:p.(Thr145Arg)","0.999254","0.5000047465682655","0.9992539882659912","0.7476528615363515","","","","","","","","","","","","","ENSG00000163817","SLC6A20","HGNC:30927","SLC6A20","54716","ENSG00000163817","uc011bai.3","0.7476528615363515","0.5000047465682655","0.9992539882659912","OMIM:138500 Hyperglycinuria-autosomal_dominant;OMIM:242600 Iminoglycinuria, digenic-autosomal_recessive;ORPHA:42062 Iminoglycinuria-autosomal_recessive","206","0/1","Het","137","83,54","0.605839416058394","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Hyperglycinuria(138500)|Iminoglycinuria(242600)","Hydroxyprolinuria(HP:0003080)|Hyperglycinuria(HP:0003108)|Prolinuria(HP:0003137)|Abnormality of the eye(HP:0000478)|Hyperglycinuria(HP:0003108)|Prolinuria(HP:0003137)|Autosomal recessive inheritance(HP:0000007)|Intellectual disability(HP:0001249)|Hydroxyprolinuria(HP:0003080)|Calcium oxalate nephrolithiasis(HP:0008672)|Hyperglycinuria(HP:0003108)|Autosomal dominant inheritance(HP:0000006)","Transport of small hydrophilic substances across cell membranes is mediated by substrate-specific transporter proteins which have been classified into several families of related genes. The protein encoded by this gene belongs to the sodium:neurotransmitter symporter (SNF) family and functions as a proline transporter expressed in kidney and small intestine. Mutations in this gene are associated with Hyperglycinuria and Iminoglycinuria. [provided by RefSeq, Jul 2020]","solute carrier family 6 member 20","amino acid transport(GO:0006865)|amino acid transport(GO:0006865)|glycine transport(GO:0015816)|proline transport(GO:0015824)|amino-acid betaine transport(GO:0015838)|sodium ion transmembrane transport(GO:0035725)|amino acid import across plasma membrane(GO:0089718)|transport across blood-brain barrier(GO:0150104)|L-isoleucine import across plasma membrane(GO:1903806)|L-proline import across plasma membrane(GO:1904271)|L-proline import across plasma membrane(GO:1904271)|proline import across plasma membrane(GO:1905647)","plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|apical plasma membrane(GO:0016324)|apical plasma membrane(GO:0016324)","proline:sodium symporter activity(GO:0005298)|protein binding(GO:0005515)|amino acid transmembrane transporter activity(GO:0015171)|amino acid transmembrane transporter activity(GO:0015171)|amino acid transmembrane transporter activity(GO:0015171)|neutral amino acid transmembrane transporter activity(GO:0015175)|neutral amino acid transmembrane transporter activity(GO:0015175)|L-isoleucine transmembrane transporter activity(GO:0015188)|L-proline transmembrane transporter activity(GO:0015193)|L-proline transmembrane transporter activity(GO:0015193)|L-proline transmembrane transporter activity(GO:0015193)|amino-acid betaine transmembrane transporter activity(GO:0015199)","","","Wp nuclear receptors metapathway|Wp nrf2 pathway|Wp proximal tubule transport","Amino acid transport across the plasma membrane|Transport of small molecules|Transport of bile salts and organic acids metal ions and amine compounds|Transport of inorganic cations anions and amino acids oligopeptides|Slc mediated transmembrane transport|Na cl dependent neurotransmitter transporters|Slc transporter disorders|Disorders of transmembrane transporters","","","",".;.;.;.","","","","","","","","","","","","D","0.001","D","0.002","D","0.998","D","0.956","D","0.000","D","0.999","M","3.45","T","-0.91","D","-3.86","0.834","D","0.378","D","0.631","D","0.111","0.774","D","0.996","25.0","3.508","5.47","5.628","19.322"
"chr15","43641162","43641162","G>A","","ADAL","exonic","nonsynonymous SNV","","ADAL:NM_001012969:exon10:c.G691A:p.G231R,ADAL:NM_001159280:exon10:c.G610A:p.G204R","ADAL","exonic","nonsynonymous SNV","","ADAL:ENST00000422466.6_1:exon7:c.G610A:p.G204R,ADAL:ENST00000610420.4_1:exon8:c.G691A:p.G231R,ADAL:ENST00000389651.8_1:exon10:c.G691A:p.G231R,ADAL:ENST00000428046.7_1:exon10:c.G610A:p.G204R,ADAL:ENST00000562188.7_1:exon11:c.G691A:p.G231R","ADAL:ENST00000389651.4:c.691G>A:p.(Gly231Arg)","0.9986871","0.5003838850825559","0.9986870884895324","0.7474140573490339","0.5003838850825559","0.9986794888973236","0.7474008811205598","","","","","","","","","","ENSG00000168803","ADAL","HGNC:31853","ADAL","161823","ENSG00000168803","uc059iit.1","0.7474140573490339","0.5003838850825559","0.9986870884895325","","207","0/1","Het","139","92,47","0.661870503597122","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","adenosine deaminase like","adenosine catabolic process(GO:0006154)|nucleotide metabolic process(GO:0009117)|inosine biosynthetic process(GO:0046103)","cytosol(GO:0005829)","adenosine deaminase activity(GO:0004000)|metal ion binding(GO:0046872)|N6-mAMP deaminase activity(GO:0062154)","","","","Metabolism of nucleotides|Abacavir transport and metabolism|Abacavir metabolism|Purine salvage|Nucleotide salvage","","","","Adenosine/AMP","","Score=825;Name=V$CEBP_C","0.00001194","","","0.","","","","1.194e-05","0","D","0.0","D","0.0","D","1.0","D","0.998","D","0.000","D","1","M","3.46","D","-2.12","D","-7.63","0.985","D","0.935","D","0.846","D","0.526","0.942","D","0.998","27.5","3.973","4.92","9.005","15.963"
"chr15","43643241","43643242","TA>-","","ADAL","splicing","","NM_001159280:exon11:r.spl","","ADAL","splicing","","ENST00000562188.7_1:exon12:r.spl;ENST00000428046.7_1:exon11:r.spl;ENST00000422466.6_1:exon8:r.spl","","ADAL:ENST00000422466.2:c.873+2_873+3del:p.?","0.9986719","","","","0.5003838850825559","0.9986794888973236","0.7474008811205598","","","","","","","","","","ENSG00000168803","ADAL","HGNC:31853","ADAL","161823","ENSG00000168803","uc059iit.1","0.7474140573490339","0.5003838850825559","0.9986870884895325","","208","0/1","Het","85","42,43","0.494117647058824","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","adenosine deaminase like","adenosine catabolic process(GO:0006154)|nucleotide metabolic process(GO:0009117)|inosine biosynthetic process(GO:0046103)","cytosol(GO:0005829)","adenosine deaminase activity(GO:0004000)|metal ion binding(GO:0046872)|N6-mAMP deaminase activity(GO:0062154)","","","","Metabolism of nucleotides|Abacavir transport and metabolism|Abacavir metabolism|Purine salvage|Nucleotide salvage","","","","","","","0.00009174","","","","","","","6.494e-06","9.174e-05","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr12","52708591","52708591","A>G","","KRT83","exonic","nonsynonymous SNV","","KRT83:NM_002282:exon9:c.T1306C:p.S436P","KRT83","exonic","nonsynonymous SNV","","KRT83:ENST00000293670.3_1:exon9:c.T1306C:p.S436P","KRT83:ENST00000293670.3:c.1306T>C:p.(Ser436Pro)","0.999","0.5000138611248985","0.9990000128746032","0.7472304412516283","","","","","","","","","","","","","ENSG00000170523","KRT83","HGNC:6460","KRT83","3889","ENSG00000170523","uc001saf.2","0.7472304412516283","0.5000138611248985","0.9990000128746033","OMIM:158000 Monilethrix-autosomal_dominant;OMIM:617756 Erythrokeratodermia variabilis et progressiva 5-autosomal_recessive;ORPHA:316 Progressive symmetric erythrokeratodermia-autosomal_recessive;ORPHA:573 Monilethrix-autosomal_dominant","209","0/1","Het","107","64,43","0.598130841121495","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Monilethrix(158000)|Erythrokeratodermia variabilis et progressiva 5(617756)","Autosomal recessive inheritance(HP:0000007)|Palmoplantar hyperkeratosis(HP:0000972)|Joint stiffness(HP:0001387)|Perifollicular hyperkeratosis(HP:0007468)|Keratosis pilaris(HP:0032152)|Brittle hair(HP:0002299)|Sparse hair(HP:0008070)|Alopecia(HP:0001596)|Autosomal dominant inheritance(HP:0000006)|Variable expressivity(HP:0003828)|Heterogeneous(HP:0001425)|Nail dysplasia(HP:0002164)|Infantile onset(HP:0003593)|Nail dystrophy(HP:0008404)|Cataract(HP:0000518)|Brittle hair(HP:0002299)|Abnormal eyelash morphology(HP:0000499)|Follicular hyperkeratosis(HP:0007502)|Patchy alopecia(HP:0002232)|Abnormality of the dentition(HP:0000164)|Intellectual disability(HP:0001249)|Schizophrenia(HP:0100753)|Cognitive impairment(HP:0100543)|Sparse hair(HP:0008070)|Fine hair(HP:0002213)|Slow-growing hair(HP:0002217)|Abnormality of the nail(HP:0001597)|Abnormal eyebrow morphology(HP:0000534)|Erythema(HP:0010783)|Skin plaque(HP:0200035)|Palmoplantar keratoderma(HP:0000982)","The protein encoded by this gene is a member of the keratin gene family. As a type II hair keratin, it is a basic protein which heterodimerizes with type I keratins to form hair and nails. The type II hair keratins are clustered in a region of chromosome 12q13 and are grouped into two distinct subfamilies based on structure similarity. One subfamily, consisting of KRTHB1, KRTHB3, and KRTHB6, is highly related. The other less-related subfamily includes KRTHB2, KRTHB4, and KRTHB5. All hair keratins are expressed in the hair follicle; this hair keratin, as well as KRTHB1 and KRTHB6, is found primarily in the hair cortex. [provided by RefSeq, Jul 2008]","keratin 83","aging(GO:0007568)|epidermis development(GO:0008544)|hair cycle(GO:0042633)","extracellular space(GO:0005615)|cytosol(GO:0005829)|keratin filament(GO:0045095)","protein binding(GO:0005515)","","","","Developmental biology|Keratinization|Formation of the cornified envelope","","","","","","Score=742;Name=V$TCF11MAFG_01","","","","","","","","","","D","0.003","D","0.018","D","1.0","D","0.999","U","0.001","D","0.562","M","3.36","D","-2.23","D","-4.08","0.519","D","0.549","D","0.689","D","0.044","0.585","D","0.993","25.8","3.710","3.93","2.058","9.452"
"chr11","76062366","76062366","A>C","","PRKRIR","exonic","nonsynonymous SNV","","PRKRIR:NM_004705:exon5:c.T1828G:p.S610A","THAP12","exonic","nonsynonymous SNV","","THAP12:ENST00000260045.8_1:exon5:c.T1828G:p.S610A,THAP12:ENST00000682527.1_1:exon5:c.T1633G:p.S545A","THAP12:ENST00000260045.3:c.1828T>G:p.(Ser610Ala)","0.99885714","0.5000014461169258","0.9988571405410768","0.7469581420898791","0.5000014461169258","0.9974051415920258","0.7444294035408582","","","","","","","","","","ENSG00000137492","THAP12","HGNC:9440","THAP12","5612","ENSG00000137492","uc001oxh.2","0.7469581420898791","0.5000014461169258","0.9988571405410767","","210","0/1","Het","97","84,13","0.865979381443299","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","THAP domain containing 12","signal transduction(GO:0007165)|negative regulation of cell population proliferation(GO:0008285)","","DNA binding(GO:0003677)|protein binding(GO:0005515)|metal ion binding(GO:0046872)|protein dimerization activity(GO:0046983)","","","","","","","SpliceAI>C|PRKRIR|0.01|0.00|0.00|0.00|-4|-36|7|-47","","","Score=824;Name=V$GRE_C","0.000008905","","","","","","","8.905e-06","0","T","0.539","T","1.0","B","0.009","B","0.004","D","0.000","D","0.999","L","1.46","T","2.01","N","-1.37","0.092","T","-1.083","T","0.042","T","0.002","0.059","T","0.268","19.73","1.999","5.33","5.058","15.743"
"chr11","76062520","76062520","T>A","","PRKRIR","exonic","nonsynonymous SNV","","PRKRIR:NM_004705:exon5:c.A1674T:p.R558S","THAP12","exonic","nonsynonymous SNV","","THAP12:ENST00000260045.8_1:exon5:c.A1674T:p.R558S,THAP12:ENST00000682527.1_1:exon5:c.A1479T:p.R493S","THAP12:ENST00000260045.3:c.1674A>T:p.(Arg558Ser)","0.99595314","","","","0.5000014461169258","0.9974051415920258","0.7444294035408582","","","","","","","","","","ENSG00000137492","THAP12","HGNC:9440","THAP12","5612","ENSG00000137492","uc001oxh.2","0.7469581420898791","0.5000014461169258","0.9988571405410767","","211","0/1","Het","74","62,12","0.837837837837838","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","THAP domain containing 12","signal transduction(GO:0007165)|negative regulation of cell population proliferation(GO:0008285)","","DNA binding(GO:0003677)|protein binding(GO:0005515)|metal ion binding(GO:0046872)|protein dimerization activity(GO:0046983)","","","","","","","SpliceAI>A|PRKRIR|0.00|0.00|0.00|0.00|-10|0|-27|-10","","","","0.000004571","","","","","","","4.571e-06","0","D","0.017","D","0.025","P","0.594","B","0.295","D","0.000","D","0.996","M","2.515","","","N","-1.46","0.504","T","-0.988","T","0.146","T","0.002","0.170","D","0.615","22.2","2.353","4.98","0.067","9.968"
"chr19","19735202","19735202","G>A","","LPAR2","exonic","nonsynonymous SNV","","LPAR2:NM_004720:exon3:c.C919T:p.R307C","LPAR2","exonic","nonsynonymous SNV","","LPAR2:ENST00000407877.8_1:exon3:c.C919T:p.R307C,LPAR2:ENST00000586703.1_1:exon3:c.C919T:p.R307C,LPAR2:ENST00000542587.5_1:exon6:c.C919T:p.R307C","LPAR2:ENST00000407877.3:c.919C>T:p.(Arg307Cys)","0.9971306","0.5013484783703461","0.997130572795868","0.7466074159373843","","","","","","","","","","","","","ENSG00000064547","LPAR2","HGNC:3168","LPAR2","9170","ENSG00000064547","uc002nnc.6","0.7466074159373843","0.5013484783703461","0.9971305727958679","","212","0/1","Het","112","62,50","0.553571428571429","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of family I of the G protein-coupled receptors, as well as the EDG family of proteins. This protein functions as a lysophosphatidic acid (LPA) receptor and contributes to Ca2+ mobilization, a critical cellular response to LPA in cells, through association with Gi and Gq proteins. An alternative splice variant has been described but its full length sequence has not been determined. [provided by RefSeq, Jul 2008]","lysophosphatidic acid receptor 2","G protein-coupled receptor signaling pathway(GO:0007186)|adenylate cyclase-activating G protein-coupled receptor signaling pathway(GO:0007189)|activation of phospholipase C activity(GO:0007202)|positive regulation of cytosolic calcium ion concentration(GO:0007204)|regulation of metabolic process(GO:0019222)","cytoplasm(GO:0005737)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|cell surface(GO:0009986)|endocytic vesicle(GO:0030139)","G protein-coupled receptor activity(GO:0004930)|protein binding(GO:0005515)|lipid binding(GO:0008289)|lysophosphatidic acid receptor activity(GO:0070915)","chronic leukemia(DOID:1036)|breast cancer(DOID:1612)|cancer(DOID:162)|colon cancer(DOID:219)","Neuroactive ligand receptor interaction","Wp focal adhesionpi3kaktmtorsignaling pathway|Wp pi3kakt signaling pathway","Signaling by gpcr|Class a 1 rhodopsin like receptors|G alpha q signalling events|G alpha i signalling events|Lysosphingolipid and lpa receptors|Gpcr ligand binding","Akap13 pathway","","SpliceAI>A|LPAR2|0.00|0.00|0.00|0.00|-33|23|-27|-39",".;.;.","","Score=927;Name=V$HSF2_01","0.00002786","","","0.","0.","","","2.786e-05","0","T","0.177","D","0.01","D","1.0","P","0.899","N","0.007","D","1.000","M","2.095","T","1.03","N","-1.93","0.483","T","-1.004","T","0.135","T","0.021","0.140","T","0.307","29.0","4.145","4.56","2.220","10.008"
"chr1","85279584","85279584","T>G","","LPAR3","exonic","nonsynonymous SNV","","LPAR3:NM_012152:exon3:c.A1007C:p.Q336P","LPAR3","exonic","nonsynonymous SNV","","LPAR3:ENST00000440886.1_1:exon2:c.A1007C:p.Q336P,LPAR3:ENST00000370611.4_1:exon3:c.A1007C:p.Q336P","LPAR3:ENST00000370611.3:c.1007A>C:p.(Gln336Pro)","0.99712366","0.5013482494978234","0.997123658657074","0.7465949527797332","","","","","","","","","","","","","ENSG00000171517","LPAR3","HGNC:14298","LPAR3","23566","ENSG00000171517","uc009wcj.2","0.7465949527797332","0.5013482494978234","0.997123658657074","","213","0/1","Het","136","68,68","0.5","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the G protein-coupled receptor family, as well as the EDG family of proteins. This protein functions as a cellular receptor for lysophosphatidic acid and mediates lysophosphatidic acid-evoked calcium mobilization. This receptor couples predominantly to G(q/11) alpha proteins. [provided by RefSeq, Jul 2008]","lysophosphatidic acid receptor 3","G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187)|adenylate cyclase-activating G protein-coupled receptor signaling pathway(GO:0007189)|positive regulation of cytosolic calcium ion concentration(GO:0007204)|chemical synaptic transmission(GO:0007268)|regulation of metabolic process(GO:0019222)|bleb assembly(GO:0032060)|positive regulation of MAPK cascade(GO:0043410)|positive regulation of collateral sprouting(GO:0048672)|positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway(GO:0051482)|positive regulation of calcium ion transport(GO:0051928)","cytoplasm(GO:0005737)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|axon(GO:0030424)|synapse(GO:0045202)","G-protein alpha-subunit binding(GO:0001965)|G protein-coupled receptor activity(GO:0004930)|protein binding(GO:0005515)|phospholipid binding(GO:0005543)|lipid binding(GO:0008289)|lysophosphatidic acid receptor activity(GO:0070915)","chronic leukemia(DOID:1036)|cancer(DOID:162)|osteosarcoma(DOID:3347)|rheumatoid arthritis(DOID:7148)|arthritis(DOID:848)","Neuroactive ligand receptor interaction","Wp focal adhesionpi3kaktmtorsignaling pathway|Wp pi3kakt signaling pathway","Signaling by gpcr|Class a 1 rhodopsin like receptors|G alpha q signalling events|G alpha i signalling events|Lysosphingolipid and lpa receptors|Gpcr ligand binding","Akap13 pathway","","",".;.","","","0.00005443","0.0002","0.001","0.","0.0001","","","3.978e-06","5.443e-05","T","0.14","T","0.334","P","0.894","B","0.368","N","0.009","D","1.000","N","0.55","T","-0.89","N","0.05","0.24","T","-0.743","T","0.139","D","0.046","0.242","T","0.452","22.8","2.624","5.85","3.906","15.410"
"chr12","125438533","125438533","C>T","","DHX37","exonic","nonsynonymous SNV","","DHX37:NM_032656:exon20:c.G2588A:p.G863E","DHX37","exonic","nonsynonymous SNV","","DHX37:ENST00000308736.7_1:exon20:c.G2588A:p.G863E","DHX37:ENST00000308736.2:c.2588G>A:p.(Gly863Glu)","0.9984362","0.500182968316949","0.9984362125396729","0.746583926306229","","","","","","","","","","","","","ENSG00000150990","DHX37","HGNC:17210","DHX37","57647","ENSG00000150990","uc001ugy.4","0.746583926306229","0.500182968316949","0.9984362125396729","OMIM:273250 46, XY sex reversal 11-autosomal_dominant;OMIM:618731 Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies-autosomal_recessive;ORPHA:242 46,XY complete gonadal dysgenesis-autosomal_dominant_and_recessive;ORPHA:251510 46,XY partial gonadal dysgenesis-autosomal_dominant_and_recessive;ORPHA:983 Testicular regression syndrome-autosomal_dominant","214","0/1","Het","71","38,33","0.535211267605634","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","46,xy sex reversal 11(273250)|Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies(618731)","Testicular dysgenesis(HP:0008715)|Male pseudohermaphroditism(HP:0000037)|Polycystic ovaries(HP:0000147)|Hypogonadotropic hypogonadism(HP:0000044)|Ophthalmoplegia(HP:0000602)|Downturned corners of mouth(HP:0002714)|Infantile spasms(HP:0012469)|Colpocephaly(HP:0030048)|Cerebellar hypoplasia(HP:0001321)|Small nail(HP:0001792)|Hypertelorism(HP:0000316)|Scoliosis(HP:0002650)|Strabismus(HP:0000486)|Midface retrusion(HP:0011800)|Blindness(HP:0000618)|Plagiocephaly(HP:0001357)|Delayed CNS myelination(HP:0002188)|Macrodontia(HP:0001572)|Ptosis(HP:0000508)|Pointed chin(HP:0000307)|Global developmental delay(HP:0001263)|Autosomal recessive inheritance(HP:0000007)|Cervical platyspondyly(HP:0004558)|Protruding ear(HP:0000411)|Nystagmus(HP:0000639)|Short philtrum(HP:0000322)|Microcephaly(HP:0000252)|Polymicrogyria(HP:0002126)|Broad neck(HP:0000475)|Facial asymmetry(HP:0000324)|Tooth agenesis(HP:0009804)|Anteverted nares(HP:0000463)|Gonadal dysgenesis with female appearance, male(HP:0008723)|Aplasia of the uterus(HP:0000151)|Vanishing testis(HP:0012870)|Decreased antimullerian hormone level(HP:0031103)|Absence of pubertal development(HP:0008197)|Elevated circulating follicle stimulating hormone level(HP:0008232)|Elevated circulating luteinizing hormone level(HP:0011969)|Autosomal dominant inheritance(HP:0000006)|Primary amenorrhea(HP:0000786)|Urogenital sinus anomaly(HP:0100779)|Decreased serum testosterone concentration(HP:0040171)|Urogenital sinus anomaly(HP:0100779)|Male infertility(HP:0003251)|Azoospermia(HP:0000027)|Sparse pubic hair(HP:0002225)|Hypospadias(HP:0000047)|Ovarian gonadoblastoma(HP:0000149)|Gynecomastia(HP:0000771)|Gonadal dysgenesis(HP:0000133)|Abnormal sex determination(HP:0012244)|Elevated circulating follicle stimulating hormone level(HP:0008232)|Abnormality of the scrotum(HP:0000045)|Nephrotic syndrome(HP:0000100)|Decreased serum testosterone concentration(HP:0040171)|Hypergonadotropic hypogonadism(HP:0000815)|Clitoral hypertrophy(HP:0008665)|Cryptorchidism(HP:0000028)|Ambiguous genitalia(HP:0000062)|Female external genitalia in individual with 46,XY karyotype(HP:0008730)|Abnormality of cardiovascular system morphology(HP:0030680)|Delayed skeletal maturation(HP:0002750)|Micropenis(HP:0000054)|Decreased serum estradiol(HP:0008214)|Decreased testicular size(HP:0008734)|Osteoporosis(HP:0000939)|Primary gonadal insufficiency(HP:0008193)|Decreased fertility in females(HP:0000868)|Testicular gonadoblastoma(HP:0000030)|Absence of secondary sex characteristics(HP:0008187)|Delayed puberty(HP:0000823)|Nephroblastoma(HP:0002667)|Abnormal labia morphology(HP:0000058)|Streak ovary(HP:0010464)|Adrenal insufficiency(HP:0000846)|Sparse axillary hair(HP:0002215)|Vanishing testis(HP:0012870)|Primary amenorrhea(HP:0000786)|Hypoplasia of the vagina(HP:0008726)|Elevated circulating luteinizing hormone level(HP:0011969)|Decreased fertility(HP:0000144)|Male pseudohermaphroditism(HP:0000037)|Abnormality of male internal genitalia(HP:0000022)|Hypoplasia of penis(HP:0008736)|Decreased testicular size(HP:0008734)|Ambiguous genitalia(HP:0000062)|Abnormal morphology of female internal genitalia(HP:0000008)|Abnormality of the face(HP:0000271)|Agonadism(HP:0008633)|Absent testis(HP:0010469)","This gene encodes a DEAD box protein. DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. [provided by RefSeq, Jul 2008]","DEAH-box helicase 37","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462)|brain development(GO:0007420)|ribosome biogenesis(GO:0042254)|ribosome assembly(GO:0042255)|positive regulation of male gonad development(GO:2000020)","intracellular anatomical structure(GO:0005622)|nucleoplasm(GO:0005654)|nucleolus(GO:0005730)|nucleolus(GO:0005730)|cytoplasm(GO:0005737)|nuclear membrane(GO:0031965)","RNA binding(GO:0003723)|RNA helicase activity(GO:0003724)|protein binding(GO:0005515)|ATP binding(GO:0005524)|ATP hydrolysis activity(GO:0016887)|U3 snoRNA binding(GO:0034511)","","","","Rrna modification in the nucleus and cytosol|Rrna processing|Metabolism of rna","","","",".;.","","Score=813;Name=V$RFX1_02","","","","","","","","","","D","0.021","D","0.043","P","0.937","B","0.43","D","0.000","D","1","M","2.765","T","4.29","D","-7.09","0.969","T","-1.082","T","0.023","D","0.050","0.432","D","0.989","23.4","2.912","5.23","7.357","18.397"
"chr15","75143750","75143750","G>C","","SCAMP2","exonic","nonsynonymous SNV","","SCAMP2:NM_005697:exon5:c.C416G:p.T139R","SCAMP2","exonic","nonsynonymous SNV","","SCAMP2:ENST00000268099.13_1:exon5:c.C416G:p.T139R","SCAMP2:ENST00000268099.9:c.416C>G:p.(Thr139Arg)","0.998","0.5000854069439811","0.9980000257492064","0.745632993140095","","","","","","","","","","","","","ENSG00000140497","SCAMP2","HGNC:10564","SCAMP2","10066","ENSG00000140497","uc002azb.2","0.745632993140095","0.5000854069439811","0.9980000257492065","","215","0/1","Het","83","46,37","0.55421686746988","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene product belongs to the SCAMP family of proteins which are secretory carrier membrane proteins. They function as carriers to the cell surface in post-golgi recycling pathways. Different family members are highly related products of distinct genes, and are usually expressed together. These findings suggest that the SCAMPs may function at the same site during vesicular transport rather than in separate pathways. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]","secretory carrier membrane protein 2","post-Golgi vesicle-mediated transport(GO:0006892)|protein transport(GO:0015031)|protein transport(GO:0015031)","Golgi apparatus(GO:0005794)|integral component of membrane(GO:0016021)|transport vesicle(GO:0030133)|trans-Golgi network membrane(GO:0032588)|trans-Golgi network membrane(GO:0032588)|intracellular membrane-bounded organelle(GO:0043231)|recycling endosome membrane(GO:0055038)|recycling endosome membrane(GO:0055038)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)","","","Wp serotonin transporter activity|Wp monoamine transport","","","","",".;.;.;.","","Score=777;Name=V$SEF1_C","","","","","","","","","","D","0.002","D","0.005","B","0.084","B","0.251","N","0.023","N","0.952","L","0.97","T","2.31","N","-2.03","0.236","T","-0.999","T","0.042","T","0.009","0.111","D","0.803","22.0","2.296","5.5","3.147","8.541"
"chr6","10529910","10529910","C>T","","GCNT2","exonic","nonsynonymous SNV","","GCNT2:NM_145649:exon3:c.C766T:p.H256Y","GCNT2","exonic","nonsynonymous SNV","","GCNT2:ENST00000379597.7_1:exon1:c.C766T:p.H256Y,GCNT2:ENST00000495262.7_1:exon3:c.C766T:p.H256Y","GCNT2:ENST00000379597.3:c.766C>T:p.(His256Tyr)","0.99733627","0.5006232458981685","0.9973362684249878","0.7455371535276899","","","","","","","","","","","","","ENSG00000111846","GCNT2","HGNC:4204","GCNT2","2651","ENSG00000111846","uc010jol.4","0.7455371535276899","0.5006232458981685","0.9973362684249878","OMIM:110800 Adult i phenotype without cataract-autosomal_dominant;OMIM:116700 Cataract 13 with adult i phenotype-autosomal_recessive","216","0/1","Het","142","78,64","0.549295774647887","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Blood group, i system(110800)|Cataract 13 with adult i phenotype(116700)","Blood group antigen abnormality(HP:0010970)|Autosomal dominant inheritance(HP:0000006)|Developmental cataract(HP:0000519)|Autosomal recessive inheritance(HP:0000007)","This gene encodes the enzyme responsible for formation of the blood group I antigen. The i and I antigens are distinguished by linear and branched poly-N-acetyllactosaminoglycans, respectively. The encoded protein is the I-branching enzyme, a beta-1,6-N-acetylglucosaminyltransferase responsible for the conversion of fetal i antigen to adult I antigen in erythrocytes during embryonic development. Mutations in this gene have been associated with adult i blood group phenotype. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]","glucosaminyl (N-acetyl) transferase 2 (I blood group)","glycosaminoglycan biosynthetic process(GO:0006024)|protein glycosylation(GO:0006486)|protein glycosylation(GO:0006486)|transforming growth factor beta receptor signaling pathway(GO:0007179)|transforming growth factor beta receptor signaling pathway(GO:0007179)|multicellular organism development(GO:0007275)|positive regulation of cell population proliferation(GO:0008284)|posttranscriptional regulation of gene expression(GO:0010608)|positive regulation of epithelial to mesenchymal transition(GO:0010718)|negative regulation of cell-substrate adhesion(GO:0010812)|positive regulation of cell migration(GO:0030335)|positive regulation of heterotypic cell-cell adhesion(GO:0034116)|maintenance of lens transparency(GO:0036438)|positive regulation of protein kinase B signaling(GO:0051897)|positive regulation of ERK1 and ERK2 cascade(GO:0070374)","Golgi membrane(GO:0000139)|Golgi apparatus(GO:0005794)|membrane(GO:0016020)|integral component of membrane(GO:0016021)","N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109)|acetylglucosaminyltransferase activity(GO:0008375)","cataract(DOID:83)","Glycosphingolipid biosynthesis lacto and neolacto series","","","","Hypoxia|Xenobiotic metabolism","",".;.","","","0.00002388","","","0.","0.","","","2.388e-05","0","","","T","0.076","B","0.36","P","0.463","D","0.000","D","1.000","M","2.635","T","2.88","D","-5.82","0.561","T","-1.155","T","0.045","T","0.020","0.177","D","0.805","24.9","3.462","5.7","3.061","19.494"
"chr19","55284943","55284943","C>A","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon3:c.C229A:p.H77N","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon3:c.C229A:p.H77N,KIR2DL1:ENST00000336077.11_1:exon3:c.C229A:p.H77N","KIR2DL1:ENST00000291633.7:c.229C>A:p.(His77Asn)","0.9972141","0.500015391569832","0.9972140789031982","0.7441230255743961","0.500015391569832","0.9967184960842131","0.7432554703319714","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","217","0/1","Het","307","272,35","0.885993485342019","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>A|KIR2DL1|0.00|0.00|0.00|0.00|-5|-43|-1|8","Immunoglobulin|Immunoglobulin","","","0.00001642","","","0.","0.","","","1.642e-05","0","D","0.001","T","0.133","D","0.971","P","0.71","","","N","1","","","T","2.0","D","-4.62","0.253","T","-1.019","T","0.091","T","6.72E-4","0.060","T","0.082","12.54","0.877","1.24","0.110","3.196"
"chr19","55284944","55284944","A>T","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon3:c.A230T:p.H77L","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon3:c.A230T:p.H77L,KIR2DL1:ENST00000336077.11_1:exon3:c.A230T:p.H77L","KIR2DL1:ENST00000291633.7:c.230A>T:p.(His77Leu)","0.9962229","","","","0.500015391569832","0.9967184960842131","0.7432554703319714","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","218","0/1","Het","305","271,34","0.888524590163934","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>T|KIR2DL1|0.00|0.00|0.00|0.00|17|-44|-44|7","Immunoglobulin|Immunoglobulin","","","0.00001642","","","0.","0.","","","1.642e-05","0","D","0.002","T","0.31","P","0.757","B","0.147","","","N","1","","","T","2.06","D","-6.99","0.294","T","-1.038","T","0.036","T","8.15E-4","0.071","T","0.073","8.772","0.436","1.24","-0.270","3.947"
"chr19","55284962","55284962","C>G","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon3:c.C248G:p.A83G","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon3:c.C248G:p.A83G,KIR2DL1:ENST00000336077.11_1:exon3:c.C248G:p.A83G","KIR2DL1:ENST00000291633.7:c.248C>G:p.(Ala83Gly)","0.955","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","219","0/1","Het","359","310,49","0.863509749303621","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","","","","","","","","","","T","0.053","T","0.104","B","0.1","B","0.33","","","N","1","","","T","2.06","N","-2.38","0.208","T","-0.864","T","0.092","T","0.001","0.067","T","0.223","10.16","0.583","1.24","0.259","3.815"
"chr19","55284916","55284916","G>C","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon3:c.G202C:p.D68H","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon3:c.G202C:p.D68H,KIR2DL1:ENST00000336077.11_1:exon3:c.G202C:p.D68H","KIR2DL1:ENST00000291633.7:c.202G>C:p.(Asp68His)","0.945","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","220","0/1","Het","295","269,26","0.911864406779661","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","","","","","","","","","","T","0.064","T","0.247","B","0.444","B","0.198","","","N","1","","","T","2.03","D","-2.52","0.188","T","-1.006","T","0.041","T","8.05E-4","0.038","T","0.074","4.882","0.138","1.24","-0.459","2.604"
"chr19","55284986","55284986","C>A","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon3:c.C272A:p.T91K","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon3:c.C272A:p.T91K,KIR2DL1:ENST00000336077.11_1:exon3:c.C272A:p.T91K","KIR2DL1:ENST00000291633.7:c.272C>A:p.(Thr91Lys)","0.91505533","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","221","0/1","Het","389","288,101","0.740359897172236","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>A|KIR2DL1|0.00|0.00|0.00|0.00|-25|6|0|32","Immunoglobulin|Immunoglobulin","","","0.00003691","","","0.","0.","","","3.691e-05","0","T","0.088","T","0.064","D","0.978","P","0.841","","","N","1","","","T","1.73","D","-3.36","0.24","T","-1.051","T","0.072","T","0.002","0.046","T","0.046","14.29","1.136","1.24","-1.330","3.815"
"chr19","55286796","55286796","G>A","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon4:c.G550A:p.D184N","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon4:c.G550A:p.D184N,KIR2DL1:ENST00000336077.11_1:exon4:c.G550A:p.D184N","KIR2DL1:ENST00000291633.7:c.550G>A:p.(Asp184Asn)","0.8731583","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","222","0/1","Het","550","420,130","0.763636363636364","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","0.0004","0.0004","","0.","0.","","","0","0","T","0.135","T","0.362","B","0.028","B","0.014","","","N","1","","","T","2.08","N","-2.02","0.061","T","-1.006","T","0.030","T","3.54E-4","0.006","T","0.039","3.235","0.039","1.1","-0.927","4.035"
"chr19","55286809","55286809","G>A","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon4:c.G563A:p.G188D","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon4:c.G563A:p.G188D,KIR2DL1:ENST00000336077.11_1:exon4:c.G563A:p.G188D","KIR2DL1:ENST00000291633.7:c.563G>A:p.(Gly188Asp)","0.8658552","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","223","0/1","Het","564","447,117","0.792553191489362","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","0.00005601","0.005","","0.0001","0.","","","5.601e-05","0","T","0.059","D","0.048","P","0.72","B","0.369","","","N","1","","","T","2.12","D","-5.57","0.13","T","-1.027","T","0.066","","","0.078","T","0.140","12.95","0.932","1.1","-0.581","5.593"
"chr19","55290108","55290108","A>G","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon5:c.A709G:p.K237E","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon5:c.A709G:p.K237E,KIR2DL1:ENST00000336077.11_1:exon5:c.A709G:p.K237E","KIR2DL1:ENST00000291633.7:c.709A>G:p.(Lys237Glu)","0.8401079","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","224","0/1","Het","239","206,33","0.861924686192469","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","0.001","0.0002","0.001","0.0001","0.0006","","","0.0001","0.0008","T","0.156","T","0.334","B","0.001","B","0.01","","","N","1","","","T","7.18","N","-1.63","0.118","T","-0.965","T","0.001","T","7.01E-4","0.012","T","0.013","6.141","0.221","0.569","-0.199",""
"chr19","55286769","55286769","C>A","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon4:c.C523A:p.P175T","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon4:c.C523A:p.P175T,KIR2DL1:ENST00000336077.11_1:exon4:c.C523A:p.P175T","KIR2DL1:ENST00000291633.7:c.523C>A:p.(Pro175Thr)","0.82752395","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","225","0/1","Het","559","436,123","0.779964221824687","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>A|KIR2DL1|0.00|0.00|0.01|0.00|-37|-2|5|-2","Immunoglobulin|Immunoglobulin","","","0.00007928","","","0.0001","0.0001","0.0001","","7.928e-05","0","T","0.173","T","0.476","B","0.001","B","0.002","","","N","1","","","T","2.17","D","-3.48","0.043","T","-1.005","T","0.031","T","3.59E-4","0.084","T","0.020","0.026","-0.664","1.1","-1.918","3.668"
"chr19","55286781","55286781","G>A","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon4:c.G535A:p.G179R","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon4:c.G535A:p.G179R,KIR2DL1:ENST00000336077.11_1:exon4:c.G535A:p.G179R","KIR2DL1:ENST00000291633.7:c.535G>A:p.(Gly179Arg)","0.5976858","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","226","0/1","Het","560","456,104","0.814285714285714","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","0.00005724","0.0004","","0.0001","0.","0.0002","0.0002","5.724e-05","0","T","0.462","T","0.097","P","0.896","B","0.274","","","N","1","","","T","2.11","D","-6.11","0.139","T","-1.032","T","0.035","T","7.18E-4","0.153","T","0.117","12.54","0.877","1.1","0.300","4.881"
"chr19","55285045","55285045","G>T","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon3:c.G331T:p.V111L","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon3:c.G331T:p.V111L,KIR2DL1:ENST00000336077.11_1:exon3:c.G331T:p.V111L","KIR2DL1:ENST00000291633.7:c.331G>T:p.(Val111Leu)","0.5936874","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","227","0/1","Het","334","196,138","0.586826347305389","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>T|KIR2DL1|0.00|0.01|0.01|0.01|39|0|39|-1","Immunoglobulin|Immunoglobulin","","","0.00008228","","","0.0001","0.","","","8.228e-05","0","T","1.0","T","0.356","B","0.0","B","0.0","","","N","1","","","T","5.84","N","1.71","0.163","T","-0.934","T","0.001","T","7.57E-4","0.113","T","0.007","1.772","-0.064","1.24","-0.572","2.270"
"chr19","55286854","55286854","A>G","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon4:c.A608G:p.H203R","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon4:c.A608G:p.H203R,KIR2DL1:ENST00000336077.11_1:exon4:c.A608G:p.H203R","KIR2DL1:ENST00000291633.7:c.608A>G:p.(His203Arg)","0.5841679","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","228","0/1","Het","470","264,206","0.561702127659575","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>G|KIR2DL1|0.00|0.00|0.00|0.00|-17|17|-1|3","Immunoglobulin|Immunoglobulin","","","0.00008076","0.0008","","0.0001","0.","","","8.076e-05","0","T","1.0","T","0.948","B","0.0","B","0.0","","","N","1","","","T","5.87","N","0.93","0.037","T","-0.947","T","0.001","T","5.1E-4","0.021","T","0.009","0.005","-0.897","1.1","-2.882","5.937"
"chr19","55284976","55284976","A>G","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon3:c.A262G:p.S88G","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon3:c.A262G:p.S88G,KIR2DL1:ENST00000336077.11_1:exon3:c.A262G:p.S88G","KIR2DL1:ENST00000291633.7:c.262A>G:p.(Ser88Gly)","0.582879","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","229","0/1","Het","374","320,54","0.855614973262032","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>G|KIR2DL1|0.00|0.00|0.00|0.00|16|2|10|20","Immunoglobulin|Immunoglobulin","","","0.0019","0.0008","0.001","0.0009","0.0019","","","0.0009","0.0014","T","1.0","T","1.0","B","0.0","B","0.0","","","N","1","","","T","1.91","N","1.79","0.085","T","-0.971","T","0.013","T","6.53E-4","0.020","T","0.004","0.333","-0.314","1.24","-0.271","4.062"
"chr19","55286775","55286775","->CA","","KIR2DL1","exonic","frameshift insertion","","KIR2DL1:NM_014218:exon4:c.529_530insCA:p.V177Afs*72","KIR2DL1","exonic","frameshift insertion","","KIR2DL1:ENST00000291633.7_1:exon4:c.529_530insCA:p.V177Afs*75,KIR2DL1:ENST00000336077.11_1:exon4:c.529_530insCA:p.V177Afs*72","KIR2DL1:ENST00000291633.7:c.529_530insCA:p.(Val177Alafs*75)","0.37950778","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","230","0/1","Het","568","497,71","0.875","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","","","","0.0066","","","0.0022","0.0027","","","0.0049","0.0066","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55286773","55286774","AG>-","","KIR2DL1","exonic","frameshift deletion","","KIR2DL1:NM_014218:exon4:c.527_528del:p.K176Sfs*8","KIR2DL1","exonic","frameshift deletion","","KIR2DL1:ENST00000291633.7_1:exon4:c.527_528del:p.K176Sfs*8,KIR2DL1:ENST00000336077.11_1:exon4:c.527_528del:p.K176Sfs*8","KIR2DL1:ENST00000291633.7:c.527_528del:p.(Lys176Serfs*8)","0.37230402","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","231","0/1","Het","573","501,72","0.87434554973822","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","","","","0.0066","","","0.0023","0.0027","","","0.0050","0.0066","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55286665","55286665","T>A","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon4:c.T419A:p.L140Q","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon4:c.T419A:p.L140Q,KIR2DL1:ENST00000336077.11_1:exon4:c.T419A:p.L140Q","KIR2DL1:ENST00000291633.7:c.419T>A:p.(Leu140Gln)","0.30822906","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","232","0/1","Het","334","256,78","0.766467065868264","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>A|KIR2DL1|0.00|0.08|0.00|0.00|2|-48|1|-49","Immunoglobulin|Immunoglobulin","","","0.0011","","","0.0001","0.0001","","","0.0011","0.0003","T","1.0","T","0.509","B","0.0","B","0.001","","","N","1","","","T","5.74","N","2.85","0.061","T","-0.971","T","0.001","T","4.74E-4","0.020","T","0.003","0.110","-0.470","0.929","-3.128","2.982"
"chr19","55284908","55284908","T>C","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon3:c.T194C:p.M65T","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon3:c.T194C:p.M65T,KIR2DL1:ENST00000336077.11_1:exon3:c.T194C:p.M65T","KIR2DL1:ENST00000291633.7:c.194T>C:p.(Met65Thr)","0.22000003","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","233","0/1","Het","302","278,24","0.920529801324503","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","","","","","","","","","","T","0.78","T","0.571","B","0.0","B","0.0","","","N","1","","","T","2.17","N","0.03","0.059","T","-1.060","T","0.012","T","4.07E-4","0.010","T","0.034","0.002","-1.027","1.24","-7.488","2.679"
"chr19","55285082","55285082","T>C","","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:NM_014218:exon3:c.T368C:p.I123T","KIR2DL1","exonic","nonsynonymous SNV","","KIR2DL1:ENST00000291633.7_1:exon3:c.T368C:p.I123T,KIR2DL1:ENST00000336077.11_1:exon3:c.T368C:p.I123T","KIR2DL1:ENST00000291633.7:c.368T>C:p.(Ile123Thr)","0.0009944846","","","","","","","","","","","","","","","","ENSG00000125498","KIR2DL1","HGNC:6329","KIR2DL1","3802","ENSG00000125498","uc002qhb.2","0.7441230255743961","0.500015391569832","0.9972140789031982","","235","0/1","Het","260","210,50","0.807692307692308","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1","natural killer cell inhibitory signaling pathway(GO:0002769)|immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","chronic leukemia(DOID:1036)|leukemia(DOID:1240)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|rheumatoid arthritis(DOID:7148)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|Sezary's disease(DOID:8541)|disease(DOID:4)|viral infectious disease(DOID:934)|cancer(DOID:162)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>C|KIR2DL1|0.00|0.00|0.02|0.01|17|-37|2|-38",".;.","","","0.0000379","0.0004","","0.0001","0.","","","3.79e-05","0","T","1.0","T","1.0","B","0.0","B","0.001","","","N","1","","","T","6.1","N","3.82","0.094","T","-0.937","T","0.000","T","0.002","0.090","T","0.023","4.706","0.127","1.24","-0.040","3.801"
"chr17","47041748","47041748","A>G","","GIP","exonic","nonsynonymous SNV","","GIP:NM_004123:exon3:c.T181C:p.Y61H","GIP","exonic","nonsynonymous SNV","","GIP:ENST00000357424.2_1:exon3:c.T181C:p.Y61H","GIP:ENST00000357424.2:c.181T>C:p.(Tyr61His)","0.9944855","0.502325312467292","0.9944854974746704","0.7439233783183509","","","","","","","","","","","","","ENSG00000159224","GIP","HGNC:4270","GIP","2695","ENSG00000159224","uc002iol.2","0.7439233783183509","0.502325312467292","0.9944854974746704","","237","0/1","Het","109","55,54","0.504587155963303","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes an incretin hormone and belongs to the glucagon superfamily. The encoded protein is important in maintaining glucose homeostasis as it is a potent stimulator of insulin secretion from pancreatic beta-cells following food ingestion and nutrient absorption. This gene stimulates insulin secretion via its G protein-coupled receptor activation of adenylyl cyclase and other signal transduction pathways. It is a relatively poor inhibitor of gastric acid secretion. [provided by RefSeq, Jul 2008]","gastric inhibitory polypeptide","signal transduction(GO:0007165)|adenylate cyclase-activating G protein-coupled receptor signaling pathway(GO:0007189)|female pregnancy(GO:0007565)|memory(GO:0007613)|adult locomotory behavior(GO:0008344)|response to xenobiotic stimulus(GO:0009410)|response to glucose(GO:0009749)|response to selenium ion(GO:0010269)|response to acidic pH(GO:0010447)|positive regulation of glucose transmembrane transport(GO:0010828)|response to organic cyclic compound(GO:0014070)|sensory perception of pain(GO:0019233)|endocrine pancreas development(GO:0031018)|positive regulation of insulin secretion(GO:0032024)|response to lipid(GO:0033993)|exploration behavior(GO:0035640)|gastric inhibitory peptide signaling pathway(GO:0038192)|regulation of fatty acid biosynthetic process(GO:0042304)|response to starvation(GO:0042594)|response to amino acid(GO:0043200)|response to peptide hormone(GO:0043434)|positive regulation of cAMP-mediated signaling(GO:0043950)|response to axon injury(GO:0048678)|regulation of insulin secretion(GO:0050796)|digestive system development(GO:0055123)|long-term synaptic potentiation(GO:0060291)|positive regulation of glucagon secretion(GO:0070094)|triglyceride homeostasis(GO:0070328)","extracellular region(GO:0005576)|extracellular space(GO:0005615)|endoplasmic reticulum lumen(GO:0005788)|secretory granule lumen(GO:0034774)|neuronal cell body(GO:0043025)","hormone activity(GO:0005179)|protein binding(GO:0005515)|gastric inhibitory polypeptide receptor binding(GO:0031767)|glucagon receptor binding(GO:0031769)","gestational diabetes(DOID:11714)|hyperinsulinism(DOID:2018)|syndrome(DOID:225)|obesity(DOID:9970)","","","Peptide hormone metabolism|Signaling by gpcr|Class b 2 secretin family receptors|Incretin synthesis secretion and inactivation|Synthesis secretion and inactivation of glucose dependent insulinotropic polypeptide gip|G alpha s signalling events|Glucagon type ligand receptors|Gpcr ligand binding|Infectious disease|Leishmania infection|Adora2b mediated anti inflammatory cytokines production|Anti inflammatory response favouring leishmania parasite infection","","","","Glucagon/GIP/secretin/VIP|Glucagon/GIP/secretin/VIP|Glucagon/GIP/secretin/VIP","","","0.00001988","0.0004","0.002","0.","0.0003","","","1.988e-05","0.0003","D","0.0","D","0.0","D","1.0","D","0.999","D","0.000","D","0.978","M","2.85","T","0.51","D","-4.35","0.887","T","-0.311","T","0.333","T","0.018","0.457","D","0.897","26.4","3.823","5.32","3.953","11.584"
"chr1","45811650","45811650","C>T","","TESK2","exonic","nonsynonymous SNV","","TESK2:NM_007170:exon10:c.G896A:p.R299H","TESK2","exonic","nonsynonymous SNV","","TESK2:ENST00000372084.5_1:exon8:c.G809A:p.R270H,TESK2:ENST00000372086.4_1:exon10:c.G896A:p.R299H","TESK2:ENST00000341771.6:c.809G>A:p.(Arg270His)","0.9968256","0.5001551110908622","0.9968255758285522","0.7437199947001705","","","","","","","","","","","","","ENSG00000070759","TESK2","HGNC:11732","TESK2","10420","ENSG00000070759","uc001cns.2","0.7437199947001705","0.5001551110908622","0.9968255758285522","","239","0/1","Het","70","39,31","0.557142857142857","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene product is a serine/threonine protein kinase that contains an N-terminal protein kinase domain that is structurally similar to the kinase domains of testis-specific protein kinase-1 and the LIM motif-containing protein kinases (LIMKs). Its overall structure is most related to the former, indicating that it belongs to the TESK subgroup of the LIMK/TESK family of protein kinases. This gene is predominantly expressed in testis and prostate. The developmental expression pattern of the rat gene in testis suggests an important role for this gene in meitoic stages and/or early stages of spermiogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]","testis associated actin remodelling kinase 2","protein phosphorylation(GO:0006468)|spermatogenesis(GO:0007283)|peptidyl-tyrosine phosphorylation(GO:0018108)|actin cytoskeleton organization(GO:0030036)|actin cytoskeleton organization(GO:0030036)|focal adhesion assembly(GO:0048041)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|nuclear body(GO:0016604)","protein kinase activity(GO:0004672)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine/tyrosine kinase activity(GO:0004712)|transmembrane receptor protein tyrosine kinase activity(GO:0004714)|protein binding(GO:0005515)|ATP binding(GO:0005524)|metal ion binding(GO:0046872)|protein serine kinase activity(GO:0106310)","","","Wp focal adhesion|Wp regulation of microtubule cytoskeleton","","","","",".;Serine-threonine/tyrosine-protein","","","0.00001202","0.0002","0.001","0.","0.0002","","","1.202e-05","0.0001","D","0.0","D","0.006","D","1.0","D","0.977","D","0.000","D","1.000","H","4.665","D","-4.89","D","-3.95","0.88","D","1.038","D","0.982","D","0.378","0.922","D","1.000","32","4.538","5.54","5.751","19.543"
"chr2","69049787","69049787","G>T","","ARHGAP25","exonic","nonsynonymous SNV","","ARHGAP25:NM_001166276:exon9:c.G1495T:p.V499F,ARHGAP25:NM_001166277:exon9:c.G1396T:p.V466F,ARHGAP25:NM_014882:exon9:c.G1492T:p.V498F,ARHGAP25:NM_001007231:exon10:c.G1516T:p.V506F","ARHGAP25","exonic","nonsynonymous SNV","","ARHGAP25:ENST00000479844.1_1:exon4:c.G595T:p.V199F,ARHGAP25:ENST00000409030.7_1:exon9:c.G1492T:p.V498F,ARHGAP25:ENST00000409220.5_1:exon9:c.G1495T:p.V499F,ARHGAP25:ENST00000467265.5_1:exon9:c.G1396T:p.V466F,ARHGAP25:ENST00000409202.8_1:exon10:c.G1516T:p.V506F","ARHGAP25:ENST00000295381.3:c.1513G>T:p.(Val505Phe)","0.99653065","0.5003669302386697","0.9965306520462036","0.7436233925554295","","","","","","","","","","","","","ENSG00000163219","ARHGAP25","HGNC:28951","ARHGAP25","9938","ENSG00000163219","uc010fdg.4","0.7436233925554295","0.5003669302386697","0.9965306520462036","","240","0/1","Het","120","65,55","0.541666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","ARHGAPs, such as ARHGAP25, encode negative regulators of Rho GTPases (see ARHA; MIM 165390), which are implicated in actin remodeling, cell polarity, and cell migration (Katoh and Katoh, 2004 [PubMed 15254788]).[supplied by OMIM, Mar 2008]","Rho GTPase activating protein 25","phagocytosis, engulfment(GO:0006911)|phagocytosis, engulfment(GO:0006911)|actin filament organization(GO:0007015)|actin filament organization(GO:0007015)|signal transduction(GO:0007165)|negative regulation of small GTPase mediated signal transduction(GO:0051058)|negative regulation of small GTPase mediated signal transduction(GO:0051058)|activation of GTPase activity(GO:0090630)","phagocytic cup(GO:0001891)|phagocytic cup(GO:0001891)","GTPase activator activity(GO:0005096)","","","","Rho gtpase cycle|Rac1 gtpase cycle|Signaling by rho gtpases miro gtpases and rhobtb3","","","",".;.;.;.;.","","","0.00001997","","","0.","","","","1.997e-05","0.0003","D","0.003","T","0.12","P","0.917","P","0.541","N","0.017","D","1.000","","","T","2.58","D","-3.49","0.505","T","-1.044","T","0.109","T","0.018","0.124","D","0.898","23.1","2.760","5.16","3.053","11.563"
"chr1","151143037","151143037","G>A","","TMOD4","exonic","stopgain","","TMOD4:NM_013353:exon9:c.C973T:p.R325X","TMOD4","exonic","stopgain","","TMOD4:ENST00000295314.9_1:exon9:c.C973T:p.R325X","TMOD4:ENST00000416280.2:c.766C>T:p.(Arg256*)","0.9963797","0.5000394851522287","0.9963796734809875","0.7427090889387651","","","","","","","","","","","","","ENSG00000163157","TMOD4","HGNC:11874","TMOD4","29765","ENSG00000163157","uc001exc.5","0.7427090889387651","0.5000394851522287","0.9963796734809875","","241","0/1","Het","151","72,79","0.47682119205298","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","tropomodulin 4","muscle contraction(GO:0006936)|actin filament organization(GO:0007015)|myofibril assembly(GO:0030239)|pointed-end actin filament capping(GO:0051694)","cytoskeleton(GO:0005856)|striated muscle thin filament(GO:0005865)|striated muscle thin filament(GO:0005865)|myofibril(GO:0030016)","protein binding(GO:0005515)|tropomyosin binding(GO:0005523)|actin filament binding(GO:0051015)","","","","Striated muscle contraction|Muscle contraction","","","","","","Score=819;Name=V$MYCMAX_01","0.00002387","","","0.","0.","","","2.387e-05","0","","","","","","","","","D","0.000","D","1","","","","","","","0.358","","","","","","","","","","39","7.754","5.88","3.311","7.409"
"chr1","35227528","35227528","C>T","","GJB4","exonic","nonsynonymous SNV","","GJB4:NM_153212:exon2:c.C673T:p.R225W","GJB4","exonic","nonsynonymous SNV","","GJB4:ENST00000339480.3_1:exon2:c.C673T:p.R225W","GJB4:ENST00000339480.1:c.673C>T:p.(Arg225Trp)","0.9961801","0.5000022817966965","0.9961801171302797","0.7422847506213535","","","","","","","","","","","","","ENSG00000189433","GJB4","HGNC:4286","GJB4","127534","ENSG00000189433","uc001bxv.1","0.7422847506213535","0.5000022817966965","0.9961801171302795","OMIM:617524 Erythrokeratodermia variabilis et progressiva 2-autosomal_dominant;ORPHA:317 Erythrokeratodermia variabilis-autosomal_dominant","242","0/1","Het","115","70,45","0.608695652173913","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Erythrokeratodermia variabilis et progressiva 2(617524)","Palmoplantar keratoderma(HP:0000982)|Hypertrichosis(HP:0000998)|Erythema(HP:0010783)|Autosomal dominant inheritance(HP:0000006)|Tapered finger(HP:0001182)|Alopecia(HP:0001596)|Protruding ear(HP:0000411)|Patchy palmoplantar hyperkeratosis(HP:0005588)|Neoplasm of the skin(HP:0008069)|Abnormality of the nail(HP:0001597)|Corneal opacity(HP:0007957)|Abnormal testis morphology(HP:0000035)|Cutaneous photosensitivity(HP:0000992)|Dry skin(HP:0000958)|Erythema(HP:0010783)|Intellectual disability(HP:0001249)|Generalized hirsutism(HP:0002230)|Glaucoma(HP:0000501)|Diabetes mellitus(HP:0000819)|Hearing impairment(HP:0000365)|Skin rash(HP:0000988)|Cataract(HP:0000518)|Short stature(HP:0004322)|Abnormal blistering of the skin(HP:0008066)|Microcephaly(HP:0000252)|Abnormality of cardiovascular system morphology(HP:0030680)|Hypermelanotic macule(HP:0001034)|Brachydactyly(HP:0001156)|Weight loss(HP:0001824)","This gene encodes a transmembrane connexin protein that is a component of gap junctions. Mutations in this gene have been associated with erythrokeratodermia variabilis, progressive symmetric erythrokeratoderma and hearing impairment. [provided by RefSeq, Dec 2009]","gap junction protein beta 4","cell-cell signaling(GO:0007267)|cell-cell signaling(GO:0007267)|sensory perception of smell(GO:0007608)|olfactory behavior(GO:0042048)|transmembrane transport(GO:0055085)|gap junction-mediated intercellular transport(GO:1990349)","nucleoplasm(GO:0005654)|nucleolus(GO:0005730)|integral component of plasma membrane(GO:0005887)|connexin complex(GO:0005922)|connexin complex(GO:0005922)|cell junction(GO:0030054)","gap junction channel activity(GO:0005243)|gap junction channel activity(GO:0005243)|protein binding(GO:0005515)","","","Wp calcium regulation in the cardiac cell","Gap junction trafficking and regulation|Gap junction assembly|Membrane trafficking|Vesicle mediated transport","","","","","","","0.00001594","","","0.","0.","","","1.594e-05","0","D","0.003","D","0.01","D","0.958","B","0.394","N","0.654","N","1","L","1.735","D","-4.58","N","-1.54","0.207","D","0.311","D","0.797","D","0.151","0.339","D","0.638","22.1","2.323","5.64","-0.646","4.190"
"chr14","100801285","100801285","C>T","","WARS","exonic","nonsynonymous SNV","","WARS:NM_213645:exon10:c.G1220A:p.R407Q,WARS:NM_213646:exon10:c.G1220A:p.R407Q,WARS:NM_004184:exon11:c.G1343A:p.R448Q,WARS:NM_173701:exon11:c.G1343A:p.R448Q","WARS1","exonic","nonsynonymous SNV","","WARS1:ENST00000344102.9_1:exon10:c.G1220A:p.R407Q,WARS1:ENST00000358655.8_1:exon10:c.G1220A:p.R407Q,WARS1:ENST00000355338.6_1:exon11:c.G1343A:p.R448Q,WARS1:ENST00000392882.7_1:exon11:c.G1343A:p.R448Q,WARS1:ENST00000556645.5_1:exon11:c.G1220A:p.R407Q,WARS1:ENST00000557135.5_1:exon12:c.G1343A:p.R448Q","WARS1:ENST00000344102.5:c.1220G>A:p.(Arg407Gln)","0.9958382","0.5002165428013541","0.995838224887848","0.7421101074958191","","","","","","","","","","","","","ENSG00000140105","WARS1","HGNC:12729","WARS1","7453","ENSG00000140105","uc001yhl.2","0.7421101074958191","0.5002165428013541","0.9958382248878479","OMIM:617721 Neuronopathy, distal hereditary motor, type IX-autosomal_dominant","243","0/1","Het","96","52,44","0.541666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Neuronopathy, distal hereditary motor, type ix(617721)","Autosomal dominant inheritance(HP:0000006)|Pes cavus(HP:0001761)|Hyporeflexia(HP:0001265)|Motor axonal neuropathy(HP:0007002)|Slowly progressive(HP:0003677)|Difficulty walking(HP:0002355)|Juvenile onset(HP:0003621)","Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Two forms of tryptophanyl-tRNA synthetase exist, a cytoplasmic form, named WARS, and a mitochondrial form, named WARS2. Tryptophanyl-tRNA synthetase (WARS) catalyzes the aminoacylation of tRNA(trp) with tryptophan and is induced by interferon. Tryptophanyl-tRNA synthetase belongs to the class I tRNA synthetase family. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]","tryptophanyl-tRNA synthetase 1","angiogenesis(GO:0001525)|negative regulation of protein phosphorylation(GO:0001933)|translation(GO:0006412)|tryptophanyl-tRNA aminoacylation(GO:0006436)|tryptophanyl-tRNA aminoacylation(GO:0006436)|negative regulation of protein kinase activity(GO:0006469)|negative regulation of cell population proliferation(GO:0008285)|positive regulation of gene expression(GO:0010628)|regulation of protein ADP-ribosylation(GO:0010835)|positive regulation of protein-containing complex assembly(GO:0031334)|regulation of angiogenesis(GO:0045765)","nucleus(GO:0005634)|nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytosol(GO:0005829)|protein-containing complex(GO:0032991)|extracellular exosome(GO:0070062)","tryptophan-tRNA ligase activity(GO:0004830)|tryptophan-tRNA ligase activity(GO:0004830)|tryptophan-tRNA ligase activity(GO:0004830)|protein binding(GO:0005515)|ATP binding(GO:0005524)|kinase inhibitor activity(GO:0019210)|protein kinase binding(GO:0019901)|protein domain specific binding(GO:0019904)|protein homodimerization activity(GO:0042803)","cancer(DOID:162)|disease(DOID:4)","Aminoacyl trna biosynthesis|Tryptophan metabolism","Wp tryptophan metabolism|Wp amino acid metabolism|Wp photodynamic therapyinduced unfolded protein response","Cytosolic trna aminoacylation|Trna aminoacylation|Translation","","Interferon alpha response|Interferon gamma response|Mtorc1 signaling|Allograft rejection","SpliceAI>T|WARS|0.00|0.00|0.00|0.00|25|12|-10|5",".;.;.;.;.;.","","Score=887;Name=V$CEBP_Q2","0.00005437","","","0.","0.","","","4.817e-05","5.437e-05","D","0.015","T","0.064","P","0.65","B","0.048","D","0.000","D","1.000","M","2.79","T","-0.75","D","-2.58","0.588","T","-0.056","T","0.399","D","0.046","0.358","T","0.444","25.0","3.499","5.22","3.985","19.149"
"chr15","72495523","72495523","G>A","","PKM","exonic","nonsynonymous SNV","","PKM:NM_001206799:exon9:c.C1162T:p.R388C,PKM:NM_001316318:exon9:c.C1252T:p.R418C,PKM:NM_182470:exon9:c.C1147T:p.R383C,PKM:NM_182471:exon9:c.C1147T:p.R383C,PKM:NM_001206796:exon10:c.C1369T:p.R457C","PKM","exonic","nonsynonymous SNV","","PKM:ENST00000568883.5_1:exon6:c.C652T:p.R218C,PKM:ENST00000319622.10_1:exon9:c.C1147T:p.R383C,PKM:ENST00000565184.6_1:exon9:c.C1252T:p.R418C,PKM:ENST00000568459.5_1:exon9:c.C1147T:p.R383C,PKM:ENST00000565154.6_1:exon10:c.C1369T:p.R457C","PKM:ENST00000319622.6:c.1147C>T:p.(Arg383Cys)","0.99193925","0.5035196670796722","0.9919392466545104","0.7418280778665252","","","","","","","","","","","","","ENSG00000067225","PKM","HGNC:9021","PKM","5315","ENSG00000067225","uc002aty.3","0.7418280778665252","0.5035196670796722","0.9919392466545105","","244","0/1","Het","76","46,30","0.605263157894737","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein involved in glycolysis. The encoded protein is a pyruvate kinase that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate to ADP, generating ATP and pyruvate. This protein has been shown to interact with thyroid hormone and may mediate cellular metabolic effects induced by thyroid hormones. This protein has been found to bind Opa protein, a bacterial outer membrane protein involved in gonococcal adherence to and invasion of human cells, suggesting a role of this protein in bacterial pathogenesis. Several alternatively spliced transcript variants encoding a few distinct isoforms have been reported. [provided by RefSeq, May 2011]","pyruvate kinase M1/2","glycolytic process(GO:0006096)|glycolytic process(GO:0006096)|programmed cell death(GO:0012501)|cellular response to insulin stimulus(GO:0032869)|positive regulation of sprouting angiogenesis(GO:1903672)|positive regulation of cytoplasmic translation(GO:2000767)","extracellular region(GO:0005576)|nucleus(GO:0005634)|nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|mitochondrion(GO:0005739)|rough endoplasmic reticulum(GO:0005791)|cytosol(GO:0005829)|cytosol(GO:0005829)|cytosol(GO:0005829)|cilium(GO:0005929)|vesicle(GO:0031982)|secretory granule lumen(GO:0034774)|collagen-containing extracellular matrix(GO:0062023)|extracellular exosome(GO:0070062)|extracellular vesicle(GO:1903561)|ficolin-1-rich granule lumen(GO:1904813)","magnesium ion binding(GO:0000287)|RNA binding(GO:0003723)|mRNA binding(GO:0003729)|pyruvate kinase activity(GO:0004743)|pyruvate kinase activity(GO:0004743)|pyruvate kinase activity(GO:0004743)|protein binding(GO:0005515)|ATP binding(GO:0005524)|kinase activity(GO:0016301)|MHC class II protein complex binding(GO:0023026)|potassium ion binding(GO:0030955)|cadherin binding(GO:0045296)","lymphoid leukemia(DOID:1037)|obsessive-compulsive disorder(DOID:10933)|leukemia(DOID:1240)|cancer(DOID:162)|squamous cell carcinoma(DOID:1749)|syndrome(DOID:225)|pancreatic ductal adenocarcinoma(DOID:3498)|benign pleural mesothelioma(DOID:5157)|malignant pleural mesothelioma(DOID:7474)|embryoma(DOID:4766)|Gilles de la Tourette syndrome(DOID:11119)|lung cancer(DOID:1324)","Glycolysis gluconeogenesis|Purine metabolism|Pyruvate metabolism|Type ii diabetes mellitus","Wp pathways in clear cell renal cell carcinoma|Wp glycolysis and gluconeogenesis|Wp amino acid metabolism|Wp photodynamic therapyinduced hif1 survival signaling|Wp metabolic reprogramming in colon cancer|Wp computational model of aerobic glycolysis|Wp glycolysis in senescence","Innate immune system|Neutrophil degranulation|Glycolysis|Glucose metabolism|Metabolism of carbohydrates","","Glycolysis","",".;.;Pyruvate","","","0.00004377","","","0.0001","0.0006","","","4.377e-05","0.0004","T","0.118","T","0.22","B","0.008","B","0.013","D","0.000","D","1","","","D","-5.82","D","-4.88","0.807","D","1.081","D","0.941","D","0.111","0.651","T","0.420","25.0","3.519","5.75","10.003","19.942"
"chr20","23028910","23028910","G>A","","THBD","exonic","nonsynonymous SNV","","THBD:NM_000361:exon1:c.C1232T:p.T411I","THBD","exonic","nonsynonymous SNV","","THBD:ENST00000377103.3_1:exon1:c.C1232T:p.T411I","THBD:ENST00000377103.2:c.1232C>T:p.(Thr411Ile)","0.9948982","0.5007553865434602","0.9948982000350952","0.741529410675227","","","","","","","","","","","","","ENSG00000178726","THBD","HGNC:11784","THBD","7056","ENSG00000178726","uc002wss.4","0.741529410675227","0.5007553865434602","0.9948982000350952","OMIM:612926 Hemolytic uremic syndrome, atypical, susceptibility to, 6-autosomal_dominant;OMIM:614486 Thrombophilia due to thrombomodulin defect-unknown","246","0/1","Het","220","106,114","0.481818181818182","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Hemolytic uremic syndrome, atypical, susceptibility to, 6(612926)|Thrombophilia due to thrombomodulin defect(614486)","Hypertension(HP:0000822)|Proteinuria(HP:0000093)|Thrombocytopenia(HP:0001873)|Autosomal dominant inheritance(HP:0000006)|Elevated circulating creatinine concentration(HP:0003259)|Acute kidney injury(HP:0001919)|Microangiopathic hemolytic anemia(HP:0001937)|Anuria(HP:0100519)|Hematuria(HP:0000790)|Increased blood urea nitrogen(HP:0003138)|Hemolytic-uremic syndrome(HP:0005575)|Hypercoagulability(HP:0100724)|Deep venous thrombosis(HP:0002625)","The protein encoded by this intronless gene is an endothelial-specific type I membrane receptor that binds thrombin. This binding results in the activation of protein C, which degrades clotting factors Va and VIIIa and reduces the amount of thrombin generated. Mutations in this gene are a cause of thromboembolic disease, also known as inherited thrombophilia. [provided by RefSeq, Jul 2008]","thrombomodulin","female pregnancy(GO:0007565)|blood coagulation(GO:0007596)|response to X-ray(GO:0010165)|negative regulation of platelet activation(GO:0010544)|negative regulation of blood coagulation(GO:0030195)|response to lipopolysaccharide(GO:0032496)|response to cAMP(GO:0051591)|negative regulation of fibrinolysis(GO:0051918)","extracellular space(GO:0005615)|vacuolar membrane(GO:0005774)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|external side of plasma membrane(GO:0009897)|cell surface(GO:0009986)|apicolateral plasma membrane(GO:0016327)","transmembrane signaling receptor activity(GO:0004888)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|signaling receptor activity(GO:0038023)","pre-eclampsia(DOID:10591)|brucellosis(DOID:11077)|disseminated intravascular coagulation(DOID:11247)|heart disease(DOID:114)|hemolytic-uremic syndrome(DOID:12554)|HELLP syndrome(DOID:13133)|Behcet's disease(DOID:13241)|vascular disease(DOID:178)|melanoma(DOID:1909)|atherosclerosis(DOID:1936)|syndrome(DOID:225)|ischemia(DOID:326)|brain infarction(DOID:3454)|liver cirrhosis(DOID:5082)|pneumonia(DOID:552)|myocardial infarction(DOID:5844)|bronchitis(DOID:6132)|hepatocellular carcinoma(DOID:684)|diabetes mellitus(DOID:9351)|diabetic neuropathy(DOID:9743)","Complement and coagulation cascades","Wp nuclear receptors metapathway|Wp supression of hmgb1 mediated inflammation by thbd|Wp glucocorticoid receptor pathway|Wp complement and coagulation cascades|Wp vitamin d receptor pathway","Hemostasis|Common pathway of fibrin clot formation|Formation of fibrin clot clotting cascade|Cell surface interactions at the vascular wall","","Angiogenesis|Coagulation","","Thrombomodulin-like,","","","","","","","","","","","","D","0.005","D","0.028","D","0.975","P","0.592","U","0.462","N","1","M","2.455","T","-1.37","D","-2.68","0.233","T","-0.306","D","0.552","D","0.380","0.368","D","0.910","23.2","2.811","4.82","0.994","14.400"
"chr7","105255228","105255228","G>A","","ATXN7L1","exonic","nonsynonymous SNV","","ATXN7L1:NM_138495:exon8:c.C1181T:p.S394L,ATXN7L1:NM_020725:exon10:c.C1553T:p.S518L","ATXN7L1","exonic","nonsynonymous SNV","","ATXN7L1:ENST00000477775.5_1:exon8:c.C1181T:p.S394L,ATXN7L1:ENST00000419735.8_1:exon10:c.C1553T:p.S518L","ATXN7L1:ENST00000388807.4:c.533C>T:p.(Ser178Leu)","0.9956427","0.500004853129667","0.9956427216529846","0.7413446266317003","","","","","","","","","","","","","ENSG00000146776","ATXN7L1","HGNC:22210","ATXN7L1","222255","ENSG00000146776","uc003vde.3","0.7413446266317003","0.500004853129667","0.9956427216529846","","247","0/1","Het","119","68,51","0.571428571428571","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ataxin 7 like 1","","","protein binding(GO:0005515)","","","","","","","",".;.;.;.","","Score=912;Name=V$CP2_01","0.00009169","0.0002","","0.0001","0.","","","4.56e-05","9.169e-05","D","0.011","T","0.098","P","0.897","B","0.148","D","0.000","D","0.998","L","1.935","T","2.36","N","-2.22","0.265","T","-1.012","T","0.132","T","0.015","0.186","T","0.116","24.8","3.440","5.7","4.237","19.841"
"chr8","27309003","27309003","C>T","","PTK2B","exonic","nonsynonymous SNV","","PTK2B:NM_173175:exon26:c.C2399T:p.T800M,PTK2B:NM_173176:exon27:c.C2525T:p.T842M,PTK2B:NM_004103:exon28:c.C2525T:p.T842M,PTK2B:NM_173174:exon32:c.C2525T:p.T842M","PTK2B","exonic","nonsynonymous SNV","","PTK2B:ENST00000517339.5_1:exon25:c.C2399T:p.T800M,PTK2B:ENST00000420218.3_1:exon26:c.C2399T:p.T800M,PTK2B:ENST00000346049.10_1:exon27:c.C2525T:p.T842M,PTK2B:ENST00000397501.5_1:exon32:c.C2525T:p.T842M","PTK2B:ENST00000338238.4:c.2399C>T:p.(Thr800Met)","0.9870348","0.5072860140353441","0.987034797668457","0.7406980022370744","","","","","","","","","","","","","ENSG00000120899","PTK2B","HGNC:9612","PTK2B","2185","ENSG00000120899","uc003xfn.3","0.7406980022370744","0.5072860140353441","0.987034797668457","","248","0/1","Het","156","85,71","0.544871794871795","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a cytoplasmic protein tyrosine kinase which is involved in calcium-induced regulation of ion channels and activation of the map kinase signaling pathway. The encoded protein may represent an important signaling intermediate between neuropeptide-activated receptors or neurotransmitters that increase calcium flux and the downstream signals that regulate neuronal activity. The encoded protein undergoes rapid tyrosine phosphorylation and activation in response to increases in the intracellular calcium concentration, nicotinic acetylcholine receptor activation, membrane depolarization, or protein kinase C activation. This protein has been shown to bind CRK-associated substrate, nephrocystin, GTPase regulator associated with FAK, and the SH2 domain of GRB2. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]","protein tyrosine kinase 2 beta","MAPK cascade(GO:0000165)|oocyte maturation(GO:0001556)|response to hypoxia(GO:0001666)|positive regulation of cell-matrix adhesion(GO:0001954)|sprouting angiogenesis(GO:0002040)|adaptive immune response(GO:0002250)|marginal zone B cell differentiation(GO:0002315)|protein phosphorylation(GO:0006468)|apoptotic process(GO:0006915)|cellular defense response(GO:0006968)|response to osmotic stress(GO:0006970)|signal transduction(GO:0007165)|cell surface receptor signaling pathway(GO:0007166)|transmembrane receptor protein tyrosine kinase signaling pathway(GO:0007169)|signal complex assembly(GO:0007172)|epidermal growth factor receptor signaling pathway(GO:0007173)|positive regulation of cytosolic calcium ion concentration(GO:0007204)|integrin-mediated signaling pathway(GO:0007229)|positive regulation of cell population proliferation(GO:0008284)|negative regulation of cell population proliferation(GO:0008285)|regulation of cell shape(GO:0008360)|response to xenobiotic stimulus(GO:0009410)|response to mechanical stimulus(GO:0009612)|response to hormone(GO:0009725)|response to glucose(GO:0009749)|response to lithium ion(GO:0010226)|positive regulation of endothelial cell migration(GO:0010595)|negative regulation of muscle cell apoptotic process(GO:0010656)|regulation of cGMP-mediated signaling(GO:0010752)|regulation of macrophage chemotaxis(GO:0010758)|positive regulation of neuron projection development(GO:0010976)|glial cell proliferation(GO:0014009)|peptidyl-tyrosine phosphorylation(GO:0018108)|cell differentiation(GO:0030154)|regulation of cell adhesion(GO:0030155)|regulation of cell adhesion(GO:0030155)|positive regulation of cell growth(GO:0030307)|positive regulation of cell migration(GO:0030335)|negative regulation of bone mineralization(GO:0030502)|positive regulation of actin filament polymerization(GO:0030838)|neuron projection development(GO:0031175)|regulation of inositol trisphosphate biosynthetic process(GO:0032960)|tumor necrosis factor-mediated signaling pathway(GO:0033209)|ionotropic glutamate receptor signaling pathway(GO:0035235)|response to immobilization stress(GO:0035902)|peptidyl-tyrosine autophosphorylation(GO:0038083)|peptidyl-tyrosine autophosphorylation(GO:0038083)|response to cocaine(GO:0042220)|response to hydrogen peroxide(GO:0042542)|activation of Janus kinase activity(GO:0042976)|negative regulation of apoptotic process(GO:0043066)|stress fiber assembly(GO:0043149)|negative regulation of potassium ion transport(GO:0043267)|positive regulation of JUN kinase activity(GO:0043507)|negative regulation of neuron apoptotic process(GO:0043524)|blood vessel endothelial cell migration(GO:0043534)|positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552)|innate immune response(GO:0045087)|positive regulation of nitric oxide biosynthetic process(GO:0045429)|bone resorption(GO:0045453)|response to ethanol(GO:0045471)|negative regulation of myeloid cell differentiation(GO:0045638)|positive regulation of translation(GO:0045727)|positive regulation of angiogenesis(GO:0045766)|positive regulation of protein kinase activity(GO:0045860)|positive regulation of JNK cascade(GO:0046330)|protein autophosphorylation(GO:0046777)|vascular endothelial growth factor receptor signaling pathway(GO:0048010)|focal adhesion assembly(GO:0048041)|regulation of synaptic plasticity(GO:0048167)|positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731)|regulation of calcium-mediated signaling(GO:0050848)|positive regulation of nitric-oxide synthase activity(GO:0051000)|regulation of release of sequestered calcium ion into cytosol(GO:0051279)|response to cAMP(GO:0051591)|response to calcium ion(GO:0051592)|positive regulation of synaptic transmission, glutamatergic(GO:0051968)|long-term synaptic potentiation(GO:0060291)|long-term synaptic depression(GO:0060292)|protein-containing complex assembly(GO:0065003)|chemokine-mediated signaling pathway(GO:0070098)|positive regulation of ERK1 and ERK2 cascade(GO:0070374)|cellular response to retinoic acid(GO:0071300)|cellular response to fluid shear stress(GO:0071498)|endothelin receptor signaling pathway(GO:0086100)|activation of GTPase activity(GO:0090630)|regulation of ubiquitin-dependent protein catabolic process(GO:2000058)|positive regulation of ubiquitin-dependent protein catabolic process(GO:2000060)|regulation of establishment of cell polarity(GO:2000114)|regulation of actin cytoskeleton reorganization(GO:2000249)|regulation of NMDA receptor activity(GO:2000310)|positive regulation of reactive oxygen species metabolic process(GO:2000379)|positive regulation of excitatory postsynaptic potential(GO:2000463)|positive regulation of B cell chemotaxis(GO:2000538)|positive regulation of DNA biosynthetic process(GO:2000573)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytoskeleton(GO:0005856)|focal adhesion(GO:0005925)|focal adhesion(GO:0005925)|cell cortex(GO:0005938)|postsynaptic density(GO:0014069)|postsynaptic density(GO:0014069)|NMDA selective glutamate receptor complex(GO:0017146)|lamellipodium(GO:0030027)|dendrite(GO:0030425)|growth cone(GO:0030426)|extrinsic component of cytoplasmic side of plasma membrane(GO:0031234)|neuronal cell body(GO:0043025)|dendritic spine(GO:0043197)|cell body(GO:0044297)|membrane raft(GO:0045121)|perinuclear region of cytoplasm(GO:0048471)|apical dendrite(GO:0097440)|glutamatergic synapse(GO:0098978)","calmodulin-dependent protein kinase activity(GO:0004683)|protein tyrosine kinase activity(GO:0004713)|transmembrane receptor protein tyrosine kinase activity(GO:0004714)|non-membrane spanning protein tyrosine kinase activity(GO:0004715)|non-membrane spanning protein tyrosine kinase activity(GO:0004715)|NMDA glutamate receptor activity(GO:0004972)|signaling receptor binding(GO:0005102)|protein binding(GO:0005515)|ATP binding(GO:0005524)|protein C-terminus binding(GO:0008022)|ubiquitin protein ligase binding(GO:0031625)|3-phosphoinositide-dependent protein kinase binding(GO:0043423)|protein-containing complex binding(GO:0044877)","hypertension(DOID:10763)|osteoporosis(DOID:11476)|leukemia(DOID:1240)|cancer(DOID:162)|hepatocellular carcinoma(DOID:684)","Calcium signaling pathway|Chemokine signaling pathway|Natural killer cell mediated cytotoxicity|Leukocyte transendothelial migration|Gnrh signaling pathway","Wp egfegfr signaling pathway|Wp signaling of hepatocyte growth factor receptor|Wp chemokine signaling pathway|Wp il7 signaling pathway|Wp il2 signaling pathway|Wp oncostatin m signaling pathway|Wp apoptosisrelated network due to altered notch3 in ovarian cancer|Wp brainderived neurotrophic factor bdnf signaling pathway|Wp tcell antigen receptor tcr signaling pathway|Wp vegfavegfr2 signaling pathway|Wp netrinunc5b signaling pathway|Wp hepatitis b infection","Cytokine signaling in immune system|Cell cell communication|Signaling by vegf|Signal regulatory protein family interactions|Signaling by interleukins|Interleukin 2 family signaling|Signaling by receptor tyrosine kinases|Interleukin 2 signaling","Hbx pathway|Ion pathway|At1r pathway|Biopeptides pathway|Cxcr4 pathway|Il7 pathway|Pyk2 pathway|Ccr5 pathway|Nkcells pathway|Ach pathway|Met pathway|Par1 pathway","Androgen response","",".;.;.;.","","Score=826;Name=V$SRF_Q6","0.00005437","","","0.","0.0001","","","1.592e-05","5.437e-05","T","0.236","T","0.195","P","0.646","B","0.12","N","0.155","D","0.971","L","1.78","T","-0.87","N","-0.45","0.503","T","-0.438","T","0.304","D","0.050","0.323","T","0.297","18.58","1.849","5.51","0.971","12.793"
"chr7","100676720","100676720","G>T","","MUC17","exonic","nonsynonymous SNV","","MUC17:NM_001040105:exon3:c.G2023T:p.G675C","MUC17","exonic","nonsynonymous SNV","","MUC17:ENST00000306151.9_1:exon3:c.G2023T:p.G675C","MUC17:ENST00000306151.4:c.2023G>T:p.(Gly675Cys)","0.995","","","","0.500213938561501","0.9950000047683716","0.7406288894161156","","","","","","","","","","ENSG00000169876","MUC17","HGNC:16800","MUC17","140453","ENSG00000169876","uc003uxp.2","0.7406288894161156","0.500213938561501","0.9950000047683716","","249","1/1","Hom","2","0,2","0","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a membrane-bound mucin that provides protection to gut epithelial cells. The encoded protein contains about 60 tandem repeats, with each repeat being around 60 aa. N-glycosylation enables the encoded protein to localize on the cell surface, while the C-terminus interacts with the scaffold protein PDZ domain containing 1 (PDZK1). Two transcript variants, one protein-coding and the other non-protein coding, have been found for this gene. [provided by RefSeq, Nov 2015]","mucin 17, cell surface associated","cellular homeostasis(GO:0019725)","extracellular region(GO:0005576)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|external side of plasma membrane(GO:0009897)|external side of plasma membrane(GO:0009897)|integral component of membrane(GO:0016021)|apical plasma membrane(GO:0016324)|apical plasma membrane(GO:0016324)|collagen-containing extracellular matrix(GO:0062023)","protein binding(GO:0005515)|PDZ domain binding(GO:0030165)|extracellular matrix constituent, lubricant activity(GO:0030197)|extracellular matrix constituent, lubricant activity(GO:0030197)","","","","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","","","","","","","","","","","","","","D","0.005","","","P","0.953","B","0.129","","","N","1","M","1.995","T","3.84","N","-0.74","0.137","T","-0.903","T","0.006","T","0.002","0.094","T","0.136","9.635","0.525","1.33","-1.053","5.014"
"chr7","100684422","100684422","T>C","","MUC17","exonic","nonsynonymous SNV","","MUC17:NM_001040105:exon3:c.T9725C:p.L3242P","MUC17","exonic","nonsynonymous SNV","","MUC17:ENST00000306151.9_1:exon3:c.T9725C:p.L3242P","MUC17:ENST00000306151.4:c.9725T>C:p.(Leu3242Pro)","0.979","0.500213938561501","0.9789999723434448","0.7114216205854683","","","","","","","","","","","","","ENSG00000169876","MUC17","HGNC:16800","MUC17","140453","ENSG00000169876","uc003uxp.2","0.7406288894161156","0.500213938561501","0.9950000047683716","","250","0/1","Het","6","2,4","0.333333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a membrane-bound mucin that provides protection to gut epithelial cells. The encoded protein contains about 60 tandem repeats, with each repeat being around 60 aa. N-glycosylation enables the encoded protein to localize on the cell surface, while the C-terminus interacts with the scaffold protein PDZ domain containing 1 (PDZK1). Two transcript variants, one protein-coding and the other non-protein coding, have been found for this gene. [provided by RefSeq, Nov 2015]","mucin 17, cell surface associated","cellular homeostasis(GO:0019725)","extracellular region(GO:0005576)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|external side of plasma membrane(GO:0009897)|external side of plasma membrane(GO:0009897)|integral component of membrane(GO:0016021)|apical plasma membrane(GO:0016324)|apical plasma membrane(GO:0016324)|collagen-containing extracellular matrix(GO:0062023)","protein binding(GO:0005515)|PDZ domain binding(GO:0030165)|extracellular matrix constituent, lubricant activity(GO:0030197)|extracellular matrix constituent, lubricant activity(GO:0030197)","","","","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","","","","","","","","","","","","","","T","0.098","","","D","0.984","D","0.979","","","N","1","L","1.935","T","4.41","N","0.29","0.056","T","-0.857","T","0.008","T","7.54E-4","0.034","T","0.132","15.05","1.273","0.441","0.175","5.254"
"chr17","53155439","53155439","G>A","","STXBP4","exonic","nonsynonymous SNV","","STXBP4:NM_178509:exon14:c.G1189A:p.E397K","STXBP4","exonic","nonsynonymous SNV","","STXBP4:ENST00000434978.6_1:exon13:c.G1123A:p.E375K,STXBP4:ENST00000376352.6_1:exon14:c.G1189A:p.E397K","STXBP4:ENST00000376352.2:c.1189G>A:p.(Glu397Lys)","0.9950566","0.5000449822691735","0.9950566291809082","0.7403913494801765","","","","","","","","","","","","","ENSG00000166263","STXBP4","HGNC:19694","STXBP4","252983","ENSG00000166263","uc002iuf.2","0.7403913494801765","0.5000449822691735","0.9950566291809082","","251","0/1","Het","44","23,21","0.522727272727273","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","syntaxin binding protein 4","protein targeting(GO:0006605)|cellular response to DNA damage stimulus(GO:0006974)|insulin receptor signaling pathway(GO:0008286)|regulation of glucose transmembrane transport(GO:0010827)|positive regulation of keratinocyte proliferation(GO:0010838)|protein stabilization(GO:0050821)|regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178)|regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178)|cellular response to interferon-gamma(GO:0071346)|positive regulation of cell cycle G1/S phase transition(GO:1902808)","cytoplasmic vesicle(GO:0031410)|phagocytic vesicle(GO:0045335)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)|syntaxin binding(GO:0019905)|syntaxin binding(GO:0019905)","","","Wp insulin signaling","","","","",".;.","","","0.00002867","","","0.","0.0002","","","2.867e-05","0.0003","D","0.021","T","0.076","D","0.969","P","0.711","D","0.001","D","1","M","2.615","T","0.9","N","-1.53","0.359","T","-0.789","T","0.202","D","0.025","0.140","T","0.269","32","4.649","5.33","9.664","18.376"
"chr19","55377348","55377348","G>C","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.G1038C:p.W346C,KIR3DL2:NM_006737:exon7:c.G1089C:p.W363C","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.G1038C:p.W346C,KIR3DL2:ENST00000326321.7_1:exon7:c.G1089C:p.W363C","KIR3DL1:ENST00000402254.2:c.1089G>C:p.(Trp363Cys)","0.995","0.500005618438081","0.9950000047683716","0.7402127070491946","0.500005618438081","0.9939999878406524","0.7384427579338307","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","252","0/1","Het","106","85,21","0.80188679245283","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","","","","","","","","","","D","0.011","T","0.055","D","0.999","D","0.995","U","0.005","N","1.000","M","2.65","T","7.12","D","-8.3","0.417","T","-0.938","T","0.005","T","5.45E-4","0.087","D","0.919","21.5","2.211","0.792","0.848","4.875"
"chr19","55377325","55377325","C>T","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.C1015T:p.L339F,KIR3DL2:NM_006737:exon7:c.C1066T:p.L356F","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.C1015T:p.L339F,KIR3DL2:ENST00000326321.7_1:exon7:c.C1066T:p.L356F","KIR3DL1:ENST00000402254.2:c.1066C>T:p.(Leu356Phe)","0.993","","","","0.500005618438081","0.9939999878406524","0.7384427579338307","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","253","0/1","Het","102","82,20","0.803921568627451","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","Name=CT-rich","","","","","","","","","","","T","0.749","T","0.137","D","0.999","D","0.993","U","0.959","N","1","L","1.67","T","6.68","N","-0.57","0.144","T","-0.940","T","0.004","T","6.53E-4","0.046","T","0.150","6.278","0.230","0.792","-0.403","2.405"
"chr19","55377343","55377343","C>T","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.C1033T:p.R345C,KIR3DL2:NM_006737:exon7:c.C1084T:p.R362C","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.C1033T:p.R345C,KIR3DL2:ENST00000326321.7_1:exon7:c.C1084T:p.R362C","KIR3DL1:ENST00000402254.2:c.1084C>T:p.(Arg362Cys)","0.98164225","","","","","","","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","254","0/1","Het","106","86,20","0.811320754716981","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","0.00001195","","","0.","0.","","","1.195e-05","0","D","0.049","D","0.045","D","0.998","P","0.724","U","0.003","N","1","M","2.18","T","7.01","D","-3.01","0.177","T","-0.926","T","0.005","T","7.08E-4","0.076","T","0.077","18.07","1.783","0.792","-0.462","4.875"
"chr19","55331287","55331287","G>T","","KIR3DL1","exonic","nonsynonymous SNV","","KIR3DL1:NM_013289:exon4:c.G475T:p.G159W","KIR3DL1","exonic","nonsynonymous SNV","","KIR3DL1:ENST00000358178.4_1:exon3:c.G190T:p.G64W,KIR3DL1:ENST00000326542.11_1:exon4:c.G475T:p.G159W,KIR3DL1:ENST00000391728.8_1:exon4:c.G475T:p.G159W","KIR3DL1:ENST00000326542.7:c.475G>T:p.(Gly159Trp)","0.981","","","","","","","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","255","0/1","Het","174","100,74","0.574712643678161","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Human immunodeficiency virus type 1, susceptibility to(609423)","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1","immune response(GO:0006955)|natural killer cell mediated cytotoxicity(GO:0042267)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","amyloid-beta binding(GO:0001540)|protein binding(GO:0005515)|HLA-B specific inhibitory MHC class I receptor activity(GO:0030109)","leukemia(DOID:1240)|sclerosing cholangitis(DOID:14268)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|human immunodeficiency virus infectious disease(DOID:526)|primary immunodeficiency disease(DOID:612)|spondylitis(DOID:6590)|hepatocellular carcinoma(DOID:684)|ankylosing spondylitis(DOID:7147)|diabetes mellitus(DOID:9351)|cholangitis(DOID:9446)|endometriosis of uterus(DOID:288)|beta thalassemia(DOID:12241)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>T|KIR3DL1|0.00|0.00|0.00|0.01|36|-41|-2|-41","Immunoglobulin|Immunoglobulin","","","0","","","","","","","0","0","D","0.033","D","0.004","P","0.783","P","0.651","U","0.009","N","1","H","3.505","T","5.1","D","-4.48","0.325","T","-1.041","T","0.031","T","0.002","0.133","T","0.473","18.75","1.873","1.44","0.307","6.339"
"chr19","55377302","55377302","T>C","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.T992C:p.V331A,KIR3DL2:NM_006737:exon7:c.T1043C:p.V348A","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.T992C:p.V331A,KIR3DL2:ENST00000326321.7_1:exon7:c.T1043C:p.V348A","KIR3DL1:ENST00000402254.2:c.1043T>C:p.(Val348Ala)","0.966","","","","","","","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","256","0/1","Het","101","84,17","0.831683168316832","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","Name=CT-rich","","","","","","","","","","","T","0.162","T","0.986","D","0.98","D","0.966","N","0.029","N","1","N","0.395","T","7.27","N","-0.92","0.126","T","-0.917","T","0.002","T","4.01E-4","0.065","T","0.139","0.183","-0.399","0.792","-0.401","5.878"
"chr19","55377265","55377265","T>C","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.T955C:p.C319R,KIR3DL2:NM_006737:exon7:c.T1006C:p.C336R","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.T955C:p.C319R,KIR3DL2:ENST00000326321.7_1:exon7:c.T1006C:p.C336R","KIR3DL1:ENST00000402254.2:c.1006T>C:p.(Cys336Arg)","0.866","","","","","","","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","257","0/1","Het","83","68,15","0.819277108433735","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","","","","","","","","","","T","0.134","T","0.451","B","0.0","B","0.0","","","N","1.000","N","-1.04","T","7.31","N","0.16","0.083","T","-0.976","T","0.001","T","0.001","0.009","T","0.059","6.833","0.271","0.609","-1.665",""
"chr19","55377280","55377280","G>A","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.G970A:p.V324I,KIR3DL2:NM_006737:exon7:c.G1021A:p.V341I","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.G970A:p.V324I,KIR3DL2:ENST00000326321.7_1:exon7:c.G1021A:p.V341I","KIR3DL1:ENST00000402254.2:c.1021G>A:p.(Val341Ile)","0.848","","","","","","","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","258","0/1","Het","87","72,15","0.827586206896552","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>A|KIR3DL2|0.00|0.00|0.00|0.00|-30|-10|-3|-21",".;.","","","","","","","","","","","","T","0.164","T","0.419","B","0.002","B","0.01","","","N","1","L","1.11","T","7.18","N","-0.21","0.072","T","-0.975","T","0.001","T","5.53E-4","0.008","T","0.082","0.009","-0.805","0.792","-0.835","3.986"
"chr19","55377875","55377875","C>G","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon7:c.C1105G:p.Q369E,KIR3DL2:NM_006737:exon8:c.C1156G:p.Q386E","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon7:c.C1105G:p.Q369E,KIR3DL2:ENST00000326321.7_1:exon8:c.C1156G:p.Q386E","KIR3DL1:ENST00000402254.2:c.1156C>G:p.(Gln386Glu)","0.6","","","","","","","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","261","0/1","Het","167","143,24","0.856287425149701","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","","","","","","","","","","T","1.0","T","1.0","B","0.0","B","0.0","","","N","1","N","-1.08","T","7.15","N","1.42","0.047","T","-0.988","T","0.000","T","4.87E-4","0.019","T","0.048","0.010","-0.790","1.05","0.363","6.644"
"chr19","55377319","55377319","C>A","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.C1009A:p.L337I,KIR3DL2:NM_006737:exon7:c.C1060A:p.L354I","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.C1009A:p.L337I,KIR3DL2:ENST00000326321.7_1:exon7:c.C1060A:p.L354I","KIR3DL1:ENST00000402254.2:c.1060C>A:p.(Leu354Ile)","0.491","","","","","","","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","264","0/1","Het","99","79,20","0.797979797979798","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","Name=CT-rich","","","","","","","","","","","T","0.509","T","1.0","B","0.01","B","0.009","N","0.026","N","1","N","-0.22","T","6.79","N","1.13","0.193","T","-0.867","T","0.001","T","7.73E-4","0.013","T","0.241","0.001","-1.449","0.756","-0.986","6.404"
"chr19","55377340","55377340","T>C","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.T1030C:p.Y344H,KIR3DL2:NM_006737:exon7:c.T1081C:p.Y361H","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.T1030C:p.Y344H,KIR3DL2:ENST00000326321.7_1:exon7:c.T1081C:p.Y361H","KIR3DL1:ENST00000402254.2:c.1081T>C:p.(Tyr361His)","0.0039967652","","","","","","","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","278","0/1","Het","105","83,22","0.79047619047619","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","0.000007961","","","","","","","7.961e-06","0","T","1.0","T","0.639","B","0.001","B","0.004","N","0.001","N","1","N","-1.885","T","7.23","N","2.95","0.108","T","-0.904","T","0.000","T","9.29E-4","0.052","T","0.056","0.064","-0.545","0.792","-0.520","4.953"
"chr19","55377307","55377307","T>A","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.T997A:p.F333I,KIR3DL2:NM_006737:exon7:c.T1048A:p.F350I","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.T997A:p.F333I,KIR3DL2:ENST00000326321.7_1:exon7:c.T1048A:p.F350I","KIR3DL1:ENST00000402254.2:c.1048T>A:p.(Phe350Ile)","0.0009997969","","","","","","","","","","","","","","","","ENSG00000167633","KIR3DL1","HGNC:6338","KIR3DL1","3811","ENSG00000167633","uc002qhk.5","0.7402127070491946","0.500005618438081","0.9950000047683716","","281","0/1","Het","104","87,17","0.836538461538462","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","Name=CT-rich","","0.000003977","","","0.","0.","","","3.977e-06","0","T","1.0","T","1.0","B","0.0","B","0.001","N","0.521","N","1","N","-2.095","T","7.34","N","2.41","0.177","T","-0.951","T","0.000","T","5.53E-4","0.025","T","0.102","0.464","-0.265","0.792","-3.473","1.833"
"chr10","126678112","126678112","T>C","","CTBP2","exonic","nonsynonymous SNV","","CTBP2:NM_022802:exon9:c.A2933G:p.N978S,CTBP2:NM_001083914:exon11:c.A1313G:p.N438S,CTBP2:NM_001290214:exon11:c.A1313G:p.N438S,CTBP2:NM_001290215:exon11:c.A1313G:p.N438S,CTBP2:NM_001329:exon11:c.A1313G:p.N438S","CTBP2","exonic","nonsynonymous SNV","","CTBP2:ENST00000309035.11_1:exon9:c.A2933G:p.N978S,CTBP2:ENST00000334808.10_1:exon9:c.A1517G:p.N506S,CTBP2:ENST00000337195.9_1:exon11:c.A1313G:p.N438S,CTBP2:ENST00000411419.6_1:exon11:c.A1313G:p.N438S,CTBP2:ENST00000494626.6_1:exon11:c.A1313G:p.N438S,CTBP2:ENST00000531469.5_1:exon11:c.A1313G:p.N438S","CTBP2:ENST00000309035.6:c.2933A>G:p.(Asn978Ser)","0.99321777","","","","0.5013145264238119","0.9932494461536407","0.7397371915121442","","","","","","","","","","ENSG00000175029","CTBP2","HGNC:2495","CTBP2","1488","ENSG00000175029","uc009yal.4","0.7397932015073275","0.5013145264238119","0.9932811260223389","","283","0/1","Het","84","75,9","0.892857142857143","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene produces alternative transcripts encoding two distinct proteins. One protein is a transcriptional repressor, while the other isoform is a major component of specialized synapses known as synaptic ribbons. Both proteins contain a NAD+ binding domain similar to NAD+-dependent 2-hydroxyacid dehydrogenases. A portion of the 3' untranslated region was used to map this gene to chromosome 21q21.3; however, it was noted that similar loci elsewhere in the genome are likely. Blast analysis shows that this gene is present on chromosome 10. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Feb 2014]","C-terminal binding protein 2","negative regulation of transcription by RNA polymerase II(GO:0000122)|negative regulation of cell population proliferation(GO:0008285)|synaptic vesicle docking(GO:0016081)|viral genome replication(GO:0019079)|positive regulation of chromatin binding(GO:0035563)|negative regulation of transcription, DNA-templated(GO:0045892)|positive regulation of transcription by RNA polymerase II(GO:0045944)|positive regulation of retinoic acid receptor signaling pathway(GO:0048386)|maintenance of presynaptic active zone structure(GO:0048790)|white fat cell differentiation(GO:0050872)|cellular response to leukemia inhibitory factor(GO:1990830)","nucleus(GO:0005634)|nucleus(GO:0005634)|transcription repressor complex(GO:0017053)|photoreceptor ribbon synapse(GO:0098684)|presynaptic active zone cytoplasmic component(GO:0098831)|glutamatergic synapse(GO:0098978)|GABA-ergic synapse(GO:0098982)|presynaptic cytosol(GO:0099523)","transcription corepressor binding(GO:0001222)|chromatin binding(GO:0003682)|transcription coactivator activity(GO:0003713)|transcription corepressor activity(GO:0003714)|protein binding(GO:0005515)|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616)|protein kinase binding(GO:0019901)|retinoic acid receptor binding(GO:0042974)|protein-containing complex binding(GO:0044877)|NAD binding(GO:0051287)|structural constituent of presynaptic active zone(GO:0098882)","leukemia(DOID:1240)","Wnt signaling pathway|Notch signaling pathway|Pathways in cancer|Chronic myeloid leukemia","Wp wnt signaling pathway and pluripotency|Wp neural crest differentiation|Wp mesodermal commitment pathway|Wp ncrnas involved in wnt signaling in hepatocellular carcinoma|Wp notch signaling|Wp endoderm differentiation|Wp wnt signaling|Wp lncrna involvement in canonical wnt signaling and colorectal cancer|Wp ciliary landscape","Degradation of beta catenin by the destruction complex|Signaling by wnt|Repression of wnt target genes|Signaling by wnt in cancer|Diseases of signal transduction by growth factor receptors and second messengers|Sensory processing of sound|Sensory perception","","","",".;.;.;.;.;.","","Score=747;Name=V$PAX4_04","0.00005437","","","","","","","3.984e-06","5.437e-05","D","0.048","T","0.553","B","0.017","B","0.044","N","0.041","N","0.547","L","1.1","D","-1.58","N","-0.98","0.097","T","-0.266","T","0.330","D","0.041","0.362","T","0.437","20.8","2.121","5.12","2.629","11.061"
"chr2","74657488","74657488","G>A","","RTKN","exonic","nonsynonymous SNV","","RTKN:NM_001015055:exon5:c.C436T:p.R146C,RTKN:NM_001015056:exon5:c.C286T:p.R96C,RTKN:NM_033046:exon6:c.C397T:p.R133C","RTKN","exonic","nonsynonymous SNV","","RTKN:ENST00000233330.6_1:exon5:c.C286T:p.R96C,RTKN:ENST00000272430.10_1:exon5:c.C436T:p.R146C,RTKN:ENST00000305557.9_1:exon6:c.C397T:p.R133C","RTKN:ENST00000233330.6:c.286C>T:p.(Arg96Cys)","0.9927787","0.5003844495222438","0.9927787184715272","0.7370345831976491","","","","","","","","","","","","","ENSG00000114993","RTKN","HGNC:10466","RTKN","6242","ENSG00000114993","uc002slc.4","0.7370345831976491","0.5003844495222438","0.9927787184715271","","295","0/1","Het","69","33,36","0.478260869565217","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a scaffold protein that interacts with GTP-bound Rho proteins. Binding of this protein inhibits the GTPase activity of Rho proteins. This protein may interfere with the conversion of active, GTP-bound Rho to the inactive GDP-bound form by RhoGAP. Rho proteins regulate many important cellular processes, including cytokinesis, transcription, smooth muscle contraction, cell growth and transformation. Dysregulation of the Rho signal transduction pathway has been implicated in many forms of cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]","rhotekin","mitotic cytokinesis(GO:0000281)|actomyosin contractile ring assembly(GO:0000915)|apoptotic process(GO:0006915)|signal transduction(GO:0007165)|Rho protein signal transduction(GO:0007266)|septin ring organization(GO:0031106)|regulation of apoptotic process(GO:0042981)|negative regulation of catalytic activity(GO:0043086)","cellular_component(GO:0005575)|actomyosin contractile ring(GO:0005826)|cytosol(GO:0005829)","GTPase inhibitor activity(GO:0005095)|GTPase inhibitor activity(GO:0005095)|protein binding(GO:0005515)|GTP binding(GO:0005525)|small GTPase binding(GO:0031267)","amyotrophic neuralgia(DOID:10383)|cancer(DOID:162)|bladder carcinoma(DOID:4007)|brachial plexus neuritis(DOID:3689)","","Wp g13 signaling pathway","Rho gtpase effectors|Rho gtpases activate rhotekin and rhophilins|Rhoa gtpase cycle|Rho gtpase cycle|Rhob gtpase cycle|Rhoc gtpase cycle|Signaling by rho gtpases miro gtpases and rhobtb3","","","",".;Anillin","","","0.00006764","","","0.","0.0001","","","6.764e-05","5.438e-05","D","0.015","D","0.001","D","1.0","D","0.944","D","0.000","D","1","M","2.34","T","0.75","D","-7.31","0.898","T","-0.493","T","0.298","D","0.029","0.608","D","0.702","32","4.716","5.17","9.432","16.199"
"chr19","49242252","49242252","A>C","","RASIP1","exonic","nonsynonymous SNV","","RASIP1:NM_017805:exon3:c.T788G:p.L263R","RASIP1","exonic","nonsynonymous SNV","","RASIP1:ENST00000222145.9_1:exon3:c.T788G:p.L263R","RASIP1:ENST00000222145.4:c.788T>G:p.(Leu263Arg)","0.992","0.5000685791455908","0.9919999837875366","0.7350071178930475","","","","","","","","","","","","","ENSG00000105538","RASIP1","HGNC:24716","RASIP1","54922","ENSG00000105538","uc002pki.4","0.7350071178930475","0.5000685791455908","0.9919999837875366","","298","0/1","Het","7","4,3","0.571428571428571","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","Ras interacting protein 1","angiogenesis(GO:0001525)|angiogenesis(GO:0001525)|vasculogenesis(GO:0001570)|signal transduction(GO:0007165)|negative regulation of autophagy(GO:0010507)|positive regulation of integrin activation(GO:0033625)|negative regulation of Rho protein signal transduction(GO:0035024)|negative regulation of Rho protein signal transduction(GO:0035024)|regulation of GTPase activity(GO:0043087)|regulation of GTPase activity(GO:0043087)|branching morphogenesis of an epithelial tube(GO:0048754)|negative regulation of membrane permeability(GO:1905709)|negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299)|negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299)","Golgi stack(GO:0005795)|cell-cell junction(GO:0005911)|cell-cell junction(GO:0005911)|protein-containing complex(GO:0032991)|perinuclear region of cytoplasm(GO:0048471)","protein binding(GO:0005515)|protein homodimerization activity(GO:0042803)|GTPase binding(GO:0051020)|GTPase binding(GO:0051020)","","","","","","","","","","Score=775;Name=V$PAX5_02","","","","","","","","","","D","0.008","T","0.194","D","0.969","P","0.638","N","0.830","D","0.953","N","0.69","T","3.21","N","-1.14","0.33","T","-1.046","T","0.029","D","0.160","0.076","T","0.420","22.6","2.530","4.11","3.395","11.357"
"chr2","160285729","160285729","C>T","","BAZ2B","exonic","nonsynonymous SNV","","BAZ2B:NM_001289975:exon11:c.G2231A:p.R744H,BAZ2B:NM_013450:exon11:c.G2237A:p.R746H","BAZ2B","exonic","nonsynonymous SNV","","BAZ2B:ENST00000343439.9_1:exon7:c.G1355A:p.R452H,BAZ2B:ENST00000392782.5_1:exon11:c.G2231A:p.R744H,BAZ2B:ENST00000392783.7_1:exon11:c.G2237A:p.R746H","BAZ2B:ENST00000343439.5:c.1937G>A:p.(Arg646His)","0.99185324","0.5000066070711","0.9918532371520996","0.7346189779647493","","","","","","","","","","","","","ENSG00000123636","BAZ2B","HGNC:963","BAZ2B","29994","ENSG00000123636","uc002uao.4","0.7346189779647493","0.5000066070711","0.9918532371520996","","300","0/1","Het","35","23,12","0.657142857142857","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene belongs to the bromodomain gene family. Members of this gene family encode proteins that are integral components of chromatin remodeling complexes. The encoded protein showed strong preference for the activating H3K14Ac mark in a histone peptide screen, suggesting a potential role in transcriptional activation. This gene may be associated with susceptibility to sudden cardiac death (SCD). [provided by RefSeq, Aug 2016]","bromodomain adjacent to zinc finger domain 2B","chromatin remodeling(GO:0006338)|regulation of transcription by RNA polymerase II(GO:0006357)|modulation of age-related behavioral decline(GO:0090647)","nucleus(GO:0005634)","DNA binding(GO:0003677)|protein binding(GO:0005515)|metal ion binding(GO:0046872)","","","","","","","",".;Methyl-CpG","","","0.000008264","","","","","","","8.264e-06","5.815e-05","D","0.038","T","0.078","P","0.88","B","0.306","N","0.037","D","0.993","M","2.01","D","-5.75","D","-2.71","0.229","D","1.158","D","0.936","D","0.097","0.526","D","0.835","23.2","2.817","5.2","1.648","14.112"
"chr2","118579477","118579477","C>T","","DDX18","exonic","nonsynonymous SNV","","DDX18:NM_006773:exon6:c.C791T:p.A264V","DDX18","exonic","nonsynonymous SNV","","DDX18:ENST00000263239.7_1:exon6:c.C791T:p.A264V","DDX18:ENST00000263239.2:c.791C>T:p.(Ala264Val)","0.991383","0.5001735513942549","0.9913830161094666","0.7341150841778236","","","","","","","","","","","","","ENSG00000088205","DDX18","HGNC:2741","DDX18","8886","ENSG00000088205","uc002tlh.2","0.7341150841778236","0.5001735513942549","0.9913830161094666","","302","0/1","Het","20","13,7","0.65","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a DEAD box protein, and it is activated by Myc protein. [provided by RefSeq, Jul 2008]","DEAD-box helicase 18","maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463)|cellular response to estradiol stimulus(GO:0071392)","chromosome(GO:0005694)|nucleolus(GO:0005730)|nucleolus(GO:0005730)|membrane(GO:0016020)","RNA binding(GO:0003723)|RNA helicase activity(GO:0003724)|protein binding(GO:0005515)|ATP binding(GO:0005524)|ATP hydrolysis activity(GO:0016887)","","","","","","Myc targets v1|Myc targets v2","SpliceAI>T|DDX18|0.38|0.17|0.00|0.00|26|-8|25|-6","DEAD/DEAH","","","","","","","","","","","","D","0.001","D","0.031","P","0.755","B","0.345","N","0.000","D","1","L","1.19","T","2.16","D","-3.36","0.937","T","-1.018","T","0.084","T","0.018","0.505","D","0.972","25.8","3.699","5.4","7.387","17.796"
"chr14","20846959","20846959","G>A","","TEP1","exonic","nonsynonymous SNV","","TEP1:NM_007110:exon37:c.C5306T:p.P1769L","TEP1","exonic","nonsynonymous SNV","","TEP1:ENST00000556935.5_1:exon35:c.C4982T:p.P1661L,TEP1:ENST00000262715.10_1:exon37:c.C5306T:p.P1769L","TEP1:ENST00000262715.5:c.5306C>T:p.(Pro1769Leu)","0.99139297","0.5000780787086114","0.991392970085144","0.7339391853957203","","","","","","","","","","","","","ENSG00000129566","TEP1","HGNC:11726","TEP1","7011","ENSG00000129566","uc001vxe.4","0.7339391853957203","0.5000780787086114","0.991392970085144","","303","0/1","Het","99","60,39","0.606060606060606","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene product is a component of the ribonucleoprotein complex responsible for telomerase activity which catalyzes the addition of new telomeres on the chromosome ends. The telomerase-associated proteins are conserved from ciliates to humans. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]","telomerase associated protein 1","telomere maintenance via recombination(GO:0000722)|telomere maintenance via recombination(GO:0000722)|RNA-dependent DNA biosynthetic process(GO:0006278)","chromosome, telomeric region(GO:0000781)|telomerase holoenzyme complex(GO:0005697)|telomerase holoenzyme complex(GO:0005697)|cytoplasm(GO:0005737)|nuclear matrix(GO:0016363)|ribonucleoprotein complex(GO:1990904)","p53 binding(GO:0002039)|telomerase activity(GO:0003720)|telomerase activity(GO:0003720)|RNA binding(GO:0003723)|protein binding(GO:0005515)|ATP binding(GO:0005524)|enzyme binding(GO:0019899)|telomerase RNA binding(GO:0070034)|telomerase RNA binding(GO:0070034)","squamous cell carcinoma(DOID:1749)|pancreatic carcinoma(DOID:4905)","","","","Tel pathway","","SpliceAI>A|TEP1|0.00|0.00|0.00|0.00|-36|43|-22|-46","WD40-repeat-containing","","Score=762;Name=V$YY1_02","0.00003581","","","0.","0.0003","","","3.581e-05","0.0001","D","0.014","T","0.551","P","0.747","B","0.397","N","0.002","D","1.000","M","2.795","T","-0.55","D","-6.13","0.304","T","-0.206","T","0.405","D","0.043","0.537","D","0.947","23.0","2.706","5.76","2.706","6.729"
"chr8","139825250","139825250","G>A","","COL22A1","exonic","nonsynonymous SNV","","COL22A1:NM_152888:exon8:c.C1258T:p.R420W","COL22A1","exonic","nonsynonymous SNV","","COL22A1:ENST00000303045.11_1:exon8:c.C1258T:p.R420W","COL22A1:ENST00000303045.6:c.1258C>T:p.(Arg420Trp)","0.991274","0.5000116727514978","0.9912739992141724","0.7335908961327453","","","","","","","","","","","","","ENSG00000169436","COL22A1","HGNC:22989","COL22A1","169044","ENSG00000169436","uc003yvd.3","0.7335908961327453","0.5000116727514978","0.9912739992141724","","304","0/1","Het","86","49,37","0.569767441860465","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes member of the collagen family which is thought to contribute to the stabilization of myotendinous junctions and strengthen skeletal muscle attachments during contractile activity. It belongs to the fibril-associated collagens with interrupted triple helix (FACIT) subset of the collagen superfamily, which associate with collagen fibers through their C-terminal collagenous domains and mediate protein-protein interactions through their N-terminal noncollagenous domains. The encoded protein is deposited in the basement membrane zone of the myotendinous junction which is present only at the tissue junctions of muscles, tendons, the heart, articular cartilage, and skin. A knockdown of the orthologous zebrafish gene induces a muscular dystrophy by disruption of the myotendinous junction. [provided by RefSeq, May 2017]","collagen type XXII alpha 1 chain","angiogenesis(GO:0001525)|endothelial cell morphogenesis(GO:0001886)|extracellular matrix organization(GO:0030198)","extracellular region(GO:0005576)|collagen trimer(GO:0005581)|extracellular space(GO:0005615)|endoplasmic reticulum lumen(GO:0005788)|extracellular matrix(GO:0031012)","extracellular matrix structural constituent(GO:0005201)","","","","Extracellular matrix organization|Collagen formation|Collagen biosynthesis and modifying enzymes|Collagen chain trimerization","","","","Laminin","","Score=755;Name=V$PPARA_01","0.00006363","","","0.0001","0.0002","0.0002","","6.363e-05","0.0004","D","0.002","D","0.002","D","1.0","D","0.99","U","0.001","D","1.000","L","1.08","T","4.43","N","-2.26","0.521","T","-0.872","T","0.014","D","0.028","0.257","T","0.121","27.3","3.952","4.72","0.867","11.386"
"chr13","96743358","96743358","G>T","","HS6ST3","exonic","nonsynonymous SNV","","HS6ST3:NM_153456:exon1:c.G242T:p.G81V","HS6ST3","exonic","nonsynonymous SNV","","HS6ST3:ENST00000376705.4_1:exon1:c.G242T:p.G81V","HS6ST3:ENST00000376705.2:c.242G>T:p.(Gly81Val)","0.989","0.5009639225900173","0.9890000224113464","0.7314384201915085","","","","","","","","","","","","","ENSG00000185352","HS6ST3","HGNC:19134","HS6ST3","266722","ENSG00000185352","uc001vmw.4","0.7314384201915085","0.5009639225900173","0.9890000224113464","","306","0/1","Het","52","47,5","0.903846153846154","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Heparan sulfate (HS) sulfotransferases, such as HS6ST3, modify HS to generate structures required for interactions between HS and a variety of proteins. These interactions are implicated in proliferation and differentiation, adhesion, migration, inflammation, blood coagulation, and other diverse processes (Habuchi et al., 2000 [PubMed 10644753]).[supplied by OMIM, Mar 2008]","heparan sulfate 6-O-sulfotransferase 3","heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015)","integral component of membrane(GO:0016021)","heparan sulfate 6-O-sulfotransferase activity(GO:0017095)","","Glycosaminoglycan biosynthesis heparan sulfate","Wp metapathway biotransformation phase i and ii","Glycosaminoglycan metabolism|Heparan sulfate heparin hs gag metabolism|Hs gag biosynthesis|Metabolism of carbohydrates","","","SpliceAI>T|HS6ST3|0.00|0.00|0.00|0.00|-1|32|-2|30","","Name=GC_rich","","","","","","","","","","","D","0.011","D","0.011","B","0.028","B","0.017","U","0.005","N","0.949","L","0.805","D","-1.96","N","-0.32","0.39","T","-0.699","T","0.326","D","0.780","0.106","T","0.127","14.04","1.094","3.1","1.317","4.401"
"chr10","118196364","118196364","C>T","","PNLIPRP3","exonic","nonsynonymous SNV","","PNLIPRP3:NM_001011709:exon2:c.C191T:p.P64L","PNLIPRP3","exonic","nonsynonymous SNV","","PNLIPRP3:ENST00000369230.4_1:exon2:c.C191T:p.P64L","PNLIPRP3:ENST00000369230.3:c.191C>T:p.(Pro64Leu)","0.98977625","0.5000268442654487","0.9897762537002563","0.7309250757830774","0.5000268442654487","0.7278092950582504","0.1967813609781998","","","","","","","","","","ENSG00000203837","PNLIPRP3","HGNC:23492","PNLIPRP3","119548","ENSG00000203837","uc001lcl.5","0.7309250757830774","0.5000268442654487","0.9897762537002563","","308","0/1","Het","40","18,22","0.45","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","pancreatic lipase related protein 3","lipid catabolic process(GO:0016042)","extracellular space(GO:0005615)","triglyceride lipase activity(GO:0004806)|lipase activity(GO:0016298)","hepatocellular carcinoma(DOID:684)","","","Digestion of dietary lipid|Digestion|Digestion and absorption","","","","Lipase/vitellogenin|Lipase,","","","0.00001653","0.0002","0.001","0.","0.0001","","","1.653e-05","0.0002","D","0.007","D","0.009","B","0.31","B","0.128","U","0.053","N","1","L","1.92","D","-2.86","D","-6.5","0.261","T","-0.051","D","0.671","D","0.028","0.265","T","0.222","15.51","1.361","4.45","0.184","14.300"
"chr2","39583424","39583424","G>C","","MAP4K3","exonic","nonsynonymous SNV","","MAP4K3:NM_001270425:exon3:c.C211G:p.P71A,MAP4K3:NM_003618:exon3:c.C211G:p.P71A","MAP4K3","exonic","nonsynonymous SNV","","MAP4K3:ENST00000263881.8_1:exon3:c.C211G:p.P71A,MAP4K3:ENST00000341681.9_1:exon3:c.C211G:p.P71A,MAP4K3:ENST00000437545.5_1:exon3:c.C22G:p.P8A,MAP4K3:ENST00000484274.1_1:exon3:c.C211G:p.P71A","MAP4K3:ENST00000263881.3:c.211C>G:p.(Pro71Ala)","0.989303","0.5001221765123773","0.9893029928207396","0.7302646448598358","0.5001221765123773","0.8936993777751923","0.5294559141603569","","","","","","","","","","ENSG00000011566","MAP4K3","HGNC:6865","MAP4K3","8491","ENSG00000011566","uc002rro.4","0.7302646448598358","0.5001221765123773","0.9893029928207397","","310","0/1","Het","74","43,31","0.581081081081081","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the mitogen-activated protein kinase kinase kinase kinase family. The encoded protein activates key effectors in cell signalling, among them c-Jun. Alternatively spliced transcripts encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]","mitogen-activated protein kinase kinase kinase kinase 3","protein phosphorylation(GO:0006468)|JNK cascade(GO:0007254)|response to UV(GO:0009411)|response to tumor necrosis factor(GO:0034612)|intracellular signal transduction(GO:0035556)","","protein kinase activity(GO:0004672)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein binding(GO:0005515)|ATP binding(GO:0005524)|MAP kinase kinase kinase kinase activity(GO:0008349)|protein serine kinase activity(GO:0106310)","","Mapk signaling pathway","Wp angiopoietin like protein 8 regulatory pathway|Wp insulin signaling|Wp mapk signaling pathway|Wp hippoyap signaling pathway|Wp mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms","","Mapk pathway","Adipogenesis","","Protein","","Score=903;Name=V$HFH3_01","","","","","","","","","","T","0.354","T","0.283","B","0.0","B","0.002","N","0.000","D","0.989","L","1.8","T","1.42","N","-1.88","0.234","T","-1.079","T","0.068","T","0.008","0.133","T","0.153","15.29","1.319","5.48","0.036","3.348"
"chr12","57454690","57454690","C>T","","NEMP1","exonic","nonsynonymous SNV","","NEMP1:NM_015257:exon7:c.G800A:p.R267H,NEMP1:NM_001130963:exon8:c.G1019A:p.R340H","NEMP1","exonic","nonsynonymous SNV","","NEMP1:ENST00000379391.7_1:exon7:c.G800A:p.R267H,NEMP1:ENST00000300128.9_1:exon8:c.G1019A:p.R340H","NEMP1:ENST00000300128.4:c.1019G>A:p.(Arg340His)","0.98940575","0.5000020894847239","0.9894057512283324","0.7302046544670668","","","","","","","","","","","","","ENSG00000166881","NEMP1","HGNC:29001","NEMP1","23306","ENSG00000166881","","0.7302046544670668","0.5000020894847239","0.9894057512283325","","312","0/1","Het","97","72,25","0.742268041237113","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","nuclear envelope integral membrane protein 1","nuclear membrane organization(GO:0071763)","nuclear envelope(GO:0005635)|nuclear envelope(GO:0005635)|nuclear inner membrane(GO:0005637)|integral component of membrane(GO:0016021)","molecular_function(GO:0003674)","","","","","","","",".;.","","","0.00005574","0.0002","0.001","0.","0.0007","","","5.574e-05","0.0008","D","0.021","D","0.003","D","1.0","D","0.998","D","0.000","D","1","","","T","0.7","D","-3.95","0.83","T","-0.415","T","0.335","D","0.035","0.655","D","0.762","31","4.361","5.86","7.867","17.68"
"chr12","11244067","11244067","->TT","","TAS2R43","exonic","frameshift insertion","","TAS2R43:NM_176884:exon1:c.761_762insAA:p.S254Rfs*27","TAS2R43","exonic","frameshift insertion","","TAS2R43:ENST00000531678.1_1:exon1:c.761_762insAA:p.S254Rfs*27","TAS2R43:ENST00000531678.1:c.761_762insAA:p.(Ser254Argfs*27)","0.98713034","0.5011178685817868","0.987130343914032","0.7283687941571366","","","","","","","","","","","","","ENSG00000255374","TAS2R43","HGNC:18875","TAS2R43","259289","ENSG00000255374","uc001qzq.1","0.7283687941571366","0.5011178685817868","0.987130343914032","","316","0/1","Het","235","195,40","0.829787234042553","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","TAS2R43 belongs to the large TAS2R receptor family. TAS2Rs are expressed on the surface of taste receptor cells and mediate the perception of bitterness through a G protein-coupled second messenger pathway (Conte et al., 2002 [PubMed 12584440]). For further information on TAS2Rs, see MIM 604791.[supplied by OMIM, Mar 2009]","taste 2 receptor member 43","detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580)|detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580)|G protein-coupled receptor signaling pathway(GO:0007186)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|integral component of membrane(GO:0016021)|motile cilium(GO:0031514)|ciliary membrane(GO:0060170)","G protein-coupled receptor activity(GO:0004930)|taste receptor activity(GO:0008527)|bitter taste receptor activity(GO:0033038)|bitter taste receptor activity(GO:0033038)","","Taste transduction","","Signaling by gpcr|G alpha i signalling events|Class c 3 metabotropic glutamate pheromone receptors|Gpcr ligand binding","","","gnomad>TRUE;SpliceAI>ATT|PRH1-PRR4|0.00|0.00|0.00|0.00|16|-35|22|-47>ATT|TAS2R43|0.09|0.05|0.00|0.00|16|-35|22|16","","","","0.001","","","0.001","0.0001","","","0.0005","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr16","461507","461507","G>A","","DECR2","exonic","nonsynonymous SNV","","DECR2:NM_020664:exon8:c.G808A:p.G270R","DECR2","exonic","nonsynonymous SNV","","DECR2:ENST00000219481.10_1:exon8:c.G808A:p.G270R,DECR2:ENST00000424398.6_1:exon8:c.G772A:p.G258R","DECR2:ENST00000219481.5:c.808G>A:p.(Gly270Arg)","0.98684067","0.5000060570428104","0.9868406653404236","0.7255468613082985","","","","","","","","","","","","","ENSG00000242612","DECR2","HGNC:2754","DECR2","26063","ENSG00000242612","uc002chb.4","0.7255468613082985","0.5000060570428104","0.9868406653404236","","317","0/1","Het","124","70,54","0.564516129032258","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","2,4-dienoyl-CoA reductase 2","unsaturated fatty acid biosynthetic process(GO:0006636)|fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540)","peroxisomal membrane(GO:0005778)|cytosol(GO:0005829)","protein binding(GO:0005515)|2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670)|trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166)|trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166)","","Peroxisome","","Beta oxidation of very long chain fatty acids|Peroxisomal lipid metabolism|Metabolism of lipids|Fatty acid metabolism|Peroxisomal protein import|Protein localization","","","",".;.","","","0.0009","","","0.0001","","","","0.0001","0.0009","D","0.001","D","0.001","D","1.0","D","0.999","N","0.000","D","1","H","4.135","D","-1.87","D","-6.1","0.989","D","0.923","D","0.845","D","0.341","0.795","T","0.474","23.6","3.015","5.33","9.780","13.079"
"chr19","19356195","19356195","C>T","","NCAN","exonic","nonsynonymous SNV","","NCAN:NM_004386:exon13:c.C3566T:p.A1189V","NCAN","exonic","nonsynonymous SNV","","NCAN:ENST00000252575.11_1:exon13:c.C3566T:p.A1189V","NCAN:ENST00000252575.6:c.3566C>T:p.(Ala1189Val)","0.98624355","0.5002405603445368","0.9862435460090636","0.7249398424838902","","","","","","","","","","","","","ENSG00000130287","NCAN","HGNC:2465","NCAN","1463","ENSG00000130287","uc002nlz.4","0.7249398424838902","0.5002405603445368","0.9862435460090637","","320","0/1","Het","180","101,79","0.561111111111111","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Neurocan is a chondroitin sulfate proteoglycan thought to be involved in the modulation of cell adhesion and migration.[supplied by OMIM, Jul 2002]","neurocan","skeletal system development(GO:0001501)|cell adhesion(GO:0007155)|central nervous system development(GO:0007417)","extracellular region(GO:0005576)|Golgi lumen(GO:0005796)|extracellular matrix(GO:0031012)|lysosomal lumen(GO:0043202)","calcium ion binding(GO:0005509)|hyaluronic acid binding(GO:0005540)|carbohydrate binding(GO:0030246)","","","Wp spinal cord injury","Developmental biology|Extracellular matrix organization|Glycosaminoglycan metabolism|Heparan sulfate heparin hs gag metabolism|Chondroitin sulfate dermatan sulfate metabolism|A tetrasaccharide linker sequence is required for gag synthesis|Chondroitin sulfate biosynthesis|Dermatan sulfate biosynthesis|Cs ds degradation|Ecm proteoglycans|Diseases associated with glycosaminoglycan metabolism|Defective b4galt7 causes eds progeroid type|Defective chst3 causes sedcjd|Defective chst14 causes eds musculocontractural type|Defective chsy1 causes tpbs|L1cam interactions|Ncam signaling for neurite out growth|Diseases of glycosylation|Ncam1 interactions|Diseases of metabolism|Metabolism of carbohydrates|Nervous system development","","Hypoxia","","C-type","","","0.00002784","0.0002","0.001","0.","0.0002","","","2.784e-05","0.0001","T","0.108","D","0.009","D","0.999","P","0.889","N","0.002","D","0.989","N","0.345","T","2.14","N","-1.89","0.588","T","-1.085","T","0.067","D","0.034","0.183","T","0.461","25.4","3.605","4.76","1.331","15.312"
"chr22","37708154","37708154","G>A","","CYTH4","exonic","nonsynonymous SNV","","CYTH4:NM_013385:exon12:c.G1051A:p.E351K","CYTH4","exonic","nonsynonymous SNV","","CYTH4:ENST00000248901.11_1:exon12:c.G1051A:p.E351K","CYTH4:ENST00000248901.6:c.1051G>A:p.(Glu351Lys)","0.98602337","0.5000153080873133","0.9860233664512634","0.7240689032732411","","","","","","","","","","","","","ENSG00000100055","CYTH4","HGNC:9505","CYTH4","27128","ENSG00000100055","uc003arf.4","0.7240689032732411","0.5000153080873133","0.9860233664512634","","322","0/1","Het","176","93,83","0.528409090909091","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the PSCD family of proteins, which have an N-terminal coiled-coil motif, a central Sec7 domain, and a C-terminal pleckstrin homology (PH) domain. The coiled-coil motif is involved in homodimerization, the Sec7 domain contains guanine-nucleotide exchange protein (GEP) activity, and the PH domain interacts with phospholipids and is responsible for association of PSCDs with membranes. Members of this family function as GEPs for ADP-ribosylation factors (ARFs), which are guanine nucleotide-binding proteins involved in vesicular trafficking pathways. This protein exhibits GEP activity in vitro with ARF1 and ARF5, but is inactive with ARF6. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]","cytohesin 4","regulation of ARF protein signal transduction(GO:0032012)|regulation of catalytic activity(GO:0050790)","Golgi membrane(GO:0000139)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|centriolar satellite(GO:0034451)|intercellular bridge(GO:0045171)","guanyl-nucleotide exchange factor activity(GO:0005085)|protein binding(GO:0005515)|lipid binding(GO:0008289)","","","","Membrane trafficking|Vesicle mediated transport|Intra golgi traffic|Intra golgi and retrograde golgi to er traffic","Arap pathway","","SpliceAI>A|CYTH4|0.00|0.00|0.00|0.00|19|-3|-9|32","Pleckstrin","","","0.0001","","","","","","","0.0001","0","T","0.367","T","0.562","B","0.059","B","0.067","D","0.000","D","1.000","N","-0.405","T","-0.94","N","-0.05","0.287","T","-1.084","T","0.073","D","0.032","0.279","T","0.057","16.83","1.596","4.71","0.405","11.572"
"chr8","52733209","52733209","A>G","","PCMTD1","exonic","nonsynonymous SNV","","PCMTD1:NM_001286782:exon4:c.T548C:p.I183T,PCMTD1:NM_001286783:exon6:c.T248C:p.I83T,PCMTD1:NM_052937:exon6:c.T776C:p.I259T","PCMTD1","exonic","nonsynonymous SNV","","PCMTD1:ENST00000544451.2_1:exon4:c.T548C:p.I183T,PCMTD1:ENST00000522514.6_1:exon6:c.T776C:p.I259T,PCMTD1:ENST00000360540.9_1:exon7:c.T776C:p.I259T","PCMTD1:ENST00000360540.5:c.776T>C:p.(Ile259Thr)","0.9846711","","","","0.5000011543399978","0.9844200313091278","0.7210877312785594","","","","","","","","","","ENSG00000168300","PCMTD1","HGNC:30483","PCMTD1","115294","ENSG00000168300","uc064msu.1","0.7210877312785594","0.5000011543399978","0.9844200313091278","","323","0/1","Het","124","113,11","0.911290322580645","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1","protein methylation(GO:0006479)","cytoplasm(GO:0005737)|membrane(GO:0016020)","protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719)|protein binding(GO:0005515)","","","","","","","",".;.;.","","Score=838;Name=V$POU6F1_01","0.00000404","","","0.0001","0.","","","4.04e-06","0","D","0.019","T","0.052","D","0.975","P","0.591","D","0.000","D","1.000","L","1.5","T","0.91","N","-2.27","0.36","T","-0.965","T","0.123","T","0.010","0.195","T","0.354","23.5","2.953","5.77","6.591","16.086"
"chr8","52733214","52733214","A>C","","PCMTD1","exonic","nonsynonymous SNV","","PCMTD1:NM_001286782:exon4:c.T543G:p.N181K,PCMTD1:NM_001286783:exon6:c.T243G:p.N81K,PCMTD1:NM_052937:exon6:c.T771G:p.N257K","PCMTD1","exonic","nonsynonymous SNV","","PCMTD1:ENST00000544451.2_1:exon4:c.T543G:p.N181K,PCMTD1:ENST00000522514.6_1:exon6:c.T771G:p.N257K,PCMTD1:ENST00000360540.9_1:exon7:c.T771G:p.N257K","PCMTD1:ENST00000360540.5:c.771T>G:p.(Asn257Lys)","0.98416895","","","","0.5000011543399978","0.9844200313091278","0.7210877312785594","","","","","","","","","","ENSG00000168300","PCMTD1","HGNC:30483","PCMTD1","115294","ENSG00000168300","uc064msu.1","0.7210877312785594","0.5000011543399978","0.9844200313091278","","324","0/1","Het","112","101,11","0.901785714285714","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1","protein methylation(GO:0006479)","cytoplasm(GO:0005737)|membrane(GO:0016020)","protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719)|protein binding(GO:0005515)","","","","","","","",".;.;.","","","0.0001","","","0.0001","0.","","","0","0","T","0.477","T","0.59","D","0.995","P","0.88","D","0.000","D","1.000","N","0.55","T","0.84","N","-0.54","0.643","T","-0.950","T","0.106","T","0.010","0.134","D","0.569","13.54","1.016","5.56","3.316","11.477"
"chr12","70965039","70965039","C>T","","PTPRB","exonic","nonsynonymous SNV","","PTPRB:NM_001206971:exon10:c.G2213A:p.R738H,PTPRB:NM_001206972:exon11:c.G2483A:p.R828H,PTPRB:NM_002837:exon11:c.G2483A:p.R828H,PTPRB:NM_001109754:exon13:c.G3137A:p.R1046H","PTPRB","exonic","nonsynonymous SNV","","PTPRB:ENST00000550857.5_1:exon10:c.G2213A:p.R738H,PTPRB:ENST00000261266.9_1:exon11:c.G2483A:p.R828H,PTPRB:ENST00000538708.5_1:exon11:c.G2483A:p.R828H,PTPRB:ENST00000550358.5_1:exon12:c.G2873A:p.R958H,PTPRB:ENST00000334414.11_1:exon13:c.G3137A:p.R1046H,PTPRB:ENST00000551525.5_1:exon13:c.G3134A:p.R1045H","PTPRB:ENST00000261266.5:c.2483G>A:p.(Arg828His)","0.9834628","0.500588456983678","0.9834628105163574","0.7205471592933418","0.500588456983678","0.9121901988983154","0.5726382122673953","","","","","","","","","","ENSG00000127329","PTPRB","HGNC:9665","PTPRB","5787","ENSG00000127329","uc001swc.6","0.7205471592933418","0.500588456983678","0.9834628105163574","","326","0/1","Het","89","60,29","0.674157303370786","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and one intracytoplasmic catalytic domain, thus belongs to receptor type PTP. The extracellular region of this PTP is composed of multiple fibronectin type_III repeats, which was shown to interact with neuronal receptor and cell adhesion molecules, such as contactin and tenascin C. This protein was also found to interact with sodium channels, and thus may regulate sodium channels by altering tyrosine phosphorylation status. The functions of the interaction partners of this protein implicate the roles of this PTP in cell adhesion, neurite growth, and neuronal differentiation. Alternate transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]","protein tyrosine phosphatase receptor type B","angiogenesis(GO:0001525)|protein dephosphorylation(GO:0006470)|phosphate-containing compound metabolic process(GO:0006796)|dephosphorylation(GO:0016311)|peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity(GO:1990264)","plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|specific granule membrane(GO:0035579)|receptor complex(GO:0043235)|receptor complex(GO:0043235)|tertiary granule membrane(GO:0070821)","transmembrane receptor protein tyrosine phosphatase activity(GO:0005001)|protein binding(GO:0005515)|cadherin binding(GO:0045296)|cadherin binding(GO:0045296)","cancer(DOID:162)|disease(DOID:4)","Adherens junction","Wp ectoderm differentiation","Innate immune system|Neutrophil degranulation","Spry pathway","","SpliceAI>T|PTPRB|0.00|0.00|0.00|0.00|24|30|24|-33",".;Fibronectin","","","0.0000483","","","0.","0.0002","","","4.83e-05","0.0002","T","0.117","D","0.028","P","0.759","B","0.417","N","0.517","N","1","L","0.895","T","0.39","N","-0.87","0.139","T","-0.879","T","0.141","D","0.029","0.190","T","0.056","9.862","0.550","5.9","0.112","3.893"
"chr12","70932745","70932745","G>A","","PTPRB","exonic","nonsynonymous SNV","","PTPRB:NM_001206971:exon24:c.C4904T:p.P1635L,PTPRB:NM_001206972:exon24:c.C4904T:p.P1635L,PTPRB:NM_002837:exon25:c.C5174T:p.P1725L,PTPRB:NM_001109754:exon27:c.C5828T:p.P1943L","PTPRB","exonic","nonsynonymous SNV","","PTPRB:ENST00000538708.5_1:exon24:c.C4904T:p.P1635L,PTPRB:ENST00000550857.5_1:exon24:c.C4904T:p.P1635L,PTPRB:ENST00000261266.9_1:exon25:c.C5174T:p.P1725L,PTPRB:ENST00000550358.5_1:exon26:c.C5564T:p.P1855L,PTPRB:ENST00000334414.11_1:exon27:c.C5828T:p.P1943L","PTPRB:ENST00000261266.5:c.5174C>T:p.(Pro1725Leu)","0.8409176","","","","0.500588456983678","0.9121901988983154","0.5726382122673953","","","","","","","","","","ENSG00000127329","PTPRB","HGNC:9665","PTPRB","5787","ENSG00000127329","uc001swc.6","0.7205471592933418","0.500588456983678","0.9834628105163574","","327","0/1","Het","85","41,44","0.482352941176471","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and one intracytoplasmic catalytic domain, thus belongs to receptor type PTP. The extracellular region of this PTP is composed of multiple fibronectin type_III repeats, which was shown to interact with neuronal receptor and cell adhesion molecules, such as contactin and tenascin C. This protein was also found to interact with sodium channels, and thus may regulate sodium channels by altering tyrosine phosphorylation status. The functions of the interaction partners of this protein implicate the roles of this PTP in cell adhesion, neurite growth, and neuronal differentiation. Alternate transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]","protein tyrosine phosphatase receptor type B","angiogenesis(GO:0001525)|protein dephosphorylation(GO:0006470)|phosphate-containing compound metabolic process(GO:0006796)|dephosphorylation(GO:0016311)|peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity(GO:1990264)","plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|specific granule membrane(GO:0035579)|receptor complex(GO:0043235)|receptor complex(GO:0043235)|tertiary granule membrane(GO:0070821)","transmembrane receptor protein tyrosine phosphatase activity(GO:0005001)|protein binding(GO:0005515)|cadherin binding(GO:0045296)|cadherin binding(GO:0045296)","cancer(DOID:162)|disease(DOID:4)","Adherens junction","Wp ectoderm differentiation","Innate immune system|Neutrophil degranulation","Spry pathway","","SpliceAI>A|PTPRB|0.00|0.00|0.00|0.00|-3|49|19|-41",".;PTP","","","0.0078","0.001","0.005","0.0006","0.0078","","","0.0005","0.0064","T","0.07","T","0.199","P","0.933","B","0.26","D","0.000","D","1","L","1.7","T","2.72","D","-7.81","0.664","T","-1.150","T","0.028","D","0.029","0.218","T","0.163","25.2","3.548","5.85","5.403","20.154"
"chrX","1718302","1718302","G>A","","AKAP17A","exonic","nonsynonymous SNV","","AKAP17A:NM_005088:exon4:c.G1129A:p.A377T","AKAP17A","exonic","nonsynonymous SNV","","AKAP17A:ENST00000313871.9_1:exon4:c.G1129A:p.A377T,AKAP17A:ENST00000381261.8_1:exon4:c.G1129A:p.A377T","AKAP17A:ENST00000313871.3:c.1129G>A:p.(Ala377Thr)","0.9813695","","","","","","","0.5000398044721805","0.9813694953918456","0.7155002825466685","0.5000398044721805","0.9813694953918456","0.7155002825466685","","","","ENSG00000197976","AKAP17A","HGNC:18783","AKAP17A","8227","ENSG00000197976","uc004fpn.4","0.7155002825466685","0.5000398044721805","0.9813694953918457","","331","0/1","Het","87","42,45","0.482758620689655","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This locus encodes a protein kinase A anchoring protein. The encoded protein is part of the spliceosome complex and is involved in the regulation of alternate splicing in some mRNA precursors. Alternatively spliced transcript variants have been identified for this gene.[provided by RefSeq, Sep 2010]","A-kinase anchoring protein 17A","regulation of transcription, DNA-templated(GO:0006355)|mRNA processing(GO:0006397)|signal transduction(GO:0007165)|RNA splicing(GO:0008380)|B cell activation(GO:0042113)|regulation of RNA splicing(GO:0043484)|regulation of RNA splicing(GO:0043484)","nucleus(GO:0005634)|spliceosomal complex(GO:0005681)|cytosol(GO:0005829)|cytosol(GO:0005829)|nuclear speck(GO:0016607)|nuclear speck(GO:0016607)","RNA binding(GO:0003723)|protein binding(GO:0005515)|protein kinase A binding(GO:0051018)|protein kinase A binding(GO:0051018)","","","","","","","SpliceAI>A|AKAP17A|0.00|0.00|0.00|0.00|23|-25|23|-48",".;.","","","0.00007914","","","0.0001","0.","","","7.914e-05","0.0008","T","0.346","T","1.0","D","1.0","D","0.992","U","0.000","N","1","L","1.79","T","2.56","N","0.04","0.565","T","-1.022","T","0.074","T","0.021","0.194","T","0.123","18.75","1.873","1.9","7.240","7.982"
"chr2","233399991","233399991","C>T","","CHRND","exonic","nonsynonymous SNV","","CHRND:NM_001311195:exon10:c.C941T:p.S314F,CHRND:NM_001256657:exon11:c.C1478T:p.S493F,CHRND:NM_000751:exon12:c.C1523T:p.S508F,CHRND:NM_001311196:exon12:c.C1220T:p.S407F","CHRND","exonic","nonsynonymous SNV","","CHRND:ENST00000543200.5_1:exon11:c.C1478T:p.S493F,CHRND:ENST00000258385.8_1:exon12:c.C1523T:p.S508F","CHRND:ENST00000258385.3:c.1523C>T:p.(Ser508Phe)","0.981024","0.5000047078992793","0.9810240268707277","0.7147796358462505","","","","","","","","","","","","","ENSG00000135902","CHRND","HGNC:1965","CHRND","1144","ENSG00000135902","uc002vsw.5","0.7147796358462505","0.5000047078992793","0.9810240268707275","OMIM:253290 Multiple pterygium syndrome, lethal type-autosomal_recessive;OMIM:616321 ?Myasthenic syndrome, congenital, 3A, slow-channel-autosomal_dominant;OMIM:616322 Myasthenic syndrome, congenital, 3B, fast-channel-autosomal_recessive;OMIM:616323 ?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency-autosomal_recessive;ORPHA:98913 Postsynaptic congenital myasthenic syndromes-autosomal_dominant;ORPHA:98913 Postsynaptic congenital myasthenic syndromes-autosomal_recessive;ORPHA:98913 Postsynaptic congenital myasthenic syndromes-autosomal_recessive;ORPHA:98913 Postsynaptic congenital myasthenic syndromes-autosomal_dominant;ORPHA:98913 Postsynaptic congenital myasthenic syndromes-autosomal_recessive;ORPHA:98913 Postsynaptic congenital myasthenic syndromes-autosomal_recessive","332","0/1","Het","118","62,56","0.525423728813559","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Multiple pterygium syndrome, lethal type(253290)|Channel(616321)|Channel(616322)|Myasthenic syndrome, congenital, 3c, associated with acetylcholine receptor deficiency(616323)","Dysphagia(HP:0002015)|Easy fatigability(HP:0003388)|Ptosis(HP:0000508)|Infantile onset(HP:0003593)|Myopathy(HP:0003198)|Progressive(HP:0003676)|Inability to walk(HP:0002540)|Generalized muscle weakness(HP:0003324)|Autosomal dominant inheritance(HP:0000006)|Neonatal hypotonia(HP:0001319)|Respiratory insufficiency(HP:0002093)|Respiratory insufficiency(HP:0002093)|Infantile onset(HP:0003593)|Autosomal recessive inheritance(HP:0000007)|Easy fatigability(HP:0003388)|Neck muscle weakness(HP:0000467)|High palate(HP:0000218)|Facial palsy(HP:0010628)|Feeding difficulties(HP:0011968)|Decreased fetal movement(HP:0001558)|Ptosis(HP:0000508)|Neonatal hypotonia(HP:0001319)|Ophthalmoplegia(HP:0000602)|Micrognathia(HP:0000347)|Malignant hyperthermia(HP:0002047)|Short finger(HP:0009381)|Edema(HP:0000969)|Flexion contracture(HP:0001371)|Thin ribs(HP:0000883)|Polyhydramnios(HP:0001561)|Fetal akinesia sequence(HP:0001989)|Epicanthus(HP:0000286)|Akinesia(HP:0002304)|Amyoplasia(HP:0003634)|Autosomal recessive inheritance(HP:0000007)|Cystic hygroma(HP:0000476)|Multiple pterygia(HP:0001040)|Vertebral fusion(HP:0002948)|Cleft palate(HP:0000175)|Abnormal cervical curvature(HP:0005905)|Intrauterine growth retardation(HP:0001511)|Abnormal facial shape(HP:0001999)|Pulmonary hypoplasia(HP:0002089)|Hypertelorism(HP:0000316)|Hypoplastic heart(HP:0001961)|Increased susceptibility to fractures(HP:0002659)|Joint dislocation(HP:0001373)|Depressed nasal ridge(HP:0000457)|Low-set ears(HP:0000369)|Respiratory failure(HP:0002878)|Facial palsy(HP:0010628)|Reduced tendon reflexes(HP:0001315)|Thoracic kyphoscoliosis(HP:0005659)|Triceps weakness(HP:0031108)|Decreased miniature endplate potentials(HP:0003402)|Diplopia(HP:0000651)|EMG: myopathic abnormalities(HP:0003458)|Weakness of the intrinsic hand muscles(HP:0009005)|Ptosis(HP:0000508)|Restrictive ventilatory defect(HP:0002091)|Type 1 muscle fiber predominance(HP:0003803)|Weakness of long finger extensor muscles(HP:0009077)|Neck flexor weakness(HP:0003722)|Reduced vital capacity(HP:0002792)|Ankle weakness(HP:0031374)|High palate(HP:0000218)|Fatigable weakness of respiratory muscles(HP:0030196)|Fatigable weakness of neck muscles(HP:0030199)|Cyanosis(HP:0000961)|Delayed gross motor development(HP:0002194)|Hip flexor weakness(HP:0012515)|Abnormality of masticatory muscle(HP:0410011)|EMG: decremental response of compound muscle action potential to repetitive nerve stimulation(HP:0003403)|Shoulder girdle muscle weakness(HP:0003547)|Easy fatigability(HP:0003388)|Orthopnea(HP:0012764)|Drowsiness(HP:0002329)|Decreased size of nerve terminals(HP:0003443)|Ophthalmoparesis(HP:0000597)|Skeletal muscle atrophy(HP:0003202)|Exertional dyspnea(HP:0002875)|Respiratory failure(HP:0002878)|Facial palsy(HP:0010628)|Reduced tendon reflexes(HP:0001315)|Thoracic kyphoscoliosis(HP:0005659)|Triceps weakness(HP:0031108)|Decreased miniature endplate potentials(HP:0003402)|Diplopia(HP:0000651)|EMG: myopathic abnormalities(HP:0003458)|Weakness of the intrinsic hand muscles(HP:0009005)|Ptosis(HP:0000508)|Restrictive ventilatory defect(HP:0002091)|Type 1 muscle fiber predominance(HP:0003803)|Weakness of long finger extensor muscles(HP:0009077)|Neck flexor weakness(HP:0003722)|Reduced vital capacity(HP:0002792)|Ankle weakness(HP:0031374)|High palate(HP:0000218)|Fatigable weakness of respiratory muscles(HP:0030196)|Fatigable weakness of neck muscles(HP:0030199)|Cyanosis(HP:0000961)|Delayed gross motor development(HP:0002194)|Hip flexor weakness(HP:0012515)|Abnormality of masticatory muscle(HP:0410011)|EMG: decremental response of compound muscle action potential to repetitive nerve stimulation(HP:0003403)|Shoulder girdle muscle weakness(HP:0003547)|Easy fatigability(HP:0003388)|Orthopnea(HP:0012764)|Drowsiness(HP:0002329)|Decreased size of nerve terminals(HP:0003443)|Ophthalmoparesis(HP:0000597)|Skeletal muscle atrophy(HP:0003202)|Exertional dyspnea(HP:0002875)|Feeding difficulties(HP:0011968)|Ptosis(HP:0000508)|High palate(HP:0000218)|Fatigue(HP:0012378)|Autosomal recessive inheritance(HP:0000007)|Respiratory insufficiency(HP:0002093)|Generalized hypotonia(HP:0001290)|Congenital onset(HP:0003577)|Facial palsy(HP:0010628)|Dysphagia(HP:0002015)","The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]","cholinergic receptor nicotinic delta subunit","skeletal muscle contraction(GO:0003009)|cation transport(GO:0006812)|muscle contraction(GO:0006936)|signal transduction(GO:0007165)|chemical synaptic transmission(GO:0007268)|ion transmembrane transport(GO:0034220)|regulation of membrane potential(GO:0042391)|skeletal muscle tissue growth(GO:0048630)|nervous system process(GO:0050877)|musculoskeletal movement(GO:0050881)|neuromuscular process(GO:0050905)|excitatory postsynaptic potential(GO:0060079)","nucleoplasm(GO:0005654)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|acetylcholine-gated channel complex(GO:0005892)|neuromuscular junction(GO:0031594)|neuromuscular junction(GO:0031594)|neuromuscular junction(GO:0031594)|neuromuscular junction(GO:0031594)|neuron projection(GO:0043005)|synapse(GO:0045202)|postsynaptic membrane(GO:0045211)|integral component of postsynaptic specialization membrane(GO:0099060)","transmembrane signaling receptor activity(GO:0004888)|acetylcholine-gated cation-selective channel activity(GO:0022848)|neurotransmitter receptor activity(GO:0030594)|acetylcholine binding(GO:0042166)|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315)|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315)","","Neuroactive ligand receptor interaction","","Neurotransmitter receptors and postsynaptic signal transmission|Transmission across chemical synapses|Neuronal system|Acetylcholine binding and downstream events|Highly sodium permeable postsynaptic acetylcholine nicotinic receptors","","","",".;.","","","","","","","","","","","","D","0.046","D","0.047","P","0.868","B","0.38","N","0.050","D","0.958","L","1.78","T","-1.4","N","-1.6","0.196","D","0.189","D","0.570","D","0.154","0.439","D","0.963","23.5","2.972","5.13","2.962","11.597"
"chrX","37961641","37961641","C>T","","SYTL5","exonic","nonsynonymous SNV","","SYTL5:NM_001163334:exon9:c.C1109T:p.S370L,SYTL5:NM_138780:exon10:c.C1109T:p.S370L,SYTL5:NM_001163335:exon11:c.C1109T:p.S370L","SYTL5","exonic","nonsynonymous SNV","","SYTL5:ENST00000456733.2_1:exon9:c.C1109T:p.S370L,SYTL5:ENST00000297875.7_1:exon10:c.C1109T:p.S370L","SYTL5:ENST00000297875.2:c.1109C>T:p.(Ser370Leu)","0.97973824","","","","","","","0.5000264863956545","0.9797382354736328","0.7124125372073637","0.5000264863956545","0.9797382354736328","0.7124125372073637","","","","ENSG00000147041","SYTL5","HGNC:15589","SYTL5","94122","ENSG00000147041","uc004ddx.4","0.7124125372073637","0.5000264863956545","0.9797382354736328","","333","0/1","Het","33","17,16","0.515151515151515","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene belongs to the synaptotagmin-like (Slp) protein family, which contains a unique homology domain at the N-terminus, referred to as the Slp homology domain (SHD). The SHD functions as a binding site for Rab27A, which plays a role in protein transport. Expression of this gene is restricted to placenta and liver, suggesting that it might be involved in Rab27A-dependent membrane trafficking in specific tissues. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]","synaptotagmin like 5","intracellular protein transport(GO:0006886)|exocytosis(GO:0006887)","plasma membrane(GO:0005886)|exocytic vesicle(GO:0070382)","protein binding(GO:0005515)|phospholipid binding(GO:0005543)|small GTPase binding(GO:0031267)|neurexin family protein binding(GO:0042043)|metal ion binding(GO:0046872)","","","Wp deregulation of rab and rab effector genes in bladder cancer","","","","",".;.","","Score=840;Name=V$GR_Q6","0.00003283","","","0.","0.0003","","","3.283e-05","0.0004","T","0.461","T","0.722","B","0.006","B","0.003","N","0.022","D","0.994","L","1.895","T","1.93","N","-0.85","0.513","T","-1.076","T","0.040","D","0.121","0.047","T","0.173","22.6","2.518","4.83","4.762","15.357"
"chr11","1858453","1858453","G>A","","SYT8","exonic","nonsynonymous SNV","","SYT8:NM_001290332:exon9:c.G1001A:p.R334H,SYT8:NM_001290333:exon9:c.G998A:p.R333H,SYT8:NM_001290334:exon9:c.G995A:p.R332H,SYT8:NM_138567:exon9:c.G998A:p.R333H","SYT8","exonic","nonsynonymous SNV","","SYT8:ENST00000341958.3_1:exon8:c.G956A:p.R319H,SYT8:ENST00000381968.7_1:exon9:c.G998A:p.R333H","SYT8:ENST00000341958.3:c.956G>A:p.(Arg319His)","0.9844926","","","","0.5000128512820083","0.9769724905490876","0.7071512500445231","","","","","","","","","","ENSG00000149043","SYT8","HGNC:19264","SYT8","90019","ENSG00000149043","uc001lue.2","0.7071512500445231","0.5000128512820083","0.9769724905490875","","334","0/1","Het","56","35,21","0.625","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the synaptotagmin protein family. Synaptotagmins are membrane proteins that are important in neurotransmission and hormone secretion, both of which involve regulated exocytosis. Expression of the encoded protein in human pancreatic islets has been connected to activity of the promoter for the insulin gene, on the same chromosome several hundred kilobases away (PMID: 21336277 and 22928559). This association would link response to gluclose to insulin secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]","synaptotagmin 8","regulation of dopamine secretion(GO:0014059)|vesicle-mediated transport(GO:0016192)|calcium-ion regulated exocytosis(GO:0017156)|regulation of calcium ion-dependent exocytosis(GO:0017158)|synaptic vesicle endocytosis(GO:0048488)|calcium ion-regulated exocytosis of neurotransmitter(GO:0048791)|cellular response to calcium ion(GO:0071277)","acrosomal vesicle(GO:0001669)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|axon(GO:0030424)|synaptic vesicle membrane(GO:0030672)|dense core granule(GO:0031045)|exocytic vesicle(GO:0070382)","SNARE binding(GO:0000149)|phosphatidylserine binding(GO:0001786)|calcium ion binding(GO:0005509)|calcium-dependent phospholipid binding(GO:0005544)|syntaxin binding(GO:0019905)|clathrin binding(GO:0030276)","","","","Membrane trafficking|Vesicle mediated transport|Cargo recognition for clathrin mediated endocytosis|Clathrin mediated endocytosis","","","","C2","","","0.0013","0.0002","0.001","0.0001","0.0008","0.0001","","0.0001","0.0013","T","0.209","T","0.533","B","0.001","B","0.001","","","D","1","N","-0.545","T","-0.36","N","2.12","0.129","T","-1.022","T","0.106","D","0.056","0.090","T","0.026","14.13","1.109","3.61","0.422","2.919"
"chr11","1858638","1858638","C>T","","SYT8","exonic","nonsynonymous SNV","","SYT8:NM_001290332:exon9:c.C1186T:p.R396C,SYT8:NM_001290333:exon9:c.C1183T:p.R395C,SYT8:NM_001290334:exon9:c.C1180T:p.R394C,SYT8:NM_138567:exon9:c.C1183T:p.R395C","SYT8","exonic","nonsynonymous SNV","","SYT8:ENST00000341958.3_1:exon8:c.C1141T:p.R381C,SYT8:ENST00000381968.7_1:exon9:c.C1183T:p.R395C","SYT8:ENST00000341958.3:c.1141C>T:p.(Arg381Cys)","0.9694524","","","","0.5000128512820083","0.9769724905490876","0.7071512500445231","","","","","","","","","","ENSG00000149043","SYT8","HGNC:19264","SYT8","90019","ENSG00000149043","uc001lue.2","0.7071512500445231","0.5000128512820083","0.9769724905490875","","335","0/1","Het","95","56,39","0.589473684210526","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the synaptotagmin protein family. Synaptotagmins are membrane proteins that are important in neurotransmission and hormone secretion, both of which involve regulated exocytosis. Expression of the encoded protein in human pancreatic islets has been connected to activity of the promoter for the insulin gene, on the same chromosome several hundred kilobases away (PMID: 21336277 and 22928559). This association would link response to gluclose to insulin secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]","synaptotagmin 8","regulation of dopamine secretion(GO:0014059)|vesicle-mediated transport(GO:0016192)|calcium-ion regulated exocytosis(GO:0017156)|regulation of calcium ion-dependent exocytosis(GO:0017158)|synaptic vesicle endocytosis(GO:0048488)|calcium ion-regulated exocytosis of neurotransmitter(GO:0048791)|cellular response to calcium ion(GO:0071277)","acrosomal vesicle(GO:0001669)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|axon(GO:0030424)|synaptic vesicle membrane(GO:0030672)|dense core granule(GO:0031045)|exocytic vesicle(GO:0070382)","SNARE binding(GO:0000149)|phosphatidylserine binding(GO:0001786)|calcium ion binding(GO:0005509)|calcium-dependent phospholipid binding(GO:0005544)|syntaxin binding(GO:0019905)|clathrin binding(GO:0030276)","","","","Membrane trafficking|Vesicle mediated transport|Cargo recognition for clathrin mediated endocytosis|Clathrin mediated endocytosis","","","",".;.","","","0.0014","0.0002","0.001","0.0001","0.0008","","","0.0001","0.0014","D","0.014","T","0.072","B","0.002","B","0.001","","","N","1","L","1.1","T","2.9","N","-0.31","0.131","T","-0.991","T","0.019","T","0.013","0.044","T","0.044","15.28","1.316","3.85","0.760","6.736"
"chr15","86261321","86261321","C>T","","AKAP13","exonic","nonsynonymous SNV","","AKAP13:NM_001270546:exon14:c.C1795T:p.R599W,AKAP13:NM_006738:exon22:c.C5944T:p.R1982W,AKAP13:NM_007200:exon22:c.C5932T:p.R1978W","AKAP13","exonic","nonsynonymous SNV","","AKAP13:ENST00000394510.6_1:exon14:c.C1795T:p.R599W,AKAP13:ENST00000560579.5_1:exon15:c.C1780T:p.R594W,AKAP13:ENST00000361243.6_1:exon22:c.C5944T:p.R1982W,AKAP13:ENST00000394518.7_1:exon22:c.C5932T:p.R1978W","AKAP13:ENST00000361243.2:c.5944C>T:p.(Arg1982Trp)","0.96897984","0.5024897106923163","0.968979835510254","0.6971854824143601","","","","","","","","","","","","","ENSG00000170776","AKAP13","HGNC:371","AKAP13","11214","ENSG00000170776","uc002blu.3","0.6971854824143601","0.5024897106923163","0.9689798355102539","","338","0/1","Het","102","66,36","0.647058823529412","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms containing c-terminal dbl oncogene homology (DH) and pleckstrin homology (PH) domains. The DH domain is associated with guanine nucleotide exchange activation for the Rho/Rac family of small GTP binding proteins, resulting in the conversion of the inactive GTPase to the active form capable of transducing signals. The PH domain has multiple functions. Therefore, these isoforms function as scaffolding proteins to coordinate a Rho signaling pathway, function as protein kinase A-anchoring proteins and, in addition, enhance ligand-dependent activity of estrogen receptors alpha and beta. [provided by RefSeq, Jul 2012]","A-kinase anchoring protein 13","protein phosphorylation(GO:0006468)|G protein-coupled receptor signaling pathway(GO:0007186)|heart development(GO:0007507)|regulation of Rho protein signal transduction(GO:0035023)|positive regulation of Rho protein signal transduction(GO:0035025)|positive regulation of Rho protein signal transduction(GO:0035025)|intracellular signal transduction(GO:0035556)|positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123)|positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123)|positive regulation of MAP kinase activity(GO:0043406)|regulation of small GTPase mediated signal transduction(GO:0051056)|nuclear export(GO:0051168)|cardiac muscle cell differentiation(GO:0055007)|regulation of sarcomere organization(GO:0060297)|bone development(GO:0060348)|cell growth involved in cardiac muscle cell development(GO:0061049)|adrenergic receptor signaling pathway(GO:0071875)|adrenergic receptor signaling pathway(GO:0071875)|adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process(GO:0086023)","nucleus(GO:0005634)|cytosol(GO:0005829)|cytosol(GO:0005829)|cell cortex(GO:0005938)|actin cytoskeleton(GO:0015629)|membrane(GO:0016020)|cortical actin cytoskeleton(GO:0030864)|perinuclear region of cytoplasm(GO:0048471)","cAMP-dependent protein kinase activity(GO:0004691)|MAP-kinase scaffold activity(GO:0005078)|MAP-kinase scaffold activity(GO:0005078)|guanyl-nucleotide exchange factor activity(GO:0005085)|guanyl-nucleotide exchange factor activity(GO:0005085)|protein binding(GO:0005515)|small GTPase binding(GO:0031267)|metal ion binding(GO:0046872)|protein kinase A binding(GO:0051018)|molecular adaptor activity(GO:0060090)","cancer(DOID:162)|adenoma(DOID:657)","","Wp g protein signaling pathways|Wp nuclear receptors metapathway|Wp glucocorticoid receptor pathway","Nrage signals death through jnk|P75 ntr receptor mediated signalling|Cell death signalling via nrage nrif and nade|Signaling by gpcr|G alpha 12 13 signalling events|Death receptor signalling|Rhoa gtpase cycle|Rho gtpase cycle|Rhob gtpase cycle|Rhoc gtpase cycle|Signaling by rho gtpases miro gtpases and rhobtb3","Akap13 pathway","Mitotic spindle","",".;.;.;.;.","","Score=808;Name=V$PAX5_02","0.000003977","","","0.","0.","0.0001","","3.977e-06","0","D","0.028","D","0.036","D","0.998","P","0.549","","","N","1.000","L","0.895","T","-0.33","D","-3.23","0.316","T","-0.635","T","0.351","D","0.157","0.233","D","0.707","23.4","2.948","5.42","0.681","13.319"
"chr11","6816225","6816225","G>A","","OR6A2","exonic","nonsynonymous SNV","","OR6A2:NM_003696:exon1:c.C715T:p.R239C","OR6A2","exonic","nonsynonymous SNV","","OR6A2:ENST00000641196.1_1:exon2:c.C715T:p.R239C","OR6A2:ENST00000332601.3:c.715C>T:p.(Arg239Cys)","0.9652446","0.500602284213528","0.9652445912361144","0.6856819197415452","","","","","","","","","","","","","ENSG00000184933","OR6A2","HGNC:15301","OR6A2","8590","ENSG00000184933","uc001mes.2","0.6856819197415452","0.500602284213528","0.9652445912361145","","342","0/1","Het","129","78,51","0.604651162790698","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]","olfactory receptor family 6 subfamily A member 2","signal transduction(GO:0007165)|G protein-coupled receptor signaling pathway(GO:0007186)|sensory perception of smell(GO:0007608)|detection of chemical stimulus involved in sensory perception of smell(GO:0050911)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)","G protein-coupled receptor activity(GO:0004930)|olfactory receptor activity(GO:0004984)","","Olfactory transduction","Wp gpcrs class a rhodopsinlike","Olfactory signaling pathway|Sensory perception","","","","GPCR,","","","0.00003191","","","0.","0.","","","3.191e-05","0","D","0.033","D","0.013","B","0.104","B","0.051","D","0.001","N","1.000","M","2.595","T","8.05","D","-6.08","0.479","T","-0.996","T","0.001","T","0.005","0.112","T","0.157","19.91","2.023","5.07","0.533","11.189"
"chr11","4411265","4411265","C>T","","TRIM21","exonic","nonsynonymous SNV","","TRIM21:NM_003141:exon2:c.G375A:p.M125I","TRIM21","exonic","nonsynonymous SNV","","TRIM21:ENST00000254436.8_1:exon2:c.G375A:p.M125I","TRIM21:ENST00000254436.7:c.375G>A:p.(Met125Ile)","0.961","0.5000992708446574","0.9610000252723694","0.6760764245261724","","","","","","","","","","","","","ENSG00000132109","TRIM21","HGNC:11312","TRIM21","6737","ENSG00000132109","uc001lyy.2","0.6760764245261724","0.5000992708446574","0.9610000252723694","","376","0/1","Het","81","41,40","0.506172839506173","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The encoded protein is part of the RoSSA ribonucleoprotein, which includes a single polypeptide and one of four small RNA molecules. The RoSSA particle localizes to both the cytoplasm and the nucleus. RoSSA interacts with autoantigens in patients with Sjogren syndrome and systemic lupus erythematosus. Alternatively spliced transcript variants for this gene have been described but the full-length nature of only one has been determined. [provided by RefSeq, Jul 2008]","tripartite motif containing 21","protein polyubiquitination(GO:0000209)|protein polyubiquitination(GO:0000209)|protein monoubiquitination(GO:0006513)|cell cycle(GO:0007049)|regulation of gene expression(GO:0010468)|positive regulation of autophagy(GO:0010508)|positive regulation of autophagy(GO:0010508)|protein ubiquitination(GO:0016567)|protein ubiquitination(GO:0016567)|protein destabilization(GO:0031648)|negative regulation of NF-kappaB transcription factor activity(GO:0032088)|positive regulation of protein binding(GO:0032092)|regulation of type I interferon production(GO:0032479)|regulation of protein localization(GO:0032880)|negative regulation of viral transcription(GO:0032897)|response to interferon-gamma(GO:0034341)|positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123)|suppression of viral release by host(GO:0044790)|innate immune response(GO:0045087)|innate immune response(GO:0045087)|positive regulation of cell cycle(GO:0045787)|negative regulation of innate immune response(GO:0045824)|positive regulation of transcription, DNA-templated(GO:0045893)|regulation of viral entry into host cell(GO:0046596)|positive regulation of viral entry into host cell(GO:0046598)|positive regulation of DNA-binding transcription factor activity(GO:0051091)|positive regulation of NF-kappaB transcription factor activity(GO:0051092)|protein autoubiquitination(GO:0051865)|protein K63-linked ubiquitination(GO:0070534)|negative regulation of protein deubiquitination(GO:0090086)","P-body(GO:0000932)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|autophagosome(GO:0005776)|cytosol(GO:0005829)|cytosol(GO:0005829)|cytoplasmic vesicle(GO:0031410)|ribonucleoprotein complex(GO:1990904)","DNA binding(GO:0003677)|transcription coactivator activity(GO:0003713)|RNA binding(GO:0003723)|ubiquitin-protein transferase activity(GO:0004842)|ubiquitin-protein transferase activity(GO:0004842)|protein binding(GO:0005515)|zinc ion binding(GO:0008270)|protein kinase binding(GO:0019901)|identical protein binding(GO:0042802)|protein homodimerization activity(GO:0042803)|ubiquitin protein ligase activity(GO:0061630)|ubiquitin protein ligase activity(GO:0061630)","Sjogren's syndrome(DOID:12894)|squamous cell carcinoma(DOID:1749)|syndrome(DOID:225)|autoimmune disease(DOID:417)|congenital heart block(DOID:990)","Systemic lupus erythematosus","","Cytokine signaling in immune system|Adaptive immune system|Innate immune system|Sting mediated induction of host immune responses|Cytosolic sensors of pathogen associated dna|Regulation of innate immune responses to cytosolic dna|Interferon gamma signaling|Interferon signaling|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","Interferon alpha response|Interferon gamma response","","B-box-type","","","","","","","","","","","","D","0.039","T","0.161","B","0.0","B","0.004","N","0.294","N","1","N","0.455","T","1.29","N","-0.21","0.075","T","-1.022","T","0.051","T","0.008","0.061","T","0.034","10.29","0.598","4.32","-0.177","3.201"
"chr7","141803139","141803139","T>C","","MGAM","exonic","nonsynonymous SNV","","MGAM:NM_004668:exon47:c.T5396C:p.I1799T","MGAM","exonic","nonsynonymous SNV","","MGAM:ENST00000549489.6_1:exon47:c.T5396C:p.I1799T,MGAM:ENST00000620571.1_1:exon47:c.T5396C:p.I1799T,MGAM:ENST00000475668.6_1:exon70:c.T8084C:p.I2695T","MGAM:ENST00000475668.2:c.8084T>C:p.(Ile2695Thr)","0.95533615","0.5004921343643218","0.9553361535072328","0.665492087789801","","","","","","","","","","","","","ENSG00000257335","MGAM","HGNC:7043","MGAM","8972","ENSG00000257335","uc064isb.1","0.665492087789801","0.5004921343643218","0.9553361535072327","","379","0/1","Het","73","35,38","0.479452054794521","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes maltase-glucoamylase, which is a brush border membrane enzyme that plays a role in the final steps of digestion of starch. The protein has two catalytic sites identical to those of sucrase-isomaltase, but the proteins are only 59% homologous. Both are members of glycosyl hydrolase family 31, which has a variety of substrate specificities. [provided by RefSeq, Jul 2008]","maltase-glucoamylase","maltose metabolic process(GO:0000023)|starch catabolic process(GO:0005983)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|apical plasma membrane(GO:0016324)|extracellular exosome(GO:0070062)|tertiary granule membrane(GO:0070821)|ficolin-1-rich granule membrane(GO:0101003)","catalytic activity(GO:0003824)|glucan 1,4-alpha-glucosidase activity(GO:0004339)|hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553)|alpha-1,4-glucosidase activity(GO:0004558)|protein binding(GO:0005515)|carbohydrate binding(GO:0030246)|maltose alpha-glucosidase activity(GO:0032450)","polycystic ovary syndrome(DOID:11612)","Galactose metabolism|Starch and sucrose metabolism","Wp glucocorticoid receptor pathway","Innate immune system|Digestion of dietary carbohydrate|Neutrophil degranulation|Digestion|Digestion and absorption","","","",".;.;.","","","0.00005597","","","0.","0.0001","","","4.039e-06","5.597e-05","D","0.043","D","0.036","B","0.136","B","0.082","","","N","0.975","H","3.53","D","-2.63","N","-2.44","0.625","D","0.155","D","0.729","D","0.071","0.537","D","0.629","22.2","2.345","5.4","3.171","9.210"
"chr1","201195057","201195057","A>G","","IGFN1","exonic","nonsynonymous SNV","","IGFN1:NM_001164586:exon22:c.A10592G:p.H3531R","IGFN1","exonic","nonsynonymous SNV","","IGFN1:ENST00000335211.9_1:exon22:c.A10592G:p.H3531R,IGFN1:ENST00000295591.12_1:exon23:c.A3221G:p.H1074R","IGFN1:ENST00000335211.4:c.10592A>G:p.(His3531Arg)","0.9789974","","","","0.5000028021738672","0.9536922872066498","0.6609841258215644","","","","","","","","","","ENSG00000163395","IGFN1","HGNC:24607","IGFN1","91156","ENSG00000163395","uc001gwc.3","0.6609841258215644","0.5000028021738672","0.9536922872066498","","380","0/1","Het","160","95,65","0.59375","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","immunoglobulin like and fibronectin type III domain containing 1","homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156)|synapse assembly(GO:0007416)|biological_process(GO:0008150)|retina layer formation(GO:0010842)","nucleus(GO:0005634)|Z disc(GO:0030018)|synapse(GO:0045202)","protein binding(GO:0005515)","","","","","","","",".;Fibronectin","","","0.0002","0.0002","","0.0001","0.","","","0.0002","0","D","0.011","D","0.003","","","","","N","0.023","D","1","M","2.25","T","0.49","D","-5.05","0.32","T","-0.673","T","0.250","D","0.191","0.331","T","0.243","22.4","2.421","5.0","4.514","7.396"
"chr1","201181220","201181220","C>T","","IGFN1","exonic","nonsynonymous SNV","","IGFN1:NM_001164586:exon12:c.C7199T:p.T2400M","IGFN1","exonic","nonsynonymous SNV","","IGFN1:ENST00000335211.9_1:exon12:c.C7199T:p.T2400M","IGFN1:ENST00000335211.4:c.7199C>T:p.(Thr2400Met)","0.92838717","","","","0.5000028021738672","0.9536922872066498","0.6609841258215644","","","","","","","","","","ENSG00000163395","IGFN1","HGNC:24607","IGFN1","91156","ENSG00000163395","uc001gwc.3","0.6609841258215644","0.5000028021738672","0.9536922872066498","","381","0/1","Het","153","74,79","0.483660130718954","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","immunoglobulin like and fibronectin type III domain containing 1","homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156)|synapse assembly(GO:0007416)|biological_process(GO:0008150)|retina layer formation(GO:0010842)","nucleus(GO:0005634)|Z disc(GO:0030018)|synapse(GO:0045202)","protein binding(GO:0005515)","","","","","","","SpliceAI>T|IGFN1|0.00|0.00|0.00|0.00|-33|-32|-33|39","","","","0.0033","0.0006","0.003","0.0001","0.","0.0002","","0.0003","0.0033","D","0.018","T","0.063","","","","","","","N","1","","","T","0.62","N","-1.52","0.095","T","-1.019","T","0.064","T","0.014","0.022","T","0.035","12.55","0.878","2.06","-0.415","10.279"
"chr16","20430717","20430717","A>T","","ACSM5","exonic","nonsynonymous SNV","","ACSM5:NM_017888:exon4:c.A583T:p.S195C","ACSM5","exonic","nonsynonymous SNV","","ACSM5:ENST00000331849.8_1:exon4:c.A583T:p.S195C,ACSM5:ENST00000575584.5_1:exon4:c.A583T:p.S195C","ACSM5:ENST00000331849.4:c.583A>T:p.(Ser195Cys)","0.9477726","0.5000159083119797","0.9477726221084596","0.6487283129601145","0.5000159083119797","0.9227178692817688","0.5946822626076806","","","","","","","","","","ENSG00000183549","ACSM5","HGNC:26060","ACSM5","54988","ENSG00000183549","uc002dhe.4","0.6487283129601145","0.5000159083119797","0.9477726221084595","","388","0/1","Het","119","53,66","0.445378151260504","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","acyl-CoA synthetase medium chain family member 5","fatty acid biosynthetic process(GO:0006633)|acyl-CoA metabolic process(GO:0006637)","mitochondrial matrix(GO:0005759)","fatty-acyl-CoA synthase activity(GO:0004321)|ATP binding(GO:0005524)|GTP binding(GO:0005525)|fatty acid ligase activity(GO:0015645)|medium-chain fatty acid-CoA ligase activity(GO:0031956)|metal ion binding(GO:0046872)|butyrate-CoA ligase activity(GO:0047760)","","Butanoate metabolism","","Phase ii conjugation of compounds|Amino acid conjugation|Biological oxidations","","","SpliceAI>T|ACSM5|0.00|0.00|0.01|0.02|-43|2|12|40",".;AMP-dependent","","","0.0000717","","","0.","0.0002","","","7.17e-05","0.0004","D","0.044","D","0.039","P","0.932","P","0.684","N","0.417","N","1","M","2.365","T","0.73","D","-3.19","0.178","T","-1.037","T","0.098","T","0.006","0.051","D","0.701","19.01","1.906","4.65","0.351","4.751"
"chr16","20435371","20435371","G>C","","ACSM5","exonic","nonsynonymous SNV","","ACSM5:NM_017888:exon6:c.G901C:p.D301H","ACSM5","exonic","nonsynonymous SNV","","ACSM5:ENST00000331849.8_1:exon6:c.G901C:p.D301H","ACSM5:ENST00000331849.4:c.901G>C:p.(Asp301His)","0.8976631","","","","0.5000159083119797","0.9227178692817688","0.5946822626076806","","","","","","","","","","ENSG00000183549","ACSM5","HGNC:26060","ACSM5","54988","ENSG00000183549","uc002dhe.4","0.6487283129601145","0.5000159083119797","0.9477726221084595","","389","0/1","Het","83","53,30","0.63855421686747","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","acyl-CoA synthetase medium chain family member 5","fatty acid biosynthetic process(GO:0006633)|acyl-CoA metabolic process(GO:0006637)","mitochondrial matrix(GO:0005759)","fatty-acyl-CoA synthase activity(GO:0004321)|ATP binding(GO:0005524)|GTP binding(GO:0005525)|fatty acid ligase activity(GO:0015645)|medium-chain fatty acid-CoA ligase activity(GO:0031956)|metal ion binding(GO:0046872)|butyrate-CoA ligase activity(GO:0047760)","","Butanoate metabolism","","Phase ii conjugation of compounds|Amino acid conjugation|Biological oxidations","","","SpliceAI>C|ACSM5|0.00|0.00|0.00|0.06|20|-12|-22|20","AMP-dependent","","Score=886;Name=V$CDPCR3HD_01","0.0041","0.0006","0.003","0.0003","0.0039","","","0.0003","0.0041","D","0.002","D","0.019","D","0.999","D","0.972","N","0.043","D","0.960","M","2.75","T","0.4","D","-4.73","0.363","T","-0.459","T","0.304","T","0.011","0.374","T","0.246","25.0","3.514","4.56","0.845","10.26"
"chr17","56386195","56386195","G>A","","BZRAP1","exonic","nonsynonymous SNV","","BZRAP1:NM_024418:exon21:c.C4258T:p.R1420W,BZRAP1:NM_001261835:exon22:c.C4438T:p.R1480W,BZRAP1:NM_004758:exon22:c.C4438T:p.R1480W","TSPOAP1","exonic","nonsynonymous SNV","","TSPOAP1:ENST00000268893.10_1:exon21:c.C4258T:p.R1420W,TSPOAP1:ENST00000343736.9_1:exon22:c.C4438T:p.R1480W","TSPOAP1:ENST00000268893.6:c.4258C>T:p.(Arg1420Trp)","0.9452603","0.5000073505957516","0.9452602863311768","0.6434322045822157","","","","","","","","","","","","","ENSG00000005379","TSPOAP1","HGNC:16831","TSPOAP1","9256","ENSG00000005379","uc002ivx.6","0.6434322045822157","0.5000073505957516","0.9452602863311768","","391","0/1","Het","98","47,51","0.479591836734694","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","Pes cavus(HP:0001761)|Constipation(HP:0002019)|Hypokinesia(HP:0002375)|Progressive encephalopathy(HP:0002448)|Generalized hypotonia(HP:0001290)|Babinski sign(HP:0003487)|Decreased CSF homovanillic acid(HP:0003785)|Excessive salivation(HP:0003781)|Limb dystonia(HP:0002451)|Parkinsonism(HP:0001300)|Generalized dystonia(HP:0007325)|Night sweats(HP:0030166)|Fever(HP:0001945)|Postural tremor(HP:0002174)|Delayed speech and language development(HP:0000750)|Rigidity(HP:0002063)|Lower limb hyperreflexia(HP:0002395)|Talipes equinovarus(HP:0001762)|Myoclonus(HP:0001336)|Feeding difficulties(HP:0011968)|Oculogyric crisis(HP:0010553)|Focal dystonia(HP:0004373)|Ptosis(HP:0000508)|Gait ataxia(HP:0002066)|Irritability(HP:0000737)|Lethargy(HP:0001254)|Intellectual disability, mild(HP:0001256)|Brisk reflexes(HP:0001348)|Bradykinesia(HP:0002067)|Motor delay(HP:0001270)","","TSPO associated protein 1","neuromuscular synaptic transmission(GO:0007274)|biological_process(GO:0008150)|regulation of presynaptic cytosolic calcium ion concentration(GO:0099509)","cytoplasm(GO:0005737)|mitochondrion(GO:0005739)|mitochondrion(GO:0005739)|cytosol(GO:0005829)|calyx of Held(GO:0044305)|glutamatergic synapse(GO:0098978)","protein binding(GO:0005515)|benzodiazepine receptor binding(GO:0030156)|benzodiazepine receptor binding(GO:0030156)|voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels(GO:0099626)","","","","Neurotransmitter release cycle|Transmission across chemical synapses|Neuronal system|Serotonin neurotransmitter release cycle|Norepinephrine neurotransmitter release cycle|Metabolism of steroid hormones|Pregnenolone biosynthesis|Glutamate neurotransmitter release cycle|Dopamine neurotransmitter release cycle|Acetylcholine neurotransmitter release cycle|Metabolism of lipids|Metabolism of steroids","","","",".;.;.","","Score=836;Name=V$ARNT_01","0.0000744","","","0.0001","0.0008","","","7.44e-05","0.0009","D","0.042","T","0.099","B","0.003","B","0.002","N","0.259","N","1.000","M","2.125","T","3.55","N","-1.7","0.164","T","-0.951","T","0.013","T","0.007","0.089","T","0.043","11.21","0.708","5.17","2.492","4.738"
"chr4","140640752","140640752","T>C","","MAML3","exonic","nonsynonymous SNV","","MAML3:NM_018717:exon6:c.A3130G:p.M1044V","MAML3","exonic","nonsynonymous SNV","","MAML3:ENST00000509479.6_1:exon5:c.A3142G:p.M1048V","MAML3:ENST00000509479.2:c.3142A>G:p.(Met1048Val)","0.9433897","","","","0.5009906601626426","0.9294190406799316","0.611834566716447","","","","","","","","","","ENSG00000196782","MAML3","HGNC:16272","MAML3","55534","ENSG00000196782","uc062zte.1","0.611834566716447","0.5009906601626426","0.9294190406799316","","405","0/1","Het","134","74,60","0.552238805970149","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","mastermind like transcriptional coactivator 3","Notch signaling pathway(GO:0007219)|positive regulation of transcription of Notch receptor target(GO:0007221)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|nuclear speck(GO:0016607)","transcription coactivator activity(GO:0003713)|transcription coactivator activity(GO:0003713)","","Notch signaling pathway","Wp notch signaling pathway netpath|Wp canonical and noncanonical notch signaling|Wp notch signaling|Wp pathways affected in adenoid cystic carcinoma","Developmental biology|Signaling by notch|Regulation of beta cell development|Pre notch expression and processing|Signaling by notch1|Signaling by notch2|Regulation of gene expression in late stage branching morphogenesis pancreatic bud precursor cells|Notch1 intracellular domain regulates transcription|Notch2 intracellular domain regulates transcription|Signaling by notch1 pest domain mutants in cancer|Notch hlh transcription pathway|Diseases of signal transduction by growth factor receptors and second messengers|Rna polymerase ii transcription|Transcriptional regulation by runx3|Runx3 regulates notch signaling|Signaling by notch3|Notch3 intracellular domain regulates transcription|Signaling by notch4|Notch4 intracellular domain regulates transcription","","","SpliceAI>C|MAML3|0.00|0.00|0.00|0.00|30|-2|-27|16>C|MGST2|0.00|0.00|0.00|0.00|-8|43|22|-2","","","","0.004","0.0008","0.004","0.0003","0.0025","","","0.0002","0.0025","D","0.008","T","0.214","","","","","D","0.000","D","0.968","","","T","1.83","N","-1.45","0.215","T","-1.085","T","0.063","T","0.005","0.136","T","0.046","13.63","1.029","4.78","1.924","7.356"
"chr4","140811238","140811238","G>A","","MAML3","exonic","nonsynonymous SNV","","MAML3:NM_018717:exon2:c.C1352T:p.A451V","MAML3","exonic","nonsynonymous SNV","","MAML3:ENST00000509479.6_1:exon2:c.C1352T:p.A451V","MAML3:ENST00000327122.5:c.884C>T:p.(Ala295Val)","0.91544837","","","","0.5009906601626426","0.9294190406799316","0.611834566716447","","","","","","","","","","ENSG00000196782","MAML3","HGNC:16272","MAML3","55534","ENSG00000196782","uc062zte.1","0.611834566716447","0.5009906601626426","0.9294190406799316","","406","0/1","Het","89","43,46","0.48314606741573","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","mastermind like transcriptional coactivator 3","Notch signaling pathway(GO:0007219)|positive regulation of transcription of Notch receptor target(GO:0007221)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|nuclear speck(GO:0016607)","transcription coactivator activity(GO:0003713)|transcription coactivator activity(GO:0003713)","","Notch signaling pathway","Wp notch signaling pathway netpath|Wp canonical and noncanonical notch signaling|Wp notch signaling|Wp pathways affected in adenoid cystic carcinoma","Developmental biology|Signaling by notch|Regulation of beta cell development|Pre notch expression and processing|Signaling by notch1|Signaling by notch2|Regulation of gene expression in late stage branching morphogenesis pancreatic bud precursor cells|Notch1 intracellular domain regulates transcription|Notch2 intracellular domain regulates transcription|Signaling by notch1 pest domain mutants in cancer|Notch hlh transcription pathway|Diseases of signal transduction by growth factor receptors and second messengers|Rna polymerase ii transcription|Transcriptional regulation by runx3|Runx3 regulates notch signaling|Signaling by notch3|Notch3 intracellular domain regulates transcription|Signaling by notch4|Notch4 intracellular domain regulates transcription","","","SpliceAI>A|MAML3|0.00|0.00|0.00|0.00|-45|21|0|21","","","","0.00002856","0.0006","0.002","0.","0.0003","","","2.856e-05","0.0003","T","0.068","T","0.17","B","0.186","B","0.022","D","0.000","N","0.993","N","0.145","T","1.9","N","-1.21","0.091","T","-1.114","T","0.047","T","0.006","0.058","T","0.054","15.78","1.411","5.09","1.639","13.877"
"chr17","8046972","8046972","G>T","","PER1","exonic","nonsynonymous SNV","","PER1:NM_002616:exon19:c.C2684A:p.P895H","PER1","exonic","nonsynonymous SNV","","PER1:ENST00000581082.5_1:exon18:c.C2615A:p.P872H,PER1:ENST00000317276.9_1:exon19:c.C2684A:p.P895H","PER1:ENST00000317276.4:c.2684C>A:p.(Pro895His)","0.93","0.5003907031787094","0.9300000071525574","0.6116206178294679","","","","","","","","","","","","","ENSG00000179094","PER1","HGNC:8845","PER1","5187","ENSG00000179094","uc002gkd.4","0.6116206178294679","0.5003907031787094","0.9300000071525574","","407","0/1","Het","138","71,67","0.514492753623188","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Genes in this family encode components of the circadian rhythms of locomotor activity, metabolism, and behavior. This gene is upregulated by CLOCK/ARNTL heterodimers but then represses this upregulation in a feedback loop using PER/CRY heterodimers to interact with CLOCK/ARNTL. Polymorphisms in this gene may increase the risk of getting certain cancers. Alternative splicing has been observed in this gene; however, these variants have not been fully described. [provided by RefSeq, Jan 2014]","period circadian regulator 1","negative regulation of transcription by RNA polymerase II(GO:0000122)|negative regulation of transcription by RNA polymerase II(GO:0000122)|regulation of sodium ion transport(GO:0002028)|circadian rhythm(GO:0007623)|entrainment of circadian clock(GO:0009649)|posttranscriptional regulation of gene expression(GO:0010608)|circadian regulation of gene expression(GO:0032922)|circadian regulation of gene expression(GO:0032922)|regulation of hair cycle(GO:0042634)|regulation of circadian rhythm(GO:0042752)|negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124)|entrainment of circadian clock by photoperiod(GO:0043153)|entrainment of circadian clock by photoperiod(GO:0043153)|histone H3 acetylation(GO:0043966)|histone H4 acetylation(GO:0043967)|negative regulation of transcription, DNA-templated(GO:0045892)|positive regulation of transcription by RNA polymerase II(GO:0045944)|negative regulation of JNK cascade(GO:0046329)|response to cAMP(GO:0051591)|histone H3 deacetylation(GO:0070932)|circadian regulation of translation(GO:0097167)|regulation of cytokine production involved in inflammatory response(GO:1900015)|regulation of p38MAPK cascade(GO:1900744)|negative regulation of glucocorticoid receptor signaling pathway(GO:2000323)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)","transcription cis-regulatory region binding(GO:0000976)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|transcription corepressor binding(GO:0001222)|protein binding(GO:0005515)|kinase binding(GO:0019900)|chromatin DNA binding(GO:0031490)|ubiquitin protein ligase binding(GO:0031625)|E-box binding(GO:0070888)","autistic disorder(DOID:12849)|dementia(DOID:1307)|Parkinson's disease(DOID:14330)|colon carcinoma(DOID:1520)|cancer(DOID:162)|syndrome(DOID:225)|hepatocellular carcinoma(DOID:684)|neuroblastoma(DOID:769)","Circadian rhythm mammal","Wp melatonin metabolism and effects|Wp exerciseinduced circadian regulation|Wp circadian rhythm related genes","Circadian clock","Circadian pathway","Tnfa signaling via nfkb","",".;.","","Score=763;Name=V$HEN1_02","","","","","","","","","","T","0.07","T","0.13","B","0.016","B","0.007","N","0.499","N","1.000","M","2.44","T","2.43","N","-2.36","0.367","T","-1.094","T","0.038","T","0.009","0.050","D","0.528","15.76","1.409","5.32","4.108","13.133"
"chr7","80302698","80302709","TATTGTGCCTAT>-","CD36:948","CD36","exonic","nonframeshift deletion","","CD36:NM_001289908:exon9:c.1110_1121del:p.I371_I374del,CD36:NM_001127444:exon11:c.1227_1238del:p.I410_I413del,CD36:NM_001289909:exon11:c.1047_1058del:p.I350_I353del,CD36:NM_001289911:exon11:c.999_1010del:p.I334_I337del,CD36:NM_001127443:exon12:c.1227_1238del:p.I410_I413del,CD36:NM_000072:exon13:c.1227_1238del:p.I410_I413del,CD36:NM_001001547:exon13:c.1227_1238del:p.I410_I413del,CD36:NM_001001548:exon13:c.1227_1238del:p.I410_I413del","CD36","exonic","nonframeshift deletion","","CD36:ENST00000433696.6_1:exon11:c.1110_1121del:p.I371_I374del,CD36:ENST00000534394.5_1:exon11:c.999_1010del:p.I334_I337del,CD36:ENST00000432207.5_1:exon12:c.1227_1238del:p.I410_I413del,CD36:ENST00000538969.5_1:exon12:c.1047_1058del:p.I350_I353del,CD36:ENST00000309881.11_1:exon13:c.1227_1238del:p.I410_I413del,CD36:ENST00000394788.7_1:exon13:c.1227_1238del:p.I410_I413del,CD36:ENST00000447544.7_1:exon13:c.1227_1238del:p.I410_I413del,CD36:ENST00000435819.5_1:exon16:c.1227_1238del:p.I410_I413del","CD36:ENST00000309881.7:c.1228_1239del:p.(Ile410_Ile413del)","1","0.2522223748724147","1.0","0.1850362318635069","0.5044447497448294","0.9250839352607728","0.6109057503310443","","","","","","","","","","ENSG00000135218","CD36","HGNC:1663","CD36","948","ENSG00000135218","uc003uhc.4","0.6109057503310443","0.5044447497448294","0.9250839352607727","OMIM:608404 Platelet glycoprotein IV deficiency-autosomal_recessive","408","0/1","Het","59","42,17","0.711864406779661","Pathogenic/Likely_pathogenic","True","Platelet-type_bleeding_disorder_10","MONDO:MONDO:0012031,MedGen:C1842090,OMIM:608404","NC_000007.13:g.80302699_80302710del","criteria_provided,_multiple_submitters,_no_conflicts","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Platelet glycoprotein iv deficiency(608404)|Coronary heart disease, susceptibility to, 7(610938)|Malaria, susceptibility to(611162)","Autosomal recessive inheritance(HP:0000007)|Giant platelets(HP:0001902)|Abnormal bleeding(HP:0001892)|Abnormality of the endocrine system(HP:0000818)|Thrombocytopenia(HP:0001873)|Prolonged bleeding time(HP:0003010)","The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]","CD36 molecule","negative regulation of transcription by RNA polymerase II(GO:0000122)|positive regulation of cell-matrix adhesion(GO:0001954)|production of molecular mediator involved in inflammatory response(GO:0002532)|lipid metabolic process(GO:0006629)|fatty acid metabolic process(GO:0006631)|receptor-mediated endocytosis(GO:0006898)|receptor-mediated endocytosis(GO:0006898)|phagocytosis, recognition(GO:0006910)|phagocytosis, engulfment(GO:0006911)|cell adhesion(GO:0007155)|cell surface receptor signaling pathway(GO:0007166)|positive regulation of cytosolic calcium ion concentration(GO:0007204)|nitric oxide mediated signal transduction(GO:0007263)|blood coagulation(GO:0007596)|positive regulation of gene expression(GO:0010628)|negative regulation of gene expression(GO:0010629)|positive regulation of macrophage derived foam cell differentiation(GO:0010744)|positive regulation of cholesterol storage(GO:0010886)|positive regulation of cell death(GO:0010942)|long-chain fatty acid transport(GO:0015909)|long-chain fatty acid import across plasma membrane(GO:0015911)|short-chain fatty acid transport(GO:0015912)|lipid storage(GO:0019915)|lipid storage(GO:0019915)|cGMP-mediated signaling(GO:0019934)|positive regulation of blood coagulation(GO:0030194)|intestinal cholesterol absorption(GO:0030299)|cholesterol transport(GO:0030301)|receptor internalization(GO:0031623)|regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664)|positive regulation of interleukin-1 beta production(GO:0032731)|positive regulation of interleukin-12 production(GO:0032735)|positive regulation of interleukin-6 production(GO:0032755)|positive regulation of tumor necrosis factor production(GO:0032760)|response to lipid(GO:0033993)|regulation of toll-like receptor signaling pathway(GO:0034121)|triglyceride transport(GO:0034197)|plasma lipoprotein particle clearance(GO:0034381)|low-density lipoprotein particle clearance(GO:0034383)|low-density lipoprotein particle clearance(GO:0034383)|response to stilbenoid(GO:0035634)|negative regulation of protein import into nucleus(GO:0042308)|lipoprotein transport(GO:0042953)|lipoprotein transport(GO:0042953)|lipoprotein transport(GO:0042953)|positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123)|regulation of protein-containing complex assembly(GO:0043254)|apoptotic cell clearance(GO:0043277)|long-chain fatty acid import into cell(GO:0044539)|long-chain fatty acid import into cell(GO:0044539)|positive regulation of nitric oxide biosynthetic process(GO:0045429)|positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731)|defense response to Gram-positive bacterium(GO:0050830)|intestinal absorption(GO:0050892)|sensory perception of taste(GO:0050909)|positive regulation of NF-kappaB transcription factor activity(GO:0051092)|low-density lipoprotein particle mediated signaling(GO:0055096)|positive regulation of phagocytosis, engulfment(GO:0060100)|positive regulation of macrophage cytokine production(GO:0060907)|positive regulation of ERK1 and ERK2 cascade(GO:0070374)|cholesterol import(GO:0070508)|response to fatty acid(GO:0070542)|response to linoleic acid(GO:0070543)|cellular response to lipopolysaccharide(GO:0071222)|cellular response to lipoteichoic acid(GO:0071223)|cellular response to low-density lipoprotein particle stimulus(GO:0071404)|cellular response to hydroperoxide(GO:0071447)|cellular response to diacyl bacterial lipopeptide(GO:0071726)|energy homeostasis(GO:0097009)|regulation of action potential(GO:0098900)|positive regulation of cold-induced thermogenesis(GO:0120162)|cellular response to oxidised low-density lipoprotein particle stimulus(GO:0140052)|oxidised low-density lipoprotein particle clearance(GO:0150024)|amyloid-beta clearance by cellular catabolic process(GO:0150094)|amyloid-beta clearance by cellular catabolic process(GO:0150094)|positive regulation of NLRP3 inflammasome complex assembly(GO:1900227)|positive regulation of reactive oxygen species biosynthetic process(GO:1903428)|cellular response to amyloid-beta(GO:1904646)|amyloid fibril formation(GO:1990000)|lipid transport across blood-brain barrier(GO:1990379)|regulation of removal of superoxide radicals(GO:2000121)|positive regulation of blood microparticle formation(GO:2000334)","extracellular space(GO:0005615)|cytoplasm(GO:0005737)|Golgi apparatus(GO:0005794)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|caveola(GO:0005901)|external side of plasma membrane(GO:0009897)|cell surface(GO:0009986)|cell surface(GO:0009986)|cell surface(GO:0009986)|cell surface(GO:0009986)|membrane(GO:0016020)|apical plasma membrane(GO:0016324)|endocytic vesicle membrane(GO:0030666)|platelet alpha granule membrane(GO:0031092)|brush border membrane(GO:0031526)|specific granule membrane(GO:0035579)|receptor complex(GO:0043235)|membrane raft(GO:0045121)|phagocytic vesicle(GO:0045335)|cell periphery(GO:0071944)","amyloid-beta binding(GO:0001540)|amyloid-beta binding(GO:0001540)|amyloid-beta binding(GO:0001540)|low-density lipoprotein particle receptor activity(GO:0005041)|low-density lipoprotein particle receptor activity(GO:0005041)|low-density lipoprotein particle receptor activity(GO:0005041)|scavenger receptor activity(GO:0005044)|scavenger receptor activity(GO:0005044)|scavenger receptor activity(GO:0005044)|long-chain fatty acid transporter activity(GO:0005324)|long-chain fatty acid transporter activity(GO:0005324)|protein binding(GO:0005515)|high-density lipoprotein particle binding(GO:0008035)|lipid binding(GO:0008289)|short-chain fatty acid transmembrane transporter activity(GO:0015636)|low-density lipoprotein particle binding(GO:0030169)|low-density lipoprotein particle binding(GO:0030169)|Toll-like receptor binding(GO:0035325)|protein-containing complex binding(GO:0044877)|transforming growth factor beta binding(GO:0050431)|thrombospondin receptor activity(GO:0070053)|lipoteichoic acid immune receptor activity(GO:0070892)|lipoprotein particle binding(GO:0071813)|oxidised low-density lipoprotein particle receptor activity(GO:0150025)|oleate transmembrane transporter activity(GO:1901480)","glucose intolerance(DOID:10603)|Alzheimer's disease(DOID:10652)|hypertension(DOID:10763)|age related macular degeneration(DOID:10871)|heart disease(DOID:114)|polycystic ovary syndrome(DOID:11612)|familial hyperlipidemia(DOID:1168)|malaria(DOID:12365)|leukemia(DOID:1240)|keratoconjunctivitis sicca(DOID:12895)|familial combined hyperlipidemia(DOID:13809)|cerebral malaria(DOID:14069)|cancer(DOID:162)|melanoma(DOID:1909)|atherosclerosis(DOID:1936)|syndrome(DOID:225)|arteriosclerosis(DOID:2349)|hereditary elliptocytosis(DOID:2373)|osteosarcoma(DOID:3347)|coronary artery disease(DOID:3393)|inclusion body myositis(DOID:3429)|pulmonary fibrosis(DOID:3770)|macular degeneration(DOID:4448)|myocardial infarction(DOID:5844)|myositis(DOID:633)|retinal degeneration(DOID:8466)|type 2 diabetes mellitus(DOID:9352)","Ppar signaling pathway|Ecm receptor interaction|Hematopoietic cell lineage|Adipocytokine signaling pathway","Wp ppar signaling pathway|Wp vitamin a and carotenoid metabolism|Wp aryl hydrocarbon receptor netpath|Wp il18 signaling pathway|Wp genes controlling nephrogenesis","Hemostasis|Cross presentation of particulate exogenous antigens phagosomes|Antigen processing cross presentation|Developmental biology|Cytokine signaling in immune system|Adaptive immune system|Integration of energy metabolism|Toll like receptor tlr1 tlr2 cascade|Innate immune system|Toll like receptor cascades|Binding and uptake of ligands by scavenger receptors|Scavenging by class b receptors|Transcriptional regulation of white adipocyte differentiation|Regulation of lipid metabolism by pparalpha|Free fatty acids regulate insulin secretion|Regulation of insulin secretion|Signaling by interleukins|Diseases of immune system|Metabolism of lipids|Irak4 deficiency tlr2 4|Vesicle mediated transport|Regulation of tlr by endogenous ligand|Interleukin 4 and interleukin 13 signaling|Neutrophil degranulation|Platelet activation signaling and aggregation|Response to elevated platelet cytosolic ca2|Class i mhc mediated antigen processing presentation","Tsp1 pathway","Il6 jak stat3 signaling|Adipogenesis|Myogenesis|Complement|Xenobiotic metabolism|Fatty acid metabolism","SpliceAI>A|CD36|0.07|0.00|0.04|0.00|-26|-24|28|-26","","","","0.012","0.0016","0.0079","0.0008","0.012","","","0.0008","0.0107","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr7","80302123","80302123","A>T","CD36:948","CD36","exonic","nonsynonymous SNV","","CD36:NM_001289908:exon8:c.A1046T:p.Q349L,CD36:NM_001127444:exon10:c.A1163T:p.Q388L,CD36:NM_001289909:exon10:c.A983T:p.Q328L,CD36:NM_001289911:exon10:c.A935T:p.Q312L,CD36:NM_001127443:exon11:c.A1163T:p.Q388L,CD36:NM_000072:exon12:c.A1163T:p.Q388L,CD36:NM_001001547:exon12:c.A1163T:p.Q388L,CD36:NM_001001548:exon12:c.A1163T:p.Q388L","CD36","exonic","nonsynonymous SNV","","CD36:ENST00000433696.6_1:exon10:c.A1046T:p.Q349L,CD36:ENST00000534394.5_1:exon10:c.A935T:p.Q312L,CD36:ENST00000432207.5_1:exon11:c.A1163T:p.Q388L,CD36:ENST00000538969.5_1:exon11:c.A983T:p.Q328L,CD36:ENST00000309881.11_1:exon12:c.A1163T:p.Q388L,CD36:ENST00000394788.7_1:exon12:c.A1163T:p.Q388L,CD36:ENST00000447544.7_1:exon12:c.A1163T:p.Q388L,CD36:ENST00000435819.5_1:exon15:c.A1163T:p.Q388L","CD36:ENST00000309881.7:c.1163A>T:p.(Gln388Leu)","0.8501679","","","","0.5044447497448294","0.9250839352607728","0.6109057503310443","","","","","","","","","","ENSG00000135218","CD36","HGNC:1663","CD36","948","ENSG00000135218","uc003uhc.4","0.6109057503310443","0.5044447497448294","0.9250839352607727","OMIM:608404 Platelet glycoprotein IV deficiency-autosomal_recessive","409","0/1","Het","79","55,24","0.69620253164557","Uncertain_significance","False","Platelet-type_bleeding_disorder_10","MONDO:MONDO:0012031,MedGen:C1842090,OMIM:608404","NC_000007.13:g.80302123A>T","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Platelet glycoprotein iv deficiency(608404)|Coronary heart disease, susceptibility to, 7(610938)|Malaria, susceptibility to(611162)","Autosomal recessive inheritance(HP:0000007)|Giant platelets(HP:0001902)|Abnormal bleeding(HP:0001892)|Abnormality of the endocrine system(HP:0000818)|Thrombocytopenia(HP:0001873)|Prolonged bleeding time(HP:0003010)","The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]","CD36 molecule","negative regulation of transcription by RNA polymerase II(GO:0000122)|positive regulation of cell-matrix adhesion(GO:0001954)|production of molecular mediator involved in inflammatory response(GO:0002532)|lipid metabolic process(GO:0006629)|fatty acid metabolic process(GO:0006631)|receptor-mediated endocytosis(GO:0006898)|receptor-mediated endocytosis(GO:0006898)|phagocytosis, recognition(GO:0006910)|phagocytosis, engulfment(GO:0006911)|cell adhesion(GO:0007155)|cell surface receptor signaling pathway(GO:0007166)|positive regulation of cytosolic calcium ion concentration(GO:0007204)|nitric oxide mediated signal transduction(GO:0007263)|blood coagulation(GO:0007596)|positive regulation of gene expression(GO:0010628)|negative regulation of gene expression(GO:0010629)|positive regulation of macrophage derived foam cell differentiation(GO:0010744)|positive regulation of cholesterol storage(GO:0010886)|positive regulation of cell death(GO:0010942)|long-chain fatty acid transport(GO:0015909)|long-chain fatty acid import across plasma membrane(GO:0015911)|short-chain fatty acid transport(GO:0015912)|lipid storage(GO:0019915)|lipid storage(GO:0019915)|cGMP-mediated signaling(GO:0019934)|positive regulation of blood coagulation(GO:0030194)|intestinal cholesterol absorption(GO:0030299)|cholesterol transport(GO:0030301)|receptor internalization(GO:0031623)|regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664)|positive regulation of interleukin-1 beta production(GO:0032731)|positive regulation of interleukin-12 production(GO:0032735)|positive regulation of interleukin-6 production(GO:0032755)|positive regulation of tumor necrosis factor production(GO:0032760)|response to lipid(GO:0033993)|regulation of toll-like receptor signaling pathway(GO:0034121)|triglyceride transport(GO:0034197)|plasma lipoprotein particle clearance(GO:0034381)|low-density lipoprotein particle clearance(GO:0034383)|low-density lipoprotein particle clearance(GO:0034383)|response to stilbenoid(GO:0035634)|negative regulation of protein import into nucleus(GO:0042308)|lipoprotein transport(GO:0042953)|lipoprotein transport(GO:0042953)|lipoprotein transport(GO:0042953)|positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123)|regulation of protein-containing complex assembly(GO:0043254)|apoptotic cell clearance(GO:0043277)|long-chain fatty acid import into cell(GO:0044539)|long-chain fatty acid import into cell(GO:0044539)|positive regulation of nitric oxide biosynthetic process(GO:0045429)|positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731)|defense response to Gram-positive bacterium(GO:0050830)|intestinal absorption(GO:0050892)|sensory perception of taste(GO:0050909)|positive regulation of NF-kappaB transcription factor activity(GO:0051092)|low-density lipoprotein particle mediated signaling(GO:0055096)|positive regulation of phagocytosis, engulfment(GO:0060100)|positive regulation of macrophage cytokine production(GO:0060907)|positive regulation of ERK1 and ERK2 cascade(GO:0070374)|cholesterol import(GO:0070508)|response to fatty acid(GO:0070542)|response to linoleic acid(GO:0070543)|cellular response to lipopolysaccharide(GO:0071222)|cellular response to lipoteichoic acid(GO:0071223)|cellular response to low-density lipoprotein particle stimulus(GO:0071404)|cellular response to hydroperoxide(GO:0071447)|cellular response to diacyl bacterial lipopeptide(GO:0071726)|energy homeostasis(GO:0097009)|regulation of action potential(GO:0098900)|positive regulation of cold-induced thermogenesis(GO:0120162)|cellular response to oxidised low-density lipoprotein particle stimulus(GO:0140052)|oxidised low-density lipoprotein particle clearance(GO:0150024)|amyloid-beta clearance by cellular catabolic process(GO:0150094)|amyloid-beta clearance by cellular catabolic process(GO:0150094)|positive regulation of NLRP3 inflammasome complex assembly(GO:1900227)|positive regulation of reactive oxygen species biosynthetic process(GO:1903428)|cellular response to amyloid-beta(GO:1904646)|amyloid fibril formation(GO:1990000)|lipid transport across blood-brain barrier(GO:1990379)|regulation of removal of superoxide radicals(GO:2000121)|positive regulation of blood microparticle formation(GO:2000334)","extracellular space(GO:0005615)|cytoplasm(GO:0005737)|Golgi apparatus(GO:0005794)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|caveola(GO:0005901)|external side of plasma membrane(GO:0009897)|cell surface(GO:0009986)|cell surface(GO:0009986)|cell surface(GO:0009986)|cell surface(GO:0009986)|membrane(GO:0016020)|apical plasma membrane(GO:0016324)|endocytic vesicle membrane(GO:0030666)|platelet alpha granule membrane(GO:0031092)|brush border membrane(GO:0031526)|specific granule membrane(GO:0035579)|receptor complex(GO:0043235)|membrane raft(GO:0045121)|phagocytic vesicle(GO:0045335)|cell periphery(GO:0071944)","amyloid-beta binding(GO:0001540)|amyloid-beta binding(GO:0001540)|amyloid-beta binding(GO:0001540)|low-density lipoprotein particle receptor activity(GO:0005041)|low-density lipoprotein particle receptor activity(GO:0005041)|low-density lipoprotein particle receptor activity(GO:0005041)|scavenger receptor activity(GO:0005044)|scavenger receptor activity(GO:0005044)|scavenger receptor activity(GO:0005044)|long-chain fatty acid transporter activity(GO:0005324)|long-chain fatty acid transporter activity(GO:0005324)|protein binding(GO:0005515)|high-density lipoprotein particle binding(GO:0008035)|lipid binding(GO:0008289)|short-chain fatty acid transmembrane transporter activity(GO:0015636)|low-density lipoprotein particle binding(GO:0030169)|low-density lipoprotein particle binding(GO:0030169)|Toll-like receptor binding(GO:0035325)|protein-containing complex binding(GO:0044877)|transforming growth factor beta binding(GO:0050431)|thrombospondin receptor activity(GO:0070053)|lipoteichoic acid immune receptor activity(GO:0070892)|lipoprotein particle binding(GO:0071813)|oxidised low-density lipoprotein particle receptor activity(GO:0150025)|oleate transmembrane transporter activity(GO:1901480)","glucose intolerance(DOID:10603)|Alzheimer's disease(DOID:10652)|hypertension(DOID:10763)|age related macular degeneration(DOID:10871)|heart disease(DOID:114)|polycystic ovary syndrome(DOID:11612)|familial hyperlipidemia(DOID:1168)|malaria(DOID:12365)|leukemia(DOID:1240)|keratoconjunctivitis sicca(DOID:12895)|familial combined hyperlipidemia(DOID:13809)|cerebral malaria(DOID:14069)|cancer(DOID:162)|melanoma(DOID:1909)|atherosclerosis(DOID:1936)|syndrome(DOID:225)|arteriosclerosis(DOID:2349)|hereditary elliptocytosis(DOID:2373)|osteosarcoma(DOID:3347)|coronary artery disease(DOID:3393)|inclusion body myositis(DOID:3429)|pulmonary fibrosis(DOID:3770)|macular degeneration(DOID:4448)|myocardial infarction(DOID:5844)|myositis(DOID:633)|retinal degeneration(DOID:8466)|type 2 diabetes mellitus(DOID:9352)","Ppar signaling pathway|Ecm receptor interaction|Hematopoietic cell lineage|Adipocytokine signaling pathway","Wp ppar signaling pathway|Wp vitamin a and carotenoid metabolism|Wp aryl hydrocarbon receptor netpath|Wp il18 signaling pathway|Wp genes controlling nephrogenesis","Hemostasis|Cross presentation of particulate exogenous antigens phagosomes|Antigen processing cross presentation|Developmental biology|Cytokine signaling in immune system|Adaptive immune system|Integration of energy metabolism|Toll like receptor tlr1 tlr2 cascade|Innate immune system|Toll like receptor cascades|Binding and uptake of ligands by scavenger receptors|Scavenging by class b receptors|Transcriptional regulation of white adipocyte differentiation|Regulation of lipid metabolism by pparalpha|Free fatty acids regulate insulin secretion|Regulation of insulin secretion|Signaling by interleukins|Diseases of immune system|Metabolism of lipids|Irak4 deficiency tlr2 4|Vesicle mediated transport|Regulation of tlr by endogenous ligand|Interleukin 4 and interleukin 13 signaling|Neutrophil degranulation|Platelet activation signaling and aggregation|Response to elevated platelet cytosolic ca2|Class i mhc mediated antigen processing presentation","Tsp1 pathway","Il6 jak stat3 signaling|Adipogenesis|Myogenesis|Complement|Xenobiotic metabolism|Fatty acid metabolism","SpliceAI>T|CD36|0.00|0.02|0.01|0.00|-37|2|36|1",".;.;.;.;.;.;.;.;.","","","0.0064","0.0004","0.002","0.0005","0.0064","","","0.0004","0.0055","D","0.0","D","0.0","D","1.0","D","1.0","D","0.000","D","1","H","3.745","T","-1.37","D","-6.88","0.928","D","0.761","D","0.756","D","0.181","0.917","T","0.305","26.8","3.885","5.21","4.450","15.048"
"chr19","55258792","55258792","C>T","","KIR2DL3","exonic","nonsynonymous SNV","","KIR2DL3:NM_015868:exon5:c.C670T:p.P224S","KIR2DL3","exonic","nonsynonymous SNV","","KIR2DL3:ENST00000342376.4_1:exon5:c.C670T:p.P224S","KIR2DL3:ENST00000342376.3:c.670C>T:p.(Pro224Ser)","0.93","0.5000166426671058","0.9300000071525574","0.6106966174572831","","","","","","","","","","","","","ENSG00000243772","KIR2DL3","HGNC:6331","KIR2DL3","3804","ENSG00000243772","uc002qgx.4","0.6106966174572831","0.5000166426671058","0.9300000071525574","","410","0/1","Het","251","219,32","0.872509960159363","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3","immune response(GO:0006955)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|integral component of membrane(GO:0016021)","antigen binding(GO:0003823)|protein binding(GO:0005515)|signaling receptor activity(GO:0038023)|identical protein binding(GO:0042802)","leprosy(DOID:1024)|hepatitis C(DOID:1883)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|Sezary's disease(DOID:8541)|endometriosis of uterus(DOID:288)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","","","","","","","","","","","","","T","0.07","T","0.572","B","0.001","B","0.001","","","N","1","N","0.775","T","7.0","N","-2.13","0.092","T","-0.917","T","0.001","T","6.03E-4","0.035","T","0.098","0.012","-0.762","0.736","-1.125","4.977"
"chr15","44120286","44120286","G>C","","WDR76","exonic","nonsynonymous SNV","","WDR76:NM_024908:exon2:c.G184C:p.D62H","WDR76","exonic","nonsynonymous SNV","","WDR76:ENST00000263795.11_1:exon2:c.G184C:p.D62H","WDR76:ENST00000263795.6:c.184G>C:p.(Asp62His)","0.928","0.500024982902687","0.9279999732971193","0.6063416296768197","","","","","","","","","","","","","ENSG00000092470","WDR76","HGNC:25773","WDR76","79968","ENSG00000092470","uc001zti.3","0.6063416296768197","0.500024982902687","0.9279999732971191","","414","0/1","Het","138","64,74","0.463768115942029","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","WD repeat domain 76","cellular response to DNA damage stimulus(GO:0006974)|regulation of DNA damage checkpoint(GO:2000001)","heterochromatin(GO:0000792)|nucleus(GO:0005634)|nucleus(GO:0005634)|site of DNA damage(GO:0090734)","DNA binding(GO:0003677)|protein binding(GO:0005515)|enzyme binding(GO:0019899)","cancer(DOID:162)","","","","","","","","","","","","","","","","","","","T","0.072","T","0.079","P","0.736","B","0.343","N","0.323","N","1","L","1.525","D","-1.76","N","-0.63","0.247","T","-0.509","T","0.419","D","0.077","0.237","T","0.218","14.59","1.189","4.74","1.541","8.99"
"chrX","48650368","48650368","G>T","GATA1:2623","GATA1","exonic","nonsynonymous SNV","","GATA1:NM_002049:exon3:c.G338T:p.R113L","GATA1","exonic","nonsynonymous SNV","","GATA1:ENST00000651144.1_1:exon2:c.G89T:p.R30L,GATA1:ENST00000376665.4_1:exon3:c.G338T:p.R113L,GATA1:ENST00000376670.9_1:exon3:c.G338T:p.R113L","GATA1:ENST00000376665.3:c.338G>T:p.(Arg113Leu)","0.9247754","","","","","","","0.2504909214912914","0.9247754216194152","0.1005220125876143","0.5009818429825827","0.9247754216194152","0.6016374596942876","","","","ENSG00000102145","GATA1","HGNC:4170","GATA1","2623","ENSG00000102145","uc004dkq.5","0.6016374596942876","0.5009818429825827","0.9247754216194153","OMIM:190685 Leukemia, megakaryoblastic, with or without Down syndrome, somatic-unknown;OMIM:300367 Thrombocytopenia, X-linked, with or without dyserythropoietic anemia-x_recessive;OMIM:300835 Anemia, X-linked, with/without neutropenia and/or platelet abnormalities-x_recessive;OMIM:314050 Thrombocytopenia with beta-thalassemia, X-linked-x_recessive;ORPHA:124 Blackfan-Diamond anemia-autosomal_dominant;ORPHA:231393 Beta-thalassemia-X-linked thrombocytopenia syndrome-x_recessive;ORPHA:67044 Thrombocytopenia with congenital dyserythropoietic anemia-x_recessive;ORPHA:79277 Congenital erythropoietic porphyria-autosomal_recessive","433","0/1","Het","207","125,82","0.603864734299517","Likely_benign","False","Diamond-Blackfan_anemia|GATA_binding_protein_1_related_thrombocytopenia_with_dyserythropoiesis","Human_Phenotype_Ontology:HP:0004810,Human_Phenotype_Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:ORPHA124,SNOMED_CT:88854002|MONDO:MONDO:0100089,MedGen:C1845837,SNOMED_CT:713388002","NC_000023.10:g.48650368G>T","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 1 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Down syndrome(190685)|Linked, with or without dyserythropoietic anemia(300367)|Linked, with or without neutropenia and/or platelet abnormalities(300835)|Linked(314050)","Abnormal hemoglobin(HP:0011902)|Abnormal platelet function(HP:0011869)|Splenomegaly(HP:0001744)|Abnormal bleeding(HP:0001892)|Anemia(HP:0001903)|Thrombocytopenia(HP:0001873)|X-linked recessive inheritance(HP:0001419)|Reticulocytosis(HP:0001923)|Splenomegaly(HP:0001744)|Hemolytic anemia(HP:0001878)|Epistaxis(HP:0000421)|Bruising susceptibility(HP:0000978)|Prolonged bleeding time(HP:0003010)|Thrombocytopenia(HP:0001873)|Petechiae(HP:0000967)|Hirsutism(HP:0001007)|Osteosarcoma(HP:0002669)|Microcephaly(HP:0000252)|Ventricular septal defect(HP:0001629)|Hypertelorism(HP:0000316)|Low anterior hairline(HP:0000294)|Acute myeloid leukemia(HP:0004808)|Developmental glaucoma(HP:0001087)|Cleft soft palate(HP:0000185)|Epicanthus(HP:0000286)|Thrombocytopenia(HP:0001873)|High palate(HP:0000218)|Coarctation of aorta(HP:0001680)|Strabismus(HP:0000486)|Small for gestational age(HP:0001518)|Malignant genitourinary tract tumor(HP:0006758)|Ptosis(HP:0000508)|Depressed nasal bridge(HP:0005280)|Short thumb(HP:0009778)|Horseshoe kidney(HP:0000085)|Cleft lip(HP:0410030)|Micrognathia(HP:0000347)|Short stature(HP:0004322)|Pallor(HP:0000980)|Leukopenia(HP:0001882)|Lethargy(HP:0001254)|Short neck(HP:0000470)|Reticulocytopenia(HP:0001896)|Adenocarcinoma of the colon(HP:0040276)|Microtia(HP:0008551)|Developmental cataract(HP:0000519)|Low-set ears(HP:0000369)|Triphalangeal thumb(HP:0001199)|Abnormality of the thenar eminence(HP:0001227)|Hypospadias(HP:0000047)|Partial duplication of thumb phalanx(HP:0009944)|Sprengel anomaly(HP:0000912)|Thrombocytosis(HP:0001894)|Pure red cell aplasia(HP:0012410)|Persistence of hemoglobin F(HP:0011904)|Normochromic anemia(HP:0001895)|Webbed neck(HP:0000465)|Increased mean corpuscular volume(HP:0005518)|Nonimmune hydrops fetalis(HP:0001790)|Elevated red cell adenosine deaminase level(HP:0030270)|Wide nasal bridge(HP:0000431)|Erythroid hypoplasia(HP:0012133)|Atrial septal defect(HP:0001631)|Radial artery aplasia(HP:0020118)|Neutropenia(HP:0001875)|Absent thumb(HP:0009777)|Macrocytic dyserythropoietic anemia(HP:0005532)|Renal agenesis(HP:0000104)|Myelodysplasia(HP:0002863)|Neurodevelopmental delay(HP:0012758)|Variable expressivity(HP:0003828)|Petechiae(HP:0000967)|Poikilocytosis(HP:0004447)|Anemia of inadequate production(HP:0010972)|Epistaxis(HP:0000421)|Acanthocytosis(HP:0001927)|Bruising susceptibility(HP:0000978)|X-linked recessive inheritance(HP:0001419)|Congenital thrombocytopenia(HP:0001905)|Infantile onset(HP:0003593)|Persistent bleeding after trauma(HP:0001934)|Malar flattening(HP:0000272)|Complete atrioventricular canal defect(HP:0001674)|Macroglossia(HP:0000158)|Flat face(HP:0012368)|Aganglionic megacolon(HP:0002251)|Short palm(HP:0004279)|Thickened nuchal skin fold(HP:0000474)|Hypothyroidism(HP:0000821)|Upslanted palpebral fissure(HP:0000582)|Hypotonia(HP:0001252)|Duodenal stenosis(HP:0100867)|Epicanthus(HP:0000286)|Brachycephaly(HP:0000248)|Sporadic(HP:0003745)|Short middle phalanx of the 5th finger(HP:0004220)|Brushfield spots(HP:0001088)|Microtia(HP:0008551)|Shallow acetabular fossae(HP:0003182)|Protruding tongue(HP:0010808)|Hypoplastic iliac wing(HP:0002866)|Intellectual disability(HP:0001249)|Short stature(HP:0004322)|Myeloproliferative disorder(HP:0005547)|Anal atresia(HP:0002023)|Acute megakaryocytic leukemia(HP:0006733)|Joint laxity(HP:0001388)|Atlantoaxial instability(HP:0003467)|Single transverse palmar crease(HP:0000954)|Conductive hearing impairment(HP:0000405)|Broad palm(HP:0001169)|Alzheimer disease(HP:0002511)|Macrothrombocytopenia(HP:0040185)|Poikilocytosis(HP:0004447)|Cryptorchidism(HP:0000028)|Hypochromic anemia(HP:0001931)|Abnormal lactate dehydrogenase level(HP:0045040)|Anisocytosis(HP:0011273)|Abnormal megakaryocyte morphology(HP:0012143)|Abnormality of multiple cell lineages in the bone marrow(HP:0012145)|Elliptocytosis(HP:0004445)|X-linked recessive inheritance(HP:0001419)|Impaired platelet aggregation(HP:0003540)|Infantile onset(HP:0003593)|Neutropenia(HP:0001875)|Abnormal granulocytopoietic cell morphology(HP:0012135)|Thrombocytopenia(HP:0001873)|Anisocytosis(HP:0011273)|Variable expressivity(HP:0003828)|Abnormal platelet morphology(HP:0011875)|Macrocytic anemia(HP:0001972)|Abnormal reticulocyte morphology(HP:0004312)|Increased hemoglobin(HP:0001900)|Osteolysis(HP:0002797)|Hyperpigmentation of the skin(HP:0000953)|Erythrodontia(HP:0030756)|Leukopenia(HP:0001882)|Anisocytosis(HP:0011273)|Facial hypertrichosis(HP:0002219)|Erythroid hyperplasia(HP:0012132)|Thrombocytopenia(HP:0001873)|Ectropion(HP:0000656)|Hemolytic anemia(HP:0001878)|Poikilocytosis(HP:0004447)|Reduced haptoglobin level(HP:0020181)|Increased connective tissue(HP:0009025)|Abnormal bleeding(HP:0001892)|Blindness(HP:0000618)|Abnormal blistering of the skin(HP:0008066)|Osteoporosis(HP:0000939)|Splenomegaly(HP:0001744)|Increased fecal coproporphyrin 1(HP:0033009)|Skin erosion(HP:0200041)|Hypopigmentation of the skin(HP:0001010)|Keratoconjunctivitis(HP:0001096)|Corneal ulceration(HP:0012804)|Abnormality of the amniotic fluid(HP:0001560)|Squamous cell carcinoma(HP:0002860)|Seborrhoeic blepharitis(HP:0500046)|Increased stool urobilinogen concentration(HP:0500115)|Increased erythrocyte protoporphyrin concentration(HP:0012187)|Pruritus(HP:0000989)|Thickened skin(HP:0001072)|Loss of eyelashes(HP:0011457)|Fragile skin(HP:0001030)|Reticulocytosis(HP:0001923)|Porphyrinuria(HP:0010473)|Low levels of vitamin D(HP:0100512)|Severe photosensitivity(HP:0007537)|Increased urinary porphobilinogen(HP:0012217)|Unconjugated hyperbilirubinemia(HP:0008282)|Nonimmune hydrops fetalis(HP:0001790)|Paresthesia(HP:0003401)|Scarring alopecia of scalp(HP:0004552)|Purple urine(HP:0040322)|Osteopenia(HP:0000938)|Red-brown urine(HP:0040320)|Scleritis(HP:0100532)|Recurrent bacterial skin infections(HP:0005406)","This gene encodes a protein which belongs to the GATA family of transcription factors. The protein plays an important role in erythroid development by regulating the switch of fetal hemoglobin to adult hemoglobin. Mutations in this gene have been associated with X-linked dyserythropoietic anemia and thrombocytopenia. [provided by RefSeq, Jul 2008]","GATA binding protein 1","negative regulation of transcription by RNA polymerase II(GO:0000122)|negative regulation of transcription by RNA polymerase II(GO:0000122)|in utero embryonic development(GO:0001701)|cell-cell signaling(GO:0007267)|negative regulation of cell population proliferation(GO:0008285)|male gonad development(GO:0008584)|regulation of glycoprotein biosynthetic process(GO:0010559)|regulation of definitive erythrocyte differentiation(GO:0010724)|regulation of primitive erythrocyte differentiation(GO:0010725)|erythrocyte differentiation(GO:0030218)|megakaryocyte differentiation(GO:0030219)|platelet formation(GO:0030220)|basophil differentiation(GO:0030221)|eosinophil differentiation(GO:0030222)|negative regulation of bone mineralization(GO:0030502)|positive regulation of osteoblast proliferation(GO:0033690)|embryonic hemopoiesis(GO:0035162)|eosinophil fate commitment(GO:0035854)|negative regulation of apoptotic process(GO:0043066)|cell fate commitment(GO:0045165)|positive regulation of erythrocyte differentiation(GO:0045648)|positive regulation of transcription, DNA-templated(GO:0045893)|positive regulation of transcription by RNA polymerase II(GO:0045944)|positive regulation of transcription by RNA polymerase II(GO:0045944)|positive regulation of transcription by RNA polymerase II(GO:0045944)|erythrocyte development(GO:0048821)|homeostasis of number of cells within a tissue(GO:0048873)|positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731)|platelet aggregation(GO:0070527)|dendritic cell differentiation(GO:0097028)|cellular response to thyroid hormone stimulus(GO:0097067)|negative regulation of transcription regulatory region DNA binding(GO:2000678)|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240)","chromatin(GO:0000785)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|transcription regulator complex(GO:0005667)|transcription repressor complex(GO:0017053)|protein-DNA complex(GO:0032993)","transcription cis-regulatory region binding(GO:0000976)|RNA polymerase II transcription regulatory region sequence-specific DNA binding(GO:0000977)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|p53 binding(GO:0002039)|DNA binding(GO:0003677)|DNA-binding transcription factor activity(GO:0003700)|protein binding(GO:0005515)|zinc ion binding(GO:0008270)|chromatin DNA binding(GO:0031490)|sequence-specific DNA binding(GO:0043565)|RNA polymerase II-specific DNA-binding transcription factor binding(GO:0061629)|C2H2 zinc finger domain binding(GO:0070742)|sequence-specific double-stranded DNA binding(GO:1990837)","thalassemia(DOID:10241)|leukemia(DOID:1240)|aplastic anemia(DOID:12449)|congenital dyserythropoietic anemia(DOID:1338)|thrombocytopenia(DOID:1588)|syndrome(DOID:225)|anemia(DOID:2355)|bone marrow cancer(DOID:4960)|myelofibrosis(DOID:4971)|hereditary Wilms' tumor(DOID:5183)|retinoblastoma(DOID:768)|acute lymphoblastic leukemia(DOID:9952)","","Wp hematopoietic stem cell differentiation|Wp il18 signaling pathway","Hemostasis|Rna polymerase ii transcription|Transcriptional regulation by runx1|Runx1 regulates genes involved in megakaryocyte differentiation and platelet function|Runx1 regulates transcription of genes involved in differentiation of hscs|Factors involved in megakaryocyte development and platelet production","Ahsp pathway","Heme metabolism|Il2 stat5 signaling","SpliceAI>T|GATA1|0.04|0.00|0.00|0.00|20|-37|-14|44",".;.","","","0.00005455","0.0003","0.001","0.0001","0.0008","","","5.455e-05","0.0007","T","0.098","T","0.313","B","0.133","B","0.026","N","0.415","N","0.999","N","0","D","-4.43","N","-0.45","0.301","T","-0.009","D","0.785","D","0.080","0.321","T","0.014","17.38","1.685","4.6","2.090","9.161"
"chr19","57327738","57327738","C>T","","PEG3","exonic","nonsynonymous SNV","","PEG3:NM_001146186:exon7:c.G2072A:p.R691Q,PEG3:NM_001146184:exon9:c.G2072A:p.R691Q,PEG3:NM_001146185:exon9:c.G1694A:p.R565Q,PEG3:NM_001146187:exon9:c.G1700A:p.R567Q,PEG3:NM_006210:exon10:c.G2072A:p.R691Q","PEG3","exonic","nonsynonymous SNV","","PEG3:ENST00000647621.1_1:exon8:c.G1607A:p.R536Q,PEG3:ENST00000593695.5_1:exon9:c.G1694A:p.R565Q,PEG3:ENST00000598410.5_1:exon9:c.G1700A:p.R567Q,PEG3:ENST00000649428.1_1:exon9:c.G1700A:p.R567Q,PEG3:ENST00000326441.15_1:exon10:c.G2072A:p.R691Q,PEG3:ENST00000648694.1_1:exon10:c.G1700A:p.R567Q,PEG3:ENST00000649680.1_1:exon10:c.G1700A:p.R567Q,PEG3:ENST00000649233.1_1:exon11:c.G1700A:p.R567Q,PEG3:ENST00000649876.1_1:exon11:c.G1700A:p.R567Q,PEG3:ENST00000650102.1_1:exon11:c.G1700A:p.R567Q,PEG3:ENST00000650632.1_1:exon11:c.G1700A:p.R567Q","PEG3:ENST00000326441.9:c.2072G>A:p.(Arg691Gln)","0.9248715","0.5001035263921949","0.9248715043067932","0.5996591919830895","","","","","","","","","","","","","ENSG00000198300","PEG3","HGNC:8826","PEG3","5178","ENSG00000198300","uc002qnv.3","0.5996591919830895","0.5001035263921949","0.9248715043067932","","434","0/1","Het","109","61,48","0.559633027522936","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","In human, ZIM2 and PEG3 are treated as two distinct genes though they share multiple 5' exons and a common promoter and both genes are paternally expressed (PMID:15203203). Alternative splicing events connect their shared 5' exons either with the remaining 4 exons unique to ZIM2, or with the remaining 2 exons unique to PEG3. In contrast, in other mammals ZIM2 does not undergo imprinting and, in mouse, cow, and likely other mammals as well, the ZIM2 and PEG3 genes do not share exons. Human PEG3 protein belongs to the Kruppel C2H2-type zinc finger protein family. PEG3 may play a role in cell proliferation and p53-mediated apoptosis. PEG3 has also shown tumor suppressor activity and tumorigenesis in glioma and ovarian cells. Alternative splicing of this PEG3 gene results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Sep 2009]","paternally expressed 3","negative regulation of transcription by RNA polymerase II(GO:0000122)|negative regulation of transcription by RNA polymerase II(GO:0000122)|regulation of transcription by RNA polymerase II(GO:0006357)|apoptotic process(GO:0006915)|regulation of gene expression(GO:0010468)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)|autophagosome(GO:0005776)","RNA polymerase II transcription regulatory region sequence-specific DNA binding(GO:0000977)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription repressor activity, RNA polymerase II-specific(GO:0001227)|molecular_function(GO:0003674)|metal ion binding(GO:0046872)","","","","","","Kras signaling up","SpliceAI>T|PEG3|0.00|0.00|0.00|0.00|-2|6|4|-29>T|ZIM2|0.00|0.00|0.00|0.00|-2|6|4|-29",".;.;.;.;.;.;.;.;.;.;.;.;.;.","","","0.00006379","0.0004","0.001","0.","0.0001","0.0001","0.0001","6.379e-05","0.0001","T","0.07","T","0.136","D","0.974","B","0.428","N","0.378","","","L","1.79","T","4.25","N","-1.04","0.075","T","-1.005","T","0.018","T","0.003","0.067","T","0.074","17.98","1.771","4.05","1.472","11.899"
"chr3","161221503","161221503","A>C","","OTOL1","exonic","nonsynonymous SNV","","OTOL1:NM_001080440:exon4:c.A1207C:p.I403L","OTOL1","exonic","nonsynonymous SNV","","OTOL1:ENST00000327928.4_1:exon4:c.A1207C:p.I403L","OTOL1:ENST00000327928.4:c.1207A>C:p.(Ile403Leu)","0.924","0.500000293385682","0.9240000247955322","0.5974782424277116","","","","","","","","","","","","","ENSG00000182447","OTOL1","HGNC:34071","OTOL1","131149","ENSG00000182447","uc011bpb.2","0.5974782424277116","0.500000293385682","0.9240000247955322","","435","0/1","Het","126","67,59","0.531746031746032","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a secreted glycoprotein with a C-terminal complement Cq1-like globular domain that belongs to the C1q/tumor necrosis factor-related protein (CTRP) family. The encoded protein is expressed in the inner ear and forms a multimeric complex called the otoconia, together with cerebellin-1 and otoconin-90, as part of the otoconial membrane. It contains extensive posttranslational modifications including hydroxylated prolines and glycosylated lysines. Naturally occurring mutations in this gene are associated with abnormal otoconia formation and balance deficits resulting from vestibular dysfunction. [provided by RefSeq, Jul 2017]","otolin 1","extracellular matrix organization(GO:0030198)|collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063)|otolith mineralization(GO:0045299)|protein homooligomerization(GO:0051260)","extracellular region(GO:0005576)|collagen type IV trimer(GO:0005587)|extracellular space(GO:0005615)|extracellular matrix(GO:0031012)","extracellular matrix structural constituent(GO:0005201)|calcium ion binding(GO:0005509)","","","","","","","","C1q","","","","","","","","","","","","T","0.076","T","0.153","P","0.828","P","0.621","D","0.000","N","0.984","N","0.37","D","-1.9","N","-1.53","0.205","T","-0.381","D","0.508","D","0.052","0.352","D","0.605","22.4","2.440","5.23","2.493","8.053"
"chr19","17932135","17932135","C>T","","INSL3","exonic","nonsynonymous SNV","","INSL3:NM_001265587:exon1:c.G181A:p.G61R,INSL3:NM_005543:exon1:c.G181A:p.G61R","INSL3","exonic","nonsynonymous SNV","","INSL3:ENST00000317306.8_1:exon1:c.G181A:p.G61R,INSL3:ENST00000379695.5_1:exon1:c.G181A:p.G61R","INSL3:ENST00000317306.7:c.181G>A:p.(Gly61Arg)","0.9201019","0.50024326928542","0.9201018810272216","0.5894505678336736","","","","","","","","","","","","","ENSG00000248099","INSL3","HGNC:6086","INSL3","3640","ENSG00000248099","uc002nhm.3","0.5894505678336736","0.50024326928542","0.9201018810272217","OMIM:219050 Cryptorchidism-autosomal_dominant","440","0/1","Het","20","12,8","0.6","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Cryptorchidism, unilateral or bilateral(219050)","Autosomal dominant inheritance(HP:0000006)|Unilateral cryptorchidism(HP:0012741)|Renal agenesis(HP:0000104)","This gene encodes a member of the insulin-like hormone superfamily. The encoded protein is mainly produced in gonadal tissues. Studies of the mouse counterpart suggest that this gene may be involved in the development of urogenital tract and female fertility. This protein may also act as a hormone to regulate growth and differentiation of gubernaculum, and thus mediating intra-abdominal testicular descent. Mutations in this gene may lead to cryptorchidism. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]","insulin like 3","oocyte maturation(GO:0001556)|adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway(GO:0007193)|cell-cell signaling(GO:0007267)|spermatogenesis(GO:0007283)|positive regulation of cell population proliferation(GO:0008284)|negative regulation of cell population proliferation(GO:0008285)|male gonad development(GO:0008584)|positive regulation of epithelial cell migration(GO:0010634)|negative regulation of apoptotic process(GO:0043066)|positive regulation of cAMP-mediated signaling(GO:0043950)|positive regulation of wound healing(GO:0090303)","extracellular region(GO:0005576)|extracellular space(GO:0005615)|perinuclear region of cytoplasm(GO:0048471)","G protein-coupled receptor binding(GO:0001664)|protease binding(GO:0002020)|signaling receptor binding(GO:0005102)|insulin receptor binding(GO:0005158)|hormone activity(GO:0005179)|protein binding(GO:0005515)","pre-eclampsia(DOID:10591)|cryptorchidism(DOID:11383)|osteoporosis(DOID:11476)|polycystic ovary syndrome(DOID:11612)|hyperandrogenism(DOID:11613)|male infertility(DOID:12336)|cancer(DOID:162)|syndrome(DOID:225)|thyroid gland carcinoma(DOID:3963)|thyroid gland medullary carcinoma(DOID:3973)|infertility(DOID:5223)|obesity(DOID:9970)|thyroid gland disease(DOID:50)|disease(DOID:4)","","Wp met in type 1 papillary renal cell carcinoma|Wp mammalian disorder of sexual development","Signaling by gpcr|Class a 1 rhodopsin like receptors|Peptide ligand binding receptors|G alpha s signalling events|Relaxin receptors|Gpcr ligand binding|Infectious disease|Leishmania infection|Adora2b mediated anti inflammatory cytokines production|Anti inflammatory response favouring leishmania parasite infection","","","SpliceAI>T|INSL3|0.00|0.00|0.00|0.03|-2|-9|-9|-50","Insulin-like|Insulin-like;.","","","0.00009404","","","","","","","2.124e-05","9.404e-05","T","0.233","T","0.389","B","0.008","B","0.002","","","N","1","L","1.39","D","-2.23","N","-2.23","0.124","T","-0.783","T","0.372","D","0.051","0.081","T","0.309","9.588","0.520","3.48","0.106","3.632"
"chr11","118919033","118919033","C>T","HYOU1:10525","HYOU1","exonic","nonsynonymous SNV","","HYOU1:NM_001130991:exon20:c.G2303A:p.R768H,HYOU1:NM_006389:exon20:c.G2303A:p.R768H","HYOU1","exonic","nonsynonymous SNV","","HYOU1:ENST00000612687.4_1:exon19:c.G2117A:p.R706H,HYOU1:ENST00000617285.5_1:exon20:c.G2303A:p.R768H,HYOU1:ENST00000621959.4_1:exon20:c.G2117A:p.R706H,HYOU1:ENST00000652093.1_1:exon20:c.G2303A:p.R768H","HYOU1:ENST00000404233.3:c.2303G>A:p.(Arg768His)","0.9818282","","","","0.5001713314995868","0.91652250289917","0.581290783426542","","","","","","","","","","ENSG00000149428","HYOU1","HGNC:16931","HYOU1","10525","ENSG00000149428","uc031yhc.2","0.581290783426542","0.5001713314995868","0.9165225028991699","OMIM:233600 ?Immunodeficiency 59 and hypoglycemia-autosomal_recessive","443","0/1","Het","134","79,55","0.58955223880597","Uncertain_significance","False","not_provided","MedGen:CN517202","NC_000011.9:g.118919033C>T","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Immunodeficiency 59 and hypoglycemia(233600)","Autosomal recessive inheritance(HP:0000007)|Leukocytosis(HP:0001974)|Herpes encephalitis(HP:0020098)|Pectus carinatum(HP:0000768)|Granulocytopenia(HP:0001913)|Arteritis(HP:0012089)|Sepsis(HP:0100806)|Hepatomegaly(HP:0002240)|Micrognathia(HP:0000347)|Hypochromic anemia(HP:0001931)|Death in childhood(HP:0003819)|Narrow nose(HP:0000460)|Decreased circulating antibody level(HP:0004313)|Immunodeficiency(HP:0002721)|High palate(HP:0000218)|Diarrhea(HP:0002014)|Narrow face(HP:0000275)|Acne inversa(HP:0040154)|Wide nasal bridge(HP:0000431)|Malabsorption(HP:0002024)|Thrombocytopenia(HP:0001873)|Oval face(HP:0000300)|Stomatitis(HP:0010280)|Slender finger(HP:0001238)|Recurrent skin infections(HP:0001581)|Short stature(HP:0004322)","The protein encoded by this gene belongs to the heat shock protein 70 family. This gene uses alternative transcription start sites. A cis-acting segment found in the 5' UTR is involved in stress-dependent induction, resulting in the accumulation of this protein in the endoplasmic reticulum (ER) under hypoxic conditions. The protein encoded by this gene is thought to play an important role in protein folding and secretion in the ER. Since suppression of the protein is associated with accelerated apoptosis, it is also suggested to have an important cytoprotective role in hypoxia-induced cellular perturbation. This protein has been shown to be up-regulated in tumors, especially in breast tumors, and thus it is associated with tumor invasiveness. This gene also has an alternative translation initiation site, resulting in a protein that lacks the N-terminal signal peptide. This signal peptide-lacking protein, which is only 3 amino acids shorter than the mature protein in the ER, is thought to have a housekeeping function in the cytosol. In rat, this protein localizes to both the ER by a carboxy-terminal peptide sequence and to mitochondria by an amino-terminal targeting signal. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]","hypoxia up-regulated 1","response to ischemia(GO:0002931)|endoplasmic reticulum to Golgi vesicle-mediated transport(GO:0006888)|response to endoplasmic reticulum stress(GO:0034976)|cellular response to hypoxia(GO:0071456)|cellular response to hypoxia(GO:0071456)|cellular response to hypoxia(GO:0071456)|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298)|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298)|negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382)","extracellular region(GO:0005576)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum lumen(GO:0005788)|smooth endoplasmic reticulum(GO:0005790)|focal adhesion(GO:0005925)|membrane(GO:0016020)|endoplasmic reticulum chaperone complex(GO:0034663)|extracellular exosome(GO:0070062)|endocytic vesicle lumen(GO:0071682)","protein binding(GO:0005515)|ATP binding(GO:0005524)|unfolded protein binding(GO:0051082)|chaperone binding(GO:0051087)","kidney failure(DOID:1074)|ischemia(DOID:326)|toxic encephalopathy(DOID:3602)|acute kidney failure(DOID:3021)","","Wp vegfavegfr2 signaling pathway","Binding and uptake of ligands by scavenger receptors|Scavenging by class f receptors|Ire1alpha activates chaperones|Unfolded protein response upr|Vesicle mediated transport","","Unfolded protein response","SpliceAI>T|HYOU1|0.00|0.00|0.00|0.02|7|43|-4|1",".;.;.","","","0.003","0.0006","0.003","0.0002","0.0009","","","0.0001","0.0011","","","T","0.093","D","1.0","D","0.975","D","0.000","D","1.000","M","3.025","","","","","0.444","T","-1.059","T","0.130","T","0.007","0.209","D","0.732","29.8","4.249","5.54","3.046","19.271"
"chr11","118924855","118924855","G>C","HYOU1:10525","HYOU1","exonic","nonsynonymous SNV","","HYOU1:NM_001130991:exon8:c.C772G:p.Q258E,HYOU1:NM_006389:exon8:c.C772G:p.Q258E","HYOU1","exonic","nonsynonymous SNV","","HYOU1:ENST00000532519.6_1:exon8:c.C772G:p.Q258E,HYOU1:ENST00000612687.4_1:exon8:c.C772G:p.Q258E,HYOU1:ENST00000614711.4_1:exon8:c.C772G:p.Q258E,HYOU1:ENST00000617285.5_1:exon8:c.C772G:p.Q258E,HYOU1:ENST00000652093.1_1:exon8:c.C772G:p.Q258E,HYOU1:ENST00000621959.4_1:exon9:c.C772G:p.Q258E","HYOU1:ENST00000404233.3:c.772C>G:p.(Gln258Glu)","0.8512168","","","","0.5001713314995868","0.91652250289917","0.581290783426542","","","","","","","","","","ENSG00000149428","HYOU1","HGNC:16931","HYOU1","10525","ENSG00000149428","uc031yhc.2","0.581290783426542","0.5001713314995868","0.9165225028991699","OMIM:233600 ?Immunodeficiency 59 and hypoglycemia-autosomal_recessive","444","0/1","Het","86","42,44","0.488372093023256","Likely_benign","False","not_provided","MedGen:CN517202","NC_000011.9:g.118924855G>C","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Immunodeficiency 59 and hypoglycemia(233600)","Autosomal recessive inheritance(HP:0000007)|Leukocytosis(HP:0001974)|Herpes encephalitis(HP:0020098)|Pectus carinatum(HP:0000768)|Granulocytopenia(HP:0001913)|Arteritis(HP:0012089)|Sepsis(HP:0100806)|Hepatomegaly(HP:0002240)|Micrognathia(HP:0000347)|Hypochromic anemia(HP:0001931)|Death in childhood(HP:0003819)|Narrow nose(HP:0000460)|Decreased circulating antibody level(HP:0004313)|Immunodeficiency(HP:0002721)|High palate(HP:0000218)|Diarrhea(HP:0002014)|Narrow face(HP:0000275)|Acne inversa(HP:0040154)|Wide nasal bridge(HP:0000431)|Malabsorption(HP:0002024)|Thrombocytopenia(HP:0001873)|Oval face(HP:0000300)|Stomatitis(HP:0010280)|Slender finger(HP:0001238)|Recurrent skin infections(HP:0001581)|Short stature(HP:0004322)","The protein encoded by this gene belongs to the heat shock protein 70 family. This gene uses alternative transcription start sites. A cis-acting segment found in the 5' UTR is involved in stress-dependent induction, resulting in the accumulation of this protein in the endoplasmic reticulum (ER) under hypoxic conditions. The protein encoded by this gene is thought to play an important role in protein folding and secretion in the ER. Since suppression of the protein is associated with accelerated apoptosis, it is also suggested to have an important cytoprotective role in hypoxia-induced cellular perturbation. This protein has been shown to be up-regulated in tumors, especially in breast tumors, and thus it is associated with tumor invasiveness. This gene also has an alternative translation initiation site, resulting in a protein that lacks the N-terminal signal peptide. This signal peptide-lacking protein, which is only 3 amino acids shorter than the mature protein in the ER, is thought to have a housekeeping function in the cytosol. In rat, this protein localizes to both the ER by a carboxy-terminal peptide sequence and to mitochondria by an amino-terminal targeting signal. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]","hypoxia up-regulated 1","response to ischemia(GO:0002931)|endoplasmic reticulum to Golgi vesicle-mediated transport(GO:0006888)|response to endoplasmic reticulum stress(GO:0034976)|cellular response to hypoxia(GO:0071456)|cellular response to hypoxia(GO:0071456)|cellular response to hypoxia(GO:0071456)|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298)|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298)|negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382)","extracellular region(GO:0005576)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum lumen(GO:0005788)|smooth endoplasmic reticulum(GO:0005790)|focal adhesion(GO:0005925)|membrane(GO:0016020)|endoplasmic reticulum chaperone complex(GO:0034663)|extracellular exosome(GO:0070062)|endocytic vesicle lumen(GO:0071682)","protein binding(GO:0005515)|ATP binding(GO:0005524)|unfolded protein binding(GO:0051082)|chaperone binding(GO:0051087)","kidney failure(DOID:1074)|ischemia(DOID:326)|toxic encephalopathy(DOID:3602)|acute kidney failure(DOID:3021)","","Wp vegfavegfr2 signaling pathway","Binding and uptake of ligands by scavenger receptors|Scavenging by class f receptors|Ire1alpha activates chaperones|Unfolded protein response upr|Vesicle mediated transport","","Unfolded protein response","SpliceAI>C|HYOU1|0.00|0.00|0.00|0.00|33|3|-22|31",".;.;.;.;.;.","","","0.0044","0.0008","0.003","0.0004","0.0044","","","0.0004","0.0043","T","0.189","T","0.292","D","1.0","D","0.998","D","0.000","D","1","L","1.305","T","5.48","N","-2.03","0.67","T","-0.511","T","0.006","T","0.008","0.327","T","0.163","25.0","3.518","4.46","9.298","17.303"
"chr16","74640853","74640853","A>T","","GLG1","exonic","nonsynonymous SNV","","GLG1:NM_001145666:exon1:c.T140A:p.V47E,GLG1:NM_001145667:exon1:c.T140A:p.V47E,GLG1:NM_012201:exon1:c.T140A:p.V47E","GLG1","exonic","nonsynonymous SNV","","GLG1:ENST00000205061.9_1:exon1:c.T140A:p.V47E,GLG1:ENST00000422840.7_1:exon1:c.T140A:p.V47E,GLG1:ENST00000447066.6_1:exon1:c.T140A:p.V47E,GLG1:ENST00000627032.2_1:exon1:c.T140A:p.V47E","GLG1:ENST00000205061.5:c.140T>A:p.(Val47Glu)","0.911","0.5000178925020009","0.9110000133514404","0.5685069210359367","","","","","","","","","","","","","ENSG00000090863","GLG1","HGNC:4316","GLG1","2734","ENSG00000090863","uc002fcx.4","0.5685069210359367","0.5000178925020009","0.9110000133514404","","447","0/1","Het","63","31,32","0.492063492063492","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","golgi glycoprotein 1","negative regulation of protein processing(GO:0010955)|negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512)|regulation of chondrocyte differentiation(GO:0032330)|bone morphogenesis(GO:0060349)","Golgi membrane(GO:0000139)|Golgi apparatus(GO:0005794)|cytoskeleton(GO:0005856)|plasma membrane(GO:0005886)|membrane(GO:0016020)|integral component of membrane(GO:0016021)|extracellular matrix(GO:0031012)|extracellular exosome(GO:0070062)","signaling receptor binding(GO:0005102)|fibroblast growth factor binding(GO:0017134)","","Cell adhesion molecules cams","","Hemostasis|Cell surface interactions at the vascular wall","","","",".;.;.;.;.","","","","","","","","","","","","T","0.109","D","0.03","B","0.006","B","0.009","N","0.409","N","1","N","0","T","1.94","N","-0.82","0.363","T","-0.993","T","0.024","D","0.027","0.148","T","0.042","7.534","0.325","3.91","-0.167","7.165"
"chr14","20502149","20502149","T>C","","OR4K13","exonic","nonsynonymous SNV","","OR4K13:NM_001004714:exon1:c.A769G:p.I257V","OR4K13","exonic","nonsynonymous SNV","","OR4K13:ENST00000641664.1_1:exon2:c.A769G:p.I257V,OR4K13:ENST00000641904.1_1:exon2:c.A769G:p.I257V","OR4K13:ENST00000315693.2:c.769A>G:p.(Ile257Val)","0.91011906","0.500602193758823","0.9101190567016602","0.5680120657596599","","","","","","","","","","","","","ENSG00000176253","OR4K13","HGNC:15351","OR4K13","390433","ENSG00000176253","uc010tkz.3","0.5680120657596599","0.500602193758823","0.9101190567016602","","448","0/1","Het","89","48,41","0.539325842696629","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]","olfactory receptor family 4 subfamily K member 13","G protein-coupled receptor signaling pathway(GO:0007186)|detection of chemical stimulus involved in sensory perception of smell(GO:0050911)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)","G protein-coupled receptor activity(GO:0004930)|olfactory receptor activity(GO:0004984)","","Olfactory transduction","","Olfactory signaling pathway|Sensory perception","","","SpliceAI>C|OR4K13|0.05|0.01|0.00|0.00|-23|-6|-29|11","GPCR,","","","0.00008379","0.0002","","0.0001","0.0005","0.0001","0.0001","8.379e-05","0.0003","T","0.084","T","0.396","P","0.673","P","0.458","U","0.030","N","1","L","0.95","T","8.76","N","-0.94","0.106","T","-0.961","T","0.001","T","7.29E-4","0.115","T","0.044","17.56","1.711","3.46","0.541","11.050"
"chrX","129162702","129162702","G>A","","BCORL1","exonic","nonsynonymous SNV","","BCORL1:NM_001184772:exon7:c.G4171A:p.G1391R,BCORL1:NM_021946:exon7:c.G4171A:p.G1391R","BCORL1","exonic","nonsynonymous SNV","","BCORL1:ENST00000218147.11_1:exon8:c.G4171A:p.G1391R,BCORL1:ENST00000540052.6_1:exon8:c.G4171A:p.G1391R","BCORL1:ENST00000218147.7:c.4171G>A:p.(Gly1391Arg)","0.9099811","","","","","","","","","","0.5000851043296279","0.9099810719490052","0.5663815299701617","","","","ENSG00000085185","BCORL1","HGNC:25657","BCORL1","63035","ENSG00000085185","uc065bbq.1","0.5663815299701617","0.5000851043296279","0.9099810719490051","OMIM:301029 Shukla-Vernon syndrome-x_recessive;ORPHA:528084 Non-specific syndromic intellectual disability-x_recessive","449","0/1","Het","106","63,43","0.594339622641509","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Vernon syndrome(301029)","Hip dysplasia(HP:0001385)|Retinal atrophy(HP:0001105)|Receptive language delay(HP:0010863)|Pes cavus(HP:0001761)|Wide nasal bridge(HP:0000431)|Aortic root aneurysm(HP:0002616)|Relative macrocephaly(HP:0004482)|Astigmatism(HP:0000483)|Narrow mouth(HP:0000160)|Broad hallux(HP:0010055)|Hypertelorism(HP:0000316)|Delayed gross motor development(HP:0002194)|Autistic behavior(HP:0000729)|High palate(HP:0000218)|Conductive hearing impairment(HP:0000405)|Feeding difficulties(HP:0011968)|Thin vermilion border(HP:0000233)|Nasal speech(HP:0001611)|Panic attack(HP:0025269)|Disproportionate tall stature(HP:0001519)|Smooth philtrum(HP:0000319)|Long philtrum(HP:0000343)|Joint hypermobility(HP:0001382)|Blepharophimosis(HP:0000581)|Speech apraxia(HP:0011098)|Visual impairment(HP:0000505)|Small scrotum(HP:0030276)|Scoliosis(HP:0002650)|High forehead(HP:0000348)|Microcephaly(HP:0000252)|Prominent fingertip pads(HP:0001212)|Seizure(HP:0001250)|Incisor macrodontia(HP:0011081)|Precocious puberty(HP:0000826)|Highly arched eyebrow(HP:0002553)|Impaired tandem gait(HP:0031629)|Broad thumb(HP:0011304)|Abnormal corpus callosum morphology(HP:0001273)|Hypotonia(HP:0001252)|Prominent forehead(HP:0011220)|Aphasia(HP:0002381)|Frontal cortical atrophy(HP:0006913)|Intellectual disability, mild(HP:0001256)|Sleep disturbance(HP:0002360)|Duane anomaly(HP:0009921)|Clinodactyly of hallux(HP:0040018)|Short hallux(HP:0010109)|Micrognathia(HP:0000347)|Down-sloping shoulders(HP:0200021)|Cryptorchidism(HP:0000028)|Downslanted palpebral fissures(HP:0000494)|Depressed nasal bridge(HP:0005280)|Severe global developmental delay(HP:0011344)|Cafe-au-lait spot(HP:0000957)|Papilledema(HP:0001085)|Narrow face(HP:0000275)|Frontal upsweep of hair(HP:0002236)|Macrotia(HP:0000400)|Kyphosis(HP:0002808)|Long face(HP:0000276)|Ptosis(HP:0000508)|Congenital nystagmus(HP:0006934)|Pulmonary artery dilatation(HP:0004927)|Decreased body weight(HP:0004325)|Attention deficit hyperactivity disorder(HP:0007018)|Exotropia(HP:0000577)|Autistic behavior(HP:0000729)|Wide nasal base(HP:0012810)|Downslanted palpebral fissures(HP:0000494)|Tapered finger(HP:0001182)|Generalized hypotonia(HP:0001290)|Global developmental delay(HP:0001263)|Long face(HP:0000276)|Variable expressivity(HP:0003828)|Broad-based gait(HP:0002136)|X-linked recessive inheritance(HP:0001419)|Delayed speech and language development(HP:0000750)|Seizure(HP:0001250)|Sparse hair(HP:0008070)|Hypertelorism(HP:0000316)|High forehead(HP:0000348)|Drooling(HP:0002307)|Infantile onset(HP:0003593)|Stereotypy(HP:0000733)|Cerebellar atrophy(HP:0001272)|Coarse facial features(HP:0000280)|Attention deficit hyperactivity disorder(HP:0007018)","The protein encoded by this gene is a transcriptional corepressor that is found tethered to promoter regions by DNA-binding proteins. The encoded protein can interact with several different class II histone deacetylases to repress transcription. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]","BCL6 corepressor like 1","chromatin organization(GO:0006325)","nucleoplasm(GO:0005654)|plasma membrane(GO:0005886)","","cancer(DOID:162)","","Wp mesodermal commitment pathway|Wp endoderm differentiation|Wp pathways affected in adenoid cystic carcinoma","","","","",".;.;.","","Score=859;Name=V$NFKAPPAB50_01","0.0045","0.0005","0.002","0.0003","0.0038","","","0.0003","0.0045","D","0.004","T","0.076","","","","","N","0.002","D","0.865","","","T","1.02","N","-0.17","0.6","T","-0.914","T","0.118","D","0.703","0.107","T","0.171","22.8","2.638","5.89","4.769","9.954"
"chr19","1825935","1825935","T>C","","REXO1","exonic","nonsynonymous SNV","","REXO1:NM_020695:exon3:c.A1919G:p.K640R","REXO1","exonic","nonsynonymous SNV","","REXO1:ENST00000170168.9_1:exon3:c.A1919G:p.K640R","REXO1:ENST00000170168.4:c.1919A>G:p.(Lys640Arg)","0.90017575","0.500049435566325","0.9001757502555847","0.5440559324446764","","","","","","","","","","","","","ENSG00000079313","REXO1","HGNC:24616","REXO1","57455","ENSG00000079313","uc002lua.5","0.5440559324446764","0.500049435566325","0.9001757502555847","","453","0/1","Het","79","36,43","0.455696202531646","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","RNA exonuclease 1 homolog","nucleic acid phosphodiester bond hydrolysis(GO:0090305)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nuclear body(GO:0016604)","nucleic acid binding(GO:0003676)|exonuclease activity(GO:0004527)","","","","","","","","","","","0.00003586","","","0.","0.0005","","","3.586e-05","0.0004","T","0.092","T","0.438","B","0.115","B","0.031","N","0.031","D","0.592","L","1.375","T","1.89","N","-0.91","0.316","T","-1.002","T","0.059","T","0.008","0.034","T","0.066","21.7","2.239","4.07","3.954","12.374"
"chr5","180477292","180477292","G>A","","BTNL9","exonic","nonsynonymous SNV","","BTNL9:NM_001308245:exon4:c.G659A:p.G220E,BTNL9:NM_152547:exon4:c.G659A:p.G220E","BTNL9","exonic","nonsynonymous SNV","","BTNL9:ENST00000515271.1_1:exon3:c.G452A:p.G151E,BTNL9:ENST00000327705.14_1:exon4:c.G659A:p.G220E,BTNL9:ENST00000376841.6_1:exon4:c.G659A:p.G220E","BTNL9:ENST00000327705.9:c.659G>A:p.(Gly220Glu)","0.8961542","0.5000049240006774","0.8961542248725891","0.5347653907799188","","","","","","","","","","","","","ENSG00000165810","BTNL9","HGNC:24176","BTNL9","153579","ENSG00000165810","uc003mmt.3","0.5347653907799188","0.5000049240006774","0.8961542248725891","","456","0/1","Het","182","88,94","0.483516483516484","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","butyrophilin like 9","regulation of cytokine production(GO:0001817)|T cell receptor signaling pathway(GO:0050852)","plasma membrane(GO:0005886)|external side of plasma membrane(GO:0009897)|integral component of membrane(GO:0016021)","signaling receptor binding(GO:0005102)","","","","Adaptive immune system|Butyrophilin btn family interactions","","","",".;.;.","","","0.000007954","","","0.","0.0002","","","7.954e-06","0.0001","T","0.101","T","0.151","P","0.599","B","0.206","N","0.022","N","1","M","2.325","T","3.38","D","-2.94","0.184","T","-1.051","T","0.032","T","0.004","0.056","T","0.381","11.50","0.744","4.68","0.558","1.819"
"chrX","66765158","66765158","->GCAGCAGCAGCAGCAGCA","AR:367|LOC109504725:109504725","AR","exonic","nonframeshift insertion","","AR:NM_000044:exon1:c.170_171insGCAGCAGCAGCAGCAGCA:p.Q80_E81insQQQQQQ","AR","exonic","nonframeshift insertion","","AR:ENST00000374690.9_1:exon1:c.170_171insGCAGCAGCAGCAGCAGCA:p.Q80_E81insQQQQQQ,AR:ENST00000396044.8_1:exon1:c.170_171insGCAGCAGCAGCAGCAGCA:p.Q80_E81insQQQQQQ,AR:ENST00000504326.5_1:exon1:c.170_171insGCAGCAGCAGCAGCAGCA:p.Q80_E81insQQQQQQ","AR:ENST00000374690.3:c.222_239dup:p.(Gln75_Gln80dup)","0.85","","","","","","","0.2678395491093397","0.8500000238418579","0.0631015000855692","0.5356790982186794","0.8500000238418579","0.5215442674876047","","","","ENSG00000169083","AR","HGNC:644","AR","367","ENSG00000169083","uc004dwu.3","0.5215442674876047","0.5356790982186794","0.8500000238418579","OMIM:176807 Prostate cancer, susceptibility to-autosomal_dominant;OMIM:300068 Androgen insensitivity-x_recessive;OMIM:300633 Hypospadias 1, X-linked-x_recessive;OMIM:312300 Androgen insensitivity, partial, with or without breast cancer-x_recessive;OMIM:313200 Spinal and bulbar muscular atrophy of Kennedy-x_recessive;ORPHA:481 Kennedy disease-x_recessive;ORPHA:90797 Partial androgen insensitivity syndrome-x_recessive;ORPHA:95706 Non-syndromic posterior hypospadias-x_recessive;ORPHA:99429 Complete androgen insensitivity syndrome-x_recessive","478","0/1","Het","20","16,4","0.8","Benign","False","not_specified","MedGen:CN169374","NC_000023.10:g.66765159GCA[29]","no_assertion_criteria_provided","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Prostate cancer(176807)|Androgen insensitivity syndrome(300068)|Linked(300633)|Androgen insensitivity, partial(312300)|Linked 1(313200)","Testicular atrophy(HP:0000029)|Limb muscle weakness(HP:0003690)|Gynecomastia(HP:0000771)|Dysphagia(HP:0002015)|Sensory neuropathy(HP:0000763)|Hyporeflexia(HP:0001265)|X-linked recessive inheritance(HP:0001419)|Slowly progressive(HP:0003677)|Bulbar palsy(HP:0001283)|Dysarthria(HP:0001260)|Calf muscle hypertrophy(HP:0008981)|Abnormality of the mouth(HP:0000153)|Adult onset(HP:0003581)|Tremor(HP:0001337)|Decreased fertility(HP:0000144)|Fasciculations(HP:0002380)|Elevated circulating creatine kinase concentration(HP:0003236)|Peripheral neuropathy(HP:0009830)|Muscle spasm(HP:0003394)|Somatic mutation(HP:0001428)|Prostate cancer(HP:0012125)|Autosomal dominant inheritance(HP:0000006)|Germ cell neoplasia(HP:0100728)|Primary amenorrhea(HP:0000786)|Clitoral hypertrophy(HP:0008665)|Increased serum testosterone level(HP:0030088)|High pitched voice(HP:0001620)|Fused labia majora(HP:0025486)|Aplasia of the ovary(HP:0010463)|Male sexual dysfunction(HP:0040307)|Bilateral cryptorchidism(HP:0008689)|Blind vagina(HP:0040314)|Ambiguous genitalia(HP:0000062)|Insulin insensitivity(HP:0008189)|Increased antimullerian hormone level(HP:0031102)|Bifid scrotum(HP:0000048)|Aplasia of the uterus(HP:0000151)|Azoospermia(HP:0000027)|Gynecomastia(HP:0000771)|Micropenis(HP:0000054)|Abnormality of secondary sexual hair(HP:0009888)|Urogenital sinus anomaly(HP:0100779)|Male infertility(HP:0003251)|Perineal hypospadias(HP:0000051)|Increased serum estradiol(HP:0025134)|Elevated circulating luteinizing hormone level(HP:0011969)|Type II diabetes mellitus(HP:0005978)|Testicular atrophy(HP:0000029)|Dysphonia(HP:0001618)|Erectile dysfunction(HP:0100639)|Hypotonia(HP:0001252)|Abnormal circulating lipid concentration(HP:0003119)|Hyporeflexia(HP:0001265)|Gynecomastia(HP:0000771)|Gait disturbance(HP:0001288)|Skeletal muscle atrophy(HP:0003202)|Decreased fertility(HP:0000144)|Dysarthria(HP:0001260)|Delayed puberty(HP:0000823)|Absent pubic hair(HP:0002555)|Male infertility(HP:0003251)|Aplasia of the uterus(HP:0000151)|Increased serum estradiol(HP:0025134)|Aplasia/Hypoplasia of the fallopian tube(HP:0008655)|Elevated circulating luteinizing hormone level(HP:0011969)|Abnormal circulating follicle-stimulating hormone concentration(HP:0030346)|Blind vagina(HP:0040314)|Sparse pubic hair(HP:0002225)|Increased antimullerian hormone level(HP:0031102)|Abnormality of the uterine cervix(HP:0012888)|Sparse axillary hair(HP:0002215)|Germ cell neoplasia(HP:0100728)|Absent axillary hair(HP:0002221)|Bilateral cryptorchidism(HP:0008689)|Increased serum testosterone level(HP:0030088)|Female external genitalia in individual with 46,XY karyotype(HP:0008730)|Testicular neoplasm(HP:0010788)|Tall stature(HP:0000098)|Acne(HP:0001061)|Primary amenorrhea(HP:0000786)|Depression(HP:0000716)|Congenital diaphragmatic hernia(HP:0000776)|Anal atresia(HP:0002023)|Urethral diverticulum(HP:0008722)|Androgen insufficiency(HP:0008226)|Cryptorchidism(HP:0000028)|Cleft palate(HP:0000175)|Omphalocele(HP:0001539)|Displacement of the urethral meatus(HP:0100627)|Micropenis(HP:0000054)|Ventral shortening of foreskin(HP:0012435)|Anxiety(HP:0000739)|Bifid scrotum(HP:0000048)|Small for gestational age(HP:0001518)|Esophageal atresia(HP:0002032)|Bifid scrotum(HP:0000048)|Gynecomastia(HP:0000771)|Perineal hypospadias(HP:0000051)|Absent vas deferens(HP:0012873)|Male pseudohermaphroditism(HP:0000037)|Micropenis(HP:0000054)|Hypogonadism(HP:0000135)|Infertility(HP:0000789)|Abnormal rib cage morphology(HP:0001547)|Azoospermia(HP:0000027)|X-linked recessive inheritance(HP:0001419)|Cryptorchidism(HP:0000028)|X-linked recessive inheritance(HP:0001419)|Perineal hypospadias(HP:0000051)|X-linked recessive inheritance(HP:0001419)|Labial hypoplasia(HP:0000066)|Elevated circulating luteinizing hormone level(HP:0011969)|Absent facial hair(HP:0002550)|Gynecomastia(HP:0000771)|Elevated circulating follicle stimulating hormone level(HP:0008232)|Neoplasm(HP:0002664)|Sparse axillary hair(HP:0002215)|Inguinal hernia(HP:0000023)|Growth abnormality(HP:0001507)|Female external genitalia in individual with 46,XY karyotype(HP:0008730)|Blind vagina(HP:0040314)|Primary amenorrhea(HP:0000786)|Sparse pubic hair(HP:0002225)","The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]","androgen receptor","negative regulation of transcription by RNA polymerase II(GO:0000122)|in utero embryonic development(GO:0001701)|regulation of systemic arterial blood pressure(GO:0003073)|epithelial cell morphogenesis(GO:0003382)|regulation of transcription by RNA polymerase II(GO:0006357)|signal transduction(GO:0007165)|cell-cell signaling(GO:0007267)|spermatogenesis(GO:0007283)|single fertilization(GO:0007338)|positive regulation of cell population proliferation(GO:0008284)|negative regulation of cell population proliferation(GO:0008285)|male gonad development(GO:0008584)|positive regulation of gene expression(GO:0010628)|positive regulation of gene expression(GO:0010628)|male somatic sex determination(GO:0019102)|intracellular steroid hormone receptor signaling pathway(GO:0030518)|intracellular estrogen receptor signaling pathway(GO:0030520)|androgen receptor signaling pathway(GO:0030521)|intracellular receptor signaling pathway(GO:0030522)|positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148)|Leydig cell differentiation(GO:0033327)|multicellular organism growth(GO:0035264)|positive regulation of phosphorylation(GO:0042327)|positive regulation of MAPK cascade(GO:0043410)|positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568)|positive regulation of cell differentiation(GO:0045597)|negative regulation of integrin biosynthetic process(GO:0045720)|positive regulation of integrin biosynthetic process(GO:0045726)|positive regulation of transcription, DNA-templated(GO:0045893)|positive regulation of transcription by RNA polymerase II(GO:0045944)|positive regulation of transcription by RNA polymerase II(GO:0045944)|positive regulation of transcription by RNA polymerase III(GO:0045945)|regulation of developmental growth(GO:0048638)|animal organ formation(GO:0048645)|male genitalia morphogenesis(GO:0048808)|negative regulation of epithelial cell proliferation(GO:0050680)|positive regulation of NF-kappaB transcription factor activity(GO:0051092)|activation of prostate induction by androgen receptor signaling pathway(GO:0060520)|morphogenesis of an epithelial fold(GO:0060571)|lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599)|prostate gland growth(GO:0060736)|prostate gland epithelium morphogenesis(GO:0060740)|epithelial cell differentiation involved in prostate gland development(GO:0060742)|tertiary branching involved in mammary gland duct morphogenesis(GO:0060748)|mammary gland alveolus development(GO:0060749)|positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769)|cellular response to steroid hormone stimulus(GO:0071383)|cellular response to estrogen stimulus(GO:0071391)|cellular response to testosterone stimulus(GO:0071394)|seminiferous tubule development(GO:0072520)|regulation of protein localization to plasma membrane(GO:1903076)|negative regulation of extrinsic apoptotic signaling pathway(GO:2001237)","chromatin(GO:0000785)|chromatin(GO:0000785)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|nuclear speck(GO:0016607)|protein-containing complex(GO:0032991)","transcription cis-regulatory region binding(GO:0000976)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|RNA polymerase II general transcription initiation factor binding(GO:0001091)|transcription coactivator binding(GO:0001223)|transcription coactivator binding(GO:0001223)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|chromatin binding(GO:0003682)|DNA-binding transcription factor activity(GO:0003700)|nuclear receptor activity(GO:0004879)|nuclear receptor activity(GO:0004879)|nuclear receptor activity(GO:0004879)|nuclear receptor activity(GO:0004879)|signaling receptor binding(GO:0005102)|steroid binding(GO:0005496)|androgen binding(GO:0005497)|protein binding(GO:0005515)|beta-catenin binding(GO:0008013)|beta-catenin binding(GO:0008013)|beta-catenin binding(GO:0008013)|transcription factor binding(GO:0008134)|zinc ion binding(GO:0008270)|enzyme binding(GO:0019899)|ATPase binding(GO:0051117)|RNA polymerase II-specific DNA-binding transcription factor binding(GO:0061629)|POU domain binding(GO:0070974)","cholelithiasis(DOID:10211)|prostate cancer(DOID:10283)|prostate carcinoma(DOID:10286)|chronic leukemia(DOID:1036)|pre-eclampsia(DOID:10591)|hypertension(DOID:10763)|hypospadias(DOID:10892)|cryptorchidism(DOID:11383)|osteoporosis(DOID:11476)|polycystic ovary syndrome(DOID:11612)|head and neck cancer(DOID:11934)|hypertrophic cardiomyopathy(DOID:11984)|male infertility(DOID:12336)|leukemia(DOID:1240)|gynecomastia(DOID:12698)|leiomyoma(DOID:127)|autistic disorder(DOID:12849)|azoospermia(DOID:14227)|head and neck carcinoma(DOID:1542)|cancer(DOID:162)|atherosclerosis(DOID:1936)|hepatitis B(DOID:2043)|thrombocytosis(DOID:2228)|hepatitis(DOID:2237)|syndrome(DOID:225)|progressive muscular atrophy(DOID:318)|chordoma(DOID:3302)|amyotrophic lateral sclerosis(DOID:332)|pleomorphic adenoma(DOID:452)|androgen insensitivity syndrome(DOID:4674)|sclerosing hemangioma(DOID:495)|hereditary Wilms' tumor(DOID:5183)|infertility(DOID:5223)|schizophrenia(DOID:5419)|primary ovarian insufficiency(DOID:5426)|hereditary breast ovarian cancer syndrome(DOID:5683)|pulmonary sclerosing hemangioma(DOID:5766)|migraine(DOID:6364)|acne(DOID:6543)|adenoma(DOID:657)|hepatocellular carcinoma(DOID:684)|muscular atrophy(DOID:767)|retinoblastoma(DOID:768)|alopecia(DOID:987)|obesity(DOID:9970)|disease(DOID:4)|stomach cancer(DOID:10534)|mental depression(DOID:1596)|uterine fibroid(DOID:13223)|embryoma(DOID:4766)|prostate adenocarcinoma(DOID:2526)|rheumatoid arthritis(DOID:7148)|phobic disorder(DOID:591)|endometriosis(DOID:289)|rabies(DOID:11260)|endometrial carcinoma(DOID:2871)|type 2 diabetes mellitus(DOID:9352)|esophageal cancer(DOID:5041)|cardiovascular system disease(DOID:1287)|Klinefelter syndrome(DOID:1921)|eunuchism(DOID:5003)|cutaneous fibrous histiocytoma(DOID:4418)|diabetes mellitus(DOID:9351)|Turner syndrome(DOID:3491)|renal cell carcinoma(DOID:4450)|hyperandrogenism(DOID:11613)|oligospermia(DOID:14228)","Oocyte meiosis|Pathways in cancer|Prostate cancer","Wp integrated breast cancer pathway|Wp sudden infant death syndrome sids susceptibility pathways|Wp nuclear receptors|Wp mirna regulation of prostate cancer signaling pathways|Wp androgen receptor signaling pathway|Wp genes involved in male infertility|Wp 3q29 copy number variation syndrome","Rho gtpase effectors|Sumoylation|Hsp90 chaperone cycle for steroid hormone receptors shr|Nuclear receptor transcription pathway|Sumoylation of intracellular receptors|Rho gtpases activate pkns|Activated pkn1 stimulates transcription of ar androgen receptor regulated genes klk2 and klk3|Deubiquitination|Ub specific processing proteases|Post translational protein modification|Rna polymerase ii transcription|Transcriptional regulation by runx2|Runx2 regulates osteoblast differentiation|Runx2 regulates bone development|Cellular responses to external stimuli|Signaling by rho gtpases miro gtpases and rhobtb3","","Estrogen response early|Bile acid metabolism","SpliceAI>TGCAGCAGCAGCAGCAGCA|AR|0.00|0.00|0.00|0.00|0|5|-11|5","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chrX","8504922","8504922","G>A","","ANOS1","exonic","nonsynonymous SNV","","ANOS1:NM_000216:exon11:c.C1511T:p.P504L","ANOS1","exonic","nonsynonymous SNV","","ANOS1:ENST00000262648.8_1:exon11:c.C1511T:p.P504L","ANOS1:ENST00000262648.3:c.1511C>T:p.(Pro504Leu)","0.88992286","","","","","","","","","","0.5000067635050982","0.8899228572845459","0.520507923040835","","","","ENSG00000011201","ANOS1","HGNC:6211","ANOS1","3730","ENSG00000011201","","0.520507923040835","0.5000067635050982","0.8899228572845459","OMIM:308700 Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)-x_recessive;ORPHA:478 Kallmann syndrome-x_recessive","481","0/1","Het","85","50,35","0.588235294117647","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 1 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Hypogonadotropic hypogonadism 1 with or without anosmia(308700)","Delayed skeletal maturation(HP:0002750)|Gynecomastia(HP:0000771)|Cleft palate(HP:0000175)|Delayed puberty(HP:0000823)|Abnormality of cardiovascular system morphology(HP:0030680)|Recurrent fractures(HP:0002757)|Hypotonia(HP:0001252)|Abnormality of the voice(HP:0001608)|Pes cavus(HP:0001761)|Dyspareunia(HP:0030016)|Paraplegia(HP:0010550)|Ataxia(HP:0001251)|Hyposmia(HP:0004409)|Obesity(HP:0001513)|Breast hypoplasia(HP:0003187)|Seizure(HP:0001250)|Erectile dysfunction(HP:0100639)|Abnormal morphology of female internal genitalia(HP:0000008)|Muscle weakness(HP:0001324)|Tremor(HP:0001337)|Visual impairment(HP:0000505)|Sensorineural hearing impairment(HP:0000407)|Gait disturbance(HP:0001288)|Anosmia(HP:0000458)|Cryptorchidism(HP:0000028)|Hypogonadotropic hypogonadism(HP:0000044)|Micropenis(HP:0000054)|Hypothalamic gonadotropin-releasing hormone deficiency(HP:0003164)|Ichthyosis(HP:0008064)|Decreased testicular size(HP:0008734)|Pes planus(HP:0001763)|Renal agenesis(HP:0000104)|Primary amenorrhea(HP:0000786)|Skeletal dysplasia(HP:0002652)|Dysarthria(HP:0001260)|Nystagmus(HP:0000639)|Decreased fertility(HP:0000144)|Tooth agenesis(HP:0009804)|Color vision defect(HP:0000551)|Ptosis(HP:0000508)|Anterior hypopituitarism(HP:0000830)|Reduced bone mineral density(HP:0004349)|Bimanual synkinesia(HP:0001335)|X-linked inheritance(HP:0001417)|Anosmia(HP:0000458)|Hypothalamic gonadotropin-releasing hormone deficiency(HP:0003164)|Decreased circulating follicle stimulating hormone concentration(HP:0030341)|Hypogonadotropic hypogonadism(HP:0000044)|Ataxia(HP:0001251)|Micropenis(HP:0000054)|Cryptorchidism(HP:0000028)|Decreased testicular size(HP:0008734)|Decreased circulating follicle stimulating hormone concentration(HP:0030341)|Olfactory lobe agenesis(HP:0001341)|Leydig cell insensitivity to gonadotropin(HP:0002929)|Bimanual synkinesia(HP:0001335)|Unilateral renal agenesis(HP:0000122)|Decreased circulating luteinizing hormone level(HP:0030344)|High palate(HP:0000218)|Testicular atrophy(HP:0000029)|Sparse pubic hair(HP:0002225)|Azoospermia(HP:0000027)|Hyposmia(HP:0004409)|Gynecomastia(HP:0000771)|Eunuchoid habitus(HP:0003782)|Decreased circulating luteinizing hormone level(HP:0030344)|Facial asymmetry(HP:0000324)|X-linked recessive inheritance(HP:0001419)|Pes cavus(HP:0001761)","Mutations in this gene cause the X-linked Kallmann syndrome. The encoded protein is similar in sequence to proteins known to function in neural cell adhesion and axonal migration. In addition, this cell surface protein is N-glycosylated and may have anti-protease activity. [provided by RefSeq, Jul 2008]","anosmin 1","chemotaxis(GO:0006935)|cell adhesion(GO:0007155)|axon guidance(GO:0007411)|negative regulation of endopeptidase activity(GO:0010951)|neuron differentiation(GO:0030182)","extracellular region(GO:0005576)|extracellular space(GO:0005615)|plasma membrane(GO:0005886)|cell surface(GO:0009986)|extracellular matrix(GO:0031012)","serine-type endopeptidase inhibitor activity(GO:0004867)|extracellular matrix structural constituent(GO:0005201)|protein binding(GO:0005515)|heparin binding(GO:0008201)","cancer(DOID:162)|Klinefelter syndrome(DOID:1921)|hypogonadism(DOID:1924)|syndrome(DOID:225)|atopic dermatitis(DOID:3310)|Kallmann syndrome(DOID:3614)|disease(DOID:4)","","Wp development of ureteric collection system","Signaling by fgfr|Fgfr1 ligand binding and activation|Fgfr1c ligand binding and activation|Negative regulation of fgfr1 signaling|Signaling by fgfr1|Signaling by receptor tyrosine kinases","","","SpliceAI>A|ANOS1|0.00|0.00|0.00|0.00|-16|13|14|19","Fibronectin","","","0.0027","0.0005","0.001","0.0003","0.0027","","","0.0003","0.0022","T","0.067","T","0.493","B","0.001","B","0.005","D","0.001","N","1.000","M","1.995","T","0.68","D","-2.62","0.15","T","-0.979","T","0.127","D","0.274","0.094","T","0.044","14.66","1.202","3.99","5.122","14.606"
"chr8","124358981","124358981","C>T","","ATAD2","exonic","nonsynonymous SNV","","ATAD2:NM_014109:exon17:c.G2222A:p.C741Y","ATAD2","exonic","nonsynonymous SNV","","ATAD2:ENST00000287394.10_1:exon17:c.G2222A:p.C741Y,ATAD2:ENST00000521903.5_1:exon18:c.G176A:p.C59Y","ATAD2:ENST00000287394.5:c.2222G>A:p.(Cys741Tyr)","0.8867556","0.5000107212572402","0.8867555856704712","0.5132547081415054","","","","","","","","","","","","","ENSG00000156802","ATAD2","HGNC:30123","ATAD2","29028","ENSG00000156802","uc003yqh.5","0.5132547081415054","0.5000107212572402","0.8867555856704712","","485","0/1","Het","40","20,20","0.5","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","A large family of ATPases has been described, whose key feature is that they share a conserved region of about 220 amino acids that contains an ATP-binding site. The proteins that belong to this family either contain one or two AAA (ATPases Associated with diverse cellular Activities) domains. AAA family proteins often perform chaperone-like functions that assist in the assembly, operation, or disassembly of protein complexes. The protein encoded by this gene contains two AAA domains, as well as a bromodomain. [provided by RefSeq, Jul 2008]","ATPase family AAA domain containing 2","chromatin organization(GO:0006325)|positive regulation of transcription, DNA-templated(GO:0045893)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|extracellular exosome(GO:0070062)","chromatin binding(GO:0003682)|protein binding(GO:0005515)|ATP binding(GO:0005524)|ATP hydrolysis activity(GO:0016887)|ATP hydrolysis activity(GO:0016887)|ATP hydrolysis activity(GO:0016887)|histone binding(GO:0042393)","cancer(DOID:162)","","Wp gastric cancer network 2","Rna polymerase ii transcription|Transcriptional regulation by the ap 2 tfap2 family of transcription factors|Tfap2 ap 2 family regulates transcription of growth factors and their receptors","","E2f targets","",".;.","","","","","","","","","","","","T","1.0","T","0.217","B","0.0","B","0.001","N","0.212","D","0.887","L","1.01","D","-2.86","N","-1.57","0.241","T","-0.622","T","0.374","T","0.012","0.068","T","0.062","16.98","1.621","6.02","0.998","6.135"
"chr2","179306420","179306420","A>G","","PRKRA","exonic","nonsynonymous SNV","","PRKRA:NM_001139517:exon5:c.T493C:p.S165P,PRKRA:NM_001139518:exon6:c.T451C:p.S151P,PRKRA:NM_003690:exon6:c.T526C:p.S176P,PRKRA:NM_001316362:exon7:c.T187C:p.S63P","PRKRA","exonic","nonsynonymous SNV","","PRKRA:ENST00000677981.1_1:exon4:c.T274C:p.S92P,PRKRA:ENST00000432031.6_1:exon5:c.T493C:p.S165P,PRKRA:ENST00000677689.1_1:exon5:c.T271C:p.S91P,PRKRA:ENST00000678845.1_1:exon5:c.T187C:p.S63P,PRKRA:ENST00000325748.9_1:exon6:c.T526C:p.S176P,PRKRA:ENST00000487082.5_1:exon6:c.T451C:p.S151P,PRKRA:ENST00000678775.1_1:exon6:c.T187C:p.S63P","PRKRA:ENST00000325748.4:c.526T>C:p.(Ser176Pro)","0.99920374","0.2500197700264834","0.9992037415504456","0.1805242503223356","0.5000395400529669","0.8712111413478851","0.4776582849353669","","","","","","","","","","ENSG00000180228","PRKRA","HGNC:9438","PRKRA","8575","ENSG00000180228","uc002umf.3","0.4776582849353669","0.5000395400529669","0.8712111413478851","OMIM:612067 Dystonia 16-autosomal_recessive;ORPHA:210571 Dystonia 16-autosomal_recessive","488","0/1","Het","227","189,38","0.832599118942731","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Dystonia 16(612067)","Orofacial dyskinesia(HP:0002310)|Unsteady gait(HP:0002317)|Abnormal pyramidal sign(HP:0007256)|Dysarthria(HP:0001260)|Intellectual disability(HP:0001249)|Lower limb pain(HP:0012514)|Dysphagia(HP:0002015)|Hyperreflexia(HP:0001347)|Parkinsonism(HP:0001300)|Limb dystonia(HP:0002451)|Bradykinesia(HP:0002067)|Postural tremor(HP:0002174)|Motor delay(HP:0001270)|Dysphonia(HP:0001618)|Torticollis(HP:0000473)|Limb pain(HP:0009763)|Delayed speech and language development(HP:0000750)|Motor delay(HP:0001270)|Gait disturbance(HP:0001288)|Dysarthria(HP:0001260)|Retrocollis(HP:0002544)|Hyperreflexia(HP:0001347)|Progressive(HP:0003676)|Dyskinesia(HP:0100660)|Cognitive impairment(HP:0100543)|Parkinsonism(HP:0001300)|Involuntary movements(HP:0004305)|Postural tremor(HP:0002174)|Limb dystonia(HP:0002451)|Dysphagia(HP:0002015)|Morphological abnormality of the pyramidal tract(HP:0002062)|Bradykinesia(HP:0002067)|Lower limb pain(HP:0012514)|Abnormal pyramidal sign(HP:0007256)|Laryngeal dystonia(HP:0012049)|Dysphonia(HP:0001618)|Autosomal recessive inheritance(HP:0000007)","This gene encodes a protein kinase activated by double-stranded RNA which mediates the effects of interferon in response to viral infection. Mutations in this gene have been associated with dystonia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]","protein activator of interferon induced protein kinase EIF2AK2","protein phosphorylation(GO:0006468)|immune response(GO:0006955)|negative regulation of cell population proliferation(GO:0008285)|response to virus(GO:0009615)|production of siRNA involved in RNA interference(GO:0030422)|pre-miRNA processing(GO:0031054)|cellular response to oxidative stress(GO:0034599)|production of miRNAs involved in gene silencing by miRNA(GO:0035196)|outer ear morphogenesis(GO:0042473)|middle ear morphogenesis(GO:0042474)|skeletal system morphogenesis(GO:0048705)|regulation of catalytic activity(GO:0050790)|protein stabilization(GO:0050821)|positive regulation of intrinsic apoptotic signaling pathway(GO:2001244)","nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytosol(GO:0005829)|membrane(GO:0016020)|perinuclear region of cytoplasm(GO:0048471)|RISC-loading complex(GO:0070578)","RNA binding(GO:0003723)|double-stranded RNA binding(GO:0003725)|protein binding(GO:0005515)|enzyme activator activity(GO:0008047)|enzyme binding(GO:0019899)|identical protein binding(GO:0042802)|protein homodimerization activity(GO:0042803)|pre-miRNA binding(GO:0070883)","dystonia(DOID:543)","","Wp ebola virus pathway on host|Wp vegfavegfr2 signaling pathway","Microrna mirna biogenesis|Gene silencing by rna|Small interfering rna sirna biogenesis","","","SpliceAI>G|PRKRA|0.00|0.01|0.00|0.00|6|11|11|2","Double-stranded","","","0.00005457","","","0.0001","0.001","","","3.981e-06","5.457e-05","D","0.002","D","0.007","D","0.988","D","0.936","D","0.000","D","1.000","H","4.46","D","-1.6","D","-4.69","0.827","D","0.699","D","0.732","D","0.129","0.921","D","0.997","28.4","4.082","5.7","6.702","13.477"
"chr5","82815395","82815395","C>T","","VCAN","exonic","nonsynonymous SNV","","VCAN:NM_001164098:exon7:c.C1270T:p.P424S,VCAN:NM_004385:exon7:c.C1270T:p.P424S","VCAN","exonic","nonsynonymous SNV","","VCAN:ENST00000265077.8_1:exon7:c.C1270T:p.P424S,VCAN:ENST00000342785.8_1:exon7:c.C1270T:p.P424S,VCAN:ENST00000512590.6_1:exon7:c.C1126T:p.P376S","VCAN:ENST00000265077.3:c.1270C>T:p.(Pro424Ser)","0.8674697","0.5019820800516754","0.8674697279930115","0.4741243655684169","","","","","","","","","","","","","ENSG00000038427","VCAN","HGNC:2464","VCAN","1462","ENSG00000038427","uc003kii.4","0.47412436556841697","0.5019820800516754","0.8674697279930115","OMIM:143200 Wagner syndrome 1-autosomal_dominant","491","0/1","Het","138","86,52","0.623188405797101","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Wagner vitreoretinopathy(143200)","Chorioretinal atrophy(HP:0000533)|Glaucoma(HP:0000501)|Retinal pigment epithelial atrophy(HP:0007722)|Optic atrophy(HP:0000648)|Visual field defect(HP:0001123)|Exudative vitreoretinopathy(HP:0030490)|Visual loss(HP:0000572)|Myopia(HP:0000545)|Cataract(HP:0000518)|Optically empty vitreous(HP:0030663)|Autosomal dominant inheritance(HP:0000006)|Vitreoretinopathy(HP:0007773)|Peripheral tractional retinal detachment(HP:0007643)","This gene is a member of the aggrecan/versican proteoglycan family. The protein encoded is a large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix. This protein is involved in cell adhesion, proliferation, proliferation, migration and angiogenesis and plays a central role in tissue morphogenesis and maintenance. Mutations in this gene are the cause of Wagner syndrome type 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009]","versican","skeletal system development(GO:0001501)|osteoblast differentiation(GO:0001649)|cell adhesion(GO:0007155)|multicellular organism development(GO:0007275)|central nervous system development(GO:0007417)|cell recognition(GO:0008037)","photoreceptor outer segment(GO:0001750)|extracellular region(GO:0005576)|extracellular region(GO:0005576)|extracellular space(GO:0005615)|endoplasmic reticulum lumen(GO:0005788)|Golgi lumen(GO:0005796)|membrane(GO:0016020)|extracellular matrix(GO:0031012)|interphotoreceptor matrix(GO:0033165)|lysosomal lumen(GO:0043202)|collagen-containing extracellular matrix(GO:0062023)|collagen-containing extracellular matrix(GO:0062023)|collagen-containing extracellular matrix(GO:0062023)","calcium ion binding(GO:0005509)|protein binding(GO:0005515)|glycosaminoglycan binding(GO:0005539)|hyaluronic acid binding(GO:0005540)|extracellular matrix structural constituent conferring compression resistance(GO:0030021)|extracellular matrix structural constituent conferring compression resistance(GO:0030021)|carbohydrate binding(GO:0030246)","pre-eclampsia(DOID:10591)|leiomyoma(DOID:127)|uterine fibroid(DOID:13223)|cancer(DOID:162)|vascular disease(DOID:178)|melanoma(DOID:1909)|ovarian carcinoma(DOID:4001)","Cell adhesion molecules cams","Wp spinal cord injury","Extracellular matrix organization|Glycosaminoglycan metabolism|Heparan sulfate heparin hs gag metabolism|Chondroitin sulfate dermatan sulfate metabolism|A tetrasaccharide linker sequence is required for gag synthesis|Chondroitin sulfate biosynthesis|Dermatan sulfate biosynthesis|Cs ds degradation|Ecm proteoglycans|Diseases associated with glycosaminoglycan metabolism|Defective b4galt7 causes eds progeroid type|Defective chst3 causes sedcjd|Defective chst14 causes eds musculocontractural type|Defective chsy1 causes tpbs|Diseases of glycosylation|Regulation of insulin like growth factor igf transport and uptake by insulin like growth factor binding proteins igfbps|Diseases of metabolism|Post translational protein modification|Metabolism of carbohydrates","","Apical junction|Epithelial mesenchymal transition|Glycolysis|Angiogenesis","",".;.;.","","","0.00001592","","","0.","0.0002","","","1.592e-05","0.0002","T","0.125","T","0.724","B","0.051","B","0.012","N","0.406","N","1.000","N","0.49","D","-2.19","N","-1.5","0.037","T","-0.740","T","0.345","T","0.015","0.141","T","0.009","8.995","0.458","5.2","1.059","9.068"
"chr19","35758059","35758059","C>T","","LSR","exonic","nonsynonymous SNV","","LSR:NM_001260490:exon6:c.C1012T:p.P338S,LSR:NM_205835:exon7:c.C1132T:p.P378S,LSR:NM_001260489:exon8:c.C1276T:p.P426S,LSR:NM_015925:exon8:c.C1279T:p.P427S,LSR:NM_205834:exon9:c.C1336T:p.P446S","LSR","exonic","nonsynonymous SNV","","LSR:ENST00000427250.5_1:exon6:c.C868T:p.P290S,LSR:ENST00000360798.7_1:exon7:c.C1132T:p.P378S,LSR:ENST00000347609.8_1:exon8:c.C1162T:p.P388S,LSR:ENST00000354900.7_1:exon8:c.C1279T:p.P427S,LSR:ENST00000602122.5_1:exon8:c.C1276T:p.P426S,LSR:ENST00000361790.7_1:exon9:c.C1336T:p.P446S,LSR:ENST00000605618.6_1:exon9:c.C1192T:p.P398S,LSR:ENST00000621372.4_1:exon9:c.C1336T:p.P446S","LSR:ENST00000347609.4:c.1162C>T:p.(Pro388Ser)","0.833","0.5177244720180155","0.8330000042915344","0.4362183700323831","","","","","","","","","","","","","ENSG00000105699","LSR","HGNC:29572","LSR","51599","ENSG00000105699","uc002nyl.4","0.4362183700323831","0.5177244720180155","0.8330000042915344","","497","0/1","Het","125","70,55","0.56","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","lipolysis stimulated lipoprotein receptor","liver development(GO:0001889)|maintenance of blood-brain barrier(GO:0035633)|establishment of blood-brain barrier(GO:0060856)|establishment of blood-brain barrier(GO:0060856)|establishment of skin barrier(GO:0061436)|protein localization to tricellular tight junction(GO:0061833)|tricellular tight junction assembly(GO:1904274)|tricellular tight junction assembly(GO:1904274)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|membrane(GO:0016020)|integral component of membrane(GO:0016021)|very-low-density lipoprotein particle(GO:0034361)|low-density lipoprotein particle(GO:0034362)|chylomicron(GO:0042627)|tricellular tight junction(GO:0061689)|tricellular tight junction(GO:0061689)|extracellular exosome(GO:0070062)","","cancer(DOID:162)","","","Plasma lipoprotein assembly remodeling and clearance|Transport of small molecules|Ldl clearance|Plasma lipoprotein clearance|Vldl clearance","","Estrogen response late","",".;.;.;.;.;.;.;.","","Score=795;Name=V$PPARG_03","","","","","","","","","","T","0.167","T","0.668","P","0.856","P","0.693","N","0.003","N","1","M","2.3","T","0.99","N","-1.37","0.65","T","-0.886","T","0.223","T","0.018","0.088","D","0.788","22.6","2.536","4.88","2.112","10.242"
"chr1","27684067","27684067","C>G","","MAP3K6","exonic","nonsynonymous SNV","","MAP3K6:NM_001297609:exon22:c.G3058C:p.G1020R,MAP3K6:NM_004672:exon23:c.G3082C:p.G1028R","MAP3K6","exonic","nonsynonymous SNV","","MAP3K6:ENST00000374040.7_1:exon22:c.G3058C:p.G1020R,MAP3K6:ENST00000357582.3_1:exon23:c.G3082C:p.G1028R","MAP3K6:ENST00000357582.2:c.3082G>C:p.(Gly1028Arg)","0.851","0.5000483894800709","0.8510000109672546","0.431692380250459","","","","","","","","","","","","","ENSG00000142733","MAP3K6","HGNC:6858","MAP3K6","9064","ENSG00000142733","uc057dvi.1","0.431692380250459","0.5000483894800709","0.8510000109672546","","498","0/1","Het","51","26,25","0.509803921568627","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a serine/threonine protein kinase that forms a component of protein kinase-mediated signal transduction cascades. The encoded kinase participates in the regulation of vascular endothelial growth factor (VEGF) expression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]","mitogen-activated protein kinase kinase kinase 6","MAPK cascade(GO:0000165)|protein phosphorylation(GO:0006468)|signal transduction(GO:0007165)|cellular response to stress(GO:0033554)","","magnesium ion binding(GO:0000287)|protein kinase activity(GO:0004672)|protein serine/threonine kinase activity(GO:0004674)|MAP kinase kinase kinase activity(GO:0004709)|MAP kinase kinase kinase activity(GO:0004709)|ATP binding(GO:0005524)|protein serine kinase activity(GO:0106310)","disease(DOID:4)","Mapk signaling pathway","Wp angiopoietin like protein 8 regulatory pathway|Wp insulin signaling|Wp mapk signaling pathway","","Mapk pathway","Myc targets v2","",".;.;.","","","","","","","","","","","","T","0.149","T","0.324","B","0.012","B","0.02","","","N","1.000","M","2.295","T","-0.25","N","-1.91","0.277","T","-1.019","T","0.103","D","0.042","0.044","T","0.354","20.8","2.124","5.0","4.206","6.987"
"chr16","30670916","30670916","->CCGAGA","","FBRS","exonic","nonframeshift insertion","","FBRS:NM_001105079:exon1:c.77_78insCCGAGA:p.R31_E32insDR","FBRS","exonic","nonframeshift insertion","","FBRS:ENST00000356166.11_1:exon1:c.77_78insCCGAGA:p.R31_E32insDR","FBRS:ENST00000356166.6:c.87_92dup:p.(Asp30_Arg31dup)","0.85","0.5000052856962611","0.8500000238418579","0.4293309595233583","","","","","","","","","","","","","ENSG00000156860","FBRS","HGNC:20442","FBRS","64319","ENSG00000156860","uc002dzd.4","0.4293309595233583","0.5000052856962611","0.8500000238418579","","503","0/1","Het","4","2,2","0.5","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Fibrosin is a lymphokine secreted by activated lymphocytes that induces fibroblast proliferation (Prakash and Robbins, 1998 [PubMed 9809749]).[supplied by OMIM, Mar 2008]","fibrosin","","","","","","","","","","","","","Score=772;Name=V$E2F_01","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","26087772","26087772","T>G","","NOS2","splicing","","NM_000625:exon24:c.2889-2A>C","","NOS2","splicing","","ENST00000313735.11_1:exon24:c.2889-2A>C;ENST00000646938.1_1:exon23:c.2886-2A>C;ENST00000621962.1_1:exon24:c.2772-2A>C","","NOS2:ENST00000313735.6:c.2889-2A>C:p.?","0.99816775","0.3500017135392608","0.9981677532196044","0.3815320072877066","0.3500017135392608","0.9386835098266602","0.2632115583851149","","","","","","","","","","ENSG00000007171","NOS2","HGNC:7873","NOS2","4843","ENSG00000007171","uc002gzu.4","0.38153200728770664","0.3500017135392608","0.9981677532196045","","516","0/1","Het","65","58,7","0.892307692307692","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Malaria, susceptibility to(611162)","","Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]","nitric oxide synthase 2","response to hypoxia(GO:0001666)|positive regulation of leukocyte mediated cytotoxicity(GO:0001912)|innate immune response in mucosa(GO:0002227)|arginine catabolic process(GO:0006527)|arginine catabolic process(GO:0006527)|superoxide metabolic process(GO:0006801)|nitric oxide biosynthetic process(GO:0006809)|nitric oxide biosynthetic process(GO:0006809)|inflammatory response(GO:0006954)|nitric oxide mediated signal transduction(GO:0007263)|circadian rhythm(GO:0007623)|response to bacterium(GO:0009617)|response to hormone(GO:0009725)|negative regulation of gene expression(GO:0010629)|peptidyl-cysteine S-nitrosylation(GO:0018119)|positive regulation of guanylate cyclase activity(GO:0031284)|prostaglandin secretion(GO:0032310)|response to lipopolysaccharide(GO:0032496)|positive regulation of interleukin-6 production(GO:0032755)|positive regulation of interleukin-8 production(GO:0032757)|regulation of cell population proliferation(GO:0042127)|negative regulation of protein catabolic process(GO:0042177)|defense response to bacterium(GO:0042742)|defense response to bacterium(GO:0042742)|defense response to bacterium(GO:0042742)|regulation of cellular respiration(GO:0043457)|cell redox homeostasis(GO:0045454)|negative regulation of blood pressure(GO:0045776)|regulation of insulin secretion(GO:0050796)|defense response to Gram-negative bacterium(GO:0050829)|positive regulation of killing of cells of other organism(GO:0051712)|cellular response to lipopolysaccharide(GO:0071222)|cellular response to interferon-gamma(GO:0071346)|cellular response to xenobiotic stimulus(GO:0071466)|regulation of cytokine production involved in inflammatory response(GO:1900015)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|peroxisome(GO:0005777)|peroxisomal matrix(GO:0005782)|cytosol(GO:0005829)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|vesicle membrane(GO:0012506)|cortical cytoskeleton(GO:0030863)|perinuclear region of cytoplasm(GO:0048471)","nitric-oxide synthase activity(GO:0004517)|nitric-oxide synthase activity(GO:0004517)|nitric-oxide synthase activity(GO:0004517)|protein binding(GO:0005515)|calmodulin binding(GO:0005516)|FMN binding(GO:0010181)|FMN binding(GO:0010181)|oxidoreductase activity(GO:0016491)|heme binding(GO:0020037)|tetrahydrobiopterin binding(GO:0034617)|arginine binding(GO:0034618)|protein homodimerization activity(GO:0042803)|metal ion binding(GO:0046872)|flavin adenine dinucleotide binding(GO:0050660)|flavin adenine dinucleotide binding(GO:0050660)|NADP binding(GO:0050661)","silicosis(DOID:10325)|chronic lymphocytic leukemia(DOID:1040)|tonsillitis(DOID:10456)|pre-eclampsia(DOID:10591)|Alzheimer's disease(DOID:10652)|otitis media(DOID:10754)|hypertension(DOID:10763)|gastric ulcer(DOID:10808)|age related macular degeneration(DOID:10871)|nephritis(DOID:10952)|spotted fever(DOID:11104)|head and neck cancer(DOID:11934)|primary biliary cholangitis(DOID:12236)|malaria(DOID:12365)|leukemia(DOID:1240)|aplastic anemia(DOID:12449)|paracoccidioidomycosis(DOID:12662)|autistic disorder(DOID:12849)|dementia(DOID:1307)|periventricular leukomalacia(DOID:13088)|temporal arteritis(DOID:13375)|Kawasaki disease(DOID:13378)|cerebral malaria(DOID:14069)|boutonneuse fever(DOID:14095)|Fabry disease(DOID:14499)|hypothyroidism(DOID:1459)|aggressive periodontitis(DOID:1474)|cystic fibrosis(DOID:1485)|head and neck carcinoma(DOID:1542)|cancer(DOID:162)|squamous cell carcinoma(DOID:1749)|hepatitis C(DOID:1883)|viral hepatitis(DOID:1884)|malignant fibrous histiocytoma(DOID:1907)|melanoma(DOID:1909)|hepatitis B(DOID:2043)|autoimmune hepatitis(DOID:2048)|hepatitis(DOID:2237)|syndrome(DOID:225)|anemia(DOID:2355)|chronic obstructive pulmonary disease(DOID:3083)|gingivitis(DOID:3087)|ischemia(DOID:326)|coronary artery disease(DOID:3393)|gastric adenocarcinoma(DOID:3717)|congenital diaphragmatic hernia(DOID:3827)|tuberculosis(DOID:399)|liver disease(DOID:409)|hyperglycemia(DOID:4195)|histiocytoma(DOID:4231)|fibrous histiocytoma(DOID:4415)|macular degeneration(DOID:4448)|renal cell carcinoma(DOID:4450)|allergic rhinitis(DOID:4481)|rhinitis(DOID:4483)|gallbladder carcinoma(DOID:4948)|liver cirrhosis(DOID:5082)|migraine(DOID:6364)|pulmonary hypertension(DOID:6432)|adenoma(DOID:657)|spondylitis(DOID:6590)|hepatocellular carcinoma(DOID:684)|ankylosing spondylitis(DOID:7147)|rheumatoid arthritis(DOID:7148)|retinoblastoma(DOID:768)|neuroblastoma(DOID:769)|periodontitis(DOID:824)|peritonitis(DOID:8283)|osteoarthritis(DOID:8398)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)","Arginine and proline metabolism|Calcium signaling pathway|Peroxisome|Leishmania infection|Pathways in cancer|Small cell lung cancer","Wp spinal cord injury|Wp type ii interferon signaling ifng|Wp hepatitis c and hepatocellular carcinoma|Wp agerage pathway|Wp rac1pak1p38mmp2 pathway|Wp nocgmppkg mediated neuroprotection|Wp prolactin signaling pathway|Wp circadian rhythm related genes|Wp effects of nitric oxide|Wp photodynamic therapyinduced hif1 survival signaling|Wp focal adhesionpi3kaktmtorsignaling pathway|Wp fibrin complement receptor 3 signaling pathway|Wp il18 signaling pathway|Wp small cell lung cancer|Wp urea cycle and associated pathways|Wp genes involved in male infertility|Wp no metabolism in cystic fibrosis|Wp neuroinflammation","Hemostasis|Ros and rns production in phagocytes|Cytokine signaling in immune system|Innate immune system|Nitric oxide stimulates guanylate cyclase|Platelet homeostasis|Signaling by interleukins|Infectious disease|Interleukin 4 and interleukin 13 signaling|Peroxisomal protein import|Protein localization|Infection with mycobacterium tuberculosis|Suppression of phagosomal maturation|Response of mtb to phagocytosis","Ppara pathway|No2il12 pathway","Allograft rejection","",".;.;.","","","0","","","","","","","0","0","","","","","","","","","","","D","1","","","","","","","","","","","","","","","","","33","5.403","4.59","5.197","13.201"
"chr17","26087768","26087768","G>A","","NOS2","exonic","nonsynonymous SNV","","NOS2:NM_000625:exon24:c.C2891T:p.A964V","NOS2","exonic","nonsynonymous SNV","","NOS2:ENST00000646938.1_1:exon23:c.C2888T:p.A963V,NOS2:ENST00000313735.11_1:exon24:c.C2891T:p.A964V,NOS2:ENST00000621962.1_1:exon24:c.C2774T:p.A925V","NOS2:ENST00000313735.6:c.2891C>T:p.(Ala964Val)","0.87919927","","","","0.3500017135392608","0.9386835098266602","0.2632115583851149","","","","","","","","","","ENSG00000007171","NOS2","HGNC:7873","NOS2","4843","ENSG00000007171","uc002gzu.4","0.38153200728770664","0.3500017135392608","0.9981677532196045","","517","0/1","Het","65","58,7","0.892307692307692","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Malaria, susceptibility to(611162)","","Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]","nitric oxide synthase 2","response to hypoxia(GO:0001666)|positive regulation of leukocyte mediated cytotoxicity(GO:0001912)|innate immune response in mucosa(GO:0002227)|arginine catabolic process(GO:0006527)|arginine catabolic process(GO:0006527)|superoxide metabolic process(GO:0006801)|nitric oxide biosynthetic process(GO:0006809)|nitric oxide biosynthetic process(GO:0006809)|inflammatory response(GO:0006954)|nitric oxide mediated signal transduction(GO:0007263)|circadian rhythm(GO:0007623)|response to bacterium(GO:0009617)|response to hormone(GO:0009725)|negative regulation of gene expression(GO:0010629)|peptidyl-cysteine S-nitrosylation(GO:0018119)|positive regulation of guanylate cyclase activity(GO:0031284)|prostaglandin secretion(GO:0032310)|response to lipopolysaccharide(GO:0032496)|positive regulation of interleukin-6 production(GO:0032755)|positive regulation of interleukin-8 production(GO:0032757)|regulation of cell population proliferation(GO:0042127)|negative regulation of protein catabolic process(GO:0042177)|defense response to bacterium(GO:0042742)|defense response to bacterium(GO:0042742)|defense response to bacterium(GO:0042742)|regulation of cellular respiration(GO:0043457)|cell redox homeostasis(GO:0045454)|negative regulation of blood pressure(GO:0045776)|regulation of insulin secretion(GO:0050796)|defense response to Gram-negative bacterium(GO:0050829)|positive regulation of killing of cells of other organism(GO:0051712)|cellular response to lipopolysaccharide(GO:0071222)|cellular response to interferon-gamma(GO:0071346)|cellular response to xenobiotic stimulus(GO:0071466)|regulation of cytokine production involved in inflammatory response(GO:1900015)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|peroxisome(GO:0005777)|peroxisomal matrix(GO:0005782)|cytosol(GO:0005829)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|vesicle membrane(GO:0012506)|cortical cytoskeleton(GO:0030863)|perinuclear region of cytoplasm(GO:0048471)","nitric-oxide synthase activity(GO:0004517)|nitric-oxide synthase activity(GO:0004517)|nitric-oxide synthase activity(GO:0004517)|protein binding(GO:0005515)|calmodulin binding(GO:0005516)|FMN binding(GO:0010181)|FMN binding(GO:0010181)|oxidoreductase activity(GO:0016491)|heme binding(GO:0020037)|tetrahydrobiopterin binding(GO:0034617)|arginine binding(GO:0034618)|protein homodimerization activity(GO:0042803)|metal ion binding(GO:0046872)|flavin adenine dinucleotide binding(GO:0050660)|flavin adenine dinucleotide binding(GO:0050660)|NADP binding(GO:0050661)","silicosis(DOID:10325)|chronic lymphocytic leukemia(DOID:1040)|tonsillitis(DOID:10456)|pre-eclampsia(DOID:10591)|Alzheimer's disease(DOID:10652)|otitis media(DOID:10754)|hypertension(DOID:10763)|gastric ulcer(DOID:10808)|age related macular degeneration(DOID:10871)|nephritis(DOID:10952)|spotted fever(DOID:11104)|head and neck cancer(DOID:11934)|primary biliary cholangitis(DOID:12236)|malaria(DOID:12365)|leukemia(DOID:1240)|aplastic anemia(DOID:12449)|paracoccidioidomycosis(DOID:12662)|autistic disorder(DOID:12849)|dementia(DOID:1307)|periventricular leukomalacia(DOID:13088)|temporal arteritis(DOID:13375)|Kawasaki disease(DOID:13378)|cerebral malaria(DOID:14069)|boutonneuse fever(DOID:14095)|Fabry disease(DOID:14499)|hypothyroidism(DOID:1459)|aggressive periodontitis(DOID:1474)|cystic fibrosis(DOID:1485)|head and neck carcinoma(DOID:1542)|cancer(DOID:162)|squamous cell carcinoma(DOID:1749)|hepatitis C(DOID:1883)|viral hepatitis(DOID:1884)|malignant fibrous histiocytoma(DOID:1907)|melanoma(DOID:1909)|hepatitis B(DOID:2043)|autoimmune hepatitis(DOID:2048)|hepatitis(DOID:2237)|syndrome(DOID:225)|anemia(DOID:2355)|chronic obstructive pulmonary disease(DOID:3083)|gingivitis(DOID:3087)|ischemia(DOID:326)|coronary artery disease(DOID:3393)|gastric adenocarcinoma(DOID:3717)|congenital diaphragmatic hernia(DOID:3827)|tuberculosis(DOID:399)|liver disease(DOID:409)|hyperglycemia(DOID:4195)|histiocytoma(DOID:4231)|fibrous histiocytoma(DOID:4415)|macular degeneration(DOID:4448)|renal cell carcinoma(DOID:4450)|allergic rhinitis(DOID:4481)|rhinitis(DOID:4483)|gallbladder carcinoma(DOID:4948)|liver cirrhosis(DOID:5082)|migraine(DOID:6364)|pulmonary hypertension(DOID:6432)|adenoma(DOID:657)|spondylitis(DOID:6590)|hepatocellular carcinoma(DOID:684)|ankylosing spondylitis(DOID:7147)|rheumatoid arthritis(DOID:7148)|retinoblastoma(DOID:768)|neuroblastoma(DOID:769)|periodontitis(DOID:824)|peritonitis(DOID:8283)|osteoarthritis(DOID:8398)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)","Arginine and proline metabolism|Calcium signaling pathway|Peroxisome|Leishmania infection|Pathways in cancer|Small cell lung cancer","Wp spinal cord injury|Wp type ii interferon signaling ifng|Wp hepatitis c and hepatocellular carcinoma|Wp agerage pathway|Wp rac1pak1p38mmp2 pathway|Wp nocgmppkg mediated neuroprotection|Wp prolactin signaling pathway|Wp circadian rhythm related genes|Wp effects of nitric oxide|Wp photodynamic therapyinduced hif1 survival signaling|Wp focal adhesionpi3kaktmtorsignaling pathway|Wp fibrin complement receptor 3 signaling pathway|Wp il18 signaling pathway|Wp small cell lung cancer|Wp urea cycle and associated pathways|Wp genes involved in male infertility|Wp no metabolism in cystic fibrosis|Wp neuroinflammation","Hemostasis|Ros and rns production in phagocytes|Cytokine signaling in immune system|Innate immune system|Nitric oxide stimulates guanylate cyclase|Platelet homeostasis|Signaling by interleukins|Infectious disease|Interleukin 4 and interleukin 13 signaling|Peroxisomal protein import|Protein localization|Infection with mycobacterium tuberculosis|Suppression of phagosomal maturation|Response of mtb to phagocytosis","Ppara pathway|No2il12 pathway","Allograft rejection","","FAD-binding","","","0","","","","","","","0","0","T","0.12","D","0.03","B","0.005","B","0.006","N","0.013","D","0.587","L","1.93","T","1.31","N","-2.45","0.112","T","-0.743","T","0.185","T","0.018","0.114","D","0.594","18.36","1.821","4.59","2.612","9.485"
"chrX","12734214","12734214","C>T","","FRMPD4","exonic","nonsynonymous SNV","","FRMPD4:NM_014728:exon15:c.C1636T:p.L546F","FRMPD4","exonic","nonsynonymous SNV","","FRMPD4:ENST00000672869.1_1:exon14:c.C1603T:p.L535F,FRMPD4:ENST00000380682.5_1:exon15:c.C1636T:p.L546F,FRMPD4:ENST00000616992.1_1:exon15:c.C1516T:p.L506F,FRMPD4:ENST00000672010.1_1:exon15:c.C1627T:p.L543F,FRMPD4:ENST00000675598.1_1:exon15:c.C1636T:p.L546F,FRMPD4:ENST00000640291.2_1:exon17:c.C1690T:p.L564F,FRMPD4:ENST00000656302.1_1:exon17:c.C1690T:p.L564F","FRMPD4:ENST00000380682.1:c.1636C>T:p.(Leu546Phe)","0.94969326","","","","","","","","","","0.3911647507719955","0.9496932625770568","0.3774556941232409","","","","ENSG00000169933","FRMPD4","HGNC:29007","FRMPD4","9758","ENSG00000169933","uc004cuz.2","0.3774556941232409","0.39116475077199553","0.9496932625770569","OMIM:300983 Intellectual developmental disorder, X-linked 104-x_recessive;ORPHA:777 X-linked non-syndromic intellectual disability-x_recessive","544","0/1","Het","48","34,14","0.708333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Linked 104(300983)","Hypoplasia of the corpus callosum(HP:0002079)|Delayed CNS myelination(HP:0002188)|Bifid nasal tip(HP:0000456)|Hyperreflexia(HP:0001347)|Seizure(HP:0001250)|Infantile onset(HP:0003593)|Absent speech(HP:0001344)|Delayed ability to walk(HP:0031936)|High palate(HP:0000218)|Global developmental delay(HP:0001263)|Wide nasal bridge(HP:0000431)|Spasticity(HP:0001257)|Tremor(HP:0001337)|Hyperactivity(HP:0000752)|Poor eye contact(HP:0000817)|Aggressive behavior(HP:0000718)|Abnormality of the pinna(HP:0000377)|Strabismus(HP:0000486)|Ataxia(HP:0001251)|Cerebral cortical atrophy(HP:0002120)|Frontal upsweep of hair(HP:0002236)|X-linked recessive inheritance(HP:0001419)|Retrognathia(HP:0000278)|Optic atrophy(HP:0000648)|Trigonocephaly(HP:0000243)|Nystagmus(HP:0000639)|Intellectual disability(HP:0001249)|High forehead(HP:0000348)|Thick lower lip vermilion(HP:0000179)|Pyloric stenosis(HP:0002021)|Drooling(HP:0002307)|Midface retrusion(HP:0011800)|Meckel diverticulum(HP:0002245)|Babinski sign(HP:0003487)|Moderate sensorineural hearing impairment(HP:0008504)|Mild neurosensory hearing impairment(HP:0008587)|Urinary incontinence(HP:0000020)|Global developmental delay(HP:0001263)|Generalized non-motor (absence) seizure(HP:0002121)|Clinodactyly of the 2nd toe(HP:0005824)|Intellectual disability, moderate(HP:0002342)|Delayed eruption of teeth(HP:0000684)|Autistic behavior(HP:0000729)|2-3 toe syndactyly(HP:0004691)|Periorbital fullness(HP:0000629)|Delayed speech and language development(HP:0000750)|Bilateral tonic-clonic seizure(HP:0002069)|Poor speech(HP:0002465)|Attention deficit hyperactivity disorder(HP:0007018)|Depressed nasal bridge(HP:0005280)|Broad nasal tip(HP:0000455)|Pes planus(HP:0001763)|Macrocephaly(HP:0000256)|Obesity(HP:0001513)|Intellectual disability, profound(HP:0002187)|Shortening of all distal phalanges of the fingers(HP:0006118)|Widened subarachnoid space(HP:0012704)|Small for gestational age(HP:0001518)|Long palpebral fissure(HP:0000637)|Long philtrum(HP:0000343)|Thin upper lip vermilion(HP:0000219)|Intellectual disability, severe(HP:0010864)|Downslanted palpebral fissures(HP:0000494)|Facial palsy(HP:0010628)","This gene encodes a multi-domain (WW, PDZ, FERM) containing protein. Through its interaction with other proteins (such as PSD-95), it functions as a positive regulator of dendritic spine morphogenesis and density, and is required for the maintenance of excitatory synaptic transmission. [provided by RefSeq, Jan 2010]","FERM and PDZ domain containing 4","positive regulation of synapse structural plasticity(GO:0051835)","cytoskeleton(GO:0005856)|protein-containing complex(GO:0032991)|dendritic spine(GO:0043197)|dendritic spine(GO:0043197)","protein binding(GO:0005515)|phosphatidylinositol-4,5-bisphosphate binding(GO:0005546)|phosphatidylinositol-4,5-bisphosphate binding(GO:0005546)","","","","","","","",".;.","","","0.00007794","0.0008","0.003","0.","0.0006","","","7.794e-05","0.0010","D","0.036","T","0.288","B","0.259","B","0.075","N","0.077","N","0.552","L","1.525","T","1.66","N","-0.05","0.2","T","-1.006","T","0.069","T","0.013","0.017","T","0.036","17.62","1.721","5.47","0.642","8.057"
"chr7","142458451","142458451","A>T","PRSS1:5644|TRB:6957","PRSS1","exonic","nonsynonymous SNV","","PRSS1:NM_002769:exon2:c.A86T:p.N29I","PRSS1","exonic","nonsynonymous SNV","","PRSS1:ENST00000311737.12_1:exon2:c.A86T:p.N29I,PRSS1:ENST00000486171.5_1:exon2:c.A86T:p.N29I,PRSS1:ENST00000619214.4_1:exon2:c.A86T:p.N29I","PRSS1:ENST00000311737.7:c.86A>T:p.(Asn29Ile)","1","0.3441971905552858","1.0","0.371319836094983","","","","","","","","","","","","","ENSG00000204983","PRSS1","HGNC:9475","PRSS1","5644","ENSG00000204983","uc003wak.3","0.371319836094983","0.34419719055528586","1.0","OMIM:167800 Pancreatitis, hereditary-autosomal_dominant;ORPHA:676 Hereditary chronic pancreatitis-autosomal_dominant","545","0/1","Het","46","40,6","0.869565217391304","Pathogenic","True","Hereditary_pancreatitis|Vitamin_D-dependent_rickets_type_II_with_alopecia|Trypsinogen_deficiency|Inborn_genetic_diseases|not_specified","MONDO:MONDO:0008185,MedGen:C0238339,OMIM:167800,Orphanet:ORPHA676,SNOMED_CT:68072000|MONDO:MONDO:0010186,MedGen:C0342646,OMIM:277440,SNOMED_CT:237894002|MONDO:MONDO:0013543,MedGen:C0268417,OMIM:614044|MeSH:D030342,MedGen:C0950123|MedGen:CN169374","NC_000007.13:g.142458451A>T","criteria_provided,_multiple_submitters,_no_conflicts","Benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 1 ; BA1: 1 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Pancreatitis, hereditary(167800)","Jaundice(HP:0000952)|Abdominal pain(HP:0002027)|Elevated circulating C-reactive protein concentration(HP:0011227)|Splanchnic vein thrombosis(HP:0030247)|Diabetes mellitus(HP:0000819)|Pancreatic calcification(HP:0005213)|Leukocytosis(HP:0001974)|Recurrent pancreatitis(HP:0100027)|Abnormal enzyme/coenzyme activity(HP:0012379)|Pancreatitis(HP:0001733)|Abdominal pain(HP:0002027)|Abnormal thrombosis(HP:0001977)|Pancreatic calcification(HP:0005213)|Autosomal dominant inheritance(HP:0000006)|Fever(HP:0001945)|Diabetes mellitus(HP:0000819)|Exocrine pancreatic insufficiency(HP:0001738)|Pleural effusion(HP:0002202)|Steatorrhea(HP:0002570)|Pancreatic pseudocyst(HP:0005206)","This gene encodes a trypsinogen, which is a member of the trypsin family of serine proteases. This enzyme is secreted by the pancreas and cleaved to its active form in the small intestine. It is active on peptide linkages involving the carboxyl group of lysine or arginine. Mutations in this gene are associated with hereditary pancreatitis. This gene and several other trypsinogen genes are localized to the T cell receptor beta locus on chromosome 7. [provided by RefSeq, Jul 2008]","serine protease 1","proteolysis(GO:0006508)|digestion(GO:0007586)|extracellular matrix disassembly(GO:0022617)","extracellular region(GO:0005576)|extracellular region(GO:0005576)|extracellular space(GO:0005615)|collagen-containing extracellular matrix(GO:0062023)|blood microparticle(GO:0072562)","serine-type endopeptidase activity(GO:0004252)|serine-type endopeptidase activity(GO:0004252)|metal ion binding(GO:0046872)","cancer(DOID:162)|intrahepatic cholangiocarcinoma(DOID:4928)|cholangiocarcinoma(DOID:4947)|pancreatitis(DOID:4989)|diabetes mellitus(DOID:9351)","Neuroactive ligand receptor interaction","","Degradation of the extracellular matrix|Extracellular matrix organization|Activation of matrix metalloproteinases|Cobalamin cbl vitamin b12 transport and metabolism|Metabolism of water soluble vitamins and cofactors|Metabolism of vitamins and cofactors","","","SpliceAI>T|PRSS1|0.00|0.01|0.00|0.00|11|29|28|2","Serine","","","0.48","","","0.48","0.48","","","0.2831","0.2220","D","0.045","D","0.032","B","0.0","B","0.001","D","0.000","A","0.000","N","0.46","D","-2.46","N","-1.9","0.098","T","-0.243","T","0.468","","","0.269","T","0.013","16.97","1.619","3.49","1.380","6.669"
"chr15","40558517","40558517","G>T","","BUB1B-PAK6;PAK6","exonic","nonsynonymous SNV","","PAK6:NM_001276717:exon3:c.G679T:p.A227S,BUB1B-PAK6:NM_001128629:exon4:c.G679T:p.A227S,BUB1B-PAK6:NM_001128628:exon5:c.G679T:p.A227S,PAK6:NM_001276718:exon5:c.G679T:p.A227S,PAK6:NM_020168:exon5:c.G679T:p.A227S","PAK6","exonic","nonsynonymous SNV","","PAK6:ENST00000542403.3_1:exon3:c.G679T:p.A227S,PAK6:ENST00000453867.7_1:exon4:c.G679T:p.A227S,PAK6:ENST00000260404.8_1:exon5:c.G679T:p.A227S,PAK6:ENST00000441369.6_1:exon5:c.G679T:p.A227S,PAK6:ENST00000455577.6_1:exon5:c.G679T:p.A227S,PAK6:ENST00000558658.6_1:exon5:c.G679T:p.A227S,PAK6:ENST00000560346.5_1:exon5:c.G679T:p.A227S","PAK6:ENST00000260404.4:c.679G>T:p.(Ala227Ser)","0.81717885","0.5003397605905775","0.8171788454055786","0.3583510849114983","","","","","","","","","","","","","ENSG00000137843","PAK6","HGNC:16061","PAK6","56924","ENSG00000137843","uc059hqb.1","0.3583510849114983","0.5003397605905775","0.8171788454055786","","550","0/1","Het","206","103,103","0.5","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","","","","","","","","","","","",".;.;.;.;.;.","","","0.00004496","","","0.0001","0.0008","","","4.496e-05","0.0006","T","0.414","T","0.85","B","0.001","B","0.002","N","0.817","N","0.732","N","0.345","T","-0.71","N","0.29","0.176","T","-0.927","T","0.155","T","0.012","0.059","T","0.014","14.56","1.183","4.76","0.049","3.538"
"chrX","119005311","119005311","T>C","","RNF113A","exonic","nonsynonymous SNV","","RNF113A:NM_006978:exon1:c.A266G:p.E89G","RNF113A","exonic","nonsynonymous SNV","","RNF113A:ENST00000371442.4_1:exon1:c.A266G:p.E89G","RNF113A:ENST00000371442.2:c.266A>G:p.(Glu89Gly)","0.8089172","","","","","","","0.5000260211836576","0.808917224407196","0.3403662691209453","0.2500130105918288","0.808917224407196","0.036954075288328","","","","ENSG00000125352","RNF113A","HGNC:12974","RNF113A","7737","ENSG00000125352","uc004esb.4","0.3403662691209453","0.5000260211836576","0.808917224407196","OMIM:300953 Trichothiodystrophy 5, nonphotosensitive-x_dominant;ORPHA:33364 Trichothiodystrophy-x_dominant","554","0/1","Het","163","90,73","0.552147239263804","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Trichothiodystrophy 5, nonphotosensitive(300953)","Chronic diarrhea(HP:0002028)|Sparse hair(HP:0008070)|Retinal dystrophy(HP:0000556)|Recurrent infections(HP:0002719)|Intrauterine growth retardation(HP:0001511)|Wide mouth(HP:0000154)|Short stature(HP:0004322)|Slow-growing hair(HP:0002217)|Decreased circulating antibody level(HP:0004313)|Cutis marmorata(HP:0000965)|Mandibular prognathia(HP:0000303)|Broad-based gait(HP:0002136)|X-linked dominant inheritance(HP:0001423)|Global brain atrophy(HP:0002283)|Brittle hair(HP:0002299)|High forehead(HP:0000348)|Micropenis(HP:0000054)|Dandy-Walker malformation(HP:0001305)|Progressive microcephaly(HP:0000253)|Intellectual disability, profound(HP:0002187)|Progeroid facial appearance(HP:0005328)|Cutaneous photosensitivity(HP:0000992)|Optic nerve hypoplasia(HP:0000609)|Widely spaced primary teeth(HP:0006313)|Tiger tail banding(HP:0045055)|Squamous cell carcinoma(HP:0002860)|Cryptorchidism(HP:0000028)|Cardiomyopathy(HP:0001638)|Enamel hypoplasia(HP:0006297)|Increased mean corpuscular hemoglobin concentration(HP:0025548)|Spasticity(HP:0001257)|Abnormality of prenatal development or birth(HP:0001197)|Tiger tail banding(HP:0045055)|Split nail(HP:0001809)|Ventricular septal defect(HP:0001629)|Carious teeth(HP:0000670)|Craniosynostosis(HP:0001363)|Aplasia/Hypoplasia of the nails(HP:0008386)|Increased bone mineral density(HP:0011001)|Impaired social reciprocity(HP:0012760)|Ridged nail(HP:0001807)|Eczema(HP:0000964)|Gonadal dysgenesis(HP:0000133)|Neutropenia(HP:0001875)|Gait ataxia(HP:0002066)|Bird-like facies(HP:0000320)|Hypoplasia of mandible relative to maxilla(HP:0410219)|Astigmatism(HP:0000483)|Alopecia of scalp(HP:0002293)|Absence of subcutaneous fat(HP:0007485)|Cerebral dysmyelination(HP:0007266)|Bilateral sensorineural hearing impairment(HP:0008619)|Paraplegia/paraparesis(HP:0010551)|Ectropion(HP:0000656)|Delayed skeletal maturation(HP:0002750)|Ichthyosis(HP:0008064)|Osteopenia(HP:0000938)|Congenital exfoliative erythroderma(HP:0007381)|Low-set nipples(HP:0002562)|Concave nail(HP:0001598)|Microcornea(HP:0000482)|Defective DNA repair after ultraviolet radiation damage(HP:0003079)|Cutaneous photosensitivity(HP:0000992)|Panhypogammaglobulinemia(HP:0003139)|Dystrophic fingernails(HP:0008391)|Hypotelorism(HP:0000601)|Bilateral microphthalmos(HP:0007633)|Esotropia(HP:0000565)|Bronchospasm(HP:0025428)|Prematurely aged appearance(HP:0007495)|Clubbing(HP:0001217)|Umbilical hernia(HP:0001537)|Ventriculomegaly(HP:0002119)|Intrauterine growth retardation(HP:0001511)|Developmental cataract(HP:0000519)|Dysphonia(HP:0001618)|Anemia(HP:0001903)|Microcephaly(HP:0000252)|Coarse facial features(HP:0000280)|Multiple joint contractures(HP:0002828)|Generalized hyperreflexia(HP:0007034)|Abnormal pyramidal sign(HP:0007256)|Numerous pigmented freckles(HP:0007587)|Cerebral cortical atrophy(HP:0002120)|Thoracic kyphosis(HP:0002942)|Fragile nails(HP:0001808)|Dysarthria(HP:0001260)|Recurrent bronchopulmonary infections(HP:0006538)|Peripheral neuropathy(HP:0009830)|Global developmental delay(HP:0001263)|Generalized hypotonia(HP:0001290)|Psychomotor retardation(HP:0025356)|Retrognathia(HP:0000278)|Intention tremor(HP:0002080)|Hyporeflexia(HP:0001265)|Generalized-onset seizure(HP:0002197)|Macular degeneration(HP:0000608)|Hypertelorism(HP:0000316)|Keratoconjunctivitis sicca(HP:0001097)|Joint dislocation(HP:0001373)|Myopia(HP:0000545)|Epicanthus(HP:0000286)|Nystagmus(HP:0000639)|Photophobia(HP:0000613)|Periventricular leukomalacia(HP:0006970)|Partial agenesis of the corpus callosum(HP:0001338)|Brittle hair(HP:0002299)|Diffuse cerebellar atrophy(HP:0100275)|Protruding ear(HP:0000411)|Dry skin(HP:0000958)|Sparse scalp hair(HP:0002209)|High, narrow palate(HP:0002705)","This intronless gene encodes a protein which contains a C3H1-type zinc finger domain and a C3HC4 Ring-type (Really Interesting New Gene-type) zinc finger domain. The Ring-type zinc finger domain is identified in various tumor suppressors, DNA repair genes and cytokine receptor-associated molecules, and is probably involved in mediating protein-protein interactions. [provided by RefSeq, May 2010]","ring finger protein 113A","mRNA splicing, via spliceosome(GO:0000398)|DNA repair(GO:0006281)|protein ubiquitination(GO:0016567)|isopeptide cross-linking via N6-glycyl-L-lysine(GO:0018276)|snoRNA splicing(GO:0034247)|negative regulation of chemokine-mediated signaling pathway(GO:0070100)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|U2-type spliceosomal complex(GO:0005684)|nuclear speck(GO:0016607)|U2-type precatalytic spliceosome(GO:0071005)","protein binding(GO:0005515)|metal ion binding(GO:0046872)|ubiquitin protein ligase activity(GO:0061630)","","","","","","","","","","","","","","","","","","","","T","0.191","T","0.284","B","0.002","B","0.002","N","0.068","N","1","N","0.05","T","1.38","N","-0.86","0.12","T","-1.068","T","0.041","T","0.005","0.109","T","0.122","0.348","-0.307","3.3","1.695","0.947"
"chrX","32563348","32563348","G>C","DMD:1756","DMD","exonic","nonsynonymous SNV","","DMD:NM_000109:exon17:c.C2072G:p.A691G,DMD:NM_004006:exon17:c.C2096G:p.A699G,DMD:NM_004009:exon17:c.C2084G:p.A695G,DMD:NM_004010:exon17:c.C1727G:p.A576G","DMD","exonic","nonsynonymous SNV","","DMD:ENST00000288447.9_1:exon17:c.C2072G:p.A691G,DMD:ENST00000357033.9_1:exon17:c.C2096G:p.A699G,DMD:ENST00000378677.6_1:exon17:c.C2084G:p.A695G","DMD:ENST00000288447.4:c.2072C>G:p.(Ala691Gly)","0.79404014","","","","","","","","","","0.501779169193469","0.7940401434898376","0.3143053173616891","","","","ENSG00000198947","DMD","HGNC:2928","DMD","1756","ENSG00000198947","uc004dda.2","0.3143053173616891","0.501779169193469","0.7940401434898376","OMIM:300376 Becker muscular dystrophy-x_recessive;OMIM:302045 Cardiomyopathy, dilated, 3B-x_linked;OMIM:310200 Duchenne muscular dystrophy-x_recessive;ORPHA:154 Familial isolated dilated cardiomyopathy-x_linked;ORPHA:777 X-linked non-syndromic intellectual disability-x_recessive;ORPHA:98895 Becker muscular dystrophy-x_recessive;ORPHA:98896 Duchenne muscular dystrophy-x_recessive","577","0/1","Het","117","69,48","0.58974358974359","Conflicting_interpretations_of_pathogenicity","True","Dystrophin_deficiency|Cardiomyopathy|Becker_muscular_dystrophy|Dilated_cardiomyopathy_3B|Duchenne_muscular_dystrophy|not_specified|not_provided",".|Human_Phenotype_Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:ORPHA167848,SNOMED_CT:85898001|MONDO:MONDO:0010311,MedGen:C0917713,OMIM:300376,Orphanet:ORPHA98895,SNOMED_CT:387732009|MONDO:MONDO:0010542,MedGen:C3668940,OMIM:302045|MONDO:MONDO:0010679,MedGen:C0013264,OMIM:310200,Orphanet:ORPHA98896,SNOMED_CT:76670001|MedGen:CN169374|MedGen:CN517202","NC_000023.10:g.32563348G>C","criteria_provided,_conflicting_interpretations","Benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 1 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 1 ; BP7: 0","Muscular dystrophy, becker type(300376)|Cardiomyopathy, dilated, 3b(302045)|Muscular dystrophy, duchenne type(310200)","Dilated cardiomyopathy(HP:0001644)|X-linked inheritance(HP:0001417)|Global developmental delay(HP:0001263)|Calf muscle hypertrophy(HP:0008981)|Skeletal muscle atrophy(HP:0003202)|Proximal muscle weakness(HP:0003701)|Motor delay(HP:0001270)|Scoliosis(HP:0002650)|Delayed speech and language development(HP:0000750)|Respiratory insufficiency(HP:0002093)|Cardiomyopathy(HP:0001638)|Progressive muscle weakness(HP:0003323)|Cognitive impairment(HP:0100543)|Flexion contracture(HP:0001371)|Elevated circulating creatine kinase concentration(HP:0003236)|Specific learning disability(HP:0001328)|Waddling gait(HP:0002515)|Intellectual disability, mild(HP:0001256)|Generalized hypotonia(HP:0001290)|Hypoventilation(HP:0002791)|Respiratory insufficiency(HP:0002093)|Scoliosis(HP:0002650)|Calf muscle pseudohypertrophy(HP:0003707)|Gowers sign(HP:0003391)|X-linked recessive inheritance(HP:0001419)|Flexion contracture(HP:0001371)|Respiratory failure(HP:0002878)|Abnormal EKG(HP:0003115)|Arrhythmia(HP:0011675)|Hyperlordosis(HP:0003307)|Muscular dystrophy(HP:0003560)|Childhood onset(HP:0011463)|Hypotonia(HP:0001252)|Hyporeflexia(HP:0001265)|Dilated cardiomyopathy(HP:0001644)|Waddling gait(HP:0002515)|Cardiomyopathy(HP:0001638)|Elevated circulating creatine kinase concentration(HP:0003236)|Congestive heart failure(HP:0001635)|Elevated circulating creatine kinase concentration(HP:0003236)|Hyporeflexia(HP:0001265)|Calf muscle pseudohypertrophy(HP:0003707)|Muscle weakness(HP:0001324)|Arrhythmia(HP:0011675)|Muscular dystrophy(HP:0003560)|Cardiomyopathy(HP:0001638)|X-linked recessive inheritance(HP:0001419)|Myalgia(HP:0003326)|Adult onset(HP:0003581)|Abnormal EKG(HP:0003115)|Difficulty climbing stairs(HP:0003551)|Elevated hepatic transaminase(HP:0002910)|Toe walking(HP:0040083)|Elevated circulating creatine kinase concentration(HP:0003236)|Abnormal urinary color(HP:0012086)|Muscle weakness(HP:0001324)|Falls(HP:0002527)|Myoglobinuria(HP:0002913)|Fatigue(HP:0012378)|Myalgia(HP:0003326)|Difficulty walking(HP:0002355)|Skeletal muscle atrophy(HP:0003202)|Pes planus(HP:0001763)|Exercise intolerance(HP:0003546)|Muscle spasm(HP:0003394)|Thick lower lip vermilion(HP:0000179)|Pyloric stenosis(HP:0002021)|Drooling(HP:0002307)|Midface retrusion(HP:0011800)|Meckel diverticulum(HP:0002245)|Babinski sign(HP:0003487)|Moderate sensorineural hearing impairment(HP:0008504)|Mild neurosensory hearing impairment(HP:0008587)|Urinary incontinence(HP:0000020)|Global developmental delay(HP:0001263)|Generalized non-motor (absence) seizure(HP:0002121)|Clinodactyly of the 2nd toe(HP:0005824)|Intellectual disability, moderate(HP:0002342)|Delayed eruption of teeth(HP:0000684)|Autistic behavior(HP:0000729)|2-3 toe syndactyly(HP:0004691)|Periorbital fullness(HP:0000629)|Delayed speech and language development(HP:0000750)|Bilateral tonic-clonic seizure(HP:0002069)|Poor speech(HP:0002465)|Attention deficit hyperactivity disorder(HP:0007018)|Depressed nasal bridge(HP:0005280)|Broad nasal tip(HP:0000455)|Pes planus(HP:0001763)|Macrocephaly(HP:0000256)|Obesity(HP:0001513)|Intellectual disability, profound(HP:0002187)|Shortening of all distal phalanges of the fingers(HP:0006118)|Widened subarachnoid space(HP:0012704)|Small for gestational age(HP:0001518)|Long palpebral fissure(HP:0000637)|Long philtrum(HP:0000343)|Thin upper lip vermilion(HP:0000219)|Intellectual disability, severe(HP:0010864)|Downslanted palpebral fissures(HP:0000494)|Facial palsy(HP:0010628)|Palmoplantar keratoderma(HP:0000982)|Elevated circulating creatine kinase concentration(HP:0003236)|Lipoatrophy(HP:0100578)|Abnormality of neutrophils(HP:0001874)|Myopathy(HP:0003198)|EMG abnormality(HP:0003457)|Dilated cardiomyopathy(HP:0001644)|Sensorineural hearing impairment(HP:0000407)","This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]","dystrophin","regulation of heart rate(GO:0002027)|cytoskeleton organization(GO:0007010)|muscle organ development(GO:0007517)|skeletal muscle tissue development(GO:0007519)|regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880)|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881)|regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809)|regulation of skeletal muscle contraction(GO:0014819)|actin cytoskeleton organization(GO:0030036)|negative regulation of peptidyl-serine phosphorylation(GO:0033137)|cellular protein localization(GO:0034613)|cellular protein-containing complex assembly(GO:0034622)|maintenance of blood-brain barrier(GO:0035633)|response to muscle stretch(GO:0035994)|peptide biosynthetic process(GO:0043043)|muscle cell cellular homeostasis(GO:0046716)|neuron development(GO:0048666)|muscle cell development(GO:0055001)|muscle cell development(GO:0055001)|cardiac muscle contraction(GO:0060048)|regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314)|cardiac muscle cell action potential(GO:0086001)|regulation of muscle system process(GO:0090257)|regulation of voltage-gated calcium channel activity(GO:1901385)|negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083)|positive regulation of sodium ion transmembrane transporter activity(GO:2000651)","cytosol(GO:0005829)|cytoskeleton(GO:0005856)|plasma membrane(GO:0005886)|cell surface(GO:0009986)|dystrophin-associated glycoprotein complex(GO:0016010)|dystrophin-associated glycoprotein complex(GO:0016010)|dystrophin-associated glycoprotein complex(GO:0016010)|syntrophin complex(GO:0016013)|lateral plasma membrane(GO:0016328)|Z disc(GO:0030018)|cell junction(GO:0030054)|cell-substrate junction(GO:0030055)|filopodium(GO:0030175)|cortical actin cytoskeleton(GO:0030864)|filopodium membrane(GO:0031527)|protein-containing complex(GO:0032991)|sarcolemma(GO:0042383)|sarcolemma(GO:0042383)|cell projection(GO:0042995)|costamere(GO:0043034)|neuron projection terminus(GO:0044306)|membrane raft(GO:0045121)|synapse(GO:0045202)|postsynaptic membrane(GO:0045211)","dystroglycan binding(GO:0002162)|actin binding(GO:0003779)|actin binding(GO:0003779)|structural constituent of cytoskeleton(GO:0005200)|protein binding(GO:0005515)|zinc ion binding(GO:0008270)|structural constituent of muscle(GO:0008307)|structural constituent of muscle(GO:0008307)|myosin binding(GO:0017022)|vinculin binding(GO:0017166)|nitric-oxide synthase binding(GO:0050998)|actin filament binding(GO:0051015)","chronic lymphocytic leukemia(DOID:1040)|intellectual disability(DOID:1059)|myotonic dystrophy type 1(DOID:11722)|Duchenne muscular dystrophy(DOID:11723)|facioscapulohumeral muscular dystrophy(DOID:11727)|leukemia(DOID:1240)|dilated cardiomyopathy(DOID:12930)|melanoma(DOID:1909)|embryonal rhabdomyosarcoma(DOID:3246)|rhabdomyosarcoma(DOID:3247)|neuromuscular disease(DOID:440)|muscular atrophy(DOID:767)|myocarditis(DOID:820)|muscular dystrophy(DOID:9884)","Hypertrophic cardiomyopathy hcm|Arrhythmogenic right ventricular cardiomyopathy arvc|Dilated cardiomyopathy|Viral myocarditis","Wp arrhythmogenic right ventricular cardiomyopathy|Wp striated muscle contraction pathway|Wp ectoderm differentiation|Wp viral acute myocarditis","Extracellular matrix organization|Non integrin membrane ecm interactions|Striated muscle contraction|Muscle contraction","Agr pathway","G2m checkpoint|Myogenesis","SpliceAI>C|DMD|0.00|0.00|0.00|0.00|42|-35|1|11",".;.;.;.;.","","Score=941;Name=V$P53_02","0.0077","0.0005","0.002","0.0006","0.0073","","","0.0006","0.0077","T","0.054","D","0.021","B","0.001","B","0.0","N","0.239","N","0.940","","","T","0.08","N","-0.78","0.137","T","-0.448","T","0.356","T","0.018","0.127","T","0.070","20.5","2.078","5.64","5.734","15.303"
"chr12","40859390","40859390","->GACCA","","MUC19","exonic","unknown","","UNKNOWN","RP11-115F18.1;RNU6-713P","intergenic","","dist=21741;dist=88573","","MUC19:ENST00000454784.4:c.3884-1_3884insACCAG:p.?","1","0.3189837241610102","1.0","0.3124606572284411","0.3189837241610102","0.507300999481231","0.0049005536128879","","","","","","","","","","ENSG00000205592","MUC19","HGNC:14362","MUC19","283463","ENSG00000205592","uc058msm.1","0.31246065722844113","0.31898372416101023","1.0","","579","0/1","Het","38","27,11","0.710526315789474","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a member of the gel-forming mucin protein family. Mucin family members are glycoproteins that have tandem repeats which are extensively O-glycosylated. The structural features of mucin proteins are responsible for the gel-like properties of mucus. The encoded protein may be involved in disruption of the ocular surface in Sjogren syndrome. [provided by RefSeq, Apr 2014]","mucin 19, oligomeric","","extracellular region(GO:0005576)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)","","mucoepidermoid carcinoma(DOID:4531)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr11","64490435","64490436","CA>-","","NRXN2","splicing","","NM_015080:exon1:r.spl;NM_138732:exon1:r.spl","","NRXN2","splicing","","ENST00000377559.7_1:exon1:r.spl;ENST00000265459.11_1:exon1:r.spl","","NRXN2:ENST00000265459.6:c.-245+7_-245+8del:p.(=)","0.79425687","0.5000265036233031","0.794256865978241","0.3108185346084384","","","","","","","","","","","","","ENSG00000110076","NRXN2","HGNC:8009","NRXN2","9379","ENSG00000110076","uc021qkw.2","0.31081853460843845","0.5000265036233031","0.794256865978241","","582","0/1","Het","3","1,2","0.333333333333333","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010]","neurexin 2","neuron cell-cell adhesion(GO:0007158)|signal transduction(GO:0007165)|chemical synaptic transmission(GO:0007268)|neurotransmitter secretion(GO:0007269)|synapse assembly(GO:0007416)|adult behavior(GO:0030534)|social behavior(GO:0035176)|vocal learning(GO:0042297)|vocalization behavior(GO:0071625)|postsynaptic membrane assembly(GO:0097104)|gephyrin clustering involved in postsynaptic density assembly(GO:0097116)|neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118)|postsynaptic density protein 95 clustering(GO:0097119)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|protein-containing complex(GO:0032991)|presynapse(GO:0098793)","transmembrane signaling receptor activity(GO:0004888)|calcium channel regulator activity(GO:0005246)|metal ion binding(GO:0046872)|cell adhesion molecule binding(GO:0050839)|neuroligin family protein binding(GO:0097109)","","Cell adhesion molecules cams","Wp disruption of postsynaptic signalling by cnv","Neuronal system|Neurexins and neuroligins|Protein protein interactions at synapses","","Apical junction","","","Name=C-rich","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr7","99769449","99769449","C>T","","GPC2","exonic","nonsynonymous SNV","","GPC2:NM_152742:exon7:c.G1123A:p.E375K","GPC2","exonic","nonsynonymous SNV","","GPC2:ENST00000292377.4_1:exon7:c.G1123A:p.E375K","GPC2:ENST00000292377.2:c.1123G>A:p.(Glu375Lys)","0.791","0.5012530565727502","0.7910000085830688","0.3071544681183993","","","","","","","","","","","","","ENSG00000213420","GPC2","HGNC:4450","GPC2","221914","ENSG00000213420","uc003utv.3","0.3071544681183993","0.5012530565727502","0.7910000085830688","","586","0/1","Het","78","45,33","0.576923076923077","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","glypican 2","smoothened signaling pathway(GO:0007224)|regulation of signal transduction(GO:0009966)|positive regulation of neuron projection development(GO:0010976)|cell migration(GO:0016477)|neuron differentiation(GO:0030182)|regulation of protein localization to membrane(GO:1905475)","extracellular space(GO:0005615)|endoplasmic reticulum(GO:0005783)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|cell surface(GO:0009986)|lysosomal lumen(GO:0043202)|synapse(GO:0045202)|anchored component of plasma membrane(GO:0046658)|collagen-containing extracellular matrix(GO:0062023)","protein binding(GO:0005515)","","","","Glycosaminoglycan metabolism|Heparan sulfate heparin hs gag metabolism|Chondroitin sulfate dermatan sulfate metabolism|Metabolism of vitamins and cofactors|A tetrasaccharide linker sequence is required for gag synthesis|Hs gag biosynthesis|Hs gag degradation|Visual phototransduction|Diseases associated with glycosaminoglycan metabolism|Defective b4galt7 causes eds progeroid type|Defective ext2 causes exostoses 2|Diseases of glycosylation|Diseases of metabolism|Metabolism of fat soluble vitamins|Metabolism of carbohydrates|Sensory perception","","","","","","","","","","","","","","","","T","0.209","T","0.842","P","0.806","B","0.264","N","0.375","N","0.598","L","1.935","T","0.79","N","-1.13","0.344","T","-1.040","T","0.072","D","0.397","0.198","D","0.681","21.0","2.145","4.3","1.747","8.185"
"chr17","8076848","8076848","A>C","TMEM107:84314|SNORD118:727676","TMEM107","UTR3","","NM_032354:c.*673T>G;NM_183065:c.*673T>G","","SNORD118","ncRNA_exonic","","","","TMEM107:ENST00000449985.2:c.*722T>G:p.(=)","0.9898932","0.1575489621423348","0.9898931980133056","0.0717912076588515","0.3269368819733189","0.9866919815540314","0.3040280007127321","","","","","","","","","","ENSG00000179029","TMEM107","HGNC:28128","TMEM107","84314","ENSG00000179029","uc002gkg.5","0.3040280007127321","0.3269368819733189","0.9866919815540314","OMIM:617562 Meckel syndrome 13-autosomal_recessive;OMIM:617562 ?Joubert syndrome 29-autosomal_recessive;OMIM:617563 Orofaciodigital syndrome XVI-autosomal_recessive;ORPHA:564 Meckel syndrome-autosomal_recessive","592","0/1","Het","22","13,9","0.590909090909091","Pathogenic","True","Leukoencephalopathy_with_calcifications_and_cysts","MONDO:MONDO:0013803,MedGen:C3281200,OMIM:614561,Orphanet:ORPHA542310","NC_000017.10:g.8076848A>C","no_assertion_criteria_provided","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Meckel syndrome 13(617562)|Orofaciodigital syndrome xvi(617563)","Retrognathia(HP:0000278)|Postaxial hand polydactyly(HP:0001162)|Depressed nasal bridge(HP:0005280)|Hamartoma of tongue(HP:0011802)|Apnea(HP:0002104)|Ventriculomegaly(HP:0002119)|Ptosis(HP:0000508)|Retinopathy(HP:0000488)|Oculomotor apraxia(HP:0000657)|Molar tooth sign on MRI(HP:0002419)|Low-set ears(HP:0000369)|Inguinal hernia(HP:0000023)|Global developmental delay(HP:0001263)|Generalized hypotonia(HP:0001290)|Gray matter heterotopia(HP:0002282)|Inability to walk(HP:0002540)|Intellectual disability, severe(HP:0010864)|Ataxia(HP:0001251)|Short palpebral fissure(HP:0012745)|Autosomal recessive inheritance(HP:0000007)|Lobar holoprosencephaly(HP:0006870)|Dandy-Walker malformation(HP:0001305)|Pancreatic fibrosis(HP:0100732)|Aplasia/Hypoplasia of the iris(HP:0008053)|Talipes(HP:0001883)|Postaxial hand polydactyly(HP:0001162)|Sloping forehead(HP:0000340)|Microcornea(HP:0000482)|Postaxial foot polydactyly(HP:0001830)|Anencephaly(HP:0002323)|Furrowed tongue(HP:0000221)|Anophthalmia(HP:0000528)|Pancreatic cysts(HP:0001737)|Hydrocephalus(HP:0000238)|Cystic liver disease(HP:0006706)|Asplenia(HP:0001746)|Multicystic kidney dysplasia(HP:0000003)|Microcephaly(HP:0000252)|Cleft palate(HP:0000175)|True hermaphroditism(HP:0010459)|Low-set, posteriorly rotated ears(HP:0000368)|Abnormal chorioretinal morphology(HP:0000532)|Depressed nasal ridge(HP:0000457)|Cataract(HP:0000518)|Bowing of the long bones(HP:0006487)|Cryptorchidism(HP:0000028)|Accessory spleen(HP:0001747)|Microphthalmia(HP:0000568)|Male pseudohermaphroditism(HP:0000037)|Sclerocornea(HP:0000647)|Ureteral duplication(HP:0000073)|Optic atrophy(HP:0000648)|Urethral atresia(HP:0000068)|Full cheeks(HP:0000293)|Preaxial hand polydactyly(HP:0001177)|Aplasia/Hypoplasia of the tongue(HP:0010295)|Hypertelorism(HP:0000316)|Aplasia/Hypoplasia of the corpus callosum(HP:0007370)|Congenital hepatic fibrosis(HP:0002612)|Oligohydramnios(HP:0001562)|Micrognathia(HP:0000347)|Situs inversus totalis(HP:0001696)|Encephalocele(HP:0002084)|Ataxia(HP:0001251)|Cerebellar hypoplasia(HP:0001321)|Molar tooth sign on MRI(HP:0002419)|Oculomotor apraxia(HP:0000657)|Micrognathia(HP:0000347)|Flexion contracture(HP:0001371)|Autosomal recessive inheritance(HP:0000007)|Retinopathy(HP:0000488)|Global developmental delay(HP:0001263)|Intellectual disability(HP:0001249)|Polycystic kidney dysplasia(HP:0000113)|Occipital encephalocele(HP:0002085)","This gene encodes a transmembrane protein and component of the primary cilia transition zone. The encoded protein regulates ciliogenesis and ciliary protein composition. Human fibroblasts expressing a mutant allele of this gene exhibit reduced numbers of cilia, altered cilia length, and impaired sonic hedgehog signaling. In human patients, different mutations in this gene cause different ciliopathies, including Meckel-Gruber syndrome and orofaciodigital syndrome. [provided by RefSeq, May 2017]","transmembrane protein 107","detection of nodal flow(GO:0003127)|regulation of gene expression(GO:0010468)|neural tube patterning(GO:0021532)|embryonic digit morphogenesis(GO:0042733)|roof of mouth development(GO:0060021)|cilium assembly(GO:0060271)|cilium assembly(GO:0060271)|craniofacial suture morphogenesis(GO:0097094)|protein localization to ciliary transition zone(GO:1904491)|non-motile cilium assembly(GO:1905515)|non-motile cilium assembly(GO:1905515)","integral component of membrane(GO:0016021)|ciliary transition zone(GO:0035869)|MKS complex(GO:0036038)|MKS complex(GO:0036038)","molecular_function(GO:0003674)|protein binding(GO:0005515)","","","Wp genes related to primary cilium development based on crispr|Wp ciliopathies","","","","","","Name=U8","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","8076825","8076825","T>C","TMEM107:84314|SNORD118:727676","TMEM107","UTR3","","NM_032354:c.*696A>G;NM_183065:c.*696A>G","","SNORD118","ncRNA_exonic","","","","TMEM107:ENST00000449985.2:c.*745A>G:p.(=)","0.98349077","","","","0.3269368819733189","0.9866919815540314","0.3040280007127321","","","","","","","","","","ENSG00000179029","TMEM107","HGNC:28128","TMEM107","84314","ENSG00000179029","uc002gkg.5","0.3040280007127321","0.3269368819733189","0.9866919815540314","OMIM:617562 Meckel syndrome 13-autosomal_recessive;OMIM:617562 ?Joubert syndrome 29-autosomal_recessive;OMIM:617563 Orofaciodigital syndrome XVI-autosomal_recessive;ORPHA:564 Meckel syndrome-autosomal_recessive","593","0/1","Het","17","9,8","0.529411764705882","Pathogenic","True","Leukoencephalopathy_with_calcifications_and_cysts|not_provided","MONDO:MONDO:0013803,MedGen:C3281200,OMIM:614561,Orphanet:ORPHA542310|MedGen:CN517202","NC_000017.10:g.8076825T>C","no_assertion_criteria_provided","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Meckel syndrome 13(617562)|Orofaciodigital syndrome xvi(617563)","Retrognathia(HP:0000278)|Postaxial hand polydactyly(HP:0001162)|Depressed nasal bridge(HP:0005280)|Hamartoma of tongue(HP:0011802)|Apnea(HP:0002104)|Ventriculomegaly(HP:0002119)|Ptosis(HP:0000508)|Retinopathy(HP:0000488)|Oculomotor apraxia(HP:0000657)|Molar tooth sign on MRI(HP:0002419)|Low-set ears(HP:0000369)|Inguinal hernia(HP:0000023)|Global developmental delay(HP:0001263)|Generalized hypotonia(HP:0001290)|Gray matter heterotopia(HP:0002282)|Inability to walk(HP:0002540)|Intellectual disability, severe(HP:0010864)|Ataxia(HP:0001251)|Short palpebral fissure(HP:0012745)|Autosomal recessive inheritance(HP:0000007)|Lobar holoprosencephaly(HP:0006870)|Dandy-Walker malformation(HP:0001305)|Pancreatic fibrosis(HP:0100732)|Aplasia/Hypoplasia of the iris(HP:0008053)|Talipes(HP:0001883)|Postaxial hand polydactyly(HP:0001162)|Sloping forehead(HP:0000340)|Microcornea(HP:0000482)|Postaxial foot polydactyly(HP:0001830)|Anencephaly(HP:0002323)|Furrowed tongue(HP:0000221)|Anophthalmia(HP:0000528)|Pancreatic cysts(HP:0001737)|Hydrocephalus(HP:0000238)|Cystic liver disease(HP:0006706)|Asplenia(HP:0001746)|Multicystic kidney dysplasia(HP:0000003)|Microcephaly(HP:0000252)|Cleft palate(HP:0000175)|True hermaphroditism(HP:0010459)|Low-set, posteriorly rotated ears(HP:0000368)|Abnormal chorioretinal morphology(HP:0000532)|Depressed nasal ridge(HP:0000457)|Cataract(HP:0000518)|Bowing of the long bones(HP:0006487)|Cryptorchidism(HP:0000028)|Accessory spleen(HP:0001747)|Microphthalmia(HP:0000568)|Male pseudohermaphroditism(HP:0000037)|Sclerocornea(HP:0000647)|Ureteral duplication(HP:0000073)|Optic atrophy(HP:0000648)|Urethral atresia(HP:0000068)|Full cheeks(HP:0000293)|Preaxial hand polydactyly(HP:0001177)|Aplasia/Hypoplasia of the tongue(HP:0010295)|Hypertelorism(HP:0000316)|Aplasia/Hypoplasia of the corpus callosum(HP:0007370)|Congenital hepatic fibrosis(HP:0002612)|Oligohydramnios(HP:0001562)|Micrognathia(HP:0000347)|Situs inversus totalis(HP:0001696)|Encephalocele(HP:0002084)|Ataxia(HP:0001251)|Cerebellar hypoplasia(HP:0001321)|Molar tooth sign on MRI(HP:0002419)|Oculomotor apraxia(HP:0000657)|Micrognathia(HP:0000347)|Flexion contracture(HP:0001371)|Autosomal recessive inheritance(HP:0000007)|Retinopathy(HP:0000488)|Global developmental delay(HP:0001263)|Intellectual disability(HP:0001249)|Polycystic kidney dysplasia(HP:0000113)|Occipital encephalocele(HP:0002085)","This gene encodes a transmembrane protein and component of the primary cilia transition zone. The encoded protein regulates ciliogenesis and ciliary protein composition. Human fibroblasts expressing a mutant allele of this gene exhibit reduced numbers of cilia, altered cilia length, and impaired sonic hedgehog signaling. In human patients, different mutations in this gene cause different ciliopathies, including Meckel-Gruber syndrome and orofaciodigital syndrome. [provided by RefSeq, May 2017]","transmembrane protein 107","detection of nodal flow(GO:0003127)|regulation of gene expression(GO:0010468)|neural tube patterning(GO:0021532)|embryonic digit morphogenesis(GO:0042733)|roof of mouth development(GO:0060021)|cilium assembly(GO:0060271)|cilium assembly(GO:0060271)|craniofacial suture morphogenesis(GO:0097094)|protein localization to ciliary transition zone(GO:1904491)|non-motile cilium assembly(GO:1905515)|non-motile cilium assembly(GO:1905515)","integral component of membrane(GO:0016021)|ciliary transition zone(GO:0035869)|MKS complex(GO:0036038)|MKS complex(GO:0036038)","molecular_function(GO:0003674)|protein binding(GO:0005515)","","","Wp genes related to primary cilium development based on crispr|Wp ciliopathies","","","","","","Name=U8","","0.00006463","","","0.0001","0.0001","","","6.463e-05","5.688e-05","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr15","51514597","51514597","G>A","","CYP19A1","exonic","nonsynonymous SNV","","CYP19A1:NM_000103:exon5:c.C577T:p.R193C,CYP19A1:NM_031226:exon6:c.C577T:p.R193C","CYP19A1","exonic","nonsynonymous SNV","","CYP19A1:ENST00000405913.7_1:exon4:c.C577T:p.R193C,CYP19A1:ENST00000559878.5_1:exon4:c.C577T:p.R193C,CYP19A1:ENST00000396402.6_1:exon5:c.C577T:p.R193C,CYP19A1:ENST00000557858.5_1:exon5:c.C577T:p.R193C,CYP19A1:ENST00000396404.8_1:exon6:c.C577T:p.R193C","CYP19A1:ENST00000260433.2:c.577C>T:p.(Arg193Cys)","0.7859792","0.5036246229428798","0.7859792113304138","0.302606806524098","","","","","","","","","","","","","ENSG00000137869","CYP19A1","HGNC:2594","CYP19A1","1588","ENSG00000137869","uc001zza.5","0.302606806524098","0.5036246229428798","0.7859792113304138","OMIM:139300 Aromatase excess syndrome-autosomal_dominant;OMIM:613546 Aromatase deficiency-autosomal_recessive;ORPHA:91 Aromatase deficiency-autosomal_recessive","595","0/1","Het","106","71,35","0.669811320754717","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Aromatase excess syndrome(139300)|Aromatase deficiency(613546)","Autosomal recessive inheritance(HP:0000007)|Ovarian cyst(HP:0000138)|Delayed skeletal maturation(HP:0002750)|Female pseudohermaphroditism(HP:0010458)|Hypergonadotropic hypogonadism(HP:0000815)|Primary amenorrhea(HP:0000786)|Autosomal dominant inheritance(HP:0000006)|Short stature(HP:0004322)|Gynecomastia(HP:0000771)|Accelerated skeletal maturation(HP:0005616)|Generalized hirsutism(HP:0002230)|Growth delay(HP:0001510)|Hypergonadotropic hypogonadism(HP:0000815)|Hyperlipidemia(HP:0003077)|Female pseudohermaphroditism(HP:0010458)|Hepatic steatosis(HP:0001397)|Genu valgum(HP:0002857)|Delayed epiphyseal ossification(HP:0002663)|Eunuchoid habitus(HP:0003782)|Female infertility(HP:0008222)|Ambiguous genitalia, female(HP:0000061)|Bone pain(HP:0002653)|Type II diabetes mellitus(HP:0005978)|Tall stature(HP:0000098)|Osteoporosis(HP:0000939)|Acanthosis nigricans(HP:0000956)|Male infertility(HP:0003251)|Maternal virilization in pregnancy(HP:0008072)|Enlarged polycystic ovaries(HP:0008675)|Obesity(HP:0001513)|Primary amenorrhea(HP:0000786)|Osteopenia(HP:0000938)|Delayed skeletal maturation(HP:0002750)|Cryptorchidism(HP:0000028)|Insulin resistance(HP:0000855)|Macroorchidism, postpubertal(HP:0002050)","This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]","cytochrome P450 family 19 subfamily A member 1","steroid biosynthetic process(GO:0006694)|estrogen biosynthetic process(GO:0006703)|androgen catabolic process(GO:0006710)|female gonad development(GO:0008585)|sterol metabolic process(GO:0016125)|electron transport chain(GO:0022900)|response to estradiol(GO:0032355)|positive regulation of estradiol secretion(GO:2000866)","endoplasmic reticulum(GO:0005783)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum membrane(GO:0005789)|membrane(GO:0016020)|integral component of membrane(GO:0016021)","iron ion binding(GO:0005506)|steroid hydroxylase activity(GO:0008395)|electron transfer activity(GO:0009055)|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712)|oxygen binding(GO:0019825)|heme binding(GO:0020037)|aromatase activity(GO:0070330)|aromatase activity(GO:0070330)","prostate carcinoma(DOID:10286)|Alzheimer's disease(DOID:10652)|hypertension(DOID:10763)|essential hypertension(DOID:10825)|osteoporosis(DOID:11476)|polycystic ovary syndrome(DOID:11612)|hyperandrogenism(DOID:11613)|male infertility(DOID:12336)|leukemia(DOID:1240)|gynecomastia(DOID:12698)|leiomyoma(DOID:127)|uterine fibroid(DOID:13223)|estrogen excess(DOID:14336)|breast cancer(DOID:1612)|cancer(DOID:162)|atherosclerosis(DOID:1936)|syndrome(DOID:225)|breast carcinoma(DOID:3459)|choriocarcinoma(DOID:3594)|prostate disease(DOID:47)|hereditary Wilms' tumor(DOID:5183)|infertility(DOID:5223)|hereditary breast ovarian cancer syndrome(DOID:5683)|hepatocellular carcinoma(DOID:684)|neuroblastoma(DOID:769)|sporadic breast cancer(DOID:8029)|osteoarthritis(DOID:8398)|obesity(DOID:9970)","Steroid hormone biosynthesis","Wp integrated breast cancer pathway|Wp ovarian infertility genes|Wp tryptophan metabolism|Wp metapathway biotransformation phase i and ii|Wp follicle stimulating hormone fsh signaling pathway|Wp oxidation by cytochrome p450|Wp relationship between inflammation cox2 and egfr|Wp classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism","Estrogen biosynthesis|Metabolism of steroid hormones|Biological oxidations|Cytochrome p450 arranged by substrate type|Phase i functionalization of compounds|Endogenous sterols|Metabolism of lipids|Metabolic disorders of biological oxidation enzymes|Diseases of metabolism|Metabolism of steroids","","","SpliceAI>A|CYP19A1|0.00|0.00|0.00|0.00|-38|48|46|-32",".;.;.;.;.;.;.","","","0.000007957","","","0.","0.","","","7.957e-06","0","T","0.252","T","0.957","B","0.002","B","0.001","N","0.000","D","0.786","N","0.205","T","-0.42","N","2.93","0.297","T","-0.983","T","0.120","T","0.025","0.313","T","0.089","15.40","1.340","5.96","1.267","11.123"
"chr15","91452720","91452720","A>C","","MAN2A2","exonic","nonsynonymous SNV","","MAN2A2:NM_006122:exon8:c.A1360C:p.N454H","MAN2A2","exonic","nonsynonymous SNV","","MAN2A2:ENST00000360468.7_1:exon8:c.A1360C:p.N454H,MAN2A2:ENST00000559717.6_1:exon9:c.A1360C:p.N454H","MAN2A2:ENST00000360468.3:c.1360A>C:p.(Asn454His)","0.9833617","","","","0.5026166448369622","0.7799627482891083","0.2889176448146353","","","","","","","","","","ENSG00000196547","MAN2A2","HGNC:6825","MAN2A2","4122","ENSG00000196547","uc010bnz.3","0.2889176448146353","0.5026166448369622","0.7799627482891083","","597","0/1","Het","40","17,23","0.425","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","mannosidase alpha class 2A member 2","mannose metabolic process(GO:0006013)|protein glycosylation(GO:0006486)|N-glycan processing(GO:0006491)|protein deglycosylation(GO:0006517)","Golgi membrane(GO:0000139)|Golgi membrane(GO:0000139)|integral component of membrane(GO:0016021)","alpha-mannosidase activity(GO:0004559)|mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572)|hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799)|carbohydrate binding(GO:0030246)|metal ion binding(GO:0046872)","","N glycan biosynthesis","","Membrane trafficking|Asparagine n linked glycosylation|Vesicle mediated transport|Post translational protein modification|Intra golgi traffic|Intra golgi and retrograde golgi to er traffic|Transport to the golgi and subsequent modification|N glycan antennae elongation in the medial trans golgi|Reactions specific to the complex n glycan synthesis pathway","Aman pathway|Erad pathway","","SpliceAI>C|MAN2A2|0.00|0.00|0.00|0.05|-7|15|16|8","Glycoside","","","0.00008754","0.0006","0.003","0.0001","0.001","","","8.754e-05","0.0012","T","0.187","T","0.253","B","0.0","B","0.002","N","0.008","D","1","N","0.205","T","1.99","N","-0.46","0.133","T","-1.090","T","0.028","T","0.004","0.061","T","0.026","16.34","1.513","5.74","2.126","16.082"
"chr2","108479427","108479427","G>A","","RGPD4","exonic","nonsynonymous SNV","","RGPD4:NM_182588:exon17:c.G2408A:p.R803Q","RGPD4","exonic","nonsynonymous SNV","","RGPD4:ENST00000408999.4_1:exon17:c.G2408A:p.R803Q","RGPD4:ENST00000354986.4:c.2408G>A:p.(Arg803Gln)","0.7748483","0.5002281146589667","0.7748482823371887","0.2743935384773616","0.5002281146589667","0.4557860940694809","0.0197888187423416","","","","","","","","","","ENSG00000196862","RGPD4","HGNC:32417","RGPD4","285190","ENSG00000196862","uc010ywk.3","0.27439353847736164","0.5002281146589667","0.7748482823371887","","604","0/1","Het","166","90,76","0.542168674698795","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","RANBP2 like and GRIP domain containing 4","NLS-bearing protein import into nucleus(GO:0006607)|regulation of catalytic activity(GO:0050790)","nuclear pore(GO:0005643)|cytoplasm(GO:0005737)","GTPase activator activity(GO:0005096)","","","","","","","SpliceAI>A|RGPD4|0.00|0.00|0.00|0.00|9|-22|-3|46","","","Score=845;Name=V$CDPCR1_01","0.00006174","","","0.0001","0.0005","","","6.174e-05","0.0003","T","0.222","T","0.529","B","0.003","B","0.0","","","N","0.964","N","-0.035","T","1.95","N","-0.83","0.176","T","-0.996","T","0.025","T","0.002","0.028","T","0.014","12.75","0.904","2.3","1.451","6.146"
"chr9","113137746","113137748","AAA>-","","SVEP1","splicing","","NM_153366:exon46:r.spl","","SVEP1","splicing","","ENST00000374469.6_1:exon46:r.spl;ENST00000401783.6_1:exon46:r.spl","","SVEP1:ENST00000297826.5:c.4283-5_4283-3del:p.?","0.8","0.4564903113011568","0.800000011920929","0.232171730573397","","","","","","","","","","","","","ENSG00000165124","SVEP1","HGNC:15985","SVEP1","79987","ENSG00000165124","uc010mtz.4","0.23217173057339704","0.4564903113011568","0.800000011920929","","614","0/1","Het","52","22,30","0.423076923076923","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1","lymph circulation(GO:0003017)|cell adhesion(GO:0007155)|epidermis development(GO:0008544)|gene expression(GO:0010467)|lymph vessel morphogenesis(GO:0036303)|Tie signaling pathway(GO:0048014)|tight junction organization(GO:0120193)","extracellular space(GO:0005615)|nucleus(GO:0005634)|cytoplasm(GO:0005737)|membrane(GO:0016020)","chromatin binding(GO:0003682)|calcium ion binding(GO:0005509)","","","","","","","SpliceAI>T|SVEP1|0.04|0.00|0.00|0.00|-2|17|-2|3","","Name=(A)n","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr21","33691626","33691626","C>T","","URB1","exonic","nonsynonymous SNV","","URB1:NM_014825:exon36:c.G5693A:p.R1898H","URB1","exonic","nonsynonymous SNV","","URB1:ENST00000382751.4_1:exon36:c.G5693A:p.R1898H","URB1:ENST00000382751.3:c.5693G>A:p.(Arg1898His)","0.7273404","0.5000013955763052","0.7273404002189636","0.1960599136179676","","","","","","","","","","","","","ENSG00000142207","URB1","HGNC:17344","URB1","9875","ENSG00000142207","uc002ypn.3","0.19605991361796765","0.5000013955763052","0.7273404002189636","","621","0/1","Het","190","113,77","0.594736842105263","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","URB1 ribosome biogenesis homolog","maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463)|maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466)|biological_process(GO:0008150)","fibrillar center(GO:0001650)|nucleolus(GO:0005730)|nucleolus(GO:0005730)|nucleolus(GO:0005730)","RNA binding(GO:0003723)","","","","","","","SpliceAI>T|URB1|0.00|0.00|0.00|0.00|-16|22|48|50","","","","0.00001955","","","","","","","1.955e-05","0","T","0.272","T","0.214","B","0.0","B","0.0","N","0.915","N","1","N","0.14","T","1.55","N","-0.31","0.024","T","-0.996","T","0.029","T","0.005","0.002","T","0.168","0.340","-0.311","4.63","-0.046","3.489"
"chr10","55912900","55912900","T>C","","PCDH15","exonic","nonsynonymous SNV","","PCDH15:NM_001142767:exon13:c.A1633G:p.T545A,PCDH15:NM_001142768:exon13:c.A1678G:p.T560A,PCDH15:NM_001142773:exon13:c.A1678G:p.T560A,PCDH15:NM_001142764:exon14:c.A1744G:p.T582A,PCDH15:NM_001142765:exon14:c.A1744G:p.T582A,PCDH15:NM_001142766:exon14:c.A1744G:p.T582A,PCDH15:NM_033056:exon14:c.A1744G:p.T582A,PCDH15:NM_001142763:exon15:c.A1759G:p.T587A","PCDH15","exonic","nonsynonymous SNV","","PCDH15:ENST00000409834.5_1:exon7:c.A577G:p.T193A,PCDH15:ENST00000395433.5_1:exon13:c.A1678G:p.T560A,PCDH15:ENST00000320301.11_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000361849.7_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000373955.5_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000373965.6_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000395430.5_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000395446.5_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000437009.5_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000616114.4_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000617271.4_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000644397.2_1:exon14:c.A1744G:p.T582A,PCDH15:ENST00000373957.7_1:exon15:c.A1759G:p.T587A,PCDH15:ENST00000395445.6_1:exon15:c.A1765G:p.T589A,PCDH15:ENST00000621708.4_1:exon15:c.A1759G:p.T587A,PCDH15:ENST00000613657.5_1:exon16:c.A1780G:p.T594A","PCDH15:ENST00000320301.6:c.1744A>G:p.(Thr582Ala)","1","0.2566604693420231","1.0","0.1920941078203386","","","","","","","","","","","","","ENSG00000150275","PCDH15","HGNC:14674","PCDH15","65217","ENSG00000150275","uc057tid.1","0.19209410782033864","0.25666046934202313","1.0","OMIM:601067 Usher syndrome, type 1D/F digenic-autosomal_recessive;OMIM:602083 Usher syndrome, type 1F-autosomal_recessive;OMIM:609533 Deafness, autosomal recessive 23-autosomal_recessive;ORPHA:231169 Usher syndrome type 1-autosomal_recessive;ORPHA:231169 Usher syndrome type 1-autosomal_recessive","622","0/1","Het","61","34,27","0.557377049180328","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Usher syndrome, type id(601067)|Usher syndrome, type if(602083)|Deafness, autosomal recessive 23(609533)","Vestibular dysfunction(HP:0001751)|Autosomal recessive inheritance(HP:0000007)|Rod-cone dystrophy(HP:0000510)|Hearing impairment(HP:0000365)|Autosomal recessive inheritance(HP:0000007)|Infantile onset(HP:0003593)|Sensorineural hearing impairment(HP:0000407)|Intellectual disability(HP:0001249)|Iris hypopigmentation(HP:0007730)|Hemianopia(HP:0012377)|Nyctalopia(HP:0000662)|Cataract(HP:0000518)|Abnormal dental enamel morphology(HP:0000682)|Anxiety(HP:0000739)|Abnormal cochlea morphology(HP:0000375)|Schizophrenia(HP:0100753)|High hypermetropia(HP:0008499)|Ataxia(HP:0001251)|Global developmental delay(HP:0001263)|Cerebral cortical atrophy(HP:0002120)|Sensorineural hearing impairment(HP:0000407)|Depression(HP:0000716)|Abnormal electroretinogram(HP:0000512)|Vestibular hypofunction(HP:0001756)|Hallucinations(HP:0000738)|Aplasia/Hypoplasia of the cerebellum(HP:0007360)|Scotoma(HP:0000575)|Visual loss(HP:0000572)|Subcortical cerebral atrophy(HP:0012157)|Autosomal recessive inheritance(HP:0000007)|Motor delay(HP:0001270)|Rod-cone dystrophy(HP:0000510)|Congenital sensorineural hearing impairment(HP:0008527)","This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]","protocadherin related 15","cell adhesion(GO:0007155)|homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156)|sensory perception of sound(GO:0007605)|sensory perception of sound(GO:0007605)|photoreceptor cell maintenance(GO:0045494)|inner ear development(GO:0048839)|sensory perception of light stimulus(GO:0050953)|equilibrioception(GO:0050957)","photoreceptor outer segment(GO:0001750)|extracellular region(GO:0005576)|integral component of plasma membrane(GO:0005887)|stereocilium(GO:0032420)|synapse(GO:0045202)","calcium ion binding(GO:0005509)","syndrome(DOID:225)|disease(DOID:4)","","","Sensory processing of sound|Sensory processing of sound by outer hair cells of the cochlea|Sensory perception","","","","Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;.;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;.;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;Cadherin-like|Cadherin-like|Cadherin-like;.","","","","","","","","","","","","D","0.014","D","0.006","D","1.0","D","0.999","","","D","1","M","2.795","T","0.51","D","-3.12","0.859","T","-0.262","T","0.362","D","0.116","0.532","D","0.928","23.8","3.099","5.83","7.467","15.873"
"chr6","33635728","33635728","A>G","","ITPR3","exonic","nonsynonymous SNV","","ITPR3:NM_002224:exon16:c.A1873G:p.N625D","ITPR3","exonic","nonsynonymous SNV","","ITPR3:ENST00000605930.3_1:exon16:c.A1873G:p.N625D,ITPR3:ENST00000374316.9_1:exon17:c.A1873G:p.N625D","ITPR3:ENST00000374316.5:c.1873A>G:p.(Asn625Asp)","0.999998","0.2510559512302279","0.9999979734420776","0.1832120908474029","","","","","","","","","","","","","ENSG00000096433","ITPR3","HGNC:6182","ITPR3","3710","ENSG00000096433","uc063nyh.1","0.18321209084740292","0.25105595123022795","0.9999979734420776","OMIM:222100 Diabetes, type 1, susceptibility to-autosomal_recessive","630","0/1","Het","69","40,29","0.579710144927536","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Type 1 diabetes mellitus(222100)","Polydipsia(HP:0001959)|Polyphagia(HP:0002591)|Hyperglycemia(HP:0003074)|Decreased level of 1,5 anhydroglucitol in serum(HP:0410050)|Heterogeneous(HP:0001425)|Polyuria(HP:0000103)|Autoimmunity(HP:0002960)|Diabetes mellitus(HP:0000819)|Ketoacidosis(HP:0001993)","This gene encodes a receptor for inositol 1,4,5-trisphosphate, a second messenger that mediates the release of intracellular calcium. The receptor contains a calcium channel at the C-terminus and the ligand-binding site at the N-terminus. Knockout studies in mice suggest that type 2 and type 3 inositol 1,4,5-trisphosphate receptors play a key role in exocrine secretion underlying energy metabolism and growth. [provided by RefSeq, Aug 2010]","inositol 1,4,5-trisphosphate receptor type 3","G protein-coupled receptor signaling pathway(GO:0007186)|positive regulation of cytosolic calcium ion concentration(GO:0007204)|memory(GO:0007613)|inositol phosphate-mediated signaling(GO:0048016)|sensory perception of bitter taste(GO:0050913)|sensory perception of sweet taste(GO:0050916)|sensory perception of umami taste(GO:0050917)|release of sequestered calcium ion into cytosol(GO:0051209)|response to calcium ion(GO:0051592)|long-term synaptic potentiation(GO:0060291)|calcium ion transport into cytosol(GO:0060402)","nuclear outer membrane(GO:0005640)|nucleoplasm(GO:0005654)|nucleolus(GO:0005730)|cytoplasm(GO:0005737)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum membrane(GO:0005789)|endoplasmic reticulum membrane(GO:0005789)|endoplasmic reticulum membrane(GO:0005789)|endoplasmic reticulum membrane(GO:0005789)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|brush border(GO:0005903)|membrane(GO:0016020)|sarcoplasmic reticulum(GO:0016529)|cytoplasmic vesicle membrane(GO:0030659)|secretory granule membrane(GO:0030667)|platelet dense tubular network membrane(GO:0031095)|neuronal cell body(GO:0043025)|myelin sheath(GO:0043209)|receptor complex(GO:0043235)|apical part of cell(GO:0045177)","inositol hexakisphosphate binding(GO:0000822)|inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220)|inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220)|inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|calcium-release channel activity(GO:0015278)|phosphatidylinositol binding(GO:0035091)|inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533)|inositol 1,4,5 trisphosphate binding(GO:0070679)|inositol 1,4,5 trisphosphate binding(GO:0070679)","Huntington's disease(DOID:12858)|Sjogren's syndrome(DOID:12894)|Kawasaki disease(DOID:13378)|cancer(DOID:162)|syndrome(DOID:225)|diabetes mellitus(DOID:9351)|systemic lupus erythematosus(DOID:9074)|stomach cancer(DOID:10534)|disease(DOID:4)|type 2 diabetes mellitus(DOID:9352)","Taste transduction|Calcium signaling pathway|Phosphatidylinositol signaling system|Oocyte meiosis|Vascular smooth muscle contraction|Gap junction|Long term potentiation|Long term depression|Gnrh signaling pathway|Alzheimers disease","Wp calcium regulation in the cardiac cell|Wp alzheimers disease|Wp mfap5mediated ovarian cancer cell motility and invasiveness|Wp myometrial relaxation and contraction pathways|Wp gpr40 pathway|Wp vitamin dsensitive calcium signaling in depression|Wp renin angiotensin aldosterone system raas|Wp airway smooth muscle cell contraction","Hemostasis|Opioid signalling|G protein mediated events|Effects of pip2 hydrolysis|Adaptive immune system|Elevation of cytosolic ca2 levels|Dag and ip3 signaling|Integration of energy metabolism|Innate immune system|Signaling by vegf|Signaling by wnt|Fcgamma receptor fcgr dependent phagocytosis|Role of phospholipids in phagocytosis|Fc epsilon receptor fceri signaling|Fceri mediated ca 2 mobilization|Signaling by gpcr|Glucagon like peptide 1 glp1 regulates insulin secretion|Beta catenin independent wnt signaling|Muscle contraction|Ca2 pathway|G alpha q signalling events|Platelet homeostasis|Platelet calcium homeostasis|G alpha i signalling events|Regulation of insulin secretion|Vegfr2 mediated cell proliferation|Cardiac conduction|Ion homeostasis|Clec7a dectin 1 induces nfat activation|Clec7a dectin 1 signaling|C type lectin receptors clrs|Infectious disease|Platelet activation signaling and aggregation|Intracellular signaling by second messengers|Signaling by receptor tyrosine kinases|Leishmania infection|Anti inflammatory response favouring leishmania parasite infection|Fcgr3a mediated il10 synthesis|Antigen activates b cell receptor bcr leading to generation of second messengers|Signaling by the b cell receptor bcr","","","","RIH","","Score=858;Name=V$ZID_01","","","","","","","","","","D","0.006","D","0.009","D","0.973","P","0.825","D","0.000","D","1.000","M","2.69","D","-3.73","D","-4.36","0.596","D","0.989","D","0.893","D","0.154","0.869","D","0.994","28.1","4.042","5.28","9.288","15.203"
"chr12","133338300","133338300","G>A","","ANKLE2","exonic","nonsynonymous SNV","","ANKLE2:NM_015114:exon1:c.C85T:p.R29W","ANKLE2","exonic","nonsynonymous SNV","","ANKLE2:ENST00000357997.10_1:exon1:c.C85T:p.R29W","ANKLE2:ENST00000337516.5:c.85C>T:p.(Arg29Trp)","1","0.2501095455081668","1.0","0.1817473184776462","","","","","","","","","","","","","ENSG00000176915","ANKLE2","HGNC:29101","ANKLE2","23141","ENSG00000176915","uc001ukx.3","0.18174731847764625","0.2501095455081668","1.0","OMIM:616681 Microcephaly 16, primary, autosomal recessive-autosomal_recessive;ORPHA:2512 Autosomal recessive primary microcephaly-autosomal_recessive","631","0/1","Het","8","6,2","0.75","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Microcephaly 16, primary, autosomal recessive(616681)","Global developmental delay(HP:0001263)|Agenesis of corpus callosum(HP:0001274)|Short stature(HP:0004322)|Autosomal recessive inheritance(HP:0000007)|Micrognathia(HP:0000347)|Glaucoma(HP:0000501)|Spastic tetraplegia(HP:0002510)|Decreased body weight(HP:0004325)|Knee flexion contracture(HP:0006380)|Open mouth(HP:0000194)|Sloping forehead(HP:0000340)|Microcephaly(HP:0000252)|Telecanthus(HP:0000506)|Simplified gyral pattern(HP:0009879)|Seizure(HP:0001250)|Ptosis(HP:0000508)|Adducted thumb(HP:0001181)|Cryptorchidism(HP:0000028)|Unilateral renal agenesis(HP:0000122)|Thin upper lip vermilion(HP:0000219)|Abnormal cortical bone morphology(HP:0003103)|Short stature(HP:0004322)|Upslanted palpebral fissure(HP:0000582)|Ventriculomegaly(HP:0002119)|Global developmental delay(HP:0001263)|Agenesis of corpus callosum(HP:0001274)|Hyperreflexia(HP:0001347)|Hypoplasia of the frontal lobes(HP:0007333)|Vesicoureteral reflux(HP:0000076)|Gray matter heterotopia(HP:0002282)|Microcephaly(HP:0000252)|Sloping forehead(HP:0000340)|Intellectual disability, severe(HP:0010864)|Pachygyria(HP:0001302)","This gene encodes a member of the LEM family of inner nuclear membrane proteins. The encoded protein functions as a mitotic regulator through postmitotic formation of the nuclear envelope. Mutations in this gene cause morphology defects in the nuclear envelope and BAF hyperphosphorylation. [provided by RefSeq, Mar 2014]","ankyrin repeat and LEM domain containing 2","mitotic nuclear membrane reassembly(GO:0007084)|central nervous system development(GO:0007417)|positive regulation of protein dephosphorylation(GO:0035307)|positive regulation of protein dephosphorylation(GO:0035307)|negative regulation of phosphorylation(GO:0042326)|negative regulation of phosphorylation(GO:0042326)|negative regulation of apoptotic process(GO:0043066)|regulation of catalytic activity(GO:0050790)|cell division(GO:0051301)","endoplasmic reticulum(GO:0005783)|endoplasmic reticulum membrane(GO:0005789)|membrane(GO:0016020)|integral component of endoplasmic reticulum membrane(GO:0030176)","protein binding(GO:0005515)|protein phosphatase regulator activity(GO:0019888)|protein phosphatase 2A binding(GO:0051721)|protein phosphatase 2A binding(GO:0051721)","","","","Cell cycle|Mitotic metaphase and anaphase|Initiation of nuclear envelope ne reformation|Nuclear envelope ne reassembly|M phase|Cell cycle mitotic|Rho gtpase cycle|Rac2 gtpase cycle|Rhog gtpase cycle|Signaling by rho gtpases miro gtpases and rhobtb3","","","","","","","0","","","","","","","0","0","D","0.021","D","0.036","D","1.0","D","0.958","N","0.003","D","1","L","0.975","T","1.78","N","-0.88","0.424","T","-1.040","T","0.116","D","0.904","0.187","D","0.878","30","4.271","3.47","1.221","9.020"
"chr1","113641340","113641340","A>C","","LRIG2","exonic","nonsynonymous SNV","","LRIG2:NM_014813:exon9:c.A1105C:p.N369H,LRIG2:NM_001312686:exon10:c.A796C:p.N266H","LRIG2","exonic","nonsynonymous SNV","","LRIG2:ENST00000361127.6_1:exon9:c.A1105C:p.N369H","LRIG2:ENST00000361127.5:c.1105A>C:p.(Asn369His)","1","0.2500305828507407","1.0","0.1816252881513362","","","","","","","","","","","","","ENSG00000198799","LRIG2","HGNC:20889","LRIG2","9860","ENSG00000198799","uc001edf.2","0.18162528815133627","0.25003058285074076","1.0","OMIM:615112 Urofacial syndrome 2-autosomal_recessive;ORPHA:2704 Ochoa syndrome-autosomal_recessive","634","0/1","Het","133","80,53","0.601503759398496","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Urofacial syndrome 2(615112)","Urinary urgency(HP:0000012)|Renal insufficiency(HP:0000083)|Vesicoureteral reflux(HP:0000076)|Constipation(HP:0002019)|Autosomal recessive inheritance(HP:0000007)|Hydronephrosis(HP:0000126)|Recurrent urinary tract infections(HP:0000010)|Enuresis(HP:0000805)|Cryptorchidism(HP:0000028)|Hypertension(HP:0000822)|Vesicoureteral reflux(HP:0000076)|Urinary incontinence(HP:0000020)|Constipation(HP:0002019)|Recurrent urinary tract infections(HP:0000010)|Hydronephrosis(HP:0000126)|Renal insufficiency(HP:0000083)|Bowel incontinence(HP:0002607)|Polydipsia(HP:0001959)|Urethral obstruction(HP:0000796)","This gene encodes a transmembrane protein containing leucine-rich repeats and immunoglobulin-like domains. The encoded protein promotes epidermal growth factor signalling, resulting in increased proliferation. Its expression in the cytoplasm of glioma cells is correlated with poor survival. Mutations in this gene can cause urofacial syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]","leucine rich repeats and immunoglobulin like domains 2","sensory perception of sound(GO:0007605)|regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640)|negative regulation of axon regeneration(GO:0048681)|negative regulation of membrane protein ectodomain proteolysis(GO:0051045)|innervation(GO:0060384)|positive regulation of protein localization to cell surface(GO:2000010)|regulation of neuron migration(GO:2001222)","extracellular space(GO:0005615)|cytoplasm(GO:0005737)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|growth cone(GO:0030426)|extracellular matrix(GO:0031012)|neuronal cell body(GO:0043025)|intracellular vesicle(GO:0097708)","signaling receptor binding(GO:0005102)|protein binding(GO:0005515)","oligodendroglioma(DOID:3181)","","","","","","","","","","","","","","","","","","","D","0.001","D","0.002","D","1.0","D","1.0","D","0.000","D","1","H","4.585","T","-0.26","D","-4.27","0.94","D","0.471","D","0.584","D","0.118","0.707","D","1.000","26.9","3.906","5.54","8.925","15.671"
"chr3","33175692","33175692","A>G","","CRTAP","exonic","nonsynonymous SNV","","CRTAP:NM_006371:exon6:c.A1087G:p.N363D","CRTAP","exonic","nonsynonymous SNV","","CRTAP:ENST00000449224.1_1:exon5:c.A958G:p.N320D,CRTAP:ENST00000320954.11_1:exon6:c.A1087G:p.N363D","CRTAP:ENST00000320954.6:c.1087A>G:p.(Asn363Asp)","1","0.2500078354851212","1.0","0.1815901457889548","","","","","","","","","","","","","ENSG00000170275","CRTAP","HGNC:2379","CRTAP","10491","ENSG00000170275","uc003cfl.5","0.1815901457889548","0.2500078354851212","1.0","OMIM:610682 Osteogenesis imperfecta, type VII-autosomal_recessive","637","0/1","Het","61","39,22","0.639344262295082","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Osteogenesis imperfecta, type vii(610682)","Multiple rib fractures(HP:0006640)|Wide anterior fontanel(HP:0000260)|Absent pulmonary artery(HP:0004960)|Coxa vara(HP:0002812)|Bowing of the legs(HP:0002979)|Crumpled long bones(HP:0006367)|Multiple prenatal fractures(HP:0005855)|Wormian bones(HP:0002645)|Long philtrum(HP:0000343)|Vertebral compression fracture(HP:0002953)|Proptosis(HP:0000520)|Externally rotated/abducted legs(HP:0003783)|Blue sclerae(HP:0000592)|Narrow chest(HP:0000774)|Autosomal recessive inheritance(HP:0000007)|Delayed cranial suture closure(HP:0000270)|Death in infancy(HP:0001522)|Hypoplastic pulmonary veins(HP:0005304)|Breech presentation(HP:0001623)|Scoliosis(HP:0002650)|Hydronephrosis(HP:0000126)|Round face(HP:0000311)|Osteopenia(HP:0000938)|Recurrent fractures(HP:0002757)|Wide cranial sutures(HP:0010537)|Rhizomelia(HP:0008905)|Protrusio acetabuli(HP:0003179)|Decreased calvarial ossification(HP:0005474)|Pectus excavatum(HP:0000767)|Micromelia(HP:0002983)","The protein encoded by this gene is similar to the chicken and mouse CRTAP genes. The encoded protein is a scaffolding protein that may influence the activity of at least one member of the cytohesin/ARNO family in response to specific cellular stimuli. Defects in this gene are associated with osteogenesis imperfecta, a connective tissue disorder characterized by bone fragility and low bone mass. [provided by RefSeq, Jul 2008]","cartilage associated protein","spermatogenesis(GO:0007283)|peptidyl-proline hydroxylation to 3-hydroxy-L-proline(GO:0018400)|collagen fibril organization(GO:0030199)|protein stabilization(GO:0050821)|chaperone-mediated protein folding(GO:0061077)|negative regulation of post-translational protein modification(GO:1901874)","extracellular space(GO:0005615)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum lumen(GO:0005788)|protein-containing complex(GO:0032991)","protein binding(GO:0005515)|collagen binding(GO:0005518)","osteogenesis imperfecta(DOID:12347)|connective tissue disease(DOID:65)","","Wp type i collagen synthesis in the context of osteogenesis imperfecta","Extracellular matrix organization|Collagen formation|Collagen biosynthesis and modifying enzymes","","","",".;.","","","","","","","","","","","","D","0.005","D","0.017","D","0.998","D","0.991","D","0.000","D","1","M","2.265","T","0.37","D","-3.23","0.822","T","-0.428","T","0.367","D","0.071","0.370","D","0.975","26.0","3.758","4.96","8.456","14.934"
"chr19","19308935","19308935","T>C","","RFXANK","exonic","nonsynonymous SNV","","RFXANK:NM_001278728:exon5:c.T389C:p.L130P,RFXANK:NM_001278727:exon6:c.T392C:p.L131P,RFXANK:NM_134440:exon6:c.T389C:p.L130P,RFXANK:NM_003721:exon7:c.T458C:p.L153P","RFXANK","exonic","nonsynonymous SNV","","RFXANK:ENST00000392324.8_1:exon5:c.T389C:p.L130P,RFXANK:ENST00000407360.7_1:exon6:c.T458C:p.L153P,RFXANK:ENST00000456252.7_1:exon6:c.T392C:p.L131P,RFXANK:ENST00000303088.9_1:exon7:c.T458C:p.L153P","RFXANK:ENST00000303088.4:c.458T>C:p.(Leu153Pro)","1","0.2500060779598243","1.0","0.1815874308116279","","","","","","","","","","","","","ENSG00000064490","RFXANK","HGNC:9987","RFXANK","8625","ENSG00000064490","uc002nls.4","0.1815874308116279","0.2500060779598243","1.0","OMIM:209920 MHC class II deficiency, complementation group B-autosomal_recessive;ORPHA:572 Immunodeficiency by defective expression of MHC class II-autosomal_recessive","638","0/1","Het","174","102,72","0.586206896551724","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Bare lymphocyte syndrome, type ii(209920)","Rhinitis(HP:0012384)|Skin rash(HP:0000988)|Abnormal facial shape(HP:0001999)|Decreased circulating beta-2-microglobulin level(HP:0025347)|Recurrent candida infections(HP:0005401)|Decreased proportion of CD4-positive helper T cells(HP:0005407)|Reduced MHC II surface expression(HP:0031390)|Acute otitis media(HP:0000371)|Autoimmune thrombocytopenia(HP:0001973)|Decreased lymphocyte proliferation in response to mitogen(HP:0031381)|Dysarthria(HP:0001260)|Gait ataxia(HP:0002066)|Recurrent respiratory infections(HP:0002205)|Recurrent protozoan infections(HP:0005386)|Recurrent infection of the gastrointestinal tract(HP:0004798)|Autoimmune hemolytic anemia(HP:0001890)|Neutropenia in presence of anti-neutropil antibodies(HP:0001904)|Protracted diarrhea(HP:0004385)|Lack of T cell function(HP:0005354)|Abnormal CD4:CD8 ratio(HP:0031394)|Chronic hepatitis due to cryptosporidium infection(HP:0200124)|Chronic mucocutaneous candidiasis(HP:0002728)|Sinusitis(HP:0000246)|Recurrent herpes(HP:0005353)|Pancytopenia(HP:0001876)|Failure to thrive(HP:0001508)|Sclerosing cholangitis(HP:0030991)|Recurrent Staphylococcus aureus infections(HP:0002726)|Panhypogammaglobulinemia(HP:0003139)|Villous atrophy(HP:0011473)|Autosomal recessive inheritance(HP:0000007)|Protracted diarrhea(HP:0004385)|Recurrent bacterial infections(HP:0002718)|Infectious encephalitis(HP:0002383)|Chronic mucocutaneous candidiasis(HP:0002728)|Colitis(HP:0002583)|Cutaneous anergy(HP:0002965)|Chronic lymphocytic meningitis(HP:0007041)|Recurrent protozoan infections(HP:0005386)|Viral hepatitis(HP:0006562)|Recurrent urinary tract infections(HP:0000010)|Failure to thrive(HP:0001508)|Cholangitis(HP:0030151)|Recurrent lower respiratory tract infections(HP:0002783)|Recurrent upper respiratory tract infections(HP:0002788)|Recurrent fungal infections(HP:0002841)|Recurrent viral infections(HP:0004429)|Neutropenia(HP:0001875)|Panhypogammaglobulinemia(HP:0003139)|Agammaglobulinemia(HP:0004432)|Malabsorption(HP:0002024)","Major histocompatibility (MHC) class II molecules are transmembrane proteins that have a central role in development and control of the immune system. The protein encoded by this gene, along with regulatory factor X-associated protein and regulatory factor-5, forms a complex that binds to the X box motif of certain MHC class II gene promoters and activates their transcription. Once bound to the promoter, this complex associates with the non-DNA-binding factor MHC class II transactivator, which controls the cell type specificity and inducibility of MHC class II gene expression. This protein contains ankyrin repeats involved in protein-protein interactions. Mutations in this gene have been linked to bare lymphocyte syndrome type II, complementation group B. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2013]","regulatory factor X associated ankyrin containing protein","regulation of transcription by RNA polymerase II(GO:0006357)|Ras protein signal transduction(GO:0007265)|regulation of gene expression(GO:0010468)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytosol(GO:0005829)|intercellular bridge(GO:0045171)|RNA polymerase II transcription regulator complex(GO:0090575)","RNA polymerase II transcription regulatory region sequence-specific DNA binding(GO:0000977)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|protein binding(GO:0005515)|histone deacetylase binding(GO:0042826)","cancer(DOID:162)|primary immunodeficiency disease(DOID:612)","Primary immunodeficiency|Antigen processing and presentation","","","","","","Ankyrin","","","","","","","","","","","","T","0.084","T","0.273","D","1.0","D","0.995","D","0.000","D","1","N","0.625","T","-0.52","D","-3.52","0.724","T","-0.482","T","0.355","D","0.082","0.516","D","0.959","25.2","3.569","4.38","7.910","11.579"
"chr20","17968847","17968847","A>C","","MGME1","exonic","nonsynonymous SNV","","MGME1:NM_052865:exon4:c.A770C:p.K257T,MGME1:NM_001310338:exon5:c.A815C:p.K272T","MGME1","exonic","nonsynonymous SNV","","MGME1:ENST00000377709.1_1:exon4:c.A530C:p.K177T,MGME1:ENST00000377710.10_1:exon4:c.A770C:p.K257T","MGME1:ENST00000377709.1:c.530A>C:p.(Lys177Thr)","1","0.2500009208889651","1.0","0.1815794644909971","","","","","","","","","","","","","ENSG00000125871","MGME1","HGNC:16205","MGME1","92667","ENSG00000125871","uc002wqh.5","0.18157946449099713","0.2500009208889651","1.0","OMIM:615084 Mitochondrial DNA depletion syndrome 11-autosomal_recessive;ORPHA:352447 Progressive external ophthalmoplegia-myopathy-emaciation syndrome-autosomal_recessive","640","0/1","Het","91","53,38","0.582417582417582","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Mitochondrial dna depletion syndrome 11(615084)","Dysphonia(HP:0001618)|Ragged-red muscle fibers(HP:0003200)|Cerebellar atrophy(HP:0001272)|Dyspnea(HP:0002094)|Decreased mitochondrial number(HP:0040013)|Myopathy(HP:0003198)|Diarrhea(HP:0002014)|Respiratory insufficiency due to muscle weakness(HP:0002747)|Ptosis(HP:0000508)|Exercise intolerance(HP:0003546)|Nephrolithiasis(HP:0000787)|Spinal rigidity(HP:0003306)|Easy fatigability(HP:0003388)|Hypergonadotropic hypogonadism(HP:0000815)|Intellectual disability(HP:0001249)|Hyporeflexia(HP:0001265)|Dilated cardiomyopathy(HP:0001644)|Elevated circulating creatine kinase concentration(HP:0003236)|Arrhythmia(HP:0011675)|Progressive external ophthalmoplegia(HP:0000590)|Dysphagia(HP:0002015)|Poor appetite(HP:0004396)|Microcephaly(HP:0000252)|Generalized amyotrophy(HP:0003700)|Respiratory failure(HP:0002878)|Recurrent infections(HP:0002719)|Kyphosis(HP:0002808)|Spinal deformities(HP:0008443)|Weakness of facial musculature(HP:0030319)|Nasal speech(HP:0001611)|Nausea(HP:0002018)|Autosomal recessive inheritance(HP:0000007)|Recurrent infections(HP:0002719)|Easy fatigability(HP:0003388)|Microcephaly(HP:0000252)|Ptosis(HP:0000508)|Nausea(HP:0002018)|Facial palsy(HP:0010628)|Hypergonadotropic hypogonadism(HP:0000815)|Hyporeflexia(HP:0001265)|Cerebellar hypoplasia(HP:0001321)|Proximal amyotrophy(HP:0007126)|Dilated cardiomyopathy(HP:0001644)|Diarrhea(HP:0002014)|Spinal rigidity(HP:0003306)|Arrhythmia(HP:0011675)|Generalized amyotrophy(HP:0003700)|Dysphonia(HP:0001618)|Spinal deformities(HP:0008443)|Intellectual disability(HP:0001249)|Kyphosis(HP:0002808)|Progressive external ophthalmoplegia(HP:0000590)|Nasal speech(HP:0001611)|Progressive(HP:0003676)|Exercise intolerance(HP:0003546)|Respiratory insufficiency(HP:0002093)|Elevated circulating creatine kinase concentration(HP:0003236)|Dyspnea(HP:0002094)","The protein encoded by this gene is a nuclear-encoded mitochondrial protein necessary for the maintenance of mitochondrial genome synthesis. The encoded protein is a RecB-type exonuclease and primarily cleaves single-stranded DNA. Defects in this gene have been associated with mitochondrial DNA depletion syndrome-11. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]","mitochondrial genome maintenance exonuclease 1","mitochondrial genome maintenance(GO:0000002)|mitochondrial DNA replication(GO:0006264)|mitochondrial DNA replication(GO:0006264)|mitochondrial DNA repair(GO:0043504)|nucleic acid phosphodiester bond hydrolysis(GO:0090305)","mitochondrion(GO:0005739)|mitochondrion(GO:0005739)","protein binding(GO:0005515)|single-stranded DNA exodeoxyribonuclease activity(GO:0008297)|single-stranded DNA exodeoxyribonuclease activity(GO:0008297)","","","","","","","","PD-(D/E)XK","","","","","","","","","","","","D","0.002","D","0.005","D","1.0","D","0.997","D","0.000","D","1","M","3.145","T","0.65","D","-5.38","0.451","T","-0.324","T","0.340","D","0.069","0.271","D","0.992","27.4","3.964","5.62","4.258","15.483"
"chr14","76219261","76219261","A>G","TTLL5:23093","TTLL5","exonic","nonsynonymous SNV","","TTLL5:NM_015072:exon18:c.A1513G:p.M505V","TTLL5","exonic","startloss","","TTLL5:ENST00000554510.5_1:exon2:c.A1G:p.M1?,TTLL5:ENST00000556893.5_1:exon3:c.A127G:p.M43V,TTLL5:ENST00000298832.14_1:exon18:c.A1513G:p.M505V,TTLL5:ENST00000557636.5_1:exon19:c.A1555G:p.M519V","TTLL5:ENST00000554510.1:c.1A>G:p.0?","0.9960685","0.2500103367456177","0.9960684776306152","0.1762895281887594","","","","","","","","","","","","","ENSG00000119685","TTLL5","HGNC:19963","TTLL5","23093","ENSG00000119685","uc001xrx.4","0.17628952818875945","0.2500103367456177","0.9960684776306152","OMIM:615860 Cone-rod dystrophy 19-autosomal_recessive;ORPHA:1872 Cone rod dystrophy-autosomal_recessive","642","0/1","Het","56","36,20","0.642857142857143","Uncertain_significance","False","not_provided","MedGen:CN517202","NC_000014.8:g.76219261A>G","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Rod dystrophy 19(615860)","Color vision defect(HP:0000551)|Visual impairment(HP:0000505)|Abnormality of retinal pigmentation(HP:0007703)|Photophobia(HP:0000613)|Nyctalopia(HP:0000662)|Cone/cone-rod dystrophy(HP:0000548)|Autosomal recessive inheritance(HP:0000007)|Retinal dystrophy(HP:0000556)","This gene encodes a member of the tubulin tyrosine ligase like protein family. This protein interacts with two glucocorticoid receptor coactivators, transcriptional intermediary factor 2 and steroid receptor coactivator 1. This protein may function as a coregulator of glucocorticoid receptor mediated gene induction and repression. This protein may also function as an alpha tubulin polyglutamylase.[provided by RefSeq, Feb 2010]","tubulin tyrosine ligase like 5","microtubule cytoskeleton organization(GO:0000226)|protein polyglutamylation(GO:0018095)|protein polyglutamylation(GO:0018095)|retina development in camera-type eye(GO:0060041)","nucleus(GO:0005634)|centrosome(GO:0005813)|cytosol(GO:0005829)|cytosol(GO:0005829)|microtubule(GO:0005874)|plasma membrane(GO:0005886)|cilium(GO:0005929)","ATP binding(GO:0005524)|tubulin binding(GO:0015631)|tubulin-glutamic acid ligase activity(GO:0070740)|tubulin-glutamic acid ligase activity(GO:0070740)","","","Wp ciliopathies","Post translational protein modification|Carboxyterminal post translational modifications of tubulin","","","SpliceAI>G|TTLL5|0.00|0.00|0.00|0.00|-45|-25|37|43",".;.;.;.","","","0.00005437","","","0.0001","0.","","","4.777e-05","5.437e-05","D","0.033","T","0.128","P","0.856","P","0.648","D","0.000","D","0.969","M","2.25","T","3.89","N","-1.35","0.805","T","-0.863","T","0.203","D","0.028","0.158","T","0.210","23.0","2.728","5.74","6.135","14.306"
"chr19","8666020","8666020","G>A","ADAMTS10:81794","ADAMTS10","exonic","nonsynonymous SNV","","ADAMTS10:NM_030957:exon6:c.C602T:p.P201L","ADAMTS10","exonic","nonsynonymous SNV","","ADAMTS10:ENST00000270328.8_1:exon5:c.C602T:p.P201L,ADAMTS10:ENST00000597188.6_1:exon6:c.C602T:p.P201L","ADAMTS10:ENST00000270328.4:c.602C>T:p.(Pro201Leu)","0.99519587","0.25003104267671","0.9951958656311036","0.1751599281006195","","","","","","","","","","","","","ENSG00000142303","ADAMTS10","HGNC:13201","ADAMTS10","81794","ENSG00000142303","uc002mkj.3","0.1751599281006195","0.25003104267671006","0.9951958656311035","OMIM:277600 Weill-Marchesani syndrome 1, recessive-autosomal_recessive;ORPHA:3449 Weill-Marchesani syndrome-autosomal_recessive","643","0/1","Het","73","29,44","0.397260273972603","Uncertain_significance","False","not_provided","MedGen:CN517202","NC_000019.9:g.8666020G>A","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 1 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Marchesani syndrome 1(277600)","Short stature(HP:0004322)|Broad ribs(HP:0000885)|Cataract(HP:0000518)|Scoliosis(HP:0002650)|Broad metacarpals(HP:0001230)|Mitral regurgitation(HP:0001653)|Autosomal recessive inheritance(HP:0000007)|Spinal canal stenosis(HP:0003416)|Broad palm(HP:0001169)|Microspherophakia(HP:0030961)|Broad phalanges of the hand(HP:0009768)|Joint stiffness(HP:0001387)|Lumbar hyperlordosis(HP:0002938)|Abnormality of dental morphology(HP:0006482)|Thin bony cortex(HP:0002753)|Depressed nasal bridge(HP:0005280)|Narrow palate(HP:0000189)|Thickened skin(HP:0001072)|Proportionate short stature(HP:0003508)|Brachydactyly(HP:0001156)|Aortic valve stenosis(HP:0001650)|Ectopia lentis(HP:0001083)|Broad metatarsal(HP:0001783)|Broad skull(HP:0002682)|Ventricular septal defect(HP:0001629)|Pulmonic stenosis(HP:0001642)|Tooth malposition(HP:0000692)|High myopia(HP:0011003)|Hypoplasia of the maxilla(HP:0000327)|Blindness(HP:0000618)|Brachycephaly(HP:0000248)|Glaucoma(HP:0000501)|Shallow orbits(HP:0000586)|Intellectual disability, mild(HP:0001256)|Patent ductus arteriosus(HP:0001643)|Shallow anterior chamber(HP:0000594)|Thickened skin(HP:0001072)|Limitation of joint mobility(HP:0001376)|Intellectual disability, mild(HP:0001256)|Glaucoma(HP:0000501)|Pulmonic stenosis(HP:0001642)|Visual loss(HP:0000572)|Short stature(HP:0004322)|Short thumb(HP:0009778)|Ectopia lentis(HP:0001083)|Mitral regurgitation(HP:0001653)|Ventricular septal defect(HP:0001629)|Cataract(HP:0000518)|Brachydactyly(HP:0001156)|Aortic valve stenosis(HP:0001650)|High myopia(HP:0011003)","This gene belongs to the ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin type-1 motifs) family of zinc-dependent proteases. ADAMTS proteases are complex secreted enzymes containing a prometalloprotease domain of the reprolysin type attached to an ancillary domain with a highly conserved structure that includes at least one thrombospondin type 1 repeat. They have been demonstrated to have important roles in connective tissue organization, coagulation, inflammation, arthritis, angiogenesis and cell migration. The product of this gene plays a major role in growth and in skin, lens, and heart development. It is also a candidate gene for autosomal recessive Weill-Marchesani syndrome. [provided by RefSeq, Jul 2008]","ADAM metallopeptidase with thrombospondin type 1 motif 10","proteolysis(GO:0006508)|biological_process(GO:0008150)|extracellular matrix organization(GO:0030198)","microfibril(GO:0001527)|extracellular region(GO:0005576)|extracellular matrix(GO:0031012)|collagen-containing extracellular matrix(GO:0062023)","molecular_function(GO:0003674)|metalloendopeptidase activity(GO:0004222)|protein binding(GO:0005515)|metal ion binding(GO:0046872)","myopia(DOID:11830)|glaucoma(DOID:1686)","","Wp tgfbeta receptor signalling in skeletal dysplasias","Diseases of glycosylation|Diseases associated with o glycosylation of proteins|O linked glycosylation|O glycosylation of tsr domain containing proteins|Diseases of metabolism|Post translational protein modification","","","",".;.","","","0.00004025","0.0002","0.001","0.","0.0001","","","4.025e-05","0.0003","T","0.328","T","0.074","","","","","D","0.000","D","1","","","T","0.24","N","-1.89","0.856","T","-0.979","T","0.126","D","0.034","0.227","T","0.124","23.7","3.072","5.47","8.924","18.328"
"chr3","48423515","48423515","A>G","","FBXW12","exonic","nonsynonymous SNV","","FBXW12:NM_001159927:exon9:c.A1025G:p.H342R,FBXW12:NM_001159929:exon9:c.A1178G:p.H393R,FBXW12:NM_207102:exon10:c.A1235G:p.H412R","FBXW12","exonic","nonsynonymous SNV","","FBXW12:ENST00000436231.5_1:exon7:c.A764G:p.H255R,FBXW12:ENST00000415155.5_1:exon9:c.A1025G:p.H342R,FBXW12:ENST00000445170.5_1:exon9:c.A1178G:p.H393R,FBXW12:ENST00000296438.9_1:exon10:c.A1235G:p.H412R","FBXW12:ENST00000296438.5:c.1235A>G:p.(His412Arg)","0.6721651","0.527622092833837","0.6721650958061218","0.1637317042122505","","","","","","","","","","","","","ENSG00000164049","FBXW12","HGNC:20729","FBXW12","285231","ENSG00000164049","uc003csr.3","0.16373170421225053","0.527622092833837","0.6721650958061218","","647","0/1","Het","135","84,51","0.622222222222222","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Members of the F-box protein family, such as FBXW12, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1 (MIM 601434), cullin (see CUL1; MIM 603034), and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains (Jin et al., 2004 [PubMed 15520277]).[supplied by OMIM, Mar 2008]","F-box and WD repeat domain containing 12","","cytosol(GO:0005829)","","","","","Adaptive immune system|Post translational protein modification|Neddylation|Antigen processing ubiquitination proteasome degradation|Class i mhc mediated antigen processing presentation","","","",".;.;.;.","","","","","","","","","","","","T","0.341","T","0.409","B","0.277","B","0.03","N","0.037","N","1","N","0.69","T","2.0","N","-1.23","0.274","T","-1.013","T","0.112","T","0.013","0.012","D","0.506","0.002","-1.092","3.94","-0.366","9.053"
"chr16","5145458","5145458","G>A","","EEF2KMT","exonic","nonsynonymous SNV","","EEF2KMT:NM_001289029:exon2:c.C154T:p.H52Y,EEF2KMT:NM_201400:exon2:c.C154T:p.H52Y,EEF2KMT:NM_201598:exon2:c.C154T:p.H52Y","EEF2KMT","exonic","nonsynonymous SNV","","EEF2KMT:ENST00000427587.9_1:exon2:c.C154T:p.H52Y,EEF2KMT:ENST00000458008.8_1:exon2:c.C154T:p.H52Y,EEF2KMT:ENST00000587133.1_1:exon2:c.C154T:p.H52Y","EEF2KMT:ENST00000427587.4:c.154C>T:p.(His52Tyr)","0.6988927","0.5000020672371193","0.6988927125930786","0.1581103649663219","","","","","","","","","","","","","ENSG00000118894","EEF2KMT","HGNC:32221","EEF2KMT","196483","ENSG00000118894","","0.15811036496632197","0.5000020672371193","0.6988927125930786","","649","0/1","Het","128","65,63","0.5078125","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","eukaryotic elongation factor 2 lysine methyltransferase","protein methylation(GO:0006479)|peptidyl-lysine trimethylation(GO:0018023)|peptidyl-lysine trimethylation(GO:0018023)","cytoplasm(GO:0005737)|cytosol(GO:0005829)|protein-containing complex(GO:0032991)","protein binding(GO:0005515)|protein-lysine N-methyltransferase activity(GO:0016279)|protein-lysine N-methyltransferase activity(GO:0016279)|protein-lysine N-methyltransferase activity(GO:0016279)","","","","Post translational protein modification|Protein methylation","","","SpliceAI>A|EEF2KMT|0.00|0.00|0.00|0.00|-6|1|2|-5",".;.;.","","Score=840;Name=V$MRF2_01","","","","","","","","","","T","0.348","D","0.011","B","0.0","B","0.006","U","0.385","N","0.911","","","T","2.32","N","-1.08","0.408","T","-0.992","T","0.036","T","0.005","0.091","T","0.218","16.14","1.478","4.06","2.648","10.208"
"chr15","50774228","50774228","A>T","","USP8","exonic","nonsynonymous SNV","","USP8:NM_001283049:exon9:c.A1538T:p.H513L,USP8:NM_001128610:exon11:c.A1769T:p.H590L,USP8:NM_005154:exon11:c.A1769T:p.H590L","USP8","exonic","nonsynonymous SNV","","USP8:ENST00000425032.7_1:exon9:c.A1538T:p.H513L,USP8:ENST00000307179.9_1:exon11:c.A1769T:p.H590L,USP8:ENST00000396444.7_1:exon11:c.A1769T:p.H590L","USP8:ENST00000307179.4:c.1769A>T:p.(His590Leu)","0.685","0.5012133109848946","0.6850000023841858","0.1433975165202511","","","","","","","","","","","","","ENSG00000138592","USP8","HGNC:12631","USP8","9101","ENSG00000138592","uc001zyn.6","0.14339751652025115","0.5012133109848946","0.6850000023841858","OMIM:219090 Pituitary adenoma 4, ACTH-secreting, somatic-autosomal_dominant_and_recessive;ORPHA:96253 Cushing disease-autosomal_dominant_and_recessive","655","0/1","Het","86","41,45","0.476744186046512","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Secreting(219090)","Spastic gait(HP:0002064)|Intellectual disability(HP:0001249)|Nystagmus(HP:0000639)|Clonus(HP:0002169)|Spastic paraplegia(HP:0001258)|Lower limb hyperreflexia(HP:0002395)|Limb hypertonia(HP:0002509)|Talipes equinovarus(HP:0001762)|Oligomenorrhea(HP:0000876)|Thin skin(HP:0000963)|Bruising susceptibility(HP:0000978)|Abdominal obesity(HP:0012743)|Poor wound healing(HP:0001058)|Obesity(HP:0001513)|Pituitary adenoma(HP:0002893)|Autosomal dominant inheritance(HP:0000006)|Nephrolithiasis(HP:0000787)|Ecchymosis(HP:0031364)|Psychotic mentation(HP:0001345)|Abnormal fear/anxiety-related behavior(HP:0100852)|Striae distensae(HP:0001065)|Increased circulating ACTH level(HP:0003154)|Skeletal muscle atrophy(HP:0003202)|Vertebral compression fracture(HP:0002953)|Autosomal recessive inheritance(HP:0000007)|Edema(HP:0000969)|Osteoporosis(HP:0000939)|Impaired glucose tolerance(HP:0040270)|Kyphosis(HP:0002808)|Hypokalemia(HP:0002900)|Biconcave vertebral bodies(HP:0004586)|Emotional lability(HP:0000712)|Hirsutism(HP:0001007)|Hypertension(HP:0000822)|Alkalosis(HP:0001948)|Facial erythema(HP:0001041)|Hypertension(HP:0000822)|Recurrent fractures(HP:0002757)|Fatigue(HP:0012378)|Avascular necrosis(HP:0010885)|Round face(HP:0000311)|Recurrent skin infections(HP:0001581)|Visual loss(HP:0000572)|Telangiectasia of the skin(HP:0100585)|Anxiety(HP:0000739)|Bipolar affective disorder(HP:0007302)|Depression(HP:0000716)|Metrorrhagia(HP:0100608)|Cataract(HP:0000518)|Nephrolithiasis(HP:0000787)|Sleep disturbance(HP:0002360)|Psychosis(HP:0000709)|Pituitary adenoma(HP:0002893)|Thin skin(HP:0000963)|Cardiomyopathy(HP:0001638)|Adrenal hyperplasia(HP:0008221)|Venous thrombosis(HP:0004936)|Lipodystrophy(HP:0009125)|Osteoporosis(HP:0000939)|Menorrhagia(HP:0000132)|Truncal obesity(HP:0001956)|Abdominal pain(HP:0002027)|Immunodeficiency(HP:0002721)|Lethargy(HP:0001254)|Myopathy(HP:0003198)|Onychomycosis(HP:0012203)|Failure to thrive(HP:0001508)|Generalized hyperpigmentation(HP:0007440)|Infertility(HP:0000789)|Diabetes mellitus(HP:0000819)|Bruising susceptibility(HP:0000978)|Acne(HP:0001061)|Hypokalemia(HP:0002900)|Generalized hirsutism(HP:0002230)|Headache(HP:0002315)|Premature ovarian insufficiency(HP:0008209)","This gene encodes a protein that belongs to the ubiquitin-specific processing protease family of proteins. The encoded protein is thought to regulate the morphology of the endosome by ubiquitination of proteins on this organelle and is involved in cargo sorting and membrane trafficking at the early endosome stage. This protein is required for the cell to enter the S phase of the cell cycle and also functions as a positive regulator in the Hedgehog signaling pathway in development. Pseudogenes of this gene are present on chromosomes 2 and 6. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]","ubiquitin specific peptidase 8","mitotic cytokinesis(GO:0000281)|ubiquitin-dependent protein catabolic process(GO:0006511)|endosome organization(GO:0007032)|endosome organization(GO:0007032)|Ras protein signal transduction(GO:0007265)|protein deubiquitination(GO:0016579)|protein deubiquitination(GO:0016579)|regulation of protein stability(GO:0031647)|regulation of protein localization(GO:0032880)|protein K63-linked deubiquitination(GO:0070536)|protein K63-linked deubiquitination(GO:0070536)|protein K48-linked deubiquitination(GO:0071108)|protein K48-linked deubiquitination(GO:0071108)|cellular response to dexamethasone stimulus(GO:0071549)|positive regulation of canonical Wnt signaling pathway(GO:0090263)|regulation of protein catabolic process at postsynapse, modulating synaptic transmission(GO:0099576)|cellular response to nerve growth factor stimulus(GO:1990090)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|early endosome(GO:0005769)|cytosol(GO:0005829)|cytosol(GO:0005829)|cytosol(GO:0005829)|postsynaptic density(GO:0014069)|extrinsic component of plasma membrane(GO:0019897)|extrinsic component of plasma membrane(GO:0019897)|midbody(GO:0030496)|midbody(GO:0030496)|extrinsic component of endosome membrane(GO:0031313)|dendritic spine(GO:0043197)|glutamatergic synapse(GO:0098978)","cysteine-type endopeptidase activity(GO:0004197)|thiol-dependent deubiquitinase(GO:0004843)|thiol-dependent deubiquitinase(GO:0004843)|thiol-dependent deubiquitinase(GO:0004843)|protein binding(GO:0005515)|SH3 domain binding(GO:0017124)|cadherin binding(GO:0045296)","","Endocytosis","Wp egfegfr signaling pathway|Wp genes involved in male infertility","Signaling by erbb2|Downregulation of erbb2 erbb3 signaling|Signaling by wnt|Tcf dependent signaling in response to wnt|Regulation of fzd by ubiquitination|Deubiquitination|Ub specific processing proteases|Post translational protein modification|Signaling by met|Negative regulation of met activity|Downregulation of erbb2 signaling|Signaling by receptor tyrosine kinases","","Complement","",".;.;.","","","","","","","","","","","","T","0.44","T","0.325","B","0.012","B","0.006","N","0.986","N","1.000","N","0","T","2.3","N","-1.35","0.151","T","-0.964","T","0.029","T","0.005","0.026","T","0.020","9.023","0.461","5.37","0.784","10.553"
"chr11","1016733","1016733","G>T","","MUC6","exonic","nonsynonymous SNV","","MUC6:NM_005961:exon31:c.C6068A:p.T2023K","MUC6","exonic","nonsynonymous SNV","","MUC6:ENST00000421673.7_1:exon31:c.C6068A:p.T2023K","MUC6:ENST00000421673.2:c.6068C>A:p.(Thr2023Lys)","0.7259964","","","","0.5024751983582973","0.6831677258014679","0.1429423315915595","","","","","","","","","","ENSG00000184956","MUC6","HGNC:7517","MUC6","4588","ENSG00000184956","uc001lsw.3","0.14294233159155958","0.5024751983582973","0.6831677258014679","","656","0/1","Het","184","164,20","0.891304347826087","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the mucin protein family. Mucins are high molecular weight glycoproteins produced by many epithelial tissues. The protein encoded by this gene is secreted and forms an insoluble mucous barrier that protects the gut lumen. [provided by RefSeq, Dec 2016]","mucin 6, oligomeric mucus/gel-forming","maintenance of gastrointestinal epithelium(GO:0030277)","extracellular space(GO:0005615)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|extracellular matrix(GO:0031012)","extracellular matrix structural constituent(GO:0005201)","cancer(DOID:162)|laryngitis(DOID:3437)|adenoma(DOID:657)|adenocarcinoma(DOID:299)|stomach carcinoma(DOID:5517)|disease(DOID:4)|prostate cancer(DOID:10283)|embryoma(DOID:4766)","","Wp gastric acid production","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","","","","","0.00002024","0.0004","","0.0013","0.0011","","","2.024e-05","0.0002","T","0.052","T","0.473","B","0.02","B","0.005","","","N","1","L","0.895","T","2.16","N","-1.3","0.08","T","-0.994","T","0.022","T","0.002","0.005","T","0.060","0.001","-1.371","2.8","-3.254","3.268"
"chr11","1017186","1017186","A>G","","MUC6","exonic","nonsynonymous SNV","","MUC6:NM_005961:exon31:c.T5615C:p.M1872T","MUC6","exonic","nonsynonymous SNV","","MUC6:ENST00000421673.7_1:exon31:c.T5615C:p.M1872T","MUC6:ENST00000421673.2:c.5615T>C:p.(Met1872Thr)","0.47911444","0.5024751983582973","0.4791144430637359","0.0249637345348268","","","","","","","","","","","","","ENSG00000184956","MUC6","HGNC:7517","MUC6","4588","ENSG00000184956","uc001lsw.3","0.14294233159155958","0.5024751983582973","0.6831677258014679","","658","0/1","Het","297","256,41","0.861952861952862","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the mucin protein family. Mucins are high molecular weight glycoproteins produced by many epithelial tissues. The protein encoded by this gene is secreted and forms an insoluble mucous barrier that protects the gut lumen. [provided by RefSeq, Dec 2016]","mucin 6, oligomeric mucus/gel-forming","maintenance of gastrointestinal epithelium(GO:0030277)","extracellular space(GO:0005615)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|extracellular matrix(GO:0031012)","extracellular matrix structural constituent(GO:0005201)","cancer(DOID:162)|laryngitis(DOID:3437)|adenoma(DOID:657)|adenocarcinoma(DOID:299)|stomach carcinoma(DOID:5517)|disease(DOID:4)|prostate cancer(DOID:10283)|embryoma(DOID:4766)","","Wp gastric acid production","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","gnomad>TRUE;SpliceAI>G|MUC6|0.03|0.00|0.00|0.00|28|-9|28|-9","","","","0.00005501","","","0.026","0.022","","","5.501e-05","0.0001","T","0.519","T","1.0","B","0.047","B","0.094","","","N","1","N","-1.7","T","2.48","N","0.66","0.004","T","-0.975","T","0.008","","","0.021","T","0.039","0.001","-1.367","3.05","-7.795","1.501"
"chr17","80545133","80545133","G>A","","FOXK2","exonic","nonsynonymous SNV","","FOXK2:NM_004514:exon8:c.G1771A:p.G591S","FOXK2","exonic","nonsynonymous SNV","","FOXK2:ENST00000335255.10_1:exon8:c.G1771A:p.G591S","FOXK2:ENST00000335255.5:c.1771G>A:p.(Gly591Ser)","0.6855643","0.5000214171413973","0.6855642795562744","0.1425145277745814","","","","","","","","","","","","","ENSG00000141568","FOXK2","HGNC:6036","FOXK2","3607","ENSG00000141568","uc002kfn.4","0.14251452777458143","0.5000214171413973","0.6855642795562744","","659","0/1","Het","58","26,32","0.448275862068966","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene contains a fork head DNA binding domain. This protein can bind to the purine-rich motifs of the HIV long terminal repeat (LTR), and to the similar purine-rich motif in the interleukin 2 (IL2) promoter. It may be involved in the regulation of viral and cellular promoter elements. [provided by RefSeq, Jul 2008]","forkhead box K2","negative regulation of transcription by RNA polymerase II(GO:0000122)|cellular glucose homeostasis(GO:0001678)|regulation of transcription, DNA-templated(GO:0006355)|regulation of transcription by RNA polymerase II(GO:0006357)|negative regulation of autophagy(GO:0010507)|regulation of glucose metabolic process(GO:0010906)|response to starvation(GO:0042594)|negative regulation of transcription, DNA-templated(GO:0045892)|positive regulation of transcription, DNA-templated(GO:0045893)|positive regulation of transcription by RNA polymerase II(GO:0045944)|canonical glycolysis(GO:0061621)","chromatin(GO:0000785)|nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|mitochondrion(GO:0005739)|intracellular membrane-bounded organelle(GO:0043231)","magnesium ion binding(GO:0000287)|transcription cis-regulatory region binding(GO:0000976)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription repressor activity, RNA polymerase II-specific(GO:0001227)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|DNA-binding transcription factor activity(GO:0003700)|DNA-binding transcription factor activity(GO:0003700)|protein binding(GO:0005515)|sequence-specific DNA binding(GO:0043565)","","","","Deubiquitination|Uch proteinases|Post translational protein modification","","","SpliceAI>A|FOXK2|0.00|0.00|0.02|0.00|2|6|5|15","","","","0.0005","","","0.0002","0.0005","","","0.0002","0.0004","T","0.31","T","0.125","B","0.015","B","0.011","N","0.088","N","0.750","L","1.005","D","-3.16","N","-0.91","0.141","T","-0.447","D","0.578","D","0.031","0.210","T","0.016","17.85","1.753","4.88","2.798","8.750"
"chr12","42538423","42538423","A>G","","GXYLT1","exonic","nonsynonymous SNV","","GXYLT1:NM_001099650:exon1:c.T26C:p.V9A,GXYLT1:NM_173601:exon1:c.T26C:p.V9A","GXYLT1","exonic","nonsynonymous SNV","","GXYLT1:ENST00000280876.6_1:exon1:c.T26C:p.V9A,GXYLT1:ENST00000398675.8_1:exon1:c.T26C:p.V9A","GXYLT1:ENST00000280876.6:c.26T>C:p.(Val9Ala)","0.8720504","","","","0.5002243148919661","0.6734334379434586","0.1296723782964968","","","","","","","","","","ENSG00000151233","GXYLT1","HGNC:27482","GXYLT1","283464","ENSG00000151233","uc001rms.5","0.12967237829649686","0.5002243148919661","0.6734334379434586","","663","0/1","Het","9","7,2","0.777777777777778","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","GXYLT1 is a xylosyltransferase (EC 2.4.2.-) that adds the first xylose to O-glucose-modified residues in the epidermal growth factor (EGF; MIM 131530) repeats of proteins such as NOTCH1 (MIM 190198) (Sethi et al., 2010 [PubMed 19940119]).[supplied by OMIM, Mar 2010]","glucoside xylosyltransferase 1","O-glycan processing(GO:0016266)|O-glycan processing(GO:0016266)","integral component of membrane(GO:0016021)","UDP-xylosyltransferase activity(GO:0035252)|UDP-xylosyltransferase activity(GO:0035252)|UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity(GO:0140563)","","","Wp genotoxicity pathway","","","","",".;.","","","","","","","","","","","","T","0.082","T","1.0","B","0.009","B","0.007","N","0.173","N","1.000","N","0.55","","","N","-0.05","0.304","T","-1.025","T","0.060","D","0.171","0.058","T","0.150","18.60","1.852","3.5","2.184","7.322"
"chr12","42538415","42538415","C>G","","GXYLT1","exonic","nonsynonymous SNV","","GXYLT1:NM_001099650:exon1:c.G34C:p.V12L,GXYLT1:NM_173601:exon1:c.G34C:p.V12L","GXYLT1","exonic","nonsynonymous SNV","","GXYLT1:ENST00000280876.6_1:exon1:c.G34C:p.V12L,GXYLT1:ENST00000398675.8_1:exon1:c.G34C:p.V12L","GXYLT1:ENST00000280876.6:c.34G>C:p.(Val12Leu)","0.47481647","","","","0.5002243148919661","0.6734334379434586","0.1296723782964968","","","","","","","","","","ENSG00000151233","GXYLT1","HGNC:27482","GXYLT1","283464","ENSG00000151233","uc001rms.5","0.12967237829649686","0.5002243148919661","0.6734334379434586","","664","0/1","Het","12","8,4","0.666666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","GXYLT1 is a xylosyltransferase (EC 2.4.2.-) that adds the first xylose to O-glucose-modified residues in the epidermal growth factor (EGF; MIM 131530) repeats of proteins such as NOTCH1 (MIM 190198) (Sethi et al., 2010 [PubMed 19940119]).[supplied by OMIM, Mar 2010]","glucoside xylosyltransferase 1","O-glycan processing(GO:0016266)|O-glycan processing(GO:0016266)","integral component of membrane(GO:0016021)","UDP-xylosyltransferase activity(GO:0035252)|UDP-xylosyltransferase activity(GO:0035252)|UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity(GO:0140563)","","","Wp genotoxicity pathway","","","","SpliceAI>G|GXYLT1|0.00|0.00|0.00|0.00|-38|5|10|5",".;.","","","","","","","","","","","","T","1.0","T","1.0","B","0.0","B","0.0","N","0.948","N","1.000","N","-0.55","","","N","0.56","0.088","T","-0.998","T","0.029","D","0.052","0.022","T","0.064","10.85","0.663","3.5","0.223","5.992"
"chr12","42538412","42538412","C>T","","GXYLT1","exonic","nonsynonymous SNV","","GXYLT1:NM_001099650:exon1:c.G37A:p.A13T,GXYLT1:NM_173601:exon1:c.G37A:p.A13T","GXYLT1","exonic","nonsynonymous SNV","","GXYLT1:ENST00000280876.6_1:exon1:c.G37A:p.A13T,GXYLT1:ENST00000398675.8_1:exon1:c.G37A:p.A13T","GXYLT1:ENST00000280876.6:c.37G>A:p.(Ala13Thr)","0.3507849","","","","","","","","","","","","","","","","ENSG00000151233","GXYLT1","HGNC:27482","GXYLT1","283464","ENSG00000151233","uc001rms.5","0.12967237829649686","0.5002243148919661","0.6734334379434586","","665","0/1","Het","12","8,4","0.666666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","GXYLT1 is a xylosyltransferase (EC 2.4.2.-) that adds the first xylose to O-glucose-modified residues in the epidermal growth factor (EGF; MIM 131530) repeats of proteins such as NOTCH1 (MIM 190198) (Sethi et al., 2010 [PubMed 19940119]).[supplied by OMIM, Mar 2010]","glucoside xylosyltransferase 1","O-glycan processing(GO:0016266)|O-glycan processing(GO:0016266)","integral component of membrane(GO:0016021)","UDP-xylosyltransferase activity(GO:0035252)|UDP-xylosyltransferase activity(GO:0035252)|UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity(GO:0140563)","","","Wp genotoxicity pathway","","","","SpliceAI>T|GXYLT1|0.06|0.00|0.00|0.00|-35|-1|8|-1",".;.","","","","","","","","","","","","T","0.092","T","0.203","B","0.039","B","0.023","N","0.435","N","0.946","N","0.55","","","N","-0.75","0.202","T","-1.046","T","0.067","D","0.231","0.027","T","0.460","23.2","2.833","3.5","3.034","11.844"
"chrX","21761945","21761945","T>C","SMPX:23676","SMPX","exonic","nonsynonymous SNV","","SMPX:NM_014332:exon3:c.A55G:p.N19D","SMPX","exonic","nonsynonymous SNV","","SMPX:ENST00000379494.4_1:exon3:c.A55G:p.N19D,SMPX:ENST00000646008.1_1:exon3:c.A55G:p.N19D","SMPX:ENST00000379494.3:c.55A>G:p.(Asn19Asp)","0.9543959","","","","","","","","","","0.2500035287532682","0.9543958902359008","0.1273633428814368","","","","ENSG00000091482","SMPX","HGNC:11122","SMPX","23676","ENSG00000091482","uc004daa.4","0.12736334288143683","0.25000352875326826","0.9543958902359009","OMIM:300066 Deafness, X-linked 4-x_dominant","667","0/1","Het","41","15,26","0.365853658536585","Benign","False","not_provided","MedGen:CN517202","NC_000023.10:g.21761945T>C","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Linked 4(300066)","High-frequency hearing impairment(HP:0005101)|Sensorineural hearing impairment(HP:0000407)|X-linked dominant inheritance(HP:0001423)|Childhood onset(HP:0011463)","This gene encodes a small protein that has no known functional domains. Mutations in this gene are a cause of X-linked deafness-4, and the encoded protein may play a role in the maintenance of inner ear cells subjected to mechanical stress. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2011]","small muscle protein X-linked","striated muscle contraction(GO:0006941)","nucleus(GO:0005634)|muscle tendon junction(GO:0005927)|M band(GO:0031430)|costamere(GO:0043034)","","","","","","","Kras signaling dn","SpliceAI>C|SMPX|0.00|0.00|0.00|0.00|9|36|-33|9",".;.;.","","Score=861;Name=V$HNF3B_01","0.0024","","","0.0001","0.0018","","","0.0002","0.0024","D","0.0","D","0.0","D","0.996","D","0.986","D","0.000","D","1.000","","","","","D","-4.15","0.962","T","-0.017","T","0.456","D","0.156","0.322","T","0.291","26.6","3.853","5.96","5.947","15.022"
"chr4","103826685","103826685","T>A","","SLC9B1","exonic","stopgain","","SLC9B1:NM_001100874:exon11:c.A1318T:p.K440X,SLC9B1:NM_139173:exon11:c.A1318T:p.K440X","SLC9B1","exonic","stopgain","","SLC9B1:ENST00000296422.12_1:exon11:c.A1318T:p.K440X,SLC9B1:ENST00000394789.7_1:exon11:c.A1318T:p.K440X","SLC9B1:ENST00000296422.7:c.1318A>T:p.(Lys440*)","0.86000735","","","","0.5001502013619756","0.651355043053627","0.1083803565995592","","","","","","","","","","ENSG00000164037","SLC9B1","HGNC:24244","SLC9B1","150159","ENSG00000164037","uc003hww.3","0.10838035659955923","0.5001502013619756","0.651355043053627","","702","0/1","Het","53","37,16","0.69811320754717","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a sodium/hydrogen exchanger and transmembrane protein. Highly conserved orthologs of this gene have been found in other mammalian species. The expression of this gene may be limited to testis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]","solute carrier family 9 member B1","single fertilization(GO:0007338)|flagellated sperm motility(GO:0030317)|ion transmembrane transport(GO:0034220)|sodium ion transmembrane transport(GO:0035725)|regulation of intracellular pH(GO:0051453)|proton transmembrane transport(GO:1902600)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|sperm principal piece(GO:0097228)","sodium:proton antiporter activity(GO:0015385)","","","","Stimuli sensing channels|Transport of small molecules|Ion channel transport","","","SpliceAI>A|SLC9B1|0.00|0.12|0.00|0.07|-14|40|-3|-14",".;Cation/H+","","","0.00005591","","","","","","","4.08e-05","5.591e-05","","","","","","","","","D","0.000","D","1","","","","","","","0.354","","","","","","","","","","37","7.151","3.47","5.507","11.373"
"chr1","29475219","29475221","CTT>-","","SRSF4","exonic","nonframeshift deletion","","SRSF4:NM_005626:exon6:c.1186_1188del:p.K396del","SRSF4","exonic","nonframeshift deletion","","SRSF4:ENST00000373795.7_1:exon6:c.1186_1188del:p.K396del","SRSF4:ENST00000373795.4:c.1186_1188del:p.(Lys396del)","0.72148657","","","","0.5262383986264467","0.6208201944828033","0.1074895112351532","","","","","","","","","","ENSG00000116350","SRSF4","HGNC:10786","SRSF4","6429","ENSG00000116350","uc001bro.4","0.10748951123515324","0.5262383986264467","0.6208201944828033","","704","0/1","Het","137","126,11","0.91970802919708","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a member of the arginine/serine-rich splicing factor family. The encoded protein likely functions in mRNA processing. [provided by RefSeq, Feb 2009]","serine and arginine rich splicing factor 4","RNA splicing, via transesterification reactions(GO:0000375)|mRNA splicing, via spliceosome(GO:0000398)|mRNA processing(GO:0006397)|RNA splicing(GO:0008380)|response to insulin(GO:0032868)|negative regulation of mRNA splicing, via spliceosome(GO:0048025)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nuclear speck(GO:0016607)|nuclear speck(GO:0016607)","RNA binding(GO:0003723)|RNA binding(GO:0003723)|mRNA binding(GO:0003729)|protein binding(GO:0005515)|sequence-specific mRNA binding(GO:1990825)","","Spliceosome","Wp mrna processing","Mrna splicing|Transport of mature transcript to cytoplasm|Processing of capped intron containing pre mrna|Rna polymerase ii transcription termination|Rna polymerase ii transcription|Metabolism of rna","","","SpliceAI>C|SRSF4|0.00|0.00|0.00|0.00|-26|3|-41|1","","","","0.0065","","","0.004","0.0043","0.0065","0.0059","0.0002","0.0002","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","10305050","10305050","T>G","","MYH8","exonic","nonsynonymous SNV","","MYH8:NM_002472:exon23:c.A2741C:p.N914T","MYH8","exonic","nonsynonymous SNV","","MYH8:ENST00000403437.2_1:exon23:c.A2741C:p.N914T","MYH8:ENST00000403437.2:c.2741A>C:p.(Asn914Thr)","0.62451357","0.5006912397220731","0.624513566493988","0.0872029055375999","0.2503456198610365","0.6950699985027313","0.0133536864108133","","","","","","","","","","ENSG00000133020","MYH8","HGNC:7578","MYH8","4626","ENSG00000133020","uc002gmm.3","0.08720290553759995","0.5006912397220731","0.624513566493988","OMIM:158300 Trismus-pseudocamptodactyly syndrome-autosomal_dominant;OMIM:608837 Carney complex variant-autosomal_dominant;ORPHA:3377 Trismus-pseudocamptodactyly syndrome-autosomal_dominant","723","0/1","Het","33","16,17","0.484848484848485","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Arthrogryposis, distal, type 7(158300)|Carney complex variant(608837)","Distal arthrogryposis(HP:0005684)|Cardiac myxoma(HP:0011672)|Trismus(HP:0000211)|Autosomal dominant inheritance(HP:0000006)|Short stature(HP:0004322)|Limitation of joint mobility(HP:0001376)|Hip dislocation(HP:0002827)|Symphalangism affecting the phalanges of the hand(HP:0009773)|Mandibular prognathia(HP:0000303)|Ptosis(HP:0000508)|Abnormality of the musculature(HP:0003011)|Short stature(HP:0004322)|Cutaneous syndactyly of toes(HP:0010621)|Facial asymmetry(HP:0000324)|Metatarsus adductus(HP:0001840)|Distal arthrogryposis(HP:0005684)|Hip dislocation(HP:0002827)|Talipes equinovarus(HP:0001762)|Hammertoe(HP:0001765)|Feeding difficulties(HP:0011968)|Micrognathia(HP:0000347)|Deep philtrum(HP:0002002)|Dysphagia(HP:0002015)|Arthrogryposis multiplex congenita(HP:0002804)|Ptosis(HP:0000508)|Trismus(HP:0000211)|Tall chin(HP:0400000)|Autosomal dominant inheritance(HP:0000006)|Macrocephaly(HP:0000256)","Myosins are actin-based motor proteins that function in the generation of mechanical force in eukaryotic cells. Muscle myosins are heterohexamers composed of 2 myosin heavy chains and 2 pairs of nonidentical myosin light chains. This gene encodes a member of the class II or conventional myosin heavy chains, and functions in skeletal muscle contraction. This gene is predominantly expressed in fetal skeletal muscle. This gene is found in a cluster of myosin heavy chain genes on chromosome 17. A mutation in this gene results in trismus-pseudocamptodactyly syndrome. [provided by RefSeq, Sep 2009]","myosin heavy chain 8","skeletal muscle contraction(GO:0003009)|protein dephosphorylation(GO:0006470)|muscle contraction(GO:0006936)|muscle filament sliding(GO:0030049)|muscle filament sliding(GO:0030049)|ATP metabolic process(GO:0046034)","cytoplasm(GO:0005737)|cytosol(GO:0005829)|muscle myosin complex(GO:0005859)|sarcomere(GO:0030017)|myosin filament(GO:0032982)","microfilament motor activity(GO:0000146)|calmodulin binding(GO:0005516)|ATP binding(GO:0005524)|structural constituent of muscle(GO:0008307)|ATP hydrolysis activity(GO:0016887)|myosin phosphatase activity(GO:0017018)|myosin light chain binding(GO:0032027)|actin filament binding(GO:0051015)","syndrome(DOID:225)|thrombophlebitis(DOID:3875)|disease(DOID:4)","Tight junction|Viral myocarditis","Wp striated muscle contraction pathway","Striated muscle contraction|Muscle contraction","","Myogenesis","","Myosin","","Score=1000;Name=V$SRY_01","0.00001591","","","0.","0.0001","","","1.591e-05","0.0002","T","0.374","T","0.452","B","0.0","B","0.0","U","0.016","N","0.890","N","0.105","D","-2.77","N","-0.09","0.189","T","-0.633","T","0.425","T","0.013","0.237","T","0.051","17.99","1.772","5.29","-0.452","11.679"
"chr2","73677983","73677983","G>T","ALMS1:7840","ALMS1","exonic","nonsynonymous SNV","","ALMS1:NM_015120:exon8:c.G4326T:p.L1442F","ALMS1","exonic","nonsynonymous SNV","","ALMS1:ENST00000484298.5_1:exon7:c.G4200T:p.L1400F,ALMS1:ENST00000613296.6_1:exon8:c.G4326T:p.L1442F,ALMS1:ENST00000614410.4_1:exon8:c.G4326T:p.L1442F","ALMS1:ENST00000264448.6:c.4326G>T:p.(Leu1442Phe)","0.38388386","","","","0.5032323910854757","0.6169419437646866","0.0838309763459647","","","","","","","","","","ENSG00000116127","ALMS1","HGNC:428","ALMS1","7840","ENSG00000116127","uc032nrd.1","0.08383097634596473","0.5032323910854757","0.6169419437646866","OMIM:203800 Alstrom syndrome-autosomal_recessive;ORPHA:64 Alstrm syndrome-autosomal_recessive","729","0/1","Het","112","58,54","0.517857142857143","Conflicting_interpretations_of_pathogenicity","True","Alstrom_syndrome|not_specified|not_provided","MONDO:MONDO:0008763,MedGen:C0268425,OMIM:203800,Orphanet:ORPHA64,SNOMED_CT:63702009|MedGen:CN169374|MedGen:CN517202","NC_000002.11:g.73677983G>T","criteria_provided,_conflicting_interpretations","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 1 ; BP7: 0","Alstrom syndrome(203800)","Chronic bronchitis(HP:0004469)|Retinal pigment epithelial atrophy(HP:0007722)|Kyphosis(HP:0002808)|Otitis media(HP:0000388)|Incoordination(HP:0002311)|Cirrhosis(HP:0001394)|Hypergonadotropic hypogonadism(HP:0000815)|Hepatic failure(HP:0001399)|Detrusor sphincter dyssynergia(HP:0025488)|Elevated gamma-glutamyltransferase level(HP:0030948)|Hyperinsulinemia(HP:0000842)|Truncal obesity(HP:0001956)|Abnormality of dental color(HP:0011073)|Testicular fibrosis(HP:0012860)|Hirsutism(HP:0001007)|Elevated circulating thyroid-stimulating hormone concentration(HP:0002925)|Splenomegaly(HP:0001744)|Portal hypertension(HP:0001409)|Autistic behavior(HP:0000729)|Hypertriglyceridemia(HP:0002155)|Primary hypothyroidism(HP:0000832)|Hepatitis(HP:0012115)|Esophageal varix(HP:0002040)|Stage 5 chronic kidney disease(HP:0003774)|Recurrent cystitis(HP:0012786)|Hepatic encephalopathy(HP:0002480)|Delayed ability to stand(HP:0025335)|Decreased circulating T4 level(HP:0031507)|Hepatic steatosis(HP:0001397)|Photophobia(HP:0000613)|Hyoplasia of the Leydig cells(HP:0010790)|Decreased testicular size(HP:0008734)|Recurrent pneumonia(HP:0006532)|Nystagmus(HP:0000639)|Lumbar scoliosis(HP:0004626)|Delayed ability to walk(HP:0031936)|Urinary retention(HP:0000016)|Cone/cone-rod dystrophy(HP:0000548)|Hepatomegaly(HP:0002240)|Dorsocervical fat pad(HP:0025383)|Delayed ability to sit(HP:0025336)|Decreased response to growth hormone stimulation test(HP:0000824)|Urinary incontinence(HP:0000020)|Round face(HP:0000311)|Myocardial fibrosis(HP:0001685)|Dysuria(HP:0100518)|Delayed menarche(HP:0012569)|Abnormal liver physiology(HP:0031865)|Respiratory distress(HP:0002098)|Typical absence seizure(HP:0011147)|Short toe(HP:0001831)|Receptive language delay(HP:0010863)|Gingivitis(HP:0000230)|Acanthosis nigricans(HP:0000956)|Somatic sensory dysfunction(HP:0003474)|Restrictive ventilatory defect(HP:0002091)|Tooth agenesis(HP:0009804)|Ataxia(HP:0001251)|Severe sensorineural hearing impairment(HP:0008625)|Hyperostosis frontalis interna(HP:0004438)|Recurrent sinusitis(HP:0011108)|Decreased fertility in males(HP:0012041)|Chronic pulmonary obstruction(HP:0006510)|Frontal balding(HP:0002292)|Urinary urgency(HP:0000012)|Polycystic ovaries(HP:0000147)|Progressive sensorineural hearing impairment(HP:0000408)|Short stature(HP:0004322)|Pancreatitis(HP:0001733)|Dilated cardiomyopathy(HP:0001644)|Vestibular dysfunction(HP:0001751)|Hepatosplenomegaly(HP:0001433)|Posterior subcapsular cataract(HP:0007787)|Visual field defect(HP:0001123)|Pulmonary arterial hypertension(HP:0002092)|Precocious puberty in females(HP:0010465)|Glomerulonephritis(HP:0000099)|Micropenis(HP:0000054)|Poor fine motor coordination(HP:0007010)|Cognitive impairment(HP:0100543)|Congestive heart failure(HP:0001635)|Accelerated skeletal maturation(HP:0005616)|Insulin resistance(HP:0000855)|Abnormal coronary artery physiology(HP:0025496)|Thoracic scoliosis(HP:0002943)|Type II diabetes mellitus(HP:0005978)|Drusen(HP:0011510)|Oligospermia(HP:0000798)|Hepatic fibrosis(HP:0001395)|Optic disc pallor(HP:0000543)|Sleep disturbance(HP:0002360)|Short finger(HP:0009381)|Specific learning disability(HP:0001328)|Hypertension(HP:0000822)|Epigastric pain(HP:0410019)|Visual loss(HP:0000572)|Myalgia(HP:0003326)|Pes planus(HP:0001763)|Elevated hepatic transaminase(HP:0002910)|Increased circulating androgen concentration(HP:0030348)|Blindness(HP:0000618)|Polyphagia(HP:0002591)|Fine hair(HP:0002213)|Gastroesophageal reflux(HP:0002020)|Gynecomastia(HP:0000771)|Thickened ears(HP:0009894)|Deeply set eye(HP:0000490)|Irregular menstruation(HP:0000858)|Hypothyroidism(HP:0000821)|Renal insufficiency(HP:0000083)|Tubulointerstitial nephritis(HP:0001970)|Subcapsular cataract(HP:0000523)|Decreased response to growth hormone stimulation test(HP:0000824)|Hypertriglyceridemia(HP:0002155)|Kyphosis(HP:0002808)|Cone/cone-rod dystrophy(HP:0000548)|Hypertension(HP:0000822)|Hyperinsulinemia(HP:0000842)|Abnormality of the hand(HP:0001155)|Congestive heart failure(HP:0001635)|Nystagmus(HP:0000639)|Short stature(HP:0004322)|Abnormality of the dentition(HP:0000164)|Global developmental delay(HP:0001263)|Autosomal recessive inheritance(HP:0000007)|Gynecomastia(HP:0000771)|Scoliosis(HP:0002650)|Chronic active hepatitis(HP:0200120)|Pigmentary retinopathy(HP:0000580)|Elevated hepatic transaminase(HP:0002910)|Photophobia(HP:0000613)|Hepatic steatosis(HP:0001397)|Constriction of peripheral visual field(HP:0001133)|Decreased HDL cholesterol concentration(HP:0003233)|Recurrent pneumonia(HP:0006532)|Hypergonadotropic hypogonadism(HP:0000815)|Pes planus(HP:0001763)|Dilated cardiomyopathy(HP:0001644)|Progressive sensorineural hearing impairment(HP:0000408)|Truncal obesity(HP:0001956)|Alopecia(HP:0001596)|Visual loss(HP:0000572)|Insulin-resistant diabetes mellitus(HP:0000831)|Blindness(HP:0000618)|Asthma(HP:0002099)|Nephritis(HP:0000123)|Acanthosis nigricans(HP:0000956)|Irregular menstruation(HP:0000858)|Otitis media(HP:0000388)|Hyperuricemia(HP:0002149)|Hyperostosis frontalis interna(HP:0004438)|Gingivitis(HP:0000230)|Atherosclerosis(HP:0002621)|Multinodular goiter(HP:0005987)|Diabetes insipidus(HP:0000873)|Accelerated skeletal maturation(HP:0005616)|Hepatomegaly(HP:0002240)","This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]","ALMS1 centrosome and basal body associated protein","endosomal transport(GO:0016197)|regulation of centriole replication(GO:0046599)|regulation of stress fiber assembly(GO:0051492)|positive regulation of cold-induced thermogenesis(GO:0120162)","spindle pole(GO:0000922)|centrosome(GO:0005813)|centrosome(GO:0005813)|centriole(GO:0005814)|cytosol(GO:0005829)|cytosol(GO:0005829)|cilium(GO:0005929)","molecular_function(GO:0003674)|microtubule binding(GO:0008017)","syndrome(DOID:225)|diabetes mellitus(DOID:9351)|obesity(DOID:9970)","","Wp ciliopathies","Cell cycle|Organelle biogenesis and maintenance|Regulation of plk1 activity at g2 m transition|Recruitment of mitotic centrosome proteins and complexes|Recruitment of numa to mitotic centrosomes|Mitotic g2 g2 m phases|Cilium assembly|Anchoring of the basal body to the plasma membrane|Mitotic prometaphase|M phase|Cell cycle mitotic|Aurka activation by tpx2","","Mitotic spindle","SpliceAI>T|ALMS1|0.00|0.00|0.00|0.00|9|-31|-23|-31",".;.;.","","","0.0099","0.002","0.0099","0.0006","0.0077","","","0.0007","0.0082","","","T","0.301","","","","","N","0.495","N","1","","","","","","","0.19","T","-1.002","T","0.028","T","0.007","0.053","T","0.007","0.149","-0.427","4.29","-2.355","3.252"
"chr7","151716809","151716809","C>T","","GALNTL5","exonic","stopgain","","GALNTL5:NM_145292:exon9:c.C1255T:p.R419X","GALNTL5","exonic","stopgain","","GALNTL5:ENST00000392800.7_1:exon9:c.C1255T:p.R419X,GALNTL5:ENST00000431418.6_1:exon10:c.C1255T:p.R419X,GALNTL5:ENST00000616416.4_1:exon10:c.C1255T:p.R419X","GALNTL5:ENST00000392800.2:c.1255C>T:p.(Arg419*)","0.98221743","","","","0.5000043912291403","0.5907775536179543","0.065055856843517","","","","","","","","","","ENSG00000106648","GALNTL5","HGNC:21725","GALNTL5","168391","ENSG00000106648","uc064jlp.1","0.06505585684351704","0.5000043912291403","0.5907775536179543","","751","0/1","Het","102","65,37","0.637254901960784","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","polypeptide N-acetylgalactosaminyltransferase like 5","protein glycosylation(GO:0006486)|spermatid development(GO:0007286)|spermatid development(GO:0007286)","Golgi apparatus(GO:0005794)|integral component of membrane(GO:0016021)|late endosome membrane(GO:0031902)","glycosyltransferase activity(GO:0016757)|metal ion binding(GO:0046872)","","O glycan biosynthesis","","O linked glycosylation|Post translational protein modification|O linked glycosylation of mucins","","","SpliceAI>T|GALNTL5|0.00|0.00|0.00|0.00|49|9|-11|13",".;.;.","","","0.0009","","","0.0001","0.0007","0.0002","0.0001","0.0001","0.0009","","","","","","","","","N","0.120","D","1","","","","","","","0.135","","","","","","","","","","39","7.640","5.01","2.982","9.636"
"chr17","3195053","3195053","T>C","","OR3A1","exonic","nonsynonymous SNV","","OR3A1:NM_002550:exon1:c.A824G:p.K275R","OR3A1","exonic","nonsynonymous SNV","","OR3A1:ENST00000615105.1_1:exon1:c.A842G:p.K281R,OR3A1:ENST00000323404.2_1:exon2:c.A824G:p.K275R","OR3A1:ENST00000323404.1:c.824A>G:p.(Lys275Arg)","0.57741946","0.5006022178567946","0.5774194598197937","0.0583208674605594","","","","","","","","","","","","","ENSG00000180090","OR3A1","HGNC:8282","OR3A1","4994","ENSG00000180090","uc002fvh.1","0.05832086746055946","0.5006022178567946","0.5774194598197937","","757","0/1","Het","86","36,50","0.418604651162791","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]","olfactory receptor family 3 subfamily A member 1","signal transduction(GO:0007165)|G protein-coupled receptor signaling pathway(GO:0007186)|detection of chemical stimulus involved in sensory perception of smell(GO:0050911)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)","G protein-coupled receptor activity(GO:0004930)|olfactory receptor activity(GO:0004984)","","Olfactory transduction","Wp gpcrs class a rhodopsinlike|Wp gpcrs other","Olfactory signaling pathway|Sensory perception","","","","GPCR,","","Score=887;Name=V$GATA_C","0.00005437","0.0002","0.001","0.","0.0001","","","3.977e-06","5.437e-05","T","0.421","T","0.399","B","0.432","B","0.344","D","0.000","N","1","L","1.095","T","8.59","N","-1.02","0.47","T","-1.028","T","0.001","T","0.003","0.188","T","0.431","14.27","1.133","5.01","3.022","3.461"
"chr1","22179539","22179539","C>T","HSPG2:3339","HSPG2","exonic","nonsynonymous SNV","","HSPG2:NM_001291860:exon51:c.G6467A:p.R2156H,HSPG2:NM_005529:exon51:c.G6464A:p.R2155H","HSPG2","exonic","nonsynonymous SNV","","HSPG2:ENST00000374695.8_1:exon51:c.G6464A:p.R2155H","HSPG2:ENST00000374695.3:c.6464G>A:p.(Arg2155His)","0.82910705","0.2713224105536937","0.8291070461273193","0.0545004265364156","","","","","","","","","","","","","ENSG00000142798","HSPG2","HGNC:5273","HSPG2","3339","ENSG00000142798","uc001bfj.4","0.05450042653641566","0.27132241055369377","0.8291070461273193","OMIM:224410 Dyssegmental dysplasia, Silverman-Handmaker type-autosomal_recessive;OMIM:255800 Schwartz-Jampel syndrome, type 1-autosomal_recessive;ORPHA:1606 1p36 deletion syndrome-polygenic;ORPHA:1865 Dyssegmental dysplasia, Silverman-Handmaker type-autosomal_recessive;ORPHA:800 Schwartz-Jampel syndrome-autosomal_recessive","762","0/1","Het","52","33,19","0.634615384615385","Uncertain_significance","False","not_provided","MedGen:CN517202","NC_000001.10:g.22179539C>T","criteria_provided,_multiple_submitters,_no_conflicts","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 1 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Handmaker type(224410)|Jampel syndrome, type 1(255800)","Agenesis of corpus callosum(HP:0001274)|Abnormal cardiac septum morphology(HP:0001671)|Cerebral cortical atrophy(HP:0002120)|Depressed nasal ridge(HP:0000457)|Hypoplasia of penis(HP:0008736)|Annular pancreas(HP:0001734)|Microcephaly(HP:0000252)|Hypospadias(HP:0000047)|Delayed cranial suture closure(HP:0000270)|Long philtrum(HP:0000343)|Short stature(HP:0004322)|Strabismus(HP:0000486)|Frontal bossing(HP:0002007)|Brachydactyly(HP:0001156)|Hepatic steatosis(HP:0001397)|Abnormal intestine morphology(HP:0002242)|Global developmental delay(HP:0001263)|Cranial nerve paralysis(HP:0006824)|Horizontal eyebrow(HP:0011228)|Telangiectasia(HP:0001009)|Constipation(HP:0002019)|Clinodactyly of the 5th finger(HP:0004209)|Depressed nasal bridge(HP:0005280)|Foot polydactyly(HP:0001829)|Camptodactyly of finger(HP:0100490)|Optic atrophy(HP:0000648)|Obesity(HP:0001513)|Poor speech(HP:0002465)|Spinal canal stenosis(HP:0003416)|Low-set, posteriorly rotated ears(HP:0000368)|Abnormality of the spleen(HP:0001743)|Kyphosis(HP:0002808)|Pointed chin(HP:0000307)|Pyloric stenosis(HP:0002021)|Ventriculomegaly(HP:0002119)|Myopathy(HP:0003198)|11 pairs of ribs(HP:0000878)|Cataract(HP:0000518)|Abnormality of the neck(HP:0000464)|Hemiplegia/hemiparesis(HP:0004374)|Absent speech(HP:0001344)|Hypotonia(HP:0001252)|Self-injurious behavior(HP:0100716)|Scoliosis(HP:0002650)|Joint stiffness(HP:0001387)|Conductive hearing impairment(HP:0000405)|Seizure(HP:0001250)|Hydronephrosis(HP:0000126)|Gait disturbance(HP:0001288)|Failure to thrive(HP:0001508)|Brachycephaly(HP:0000248)|Dilated cardiomyopathy(HP:0001644)|Abnormality of the anus(HP:0004378)|Ocular albinism(HP:0001107)|Generalized hirsutism(HP:0002230)|Tetralogy of Fallot(HP:0001636)|Gastroesophageal reflux(HP:0002020)|Abnormal blistering of the skin(HP:0008066)|Renal cyst(HP:0000107)|Epicanthus(HP:0000286)|Patent ductus arteriosus(HP:0001643)|Lower limb asymmetry(HP:0100559)|Short foot(HP:0001773)|Feeding difficulties in infancy(HP:0008872)|Narrow mouth(HP:0000160)|Deeply set eye(HP:0000490)|Intellectual disability(HP:0001249)|Aortic arch aneurysm(HP:0005113)|Hip dysplasia(HP:0001385)|Wide nasal bridge(HP:0000431)|Abnormality of female external genitalia(HP:0000055)|Neuroblastoma(HP:0003006)|Midface retrusion(HP:0011800)|EEG abnormality(HP:0002353)|Bifid ribs(HP:0000892)|Hypothyroidism(HP:0000821)|High hypermetropia(HP:0008499)|Rib fusion(HP:0000902)|Cryptorchidism(HP:0000028)|Microtia(HP:0008551)|Sensorineural hearing impairment(HP:0000407)|Macule(HP:0012733)|Autism(HP:0000717)|Abnormal heart valve morphology(HP:0001654)|Dysphagia(HP:0002015)|Stereotypy(HP:0000733)|Hypogonadism(HP:0000135)|Visual impairment(HP:0000505)|Nystagmus(HP:0000639)|Polyphagia(HP:0002591)|Myalgia(HP:0003326)|Microcephaly(HP:0000252)|Cleft palate(HP:0000175)|Strabismus(HP:0000486)|Abnormality of immune system physiology(HP:0010978)|Abnormality of the ureter(HP:0000069)|Anxiety(HP:0000739)|Hyperlordosis(HP:0003307)|Hypertelorism(HP:0000316)|Hip dysplasia(HP:0001385)|Pectus carinatum(HP:0000768)|Micrognathia(HP:0000347)|Ectopia lentis(HP:0001083)|Abnormally straight spine(HP:0100795)|Generalized hirsutism(HP:0002230)|Abnormally ossified vertebrae(HP:0100569)|Mask-like facies(HP:0000298)|Intellectual disability(HP:0001249)|Abnormality of the metaphysis(HP:0000944)|Laryngomalacia(HP:0001601)|Talipes equinovarus(HP:0001762)|Attention deficit hyperactivity disorder(HP:0007018)|Visual impairment(HP:0000505)|Polyhydramnios(HP:0001561)|Pursed lips(HP:0000205)|Muscle weakness(HP:0001324)|Skeletal dysplasia(HP:0002652)|Protrusio acetabuli(HP:0003179)|Pes planus(HP:0001763)|Everted lower lip vermilion(HP:0000232)|Weak voice(HP:0001621)|Myotonia(HP:0002486)|Shoulder flexion contracture(HP:0003044)|Pectus excavatum(HP:0000767)|Feeding difficulties in infancy(HP:0008872)|Prominent nasal bridge(HP:0000426)|Delayed skeletal maturation(HP:0002750)|Micromelia(HP:0002983)|Cachexia(HP:0004326)|Inguinal hernia(HP:0000023)|Umbilical hernia(HP:0001537)|Trismus(HP:0000211)|Blepharospasm(HP:0000643)|Abnormality of the pharynx(HP:0000600)|Odontogenic neoplasm(HP:0100612)|Distichiasis(HP:0009743)|Pulmonary arterial hypertension(HP:0002092)|Low-set, posteriorly rotated ears(HP:0000368)|Supernumerary tooth(HP:0011069)|Irritability(HP:0000737)|Nephrolithiasis(HP:0000787)|Elbow dislocation(HP:0003042)|Skeletal muscle atrophy(HP:0003202)|Wormian bones(HP:0002645)|EMG abnormality(HP:0003457)|Sprengel anomaly(HP:0000912)|Joint stiffness(HP:0001387)|Blepharophimosis(HP:0000581)|Apnea(HP:0002104)|Coxa vara(HP:0002812)|Abnormality of epiphysis morphology(HP:0005930)|Platyspondyly(HP:0000926)|Gait disturbance(HP:0001288)|Spinal rigidity(HP:0003306)|Metatarsus valgus(HP:0010508)|Increased bone mineral density(HP:0011001)|Respiratory insufficiency(HP:0002093)|Malignant hyperthermia(HP:0002047)|Arrhythmia(HP:0011675)|High palate(HP:0000218)|Elevated circulating creatine kinase concentration(HP:0003236)|Ptosis(HP:0000508)|Long philtrum(HP:0000343)|Myopia(HP:0000545)|Prenatal movement abnormality(HP:0001557)|Dysphonia(HP:0001618)|Cataract(HP:0000518)|Wrist flexion contracture(HP:0001239)|Short neck(HP:0000470)|Narrow mouth(HP:0000160)|Kyphosis(HP:0002808)|Aplasia/Hypoplasia affecting the eye(HP:0008056)|Hyporeflexia(HP:0001265)|Genu valgum(HP:0002857)|Osteoporosis(HP:0000939)|High pitched voice(HP:0001620)|Abnormal eyebrow morphology(HP:0000534)|Dental malocclusion(HP:0000689)|Low anterior hairline(HP:0000294)|Hip contracture(HP:0003273)|Elevated aldolase level(HP:0012544)|Arthrogryposis multiplex congenita(HP:0002804)|Decreased testicular size(HP:0008734)|Microcornea(HP:0000482)|Myopathy(HP:0003198)|Short stature(HP:0004322)|Overfolded helix(HP:0000396)|Flexion contracture of toe(HP:0005830)|Flat face(HP:0012368)|Abnormality of the ribs(HP:0000772)|Full cheeks(HP:0000293)|Testicular torsion(HP:0100813)|Death in infancy(HP:0001522)|Coxa valga(HP:0002673)|Long eyelashes in irregular rows(HP:0007740)|Skeletal muscle hypertrophy(HP:0003712)|Hypertonia(HP:0001276)|Scoliosis(HP:0002650)|Flat face(HP:0012368)|Wide nasal bridge(HP:0000431)|Cryptorchidism(HP:0000028)|Autosomal recessive inheritance(HP:0000007)|Posteriorly rotated ears(HP:0000358)|Bowing of the long bones(HP:0006487)|Neonatal death(HP:0003811)|Calvarial skull defect(HP:0001362)|Disproportionate short-limb short stature(HP:0008873)|Anisospondyly(HP:0002879)|Short long bone(HP:0003026)|Micrognathia(HP:0000347)|Narrow mouth(HP:0000160)|Malar flattening(HP:0000272)|Short long bone(HP:0003026)|Thoracic hypoplasia(HP:0005257)|Talipes equinovarus(HP:0001762)|Pulmonary hypoplasia(HP:0002089)|Overgrowth(HP:0001548)|Single umbilical artery(HP:0001195)|Abnormality of the abdominal wall(HP:0004298)|Coxa vara(HP:0002812)|Myopia(HP:0000545)|Decreased testicular size(HP:0008734)|Intellectual disability(HP:0001249)|Ptosis(HP:0000508)|Metaphyseal widening(HP:0003016)|Low-set ears(HP:0000369)|Kyphoscoliosis(HP:0002751)|Skeletal muscle atrophy(HP:0003202)|Wrist flexion contracture(HP:0001239)|Generalized hirsutism(HP:0002230)|Anterior bowing of long bones(HP:0006473)|Hyporeflexia(HP:0001265)|Platyspondyly(HP:0000926)|Narrow palpebral fissure(HP:0045025)|High pitched voice(HP:0001620)|Micrognathia(HP:0000347)|Shoulder flexion contracture(HP:0003044)|Microcornea(HP:0000482)|Weak voice(HP:0001621)|Joint contracture of the hand(HP:0009473)|Pectus carinatum(HP:0000768)|Coxa valga(HP:0002673)|Blepharophimosis(HP:0000581)|Coronal cleft vertebrae(HP:0003417)|Pes planus(HP:0001763)|Congenital hip dislocation(HP:0001374)|Abnormality of femoral epiphysis(HP:0006499)|Flat face(HP:0012368)|Skeletal muscle hypertrophy(HP:0003712)|Osteoporosis(HP:0000939)|Short neck(HP:0000470)|Short stature(HP:0004322)|Long eyelashes in irregular rows(HP:0007740)|Hip contracture(HP:0003273)|Malignant hyperthermia(HP:0002047)|Pursed lips(HP:0000205)|Myotonia(HP:0002486)|Flexion contracture of toe(HP:0005830)|Autosomal recessive inheritance(HP:0000007)|Talipes equinovarus(HP:0001762)|Inguinal hernia(HP:0000023)|Delayed skeletal maturation(HP:0002750)|Lumbar hyperlordosis(HP:0002938)|Umbilical hernia(HP:0001537)|Full cheeks(HP:0000293)|Muscle weakness(HP:0001324)|Overfolded helix(HP:0000396)|Malar flattening(HP:0000272)|Narrow mouth(HP:0000160)|Cataract(HP:0000518)|Hypoplastic pubic bone(HP:0003173)|Pterygium(HP:0001059)|Narrow chest(HP:0000774)|Low-set ears(HP:0000369)|Micromelia(HP:0002983)|Hydrocephalus(HP:0000238)|Spontaneous abortion(HP:0005268)|Single umbilical artery(HP:0001195)|Hypoplastic ilia(HP:0000946)|Encephalocele(HP:0002084)|Increased placental thickness(HP:0032548)|Pulmonary hypoplasia(HP:0002089)|Micrognathia(HP:0000347)|Short ribs(HP:0000773)|Severe short stature(HP:0003510)|Posteriorly rotated ears(HP:0000358)|Wide nasal bridge(HP:0000431)|Hirsutism(HP:0001007)|Broad long bones(HP:0005622)|Cryptorchidism(HP:0000028)|Microcephaly(HP:0000252)|Limitation of joint mobility(HP:0001376)|Hypoplastic ischia(HP:0003175)|Hydrops fetalis(HP:0001789)|Respiratory insufficiency(HP:0002093)|Proptosis(HP:0000520)|Cleft palate(HP:0000175)|Talipes equinovarus(HP:0001762)|Short long bone(HP:0003026)|Flat face(HP:0012368)|Flexion contracture(HP:0001371)|Developmental cataract(HP:0000519)|Short neck(HP:0000470)|Abnormal heart morphology(HP:0001627)|Bowing of the legs(HP:0002979)|Anisospondyly(HP:0002879)|Clubbing of fingers(HP:0100759)|Narrow mouth(HP:0000160)","This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]","heparan sulfate proteoglycan 2","angiogenesis(GO:0001525)|lipid metabolic process(GO:0006629)|receptor-mediated endocytosis(GO:0006898)|inflammatory response(GO:0006954)|brain development(GO:0007420)|animal organ morphogenesis(GO:0009887)|tissue development(GO:0009888)|negative regulation of angiogenesis(GO:0016525)|cell differentiation(GO:0030154)|circulatory system development(GO:0072359)","extracellular region(GO:0005576)|extracellular region(GO:0005576)|basement membrane(GO:0005604)|basement membrane(GO:0005604)|extracellular space(GO:0005615)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|focal adhesion(GO:0005925)|lysosomal lumen(GO:0043202)|collagen-containing extracellular matrix(GO:0062023)|collagen-containing extracellular matrix(GO:0062023)|collagen-containing extracellular matrix(GO:0062023)|extracellular exosome(GO:0070062)|plasma membrane protein complex(GO:0098797)","amyloid-beta binding(GO:0001540)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|protein C-terminus binding(GO:0008022)|extracellular matrix structural constituent conferring compression resistance(GO:0030021)|extracellular matrix structural constituent conferring compression resistance(GO:0030021)|low-density lipoprotein particle receptor binding(GO:0050750)","Alzheimer's disease(DOID:10652)|Duchenne muscular dystrophy(DOID:11723)|spinal muscular atrophy(DOID:12377)|cancer(DOID:162)|atherosclerosis(DOID:1936)|syndrome(DOID:225)|gingival overgrowth(DOID:3086)|myopathy(DOID:423)|muscular atrophy(DOID:767)|muscular dystrophy(DOID:9884)|hyperglycemia(DOID:4195)|disease(DOID:4)|prostate cancer(DOID:10283)|myotonic disease(DOID:450)","Ecm receptor interaction","Wp hepatitis b infection","Degradation of the extracellular matrix|Extracellular matrix organization|Glycosaminoglycan metabolism|Heparan sulfate heparin hs gag metabolism|Chondroitin sulfate dermatan sulfate metabolism|Metabolism of vitamins and cofactors|A tetrasaccharide linker sequence is required for gag synthesis|Hs gag biosynthesis|Hs gag degradation|Integrin cell surface interactions|Visual phototransduction|Laminin interactions|Non integrin membrane ecm interactions|Ecm proteoglycans|Diseases associated with glycosaminoglycan metabolism|Defective b4galt7 causes eds progeroid type|Defective ext2 causes exostoses 2|Diseases of glycosylation|Diseases of metabolism|Metabolism of fat soluble vitamins|Metabolism of carbohydrates|Sensory perception|Amyloid fiber formation","","","","Immunoglobulin-like","","Score=950;Name=V$GATA2_01","0.00006779","0.0004","0.002","0.","0.0005","","","6.779e-05","0.0009","T","0.162","T","0.13","B","0.019","B","0.018","N","0.004","N","0.565","M","2.49","T","2.45","N","-1.22","0.292","T","-1.014","T","0.067","T","0.014","0.113","T","0.092","22.6","2.531","5.73","1.073","10.531"
"chr12","105455412","105455412","G>C","","ALDH1L2","exonic","nonsynonymous SNV","","ALDH1L2:NM_001034173:exon8:c.C1040G:p.T347S","ALDH1L2","exonic","nonsynonymous SNV","","ALDH1L2:ENST00000258494.14_1:exon8:c.C1040G:p.T347S,ALDH1L2:ENST00000652515.1_1:exon8:c.C1067G:p.T356S","ALDH1L2:ENST00000258494.9:c.1040C>G:p.(Thr347Ser)","0.56608593","0.502570818644017","0.566085934638977","0.0538944347656496","","","","","","","","","","","","","ENSG00000136010","ALDH1L2","HGNC:26777","ALDH1L2","160428","ENSG00000136010","uc001tlc.4","0.053894434765649646","0.502570818644017","0.566085934638977","","768","0/1","Het","51","26,25","0.509803921568627","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of both the aldehyde dehydrogenase superfamily and the formyl transferase superfamily. This member is the mitochondrial form of 10-formyltetrahydrofolate dehydrogenase (FDH), which converts 10-formyltetrahydrofolate to tetrahydrofolate and CO2 in an NADP(+)-dependent reaction, and plays an essential role in the distribution of one-carbon groups between the cytosolic and mitochondrial compartments of the cell. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2010]","aldehyde dehydrogenase 1 family member L2","one-carbon metabolic process(GO:0006730)|biosynthetic process(GO:0009058)|10-formyltetrahydrofolate catabolic process(GO:0009258)","nucleoplasm(GO:0005654)|mitochondrion(GO:0005739)|mitochondrial matrix(GO:0005759)|extracellular exosome(GO:0070062)","aldehyde dehydrogenase (NAD+) activity(GO:0004029)|protein binding(GO:0005515)|formyltetrahydrofolate dehydrogenase activity(GO:0016155)|hydroxymethyl-, formyl- and related transferase activity(GO:0016742)","","","","Metabolism of folate and pterines|Metabolism of water soluble vitamins and cofactors|Metabolism of vitamins and cofactors","","","","Phosphopantetheine","","","0.00003182","","","0.","0.0003","","","3.182e-05","0.0004","T","0.429","T","0.821","B","0.001","B","0.016","N","0.033","N","0.822","L","1.87","T","0.96","N","-0.11","0.257","T","-1.035","T","0.049","T","0.008","0.034","T","0.037","16.23","1.494","5.62","4.358","5.007"
"chr15","65968887","65968887","T>A","","DENND4A","exonic","nonsynonymous SNV","","DENND4A:NM_005848:exon23:c.A4133T:p.H1378L,DENND4A:NM_001144823:exon24:c.A4262T:p.H1421L","DENND4A","exonic","nonsynonymous SNV","","DENND4A:ENST00000431932.6_1:exon23:c.A4133T:p.H1378L,DENND4A:ENST00000635620.2_1:exon23:c.A4262T:p.H1421L,DENND4A:ENST00000443035.8_1:exon24:c.A4265T:p.H1422L","DENND4A:ENST00000431932.2:c.4133A>T:p.(His1378Leu)","0.528943","0.5000172708096216","0.5289430022239685","0.0379431906108902","","","","","","","","","","","","","ENSG00000174485","DENND4A","HGNC:24321","DENND4A","10260","ENSG00000174485","uc002aph.4","0.03794319061089026","0.5000172708096216","0.5289430022239685","","806","0/1","Het","84","47,37","0.55952380952381","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a DENN domain-containing protein that may function as a guanine nucleotide exchange factor that specifically activates ras-related protein Rab-10. This protein also contains a interferon stimulated response element-binding domain and may be involved in regulating the v-myc avian myelocytomatosis viral (MYC) oncogene. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 8. [provided by RefSeq, Mar 2016]","DENN domain containing 4A","regulation of transcription, DNA-templated(GO:0006355)|regulation of Rab protein signal transduction(GO:0032483)|regulation of catalytic activity(GO:0050790)","nucleus(GO:0005634)|cytosol(GO:0005829)|cytoplasmic vesicle(GO:0031410)","DNA binding(GO:0003677)|guanyl-nucleotide exchange factor activity(GO:0005085)|guanyl-nucleotide exchange factor activity(GO:0005085)|protein binding(GO:0005515)","","","","Membrane trafficking|Vesicle mediated transport|Rab gefs exchange gtp for gdp on rabs|Rab regulation of trafficking","","","",".;.;.","","","","","","","","","","","","T","0.474","T","0.793","B","0.0","B","0.0","N","0.026","N","1.000","N","0.755","T","3.59","N","-1.35","0.235","T","-0.950","T","0.011","T","0.003","0.040","T","0.075","15.16","1.293","5.57","0.258","7.185"
"chr1","97915615","97915615","G>A","DPYD:1806","DPYD","exonic","synonymous SNV","","DPYD:NM_000110:exon14:c.C1905T:p.N635N","DPYD","exonic","synonymous SNV","","DPYD:ENST00000370192.8_1:exon14:c.C1905T:p.N635N","DPYD:ENST00000370192.3:c.1905C>T:p.(=)","0.7946788","0.2649290720714686","0.794678807258606","0.0378280264073996","","","","","","","","","","","","","ENSG00000188641","DPYD","HGNC:3012","DPYD","1806","ENSG00000188641","uc001drv.4","0.03782802640739965","0.26492907207146865","0.794678807258606","OMIM:274270 Dihydropyrimidine dehydrogenase deficiency-autosomal_recessive;ORPHA:1675 Dihydropyrimidine dehydrogenase deficiency-autosomal_recessive","807","0/1","Het","69","47,22","0.681159420289855","Conflicting_interpretations_of_pathogenicity","True","Dihydropyrimidine_dehydrogenase_deficiency|not_provided","MONDO:MONDO:0010130,MedGen:C1959620,OMIM:274270,Orphanet:ORPHA1675|MedGen:CN517202","NC_000001.10:g.97915615G>A","criteria_provided,_conflicting_interpretations","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Dihydropyrimidine dehydrogenase deficiency(274270)","Long ear(HP:0400004)|Self-mutilation(HP:0000742)|Short nose(HP:0003196)|Micrognathia(HP:0000347)|Aggressive behavior(HP:0000718)|Intellectual disability, mild(HP:0001256)|Joint hypermobility(HP:0001382)|Deeply set eye(HP:0000490)|Obesity(HP:0001513)|Myopia(HP:0000545)|Astigmatism(HP:0000483)|Abnormality of vision(HP:0000504)|Macrocephaly(HP:0000256)|Global developmental delay(HP:0001263)|Wide mouth(HP:0000154)|Broad nasal tip(HP:0000455)|Full cheeks(HP:0000293)|Delayed speech and language development(HP:0000750)|Upslanted palpebral fissure(HP:0000582)|Shyness(HP:0100962)|Autistic behavior(HP:0000729)|Abnormal eating behavior(HP:0100738)|Macrocephaly(HP:0000256)|Hyperreflexia(HP:0001347)|Micromelia(HP:0002983)|Deep palmar crease(HP:0006191)|Downslanted palpebral fissures(HP:0000494)|Respiratory failure requiring assisted ventilation(HP:0004887)|Absent speech(HP:0001344)|Febrile seizure (within the age range of 3 months to 6 years)(HP:0002373)|Inability to walk(HP:0002540)|Focal motor seizure(HP:0011153)|Delayed eruption of teeth(HP:0000684)|Prominent forehead(HP:0011220)|Retrognathia(HP:0000278)|Prominent nasal tip(HP:0005274)|Short neck(HP:0000470)|Reduced dihydropyrimidine dehydrogenase level(HP:0003654)|Myopia(HP:0000545)|Epiphyseal dysplasia(HP:0002656)|Abnormal social behavior(HP:0012433)|Microcornea(HP:0000482)|Long eyelashes(HP:0000527)|Large earlobe(HP:0009748)|Autistic behavior(HP:0000729)|Severe global developmental delay(HP:0011344)|Cerebral atrophy(HP:0002059)|Strabismus(HP:0000486)|Hypertelorism(HP:0000316)|Irritability(HP:0000737)|Uraciluria(HP:0012127)|Deep philtrum(HP:0002002)|Severe expressive language delay(HP:0006863)|Poor suck(HP:0002033)|Intellectual disability, profound(HP:0002187)|Microcephaly(HP:0000252)|Short nail(HP:0001799)|Anteverted nares(HP:0000463)|Specific learning disability(HP:0001328)|Nystagmus(HP:0000639)|Open mouth(HP:0000194)|Macular hypoplasia(HP:0001104)|Multifocal epileptiform discharges(HP:0010841)|Abnormal aggressive, impulsive or violent behavior(HP:0006919)|High palate(HP:0000218)|Infantile muscular hypotonia(HP:0008947)|Areflexia(HP:0001284)|Astigmatism(HP:0000483)|Depressed nasal bridge(HP:0005280)|Palpebral thickening(HP:0030939)|Hyperintensity of cerebral white matter on MRI(HP:0030890)|Hypertonia(HP:0001276)|Hypotonia(HP:0001252)|Uraciluria(HP:0012127)|Failure to thrive(HP:0001508)|Delayed speech and language development(HP:0000750)|Autosomal recessive inheritance(HP:0000007)|Generalized hypotonia(HP:0001290)|Intellectual disability(HP:0001249)|Reduced dihydropyrimidine dehydrogenase level(HP:0003654)|Optic atrophy(HP:0000648)|Seizure(HP:0001250)|Agenesis of corpus callosum(HP:0001274)|Motor delay(HP:0001270)|Tetraplegia(HP:0002445)|Hyperactivity(HP:0000752)|Lethargy(HP:0001254)|Cerebral atrophy(HP:0002059)|Hypertonia(HP:0001276)|Growth delay(HP:0001510)|Coloboma(HP:0000589)|Nystagmus(HP:0000639)|Microcephaly(HP:0000252)|Microphthalmia(HP:0000568)|Autism(HP:0000717)","The protein encoded by this gene is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Mutations in this gene result in dihydropyrimidine dehydrogenase deficiency, an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]","dihydropyrimidine dehydrogenase","purine nucleobase catabolic process(GO:0006145)|pyrimidine nucleobase catabolic process(GO:0006208)|pyrimidine nucleobase catabolic process(GO:0006208)|thymine catabolic process(GO:0006210)|thymine catabolic process(GO:0006210)|uracil catabolic process(GO:0006212)|uracil catabolic process(GO:0006212)|thymidine catabolic process(GO:0006214)|CMP catabolic process(GO:0006248)|dCMP catabolic process(GO:0006249)|beta-alanine biosynthetic process(GO:0019483)|UMP catabolic process(GO:0046050)|dUMP catabolic process(GO:0046079)","cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytosol(GO:0005829)|cytosol(GO:0005829)","uracil binding(GO:0002058)|protein binding(GO:0005515)|dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113)|dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113)|dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113)|dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113)|protein homodimerization activity(GO:0042803)|protein homodimerization activity(GO:0042803)|metal ion binding(GO:0046872)|flavin adenine dinucleotide binding(GO:0050660)|NADP binding(GO:0050661)|NADP binding(GO:0050661)|iron-sulfur cluster binding(GO:0051536)|4 iron, 4 sulfur cluster binding(GO:0051539)","dihydropyrimidine dehydrogenase deficiency(DOID:14218)|colon carcinoma(DOID:1520)|cancer(DOID:162)|squamous cell carcinoma(DOID:1749)|ovarian carcinoma(DOID:4001)|biliary tract cancer(DOID:4607)|liver cirrhosis(DOID:5082)","Pantothenate and coa biosynthesis|Pyrimidine metabolism|Beta alanine metabolism|Drug metabolism other enzymes","Wp pyrimidine metabolism|Wp tyrobp causal network|Wp fluoropyrimidine activity|Wp pyrimidine metabolism and related diseases|Wp biomarkers for pyrimidine metabolism disorders","Metabolism of nucleotides|Pyrimidine catabolism|Nucleobase catabolism","","Apoptosis","SpliceAI>A|DPYD|0.00|0.00|0.00|0.00|0|4|2|-4","","","","0.0005","","","0.0003","0.","0.0003","0.0005","0.0004","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr9","38068429","38068429","C>G","","SHB","exonic","nonsynonymous SNV","","SHB:NM_003028:exon1:c.G214C:p.D72H","RP11-613M10.9;SHB","exonic","nonsynonymous SNV","","SHB:ENST00000377707.4_1:exon1:c.G214C:p.D72H,RP11-613M10.9:ENST00000540557.1_1:exon1:c.G214C:p.D72H","SHB:ENST00000377700.4:c.214G>C:p.(Asp72His)","0.8468644","","","","0.5017100733239204","0.5239917933940887","0.0369386548002881","","","","","","","","","","ENSG00000107338","SHB","HGNC:10838","SHB","6461","ENSG00000107338","uc004aax.4","0.03693865480028817","0.5017100733239204","0.5239917933940887","","809","0/1","Het","55","28,27","0.509090909090909","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","SH2 domain containing adaptor protein B","angiogenesis(GO:0001525)|apoptotic process(GO:0006915)|signal transduction(GO:0007165)|cell differentiation(GO:0030154)","nucleoplasm(GO:0005654)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|cytoplasmic ribonucleoprotein granule(GO:0036464)","phosphotyrosine residue binding(GO:0001784)|phosphotyrosine residue binding(GO:0001784)|protein binding(GO:0005515)","","","Wp vegfavegfr2 signaling pathway","Signaling by vegf|Signaling by receptor tyrosine kinases","","","SpliceAI>G|RP11-613M10.9|0.00|0.00|0.00|0.00|-8|20|-8|-50>G|SHB|0.00|0.00|0.00|0.00|-8|20|48|-39","","","Score=867;Name=V$ATF_01","0.0075","0.0002","0.001","0.0004","0.0075","","","0.0003","0.0043","D","0.003","T","0.11","P","0.516","B","0.241","N","0.004","D","0.741","N","0","T","0.93","N","-0.92","0.251","T","-0.925","T","0.065","D","0.921","0.101","T","0.053","24.3","3.270","4.07","2.307","14.171"
"chr6","157100431","157100433","GGC>-","ARID1B:57492","ARID1B","exonic","nonframeshift deletion","","ARID1B:NM_017519:exon1:c.1368_1370del:p.A460del,ARID1B:NM_020732:exon1:c.1368_1370del:p.A460del","ARID1B","exonic","nonframeshift deletion","","ARID1B:ENST00000636930.2_1:exon1:c.1617_1619del:p.A543del,ARID1B:ENST00000647938.1_1:exon1:c.1368_1370del:p.A460del,ARID1B:ENST00000346085.10_1:exon2:c.1617_1619del:p.A543del","ARID1B:ENST00000275248.4:c.1205_1207del:p.(Ala402del)","0.8173284","","","","0.2500303140786855","0.7949771285057068","0.032664121649243","","","","","","","","","","ENSG00000049618","ARID1B","HGNC:18040","ARID1B","57492","ENSG00000049618","uc003qqp.4","0.032664121649243094","0.2500303140786855","0.7949771285057068","OMIM:135900 Coffin-Siris syndrome 1-autosomal_dominant;ORPHA:1465 Coffin-Siris syndrome-autosomal_dominant;ORPHA:251056 6q25 microdeletion syndrome-unknown","821","0/1","Het","62","56,6","0.903225806451613","Benign/Likely_benign","False","Intellectual_disability|History_of_neurodevelopmental_disorder|not_provided","Human_Phenotype_Ontology:HP:0000730,Human_Phenotype_Ontology:HP:0001249,Human_Phenotype_Ontology:HP:0001267,Human_Phenotype_Ontology:HP:0001286,Human_Phenotype_Ontology:HP:0002122,Human_Phenotype_Ontology:HP:0002192,Human_Phenotype_Ontology:HP:0002316,Human_Phenotype_Ontology:HP:0002382,Human_Phenotype_Ontology:HP:0002386,Human_Phenotype_Ontology:HP:0002402,Human_Phenotype_Ontology:HP:0002458,Human_Phenotype_Ontology:HP:0002482,Human_Phenotype_Ontology:HP:0002499,Human_Phenotype_Ontology:HP:0002543,Human_Phenotype_Ontology:HP:0003767,Human_Phenotype_Ontology:HP:0006833,Human_Phenotype_Ontology:HP:0007154,Human_Phenotype_Ontology:HP:0007176,Human_Phenotype_Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756,SNOMED_CT:228156007|MedGen:C2711754|MedGen:CN517202","NC_000006.11:g.157100433CGG[3]","criteria_provided,_multiple_submitters,_no_conflicts","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Siris syndrome 1(135900)","Single transverse palmar crease(HP:0000954)|Visual impairment(HP:0000505)|Ventricular septal defect(HP:0001629)|Duodenal ulcer(HP:0002588)|Spina bifida occulta(HP:0003298)|Hoarse voice(HP:0001609)|Short chin(HP:0000331)|Intussusception(HP:0002576)|Hemangioma(HP:0001028)|Short stature(HP:0004322)|Astigmatism(HP:0000483)|Aplasia of the uterus(HP:0000151)|Coarse facial features(HP:0000280)|Hypertelorism(HP:0000316)|Wide mouth(HP:0000154)|Sandal gap(HP:0001852)|Short sternum(HP:0000879)|Severe expressive language delay(HP:0006863)|Hydronephrosis(HP:0000126)|Gastric ulcer(HP:0002592)|High palate(HP:0000218)|Microdontia(HP:0000691)|Delayed eruption of teeth(HP:0000684)|Conical tooth(HP:0000698)|Preauricular skin tag(HP:0000384)|Long philtrum(HP:0000343)|Patent ductus arteriosus(HP:0001643)|Renal hypoplasia(HP:0000089)|Cleft palate(HP:0000175)|Low-set ears(HP:0000369)|Hypoplasia of the corpus callosum(HP:0002079)|Kyphosis(HP:0002808)|Seizure(HP:0001250)|Myopia(HP:0000545)|Short distal phalanx of the 5th toe(HP:0100391)|Scoliosis(HP:0002650)|Nystagmus(HP:0000639)|Ptosis(HP:0000508)|High pitched voice(HP:0001620)|Aggressive behavior(HP:0000718)|Frontal bossing(HP:0002007)|Sparse scalp hair(HP:0002209)|Delayed ability to walk(HP:0031936)|Prominent fingertip pads(HP:0001212)|Anonychia(HP:0001798)|Short distal phalanx of the 5th finger(HP:0004227)|Facial hypertrichosis(HP:0002219)|Dry hair(HP:0011359)|Hearing impairment(HP:0000365)|Clitoral hypertrophy(HP:0008665)|Autosomal dominant inheritance(HP:0000006)|Delayed skeletal maturation(HP:0002750)|Prominent interphalangeal joints(HP:0006237)|Sacral dimple(HP:0000960)|Intellectual disability(HP:0001249)|Delayed CNS myelination(HP:0002188)|Hypotonia(HP:0001252)|Congenital diaphragmatic hernia(HP:0000776)|Abnormality of the pinna(HP:0000377)|Ectopic kidney(HP:0000086)|Brachycephaly(HP:0000248)|Recurrent respiratory infections(HP:0002205)|Retrognathia(HP:0000278)|Thick eyebrow(HP:0000574)|Autistic behavior(HP:0000729)|Umbilical hernia(HP:0001537)|Depressed nasal bridge(HP:0005280)|Broad nasal tip(HP:0000455)|Intrauterine growth retardation(HP:0001511)|Microcephaly(HP:0000252)|Dislocated radial head(HP:0003083)|Short philtrum(HP:0000322)|Long eyelashes(HP:0000527)|Tetralogy of Fallot(HP:0001636)|Thin upper lip vermilion(HP:0000219)|Hydroureter(HP:0000072)|Postnatal growth retardation(HP:0008897)|Strabismus(HP:0000486)|Lumbosacral hirsutism(HP:0009747)|Joint laxity(HP:0001388)|Posteriorly rotated ears(HP:0000358)|Thick lower lip vermilion(HP:0000179)|Plagiocephaly(HP:0001357)|Coxa valga(HP:0002673)|Downslanted palpebral fissures(HP:0000494)|Global developmental delay(HP:0001263)|Aplasia/Hypoplasia of the patella(HP:0006498)|Hypoplastic fifth fingernail(HP:0008398)|Cryptorchidism(HP:0000028)|Choanal atresia(HP:0000453)|Hypospadias(HP:0000047)|Obsessive-compulsive behavior(HP:0000722)|Delayed speech and language development(HP:0000750)|Gait ataxia(HP:0002066)|Hypotelorism(HP:0000601)|Partial agenesis of the corpus callosum(HP:0001338)|Atrial septal defect(HP:0001631)|Feeding difficulties in infancy(HP:0008872)|Dandy-Walker malformation(HP:0001305)|Hypertrichosis(HP:0000998)|Clinodactyly of the 5th finger(HP:0004209)|Intestinal malrotation(HP:0002566)|Cutis marmorata(HP:0000965)|Inguinal hernia(HP:0000023)|Abnormality of the pinna(HP:0000377)|Micrognathia(HP:0000347)|Epicanthus(HP:0000286)|Failure to thrive(HP:0001508)|Malar flattening(HP:0000272)|Camptodactyly of finger(HP:0100490)|Sensorineural hearing impairment(HP:0000407)|Neonatal hypotonia(HP:0001319)|Wide nasal bridge(HP:0000431)|Upslanted palpebral fissure(HP:0000582)|Intellectual disability, mild(HP:0001256)|Seizure(HP:0001250)|Clinodactyly of the 5th finger(HP:0004209)|Downslanted palpebral fissures(HP:0000494)|Plagiocephaly(HP:0001357)|Ventriculomegaly(HP:0002119)|Microcephaly(HP:0000252)|Hypertelorism(HP:0000316)|Long philtrum(HP:0000343)|Agenesis of corpus callosum(HP:0001274)|Global developmental delay(HP:0001263)|External genital hypoplasia(HP:0003241)|High palate(HP:0000218)|Low-set, posteriorly rotated ears(HP:0000368)|Abnormality of vision(HP:0000504)|Cleft palate(HP:0000175)|Rocker bottom foot(HP:0001838)|Short stature(HP:0004322)|Abnormality of cardiovascular system morphology(HP:0030680)|Joint laxity(HP:0001388)|Broad philtrum(HP:0000289)|Thick eyebrow(HP:0000574)|Recurrent upper respiratory tract infections(HP:0002788)|Feeding difficulties(HP:0011968)|Broad nasal tip(HP:0000455)|Patent ductus arteriosus(HP:0001643)|Short 5th finger(HP:0009237)|Autistic behavior(HP:0000729)|Depressed nasal bridge(HP:0005280)|Hernia(HP:0100790)|Dandy-Walker malformation(HP:0001305)|Horseshoe kidney(HP:0000085)|Oral aversion(HP:0012523)|Intellectual disability, severe(HP:0010864)|Microcephaly(HP:0000252)|Simplified gyral pattern(HP:0009879)|Sparse scalp hair(HP:0002209)|Ptosis(HP:0000508)|Intellectual disability, moderate(HP:0002342)|Coarse facial features(HP:0000280)|Wide mouth(HP:0000154)|Seizure(HP:0001250)|Thick nasal alae(HP:0009928)|Papillary thyroid carcinoma(HP:0002895)|Aggressive behavior(HP:0000718)|Hepatoblastoma(HP:0002884)|Visual impairment(HP:0000505)|Low anterior hairline(HP:0000294)|Hypospadias(HP:0000047)|Strabismus(HP:0000486)|Infantile muscular hypotonia(HP:0008947)|Postnatal growth retardation(HP:0008897)|Hypoplastic fifth fingernail(HP:0008398)|Hirsutism(HP:0001007)|Tetralogy of Fallot(HP:0001636)|Aspiration pneumonia(HP:0011951)|Cryptorchidism(HP:0000028)|Intrauterine growth retardation(HP:0001511)|Ventricular septal defect(HP:0001629)|Thick lower lip vermilion(HP:0000179)|Absent speech(HP:0001344)|Clinodactyly(HP:0030084)|Delayed skeletal maturation(HP:0002750)|Hyperactivity(HP:0000752)|Wide nasal base(HP:0012810)|Scoliosis(HP:0002650)|Delayed eruption of teeth(HP:0000684)|Hypoplastic fifth toenail(HP:0011937)|Short nose(HP:0003196)|Thin upper lip vermilion(HP:0000219)|Hearing impairment(HP:0000365)|Agenesis of corpus callosum(HP:0001274)|Prominent eyelashes(HP:0011231)|Myopia(HP:0000545)|Hypertrichosis(HP:0000998)|Atrial septal defect(HP:0001631)","This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]","AT-rich interaction domain 1B","regulation of transcription by RNA polymerase II(GO:0006357)|nervous system development(GO:0007399)|epigenetic maintenance of chromatin in transcription-competent conformation(GO:0045815)|positive regulation of transcription, DNA-templated(GO:0045893)","nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|SWI/SNF complex(GO:0016514)|SWI/SNF complex(GO:0016514)|brahma complex(GO:0035060)|nBAF complex(GO:0071565)","DNA binding(GO:0003677)|transcription coactivator activity(GO:0003713)|protein binding(GO:0005515)|nucleosome binding(GO:0031491)","thalassemia(DOID:10241)","","Wp tumor suppressor activity of smarcb1|Wp thermogenesis","Rmts methylate histone arginines|Chromatin modifying enzymes|Rna polymerase ii transcription|Transcriptional regulation by runx1|Runx1 interacts with co factors whose precise effect on runx1 targets is not known","","","SpliceAI>A|ARID1B|0.00|0.00|0.00|0.00|-10|-44|4|1","","Name=(CGG)n","","0.0003","","","0.","0.","","","0.0003","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr6","157100093","157100095","GCG>-","","ARID1B","exonic","nonframeshift deletion","","ARID1B:NM_017519:exon1:c.1030_1032del:p.A350del,ARID1B:NM_020732:exon1:c.1030_1032del:p.A350del","ARID1B","exonic","nonframeshift deletion","","ARID1B:ENST00000636930.2_1:exon1:c.1279_1281del:p.A433del,ARID1B:ENST00000647938.1_1:exon1:c.1030_1032del:p.A350del,ARID1B:ENST00000346085.10_1:exon2:c.1279_1281del:p.A433del","ARID1B:ENST00000275248.4:c.867_869del:p.(Ala292del)","0.77262586","","","","0.2500303140786855","0.7949771285057068","0.032664121649243","","","","","","","","","","ENSG00000049618","ARID1B","HGNC:18040","ARID1B","57492","ENSG00000049618","uc003qqp.4","0.032664121649243094","0.2500303140786855","0.7949771285057068","OMIM:135900 Coffin-Siris syndrome 1-autosomal_dominant;ORPHA:1465 Coffin-Siris syndrome-autosomal_dominant;ORPHA:251056 6q25 microdeletion syndrome-unknown","822","0/1","Het","31","27,4","0.870967741935484","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Siris syndrome 1(135900)","Single transverse palmar crease(HP:0000954)|Visual impairment(HP:0000505)|Ventricular septal defect(HP:0001629)|Duodenal ulcer(HP:0002588)|Spina bifida occulta(HP:0003298)|Hoarse voice(HP:0001609)|Short chin(HP:0000331)|Intussusception(HP:0002576)|Hemangioma(HP:0001028)|Short stature(HP:0004322)|Astigmatism(HP:0000483)|Aplasia of the uterus(HP:0000151)|Coarse facial features(HP:0000280)|Hypertelorism(HP:0000316)|Wide mouth(HP:0000154)|Sandal gap(HP:0001852)|Short sternum(HP:0000879)|Severe expressive language delay(HP:0006863)|Hydronephrosis(HP:0000126)|Gastric ulcer(HP:0002592)|High palate(HP:0000218)|Microdontia(HP:0000691)|Delayed eruption of teeth(HP:0000684)|Conical tooth(HP:0000698)|Preauricular skin tag(HP:0000384)|Long philtrum(HP:0000343)|Patent ductus arteriosus(HP:0001643)|Renal hypoplasia(HP:0000089)|Cleft palate(HP:0000175)|Low-set ears(HP:0000369)|Hypoplasia of the corpus callosum(HP:0002079)|Kyphosis(HP:0002808)|Seizure(HP:0001250)|Myopia(HP:0000545)|Short distal phalanx of the 5th toe(HP:0100391)|Scoliosis(HP:0002650)|Nystagmus(HP:0000639)|Ptosis(HP:0000508)|High pitched voice(HP:0001620)|Aggressive behavior(HP:0000718)|Frontal bossing(HP:0002007)|Sparse scalp hair(HP:0002209)|Delayed ability to walk(HP:0031936)|Prominent fingertip pads(HP:0001212)|Anonychia(HP:0001798)|Short distal phalanx of the 5th finger(HP:0004227)|Facial hypertrichosis(HP:0002219)|Dry hair(HP:0011359)|Hearing impairment(HP:0000365)|Clitoral hypertrophy(HP:0008665)|Autosomal dominant inheritance(HP:0000006)|Delayed skeletal maturation(HP:0002750)|Prominent interphalangeal joints(HP:0006237)|Sacral dimple(HP:0000960)|Intellectual disability(HP:0001249)|Delayed CNS myelination(HP:0002188)|Hypotonia(HP:0001252)|Congenital diaphragmatic hernia(HP:0000776)|Abnormality of the pinna(HP:0000377)|Ectopic kidney(HP:0000086)|Brachycephaly(HP:0000248)|Recurrent respiratory infections(HP:0002205)|Retrognathia(HP:0000278)|Thick eyebrow(HP:0000574)|Autistic behavior(HP:0000729)|Umbilical hernia(HP:0001537)|Depressed nasal bridge(HP:0005280)|Broad nasal tip(HP:0000455)|Intrauterine growth retardation(HP:0001511)|Microcephaly(HP:0000252)|Dislocated radial head(HP:0003083)|Short philtrum(HP:0000322)|Long eyelashes(HP:0000527)|Tetralogy of Fallot(HP:0001636)|Thin upper lip vermilion(HP:0000219)|Hydroureter(HP:0000072)|Postnatal growth retardation(HP:0008897)|Strabismus(HP:0000486)|Lumbosacral hirsutism(HP:0009747)|Joint laxity(HP:0001388)|Posteriorly rotated ears(HP:0000358)|Thick lower lip vermilion(HP:0000179)|Plagiocephaly(HP:0001357)|Coxa valga(HP:0002673)|Downslanted palpebral fissures(HP:0000494)|Global developmental delay(HP:0001263)|Aplasia/Hypoplasia of the patella(HP:0006498)|Hypoplastic fifth fingernail(HP:0008398)|Cryptorchidism(HP:0000028)|Choanal atresia(HP:0000453)|Hypospadias(HP:0000047)|Obsessive-compulsive behavior(HP:0000722)|Delayed speech and language development(HP:0000750)|Gait ataxia(HP:0002066)|Hypotelorism(HP:0000601)|Partial agenesis of the corpus callosum(HP:0001338)|Atrial septal defect(HP:0001631)|Feeding difficulties in infancy(HP:0008872)|Dandy-Walker malformation(HP:0001305)|Hypertrichosis(HP:0000998)|Clinodactyly of the 5th finger(HP:0004209)|Intestinal malrotation(HP:0002566)|Cutis marmorata(HP:0000965)|Inguinal hernia(HP:0000023)|Abnormality of the pinna(HP:0000377)|Micrognathia(HP:0000347)|Epicanthus(HP:0000286)|Failure to thrive(HP:0001508)|Malar flattening(HP:0000272)|Camptodactyly of finger(HP:0100490)|Sensorineural hearing impairment(HP:0000407)|Neonatal hypotonia(HP:0001319)|Wide nasal bridge(HP:0000431)|Upslanted palpebral fissure(HP:0000582)|Intellectual disability, mild(HP:0001256)|Seizure(HP:0001250)|Clinodactyly of the 5th finger(HP:0004209)|Downslanted palpebral fissures(HP:0000494)|Plagiocephaly(HP:0001357)|Ventriculomegaly(HP:0002119)|Microcephaly(HP:0000252)|Hypertelorism(HP:0000316)|Long philtrum(HP:0000343)|Agenesis of corpus callosum(HP:0001274)|Global developmental delay(HP:0001263)|External genital hypoplasia(HP:0003241)|High palate(HP:0000218)|Low-set, posteriorly rotated ears(HP:0000368)|Abnormality of vision(HP:0000504)|Cleft palate(HP:0000175)|Rocker bottom foot(HP:0001838)|Short stature(HP:0004322)|Abnormality of cardiovascular system morphology(HP:0030680)|Joint laxity(HP:0001388)|Broad philtrum(HP:0000289)|Thick eyebrow(HP:0000574)|Recurrent upper respiratory tract infections(HP:0002788)|Feeding difficulties(HP:0011968)|Broad nasal tip(HP:0000455)|Patent ductus arteriosus(HP:0001643)|Short 5th finger(HP:0009237)|Autistic behavior(HP:0000729)|Depressed nasal bridge(HP:0005280)|Hernia(HP:0100790)|Dandy-Walker malformation(HP:0001305)|Horseshoe kidney(HP:0000085)|Oral aversion(HP:0012523)|Intellectual disability, severe(HP:0010864)|Microcephaly(HP:0000252)|Simplified gyral pattern(HP:0009879)|Sparse scalp hair(HP:0002209)|Ptosis(HP:0000508)|Intellectual disability, moderate(HP:0002342)|Coarse facial features(HP:0000280)|Wide mouth(HP:0000154)|Seizure(HP:0001250)|Thick nasal alae(HP:0009928)|Papillary thyroid carcinoma(HP:0002895)|Aggressive behavior(HP:0000718)|Hepatoblastoma(HP:0002884)|Visual impairment(HP:0000505)|Low anterior hairline(HP:0000294)|Hypospadias(HP:0000047)|Strabismus(HP:0000486)|Infantile muscular hypotonia(HP:0008947)|Postnatal growth retardation(HP:0008897)|Hypoplastic fifth fingernail(HP:0008398)|Hirsutism(HP:0001007)|Tetralogy of Fallot(HP:0001636)|Aspiration pneumonia(HP:0011951)|Cryptorchidism(HP:0000028)|Intrauterine growth retardation(HP:0001511)|Ventricular septal defect(HP:0001629)|Thick lower lip vermilion(HP:0000179)|Absent speech(HP:0001344)|Clinodactyly(HP:0030084)|Delayed skeletal maturation(HP:0002750)|Hyperactivity(HP:0000752)|Wide nasal base(HP:0012810)|Scoliosis(HP:0002650)|Delayed eruption of teeth(HP:0000684)|Hypoplastic fifth toenail(HP:0011937)|Short nose(HP:0003196)|Thin upper lip vermilion(HP:0000219)|Hearing impairment(HP:0000365)|Agenesis of corpus callosum(HP:0001274)|Prominent eyelashes(HP:0011231)|Myopia(HP:0000545)|Hypertrichosis(HP:0000998)|Atrial septal defect(HP:0001631)","This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]","AT-rich interaction domain 1B","regulation of transcription by RNA polymerase II(GO:0006357)|nervous system development(GO:0007399)|epigenetic maintenance of chromatin in transcription-competent conformation(GO:0045815)|positive regulation of transcription, DNA-templated(GO:0045893)","nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|SWI/SNF complex(GO:0016514)|SWI/SNF complex(GO:0016514)|brahma complex(GO:0035060)|nBAF complex(GO:0071565)","DNA binding(GO:0003677)|transcription coactivator activity(GO:0003713)|protein binding(GO:0005515)|nucleosome binding(GO:0031491)","thalassemia(DOID:10241)","","Wp tumor suppressor activity of smarcb1|Wp thermogenesis","Rmts methylate histone arginines|Chromatin modifying enzymes|Rna polymerase ii transcription|Transcriptional regulation by runx1|Runx1 interacts with co factors whose precise effect on runx1 targets is not known","","","","","Name=(CGG)n","","0.0024","","","0.","","","","0.0024","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr15","55626174","55626174","G>C","","PIGB","exonic","nonsynonymous SNV","","PIGB:NM_004855:exon6:c.G763C:p.D255H","PIGB","exonic","nonsynonymous SNV","","PIGB:ENST00000164305.10_1:exon6:c.G763C:p.D255H,PIGB:ENST00000539642.5_1:exon6:c.G766C:p.D256H","PIGB:ENST00000164305.5:c.763G>C:p.(Asp255His)","0.79491866","0.2500510698264406","0.7949186563491821","0.0326539725373909","","","","","","","","","","","","","ENSG00000069943","PIGB","HGNC:8959","PIGB","9488","ENSG00000069943","uc002act.4","0.03265397253739095","0.25005106982644065","0.7949186563491821","OMIM:618580 Developmental and epileptic encephalopathy 80-autosomal_recessive","823","0/1","Het","132","76,56","0.575757575757576","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Developmental and epileptic encephalopathy 80(618580)","Wide mouth(HP:0000154)|Wide nasal bridge(HP:0000431)|Hyporeflexia(HP:0001265)|Peripheral axonal neuropathy(HP:0003477)|Failure to thrive(HP:0001508)|Protruding tongue(HP:0010808)|Abnormal visual fixation(HP:0025404)|Overfolded helix(HP:0000396)|Short distal phalanx of finger(HP:0009882)|Hypoplasia of the corpus callosum(HP:0002079)|Sensorimotor neuropathy(HP:0007141)|Uplifted earlobe(HP:0009909)|Areflexia(HP:0001284)|Polymicrogyria(HP:0002126)|Generalized hypotonia(HP:0001290)|Optic disc pallor(HP:0000543)|Growth delay(HP:0001510)|Hypertelorism(HP:0000316)|Tapered finger(HP:0001182)|Death in infancy(HP:0001522)|Micrognathia(HP:0000347)|Low-set ears(HP:0000369)|Increased urine alpha-ketoglutarate concentration(HP:0012402)|Pointed chin(HP:0000307)|Upslanted palpebral fissure(HP:0000582)|High palate(HP:0000218)|Coarse facial features(HP:0000280)|Visual impairment(HP:0000505)|Narrow forehead(HP:0000341)|Long philtrum(HP:0000343)|Seizure(HP:0001250)|Feeding difficulties(HP:0011968)|Talipes equinovarus(HP:0001762)|Global developmental delay(HP:0001263)|Posteriorly rotated ears(HP:0000358)|Hearing impairment(HP:0000365)|Ventriculomegaly(HP:0002119)|Tented upper lip vermilion(HP:0010804)|Smooth philtrum(HP:0000319)|Triphalangeal thumb(HP:0001199)|Small nail(HP:0001792)|Full cheeks(HP:0000293)|Elevated circulating alkaline phosphatase concentration(HP:0003155)|Autosomal recessive inheritance(HP:0000007)|Proptosis(HP:0000520)","This gene encodes a transmembrane protein that is located in the endoplasmic reticulum and is involved in GPI-anchor biosynthesis. The glycosylphosphatidylinositol (GPI) anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene is thought to encode a member of a family of dolichol-phosphate-mannose (Dol-P-Man) dependent mannosyltransferases. [provided by RefSeq, Jul 2008]","phosphatidylinositol glycan anchor biosynthesis class B","GPI anchor biosynthetic process(GO:0006506)|GPI anchor biosynthetic process(GO:0006506)|preassembly of GPI anchor in ER membrane(GO:0016254)|mannosylation(GO:0097502)","endoplasmic reticulum membrane(GO:0005789)|endoplasmic reticulum membrane(GO:0005789)|endoplasmic reticulum membrane(GO:0005789)|integral component of membrane(GO:0016021)","alpha-1,2-mannosyltransferase activity(GO:0000026)|mannosyltransferase activity(GO:0000030)|mannosyltransferase activity(GO:0000030)|glycolipid mannosyltransferase activity(GO:0004376)","","Glycosylphosphatidylinositol gpi anchor biosynthesis","","Synthesis of glycosylphosphatidylinositol gpi|Post translational modification synthesis of gpi anchored proteins|Post translational protein modification","","","",".;.;.","","","","","","","","","","","","T","0.205","T","0.197","B","0.003","B","0.014","N","0.018","N","0.830","L","1.345","T","0.02","N","-0.32","0.265","T","-1.039","T","0.096","T","0.007","0.058","T","0.175","19.30","1.945","6.03","1.079","5.821"
"chr11","1861812","1861812","G>A","","TNNI2","exonic","nonsynonymous SNV","","TNNI2:NM_001145841:exon3:c.G112A:p.E38K","TNNI2","exonic","nonsynonymous SNV","","TNNI2:ENST00000381905.3_1:exon3:c.G112A:p.E38K,TNNI2:ENST00000617947.4_1:exon3:c.G112A:p.E38K,TNNI2:ENST00000252898.11_1:exon4:c.G112A:p.E38K,TNNI2:ENST00000381906.5_1:exon5:c.G112A:p.E38K,TNNI2:ENST00000381911.6_1:exon5:c.G112A:p.E38K","TNNI2:ENST00000252898.7:c.112G>A:p.(Glu38Lys)","0.5028009","0.5003201251092833","0.5028008818626404","0.0301803320439788","","","","","","","","","","","","","ENSG00000130598","TNNI2","HGNC:11946","TNNI2","7136","ENSG00000130598","uc057xue.1","0.030180332043978877","0.5003201251092833","0.5028008818626404","OMIM:601680 Arthrogryposis, distal, type 2B1-autosomal_dominant;ORPHA:1146 Distal arthrogryposis type 1-autosomal_dominant;ORPHA:1147 Sheldon-Hall syndrome-autosomal_dominant","826","0/1","Het","90","44,46","0.488888888888889","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Arthrogryposis, distal, type 2b1(601680)","Adducted thumb(HP:0001181)|Abnormal hip bone morphology(HP:0003272)|Overlapping fingers(HP:0010557)|Joint stiffness(HP:0001387)|Talipes(HP:0001883)|Rocker bottom foot(HP:0001838)|Ulnar deviation of finger(HP:0009465)|Narrow mouth(HP:0000160)|Camptodactyly of finger(HP:0100490)|Calcaneovalgus deformity(HP:0001848)|Talipes equinovarus(HP:0001762)|Scoliosis(HP:0002650)|Autosomal dominant inheritance(HP:0000006)|Long philtrum(HP:0000343)|Ulnar deviation of the wrist(HP:0003049)|High palate(HP:0000218)|Ulnar deviation of the hand or of fingers of the hand(HP:0001193)|Narrow mouth(HP:0000160)|Micrognathia(HP:0000347)|Metatarsus adductus(HP:0001840)|Mandibular prognathia(HP:0000303)|Triangular face(HP:0000325)|Distal arthrogryposis(HP:0005684)|Short stature(HP:0004322)|Downslanted palpebral fissures(HP:0000494)|Arthrogryposis multiplex congenita(HP:0002804)|Wide nasal bridge(HP:0000431)|Rocker bottom foot(HP:0001838)|Webbed neck(HP:0000465)|Camptodactyly of finger(HP:0100490)|Abnormality of the ear(HP:0000598)|Prominent nasolabial fold(HP:0005272)|Absent phalangeal crease(HP:0006109)|Overlapping fingers(HP:0010557)|Webbed neck(HP:0000465)|Vertebral segmentation defect(HP:0003422)|High palate(HP:0000218)|Protruding ear(HP:0000411)|Narrow face(HP:0000275)|Bilateral single transverse palmar creases(HP:0007598)|Abnormal hip bone morphology(HP:0003272)|Adducted thumb(HP:0001181)|Scoliosis(HP:0002650)|Ulnar deviation of the wrist(HP:0003049)|Wide nasal bridge(HP:0000431)|Joint stiffness(HP:0001387)|Round ear(HP:0100830)|Micrognathia(HP:0000347)|Short neck(HP:0000470)|Short stature(HP:0004322)|Ulnar deviation of finger(HP:0009465)|Tarsal synostosis(HP:0008368)|Aplasia/Hypoplasia of the radius(HP:0006501)","This gene encodes a fast-twitch skeletal muscle protein, a member of the troponin I gene family, and a component of the troponin complex including troponin T, troponin C and troponin I subunits. The troponin complex, along with tropomyosin, is responsible for the calcium-dependent regulation of striated muscle contraction. Mouse studies show that this component is also present in vascular smooth muscle and may play a role in regulation of smooth muscle function. In addition to muscle tissues, this protein is found in corneal epithelium, cartilage where it is an inhibitor of angiogenesis to inhibit tumor growth and metastasis, and mammary gland where it functions as a co-activator of estrogen receptor-related receptor alpha. This protein also suppresses tumor growth in human ovarian carcinoma. Mutations in this gene cause myopathy and distal arthrogryposis type 2B. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]","troponin I2, fast skeletal type","skeletal muscle contraction(GO:0003009)|skeletal muscle contraction(GO:0003009)|muscle contraction(GO:0006936)|regulation of muscle contraction(GO:0006937)|positive regulation of transcription, DNA-templated(GO:0045893)|cardiac muscle contraction(GO:0060048)","nucleus(GO:0005634)|cytosol(GO:0005829)|troponin complex(GO:0005861)|troponin complex(GO:0005861)","actin binding(GO:0003779)|protein binding(GO:0005515)|troponin T binding(GO:0031014)","","","Wp striated muscle contraction pathway","Striated muscle contraction|Muscle contraction","","Myogenesis","",".;.;.;.;.","","","0.00002414","","","0.","0.0001","","","2.414e-05","0.0003","T","0.529","T","0.662","B","0.085","B","0.073","D","0.000","N","1.000","L","1.245","D","-3.64","N","-1.38","0.473","T","-0.134","D","0.646","D","0.652","0.361","T","0.124","13.63","1.030","2.78","3.819","14.735"
"chr11","62302543","62302543","G>A","","AHNAK","exonic","nonsynonymous SNV","","AHNAK:NM_001620:exon4:c.C274T:p.R92C,AHNAK:NM_024060:exon4:c.C274T:p.R92C","AHNAK","exonic","nonsynonymous SNV","","AHNAK:ENST00000530124.5_1:exon2:c.C274T:p.R92C,AHNAK:ENST00000257247.11_1:exon4:c.C274T:p.R92C,AHNAK:ENST00000378024.9_1:exon4:c.C274T:p.R92C","AHNAK:ENST00000257247.7:c.274C>T:p.(Arg92Cys)","0.9817359","","","","0.5022523438092321","0.491192619811045","0.0277482149778203","","","","","","","","","","ENSG00000124942","AHNAK","HGNC:347","AHNAK","79026","ENSG00000124942","uc001ntl.4","0.02774821497782031","0.5022523438092321","0.491192619811045","","836","0/1","Het","132","74,58","0.560606060606061","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a large (700 kDa) structural scaffold protein consisting of a central domain with 128 aa repeats. The encoded protein may play a role in such diverse processes as blood-brain barrier formation, cell structure and migration, cardiac calcium channel regulation, and tumor metastasis. A much shorter variant encoding a 17 kDa isoform exists for this gene, and the shorter isoform initiates a feedback loop that regulates alternative splicing of this gene. [provided by RefSeq, Oct 2016]","AHNAK nucleoprotein","regulation of RNA splicing(GO:0043484)|regulation of RNA splicing(GO:0043484)|regulation of voltage-gated calcium channel activity(GO:1901385)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|lysosomal membrane(GO:0005765)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|focal adhesion(GO:0005925)|actin cytoskeleton(GO:0015629)|membrane(GO:0016020)|T-tubule(GO:0030315)|vesicle(GO:0031982)|sarcolemma(GO:0042383)|sarcolemma(GO:0042383)|costamere(GO:0043034)|costamere(GO:0043034)|cell-cell contact zone(GO:0044291)|membrane raft(GO:0045121)|extracellular exosome(GO:0070062)|extracellular exosome(GO:0070062)","RNA binding(GO:0003723)|protein binding(GO:0005515)|S100 protein binding(GO:0044548)|cadherin binding(GO:0045296)|structural molecule activity conferring elasticity(GO:0097493)","","","","","","Il2 stat5 signaling","",".;.;.;.;.;.","","","0.003","0.0006","0.003","0.0001","0.0009","","","0.0001","0.0008","D","0.006","D","0.001","D","1.0","D","0.967","U","0.036","D","0.979","L","0.895","T","0.93","D","-6.37","0.526","T","-0.766","T","0.166","D","0.032","0.178","T","0.239","27.3","3.958","5.53","1.516","18.236"
"chr1","110282909","110282909","T>C","","GSTM3","exonic","startloss","","GSTM3:NM_000849:exon2:c.A1G:p.M1?","GSTM3","exonic","startloss","","GSTM3:ENST00000256594.7_1:exon1:c.A1G:p.M1?,GSTM3:ENST00000540225.2_1:exon1:c.A1G:p.M1?,GSTM3:ENST00000361066.7_1:exon2:c.A1G:p.M1?","GSTM3:ENST00000256594.3:c.1A>G:p.0?","0.9513473","","","","0.5034811194054782","0.4761736457585357","0.0245640099242004","","","","","","","","","","ENSG00000134202","GSTM3","HGNC:4635","GSTM3","2947","ENSG00000134202","uc057jbx.1","0.02456400992420047","0.5034811194054782","0.4761736457585357","ORPHA:586 Cystic fibrosis-autosomal_recessive","842","0/1","Het","91","42,49","0.461538461538462","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","Pulmonary fibrosis(HP:0002206)|Exocrine pancreatic insufficiency(HP:0001738)|Decreased circulating antibody level(HP:0004313)|Recurrent respiratory infections(HP:0002205)|Immunodeficiency(HP:0002721)|Malabsorption(HP:0002024)|Hepatomegaly(HP:0002240)|Biliary cirrhosis(HP:0002613)","Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Mutations of this class mu gene have been linked with a slight increase in a number of cancers, likely due to exposure with environmental toxins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]","glutathione S-transferase mu 3","glutathione metabolic process(GO:0006749)|glutathione metabolic process(GO:0006749)|establishment of blood-nerve barrier(GO:0008065)|nitrobenzene metabolic process(GO:0018916)|xenobiotic catabolic process(GO:0042178)|response to estrogen(GO:0043627)|cellular detoxification of nitrogen compound(GO:0070458)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytosol(GO:0005829)|sperm fibrous sheath(GO:0035686)|intercellular bridge(GO:0045171)|extracellular exosome(GO:0070062)","glutathione transferase activity(GO:0004364)|glutathione transferase activity(GO:0004364)|protein binding(GO:0005515)|enzyme binding(GO:0019899)|identical protein binding(GO:0042802)|protein homodimerization activity(GO:0042803)|protein homodimerization activity(GO:0042803)|glutathione binding(GO:0043295)","hypertension(DOID:10763)|essential hypertension(DOID:10825)|cancer(DOID:162)|squamous cell carcinoma(DOID:1749)|osteosarcoma(DOID:3347)|hepatocellular carcinoma(DOID:684)","Glutathione metabolism|Metabolism of xenobiotics by cytochrome p450|Drug metabolism cytochrome p450","Wp nuclear receptors metapathway|Wp exerciseinduced circadian regulation|Wp nrf2 pathway|Wp metapathway biotransformation phase i and ii","Phase ii conjugation of compounds|Glutathione conjugation|Biological oxidations","","Apical surface|Spermatogenesis","",".;.;.","","","0.006","0.0012","0.006","0.0002","0.0031","","","0.0002","0.0028","D","0.029","D","0.028","B","0.028","B","0.007","N","0.826","N","0.998","","","T","5.02","N","-0.1","0.64","T","-0.909","T","0.002","T","0.015","0.214","T","0.018","18.44","1.832","5.07","0.496","10.236"
"chr7","128119379","128119379","T>C","","METTL2B","exonic","nonsynonymous SNV","","METTL2B:NM_018396:exon3:c.T370C:p.C124R","METTL2B","exonic","nonsynonymous SNV","","METTL2B:ENST00000480046.5_1:exon2:c.T175C:p.C59R,METTL2B:ENST00000262432.13_1:exon3:c.T370C:p.C124R","METTL2B:ENST00000262432.8:c.370T>C:p.(Cys124Arg)","0.47794175","0.5000464473632746","0.4779417514801025","0.024101936078978","0.5000464473632746","0.3699548840522766","0.0090778657877965","","","","","","","","","","ENSG00000165055","METTL2B","HGNC:18272","METTL2B","55798","ENSG00000165055","uc003vnf.3","0.024101936078978092","0.5000464473632746","0.47794175148010254","","843","0/1","Het","207","189,18","0.91304347826087","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene is a member of a family of methyltransferases that share homology with, but are distinct from, the UbiE family of methyltransferases. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]","methyltransferase 2B, methylcytidine","tRNA methylation(GO:0030488)","","protein binding(GO:0005515)|tRNA (cytosine) methyltransferase activity(GO:0016427)|tRNA (cytosine-3-)-methyltransferase activity(GO:0052735)|tRNA (cytosine-3-)-methyltransferase activity(GO:0052735)","","Histidine metabolism|Tyrosine metabolism|Selenoamino acid metabolism","","","","","",".;.","","","0.000003992","","","0.0004","0.0003","","","3.992e-06","0","T","0.543","T","0.446","B","0.0","B","0.0","N","0.070","N","1.000","N","0","D","-1.5","N","-0.09","0.091","T","-0.911","T","0.159","T","0.017","0.150","T","0.011","1.609","-0.079","2.65","-0.038","3.406"
"chr7","128119380","128119380","G>C","","METTL2B","exonic","nonsynonymous SNV","","METTL2B:NM_018396:exon3:c.G371C:p.C124S","METTL2B","exonic","nonsynonymous SNV","","METTL2B:ENST00000480046.5_1:exon2:c.G176C:p.C59S,METTL2B:ENST00000262432.13_1:exon3:c.G371C:p.C124S","METTL2B:ENST00000262432.8:c.371G>C:p.(Cys124Ser)","0.26196802","","","","0.5000464473632746","0.3699548840522766","0.0090778657877965","","","","","","","","","","ENSG00000165055","METTL2B","HGNC:18272","METTL2B","55798","ENSG00000165055","uc003vnf.3","0.024101936078978092","0.5000464473632746","0.47794175148010254","","844","0/1","Het","211","190,21","0.900473933649289","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene is a member of a family of methyltransferases that share homology with, but are distinct from, the UbiE family of methyltransferases. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]","methyltransferase 2B, methylcytidine","tRNA methylation(GO:0030488)","","protein binding(GO:0005515)|tRNA (cytosine) methyltransferase activity(GO:0016427)|tRNA (cytosine-3-)-methyltransferase activity(GO:0052735)|tRNA (cytosine-3-)-methyltransferase activity(GO:0052735)","","Histidine metabolism|Tyrosine metabolism|Selenoamino acid metabolism","","","","","",".;.","","","0.000004","","","0.0004","0.0003","","","4e-06","0","T","0.758","T","0.539","B","0.0","B","0.0","N","0.070","N","1","N","-1.245","T","-1.44","N","0.31","0.028","T","-0.882","T","0.184","T","0.018","0.035","T","0.020","1.207","-0.123","2.57","-0.000","1.070"
"chr5","1033543","1033543","G>A","","NKD2","exonic","nonsynonymous SNV","","NKD2:NM_001271082:exon5:c.G259A:p.A87T,NKD2:NM_033120:exon5:c.G259A:p.A87T","NKD2","exonic","nonsynonymous SNV","","NKD2:ENST00000274150.4_1:exon5:c.G259A:p.A87T,NKD2:ENST00000296849.10_1:exon5:c.G259A:p.A87T","NKD2:ENST00000274150.4:c.259G>A:p.(Ala87Thr)","0.4723782","0.5002622998435982","0.4723781943321228","0.0229792347045988","","","","","","","","","","","","","ENSG00000145506","NKD2","HGNC:17046","NKD2","85409","ENSG00000145506","uc003jbt.3","0.022979234704598814","0.5002622998435982","0.4723781943321228","","846","0/1","Het","114","63,51","0.552631578947368","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of a family of proteins that function as negative regulators of Wnt receptor signaling through interaction with Dishevelled family members. The encoded protein participates in the delivery of transforming growth factor alpha-containing vesicles to the cell membrane. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2012]","NKD inhibitor of WNT signaling pathway 2","exocytosis(GO:0006887)|positive regulation of protein processing(GO:0010954)|Wnt signaling pathway(GO:0016055)|negative regulation of Wnt signaling pathway(GO:0030178)|positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436)|Golgi vesicle fusion to target membrane(GO:0048210)|protein localization to plasma membrane(GO:0072659)|negative regulation of canonical Wnt signaling pathway(GO:0090090)|negative regulation of canonical Wnt signaling pathway(GO:0090090)|positive regulation of protein localization to plasma membrane(GO:1903078)","cytoplasm(GO:0005737)|plasma membrane(GO:0005886)|basolateral plasma membrane(GO:0016323)|lateral plasma membrane(GO:0016328)|cytoplasmic vesicle(GO:0031410)|exocytic vesicle(GO:0070382)|cell periphery(GO:0071944)","calcium ion binding(GO:0005509)|protein binding(GO:0005515)|growth factor binding(GO:0019838)|ubiquitin protein ligase binding(GO:0031625)|myosin heavy chain binding(GO:0032036)|ATPase binding(GO:0051117)","","Wnt signaling pathway","Wp wnt signaling pathway and pluripotency|Wp ncrnas involved in wnt signaling in hepatocellular carcinoma|Wp wnt signaling|Wp lncrna involvement in canonical wnt signaling and colorectal cancer","","","","",".;.","","","0.00001993","","","0.","0.","","","1.993e-05","0","T","0.586","T","0.487","B","0.017","B","0.002","N","0.052","N","1","N","0.06","T","6.23","N","-0.59","0.09","T","-0.910","T","0.001","T","0.004","0.031","T","0.020","0.001","-1.530","3.59","-2.744","4.592"
"chr12","10541402","10541402","C>A","","KLRC4-KLRK1;KLRK1","exonic","nonsynonymous SNV","","KLRK1:NM_007360:exon2:c.G8T:p.W3L,KLRC4-KLRK1:NM_001199805:exon7:c.G8T:p.W3L","KLRK1","exonic","nonsynonymous SNV","","KLRK1:ENST00000540818.5_1:exon1:c.G8T:p.W3L,KLRK1:ENST00000240618.11_1:exon2:c.G8T:p.W3L","KLRK1:ENST00000240618.6:c.8G>T:p.(Trp3Leu)","0.4695017","0.5002266102383146","0.4695017039775848","0.0223854330144934","","","","","","","","","","","","","ENSG00000213809","KLRK1","HGNC:18788","KLRK1","22914","ENSG00000213809","uc009zhj.4","0.022385433014493417","0.5002266102383146","0.46950170397758484","","852","0/1","Het","69","52,17","0.753623188405797","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","","","","","","","","","","","",".;.","","","0.000007958","","","0.","0.0002","","","7.958e-06","0.0001","T","0.529","T","1.0","","","","","N","0.396","N","1","","","T","5.18","N","-1.89","0.265","T","-0.901","T","0.003","T","8.6E-4","0.031","T","0.047","0.050","-0.576","3.39","-0.195","5.726"
"chr10","50121521","50121521","A>C","","LRRC18","exonic","nonsynonymous SNV","","LRRC18:NM_001006939:exon1:c.T680G:p.M227R","LRRC18","exonic","nonsynonymous SNV","","LRRC18:ENST00000374160.7_1:exon1:c.T680G:p.M227R","LRRC18:ENST00000298124.3:c.680T>G:p.(Met227Arg)","0.46600002","0.5006798870163038","0.4660000205039978","0.0217925784917206","","","","","","","","","","","","","ENSG00000165383","LRRC18","HGNC:23199","LRRC18","474354","ENSG00000165383","uc057tdu.1","0.021792578491720657","0.5006798870163038","0.4660000205039978","","855","0/1","Het","124","77,47","0.620967741935484","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","leucine rich repeat containing 18","","cytoplasm(GO:0005737)","protein binding(GO:0005515)","","","","","","","","","","","","","","","","","","","","T","0.534","T","0.396","B","0.116","B","0.025","N","0.216","N","1","M","2.25","T","0.58","N","-0.99","0.203","T","-1.022","T","0.112","T","0.014","0.075","T","0.070","4.648","0.123","5.87","0.207","5.669"
"chr20","61287837","61287837","C>T","","SLCO4A1","exonic","nonsynonymous SNV","","SLCO4A1:NM_016354:exon2:c.C31T:p.L11F","SLCO4A1","exonic","nonsynonymous SNV","","SLCO4A1:ENST00000370507.5_1:exon1:c.C31T:p.L11F,SLCO4A1:ENST00000217159.6_1:exon2:c.C31T:p.L11F","SLCO4A1:ENST00000217159.1:c.31C>T:p.(Leu11Phe)","0.64786536","","","","0.5000518334491062","0.4639305174350738","0.0212548436758693","","","","","","","","","","ENSG00000101187","SLCO4A1","HGNC:10953","SLCO4A1","28231","ENSG00000101187","uc002ydb.1","0.021254843675869363","0.5000518334491062","0.46393051743507385","","856","0/1","Het","59","23,36","0.389830508474576","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","solute carrier organic anion transporter family member 4A1","sodium-independent organic anion transport(GO:0043252)|transmembrane transport(GO:0055085)|thyroid hormone transport(GO:0070327)","plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|sodium-independent organic anion transmembrane transporter activity(GO:0015347)|thyroid hormone transmembrane transporter activity(GO:0015349)","","","","Transport of small molecules|Transport of vitamins nucleosides and related molecules|Slc mediated transmembrane transport|Transport of organic anions","","","SpliceAI>T|SLCO4A1|0.00|0.00|0.00|0.00|14|25|-2|-39",".;.","","","0.0013","","","0.0005","0.0013","","","0.0002","0.0009","T","0.34","T","0.12","B","0.049","B","0.026","U","0.001","N","1","L","1.3","T","0.94","N","-0.55","0.068","T","-1.001","T","0.099","T","0.016","0.077","T","0.019","10.92","0.673","3.79","1.006","9.880"
"chr13","23915521","23915521","A>G","SACS:26278","SACS","exonic","nonsynonymous SNV","","SACS:NM_001278055:exon8:c.T2053C:p.S685P,SACS:NM_014363:exon10:c.T2494C:p.S832P","SACS","exonic","nonsynonymous SNV","","SACS:ENST00000402364.1_1:exon8:c.T244C:p.S82P,SACS:ENST00000683270.1_1:exon9:c.T2485C:p.S829P,SACS:ENST00000382292.9_1:exon10:c.T2494C:p.S832P,SACS:ENST00000682944.1_1:exon11:c.T2521C:p.S841P","SACS:ENST00000382292.3:c.2494T>C:p.(Ser832Pro)","0.7491237","","","","0.5000058036575865","0.4510786458849907","0.0189244618467909","","","","","","","","","","ENSG00000151835","SACS","HGNC:10519","SACS","26278","ENSG00000151835","uc001uon.3","0.018924461846790922","0.5000058036575865","0.4510786458849907","OMIM:270550 Spastic ataxia, Charlevoix-Saguenay type-autosomal_recessive;ORPHA:98 Autosomal recessive spastic ataxia of Charlevoix-Saguenay-autosomal_recessive","863","0/1","Het","135","76,59","0.562962962962963","Likely_benign","False","Spastic_paraplegia|Charlevoix-Saguenay_spastic_ataxia","Human_Phenotype_Ontology:HP:0001258,Human_Phenotype_Ontology:HP:0007062,Human_Phenotype_Ontology:HP:0007124,Human_Phenotype_Ontology:HP:0007216,MedGen:C0037772|MONDO:MONDO:0010041,MedGen:C1849140,OMIM:270550,Orphanet:ORPHA98","NC_000013.10:g.23915521A>G","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Saguenay type(270550)","Dysarthria(HP:0001260)|Foot dorsiflexor weakness(HP:0009027)|Babinski sign(HP:0003487)|Hypermyelinated retinal nerve fibers(HP:0007922)|Unsteady gait(HP:0002317)|Lower limb spasticity(HP:0002061)|Cerebellar vermis hypoplasia(HP:0001320)|Intention tremor(HP:0002080)|Hypoplasia of the corpus callosum(HP:0002079)|Cerebellar atrophy(HP:0001272)|Dysmetria(HP:0001310)|Impotence(HP:0000802)|Parietal cortical atrophy(HP:0012104)|Arachnoid cyst(HP:0100702)|Abnormal pons morphology(HP:0007361)|Abnormal motor evoked potentials(HP:0012896)|Distal amyotrophy(HP:0003693)|Gait ataxia(HP:0002066)|Mitral valve prolapse(HP:0001634)|Absent Achilles reflex(HP:0003438)|Impaired tactile sensation(HP:0010830)|Urinary incontinence(HP:0000020)|Abnormal foot morphology(HP:0001760)|Behavioral abnormality(HP:0000708)|Difficulty walking(HP:0002355)|Progressive cerebellar ataxia(HP:0002073)|Abnormal cerebellar peduncle morphology(HP:0011931)|Demyelinating peripheral neuropathy(HP:0007108)|Sensorimotor neuropathy(HP:0007141)|Gaze-evoked horizontal nystagmus(HP:0007979)|Impaired vibratory sensation(HP:0002495)|Dysphagia(HP:0002015)|Autosomal recessive inheritance(HP:0000007)|Scanning speech(HP:0002168)|Distal muscle weakness(HP:0002460)|Urinary urgency(HP:0000012)|Impaired smooth pursuit(HP:0007772)|Distal sensory impairment(HP:0002936)|Hyperreflexia(HP:0001347)|Scoliosis(HP:0002650)|Intellectual disability(HP:0001249)|Impaired vibration sensation in the lower limbs(HP:0002166)|Swan neck-like deformities of the fingers(HP:0006150)|Ataxia(HP:0001251)|Babinski sign(HP:0003487)|Infantile onset(HP:0003593)|Dysarthria(HP:0001260)|Decreased sensory nerve conduction velocity(HP:0003448)|Falls(HP:0002527)|Decreased number of large peripheral myelinated nerve fibers(HP:0003387)|Cerebellar vermis atrophy(HP:0006855)|Pes cavus(HP:0001761)|Dysmetria(HP:0001310)|Hyperactive patellar reflex(HP:0007083)|Spastic ataxia(HP:0002497)|Progressive truncal ataxia(HP:0007221)|Hypermyelinated retinal nerve fibers(HP:0007922)|Distal amyotrophy(HP:0003693)|Loss of Purkinje cells in the cerebellar vermis(HP:0007001)|Peroneal muscle atrophy(HP:0009049)|Onion bulb formation(HP:0003383)|Nystagmus(HP:0000639)|Upper motor neuron dysfunction(HP:0002493)|Absent Achilles reflex(HP:0003438)|Progressive gait ataxia(HP:0007240)|Hammertoe(HP:0001765)|Spastic gait(HP:0002064)|Decreased motor nerve conduction velocity(HP:0003431)","This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that """"the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins"""" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]","sacsin molecular chaperone","protein folding(GO:0006457)|negative regulation of inclusion body assembly(GO:0090084)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|mitochondrion(GO:0005739)|axon(GO:0030424)|dendrite(GO:0030425)|cell body fiber(GO:0070852)","Hsp70 protein binding(GO:0030544)|Hsp70 protein binding(GO:0030544)|chaperone binding(GO:0051087)|chaperone binding(GO:0051087)|proteasome binding(GO:0070628)","","","","","","","SpliceAI>G|SACS|0.00|0.00|0.00|0.00|8|-28|-35|23",".;.","","","0.0037","0.0002","0.001","0.0003","0.0037","","","0.0002","0.0033","T","0.187","T","0.181","B","0.04","B","0.024","N","0.006","N","0.994","L","1.7","D","-2.29","N","-1.61","0.142","T","-0.544","T","0.482","T","0.021","0.260","T","0.034","20.1","2.039","6.05","1.908","8.098"
"chr1","46715694","46715694","G>C","","RAD54L","exonic","nonsynonymous SNV","","RAD54L:NM_003579:exon3:c.G113C:p.S38T,RAD54L:NM_001142548:exon4:c.G113C:p.S38T","RAD54L","exonic","nonsynonymous SNV","","RAD54L:ENST00000371975.9_1:exon3:c.G113C:p.S38T,RAD54L:ENST00000442598.5_1:exon4:c.G113C:p.S38T,RAD54L:ENST00000671528.1_1:exon4:c.G113C:p.S38T","RAD54L:ENST00000371975.4:c.113G>C:p.(Ser38Thr)","0.44612235","0.5015382788842544","0.4461223483085632","0.0183828633321226","","","","","","","","","","","","","ENSG00000085999","RAD54L","HGNC:9826","RAD54L","8438","ENSG00000085999","uc009vye.2","0.018382863332122603","0.5015382788842544","0.44612234830856323","OMIM:114480 Breast cancer, invasive ductal-autosomal_dominant;OMIM:605027 Lymphoma, non-Hodgkin, somatic-unknown","867","0/1","Het","98","66,32","0.673469387755102","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Breast cancer(114480)|Hodgkin, familial(605027)","Heterogeneous(HP:0001425)|Autosomal dominant inheritance(HP:0000006)|Breast carcinoma(HP:0003002)|Somatic mutation(HP:0001428)|Lymphoma(HP:0002665)","The protein encoded by this gene belongs to the DEAD-like helicase superfamily, and shares similarity with Saccharomyces cerevisiae Rad54, a protein known to be involved in the homologous recombination and repair of DNA. This protein has been shown to play a role in homologous recombination related repair of DNA double-strand breaks. The binding of this protein to double-strand DNA induces a DNA topological change, which is thought to facilitate homologous DNA paring, and stimulate DNA recombination. Alternative splicing results in multiple transcript variants encoding the same protein.[provided by RefSeq, Dec 2008]","RAD54 like","DNA repair(GO:0006281)|DNA recombination(GO:0006310)|reciprocal meiotic recombination(GO:0007131)|determination of adult lifespan(GO:0008340)|response to xenobiotic stimulus(GO:0009410)|response to ionizing radiation(GO:0010212)|DNA duplex unwinding(GO:0032508)|double-strand break repair via synthesis-dependent strand annealing(GO:0045003)|meiotic cell cycle(GO:0051321)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|protein-containing complex(GO:0032991)","DNA binding(GO:0003677)|DNA helicase activity(GO:0003678)|protein binding(GO:0005515)|ATP binding(GO:0005524)|DNA translocase activity(GO:0015616)|ATP hydrolysis activity(GO:0016887)|ATP-dependent DNA/DNA annealing activity(GO:0036310)|metal ion binding(GO:0046872)|ATP-dependent chromatin remodeler activity(GO:0140658)","chronic leukemia(DOID:1036)|severe combined immunodeficiency(DOID:627)","Homologous recombination","Wp integrated breast cancer pathway","","","G2m checkpoint","",".;.;.","","","0.00001988","","","0.","0.0001","","","1.988e-05","0.0003","T","0.55","T","0.571","B","0.0","B","0.001","N","0.016","N","0.999","L","1.1","D","-2.37","N","-0.7","0.261","T","-0.729","T","0.453","T","0.010","0.120","T","0.007","13.89","1.070","4.95","1.326","8.307"
"chr20","44642043","44642043","A>T","","MMP9","exonic","nonsynonymous SNV","","MMP9:NM_004994:exon9:c.A1480T:p.T494S","MMP9","exonic","nonsynonymous SNV","","MMP9:ENST00000372330.3_1:exon9:c.A1480T:p.T494S","MMP9:ENST00000372330.3:c.1480A>T:p.(Thr494Ser)","0.727","0.2514441977255046","0.7269999980926514","0.018024030888386","","","","","","","","","","","","","ENSG00000100985","MMP9","HGNC:7176","MMP9","4318","ENSG00000100985","uc002xqz.3","0.018024030888386076","0.25144419772550464","0.7269999980926514","OMIM:613073 Metaphyseal anadysplasia 2-autosomal_recessive;ORPHA:1040 Metaphyseal anadysplasia-autosomal_recessive","868","0/1","Het","177","89,88","0.502824858757062","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Metaphyseal anadysplasia 2(613073)","Short stature(HP:0004322)|Aplasia/Hypoplasia of the radius(HP:0006501)|Joint stiffness(HP:0001387)|Bowing of the long bones(HP:0006487)|Abnormality of epiphysis morphology(HP:0005930)|Abnormality of the lower limb(HP:0002814)|Abnormality of ulnar metaphysis(HP:0004039)|Autosomal recessive inheritance(HP:0000007)|Metaphyseal irregularity(HP:0003025)|Metaphyseal widening(HP:0003016)|Short femoral neck(HP:0100864)|Bowing of the legs(HP:0002979)","Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. [provided by RefSeq, Jul 2008]","matrix metallopeptidase 9","skeletal system development(GO:0001501)|ossification(GO:0001503)|positive regulation of protein phosphorylation(GO:0001934)|proteolysis(GO:0006508)|embryo implantation(GO:0007566)|extracellular matrix disassembly(GO:0022617)|extracellular matrix organization(GO:0030198)|macrophage differentiation(GO:0030225)|positive regulation of cell migration(GO:0030335)|positive regulation of cell migration(GO:0030335)|collagen catabolic process(GO:0030574)|collagen catabolic process(GO:0030574)|cellular response to reactive oxygen species(GO:0034614)|endodermal cell differentiation(GO:0035987)|positive regulation of apoptotic process(GO:0043065)|negative regulation of apoptotic process(GO:0043066)|positive regulation of DNA binding(GO:0043388)|positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742)|ephrin receptor signaling pathway(GO:0048013)|leukocyte migration(GO:0050900)|positive regulation of keratinocyte migration(GO:0051549)|cellular response to cadmium ion(GO:0071276)|cellular response to UV-A(GO:0071492)|positive regulation of release of cytochrome c from mitochondria(GO:0090200)|regulation of neuroinflammatory response(GO:0150077)|positive regulation of receptor binding(GO:1900122)|response to amyloid-beta(GO:1904645)|positive regulation of vascular associated smooth muscle cell proliferation(GO:1904707)|negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697)|negative regulation of intrinsic apoptotic signaling pathway(GO:2001243)|negative regulation of cation channel activity(GO:2001258)|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268)","extracellular region(GO:0005576)|extracellular region(GO:0005576)|extracellular space(GO:0005615)|collagen-containing extracellular matrix(GO:0062023)|extracellular exosome(GO:0070062)|tertiary granule lumen(GO:1904724)|ficolin-1-rich granule lumen(GO:1904813)","endopeptidase activity(GO:0004175)|endopeptidase activity(GO:0004175)|metalloendopeptidase activity(GO:0004222)|metalloendopeptidase activity(GO:0004222)|metalloendopeptidase activity(GO:0004222)|serine-type endopeptidase activity(GO:0004252)|serine-type endopeptidase activity(GO:0004252)|protein binding(GO:0005515)|collagen binding(GO:0005518)|peptidase activity(GO:0008233)|metallopeptidase activity(GO:0008237)|zinc ion binding(GO:0008270)|identical protein binding(GO:0042802)","pelvic inflammatory disease(DOID:1003)|dermatomyositis(DOID:10223)|pleurisy(DOID:10247)|prostate cancer(DOID:10283)|parotitis(DOID:10301)|viral meningitis(DOID:10310)|eosinophilic meningitis(DOID:10361)|lymphoid leukemia(DOID:1037)|chronic lymphocytic leukemia(DOID:1040)|pre-eclampsia(DOID:10591)|otitis media(DOID:10754)|hypertension(DOID:10763)|essential hypertension(DOID:10825)|borderline personality disorder(DOID:10930)|nephritis(DOID:10952)|pulpitis(DOID:11121)|Henoch-Schoenlein purpura(DOID:11123)|sarcoma(DOID:1115)|heart disease(DOID:114)|pyelonephritis(DOID:11400)|polycystic ovary syndrome(DOID:11612)|Lyme disease(DOID:11729)|myopia(DOID:11830)|leukemia(DOID:1240)|newborn respiratory distress syndrome(DOID:12716)|respiratory syncytial virus infectious disease(DOID:1273)|Guillain-Barre syndrome(DOID:12842)|keratoconjunctivitis sicca(DOID:12895)|dilated cardiomyopathy(DOID:12930)|carotid stenosis(DOID:13001)|proliferative diabetic retinopathy(DOID:13207)|Behcet's disease(DOID:13241)|temporal arteritis(DOID:13375)|Kawasaki disease(DOID:13378)|angle-closure glaucoma(DOID:13550)|familial hypercholesterolemia(DOID:13810)|primary angle-closure glaucoma(DOID:1405)|cystic fibrosis(DOID:1485)|urticaria(DOID:1555)|fungal infectious disease(DOID:1564)|breast cancer(DOID:1612)|cancer(DOID:162)|glaucoma(DOID:1686)|duodenal ulcer(DOID:1724)|squamous cell carcinoma(DOID:1749)|vascular disease(DOID:178)|malignant mesothelioma(DOID:1790)|epilepsy(DOID:1826)|hepatitis C(DOID:1883)|melanoma(DOID:1909)|atherosclerosis(DOID:1936)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)|syndrome(DOID:225)|lateral sclerosis(DOID:230)|chronic obstructive pulmonary disease(DOID:3083)|gingivitis(DOID:3087)|spinal cord disease(DOID:319)|ischemia(DOID:326)|thymoma(DOID:3275)|chordoma(DOID:3302)|amyotrophic lateral sclerosis(DOID:332)|mood disorder(DOID:3324)|purpura(DOID:3326)|temporal lobe epilepsy(DOID:3328)|osteosarcoma(DOID:3347)|fibrosarcoma(DOID:3355)|coronary aneurysm(DOID:3362)|chondrosarcoma(DOID:3371)|periodontal disease(DOID:3388)|coronary artery disease(DOID:3393)|skin carcinoma(DOID:3451)|invasive lobular carcinoma(DOID:3457)|breast carcinoma(DOID:3459)|pancreatic ductal adenocarcinoma(DOID:3498)|meningioma(DOID:3565)|aortic aneurysm(DOID:3627)|pulmonary fibrosis(DOID:3770)|pituitary adenoma(DOID:3829)|lung carcinoma(DOID:3905)|lung non-small cell carcinoma(DOID:3908)|acute myocarditis(DOID:3951)|thyroid gland follicular carcinoma(DOID:3962)|thyroid gland carcinoma(DOID:3963)|tuberculosis(DOID:399)|ovarian carcinoma(DOID:4001)|gastritis(DOID:4029)|liver disease(DOID:409)|skin cancer(DOID:4159)|autoimmune disease(DOID:417)|systemic scleroderma(DOID:418)|neuromuscular disease(DOID:440)|microcystic meningioma(DOID:4594)|salivary gland adenoid cystic carcinoma(DOID:4866)|cholangiocarcinoma(DOID:4947)|sclerosing hemangioma(DOID:495)|pancreatitis(DOID:4989)|liver cirrhosis(DOID:5082)|benign pleural mesothelioma(DOID:5157)|infertility(DOID:5223)|schizophrenia(DOID:5419)|pneumonia(DOID:552)|head and neck squamous cell carcinoma(DOID:5520)|kidney disease(DOID:557)|acute pyelonephritis(DOID:559)|peripheral nervous system disease(DOID:574)|pulmonary sclerosing hemangioma(DOID:5766)|endometrioid ovary carcinoma(DOID:5828)|myocardial infarction(DOID:5844)|congestive heart failure(DOID:6000)|myositis(DOID:633)|migraine(DOID:6364)|adenoma(DOID:657)|hepatocellular carcinoma(DOID:684)|rheumatoid arthritis(DOID:7148)|T-cell lymphoblastic leukemia/lymphoma(DOID:715)|malignant pleural mesothelioma(DOID:7474)|neuroblastoma(DOID:769)|abdominal aortic aneurysm(DOID:7693)|myocarditis(DOID:820)|periodontitis(DOID:824)|osteoarthritis(DOID:8398)|corneal ulcer(DOID:8463)|arthritis(DOID:848)|lung disease(DOID:850)|diabetes mellitus(DOID:9351)|acute myocardial infarction(DOID:9408)|bacterial meningitis(DOID:9470)|meningitis(DOID:9471)|bronchiectasis(DOID:9563)|systolic heart failure(DOID:9651)|pulmonary emphysema(DOID:9675)|villonodular synovitis(DOID:9898)|allergic asthma(DOID:9415)|lung cancer(DOID:1324)|ovarian cyst(DOID:5119)|pancreatic cancer(DOID:1793)|stomach cancer(DOID:10534)|multiple sclerosis(DOID:2377)|systemic lupus erythematosus(DOID:9074)|stomach carcinoma(DOID:5517)|endometrial carcinoma(DOID:2871)|disease(DOID:4)|cervix carcinoma(DOID:2893)|endometriosis(DOID:289)|colon cancer(DOID:219)|type 2 diabetes mellitus(DOID:9352)|high grade glioma(DOID:3070)|lung adenocarcinoma(DOID:3910)|embryoma(DOID:4766)|hemarthrosis(DOID:801)|lung benign neoplasm(DOID:3683)|adenocarcinoma(DOID:299)|renal cell carcinoma(DOID:4450)|cutaneous fibrous histiocytoma(DOID:4418)|bone osteosarcoma(DOID:3376)|bone marrow disease(DOID:4961)|tropical spastic paraparesis(DOID:321)|lichen planus(DOID:9201)|lupus erythematosus(DOID:8857)|thoracic aortic aneurysm(DOID:14004)|acute myeloid leukemia(DOID:9119)|Hodgkin's lymphoma(DOID:8567)|asthma(DOID:2841)|malignant astrocytoma(DOID:3069)|lung small cell carcinoma(DOID:5409)|disease of metabolism(DOID:0014667)|obesity(DOID:9970)|esotropia(DOID:9840)|subacute sclerosing panencephalitis(DOID:8970)|rectum adenocarcinoma(DOID:1996)|retinal disease(DOID:5679)|glomerulonephritis(DOID:2921)|glioblastoma(DOID:3068)|dermatitis(DOID:2723)|esophageal cancer(DOID:5041)|carcinoma(DOID:305)|cervical squamous cell carcinoma(DOID:3744)|bronchiolitis obliterans(DOID:2799)|liver cancer(DOID:3571)|geographic tongue(DOID:1455)|pigmented villonodular synovitis(DOID:2702)|polyp of corpus uteri(DOID:9042)|laryngeal carcinoma(DOID:2600)|ovarian cancer(DOID:2394)|IgA glomerulonephritis(DOID:2986)|skin disease(DOID:37)|varicose veins(DOID:799)|brain cancer(DOID:1319)|urinary bladder cancer(DOID:11054)|type 1 diabetes mellitus(DOID:9744)","Leukocyte transendothelial migration|Pathways in cancer|Bladder cancer","Wp spinal cord injury|Wp il1 and megakaryocytes in obesity|Wp agerage pathway|Wp tnf related weak inducer of apoptosis tweak signaling pathway|Wp lung fibrosis|Wp neovascularisation processes|Wp bladder cancer|Wp photodynamic therapyinduced nfkb survival signaling|Wp mammary gland development pathway involution stage 4 of 4|Wp angiogenesis|Wp osteopontin signaling|Wp endochondral ossification|Wp matrix metalloproteinases|Wp extracellular vesicles in the crosstalk of cardiac cells|Wp epithelial to mesenchymal transition in colorectal cancer|Wp viral acute myocarditis|Wp neural crest cell migration in cancer|Wp cell migration and invasion through p75ntr|Wp neural crest cell migration during development|Wp hepatitis b infection|Wp fragile x syndrome|Wp il18 signaling pathway|Wp genes involved in male infertility|Wp endochondral ossification with skeletal dysplasias|Wp kisspeptinkisspeptin receptor system in the ovary","Developmental biology|Cytokine signaling in immune system|Signaling by scf kit|Collagen degradation|Degradation of the extracellular matrix|Extracellular matrix organization|Collagen formation|Activation of matrix metalloproteinases|Innate immune system|Assembly of collagen fibrils and other multimeric structures|Eph ephrin signaling|Eph ephrin mediated repulsion of cells|Signaling by interleukins|Interleukin 4 and interleukin 13 signaling|Neutrophil degranulation|Esr mediated signaling|Signaling by nuclear receptors|Signaling by receptor tyrosine kinases|Extra nuclear estrogen signaling|Nervous system development","Reck pathway","Apical junction|Coagulation|Allograft rejection|Kras signaling up","","","","","","","","","","","","","","T","0.273","T","0.217","B","0.092","B","0.047","D","0.000","N","0.845","N","0","T","2.13","N","-0.49","0.408","T","-0.993","T","0.020","T","0.014","0.149","D","0.719","11.44","0.736","5.0","4.107","4.830"
"chr15","85164121","85164121","G>C","","ZSCAN2","exonic","nonsynonymous SNV","","ZSCAN2:NM_181877:exon3:c.G695C:p.S232T","ZSCAN2","exonic","nonsynonymous SNV","","ZSCAN2:ENST00000358472.3_1:exon2:c.G245C:p.S82T,ZSCAN2:ENST00000327179.6_1:exon3:c.G692C:p.S231T,ZSCAN2:ENST00000448803.6_1:exon3:c.G695C:p.S232T,ZSCAN2:ENST00000546148.6_1:exon3:c.G695C:p.S232T","ZSCAN2:ENST00000327179.6:c.692G>C:p.(Ser231Thr)","1","0.0","1.0","0.0162333652752468","","","","","","","","","","","","","ENSG00000176371","ZSCAN2","HGNC:20994","ZSCAN2","54993","ENSG00000176371","uc059mrt.1","0.016233365275246874","","1.0","","875","0/1","Het","104","60,44","0.576923076923077","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene contains several copies of zinc finger motif, which is commonly found in transcriptional regulatory proteins. Studies in mice show that this gene is expressed during embryonic development, and specifically in the testis in adult mice, suggesting that it may play a role in regulating genes in germ cells. Alternative splicing of this gene results in several transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]","zinc finger and SCAN domain containing 2","regulation of transcription by RNA polymerase II(GO:0006357)|spermatogenesis(GO:0007283)|cell differentiation(GO:0030154)","nucleus(GO:0005634)","RNA polymerase II transcription regulatory region sequence-specific DNA binding(GO:0000977)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","Zinc","","","","","","","","","","","","T","0.298","T","0.119","B","0.303","B","0.094","D","0.000","D","1","N","0.575","T","0.61","N","-1.89","0.172","T","-1.059","T","0.086","T","0.013","0.100","D","0.557","21.6","2.225","5.32","0.246","16.473"
"chr3","75786042","75786042","G>-","","ZNF717","exonic","frameshift deletion","","ZNF717:NM_001128223:exon5:c.2732delC:p.S911Ffs*4,ZNF717:NM_001290208:exon5:c.2732delC:p.S911Ffs*4,ZNF717:NM_001290209:exon5:c.2582delC:p.S861Ffs*4","ZNF717","exonic","frameshift deletion","","ZNF717:ENST00000478296.5_1:exon4:c.2582delC:p.S861Ffs*31,ZNF717:ENST00000652011.2_1:exon5:c.2732delC:p.S911Ffs*31","ZNF717:ENST00000400845.3:c.2711del:p.(Ser904Phefs*?)","1","0.0","1.0","0.0162333652752468","0.0","1.0","0.0162333652752468","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","876","0/1","Het","72","65,7","0.902777777777778","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75786243","75786243","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G2531A:p.C844Y,ZNF717:NM_001290208:exon5:c.G2531A:p.C844Y,ZNF717:NM_001290209:exon5:c.G2381A:p.C794Y","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G2381A:p.C794Y,ZNF717:ENST00000652011.2_1:exon5:c.G2531A:p.C844Y","ZNF717:ENST00000400845.3:c.2510G>A:p.(Cys837Tyr)","1","","","","0.0","1.0","0.0162333652752468","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","877","0/1","Het","66","41,25","0.621212121212121","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.0","D","0.015","","","","","","","D","1","","","D","-1.94","D","-7.52","0.208","T","-0.050","D","0.770","T","0.003","0.402","D","0.914","21.5","2.209","1.46","4.030","5.69"
"chr3","75786256","75786256","T>A","","ZNF717","exonic","stopgain","","ZNF717:NM_001128223:exon5:c.A2518T:p.K840X,ZNF717:NM_001290208:exon5:c.A2518T:p.K840X,ZNF717:NM_001290209:exon5:c.A2368T:p.K790X","ZNF717","exonic","stopgain","","ZNF717:ENST00000478296.5_1:exon4:c.A2368T:p.K790X,ZNF717:ENST00000652011.2_1:exon5:c.A2518T:p.K840X","ZNF717:ENST00000400845.3:c.2497A>T:p.(Lys833*)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","878","0/1","Het","75","47,28","0.626666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","","","","","","","","","","","D","1","","","","","","","0.032","","","","","","","","","","34","5.738","1.59","3.121","7.316"
"chr3","75786278","75786278","A>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T2496G:p.H832Q,ZNF717:NM_001290208:exon5:c.T2496G:p.H832Q,ZNF717:NM_001290209:exon5:c.T2346G:p.H782Q","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T2346G:p.H782Q,ZNF717:ENST00000652011.2_1:exon5:c.T2496G:p.H832Q","ZNF717:ENST00000400845.3:c.2475T>G:p.(His825Gln)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","879","0/1","Het","97","56,41","0.577319587628866","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.002","D","0.0","","","","","","","D","1","","","D","-2.18","D","-5.94","0.203","D","0.069","D","0.747","T","0.003","0.462","D","0.722","18.26","1.808","1.59","0.061","4.797"
"chr3","75786337","75786337","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2437T:p.P813S,ZNF717:NM_001290208:exon5:c.C2437T:p.P813S,ZNF717:NM_001290209:exon5:c.C2287T:p.P763S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C2287T:p.P763S,ZNF717:ENST00000652011.2_1:exon5:c.C2437T:p.P813S","ZNF717:ENST00000400845.3:c.2416C>T:p.(Pro806Ser)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","880","0/1","Het","133","120,13","0.902255639097744","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.076","D","0.002","","","","","","","D","1","","","T","1.61","D","-5.68","0.131","T","-1.031","T","0.151","T","0.004","0.220","D","0.858","22.1","2.314","1.79","3.957","9.718"
"chr3","75786354","75786354","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2420T:p.T807I,ZNF717:NM_001290208:exon5:c.C2420T:p.T807I,ZNF717:NM_001290209:exon5:c.C2270T:p.T757I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C2270T:p.T757I,ZNF717:ENST00000652011.2_1:exon5:c.C2420T:p.T807I","ZNF717:ENST00000400845.3:c.2399C>T:p.(Thr800Ile)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","881","0/1","Het","130","114,16","0.876923076923077","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","1.0","T","1.0","","","","","","","D","1","","","T","2.14","N","0.55","0.125","T","-0.959","T","0.021","T","0.002","0.057","T","0.116","11.07","0.691","1.37","-0.327","5.176"
"chr3","75786417","75786417","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A2357G:p.Y786C,ZNF717:NM_001290208:exon5:c.A2357G:p.Y786C,ZNF717:NM_001290209:exon5:c.A2207G:p.Y736C","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A2207G:p.Y736C,ZNF717:ENST00000652011.2_1:exon5:c.A2357G:p.Y786C","ZNF717:ENST00000400845.3:c.2336A>G:p.(Tyr779Cys)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","882","0/1","Het","90","56,34","0.622222222222222","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.001","D","0.012","","","","","","","D","1","","","T","1.8","D","-6.47","0.179","T","-1.034","T","0.123","T","0.003","0.184","D","0.898","22.6","2.519","1.92","-0.316","5.118"
"chr3","75786518","75786518","A>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T2256G:p.H752Q,ZNF717:NM_001290208:exon5:c.T2256G:p.H752Q,ZNF717:NM_001290209:exon5:c.T2106G:p.H702Q","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T2106G:p.H702Q,ZNF717:ENST00000652011.2_1:exon5:c.T2256G:p.H752Q","ZNF717:ENST00000400845.3:c.2235T>G:p.(His745Gln)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","883","0/1","Het","39","16,23","0.41025641025641","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","D","0.0","D","0.001","","","","","","","D","1","","","T","-0.24","D","-5.72","0.2","T","-0.635","T","0.425","T","0.004","0.280","D","0.847","18.73","1.870","1.61","0.696","5.865"
"chr3","75786607","75786607","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G2167A:p.V723I,ZNF717:NM_001290208:exon5:c.G2167A:p.V723I,ZNF717:NM_001290209:exon5:c.G2017A:p.V673I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G2017A:p.V673I,ZNF717:ENST00000652011.2_1:exon5:c.G2167A:p.V723I","ZNF717:ENST00000400845.3:c.2146G>A:p.(Val716Ile)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","884","0/1","Het","89","61,28","0.685393258426966","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.135","T","0.506","","","","","","","D","1","","","T","3.3","N","-0.04","0.056","T","-0.932","T","0.009","T","0.002","0.062","T","0.151","10.39","0.609","1.75","-0.323","7.533"
"chr3","75786610","75786610","T>A","","ZNF717","exonic","stopgain","","ZNF717:NM_001128223:exon5:c.A2164T:p.K722X,ZNF717:NM_001290208:exon5:c.A2164T:p.K722X,ZNF717:NM_001290209:exon5:c.A2014T:p.K672X","ZNF717","exonic","stopgain","","ZNF717:ENST00000478296.5_1:exon4:c.A2014T:p.K672X,ZNF717:ENST00000652011.2_1:exon5:c.A2164T:p.K722X","ZNF717:ENST00000400845.3:c.2143A>T:p.(Lys715*)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","885","0/1","Het","85","65,20","0.764705882352941","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","D","1","","","","","","","0.011","","","","","","","","","","33","5.088","1.75","-0.051","7.595"
"chr3","75786670","75786670","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2104T:p.P702S,ZNF717:NM_001290208:exon5:c.C2104T:p.P702S,ZNF717:NM_001290209:exon5:c.C1954T:p.P652S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C1954T:p.P652S,ZNF717:ENST00000652011.2_1:exon5:c.C2104T:p.P702S","ZNF717:ENST00000400845.3:c.2083C>T:p.(Pro695Ser)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","886","0/1","Het","210","120,90","0.571428571428571","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","D","0.014","D","0.014","","","","","","","D","1","","","T","3.28","D","-2.65","0.082","T","-0.962","T","0.011","T","0.002","0.231","D","0.613","13.76","1.050","1.27","5.209","6.406"
"chr3","75786744","75786744","A>-","","ZNF717","exonic","frameshift deletion","","ZNF717:NM_001128223:exon5:c.2030delT:p.V677Efs*2,ZNF717:NM_001290208:exon5:c.2030delT:p.V677Efs*2,ZNF717:NM_001290209:exon5:c.1880delT:p.V627Efs*2","ZNF717","exonic","frameshift deletion","","ZNF717:ENST00000478296.5_1:exon4:c.1880delT:p.V627Efs*2,ZNF717:ENST00000652011.2_1:exon5:c.2030delT:p.V677Efs*2","ZNF717:ENST00000400845.3:c.2009del:p.(Val670Glufs*2)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","887","0/1","Het","368","324,44","0.880434782608696","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75786754","75786754","G>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2020A:p.R674S,ZNF717:NM_001290208:exon5:c.C2020A:p.R674S,ZNF717:NM_001290209:exon5:c.C1870A:p.R624S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C1870A:p.R624S,ZNF717:ENST00000652011.2_1:exon5:c.C2020A:p.R674S","ZNF717:ENST00000400845.3:c.1999C>A:p.(Arg667Ser)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","888","0/1","Het","378","325,53","0.85978835978836","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.056","T","0.059","","","","","","","D","1","","","T","2.9","N","0.67","0.085","T","-0.975","T","0.015","T","0.003","0.172","D","0.507","12.56","0.879","1.57","5.315","6.136"
"chr3","75786764","75786764","->T","","ZNF717","exonic","frameshift insertion","","ZNF717:NM_001128223:exon5:c.2009_2010insA:p.K672Efs*79,ZNF717:NM_001290208:exon5:c.2009_2010insA:p.K672Efs*79,ZNF717:NM_001290209:exon5:c.1859_1860insA:p.K622Efs*79","ZNF717","exonic","frameshift insertion","","ZNF717:ENST00000478296.5_1:exon4:c.1859_1860insA:p.K622Efs*79,ZNF717:ENST00000652011.2_1:exon5:c.2009_2010insA:p.K672Efs*79","ZNF717:ENST00000400845.3:c.1988_1989insA:p.(Lys665Glufs*79)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","889","0/1","Het","382","327,55","0.856020942408377","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75786773","75786773","T>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A2001T:p.R667S,ZNF717:NM_001290208:exon5:c.A2001T:p.R667S,ZNF717:NM_001290209:exon5:c.A1851T:p.R617S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A1851T:p.R617S,ZNF717:ENST00000652011.2_1:exon5:c.A2001T:p.R667S","ZNF717:ENST00000400845.3:c.1980A>T:p.(Arg660Ser)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","890","0/1","Het","376","220,156","0.585106382978723","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.02","D","0.042","","","","","","","D","1","","","T","2.96","D","-3.88","0.189","T","-1.054","T","0.045","T","0.002","0.148","T","0.344","18.83","1.883","1.71","-1.876","5.213"
"chr3","75786827","75786827","A>T","","ZNF717","exonic","stopgain","","ZNF717:NM_001128223:exon5:c.T1947A:p.C649X,ZNF717:NM_001290208:exon5:c.T1947A:p.C649X,ZNF717:NM_001290209:exon5:c.T1797A:p.C599X","ZNF717","exonic","stopgain","","ZNF717:ENST00000478296.5_1:exon4:c.T1797A:p.C599X,ZNF717:ENST00000652011.2_1:exon5:c.T1947A:p.C649X","ZNF717:ENST00000400845.3:c.1926T>A:p.(Cys642*)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","891","0/1","Het","292","137,155","0.469178082191781","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","","","","","","","","","","","D","1","","","","","","","0.025","","","","","","","","","","32","4.702","1.71","0.625","3.984"
"chr3","75786892","75786892","A>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T1882G:p.F628V,ZNF717:NM_001290208:exon5:c.T1882G:p.F628V,ZNF717:NM_001290209:exon5:c.T1732G:p.F578V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T1732G:p.F578V,ZNF717:ENST00000652011.2_1:exon5:c.T1882G:p.F628V","ZNF717:ENST00000400845.3:c.1861T>G:p.(Phe621Val)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","892","0/1","Het","182","133,49","0.730769230769231","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.002","D","0.0","","","","","","","D","1","","","T","0.84","D","-6.5","0.311","T","-0.741","T","0.353","T","0.002","0.306","D","0.995","22.3","2.373","1.9","6.666","7.880"
"chr3","75786916","75786916","C>A","","ZNF717","exonic","stopgain","","ZNF717:NM_001128223:exon5:c.G1858T:p.E620X,ZNF717:NM_001290208:exon5:c.G1858T:p.E620X,ZNF717:NM_001290209:exon5:c.G1708T:p.E570X","ZNF717","exonic","stopgain","","ZNF717:ENST00000478296.5_1:exon4:c.G1708T:p.E570X,ZNF717:ENST00000652011.2_1:exon5:c.G1858T:p.E620X","ZNF717:ENST00000400845.3:c.1837G>T:p.(Glu613*)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","893","0/1","Het","135","93,42","0.688888888888889","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","","","","","","","","","","","D","1","","","","","","","0.046","","","","","","","","","","27.2","3.940","1.9","-4.990","2.210"
"chr3","75786919","75786919","A>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T1855A:p.Y619N,ZNF717:NM_001290208:exon5:c.T1855A:p.Y619N,ZNF717:NM_001290209:exon5:c.T1705A:p.Y569N","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T1705A:p.Y569N,ZNF717:ENST00000652011.2_1:exon5:c.T1855A:p.Y619N","ZNF717:ENST00000400845.3:c.1834T>A:p.(Tyr612Asn)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","894","0/1","Het","131","90,41","0.687022900763359","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.005","D","0.001","","","","","","","D","1","","","T","1.78","D","-6.68","0.336","T","-0.994","T","0.162","T","0.002","0.125","D","0.994","22.8","2.613","1.9","4.973","7.880"
"chr3","75787015","75787015","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1759A:p.G587S,ZNF717:NM_001290208:exon5:c.G1759A:p.G587S,ZNF717:NM_001290209:exon5:c.G1609A:p.G537S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1609A:p.G537S,ZNF717:ENST00000652011.2_1:exon5:c.G1759A:p.G587S","ZNF717:ENST00000400845.3:c.1738G>A:p.(Gly580Ser)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","895","0/1","Het","83","51,32","0.614457831325301","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.006","D","0.007","","","","","","","D","0.877","","","T","1.82","D","-4.88","0.208","T","-0.810","T","0.141","T","0.002","0.147","D","0.975","22.8","2.622","1.76","3.125","9.659"
"chr3","75787042","75787042","->AAAT","","ZNF717","exonic","frameshift insertion","","ZNF717:NM_001128223:exon5:c.1731_1732insATTT:p.L578Ifs*16,ZNF717:NM_001290208:exon5:c.1731_1732insATTT:p.L578Ifs*16,ZNF717:NM_001290209:exon5:c.1581_1582insATTT:p.L528Ifs*16","ZNF717","exonic","frameshift insertion","","ZNF717:ENST00000478296.5_1:exon4:c.1581_1582insATTT:p.L528Ifs*16,ZNF717:ENST00000652011.2_1:exon5:c.1731_1732insATTT:p.L578Ifs*16","ZNF717:ENST00000400845.3:c.1710_1711insATTT:p.(Leu571Ilefs*16)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","896","0/1","Het","71","50,21","0.704225352112676","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75787044","75787044","->CTT","","ZNF717","exonic","stopgain","","ZNF717:NM_001128223:exon5:c.1729_1730insAAG:p.F577_P914del,ZNF717:NM_001290208:exon5:c.1729_1730insAAG:p.F577_P914del,ZNF717:NM_001290209:exon5:c.1579_1580insAAG:p.F527_P864del","ZNF717","exonic","stopgain","","ZNF717:ENST00000478296.5_1:exon4:c.1579_1580insAAG:p.F527_P864del,ZNF717:ENST00000652011.2_1:exon5:c.1729_1730insAAG:p.F577_P914del","ZNF717:ENST00000400845.3:c.1708_1709insAAG:p.(Phe570*)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","897","0/1","Het","68","48,20","0.705882352941177","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75787047","75787047","->ACTTATA","","ZNF717","exonic","stopgain","","ZNF717:NM_001128223:exon5:c.1726_1727insTATAAGT:p.S576Lfs*2,ZNF717:NM_001290208:exon5:c.1726_1727insTATAAGT:p.S576Lfs*2,ZNF717:NM_001290209:exon5:c.1576_1577insTATAAGT:p.S526Lfs*2","ZNF717","exonic","stopgain","","ZNF717:ENST00000478296.5_1:exon4:c.1576_1577insTATAAGT:p.S526Lfs*2,ZNF717:ENST00000652011.2_1:exon5:c.1726_1727insTATAAGT:p.S576Lfs*2","ZNF717:ENST00000400845.3:c.1705_1706insTATAAGT:p.(Ser569Leufs*2)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","898","0/1","Het","69","45,24","0.652173913043478","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75787081","75787081","A>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T1693A:p.C565S,ZNF717:NM_001290208:exon5:c.T1693A:p.C565S,ZNF717:NM_001290209:exon5:c.T1543A:p.C515S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T1543A:p.C515S,ZNF717:ENST00000652011.2_1:exon5:c.T1693A:p.C565S","ZNF717:ENST00000400845.3:c.1672T>A:p.(Cys558Ser)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","899","0/1","Het","76","58,18","0.763157894736842","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.002","D","0.0","","","","","","","D","1","","","D","-1.95","D","-9.87","0.281","D","0.010","D","0.763","T","0.005","0.311","D","0.981","22.1","2.326","1.76","6.666","7.618"
"chr3","75787116","75787116","T>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A1658C:p.H553P,ZNF717:NM_001290208:exon5:c.A1658C:p.H553P,ZNF717:NM_001290209:exon5:c.A1508C:p.H503P","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A1508C:p.H503P,ZNF717:ENST00000652011.2_1:exon5:c.A1658C:p.H553P","ZNF717:ENST00000400845.3:c.1637A>C:p.(His546Pro)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","900","0/1","Het","88","72,16","0.818181818181818","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.003","D","0.0","","","","","","","D","0.816","","","D","-2.18","D","-9.76","0.314","D","0.805","D","0.833","T","0.005","0.462","D","0.827","22.4","2.411","1.92","5.793","7.916"
"chr3","75787127","75787127","G>T","","ZNF717","exonic","stopgain","","ZNF717:NM_001128223:exon5:c.C1647A:p.Y549X,ZNF717:NM_001290208:exon5:c.C1647A:p.Y549X,ZNF717:NM_001290209:exon5:c.C1497A:p.Y499X","ZNF717","exonic","stopgain","","ZNF717:ENST00000478296.5_1:exon4:c.C1497A:p.Y499X,ZNF717:ENST00000652011.2_1:exon5:c.C1647A:p.Y549X","ZNF717:ENST00000400845.3:c.1626C>A:p.(Tyr542*)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","901","0/1","Het","97","80,17","0.824742268041237","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","","","","","","","","","","","D","1","","","","","","","0.017","","","","","","","","","","24.0","3.190","1.92","-1.117","2.952"
"chr3","75787228","75787228","A>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T1546G:p.F516V,ZNF717:NM_001290208:exon5:c.T1546G:p.F516V,ZNF717:NM_001290209:exon5:c.T1396G:p.F466V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T1396G:p.F466V,ZNF717:ENST00000652011.2_1:exon5:c.T1546G:p.F516V","ZNF717:ENST00000400845.3:c.1525T>G:p.(Phe509Val)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","902","0/1","Het","85","78,7","0.917647058823529","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.0","D","0.0","","","","","","","D","1","","","T","0.99","D","-6.9","0.254","T","-0.796","T","0.314","T","0.004","0.273","D","0.969","22.3","2.398","1.91","4.720","7.900"
"chr3","75787240","75787240","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T1534C:p.C512R,ZNF717:NM_001290208:exon5:c.T1534C:p.C512R,ZNF717:NM_001290209:exon5:c.T1384C:p.C462R","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T1384C:p.C462R,ZNF717:ENST00000652011.2_1:exon5:c.T1534C:p.C512R","ZNF717:ENST00000400845.3:c.1513T>C:p.(Cys505Arg)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","903","0/1","Het","73","60,13","0.821917808219178","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.0","D","0.0","","","","","","","D","1.000","","","D","-2.05","D","-11.74","0.271","D","0.604","D","0.786","T","0.008","0.315","D","0.975","23.1","2.793","1.9","4.956","7.866"
"chr3","75787264","75787264","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1510A:p.E504K,ZNF717:NM_001290208:exon5:c.G1510A:p.E504K,ZNF717:NM_001290209:exon5:c.G1360A:p.E454K","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1360A:p.E454K,ZNF717:ENST00000652011.2_1:exon5:c.G1510A:p.E504K","ZNF717:ENST00000400845.3:c.1489G>A:p.(Glu497Lys)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","904","0/1","Het","52","40,12","0.769230769230769","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.005","D","0.017","","","","","","","D","1","","","T","1.86","D","-3.19","0.193","T","-1.024","T","0.046","T","0.005","0.098","D","0.920","18.17","1.795","1.76","2.361","6.743"
"chr3","75787273","75787273","G>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C1501A:p.H501N,ZNF717:NM_001290208:exon5:c.C1501A:p.H501N,ZNF717:NM_001290209:exon5:c.C1351A:p.H451N","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C1351A:p.H451N,ZNF717:ENST00000652011.2_1:exon5:c.C1501A:p.H501N","ZNF717:ENST00000400845.3:c.1480C>A:p.(His494Asn)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","905","0/1","Het","47","41,6","0.872340425531915","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.0","D","0.001","","","","","","","D","0.522","","","T","-0.26","D","-6.9","0.23","D","0.136","D","0.515","T","0.009","0.408","D","0.971","23.1","2.777","1.9","5.273","9.961"
"chr3","75787276","75787276","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A1498G:p.T500A,ZNF717:NM_001290208:exon5:c.A1498G:p.T500A,ZNF717:NM_001290209:exon5:c.A1348G:p.T450A","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A1348G:p.T450A,ZNF717:ENST00000652011.2_1:exon5:c.A1498G:p.T500A","ZNF717:ENST00000400845.3:c.1477A>G:p.(Thr493Ala)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","906","0/1","Het","46","40,6","0.869565217391304","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.029","D","0.009","","","","","","","D","1","","","T","2.08","N","-1.59","0.056","T","-1.024","T","0.044","T","0.003","0.053","T","0.150","13.86","1.065","1.9","0.266","7.866"
"chr3","75787349","75787353","CCCTG>-","","ZNF717","exonic","frameshift deletion","","ZNF717:NM_001128223:exon5:c.1421_1425del:p.T474Rfs*5,ZNF717:NM_001290208:exon5:c.1421_1425del:p.T474Rfs*5,ZNF717:NM_001290209:exon5:c.1271_1275del:p.T424Rfs*5","ZNF717","exonic","frameshift deletion","","ZNF717:ENST00000478296.5_1:exon4:c.1271_1275del:p.T424Rfs*5,ZNF717:ENST00000652011.2_1:exon5:c.1421_1425del:p.T474Rfs*5","ZNF717:ENST00000400845.3:c.1400_1404del:p.(Thr467Argfs*5)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","907","0/1","Het","29","24,5","0.827586206896552","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75787405","75787405","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1369A:p.G457R,ZNF717:NM_001290208:exon5:c.G1369A:p.G457R,ZNF717:NM_001290209:exon5:c.G1219A:p.G407R","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1219A:p.G407R,ZNF717:ENST00000652011.2_1:exon5:c.G1369A:p.G457R","ZNF717:ENST00000400845.3:c.1348G>A:p.(Gly450Arg)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","908","0/1","Het","74","43,31","0.581081081081081","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.023","D","0.022","","","","","","","D","1","","","T","4.84","D","-6.27","0.129","T","-1.004","T","0.012","T","0.003","0.155","D","0.991","15.27","1.315","2.07","2.365","6.088"
"chr3","75787516","75787516","C>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1258C:p.E420Q,ZNF717:NM_001290208:exon5:c.G1258C:p.E420Q,ZNF717:NM_001290209:exon5:c.G1108C:p.E370Q","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1108C:p.E370Q,ZNF717:ENST00000652011.2_1:exon5:c.G1258C:p.E420Q","ZNF717:ENST00000400845.3:c.1237G>C:p.(Glu413Gln)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","909","0/1","Het","185","103,82","0.556756756756757","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.021","D","0.01","","","","","","","D","1","","","T","1.77","D","-2.52","0.129","T","-1.053","T","0.069","T","0.003","0.190","D","0.723","17.69","1.731","1.87","4.053","8.218"
"chr3","75787519","75787519","C>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1255T:p.G419W,ZNF717:NM_001290208:exon5:c.G1255T:p.G419W,ZNF717:NM_001290209:exon5:c.G1105T:p.G369W","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1105T:p.G369W,ZNF717:ENST00000652011.2_1:exon5:c.G1255T:p.G419W","ZNF717:ENST00000400845.3:c.1234G>T:p.(Gly412Trp)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","910","0/1","Het","184","103,81","0.559782608695652","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.0","D","0.0","","","","","","","D","1.000","","","T","4.7","D","-7.47","0.262","T","-1.104","T","0.033","T","0.005","0.122","D","0.982","22.4","2.424","1.87","2.244","6.629"
"chr3","75787646","75787647","AA>-","","ZNF717","exonic","frameshift deletion","","ZNF717:NM_001128223:exon5:c.1127_1128del:p.F376Sfs*3,ZNF717:NM_001290208:exon5:c.1127_1128del:p.F376Sfs*3,ZNF717:NM_001290209:exon5:c.977_978del:p.F326Sfs*3","ZNF717","exonic","frameshift deletion","","ZNF717:ENST00000478296.5_1:exon4:c.977_978del:p.F326Sfs*3,ZNF717:ENST00000652011.2_1:exon5:c.1127_1128del:p.F376Sfs*3","ZNF717:ENST00000400845.3:c.1106_1107del:p.(Phe369Serfs*3)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","911","0/1","Het","214","118,96","0.551401869158878","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75787732","75787732","A>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T1042G:p.F348V,ZNF717:NM_001290208:exon5:c.T1042G:p.F348V,ZNF717:NM_001290209:exon5:c.T892G:p.F298V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T892G:p.F298V,ZNF717:ENST00000652011.2_1:exon5:c.T1042G:p.F348V","ZNF717:ENST00000400845.3:c.1021T>G:p.(Phe341Val)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","912","0/1","Het","171","151,20","0.883040935672515","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.0","D","0.0","","","","","","","D","1","","","T","0.88","D","-6.58","0.197","T","-0.829","T","0.274","T","0.004","0.217","D","0.667","21.8","2.263","1.58","3.021","7.303"
"chr3","75787770","75787770","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1004A:p.G335E,ZNF717:NM_001290208:exon5:c.G1004A:p.G335E,ZNF717:NM_001290209:exon5:c.G854A:p.G285E","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G854A:p.G285E,ZNF717:ENST00000652011.2_1:exon5:c.G1004A:p.G335E","ZNF717:ENST00000400845.3:c.983G>A:p.(Gly328Glu)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","913","0/1","Het","181","133,48","0.734806629834254","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>T|ZNF717|0.00|0.00|0.00|0.00|13|0|-44|1","Zinc","","","","","","","","","","","","D","0.002","D","0.019","","","","","","","D","1","","","T","1.78","D","-6.42","0.191","T","-1.050","T","0.093","T","0.004","0.099","D","0.981","18.57","1.849","1.78","1.737","6.458"
"chr3","75788028","75788028","G>C","","ZNF717","exonic","stopgain","","ZNF717:NM_001128223:exon5:c.C746G:p.S249X,ZNF717:NM_001290208:exon5:c.C746G:p.S249X,ZNF717:NM_001290209:exon5:c.C596G:p.S199X","ZNF717","exonic","stopgain","","ZNF717:ENST00000478296.5_1:exon4:c.C596G:p.S199X,ZNF717:ENST00000652011.2_1:exon5:c.C746G:p.S249X","ZNF717:ENST00000400845.3:c.725C>G:p.(Ser242*)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","914","0/1","Het","263","192,71","0.730038022813688","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","D","1","","","","","","","0.023","","","","","","","","","","25.6","3.662","2.2","0.912","4.539"
"chr3","75788150","75788150","->G","","ZNF717","exonic","frameshift insertion","","ZNF717:NM_001128223:exon5:c.623dupC:p.Q210Sfs*3,ZNF717:NM_001290208:exon5:c.623dupC:p.Q210Sfs*3,ZNF717:NM_001290209:exon5:c.473dupC:p.Q160Sfs*3","ZNF717","exonic","frameshift insertion","","ZNF717:ENST00000478296.5_1:exon4:c.473dupC:p.Q160Sfs*3,ZNF717:ENST00000652011.2_1:exon5:c.623dupC:p.Q210Sfs*3","ZNF717:ENST00000400845.3:c.602dup:p.(Gln203Serfs*3)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","915","0/1","Het","228","132,96","0.578947368421053","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75788403","75788403","->T","","ZNF717","exonic","frameshift insertion","","ZNF717:NM_001128223:exon5:c.370dupA:p.T124Nfs*6,ZNF717:NM_001290208:exon5:c.370dupA:p.T124Nfs*6,ZNF717:NM_001290209:exon5:c.220dupA:p.T74Nfs*6","ZNF717","exonic","frameshift insertion","","ZNF717:ENST00000478296.5_1:exon4:c.220dupA:p.T74Nfs*6,ZNF717:ENST00000652011.2_1:exon5:c.370dupA:p.T124Nfs*6","ZNF717:ENST00000400845.3:c.349dup:p.(Thr117Asnfs*6)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","916","0/1","Het","228","186,42","0.815789473684211","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75790466","75790466","G>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon4:c.C238A:p.P80T,ZNF717:NM_001290208:exon4:c.C238A:p.P80T,ZNF717:NM_001290209:exon4:c.C88A:p.P30T,ZNF717:NM_001290210:exon4:c.C238A:p.P80T","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon3:c.C88A:p.P30T,ZNF717:ENST00000477374.5_1:exon4:c.C238A:p.P80T,ZNF717:ENST00000652011.2_1:exon4:c.C238A:p.P80T","ZNF717:ENST00000400845.3:c.217C>A:p.(Pro73Thr)","1","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","917","0/1","Het","160","125,35","0.78125","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Krueppel-associated","","","","","","","","","","","","D","0.001","D","0.004","","","","","","","N","1","","","T","5.36","D","-7.4","0.128","T","-0.864","T","0.173","T","0.003","0.168","D","0.975","15.75","1.407","1.97","0.262","5.821"
"chr3","75786438","75786438","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2336T:p.T779I,ZNF717:NM_001290208:exon5:c.C2336T:p.T779I,ZNF717:NM_001290209:exon5:c.C2186T:p.T729I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C2186T:p.T729I,ZNF717:ENST00000652011.2_1:exon5:c.C2336T:p.T779I","ZNF717:ENST00000400845.3:c.2315C>T:p.(Thr772Ile)","0.999999","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","918","0/1","Het","69","44,25","0.63768115942029","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0","","","","","","","0","0","T","1.0","T","1.0","","","","","","","D","1.000","","","T","2.14","N","0.0","0.019","T","-0.983","T","0.025","T","0.001","0.023","T","0.055","3.655","0.064","1.74","-1.320","5.380"
"chr3","75786759","75786759","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A2015G:p.K672R,ZNF717:NM_001290208:exon5:c.A2015G:p.K672R,ZNF717:NM_001290209:exon5:c.A1865G:p.K622R","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A1865G:p.K622R,ZNF717:ENST00000652011.2_1:exon5:c.A2015G:p.K672R","ZNF717:ENST00000400845.3:c.1994A>G:p.(Lys665Arg)","0.99972796","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","919","0/1","Het","382","161,221","0.421465968586387","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>C|ZNF717|0.00|0.00|0.00|0.00|16|-43|-13|-5","Zinc","","","0.000007877","","","","","","","7.877e-06","0","D","0.027","D","0.001","","","","","","","D","1","","","T","3.16","N","-0.9","0.034","T","-0.950","T","0.008","T","0.004","0.059","T","0.059","7.865","0.353","1.57","-0.248","4.750"
"chr3","75786288","75786288","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T2486C:p.L829P,ZNF717:NM_001290208:exon5:c.T2486C:p.L829P,ZNF717:NM_001290209:exon5:c.T2336C:p.L779P","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T2336C:p.L779P,ZNF717:ENST00000652011.2_1:exon5:c.T2486C:p.L829P","ZNF717:ENST00000400845.3:c.2465T>C:p.(Leu822Pro)","0.999","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","920","0/1","Het","102","94,8","0.92156862745098","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.001","D","0.0","","","","","","","N","1.000","","","T","1.64","D","-5.1","0.387","T","-0.929","T","0.216","T","9.9E-4","0.220","D","0.942","20.6","2.096","1.77","6.574","5.268"
"chr3","75787317","75787317","T>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A1457T:p.K486I,ZNF717:NM_001290208:exon5:c.A1457T:p.K486I,ZNF717:NM_001290209:exon5:c.A1307T:p.K436I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A1307T:p.K436I,ZNF717:ENST00000652011.2_1:exon5:c.A1457T:p.K486I","ZNF717:ENST00000400845.3:c.1436A>T:p.(Lys479Ile)","0.999","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","921","0/1","Het","30","25,5","0.833333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.001","D","0.0","","","","","","","D","0.864","","","T","1.62","D","-7.61","0.202","T","-0.927","T","0.215","T","0.001","0.122","D","0.997","20.7","2.110","2.07","2.408","5.540"
"chr3","75786035","75786035","->A","","ZNF717","exonic","stoploss","","ZNF717:NM_001128223:exon5:c.2738dupT:p.*915L,ZNF717:NM_001290208:exon5:c.2738dupT:p.*915L,ZNF717:NM_001290209:exon5:c.2588dupT:p.*865L","ZNF717","exonic","stoploss","","ZNF717:ENST00000478296.5_1:exon4:c.2588dupT:p.*865delinsLNTQPTPLWLLLQISPCSV*,ZNF717:ENST00000652011.2_1:exon5:c.2738dupT:p.*915delinsLNTQPTPLWLLLQISPCSV*","ZNF717:ENST00000478296.1:c.2588dup:p.(*865Leuext*19)","0.9987527","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","922","0/1","Het","69","55,14","0.797101449275362","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","0.00003333","","","","","","","3.333e-05","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75786597","75786597","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G2177A:p.R726Q,ZNF717:NM_001290208:exon5:c.G2177A:p.R726Q,ZNF717:NM_001290209:exon5:c.G2027A:p.R676Q","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G2027A:p.R676Q,ZNF717:ENST00000652011.2_1:exon5:c.G2177A:p.R726Q","ZNF717:ENST00000400845.3:c.2156G>A:p.(Arg719Gln)","0.9984168","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","923","0/1","Het","80","56,24","0.7","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","0.000007424","","","","","","","7.424e-06","0.0001","T","0.08","T","0.461","","","","","","","D","1","","","T","3.33","N","-0.22","0.052","T","-0.936","T","0.006","T","0.006","0.071","T","0.062","7.913","0.357","1.75","-4.902","2.730"
"chr3","75786993","75786993","T>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A1781T:p.N594I,ZNF717:NM_001290208:exon5:c.A1781T:p.N594I,ZNF717:NM_001290209:exon5:c.A1631T:p.N544I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A1631T:p.N544I,ZNF717:ENST00000652011.2_1:exon5:c.A1781T:p.N594I","ZNF717:ENST00000400845.3:c.1760A>T:p.(Asn587Ile)","0.998","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","924","0/1","Het","89","68,21","0.764044943820225","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0","","","","","","","0","0","D","0.002","D","0.011","","","","","","","N","1","","","T","3.18","D","-5.03","0.237","T","-1.053","T","0.025","T","9.2E-4","0.035","D","0.935","15.78","1.412","1.9","-2.361","3.943"
"chr3","75787416","75787416","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1358A:p.C453Y,ZNF717:NM_001290208:exon5:c.G1358A:p.C453Y,ZNF717:NM_001290209:exon5:c.G1208A:p.C403Y","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1208A:p.C403Y,ZNF717:ENST00000652011.2_1:exon5:c.G1358A:p.C453Y","ZNF717:ENST00000400845.3:c.1337G>A:p.(Cys446Tyr)","0.99601525","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","925","0/1","Het","82","48,34","0.585365853658537","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0.00001685","","","","","","","1.685e-05","0","D","0.0","D","0.0","","","","","","","D","1","","","D","-1.94","D","-10.76","0.155","D","0.102","D","0.787","T","0.007","0.345","D","0.973","22.6","2.500","2.07","5.711","10.339"
"chr3","75786942","75786942","C>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1832T:p.R611I,ZNF717:NM_001290208:exon5:c.G1832T:p.R611I,ZNF717:NM_001290209:exon5:c.G1682T:p.R561I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1682T:p.R561I,ZNF717:ENST00000652011.2_1:exon5:c.G1832T:p.R611I","ZNF717:ENST00000400845.3:c.1811G>T:p.(Arg604Ile)","0.9944845","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","926","0/1","Het","116","84,32","0.724137931034483","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>A|ZNF717|0.00|0.00|0.00|0.00|-12|22|1|-29","Zinc","","","0.00002048","0.0004","0.001","","","","","2.048e-05","0","T","0.084","D","0.008","","","","","","","D","0.814","","","T","4.29","D","-6.53","0.164","T","-0.884","T","0.007","T","0.002","0.066","D","0.648","11.55","0.749","1.9","0.121","4.080"
"chr3","75787099","75787100","CT>-","","ZNF717","exonic","frameshift deletion","","ZNF717:NM_001128223:exon5:c.1674_1675del:p.E560Kfs*4,ZNF717:NM_001290208:exon5:c.1674_1675del:p.E560Kfs*4,ZNF717:NM_001290209:exon5:c.1524_1525del:p.E510Kfs*4","ZNF717","exonic","frameshift deletion","","ZNF717:ENST00000478296.5_1:exon4:c.1524_1525del:p.E510Kfs*4,ZNF717:ENST00000652011.2_1:exon5:c.1674_1675del:p.E560Kfs*4","ZNF717:ENST00000400845.3:c.1653_1654del:p.(Glu553Lysfs*4)","0.99233234","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","927","0/1","Het","85","67,18","0.788235294117647","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>C|ZNF717|0.00|0.00|0.00|0.00|11|21|23|-44","","","","0.0001","","","","","","","0.0001","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75788130","75788130","C>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G644T:p.G215V,ZNF717:NM_001290208:exon5:c.G644T:p.G215V,ZNF717:NM_001290209:exon5:c.G494T:p.G165V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G494T:p.G165V,ZNF717:ENST00000652011.2_1:exon5:c.G644T:p.G215V","ZNF717:ENST00000400845.3:c.623G>T:p.(Gly208Val)","0.992","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","928","0/1","Het","249","146,103","0.586345381526104","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.008","D","0.007","","","","","","","N","1.000","","","T","-0.21","D","-5.3","0.157","T","-0.678","T","0.297","T","0.007","0.177","D","0.706","4.496","0.114","1.94","0.955","3.131"
"chr3","75787032","75787032","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A1742G:p.H581R,ZNF717:NM_001290208:exon5:c.A1742G:p.H581R,ZNF717:NM_001290209:exon5:c.A1592G:p.H531R","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A1592G:p.H531R,ZNF717:ENST00000652011.2_1:exon5:c.A1742G:p.H581R","ZNF717:ENST00000400845.3:c.1721A>G:p.(His574Arg)","0.99054","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","929","0/1","Het","68","47,21","0.691176470588235","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0.00004835","","","","","","","4.835e-05","0.0006","D","0.031","D","0.023","","","","","","","D","1","","","D","-2.18","D","-7.28","0.235","D","0.078","D","0.691","T","0.006","0.389","T","0.350","12.93","0.930","1.76","2.229","5.415"
"chr3","75786211","75786211","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T2563C:p.S855P,ZNF717:NM_001290208:exon5:c.T2563C:p.S855P,ZNF717:NM_001290209:exon5:c.T2413C:p.S805P","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T2413C:p.S805P,ZNF717:ENST00000652011.2_1:exon5:c.T2563C:p.S855P","ZNF717:ENST00000400845.3:c.2542T>C:p.(Ser848Pro)","0.9862293","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","930","0/1","Het","70","47,23","0.671428571428571","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0.00002135","","","","","","","2.135e-05","0","D","0.013","D","0.003","","","","","","","N","1","","","T","3.15","D","-3.1","0.116","T","-1.043","T","0.033","T","6.28E-4","0.160","T","0.298","14.79","1.225","1.59","-2.936","7.316"
"chr3","75786036","75786036","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T2738C:p.F913S,ZNF717:NM_001290208:exon5:c.T2738C:p.F913S,ZNF717:NM_001290209:exon5:c.T2588C:p.F863S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T2588C:p.F863S,ZNF717:ENST00000652011.2_1:exon5:c.T2738C:p.F913S","ZNF717:ENST00000400845.3:c.2717T>C:p.(Phe906Ser)","0.9819497","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","931","0/1","Het","67","54,13","0.805970149253731","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","D","0.018","D","0.0","","","","","","","N","1","","","T","3.32","N","0.2","0.147","T","-0.940","T","0.008","T","8.59E-4","0.112","T","0.133","13.84","1.063","1.43","-1.711","4.624"
"chr3","75787927","75787927","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T847C:p.Y283H,ZNF717:NM_001290208:exon5:c.T847C:p.Y283H,ZNF717:NM_001290209:exon5:c.T697C:p.Y233H","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T697C:p.Y233H,ZNF717:ENST00000652011.2_1:exon5:c.T847C:p.Y283H","ZNF717:ENST00000400845.3:c.826T>C:p.(Tyr276His)","0.978051","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","932","0/1","Het","164","80,84","0.48780487804878","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.124","T","0.052","","","","","","","D","0.978","","","T","1.99","D","-2.89","0.098","T","-0.976","T","0.038","T","0.002","0.040","T","0.437","14.18","1.117","1.6","2.089","4.707"
"chr3","75781272","75781272","C>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001290210:exon5:c.G278T:p.G93V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000477374.5_1:exon5:c.G278T:p.G93V","ZNF717:ENST00000477374.1:c.278G>T:p.(Gly93Val)","0.978","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","933","0/1","Het","94","69,25","0.734042553191489","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Krueppel-associated","Name=L1MCa","","","","","","","","","","","D","0.022","T","0.345","","","","","","","N","1.000","","","T","5.64","N","0.97","0.185","T","-0.903","T","0.002","T","0.003","0.011","T","0.047","9.333","0.493","","0.145",""
"chr3","75788227","75788227","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T547C:p.C183R,ZNF717:NM_001290208:exon5:c.T547C:p.C183R,ZNF717:NM_001290209:exon5:c.T397C:p.C133R","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T397C:p.C133R,ZNF717:ENST00000652011.2_1:exon5:c.T547C:p.C183R","ZNF717:ENST00000400845.3:c.526T>C:p.(Cys176Arg)","0.977","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","934","0/1","Het","155","87,68","0.561290322580645","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>G|ZNF717|0.00|0.00|0.00|0.00|36|-14|4|-3","","","","0","","","","","","","0","0","D","0.023","D","0.01","","","","","","","N","1","","","D","-2.64","D","-5.68","0.19","T","-0.165","D","0.704","T","0.012","0.451","T","0.264","0.368","-0.299","2.07","0.140","9.676"
"chr3","75786225","75786225","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2549T:p.T850I,ZNF717:NM_001290208:exon5:c.C2549T:p.T850I,ZNF717:NM_001290209:exon5:c.C2399T:p.T800I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C2399T:p.T800I,ZNF717:ENST00000652011.2_1:exon5:c.C2549T:p.T850I","ZNF717:ENST00000400845.3:c.2528C>T:p.(Thr843Ile)","0.973","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","935","0/1","Het","74","65,9","0.878378378378378","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.027","T","0.075","","","","","","","N","1","","","T","5.24","N","-2.36","0.053","T","-0.968","T","0.004","T","6.28E-4","0.081","T","0.409","7.144","0.295","1.59","-0.744","0.920"
"chr3","75781257","75781257","T>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001290210:exon5:c.A293C:p.Q98P","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000477374.5_1:exon5:c.A293C:p.Q98P","ZNF717:ENST00000477374.1:c.293A>C:p.(Gln98Pro)","0.969","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","936","0/1","Het","83","55,28","0.662650602409639","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","Name=L1MCa","","","","","","","","","","","D","0.031","T","0.204","","","","","","","N","1","","","T","5.59","N","-0.05","0.239","T","-0.957","T","0.003","T","0.002","0.029","T","0.047","0.212","-0.379","","-1.446",""
"chr3","75786042","75786042","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2732T:p.S911F,ZNF717:NM_001290208:exon5:c.C2732T:p.S911F,ZNF717:NM_001290209:exon5:c.C2582T:p.S861F","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C2582T:p.S861F,ZNF717:ENST00000652011.2_1:exon5:c.C2732T:p.S911F","ZNF717:ENST00000400845.3:c.2711C>T:p.(Ser904Phe)","0.962","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","937","0/1","Het","72","42,30","0.583333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","D","0.038","D","0.001","","","","","","","N","1","","","T","3.22","N","-1.16","0.094","T","-0.932","T","0.010","T","0.002","0.061","T","0.330","13.97","1.083","1.54","-0.650","5.509"
"chr3","75787204","75787204","C>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1570T:p.V524F,ZNF717:NM_001290208:exon5:c.G1570T:p.V524F,ZNF717:NM_001290209:exon5:c.G1420T:p.V474F","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1420T:p.V474F,ZNF717:ENST00000652011.2_1:exon5:c.G1570T:p.V524F","ZNF717:ENST00000400845.3:c.1549G>T:p.(Val517Phe)","0.951","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","938","0/1","Het","98","88,10","0.897959183673469","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","D","0.049","T","0.157","","","","","","","N","1","","","T","3.18","D","-2.6","0.148","T","-1.017","T","0.014","T","0.001","0.074","T","0.290","8.010","0.365","1.79","-3.170","4.138"
"chr3","75790472","75790472","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon4:c.G232A:p.A78T,ZNF717:NM_001290208:exon4:c.G232A:p.A78T,ZNF717:NM_001290209:exon4:c.G82A:p.A28T,ZNF717:NM_001290210:exon4:c.G232A:p.A78T","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon3:c.G82A:p.A28T,ZNF717:ENST00000477374.5_1:exon4:c.G232A:p.A78T,ZNF717:ENST00000652011.2_1:exon4:c.G232A:p.A78T","ZNF717:ENST00000400845.3:c.211G>A:p.(Ala71Thr)","0.939","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","939","0/1","Het","167","131,36","0.784431137724551","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Krueppel-associated","","","","","","","","","","","","T","0.061","T","0.063","","","","","","","N","1.000","","","T","5.61","D","-2.5","0.121","T","-1.088","T","0.057","T","0.002","0.127","D","0.560","20.6","2.090","1.97","0.124","7.497"
"chr3","75786802","75786802","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C1972T:p.R658C,ZNF717:NM_001290208:exon5:c.C1972T:p.R658C,ZNF717:NM_001290209:exon5:c.C1822T:p.R608C","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C1822T:p.R608C,ZNF717:ENST00000652011.2_1:exon5:c.C1972T:p.R658C","ZNF717:ENST00000400845.3:c.1951C>T:p.(Arg651Cys)","0.9295447","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","941","0/1","Het","303","159,144","0.524752475247525","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0.00007403","","","","","","","7.403e-05","0","T","0.067","T","0.169","","","","","","","N","1","","","T","5.42","D","-3.07","0.105","T","-0.871","T","0.003","T","0.002","0.133","T","0.178","14.26","1.132","1.71","-0.426","2.500"
"chr3","75788432","75788432","T>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A342T:p.Q114H,ZNF717:NM_001290208:exon5:c.A342T:p.Q114H,ZNF717:NM_001290209:exon5:c.A192T:p.Q64H","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A192T:p.Q64H,ZNF717:ENST00000652011.2_1:exon5:c.A342T:p.Q114H","ZNF717:ENST00000400845.3:c.321A>T:p.(Gln107His)","0.928","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","942","0/1","Het","199","159,40","0.798994974874372","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.072","T","0.155","","","","","","","N","1","","","T","0.86","N","-1.31","0.055","T","-1.013","T","0.124","T","0.002","0.113","T","0.207","15.25","1.312","2.13","-0.153","6.835"
"chr3","75786991","75786991","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1783A:p.E595K,ZNF717:NM_001290208:exon5:c.G1783A:p.E595K,ZNF717:NM_001290209:exon5:c.G1633A:p.E545K","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1633A:p.E545K,ZNF717:ENST00000652011.2_1:exon5:c.G1783A:p.E595K","ZNF717:ENST00000400845.3:c.1762G>A:p.(Glu588Lys)","0.901","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","943","0/1","Het","91","61,30","0.67032967032967","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.099","D","0.022","","","","","","","N","1","","","T","3.2","N","-2.3","0.164","T","-1.016","T","0.024","T","8.82E-4","0.063","T","0.388","18.40","1.826","1.9","-0.240","6.443"
"chr3","75788115","75788115","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C659T:p.T220M,ZNF717:NM_001290208:exon5:c.C659T:p.T220M,ZNF717:NM_001290209:exon5:c.C509T:p.T170M","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C509T:p.T170M,ZNF717:ENST00000652011.2_1:exon5:c.C659T:p.T220M","ZNF717:ENST00000400845.3:c.638C>T:p.(Thr213Met)","0.9001754","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","944","0/1","Het","276","160,116","0.579710144927536","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0.000008812","","","","","","","8.812e-06","0.0001","T","0.098","T","0.165","","","","","","","N","1","","","T","0.13","N","-0.38","0.064","T","-0.975","T","0.115","T","0.007","0.208","T","0.259","0.350","-0.307","1.94","-2.149","6.495"
"chr3","75788484","75788484","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T290C:p.I97T,ZNF717:NM_001290208:exon5:c.T290C:p.I97T,ZNF717:NM_001290209:exon5:c.T140C:p.I47T","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T140C:p.I47T,ZNF717:ENST00000652011.2_1:exon5:c.T290C:p.I97T","ZNF717:ENST00000400845.3:c.269T>C:p.(Ile90Thr)","0.898","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","945","0/1","Het","155","108,47","0.696774193548387","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","",".;.;.","","","","","","","","","","","","T","0.439","T","0.5","","","","","","","N","1","","","T","1.16","N","-0.84","0.161","T","-0.998","T","0.034","T","9.85E-4","0.228","T","0.031","6.012","0.212","1.88","-0.169","5.311"
"chr3","75787897","75787897","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A877G:p.I293V,ZNF717:NM_001290208:exon5:c.A877G:p.I293V,ZNF717:NM_001290209:exon5:c.A727G:p.I243V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A727G:p.I243V,ZNF717:ENST00000652011.2_1:exon5:c.A877G:p.I293V","ZNF717:ENST00000400845.3:c.856A>G:p.(Ile286Val)","0.879","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","947","0/1","Het","180","133,47","0.738888888888889","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.121","T","0.513","","","","","","","N","1","","","T","2.47","N","-0.05","0.049","T","-0.995","T","0.023","T","7.08E-4","0.031","T","0.047","2.594","-0.002","1.26","0.086","3.459"
"chr3","75786501","75786501","T>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A2273T:p.Y758F,ZNF717:NM_001290208:exon5:c.A2273T:p.Y758F,ZNF717:NM_001290209:exon5:c.A2123T:p.Y708F","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A2123T:p.Y708F,ZNF717:ENST00000652011.2_1:exon5:c.A2273T:p.Y758F","ZNF717:ENST00000400845.3:c.2252A>T:p.(Tyr751Phe)","0.878","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","948","0/1","Het","40","20,20","0.5","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.122","T","0.108","","","","","","","N","1","","","T","2.22","D","-2.61","0.205","T","-0.992","T","0.023","T","0.002","0.100","T","0.078","10.38","0.608","1.74","-2.251","4.017"
"chr3","75787159","75787159","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1615A:p.E539K,ZNF717:NM_001290208:exon5:c.G1615A:p.E539K,ZNF717:NM_001290209:exon5:c.G1465A:p.E489K","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1465A:p.E489K,ZNF717:ENST00000652011.2_1:exon5:c.G1615A:p.E539K","ZNF717:ENST00000400845.3:c.1594G>A:p.(Glu532Lys)","0.87115586","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","949","0/1","Het","107","75,32","0.700934579439252","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>T|ZNF717|0.00|0.00|0.00|0.00|-40|36|-3|6","Zinc","","","0.0035","","","0.0035","0.","","","0.0006","0","T","0.057","T","0.059","","","","","","","N","1","","","T","3.2","D","-2.57","0.164","T","-0.977","T","0.011","T","0.001","0.040","T","0.020","5.088","0.151","1.8","-1.723","0.971"
"chr3","75786450","75786450","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2324T:p.T775M,ZNF717:NM_001290208:exon5:c.C2324T:p.T775M,ZNF717:NM_001290209:exon5:c.C2174T:p.T725M","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C2174T:p.T725M,ZNF717:ENST00000652011.2_1:exon5:c.C2324T:p.T775M","ZNF717:ENST00000400845.3:c.2303C>T:p.(Thr768Met)","0.86427003","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","950","0/1","Het","60","35,25","0.583333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>A|ZNF717|0.00|0.00|0.00|0.00|-8|13|46|4","Zinc","","","0.0000209","","","0.","0.","","","2.09e-05","0","T","0.132","T","0.203","","","","","","","N","1","","","T","2.23","N","-0.01","0.067","T","-1.023","T","0.023","T","4.2E-4","0.013","T","0.035","0.004","-0.928","1.74","-7.775","5.455"
"chr3","75786315","75786323","CTACATTCT>-","","ZNF717","exonic","nonframeshift deletion","","ZNF717:NM_001128223:exon5:c.2451_2459del:p.E818_R820del,ZNF717:NM_001290208:exon5:c.2451_2459del:p.E818_R820del,ZNF717:NM_001290209:exon5:c.2301_2309del:p.E768_R770del","ZNF717","exonic","nonframeshift deletion","","ZNF717:ENST00000478296.5_1:exon4:c.2301_2309del:p.E768_R770del,ZNF717:ENST00000652011.2_1:exon5:c.2451_2459del:p.E818_R820del","ZNF717:ENST00000400845.3:c.2430_2438del:p.(Glu811_Arg813del)","0.85","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","951","0/1","Het","128","82,46","0.640625","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75786818","75786826","ACATTCATT>-","","ZNF717","exonic","nonframeshift deletion","","ZNF717:NM_001128223:exon5:c.1948_1956del:p.N650_C652del,ZNF717:NM_001290208:exon5:c.1948_1956del:p.N650_C652del,ZNF717:NM_001290209:exon5:c.1798_1806del:p.N600_C602del","ZNF717","exonic","nonframeshift deletion","","ZNF717:ENST00000478296.5_1:exon4:c.1798_1806del:p.N600_C602del,ZNF717:ENST00000652011.2_1:exon5:c.1948_1956del:p.N650_C652del","ZNF717:ENST00000400845.3:c.1927_1935del:p.(Asn643_Cys645del)","0.85","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","952","0/1","Het","276","141,135","0.510869565217391","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75787353","75787353","->AAA","","ZNF717","exonic","nonframeshift insertion","","ZNF717:NM_001128223:exon5:c.1420_1421insTTT:p.T474delinsIS,ZNF717:NM_001290208:exon5:c.1420_1421insTTT:p.T474delinsIS,ZNF717:NM_001290209:exon5:c.1270_1271insTTT:p.T424delinsIS","ZNF717","exonic","nonframeshift insertion","","ZNF717:ENST00000478296.5_1:exon4:c.1270_1271insTTT:p.T424delinsIS,ZNF717:ENST00000652011.2_1:exon5:c.1420_1421insTTT:p.T474delinsIS","ZNF717:ENST00000400845.3:c.1399_1400insTTT:p.(Thr467delinsIleSer)","0.85","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","953","0/1","Het","26","21,5","0.807692307692308","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75788226","75788226","C>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G548T:p.C183F,ZNF717:NM_001290208:exon5:c.G548T:p.C183F,ZNF717:NM_001290209:exon5:c.G398T:p.C133F","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G398T:p.C133F,ZNF717:ENST00000652011.2_1:exon5:c.G548T:p.C183F","ZNF717:ENST00000400845.3:c.527G>T:p.(Cys176Phe)","0.837","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","954","0/1","Het","157","87,70","0.554140127388535","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.163","D","0.039","","","","","","","N","1","","","D","-2.64","D","-5.17","0.148","T","-0.568","D","0.604","D","0.046","0.432","T","0.182","0.006","-0.863","2.07","-0.023","0.319"
"chr3","75787726","75787726","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C1048T:p.R350C,ZNF717:NM_001290208:exon5:c.C1048T:p.R350C,ZNF717:NM_001290209:exon5:c.C898T:p.R300C","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C898T:p.R300C,ZNF717:ENST00000652011.2_1:exon5:c.C1048T:p.R350C","ZNF717:ENST00000400845.3:c.1027C>T:p.(Arg343Cys)","0.80425704","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","955","0/1","Het","173","30,143","0.173410404624277","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0.00002129","","","","","","","2.129e-05","0","T","0.194","T","0.111","","","","","","","P","1","","","T","2.36","D","-2.57","0.122","T","-1.069","T","0.002","T","0.001","0.064","D","0.520","22.1","2.316","1.58","-4.415","5.246"
"chr3","75788316","75788316","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G458A:p.G153E,ZNF717:NM_001290208:exon5:c.G458A:p.G153E,ZNF717:NM_001290209:exon5:c.G308A:p.G103E","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G308A:p.G103E,ZNF717:ENST00000652011.2_1:exon5:c.G458A:p.G153E","ZNF717:ENST00000400845.3:c.437G>A:p.(Gly146Glu)","0.803","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","956","0/1","Het","174","115,59","0.660919540229885","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>T|ZNF717|0.00|0.00|0.00|0.00|-37|0|29|1","","","","","","","","","","","","","T","0.197","T","0.074","","","","","","","N","1","","","T","1.0","D","-2.66","0.098","T","-1.005","T","0.128","T","0.003","0.131","T","0.426","11.53","0.746","2.07","0.766","5.008"
"chr3","75786740","75786740","C>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G2034C:p.M678I,ZNF717:NM_001290208:exon5:c.G2034C:p.M678I,ZNF717:NM_001290209:exon5:c.G1884C:p.M628I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1884C:p.M628I,ZNF717:ENST00000652011.2_1:exon5:c.G2034C:p.M678I","ZNF717:ENST00000400845.3:c.2013G>C:p.(Met671Ile)","0.796","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","959","0/1","Het","363","310,53","0.853994490358127","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.204","T","0.066","","","","","","","N","1","","","T","3.32","N","-0.86","0.093","T","-0.958","T","0.010","T","6.81E-4","0.033","T","0.075","10.24","0.592","1.57","-0.659","9.238"
"chr3","75786298","75786298","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A2476G:p.K826E,ZNF717:NM_001290208:exon5:c.A2476G:p.K826E,ZNF717:NM_001290209:exon5:c.A2326G:p.K776E","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A2326G:p.K776E,ZNF717:ENST00000652011.2_1:exon5:c.A2476G:p.K826E","ZNF717:ENST00000400845.3:c.2455A>G:p.(Lys819Glu)","0.786","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","960","0/1","Het","109","99,10","0.908256880733945","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.214","T","0.065","","","","","","","N","1","","","T","2.32","N","-1.68","0.075","T","-1.035","T","0.033","T","0.001","0.047","T","0.175","14.60","1.191","1.77","0.009","4.917"
"chr3","75786490","75786490","C>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G2284C:p.E762Q,ZNF717:NM_001290208:exon5:c.G2284C:p.E762Q,ZNF717:NM_001290209:exon5:c.G2134C:p.E712Q","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G2134C:p.E712Q,ZNF717:ENST00000652011.2_1:exon5:c.G2284C:p.E762Q","ZNF717:ENST00000400845.3:c.2263G>C:p.(Glu755Gln)","0.763","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","961","0/1","Het","42","19,23","0.452380952380952","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.237","T","0.691","","","","","","","N","1","","","T","2.21","N","-1.08","0.122","T","-1.014","T","0.029","T","6.42E-4","0.142","T","0.106","15.37","1.335","1.74","0.726","9.616"
"chr3","75788158","75788158","G>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C616G:p.L206V,ZNF717:NM_001290208:exon5:c.C616G:p.L206V,ZNF717:NM_001290209:exon5:c.C466G:p.L156V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C466G:p.L156V,ZNF717:ENST00000652011.2_1:exon5:c.C616G:p.L206V","ZNF717:ENST00000400845.3:c.595C>G:p.(Leu199Val)","0.741","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","964","0/1","Het","220","102,118","0.463636363636364","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","0","","","","","","","0","0","T","0.259","D","0.017","","","","","","","P","1","","","T","0.2","N","0.44","0.047","T","-1.017","T","0.062","T","0.003","0.100","T","0.143","7.576","0.329","2.07","0.519","7.923"
"chr3","75788088","75788088","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G686A:p.R229K,ZNF717:NM_001290208:exon5:c.G686A:p.R229K,ZNF717:NM_001290209:exon5:c.G536A:p.R179K","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G536A:p.R179K,ZNF717:ENST00000652011.2_1:exon5:c.G686A:p.R229K","ZNF717:ENST00000400845.3:c.665G>A:p.(Arg222Lys)","0.726","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","966","0/1","Het","286","254,32","0.888111888111888","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.274","T","0.148","","","","","","","N","1","","","T","3.25","N","-1.36","0.131","T","-0.955","T","0.015","T","6.58E-4","0.022","T","0.109","2.069","-0.040","1.52","0.505","1.901"
"chr3","75790447","75790447","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon4:c.C257T:p.T86I,ZNF717:NM_001290208:exon4:c.C257T:p.T86I,ZNF717:NM_001290209:exon4:c.C107T:p.T36I,ZNF717:NM_001290210:exon4:c.C257T:p.T86I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon3:c.C107T:p.T36I,ZNF717:ENST00000477374.5_1:exon4:c.C257T:p.T86I,ZNF717:ENST00000652011.2_1:exon4:c.C257T:p.T86I","ZNF717:ENST00000400845.3:c.236C>T:p.(Thr79Ile)","0.713","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","967","0/1","Het","155","120,35","0.774193548387097","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Krueppel-associated","","","","","","","","","","","","T","0.435","T","0.397","","","","","","","N","1","","","T","5.61","N","-0.86","0.053","T","-1.031","T","0.051","T","0.002","0.335","T","0.019","0.067","-0.539","1.97","-1.744","3.515"
"chr3","75786071","75786071","C>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G2703T:p.E901D,ZNF717:NM_001290208:exon5:c.G2703T:p.E901D,ZNF717:NM_001290209:exon5:c.G2553T:p.E851D","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G2553T:p.E851D,ZNF717:ENST00000652011.2_1:exon5:c.G2703T:p.E901D","ZNF717:ENST00000400845.3:c.2682G>T:p.(Glu894Asp)","0.7","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","969","0/1","Het","88","71,17","0.806818181818182","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.3","T","0.062","","","","","","","N","1","","","T","3.23","N","-1.02","0.085","T","-0.948","T","0.010","T","0.001","0.103","T","0.064","5.398","0.171","0.741","1.331","3.115"
"chr3","75787962","75787962","G>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C812G:p.T271S,ZNF717:NM_001290208:exon5:c.C812G:p.T271S,ZNF717:NM_001290209:exon5:c.C662G:p.T221S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C662G:p.T221S,ZNF717:ENST00000652011.2_1:exon5:c.C812G:p.T271S","ZNF717:ENST00000400845.3:c.791C>G:p.(Thr264Ser)","0.68200004","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","971","0/1","Het","165","135,30","0.818181818181818","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.318","T","0.207","","","","","","","N","1","","","T","2.32","N","-0.74","0.064","T","-0.956","T","0.021","T","0.001","0.006","T","0.050","0.191","-0.393","1.04","-0.268","5.668"
"chr3","75787224","75787224","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1550A:p.R517H,ZNF717:NM_001290208:exon5:c.G1550A:p.R517H,ZNF717:NM_001290209:exon5:c.G1400A:p.R467H","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1400A:p.R467H,ZNF717:ENST00000652011.2_1:exon5:c.G1550A:p.R517H","ZNF717:ENST00000400845.3:c.1529G>A:p.(Arg510His)","0.67065626","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","972","0/1","Het","76","63,13","0.828947368421053","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0","","","","","","","0","0","T","0.329","T","0.505","","","","","","","N","1","","","T","3.13","N","-0.74","0.033","T","-0.933","T","0.013","T","9.31E-4","0.023","T","0.063","0.049","-0.579","1.79","-1.873","0.637"
"chr3","75787305","75787305","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1469A:p.R490H,ZNF717:NM_001290208:exon5:c.G1469A:p.R490H,ZNF717:NM_001290209:exon5:c.G1319A:p.R440H","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1319A:p.R440H,ZNF717:ENST00000652011.2_1:exon5:c.G1469A:p.R490H","ZNF717:ENST00000400845.3:c.1448G>A:p.(Arg483His)","0.649","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","974","0/1","Het","29","20,9","0.689655172413793","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0","","","","","","","0","0","T","0.351","T","0.42","","","","","","","N","1","","","T","5.44","N","-1.04","0.025","T","-0.928","T","0.002","T","4.95E-4","0.042","T","0.064","0.006","-0.862","2.05","-2.647","5.265"
"chr3","75787222","75787222","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T1552C:p.C518R,ZNF717:NM_001290208:exon5:c.T1552C:p.C518R,ZNF717:NM_001290209:exon5:c.T1402C:p.C468R","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T1402C:p.C468R,ZNF717:ENST00000652011.2_1:exon5:c.T1552C:p.C518R","ZNF717:ENST00000400845.3:c.1531T>C:p.(Cys511Arg)","0.62","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","977","0/1","Het","85","70,15","0.823529411764706","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>G|ZNF717|0.00|0.00|0.00|0.00|44|-27|0|2","Zinc","","","","","","","","","","","","T","0.38","T","0.621","","","","","","","N","1","","","T","3.21","N","2.23","0.019","T","-0.915","T","0.007","T","7.39E-4","0.031","T","0.054","0.792","-0.185","1.79","-1.649","2.786"
"chr3","75786619","75786619","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A2155G:p.R719G,ZNF717:NM_001290208:exon5:c.A2155G:p.R719G,ZNF717:NM_001290209:exon5:c.A2005G:p.R669G","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A2005G:p.R669G,ZNF717:ENST00000652011.2_1:exon5:c.A2155G:p.R719G","ZNF717:ENST00000400845.3:c.2134A>G:p.(Arg712Gly)","0.616","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","978","0/1","Het","122","88,34","0.721311475409836","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>C|ZNF717|0.00|0.00|0.00|0.00|13|-2|-11|43","","","","","","","","","","","","","T","0.384","T","0.302","","","","","","","N","1","","","T","3.28","N","-0.73","0.071","T","-0.955","T","0.009","T","8.57E-4","0.039","T","0.028","0.035","-0.623","1.61","-1.078","1.237"
"chr3","75786079","75786079","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G2695A:p.V899I,ZNF717:NM_001290208:exon5:c.G2695A:p.V899I,ZNF717:NM_001290209:exon5:c.G2545A:p.V849I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G2545A:p.V849I,ZNF717:ENST00000652011.2_1:exon5:c.G2695A:p.V899I","ZNF717:ENST00000400845.3:c.2674G>A:p.(Val892Ile)","0.61297673","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","980","0/1","Het","95","75,20","0.789473684210526","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.38","D","0.025","","","","","","","N","1","","","T","3.32","N","0.07","0.026","T","-0.947","T","0.008","T","0.001","0.112","T","0.104","9.754","0.538","1.29","-0.265","3.729"
"chr3","75790444","75790444","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon4:c.C260T:p.P87L,ZNF717:NM_001290208:exon4:c.C260T:p.P87L,ZNF717:NM_001290209:exon4:c.C110T:p.P37L,ZNF717:NM_001290210:exon4:c.C260T:p.P87L","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon3:c.C110T:p.P37L,ZNF717:ENST00000477374.5_1:exon4:c.C260T:p.P87L,ZNF717:ENST00000652011.2_1:exon4:c.C260T:p.P87L","ZNF717:ENST00000400845.3:c.239C>T:p.(Pro80Leu)","0.60899997","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","981","0/1","Het","156","104,52","0.666666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Krueppel-associated","","","","","","","","","","","","T","0.391","T","0.849","","","","","","","N","1","","","T","5.61","N","-1.5","0.161","T","-1.102","T","0.020","T","0.002","0.153","T","0.099","10.85","0.664","1.97","2.664","4.623"
"chr3","75788023","75788023","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G751A:p.V251I,ZNF717:NM_001290208:exon5:c.G751A:p.V251I,ZNF717:NM_001290209:exon5:c.G601A:p.V201I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G601A:p.V201I,ZNF717:ENST00000652011.2_1:exon5:c.G751A:p.V251I","ZNF717:ENST00000400845.3:c.730G>A:p.(Val244Ile)","0.595","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","984","0/1","Het","249","129,120","0.518072289156627","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.405","T","0.448","","","","","","","N","1","","","T","3.32","N","0.14","0.049","T","-0.950","T","0.007","T","4.67E-4","0.034","T","0.071","0.005","-0.876","2.2","-1.052","0.334"
"chr3","75788366","75788366","C>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G408T:p.L136F,ZNF717:NM_001290208:exon5:c.G408T:p.L136F,ZNF717:NM_001290209:exon5:c.G258T:p.L86F","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G258T:p.L86F,ZNF717:ENST00000652011.2_1:exon5:c.G408T:p.L136F","ZNF717:ENST00000400845.3:c.387G>T:p.(Leu129Phe)","0.543758","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","989","0/1","Het","260","155,105","0.596153846153846","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>A|ZNF717|0.00|0.00|0.00|0.00|-50|48|27|31","","","","0.0000776","","","0.0019","0.","","","7.76e-05","0","T","0.407","T","0.7","","","","","","","N","1","","","T","-0.45","N","-0.9","0.034","T","-0.960","T","0.189","T","0.007","0.104","T","0.079","8.901","0.448","2.13","-2.652","6.573"
"chr3","75781243","75781243","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001290210:exon5:c.A307G:p.I103V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000477374.5_1:exon5:c.A307G:p.I103V","ZNF717:ENST00000477374.1:c.307A>G:p.(Ile103Val)","0.538","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","990","0/1","Het","106","87,19","0.820754716981132","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","Name=L1MCa","","","","","","","","","","","T","0.462","T","1.0","","","","","","","N","1","","","T","5.65","N","0.25","0.154","T","-0.914","T","0.002","T","0.005","0.034","T","0.022","6.177","0.223","","0.147",""
"chr3","75786379","75786379","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A2395G:p.T799A,ZNF717:NM_001290208:exon5:c.A2395G:p.T799A,ZNF717:NM_001290209:exon5:c.A2245G:p.T749A","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A2245G:p.T749A,ZNF717:ENST00000652011.2_1:exon5:c.A2395G:p.T799A","ZNF717:ENST00000400845.3:c.2374A>G:p.(Thr792Ala)","0.5247242","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","991","0/1","Het","116","78,38","0.672413793103448","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0.00002252","","","","","","","2.252e-05","0","T","0.475","T","0.182","","","","","","","N","1","","","T","2.5","N","-0.37","0.031","T","-0.978","T","0.017","T","6.56E-4","0.015","T","0.021","1.877","-0.055","1.79","-3.477","4.801"
"chr3","75786245","75786245","T>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A2529T:p.R843S,ZNF717:NM_001290208:exon5:c.A2529T:p.R843S,ZNF717:NM_001290209:exon5:c.A2379T:p.R793S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A2379T:p.R793S,ZNF717:ENST00000652011.2_1:exon5:c.A2529T:p.R843S","ZNF717:ENST00000400845.3:c.2508A>T:p.(Arg836Ser)","0.513","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","992","0/1","Het","66","41,25","0.621212121212121","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.487","D","0.021","","","","","","","N","1","","","T","2.5","N","0.12","0.171","T","-0.966","T","0.015","T","0.001","0.187","T","0.036","5.233","0.160","1.46","-1.617","0.098"
"chr3","75786784","75786784","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A1990G:p.I664V,ZNF717:NM_001290208:exon5:c.A1990G:p.I664V,ZNF717:NM_001290209:exon5:c.A1840G:p.I614V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A1840G:p.I614V,ZNF717:ENST00000652011.2_1:exon5:c.A1990G:p.I664V","ZNF717:ENST00000400845.3:c.1969A>G:p.(Ile657Val)","0.513","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","993","0/1","Het","372","324,48","0.870967741935484","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.487","T","1.0","","","","","","","N","1","","","T","3.12","N","0.31","0.025","T","-0.925","T","0.009","T","9.34E-4","0.007","T","0.040","0.002","-1.071","1.71","-2.032","3.576"
"chr3","75788068","75788068","A>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T706G:p.F236V,ZNF717:NM_001290208:exon5:c.T706G:p.F236V,ZNF717:NM_001290209:exon5:c.T556G:p.F186V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T556G:p.F186V,ZNF717:ENST00000652011.2_1:exon5:c.T706G:p.F236V","ZNF717:ENST00000400845.3:c.685T>G:p.(Phe229Val)","0.50699997","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","994","0/1","Het","285","201,84","0.705263157894737","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.493","T","0.178","","","","","","","N","1","","","T","3.41","N","0.16","0.068","T","-0.956","T","0.007","T","6.8E-4","0.083","T","0.069","0.876","-0.170","1.94","-1.101","1.026"
"chr3","75786618","75786618","C>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G2156T:p.R719I,ZNF717:NM_001290208:exon5:c.G2156T:p.R719I,ZNF717:NM_001290209:exon5:c.G2006T:p.R669I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G2006T:p.R669I,ZNF717:ENST00000652011.2_1:exon5:c.G2156T:p.R719I","ZNF717:ENST00000400845.3:c.2135G>T:p.(Arg712Ile)","0.49394947","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","995","0/1","Het","114","102,12","0.894736842105263","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.506","T","0.226","","","","","","","N","1","","","T","3.28","N","-0.02","0.136","T","-0.929","T","0.007","T","6.99E-4","0.022","T","0.037","0.463","-0.265","1.61","-4.642","3.155"
"chr3","75787794","75787794","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T980C:p.I327T,ZNF717:NM_001290208:exon5:c.T980C:p.I327T,ZNF717:NM_001290209:exon5:c.T830C:p.I277T","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T830C:p.I277T,ZNF717:ENST00000652011.2_1:exon5:c.T980C:p.I327T","ZNF717:ENST00000400845.3:c.959T>C:p.(Ile320Thr)","0.4633561","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","996","0/1","Het","196","74,122","0.377551020408163","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>G|ZNF717|0.00|0.00|0.00|0.00|17|-11|-50|36","Zinc","","","0.0064","","","0.0017","0.","","","0.0064","0.006","T","0.379","T","0.886","","","","","","","N","1","","","T","2.36","N","-0.8","0.012","T","-0.999","T","0.013","T","7.93E-4","0.027","T","0.010","0.001","-1.310","1.59","-1.766","1.532"
"chr3","75786741","75786741","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T2033C:p.M678T,ZNF717:NM_001290208:exon5:c.T2033C:p.M678T,ZNF717:NM_001290209:exon5:c.T1883C:p.M628T","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T1883C:p.M628T,ZNF717:ENST00000652011.2_1:exon5:c.T2033C:p.M678T","ZNF717:ENST00000400845.3:c.2012T>C:p.(Met671Thr)","0.42299998","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","997","0/1","Het","366","152,214","0.415300546448087","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.577","T","0.136","","","","","","","N","1","","","T","3.17","N","0.82","0.035","T","-0.913","T","0.010","T","9.19E-4","0.064","T","0.026","1.422","-0.098","1.57","-4.932","5.111"
"chr3","75787801","75787801","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A973G:p.S325G,ZNF717:NM_001290208:exon5:c.A973G:p.S325G,ZNF717:NM_001290209:exon5:c.A823G:p.S275G","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A823G:p.S275G,ZNF717:ENST00000652011.2_1:exon5:c.A973G:p.S325G","ZNF717:ENST00000400845.3:c.952A>G:p.(Ser318Gly)","0.376","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","999","0/1","Het","195","157,38","0.805128205128205","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","0.624","T","0.333","","","","","","","N","1","","","T","2.38","N","-1.31","0.048","T","-0.968","T","0.027","T","0.001","0.017","T","0.142","2.278","-0.024","1.59","-1.459","2.772"
"chr3","75788281","75788281","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A493G:p.M165V,ZNF717:NM_001290208:exon5:c.A493G:p.M165V,ZNF717:NM_001290209:exon5:c.A343G:p.M115V","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A343G:p.M115V,ZNF717:ENST00000652011.2_1:exon5:c.A493G:p.M165V","ZNF717:ENST00000400845.3:c.472A>G:p.(Met158Val)","0.3498396","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1000","0/1","Het","158","90,68","0.569620253164557","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>C|ZNF717|0.00|0.00|0.00|0.00|-18|-2|-18|9","","","","0.0003","","","","","","","0.0003","0.0003","T","0.506","T","0.529","","","","","","","N","1","","","T","1.11","N","-0.25","0.022","T","-1.023","T","0.041","T","0.001","0.109","T","0.002","0.001","-1.592","2.07","0.089","5.125"
"chr3","75788362","75788362","A>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T412A:p.S138T,ZNF717:NM_001290208:exon5:c.T412A:p.S138T,ZNF717:NM_001290209:exon5:c.T262A:p.S88T","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T262A:p.S88T,ZNF717:ENST00000652011.2_1:exon5:c.T412A:p.S138T","ZNF717:ENST00000400845.3:c.391T>A:p.(Ser131Thr)","0.3363402","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1004","0/1","Het","258","228,30","0.883720930232558","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>T|ZNF717|0.00|0.00|0.00|0.00|-2|-46|31|35","","","","0.0018","","","0.0018","0.","","","0","0","T","0.633","T","0.267","","","","","","","N","1","","","T","0.87","N","-0.7","0.052","T","-1.016","T","0.071","T","0.002","0.016","T","0.083","0.014","-0.743","2.13","-0.526","3.827"
"chr3","75788199","75788199","T>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.A575G:p.H192R,ZNF717:NM_001290208:exon5:c.A575G:p.H192R,ZNF717:NM_001290209:exon5:c.A425G:p.H142R","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.A425G:p.H142R,ZNF717:ENST00000652011.2_1:exon5:c.A575G:p.H192R","ZNF717:ENST00000400845.3:c.554A>G:p.(His185Arg)","0.26870748","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1012","0/1","Het","187","131,56","0.700534759358289","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","0.000008274","","","","","","","8.274e-06","0","T","0.731","T","0.69","","","","","","","N","1","","","T","1.01","N","-0.98","0.018","T","-1.020","T","0.033","T","0.001","0.058","T","0.032","0.004","-0.908","1.92","-1.787","3.756"
"chr3","75786628","75786628","G>C","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2146G:p.Q716E,ZNF717:NM_001290208:exon5:c.C2146G:p.Q716E,ZNF717:NM_001290209:exon5:c.C1996G:p.Q666E","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C1996G:p.Q666E,ZNF717:ENST00000652011.2_1:exon5:c.C2146G:p.Q716E","ZNF717:ENST00000400845.3:c.2125C>G:p.(Gln709Glu)","0.20725401","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1014","0/1","Het","131","90,41","0.687022900763359","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","0.0000214","0.0006","","0.0001","0.","","","2.14e-05","0","T","0.791","T","0.546","","","","","","","N","1","","","T","3.4","N","0.09","0.044","T","-1.016","T","0.007","T","6.71E-4","0.077","T","0.052","8.320","0.393","1.61","-1.214","9.312"
"chr3","75790427","75790427","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon4:c.G277A:p.A93T,ZNF717:NM_001290208:exon4:c.G277A:p.A93T,ZNF717:NM_001290209:exon4:c.G127A:p.A43T,ZNF717:NM_001290210:exon4:c.G277A:p.G93S","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon3:c.G127A:p.A43T,ZNF717:ENST00000477374.5_1:exon4:c.G277A:p.G93S,ZNF717:ENST00000652011.2_1:exon4:c.G277A:p.A93T","ZNF717:ENST00000400845.3:c.256G>A:p.(Ala86Thr)","0.16311221","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1015","0/1","Het","146","131,15","0.897260273972603","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>T|ZNF717|0.00|0.00|0.00|0.80|-4|0|-4|0","Krueppel-associated","","","0.0045","","","0.0002","0.","","","0.0045","0","T","0.598","T","0.573","","","","","","","P","0.984","","","T","1.07","N","-0.29","0.05","T","-0.886","T","0.003","T","0.004","0.163","T","0.009","23.5","2.989","1.97","2.532","9.690"
"chr3","75787464","75787464","C>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.G1310A:p.R437K,ZNF717:NM_001290208:exon5:c.G1310A:p.R437K,ZNF717:NM_001290209:exon5:c.G1160A:p.R387K","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.G1160A:p.R387K,ZNF717:ENST00000652011.2_1:exon5:c.G1310A:p.R437K","ZNF717:ENST00000400845.3:c.1289G>A:p.(Arg430Lys)","0.14600003","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1016","0/1","Het","138","78,60","0.565217391304348","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","0","","","","","","","0","0","T","0.854","T","0.945","","","","","","","N","1","","","T","3.21","N","0.12","0.035","T","-0.935","T","0.009","T","6.17E-4","0.011","T","0.038","3.915","0.079","1.6","-3.095","3.615"
"chr3","75788434","75788434","G>T","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C340A:p.Q114K,ZNF717:NM_001290208:exon5:c.C340A:p.Q114K,ZNF717:NM_001290209:exon5:c.C190A:p.Q64K","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C190A:p.Q64K,ZNF717:ENST00000652011.2_1:exon5:c.C340A:p.Q114K","ZNF717:ENST00000400845.3:c.319C>A:p.(Gln107Lys)","0.021000028","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1028","0/1","Het","198","151,47","0.762626262626263","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","0.979","T","0.602","","","","","","","N","1","","","T","0.91","N","-0.17","0.04","T","-1.039","T","0.052","T","0.002","0.115","T","0.178","4.903","0.139","2.13","0.783","8.996"
"chr3","75786060","75786060","A>G","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.T2714C:p.V905A,ZNF717:NM_001290208:exon5:c.T2714C:p.V905A,ZNF717:NM_001290209:exon5:c.T2564C:p.V855A","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.T2564C:p.V855A,ZNF717:ENST00000652011.2_1:exon5:c.T2714C:p.V905A","ZNF717:ENST00000400845.3:c.2693T>C:p.(Val898Ala)","0","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1049","0/1","Het","86","63,23","0.732558139534884","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","","","","","","","","","","","","","T","1.0","T","1.0","","","","","","","N","1","","","T","3.35","N","0.15","0.075","T","-0.940","T","0.008","T","6.09E-4","0.189","T","0.051","5.605","0.184","1.73","-0.419","7.258"
"chr3","75786469","75786469","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C2305T:p.H769Y,ZNF717:NM_001290208:exon5:c.C2305T:p.H769Y,ZNF717:NM_001290209:exon5:c.C2155T:p.H719Y","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C2155T:p.H719Y,ZNF717:ENST00000652011.2_1:exon5:c.C2305T:p.H769Y","ZNF717:ENST00000400845.3:c.2284C>T:p.(His762Tyr)","0","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1050","0/1","Het","47","24,23","0.51063829787234","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","1.0","T","0.785","","","","","","","N","1","","","T","2.46","N","-0.09","0.16","T","-1.016","T","0.013","T","5.02E-4","0.041","T","0.089","3.028","0.026","1.74","-6.234","0.643"
"chr3","75787458","75787458","G>A","","ZNF717","exonic","nonsynonymous SNV","","ZNF717:NM_001128223:exon5:c.C1316T:p.T439I,ZNF717:NM_001290208:exon5:c.C1316T:p.T439I,ZNF717:NM_001290209:exon5:c.C1166T:p.T389I","ZNF717","exonic","nonsynonymous SNV","","ZNF717:ENST00000478296.5_1:exon4:c.C1166T:p.T389I,ZNF717:ENST00000652011.2_1:exon5:c.C1316T:p.T439I","ZNF717:ENST00000400845.3:c.1295C>T:p.(Thr432Ile)","0","","","","","","","","","","","","","","","","ENSG00000227124","ZNF717","HGNC:29448","ZNF717","100131827","ENSG00000227124","uc062lpg.1","0.016233365275246874","","1.0","","1051","0/1","Het","137","93,44","0.678832116788321","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016]","zinc finger protein 717","regulation of transcription by RNA polymerase II(GO:0006357)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","","Zinc","","","","","","","","","","","","T","1.0","T","0.531","","","","","","","N","1","","","T","3.15","N","-0.66","0.041","T","-0.969","T","0.013","T","0.001","0.137","T","0.145","2.207","-0.029","1.53","-1.120","4.944"
"chr2","133066897","133066897","G>T","","ZNF806","splicing","","NM_001304449:exon2:c.15+1G>T","","AC097532.2;RP11-725P16.2","intergenic","","dist=14947;dist=36292","","ZNF285CP:ENST00000424130.2:n.15+1G>T:","1","0.0","1.0","0.0162333652752468","0.0","0.9135000109672546","0.0074009424440427","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1052","0/1","Het","337","282,55","0.836795252225519","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075726","133075726","A>G","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.A1187G:p.E396G","AC097532.2;RP11-725P16.2","intergenic","","dist=23776;dist=27463","","ZNF285CP:ENST00000424130.2:n.1187A>G:","0.827","","","","0.0","0.9135000109672546","0.0074009424440427","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1053","0/1","Het","219","121,98","0.552511415525114","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075674","133075674","G>C","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.G1135C:p.G379R","AC097532.2;RP11-725P16.2","intergenic","","dist=23724;dist=27515","","ZNF285CP:ENST00000424130.2:n.1135G>C:","0.811","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1054","0/1","Het","172","96,76","0.558139534883721","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075027","133075027","G>A","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.G488A:p.G163E","AC097532.2;RP11-725P16.2","intergenic","","dist=23077;dist=28162","","ZNF285CP:ENST00000424130.2:n.488G>A:","0.762","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1056","0/1","Het","338","179,159","0.529585798816568","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133076118","133076118","A>-","","ZNF806","exonic","frameshift deletion","","ZNF806:NM_001304449:exon4:c.1579delA:p.N527Mfs*36","AC097532.2;RP11-725P16.2","intergenic","","dist=24168;dist=27071","","ZNF285CP:ENST00000424130.2:n.1580del:","0.7499616","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1057","0/1","Het","328","187,141","0.570121951219512","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075479","133075479","C>-","","ZNF806","exonic","frameshift deletion","","ZNF806:NM_001304449:exon4:c.940delC:p.Y315Tfs*152","AC097532.2;RP11-725P16.2","intergenic","","dist=23529;dist=27710","","ZNF285CP:ENST00000424130.2:n.942del:","0.748","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1058","0/1","Het","295","160,135","0.542372881355932","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075639","133075639","G>T","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.G1100T:p.G367V","AC097532.2;RP11-725P16.2","intergenic","","dist=23689;dist=27550","","ZNF285CP:ENST00000424130.2:n.1100G>T:","0.745","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1059","0/1","Het","209","106,103","0.507177033492823","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075904","133075904","->A","","ZNF806","exonic","frameshift insertion","","ZNF806:NM_001304449:exon4:c.1366dupA:p.N456Kfs*85","AC097532.2;RP11-725P16.2","intergenic","","dist=23954;dist=27285","","ZNF285CP:ENST00000424130.2:n.1367dup:","0.735","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1060","0/1","Het","271","142,129","0.523985239852399","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133076032","133076032","T>G","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.T1493G:p.F498C","AC097532.2;RP11-725P16.2","intergenic","","dist=24082;dist=27157","","ZNF285CP:ENST00000424130.2:n.1493T>G:","0.735","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1061","0/1","Het","363","193,170","0.53168044077135","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133076206","133076206","C>T","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.C1667T:p.A556V","AC097532.2;RP11-725P16.2","intergenic","","dist=24256;dist=26983","","ZNF285CP:ENST00000424130.2:n.1667C>T:","0.6209047","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1062","0/1","Het","305","173,132","0.567213114754098","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075615","133075615","G>C","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.G1076C:p.C359S","AC097532.2;RP11-725P16.2","intergenic","","dist=23665;dist=27574","","ZNF285CP:ENST00000424130.2:n.1076G>C:","0.59","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1063","0/1","Het","237","121,116","0.510548523206751","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075282","133075282","T>C","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.T743C:p.V248A","AC097532.2;RP11-725P16.2","intergenic","","dist=23332;dist=27907","","ZNF285CP:ENST00000424130.2:n.743T>C:","0.564","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1064","0/1","Het","343","183,160","0.533527696793003","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075207","133075207","C>T","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.C668T:p.A223V","AC097532.2;RP11-725P16.2","intergenic","","dist=23257;dist=27982","","ZNF285CP:ENST00000424130.2:n.668C>T:","0.5499505","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1065","0/1","Het","292","165,127","0.565068493150685","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","0.0004","0.0004","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075365","133075365","G>A","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.G826A:p.V276I","AC097532.2;RP11-725P16.2","intergenic","","dist=23415;dist=27824","","ZNF285CP:ENST00000424130.2:n.826G>A:","0.529","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1066","0/1","Het","374","190,184","0.508021390374332","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075104","133075104","C>T","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.C565T:p.R189C","AC097532.2;RP11-725P16.2","intergenic","","dist=23154;dist=28085","","ZNF285CP:ENST00000424130.2:n.565C>T:","0.51116556","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1067","0/1","Het","264","152,112","0.575757575757576","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","0.002","0.0004","0.002","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133074718","133074718","A>C","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.A179C:p.K60T","AC097532.2;RP11-725P16.2","intergenic","","dist=22768;dist=28471","","ZNF285CP:ENST00000424130.2:n.179A>C:","0.436","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1068","0/1","Het","117","56,61","0.478632478632479","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133070449","133070449","T>C","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon3:c.T23C:p.V8A","AC097532.2;RP11-725P16.2","intergenic","","dist=18499;dist=32740","","ZNF285CP:ENST00000424130.2:n.23T>C:","0.4319116","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1069","0/1","Het","114","73,41","0.640350877192982","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075612","133075612","C>T","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.C1073T:p.P358L","AC097532.2;RP11-725P16.2","intergenic","","dist=23662;dist=27577","","ZNF285CP:ENST00000424130.2:n.1073C>T:","0.294","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1072","0/1","Het","247","128,119","0.518218623481781","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133076155","133076155","G>A","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.G1616A:p.C539Y","AC097532.2;RP11-725P16.2","intergenic","","dist=24205;dist=27034","","ZNF285CP:ENST00000424130.2:n.1616G>A:","0.2615497","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1073","0/1","Het","346","199,147","0.57514450867052","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","0.0004","0.0004","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133076221","133076221","G>A","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.G1682A:p.R561H","AC097532.2;RP11-725P16.2","intergenic","","dist=24271;dist=26968","","ZNF285CP:ENST00000424130.2:n.1682G>A:","0.21084034","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1074","0/1","Het","287","162,125","0.564459930313589","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075386","133075386","G>A","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.G847A:p.G283R","AC097532.2;RP11-725P16.2","intergenic","","dist=23436;dist=27803","","ZNF285CP:ENST00000424130.2:n.847G>A:","0.1679828","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1075","0/1","Het","378","193,185","0.510582010582011","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133076229","133076229","A>G","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.A1690G:p.K564E","AC097532.2;RP11-725P16.2","intergenic","","dist=24279;dist=26960","","ZNF285CP:ENST00000424130.2:n.1690A>G:","0.1349516","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1076","0/1","Het","275","159,116","0.578181818181818","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133070508","133070508","G>T","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon3:c.G82T:p.A28S","AC097532.2;RP11-725P16.2","intergenic","","dist=18558;dist=32681","","ZNF285CP:ENST00000424130.2:n.82G>T:","0.087","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1077","0/1","Het","165","106,59","0.642424242424242","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133074759","133074759","A>C","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.A220C:p.K74Q","AC097532.2;RP11-725P16.2","intergenic","","dist=22809;dist=28430","","ZNF285CP:ENST00000424130.2:n.220A>C:","0.072","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1078","0/1","Het","190","95,95","0.5","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075664","133075664","T>G","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.T1125G:p.D375E","AC097532.2;RP11-725P16.2","intergenic","","dist=23714;dist=27525","","ZNF285CP:ENST00000424130.2:n.1125T>G:","0.061","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1079","0/1","Het","174","93,81","0.53448275862069","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133074745","133074745","A>T","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.A206T:p.E69V","AC097532.2;RP11-725P16.2","intergenic","","dist=22795;dist=28444","","ZNF285CP:ENST00000424130.2:n.206A>T:","0.056","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1080","0/1","Het","161","80,81","0.496894409937888","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133075069","133075069","A>G","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.A530G:p.H177R","AC097532.2;RP11-725P16.2","intergenic","","dist=23119;dist=28120","","ZNF285CP:ENST00000424130.2:n.530A>G:","0.045","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1082","0/1","Het","297","244,53","0.821548821548822","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133070556","133070556","T>C","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon3:c.T130C:p.F44L","AC097532.2;RP11-725P16.2","intergenic","","dist=18606;dist=32633","","ZNF285CP:ENST00000424130.2:n.130T>C:","0.029","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1085","0/1","Het","151","91,60","0.602649006622517","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133074876","133074876","A>G","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.A337G:p.M113V","AC097532.2;RP11-725P16.2","intergenic","","dist=22926;dist=28313","","ZNF285CP:ENST00000424130.2:n.337A>G:","0.029","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1086","0/1","Het","424","240,184","0.566037735849057","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","133074727","133074727","T>G","","ZNF806","exonic","nonsynonymous SNV","","ZNF806:NM_001304449:exon4:c.T188G:p.I63S","AC097532.2;RP11-725P16.2","intergenic","","dist=22777;dist=28462","","ZNF285CP:ENST00000424130.2:n.188T>G:","0.0059836213","","","","","","","","","","","","","","","","ENSG00000018607","ZNF285CP","HGNC:33228","ZNF285CP","646915","ENSG00000018607","","0.016233365275246874","","1.0","","1090","0/1","Het","132","64,68","0.484848484848485","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 806","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","","","","","0.0002","0.0002","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","231264881","231264881","G>T","","SP140L","exonic","nonsynonymous SNV","","SP140L:NM_001308163:exon13:c.G1057T:p.G353W,SP140L:NM_001308162:exon14:c.G1162T:p.G388W,SP140L:NM_138402:exon15:c.G1237T:p.G413W","SP140L","exonic","nonsynonymous SNV","","SP140L:ENST00000396563.8_1:exon13:c.G1057T:p.G353W,SP140L:ENST00000243810.10_1:exon14:c.G1162T:p.G388W,SP140L:ENST00000415673.7_1:exon15:c.G1237T:p.G413W,SP140L:ENST00000444636.5_1:exon15:c.G1237T:p.G413W","SP140L:ENST00000243810.6:c.1237G>T:p.(Gly413Trp)","1","0.0","1.0","0.0162333652752468","","","","","","","","","","","","","ENSG00000185404","SP140L","HGNC:25105","SP140L","93349","ENSG00000185404","uc010fxm.2","0.016233365275246874","","1.0","","1091","0/1","Het","252","149,103","0.591269841269841","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","SP140 nuclear body protein like","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)|nuclear body(GO:0016604)","DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA binding(GO:0003677)|metal ion binding(GO:0046872)","","","","","","","",".;Zinc","","","","","","","","","","","","D","0.0","D","0.0","","","","","","","N","1","H","3.67","D","-2.51","D","-5.62","0.753","D","0.187","D","0.845","D","0.073","0.554","D","0.974","22.3","2.374","3.5","2.833","6.659"
"chr5","68677842","68677842","C>T","","RAD17","exonic","nonsynonymous SNV","","RAD17:NM_133339:exon4:c.C499T:p.P167S,RAD17:NM_133341:exon4:c.C208T:p.P70S,RAD17:NM_002873:exon5:c.C466T:p.P156S,RAD17:NM_133344:exon5:c.C466T:p.P156S,RAD17:NM_001278622:exon6:c.C466T:p.P156S,RAD17:NM_133342:exon6:c.C466T:p.P156S,RAD17:NM_133343:exon6:c.C466T:p.P156S,RAD17:NM_133338:exon7:c.C466T:p.P156S","RAD17","exonic","nonsynonymous SNV","","RAD17:ENST00000282891.10_1:exon4:c.C208T:p.P70S,RAD17:ENST00000380774.7_1:exon4:c.C499T:p.P167S,RAD17:ENST00000305138.8_1:exon5:c.C466T:p.P156S,RAD17:ENST00000345306.10_1:exon5:c.C466T:p.P156S,RAD17:ENST00000354312.7_1:exon6:c.C466T:p.P156S,RAD17:ENST00000361732.6_1:exon6:c.C466T:p.P156S,RAD17:ENST00000509734.5_1:exon6:c.C499T:p.P167S,RAD17:ENST00000616683.4_1:exon6:c.C466T:p.P156S,RAD17:ENST00000354868.10_1:exon7:c.C466T:p.P156S","RAD17:ENST00000282891.6:c.208C>T:p.(Pro70Ser)","1","0.0","1.0","0.0162333652752468","","","","","","","","","","","","","ENSG00000152942","RAD17","HGNC:9807","RAD17","5884","ENSG00000152942","uc003jwo.5","0.016233365275246874","","1.0","","1092","0/1","Het","190","114,76","0.6","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is highly similar to the gene product of Schizosaccharomyces pombe rad17, a cell cycle checkpoint gene required for cell cycle arrest and DNA damage repair in response to DNA damage. This protein shares strong similarity with DNA replication factor C (RFC), and can form a complex with RFCs. This protein binds to chromatin prior to DNA damage and is phosphorylated by the checkpoint kinase ATR following damage. This protein recruits the RAD1-RAD9-HUS1 checkpoint protein complex onto chromatin after DNA damage, which may be required for its phosphorylation. The phosphorylation of this protein is required for the DNA-damage-induced cell cycle G2 arrest, and is thought to be a critical early event during checkpoint signaling in DNA-damaged cells. Multiple alternatively spliced transcript variants of this gene, which encode four distinct protein isoforms, have been reported. Two pseudogenes, located on chromosomes 7 and 13, have been identified. [provided by RefSeq, Jul 2013]","RAD17 checkpoint clamp loader component","DNA replication checkpoint signaling(GO:0000076)|DNA damage checkpoint signaling(GO:0000077)|DNA repair(GO:0006281)|cellular response to DNA damage stimulus(GO:0006974)|negative regulation of DNA replication(GO:0008156)|mitotic intra-S DNA damage checkpoint signaling(GO:0031573)|mitotic DNA replication checkpoint signaling(GO:0033314)|regulation of phosphorylation(GO:0042325)","chromosome, telomeric region(GO:0000781)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|nucleolus(GO:0005730)|Rad17 RFC-like complex(GO:0031389)","chromatin binding(GO:0003682)|DNA clamp loader activity(GO:0003689)|protein binding(GO:0005515)|ATP binding(GO:0005524)","cancer(DOID:162)","","Wp dna damage response|Wp dna irdamage and cellular response via atr|Wp gastric cancer network 2|Wp mirna regulation of dna damage response|Wp dna irdouble strand breaks dsbs and cellular response via atm","Cell cycle|Activation of atr in response to replication stress|Transcriptional regulation by tp53|Regulation of tp53 activity|Hdr through single strand annealing ssa|Hdr through homologous recombination hrr|Dna double strand break repair|Homology directed repair|Homologous dna pairing and strand exchange|Processing of dna double strand break ends|Regulation of tp53 activity through phosphorylation|G2 m dna damage checkpoint|G2 m checkpoints|Cell cycle checkpoints|Rna polymerase ii transcription|Dna repair","Atrbrca pathway","Spermatogenesis","",".;.;.;.;.;.;.;.;.;.","","","","","","","","","","","","T","0.76","T","0.73","B","0.0","B","0.002","N","0.066","D","1","N","-0.94","T","1.75","N","0.33","0.15","T","-1.046","T","0.023","T","0.006","0.023","T","0.150","18.34","1.818","5.1","0.620","9.971"
"chr11","1887763","1887763","C>T","","LSP1","exonic","nonsynonymous SNV","","LSP1:NM_001242932:exon2:c.C59T:p.P20L","LSP1","exonic","nonsynonymous SNV","","LSP1:ENST00000381775.5_1:exon2:c.C59T:p.P20L","LSP1:ENST00000381775.1:c.59C>T:p.(Pro20Leu)","1","0.0","1.0","0.0162333652752468","","","","","","","","","","","","","ENSG00000130592","LSP1","HGNC:6707","LSP1","4046","ENSG00000130592","uc001luj.3","0.016233365275246874","","1.0","","1093","0/1","Het","84","44,40","0.523809523809524","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes an intracellular F-actin binding protein. The protein is expressed in lymphocytes, neutrophils, macrophages, and endothelium and may regulate neutrophil motility, adhesion to fibrinogen matrix proteins, and transendothelial migration. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]","lymphocyte specific protein 1","chemotaxis(GO:0006935)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|cellular response to interleukin-7(GO:0098761)","plasma membrane(GO:0005886)|actin cytoskeleton(GO:0015629)|membrane(GO:0016020)|extracellular exosome(GO:0070062)","actin binding(GO:0003779)","cancer(DOID:162)|hereditary breast ovarian cancer syndrome(DOID:5683)|disease(DOID:4)","","","","","Myogenesis|Reactive oxygen species pathway","","","","","","","","","","","","","","D","0.0","","","","","","","","","N","1","","","T","1.56","N","-0.14","0.21","T","-1.004","T","0.047","T","0.004","0.027","T","0.100","12.77","0.907","2.0","-0.020","3.129"
"chr19","55358654","55358654","->GC","","KIR2DS4","exonic","frameshift insertion","","KIR2DS4:NM_001281972:exon5:c.658_659insGC:p.Y220Cfs*51,KIR2DS4:NM_001281971:exon6:c.709_710insGC:p.Y237Cfs*51","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.709_710insGC:p.(Tyr237Cysfs*51)","1","0.0","1.0","0.0162333652752468","0.0","1.0","0.0162333652752468","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1094","0/1","Het","218","174,44","0.798165137614679","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55358658","55358659","TG>-","","KIR2DS4","exonic","frameshift deletion","","KIR2DS4:NM_001281972:exon5:c.662_663del:p.M221Ifs*60,KIR2DS4:NM_001281971:exon6:c.713_714del:p.M238Ifs*60","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.714_715del:p.(Met238Ilefs*60)","1","","","","0.0","1.0","0.0162333652752468","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1095","0/1","Het","224","180,44","0.803571428571429","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55358736","55358736","->A","","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.799dup:p.(Met267Asnfs*32)","1","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1096","0/1","Het","185","146,39","0.789189189189189","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55359244","55359245","AC>-","","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.838_839del:p.(Gln280Valfs*18)","1","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1097","0/1","Het","353","277,76","0.784702549575071","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55358645","55358645","C>T","","KIR2DS4","exonic","nonsynonymous SNV","","KIR2DS4:NM_001281972:exon5:c.C649T:p.P217S,KIR2DS4:NM_001281971:exon6:c.C700T:p.P234S","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.700C>T:p.(Pro234Ser)","0.6","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1098","0/1","Het","210","168,42","0.8","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55358658","55358658","T>C","","KIR2DS4","exonic","nonsynonymous SNV","","KIR2DS4:NM_001281972:exon5:c.T662C:p.M221T,KIR2DS4:NM_001281971:exon6:c.T713C:p.M238T","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.713T>C:p.(Met238Thr)","0.6","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1099","0/1","Het","218","173,45","0.793577981651376","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55358686","55358686","A>C","","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.741A>C:p.(Lys247Asn)","0.6","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1100","0/1","Het","228","177,51","0.776315789473684","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55359210","55359210","T>A","","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.803T>A:p.(Leu268Gln)","0.6","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1101","0/1","Het","256","218,38","0.8515625","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55359227","55359227","A>G","","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.820A>G:p.(Ser274Gly)","0.6","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1102","0/1","Het","316","271,45","0.857594936708861","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55359234","55359234","A>G","","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.827A>G:p.(Gln276Arg)","0.6","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1103","0/1","Het","332","283,49","0.852409638554217","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55359255","55359255","C>G","","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.848C>G:p.(Ala283Gly)","0.6","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1104","0/1","Het","362","312,50","0.861878453038674","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55359371","55359371","A>G","","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.866A>G:p.(Lys289Arg)","0.6","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1105","0/1","Het","273","240,33","0.879120879120879","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55344239","55344239","T>G","","KIR2DS4","exonic","nonsynonymous SNV","","KIR2DS4:NM_001281971:exon1:c.T20G:p.I7S,KIR2DS4:NM_001281972:exon1:c.T20G:p.I7S","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.20T>G:p.(Ile7Ser)","0.599007","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1106","0/1","Het","216","107,109","0.49537037037037","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","SpliceAI>G|KIR2DS4|0.00|0.00|0.00|0.00|1|-23|10|14","","","","0.000008539","","","0.","0.0002","","","8.539e-06","0.0001","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55349320","55349320","G>C","","KIR2DS4","exonic","nonsynonymous SNV","","KIR2DS4:NM_001281971:exon3:c.G360C:p.M120I,KIR2DS4:NM_001281972:exon3:c.G360C:p.M120I","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.360G>C:p.(Met120Ile)","0.3106842","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1107","0/1","Het","114","101,13","0.885964912280702","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","0.00002978","0.015","0.012","0.","0.0001","","","2.978e-05","0.0002","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55349328","55349328","T>C","","KIR2DS4","exonic","nonsynonymous SNV","","KIR2DS4:NM_001281971:exon3:c.T368C:p.I123T,KIR2DS4:NM_001281972:exon3:c.T368C:p.I123T","KIR2DS4","exonic","unknown","","UNKNOWN","KIR2DS4:ENST00000339924.8:c.368T>C:p.(Ile123Thr)","0.3106842","","","","","","","","","","","","","","","","ENSG00000221957","KIR2DS4","HGNC:6336","KIR2DS4","3809","ENSG00000221957","uc061ctl.1","0.016233365275246874","","1.0","","1108","0/1","Het","112","97,15","0.866071428571429","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4","","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","leukemia(DOID:1240)|melanoma(DOID:1909)|rheumatoid arthritis(DOID:7148)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Innate immune system|Dap12 interactions","","","","","","","0.00002129","0.015","0.012","0.","0.0001","","","2.129e-05","0.0002","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55317528","55317529","GA>-","","KIR2DL4","exonic","frameshift deletion","","KIR2DL4:NM_001080770:exon4:c.484_485del:p.E162Sfs*3,KIR2DL4:NM_001080772:exon4:c.484_485del:p.E162Sfs*3","KIR2DL4","exonic","frameshift deletion","","KIR2DL4:ENST00000346587.8_1:exon3:c.199_200del:p.E67Sfs*3,KIR2DL4:ENST00000396293.5_1:exon3:c.199_200del:p.E67Sfs*3,KIR2DL4:ENST00000345540.9_1:exon4:c.484_485del:p.E162Sfs*3,KIR2DL4:ENST00000357494.8_1:exon4:c.484_485del:p.E162Sfs*3,KIR2DL4:ENST00000359085.8_1:exon4:c.484_485del:p.E162Sfs*3,KIR2DL4:ENST00000396284.6_1:exon4:c.601_602del:p.E201Sfs*3","KIR2DL4:ENST00000345540.5:c.484_485del:p.(Glu162Serfs*3)","1","0.0","1.0","0.0162333652752468","0.0","1.0","0.0162333652752468","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1110","0/1","Het","208","183,25","0.879807692307692","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55317530","55317530","->GG","","KIR2DL4","exonic","frameshift insertion","","KIR2DL4:NM_001080770:exon4:c.486_487insGG:p.A163Gfs*78,KIR2DL4:NM_001080772:exon4:c.486_487insGG:p.A163Gfs*83","KIR2DL4","exonic","frameshift insertion","","KIR2DL4:ENST00000346587.8_1:exon3:c.201_202insGG:p.A68Gfs*78,KIR2DL4:ENST00000396293.5_1:exon3:c.201_202insGG:p.A68Gfs*61,KIR2DL4:ENST00000345540.9_1:exon4:c.486_487insGG:p.A163Gfs*78,KIR2DL4:ENST00000357494.8_1:exon4:c.486_487insGG:p.A163Gfs*61,KIR2DL4:ENST00000359085.8_1:exon4:c.486_487insGG:p.A163Gfs*83,KIR2DL4:ENST00000396284.6_1:exon4:c.603_604insGG:p.A202Gfs*83","KIR2DL4:ENST00000345540.5:c.487_488insGG:p.(Ala163Glyfs*78)","1","","","","0.0","1.0","0.0162333652752468","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1111","0/1","Het","204","179,25","0.877450980392157","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55320306","55320307","GG>-","","KIR2DL4","exonic","frameshift deletion","","KIR2DL4:NM_001080770:exon5:c.674_675del:p.W225Sfs*5,KIR2DL4:NM_001080772:exon5:c.674_675del:p.W225Sfs*5","KIR2DL4","exonic","frameshift deletion","","KIR2DL4:ENST00000346587.8_1:exon4:c.389_390del:p.W130Sfs*5,KIR2DL4:ENST00000345540.9_1:exon5:c.674_675del:p.W225Sfs*5,KIR2DL4:ENST00000359085.8_1:exon5:c.674_675del:p.W225Sfs*5,KIR2DL4:ENST00000396284.6_1:exon5:c.791_792del:p.W264Sfs*5","KIR2DL4:ENST00000345540.5:c.674_675del:p.(Trp225Serfs*5)","1","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1112","0/1","Het","117","105,12","0.897435897435897","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55320308","55320308","->AT","","KIR2DL4","exonic","frameshift insertion","","KIR2DL4:NM_001080770:exon5:c.676_677insAT:p.P226Hfs*15,KIR2DL4:NM_001080772:exon5:c.676_677insAT:p.P226Hfs*20","KIR2DL4","exonic","frameshift insertion","","KIR2DL4:ENST00000346587.8_1:exon4:c.391_392insAT:p.P131Hfs*15,KIR2DL4:ENST00000345540.9_1:exon5:c.676_677insAT:p.P226Hfs*15,KIR2DL4:ENST00000359085.8_1:exon5:c.676_677insAT:p.P226Hfs*20,KIR2DL4:ENST00000396284.6_1:exon5:c.793_794insAT:p.P265Hfs*20","KIR2DL4:ENST00000345540.5:c.676_677insAT:p.(Pro226Hisfs*15)","1","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1113","0/1","Het","118","106,12","0.898305084745763","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55324674","55324674","->A","","KIR2DL4","exonic","frameshift insertion","","KIR2DL4:NM_001080772:exon6:c.802dupA:p.M271Nfs*108","KIR2DL4","exonic","frameshift insertion","","KIR2DL4:ENST00000359085.8_1:exon6:c.802dupA:p.M271Nfs*108,KIR2DL4:ENST00000396284.6_1:exon6:c.919dupA:p.D310Rfs*21","KIR2DL4:ENST00000359085.4:c.811dup:p.(Met271Asnfs*108)","1","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1114","1/1","Hom","110","7,103","0.0636363636363636","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","55317489","55317489","C>A","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon4:c.C445A:p.Q149K,KIR2DL4:NM_001080772:exon4:c.C445A:p.Q149K","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon3:c.C160A:p.Q54K,KIR2DL4:ENST00000396293.5_1:exon3:c.C160A:p.Q54K,KIR2DL4:ENST00000345540.9_1:exon4:c.C445A:p.Q149K,KIR2DL4:ENST00000357494.8_1:exon4:c.C445A:p.Q149K,KIR2DL4:ENST00000359085.8_1:exon4:c.C445A:p.Q149K,KIR2DL4:ENST00000396284.6_1:exon4:c.C562A:p.Q188K","KIR2DL4:ENST00000345540.5:c.445C>A:p.(Gln149Lys)","0.985","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1115","0/1","Het","189","158,31","0.835978835978836","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","","","","","","","","","","D","0.015","T","0.466","B","0.028","B","0.019","U","0.219","N","1","L","1.17","T","2.69","N","-0.65","0.106","T","-1.014","T","0.041","T","6.01E-4","0.027","T","0.078","0.006","-0.867","1.04","-1.932","4.213"
"chr19","55317412","55317412","A>T","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon4:c.A368T:p.Y123F,KIR2DL4:NM_001080772:exon4:c.A368T:p.Y123F","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon3:c.A83T:p.Y28F,KIR2DL4:ENST00000396293.5_1:exon3:c.A83T:p.Y28F,KIR2DL4:ENST00000345540.9_1:exon4:c.A368T:p.Y123F,KIR2DL4:ENST00000357494.8_1:exon4:c.A368T:p.Y123F,KIR2DL4:ENST00000359085.8_1:exon4:c.A368T:p.Y123F,KIR2DL4:ENST00000396284.6_1:exon4:c.A485T:p.Y162F","KIR2DL4:ENST00000345540.5:c.368A>T:p.(Tyr123Phe)","0.917","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1116","0/1","Het","103","90,13","0.87378640776699","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.;.;.;.;.","","","","","","","","","","","","T","0.083","T","0.185","B","0.029","B","0.11","","","N","1","L","1.79","T","5.76","D","-2.94","0.143","T","-0.946","T","0.005","T","4.12E-4","0.026","T","0.040","7.719","0.340","1.05","-0.279","3.728"
"chr19","55317541","55317541","T>C","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon4:c.T497C:p.L166P,KIR2DL4:NM_001080772:exon4:c.T497C:p.L166P","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon3:c.T212C:p.L71P,KIR2DL4:ENST00000396293.5_1:exon3:c.T212C:p.L71P,KIR2DL4:ENST00000345540.9_1:exon4:c.T497C:p.L166P,KIR2DL4:ENST00000357494.8_1:exon4:c.T497C:p.L166P,KIR2DL4:ENST00000359085.8_1:exon4:c.T497C:p.L166P,KIR2DL4:ENST00000396284.6_1:exon4:c.T614C:p.L205P","KIR2DL4:ENST00000345540.5:c.497T>C:p.(Leu166Pro)","0.887","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1117","0/1","Het","208","184,24","0.884615384615385","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","","","","","","","","","","T","0.176","T","0.247","B","0.008","B","0.01","","","N","1","L","0.96","T","5.72","D","-3.32","0.048","T","-0.892","T","0.002","T","0.001","0.084","T","0.069","0.041","-0.604","0.728","-4.522","0.244"
"chr19","55317415","55317415","A>G","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon4:c.A371G:p.E124G,KIR2DL4:NM_001080772:exon4:c.A371G:p.E124G","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon3:c.A86G:p.E29G,KIR2DL4:ENST00000396293.5_1:exon3:c.A86G:p.E29G,KIR2DL4:ENST00000345540.9_1:exon4:c.A371G:p.E124G,KIR2DL4:ENST00000357494.8_1:exon4:c.A371G:p.E124G,KIR2DL4:ENST00000359085.8_1:exon4:c.A371G:p.E124G,KIR2DL4:ENST00000396284.6_1:exon4:c.A488G:p.E163G","KIR2DL4:ENST00000345540.5:c.371A>G:p.(Glu124Gly)","0.878","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1118","0/1","Het","104","91,13","0.875","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.;.;.;.;.","","","","","","","","","","","","T","0.122","T","0.119","B","0.007","B","0.002","","","N","1","N","-0.045","T","2.62","D","-3.74","0.211","T","-0.937","T","0.002","T","7.65E-4","0.010","T","0.037","8.624","0.421","1.05","-0.492","4.324"
"chr19","55320293","55320293","C>T","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon5:c.C661T:p.P221S,KIR2DL4:NM_001080772:exon5:c.C661T:p.P221S","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon4:c.C376T:p.P126S,KIR2DL4:ENST00000345540.9_1:exon5:c.C661T:p.P221S,KIR2DL4:ENST00000359085.8_1:exon5:c.C661T:p.P221S,KIR2DL4:ENST00000396284.6_1:exon5:c.C778T:p.P260S","KIR2DL4:ENST00000345540.5:c.661C>T:p.(Pro221Ser)","0.82","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1119","0/1","Het","112","101,11","0.901785714285714","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.;.;.","","","","","","","","","","","","T","0.277","T","0.279","B","0.006","B","0.003","U","0.046","N","1","N","0.045","T","7.05","N","-2.36","0.061","T","-0.925","T","0.001","T","6.22E-4","0.018","T","0.114","0.033","-0.634","0.852","-0.587","2.159"
"chr19","55317429","55317429","A>T","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon4:c.A385T:p.T129S,KIR2DL4:NM_001080772:exon4:c.A385T:p.T129S","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon3:c.A100T:p.T34S,KIR2DL4:ENST00000396293.5_1:exon3:c.A100T:p.T34S,KIR2DL4:ENST00000345540.9_1:exon4:c.A385T:p.T129S,KIR2DL4:ENST00000357494.8_1:exon4:c.A385T:p.T129S,KIR2DL4:ENST00000359085.8_1:exon4:c.A385T:p.T129S,KIR2DL4:ENST00000396284.6_1:exon4:c.A502T:p.T168S","KIR2DL4:ENST00000345540.5:c.385A>T:p.(Thr129Ser)","0.6","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1122","0/1","Het","121","104,17","0.859504132231405","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.;.;.;.;.","","","0.00001991","","","0.0001","0.","","","1.991e-05","0","T","1.0","T","1.0","B","0.0","B","0.0","N","0.001","N","1","N","-3.165","T","2.73","N","1.22","0.056","T","-0.875","T","0.006","T","0.004","0.102","T","0.075","0.003","-0.976","1.05","0.292","3.134"
"chr19","55317506","55317506","C>G","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon4:c.C462G:p.I154M,KIR2DL4:NM_001080772:exon4:c.C462G:p.I154M","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon3:c.C177G:p.I59M,KIR2DL4:ENST00000396293.5_1:exon3:c.C177G:p.I59M,KIR2DL4:ENST00000345540.9_1:exon4:c.C462G:p.I154M,KIR2DL4:ENST00000357494.8_1:exon4:c.C462G:p.I154M,KIR2DL4:ENST00000359085.8_1:exon4:c.C462G:p.I154M,KIR2DL4:ENST00000396284.6_1:exon4:c.C579G:p.I193M","KIR2DL4:ENST00000345540.5:c.462C>G:p.(Ile154Met)","0.06","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1123","0/1","Het","198","169,29","0.853535353535353","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","","","","","","","","","","T","1.0","T","0.265","B","0.001","B","0.005","N","0.022","N","1","N","-1.185","T","2.71","N","0.58","0.052","T","-0.951","T","0.016","T","5.43E-4","0.009","T","0.049","0.001","-2.502","1.05","-1.305","4.6"
"chr19","55317490","55317490","A>G","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon4:c.A446G:p.Q149R,KIR2DL4:NM_001080772:exon4:c.A446G:p.Q149R","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon3:c.A161G:p.Q54R,KIR2DL4:ENST00000396293.5_1:exon3:c.A161G:p.Q54R,KIR2DL4:ENST00000345540.9_1:exon4:c.A446G:p.Q149R,KIR2DL4:ENST00000357494.8_1:exon4:c.A446G:p.Q149R,KIR2DL4:ENST00000359085.8_1:exon4:c.A446G:p.Q149R,KIR2DL4:ENST00000396284.6_1:exon4:c.A563G:p.Q188R","KIR2DL4:ENST00000345540.5:c.446A>G:p.(Gln149Arg)","0.02","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1124","0/1","Het","189","158,31","0.835978835978836","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","0","","","0.","0.","","","0","0","T","1.0","T","0.716","B","0.0","B","0.002","N","0.219","N","1","N","-0.41","T","2.67","N","0.01","0.051","T","-0.982","T","0.015","T","6.98E-4","0.005","T","0.036","0.012","-0.760","1.05","-0.066","6.415"
"chr19","55320330","55320330","T>C","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon5:c.T698C:p.F233S,KIR2DL4:NM_001080772:exon5:c.T698C:p.F233S","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon4:c.T413C:p.F138S,KIR2DL4:ENST00000345540.9_1:exon5:c.T698C:p.F233S,KIR2DL4:ENST00000359085.8_1:exon5:c.T698C:p.F233S,KIR2DL4:ENST00000396284.6_1:exon5:c.T815C:p.F272S","KIR2DL4:ENST00000345540.5:c.698T>C:p.(Phe233Ser)","0.002","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1125","0/1","Het","127","114,13","0.897637795275591","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.;.;.","","","","","","","","","","","","T","1.0","T","0.506","B","0.0","B","0.002","U","0.491","N","1","N","-1.515","T","7.25","N","2.25","0.14","T","-0.982","T","0.000","T","4.48E-4","0.009","T","0.066","1.383","-0.103","0.852","-2.798","3.991"
"chr19","55317564","55317564","A>G","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon4:c.A520G:p.I174V,KIR2DL4:NM_001080772:exon4:c.A520G:p.I174V","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon3:c.A235G:p.I79V,KIR2DL4:ENST00000396293.5_1:exon3:c.A235G:p.I79V,KIR2DL4:ENST00000345540.9_1:exon4:c.A520G:p.I174V,KIR2DL4:ENST00000357494.8_1:exon4:c.A520G:p.I174V,KIR2DL4:ENST00000359085.8_1:exon4:c.A520G:p.I174V,KIR2DL4:ENST00000396284.6_1:exon4:c.A637G:p.I213V","KIR2DL4:ENST00000345540.5:c.520A>G:p.(Ile174Val)","0.001","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1126","0/1","Het","224","196,28","0.875","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","0","","","","","","","0","0","T","1.0","T","0.716","B","0.0","B","0.0","N","0.000","N","1","N","-1.765","T","2.72","N","0.4","0.064","T","-0.970","T","0.008","T","0.002","0.047","T","0.059","0.002","-1.133","0.427","-0.997",""
"chr19","55317436","55317436","G>A","","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:NM_001080770:exon4:c.G392A:p.R131Q,KIR2DL4:NM_001080772:exon4:c.G392A:p.R131Q","KIR2DL4","exonic","nonsynonymous SNV","","KIR2DL4:ENST00000346587.8_1:exon3:c.G107A:p.R36Q,KIR2DL4:ENST00000396293.5_1:exon3:c.G107A:p.R36Q,KIR2DL4:ENST00000345540.9_1:exon4:c.G392A:p.R131Q,KIR2DL4:ENST00000357494.8_1:exon4:c.G392A:p.R131Q,KIR2DL4:ENST00000359085.8_1:exon4:c.G392A:p.R131Q,KIR2DL4:ENST00000396284.6_1:exon4:c.G509A:p.R170Q","KIR2DL4:ENST00000345540.5:c.392G>A:p.(Arg131Gln)","0.0009916899","","","","","","","","","","","","","","","","ENSG00000189013","KIR2DL4","HGNC:6332","KIR2DL4","3805","ENSG00000189013","uc002qhg.5","0.016233365275246874","","1.0","","1127","0/1","Het","134","113,21","0.843283582089552","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternate alleles of this gene are represented on multiple alternate reference loci (ALT_REF_LOCs). Alternative splicing results in multiple transcript variants, some of which may not be annotated on the primary reference assembly. [provided by RefSeq, Jul 2016]","killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4","positive regulation of natural killer cell cytokine production(GO:0002729)|cellular defense response(GO:0006968)|signal transduction(GO:0007165)|negative regulation of natural killer cell mediated cytotoxicity(GO:0045953)|positive regulation of cellular senescence(GO:2000774)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|membrane(GO:0016020)|early endosome membrane(GO:0031901)","transmembrane signaling receptor activity(GO:0004888)|protein binding(GO:0005515)|MHC class Ib receptor activity(GO:0032394)","pre-eclampsia(DOID:10591)|acute myeloid leukemia(DOID:9119)|disease(DOID:4)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","","Immunoglobulin|Immunoglobulin","","","0.0003","","","0.0003","0.","","","0.0001","0","T","1.0","T","1.0","B","0.0","B","0.0","N","0.465","N","1","N","-2.565","T","2.75","N","2.25","0.04","T","-0.952","T","0.004","T","9.42E-4","0.013","T","0.050","0.015","-0.733","1.05","-1.595","1.446"
"chr6","32487158","32487158","->CA","","HLA-DRB5","exonic","frameshift insertion","","HLA-DRB5:NM_002125:exon3:c.640_641insTG:p.T214Mfs*17","HLA-DRB5","exonic","frameshift insertion","","HLA-DRB5:ENST00000374975.4_1:exon3:c.640_641insTG:p.T214Mfs*17","HLA-DRB5:ENST00000374975.3:c.640_641insTG:p.(Thr214Metfs*17)","1","0.0","1.0","0.0162333652752468","0.0","0.715499997138977","0.0012085629556541","","","","","","","","","","ENSG00000198502","HLA-DRB5","HGNC:4953","HLA-DRB5","3127","ENSG00000198502","uc003obj.4","0.016233365275246874","","1.0","","1145","0/1","Het","59","50,9","0.847457627118644","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","HLA-DRB5 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells. The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. There are multiple pseudogenes of this gene. [provided by RefSeq, Feb 2020]","major histocompatibility complex, class II, DR beta 5","adaptive immune response(GO:0002250)|immunoglobulin production involved in immunoglobulin-mediated immune response(GO:0002381)|peptide antigen assembly with MHC class II protein complex(GO:0002503)|antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886)|positive regulation of T cell activation(GO:0050870)","Golgi membrane(GO:0000139)|lysosomal membrane(GO:0005765)|lysosomal membrane(GO:0005765)|lysosomal membrane(GO:0005765)|plasma membrane(GO:0005886)|ER to Golgi transport vesicle membrane(GO:0012507)|transport vesicle membrane(GO:0030658)|endocytic vesicle membrane(GO:0030666)|clathrin-coated endocytic vesicle membrane(GO:0030669)|late endosome membrane(GO:0031902)|late endosome membrane(GO:0031902)|trans-Golgi network membrane(GO:0032588)|MHC class II protein complex(GO:0042613)|MHC class II protein complex(GO:0042613)|extracellular exosome(GO:0070062)|integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556)","MHC class II protein complex binding(GO:0023026)|peptide antigen binding(GO:0042605)","cancer(DOID:162)|multiple sclerosis(DOID:2377)|liver disease(DOID:409)","Systemic lupus erythematosus|Cell adhesion molecules cams|Antigen processing and presentation|Hematopoietic cell lineage|Intestinal immune network for iga production|Type i diabetes mellitus|Leishmania infection|Asthma|Autoimmune thyroid disease|Allograft rejection|Graft versus host disease|Viral myocarditis","Wp allograft rejection|Wp ebola virus pathway on host|Wp pathogenesis of sarscov2 mediated by nsp9nsp10 complex","Cytokine signaling in immune system|Adaptive immune system|Tcr signaling|Generation of second messenger molecules|Mhc class ii antigen presentation|Costimulation by the cd28 family|Pd 1 signaling|Interferon gamma signaling|Interferon signaling","Blymphocyte pathway|Mhc pathway|Bbcell pathway|Eosinophils pathway|Csk pathway|Asbcell pathway|Inflam pathway|Il5 pathway|Tcra pathway|Th1th2 pathway|Ctla4 pathway","","gnomad>TRUE;SpliceAI>GCA|HLA-DRB5|0.00|0.00|0.00|0.02|-3|17|47|-11","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr1","89480231","89480231","->GG","","GBP3","exonic","frameshift insertion","","GBP3:NM_018284:exon4:c.426_427insCC:p.Y143Pfs*4","GBP3","exonic","frameshift insertion","","GBP3:ENST00000370481.9_1:exon4:c.426_427insCC:p.Y143Pfs*4","GBP3:ENST00000370481.4:c.426_427insCC:p.(Tyr143Profs*4)","1","0.0","1.0","0.0162333652752468","0.0","0.9000000059604645","0.0065436114269313","","","","","","","","","","ENSG00000117226","GBP3","HGNC:4184","GBP3","2635","ENSG00000117226","uc001dmt.4","0.016233365275246874","","1.0","","1178","0/1","Het","132","66,66","0.5","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a member of the guanylate-binding protein (GBP) family. GBPs specifically bind guanine nucleotides (GMP, GDP, and GTP) and contain two of the three consensus motifs found in typical GTP-binding proteins. The encoded protein interacts with a member of the germinal center kinase family. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2017]","guanylate binding protein 3","defense response to virus(GO:0051607)|cellular response to interferon-gamma(GO:0071346)|cellular response to interleukin-1(GO:0071347)|cellular response to tumor necrosis factor(GO:0071356)","Golgi membrane(GO:0000139)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytoplasmic vesicle(GO:0031410)|perinuclear region of cytoplasm(GO:0048471)","GTPase activity(GO:0003924)|protein binding(GO:0005515)|GTP binding(GO:0005525)|identical protein binding(GO:0042802)|protein homodimerization activity(GO:0042803)","","","","Cytokine signaling in immune system|Interferon gamma signaling|Interferon signaling","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75713659","75713660","AG>-","","FRG2C","exonic","frameshift deletion","","FRG2C:NM_001124759:exon1:c.129_130del:p.G44Qfs*9","FRG2C","exonic","frameshift deletion","","FRG2C:ENST00000308062.8_1:exon1:c.129_130del:p.G44Qfs*9,FRG2C:ENST00000464571.1_1:exon1:c.129_130del:p.G44Qfs*9","FRG2C:ENST00000308062.3:c.129_130del:p.(Gly44Glnfs*9)","1","0.0","1.0","0.0162333652752468","0.0","1.0","0.0162333652752468","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1180","0/1","Het","387","355,32","0.917312661498708","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75714806","75714806","G>-","","FRG2C","exonic","frameshift deletion","","FRG2C:NM_001124759:exon4:c.463delG:p.R156Afs*10","FRG2C","exonic","frameshift deletion","","FRG2C:ENST00000308062.8_1:exon4:c.463delG:p.R156Afs*10,FRG2C:ENST00000464571.1_1:exon4:c.460delG:p.R155Afs*10","FRG2C:ENST00000308062.3:c.465del:p.(Gly155Glyfs*11)","1","","","","0.0","1.0","0.0162333652752468","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1181","0/1","Het","461","358,103","0.776572668112798","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75714825","75714825","G>-","","FRG2C","exonic","frameshift deletion","","FRG2C:NM_001124759:exon4:c.482delG:p.R161Sfs*5","FRG2C","exonic","frameshift deletion","","FRG2C:ENST00000308062.8_1:exon4:c.482delG:p.R161Sfs*5,FRG2C:ENST00000464571.1_1:exon4:c.479delG:p.R160Sfs*5","FRG2C:ENST00000308062.3:c.483del:p.(Arg161Serfs*5)","1","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1182","0/1","Het","470","417,53","0.887234042553191","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","75715124","75715124","C>T","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.C781T:p.P261S","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.C781T:p.P261S,FRG2C:ENST00000464571.1_1:exon4:c.C778T:p.P260S","FRG2C:ENST00000308062.3:c.781C>T:p.(Pro261Ser)","1","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1183","0/1","Het","485","324,161","0.668041237113402","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.0","T","0.434","D","0.996","D","0.986","U","0.224","P","1","N","0.55","T","0.51","N","-2.21","0.021","T","-0.814","T","0.199","D","0.670","0.088","D","0.524","15.07","1.278","0.665","-0.243",""
"chr3","75715181","75715181","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.G838A:p.G280R","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.G838A:p.G280R,FRG2C:ENST00000464571.1_1:exon4:c.G835A:p.G279R","FRG2C:ENST00000308062.3:c.838G>A:p.(Gly280Arg)","1","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1184","0/1","Het","388","287,101","0.739690721649485","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.0","D","0.0","D","0.997","D","0.979","","","N","1","N","0","T","1.21","N","-1.06","0.083","T","-1.025","T","0.083","D","0.953","0.121","T","0.234","16.44","1.531","0.339","-0.755",""
"chr3","75714807","75714807","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.G464A:p.G155E","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.G464A:p.G155E,FRG2C:ENST00000464571.1_1:exon4:c.G461A:p.G154E","FRG2C:ENST00000308062.3:c.464G>A:p.(Gly155Glu)","0.998","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1185","0/1","Het","464","361,103","0.77801724137931","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.003","D","0.0","D","1.0","D","0.998","N","0.351","N","1","L","1.1","T","-0.5","N","-2.08","0.044","T","-0.694","T","0.363","D","0.887","0.199","T","0.476","16.76","1.585","","-0.271",""
"chr3","75713561","75713561","C>T","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon1:c.C31T:p.H11Y","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon1:c.C31T:p.H11Y,FRG2C:ENST00000464571.1_1:exon1:c.C31T:p.H11Y","FRG2C:ENST00000308062.3:c.31C>T:p.(His11Tyr)","0.995949","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1186","0/1","Het","234","210,24","0.897435897435897","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.004","D","0.015","P","0.908","P","0.888","U","0.087","N","1","L","0.895","T","0.89","D","-3.24","0.19","T","-0.998","T","0.136","D","0.347","0.086","D","0.558","8.955","0.454","0.517","0.855",""
"chr3","75713563","75713563","C>G","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon1:c.C33G:p.H11Q","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon1:c.C33G:p.H11Q,FRG2C:ENST00000464571.1_1:exon1:c.C33G:p.H11Q","FRG2C:ENST00000308062.3:c.33C>G:p.(His11Gln)","0.993","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1187","0/1","Het","236","211,25","0.894067796610169","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.007","D","0.022","D","0.96","D","0.944","N","0.087","N","1","L","0.895","T","0.89","D","-3.62","0.181","T","-0.992","T","0.141","D","0.374","0.108","D","0.534","8.142","0.377","0.517","0.855",""
"chr3","75715173","75715173","C>T","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.C830T:p.A277V","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.C830T:p.A277V,FRG2C:ENST00000464571.1_1:exon4:c.C827T:p.A276V","FRG2C:ENST00000308062.3:c.830C>T:p.(Ala277Val)","0.993","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1188","0/1","Het","406","302,104","0.74384236453202","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.007","D","0.0","D","0.996","D","0.971","","","N","1","N","0.345","T","1.19","N","-1.63","0.065","T","-1.024","T","0.098","D","0.811","0.083","T","0.432","14.44","1.163","0.388","-0.113",""
"chr3","75713654","75713654","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon1:c.G124A:p.G42R","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon1:c.G124A:p.G42R,FRG2C:ENST00000464571.1_1:exon1:c.G124A:p.G42R","FRG2C:ENST00000308062.3:c.124G>A:p.(Gly42Arg)","0.99","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1189","0/1","Het","380","292,88","0.768421052631579","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.01","T","0.175","B","0.133","B","0.101","","","P","1","L","0.805","T","1.51","D","-4.09","0.163","T","-1.016","T","0.044","D","0.620","0.029","T","0.132","9.267","0.486","0.775","0.021","4.875"
"chr3","75714950","75714950","C>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.C607A:p.L203M","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.C607A:p.L203M,FRG2C:ENST00000464571.1_1:exon4:c.C604A:p.L202M","FRG2C:ENST00000308062.3:c.607C>A:p.(Leu203Met)","0.986","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1190","0/1","Het","514","433,81","0.842412451361868","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.016","T","0.083","D","0.997","D","0.986","N","0.098","P","1","L","0.975","T","0.35","N","-1.32","0.166","T","-0.585","T","0.204","D","0.513","0.110","D","0.662","16.52","1.544","0.673","0.875",""
"chr3","75713555","75713555","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon1:c.G25A:p.D9N","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon1:c.G25A:p.D9N,FRG2C:ENST00000464571.1_1:exon1:c.G25A:p.D9N","FRG2C:ENST00000308062.3:c.25G>A:p.(Asp9Asn)","0.982","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1191","0/1","Het","212","173,39","0.816037735849057","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.05","T","0.185","D","0.999","D","0.982","U","0.941","P","1","L","0.805","T","1.26","N","-1.62","0.157","T","-0.951","T","0.109","D","0.259","0.097","T","0.162","12.19","0.831","0.517","1.013",""
"chr3","75714345","75714345","G>T","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon3:c.G325T:p.D109Y","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon3:c.G325T:p.D109Y,FRG2C:ENST00000464571.1_1:exon3:c.G322T:p.D108Y","FRG2C:ENST00000308062.3:c.325G>T:p.(Asp109Tyr)","0.979","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1192","0/1","Het","270","175,95","0.648148148148148","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.021","D","0.008","B","0.226","B","0.246","","","P","1","L","1.04","T","0.78","D","-3.46","0.325","T","-0.935","T","0.091","D","0.706","0.067","T","0.412","13.99","1.086","0.517","1.013",""
"chr3","75714819","75714819","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.G476A:p.R159Q","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.G476A:p.R159Q,FRG2C:ENST00000464571.1_1:exon4:c.G473A:p.R158Q","FRG2C:ENST00000308062.3:c.476G>A:p.(Arg159Gln)","0.964","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1193","0/1","Het","465","413,52","0.888172043010753","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.036","T","0.246","B","0.001","B","0.001","N","0.304","N","1","N","0.695","T","0.51","N","-0.92","0.033","T","-0.984","T","0.096","D","0.565","0.067","T","0.060","11.07","0.690","0.673","-2.562",""
"chr3","75714917","75714917","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.G574A:p.A192T","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.G574A:p.A192T,FRG2C:ENST00000464571.1_1:exon4:c.G571A:p.A191T","FRG2C:ENST00000308062.3:c.574G>A:p.(Ala192Thr)","0.959","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1194","0/1","Het","516","453,63","0.877906976744186","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","D","0.041","T","0.09","B","0.001","B","0.002","N","0.990","P","1","L","0.975","T","0.7","N","-1.29","0.088","T","-0.978","T","0.082","D","0.311","0.031","T","0.065","9.255","0.484","0.397","0.062",""
"chr3","75714771","75714771","A>G","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.A428G:p.D143G","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.A428G:p.D143G,FRG2C:ENST00000464571.1_1:exon4:c.A425G:p.D142G","FRG2C:ENST00000308062.3:c.428A>G:p.(Asp143Gly)","0.943","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1195","0/1","Het","376","337,39","0.896276595744681","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.08","T","0.42","D","0.99","D","0.943","N","0.025","N","1","L","0.895","T","0.88","D","-2.56","0.091","T","-0.931","T","0.139","D","0.281","0.165","T","0.420","14.45","1.163","0.517","-0.461",""
"chr3","75714929","75714929","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.G586A:p.A196T","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.G586A:p.A196T,FRG2C:ENST00000464571.1_1:exon4:c.G583A:p.A195T","FRG2C:ENST00000308062.3:c.586G>A:p.(Ala196Thr)","0.94200003","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1196","0/1","Het","518","446,72","0.861003861003861","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.058","T","0.203","D","0.99","P","0.905","N","0.731","P","1","L","0.805","T","0.74","N","-1.72","0.075","T","-0.867","T","0.144","D","0.351","0.027","T","0.185","10.54","0.627","0.397","-0.014",""
"chr3","75714809","75714809","C>T","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.C466T:p.R156C","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.C466T:p.R156C,FRG2C:ENST00000464571.1_1:exon4:c.C463T:p.R155C","FRG2C:ENST00000308062.3:c.466C>T:p.(Arg156Cys)","0.939","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1197","0/1","Het","453","406,47","0.896247240618102","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.061","D","0.008","B","0.0","B","0.001","N","0.054","N","1","L","0.805","T","0.67","N","-1.75","0.068","T","-0.996","T","0.093","D","0.813","0.052","T","0.139","12.53","0.875","0.616","0.850",""
"chr3","75713618","75713618","A>T","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon1:c.A88T:p.T30S","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon1:c.A88T:p.T30S,FRG2C:ENST00000464571.1_1:exon1:c.A88T:p.T30S","FRG2C:ENST00000308062.3:c.88A>T:p.(Thr30Ser)","0.889","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1198","0/1","Het","358","297,61","0.829608938547486","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.111","T","0.444","B","0.0","B","0.001","","","N","1","N","0.55","T","1.49","N","-0.84","0.071","T","-1.033","T","0.034","D","0.525","0.064","T","0.075","0.001","-1.260","0.775","-0.696","1.423"
"chr3","75714825","75714825","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.G482A:p.R161K","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.G482A:p.R161K,FRG2C:ENST00000464571.1_1:exon4:c.G479A:p.R160K","FRG2C:ENST00000308062.3:c.482G>A:p.(Arg161Lys)","0.833","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1199","0/1","Het","469","375,94","0.799573560767591","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.167","T","0.563","B","0.013","B","0.015","N","0.021","P","1","L","0.975","T","0.76","N","-1.21","0.063","T","-1.048","T","0.091","D","0.391","0.070","D","0.708","9.531","0.514","0.673","1.034",""
"chr3","75714831","75714831","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.G488A:p.R163Q","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.G488A:p.R163Q,FRG2C:ENST00000464571.1_1:exon4:c.G485A:p.R162Q","FRG2C:ENST00000308062.3:c.488G>A:p.(Arg163Gln)","0.815","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1200","0/1","Het","476","416,60","0.873949579831933","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.185","T","0.211","B","0.001","B","0.001","N","0.083","N","1","L","1.04","T","0.7","N","-0.5","0.082","T","-1.028","T","0.094","D","0.412","0.048","T","0.178","11.10","0.695","0.673","1.034",""
"chr3","75714843","75714843","T>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.T500A:p.V167D","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.T500A:p.V167D,FRG2C:ENST00000464571.1_1:exon4:c.T497A:p.V166D","FRG2C:ENST00000308062.3:c.500T>A:p.(Val167Asp)","0.758","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1202","0/1","Het","488","403,85","0.825819672131147","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.242","T","0.347","B","0.106","B","0.181","N","0.226","N","1","N","0","T","1.05","N","0.29","0.104","T","-1.079","T","0.058","D","0.447","0.052","T","0.261","0.001","-1.342","0.673","-0.232",""
"chr3","75713669","75713669","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon1:c.G139A:p.A47T","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon1:c.G139A:p.A47T,FRG2C:ENST00000464571.1_1:exon1:c.G139A:p.A47T","FRG2C:ENST00000308062.3:c.139G>A:p.(Ala47Thr)","0.652","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1203","0/1","Het","383","293,90","0.765013054830287","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.348","T","0.407","B","0.014","B","0.003","","","P","1","N","0.345","T","1.45","N","-0.7","0.061","T","-1.019","T","0.028","D","0.507","0.023","T","0.058","0.004","-0.929","0.517","-1.105",""
"chr3","75714337","75714337","T>G","FRG2C:100288801","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon3:c.T317G:p.I106S","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon3:c.T317G:p.I106S,FRG2C:ENST00000464571.1_1:exon3:c.T314G:p.I105S","FRG2C:ENST00000308062.3:c.317T>G:p.(Ile106Ser)","0.6","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1204","0/1","Het","276","110,166","0.398550724637681","Benign","False","not_specified","MedGen:CN169374","NC_000003.11:g.75714337T>G","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","1.0","T","1.0","B","0.0","B","0.0","N","0.373","N","1","N","-0.975","T","1.56","N","3.81","0.102","T","-1.049","T","0.020","D","0.286","0.049","T","0.070","0.011","-0.769","0.517","-0.329",""
"chr3","75714702","75714702","A>G","FRG2C:100288801","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.A359G:p.N120S","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.A359G:p.N120S,FRG2C:ENST00000464571.1_1:exon4:c.A356G:p.N119S","FRG2C:ENST00000308062.3:c.359A>G:p.(Asn120Ser)","0.6","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1205","0/1","Het","214","98,116","0.457943925233645","Benign","False","not_specified","MedGen:CN169374","NC_000003.11:g.75714702A>G","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","1.0","T","1.0","B","0.0","B","0.0","","","N","1","N","-1.1","T","1.86","N","1.45","0.016","T","-1.032","T","0.013","D","0.498","0.016","T","0.083","0.001","-1.461","0.517","-0.760",""
"chr3","75714840","75714840","A>G","FRG2C:100288801","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.A497G:p.E166G","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.A497G:p.E166G,FRG2C:ENST00000464571.1_1:exon4:c.A494G:p.E165G","FRG2C:ENST00000308062.3:c.497A>G:p.(Glu166Gly)","0.6","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1206","0/1","Het","475","330,145","0.694736842105263","Benign","False","not_specified","MedGen:CN169374","NC_000003.11:g.75714840A>G","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","1.0","T","0.72","B","0.0","B","0.0","N","0.041","N","1","N","-0.625","T","0.96","N","0.47","0.016","T","-1.032","T","0.037","D","0.368","0.026","T","0.082","0.007","-0.833","0.673","-0.337",""
"chr3","75715118","75715118","G>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.G775A:p.A259T","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.G775A:p.A259T,FRG2C:ENST00000464571.1_1:exon4:c.G772A:p.A258T","FRG2C:ENST00000308062.3:c.775G>A:p.(Ala259Thr)","0.599","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1207","0/1","Het","488","324,164","0.663934426229508","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.401","T","0.242","B","0.0","B","0.0","U","0.121","P","1","N","0.345","T","1.29","N","-1.63","0.033","T","-1.036","T","0.060","D","0.208","0.037","T","0.098","14.93","1.251","0.665","0.985",""
"chr3","75715099","75715099","T>A","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.T756A:p.D252E","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.T756A:p.D252E,FRG2C:ENST00000464571.1_1:exon4:c.T753A:p.D251E","FRG2C:ENST00000308062.3:c.756T>A:p.(Asp252Glu)","0.376","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1213","0/1","Het","484","398,86","0.822314049586777","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","0","","","0.","","","","","","T","0.624","T","1.0","B","0.0","B","0.001","N","0.048","N","1","N","0.345","T","1.76","N","-0.31","0.016","T","-1.016","T","0.024","D","0.359","0.034","T","0.072","8.662","0.425","0.665","-0.248",""
"chr3","75714298","75714298","A>G","FRG2C:100288801","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon3:c.A278G:p.Q93R","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon3:c.A278G:p.Q93R,FRG2C:ENST00000464571.1_1:exon3:c.A275G:p.Q92R","FRG2C:ENST00000308062.3:c.278A>G:p.(Gln93Arg)","0.112999976","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1231","0/1","Het","278","123,155","0.442446043165468","Benign","False","not_specified","MedGen:CN169374","NC_000003.11:g.75714298A>G","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.892","T","0.811","B","0.0","B","0.0","","","N","1","N","-0.205","T","1.03","N","-0.08","0.05","T","-1.008","T","0.039","D","0.515","0.085","T","0.035","0.002","-1.057","0.517","-1.308",""
"chr3","75714788","75714788","A>C","","FRG2C","exonic","nonsynonymous SNV","","FRG2C:NM_001124759:exon4:c.A445C:p.S149R","FRG2C","exonic","nonsynonymous SNV","","FRG2C:ENST00000308062.8_1:exon4:c.A445C:p.S149R,FRG2C:ENST00000464571.1_1:exon4:c.A442C:p.S148R","FRG2C:ENST00000308062.3:c.445A>C:p.(Ser149Arg)","0.008000016","","","","","","","","","","","","","","","","ENSG00000172969","FRG2C","HGNC:33626","FRG2C","100288801","ENSG00000172969","uc003dpt.6","0.016233365275246874","","1.0","","1239","0/1","Het","427","382,45","0.894613583138173","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","FSHD region gene 2 family member C","","nucleus(GO:0005634)","","","","","","","","",".;.","","","","","","","","","","","","T","0.999","T","0.853","B","0.0","B","0.0","N","0.079","P","1","N","-0.145","T","1.06","N","0.69","0.103","T","-1.062","T","0.034","D","0.271","0.057","T","0.030","0.005","-0.879","0.673","-0.362",""
"chr20","29612103","29612103","T>C","","FRG1DP;FRG1BP","ncRNA_exonic;splicing","","NR_003579:exon1:c.223+2T>C","","FAM242A;AL441988.1","intergenic","","dist=15151;dist=25059","","FRG1BP:ENST00000358464.4:c.-128+2T>C:p.(=)","0.9972702","","","","","","","","","","","","","","","","ENSG00000149531","FRG1BP","HGNC:15792","FRG1BP","284802","ENSG00000149531","","0.016233365275246874","","1.0","","1248","0/1","Het","210","154,56","0.733333333333333","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","","","","","","","","","","","","","","","0.0002","0.0002","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr1","41847872","41847872","->GCCCGCGCCGGGACGCCCGCCTACTTCGGCGGCTGCAAGGGCGGCGCCTACGGCGGGGGCGGGGGCTTCGGGCCGCCGGCGATGGGCGCTCTGCGCCGTCTGCCCATGCAGACCATCCAGGAGAACAAGCAGGCCAGCTTCGTGCCGGCCGCGGCGCCCTTCCGCCCTGGGGCGCTGCCCGCGCTGCTGCCGCCGCCGCC","","FOXO6","exonic","frameshift insertion","","FOXO6:NM_001291281:exon2:c.999_1000insGCCCGCGCCGGGACGCCCGCCTACTTCGGCGGCTGCAAGGGCGGCGCCTACGGCGGGGGCGGGGGCTTCGGGCCGCCGGCGATGGGCGCTCTGCGCCGTCTGCCCATGCAGACCATCCAGGAGAACAAGCAGGCCAGCTTCGTGCCGGCCGCGGCGCCCTTCCGCCCTGGGGCGCTGCCCGCGCTGCTGCCGCCGCCGCC:p.Q337Gfs*224","FOXO6","exonic","frameshift insertion","","FOXO6:ENST00000641094.1_1:exon2:c.999_1000insGCCCGCGCCGGGACGCCCGCCTACTTCGGCGGCTGCAAGGGCGGCGCCTACGGCGGGGGCGGGGGCTTCGGGCCGCCGGCGATGGGCGCTCTGCGCCGTCTGCCCATGCAGACCATCCAGGAGAACAAGCAGGCCAGCTTCGTGCCGGCCGCGGCGCCCTTCCGCCCTGGGGCGCTGCCCGCGCTGCTGCCGCCGCCGCC:p.P334Afs*109","FOXO6:ENST00000372591.1:c.1008_1009insGGGACGCCCGCCTACTTCGGCGGCTGCAAGGGCGGCGCCTACGGCGGGGGCGGGGGCTTCGGGCCGCCGGCGATGGGCGCTCTGCGCCGTCTGCCCATGCAGACCATCCAGGAGAACAAGCAGGCCAGCTTCGTGCCGGCCGCGGCGCCCTTCCGCCCTGGGGCGCTGCCCGCGCTGCTGCCGCCGCCGCCGCCCGCGCC:p.(Gln337Glyfs*224)","1","","","","0.0","1.0","0.0162333652752468","","","","","","","","","","ENSG00000204060","FOXO6","HGNC:24814","FOXO6","100132074","ENSG00000204060","uc057fid.1","0.016233365275246874","","1.0","","1279","1/1","Hom","10","3,7","0.3","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","forkhead box O6","regulation of transcription by RNA polymerase II(GO:0006357)|regulation of transcription by RNA polymerase II(GO:0006357)|memory(GO:0007613)|positive regulation of dendritic spine development(GO:0060999)","chromatin(GO:0000785)|nucleus(GO:0005634)|nucleus(GO:0005634)|cytoplasm(GO:0005737)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|protein binding(GO:0005515)","","","Wp overview of leukocyteintrinsic hippo pathway functions","Akt phosphorylates targets in the nucleus|Pi3k akt signaling in cancer|Diseases of signal transduction by growth factor receptors and second messengers|Constitutive signaling by akt1 e17k in cancer|Rna polymerase ii transcription|Intracellular signaling by second messengers|Foxo mediated transcription|Regulation of localization of foxo transcription factors|Foxo mediated transcription of oxidative stress metabolic and neuronal genes","","","","","Name=GC_rich","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr14","105413578","105413578","G>A","","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:NM_138420:exon7:c.C8210T:p.P2737L","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:ENST00000333244.6_1:exon7:c.C8210T:p.P2737L","AHNAK2:ENST00000333244.5:c.8210C>T:p.(Pro2737Leu)","1","0.0","1.0","0.0162333652752468","0.0","0.9847051799297332","0.0141361248342059","","","","","","","","","","ENSG00000185567","AHNAK2","HGNC:20125","AHNAK2","113146","ENSG00000185567","uc010axc.2","0.016233365275246874","","1.0","","1280","0/1","Het","59","27,32","0.457627118644068","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a large nucleoprotein. The encoded protein has a tripartite domain structure with a relatively short N-terminus and a long C-terminus, separated by a large body of repeats. The N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain is thought to function in the formation of stable homodimers. The encoded protein may play a role in calcium signaling by associating with calcium channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]","AHNAK nucleoprotein 2","regulation of RNA splicing(GO:0043484)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|T-tubule(GO:0030315)|sarcolemma(GO:0042383)","protein binding(GO:0005515)","","","","","","","","","","","","","","","","","","","","D","0.0","D","0.013","D","1.0","D","0.996","","","D","0.858","M","2.985","T","3.4","D","-5.74","0.193","T","-0.906","T","0.079","T","0.010","0.141","D","0.972","22.8","2.625","3.99","0.605","9.57"
"chr14","105410512","105410512","G>A","","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:NM_138420:exon7:c.C11276T:p.A3759V","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:ENST00000333244.6_1:exon7:c.C11276T:p.A3759V","AHNAK2:ENST00000333244.5:c.11276C>T:p.(Ala3759Val)","0.96941036","","","","0.0","0.9847051799297332","0.0141361248342059","","","","","","","","","","ENSG00000185567","AHNAK2","HGNC:20125","AHNAK2","113146","ENSG00000185567","uc010axc.2","0.016233365275246874","","1.0","","1281","0/1","Het","44","42,2","0.954545454545455","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a large nucleoprotein. The encoded protein has a tripartite domain structure with a relatively short N-terminus and a long C-terminus, separated by a large body of repeats. The N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain is thought to function in the formation of stable homodimers. The encoded protein may play a role in calcium signaling by associating with calcium channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]","AHNAK nucleoprotein 2","regulation of RNA splicing(GO:0043484)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|T-tubule(GO:0030315)|sarcolemma(GO:0042383)","protein binding(GO:0005515)","","","","","","","","","","","0.00002812","","","0.","0.","","","2.812e-05","0","D","0.028","T","0.063","B","0.012","B","0.01","U","0.300","N","1","N","0.205","T","5.83","D","-2.56","0.069","T","-0.904","T","0.003","T","0.025","0.037","T","0.059","7.079","0.290","4.13","-0.804","4.779"
"chr14","105410461","105410461","G>C","","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:NM_138420:exon7:c.C11327G:p.P3776R","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:ENST00000333244.6_1:exon7:c.C11327G:p.P3776R","AHNAK2:ENST00000333244.5:c.11327C>G:p.(Pro3776Arg)","0.96760786","","","","","","","","","","","","","","","","ENSG00000185567","AHNAK2","HGNC:20125","AHNAK2","113146","ENSG00000185567","uc010axc.2","0.016233365275246874","","1.0","","1282","0/1","Het","61","47,14","0.770491803278688","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a large nucleoprotein. The encoded protein has a tripartite domain structure with a relatively short N-terminus and a long C-terminus, separated by a large body of repeats. The N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain is thought to function in the formation of stable homodimers. The encoded protein may play a role in calcium signaling by associating with calcium channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]","AHNAK nucleoprotein 2","regulation of RNA splicing(GO:0043484)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|T-tubule(GO:0030315)|sarcolemma(GO:0042383)","protein binding(GO:0005515)","","","","","","","SpliceAI>C|AHNAK2|0.00|0.00|0.00|0.00|23|-19|-17|17","","","","0.0001","","","0.","0.0001","","","","","D","0.0","D","0.0","D","0.996","D","0.944","","","N","1","M","2.17","T","3.4","D","-6.53","0.205","T","-1.083","T","0.063","T","0.005","0.146","D","0.871","15.99","1.450","4.26","2.277","5.777"
"chr14","105410383","105410383","T>C","","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:NM_138420:exon7:c.A11405G:p.K3802R","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:ENST00000333244.6_1:exon7:c.A11405G:p.K3802R","AHNAK2:ENST00000333244.5:c.11405A>G:p.(Lys3802Arg)","0.953725","","","","","","","","","","","","","","","","ENSG00000185567","AHNAK2","HGNC:20125","AHNAK2","113146","ENSG00000185567","uc010axc.2","0.016233365275246874","","1.0","","1283","0/1","Het","52","35,17","0.673076923076923","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a large nucleoprotein. The encoded protein has a tripartite domain structure with a relatively short N-terminus and a long C-terminus, separated by a large body of repeats. The N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain is thought to function in the formation of stable homodimers. The encoded protein may play a role in calcium signaling by associating with calcium channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]","AHNAK nucleoprotein 2","regulation of RNA splicing(GO:0043484)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|T-tubule(GO:0030315)|sarcolemma(GO:0042383)","protein binding(GO:0005515)","","","","","","","SpliceAI>C|AHNAK2|0.00|0.00|0.00|0.00|6|-17|-50|20","","","","0.000004028","0.0018","","0.0022","0.011","","","4.028e-06","0","D","0.028","D","0.025","P","0.921","P","0.471","U","0.737","D","1","M","2.895","T","5.58","N","-2.34","0.108","T","-0.971","T","0.008","","","0.090","D","0.639","22.6","2.544","4.41","0.539","8.305"
"chr14","105419314","105419314","T>G","","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:NM_138420:exon7:c.A2474C:p.E825A","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:ENST00000333244.6_1:exon7:c.A2474C:p.E825A","AHNAK2:ENST00000333244.5:c.2474A>C:p.(Glu825Ala)","0.60623604","","","","","","","","","","","","","","","","ENSG00000185567","AHNAK2","HGNC:20125","AHNAK2","113146","ENSG00000185567","uc010axc.2","0.016233365275246874","","1.0","","1284","0/1","Het","74","56,18","0.756756756756757","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a large nucleoprotein. The encoded protein has a tripartite domain structure with a relatively short N-terminus and a long C-terminus, separated by a large body of repeats. The N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain is thought to function in the formation of stable homodimers. The encoded protein may play a role in calcium signaling by associating with calcium channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]","AHNAK nucleoprotein 2","regulation of RNA splicing(GO:0043484)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|T-tubule(GO:0030315)|sarcolemma(GO:0042383)","protein binding(GO:0005515)","","","","","","","SpliceAI>G|AHNAK2|0.00|0.00|0.00|0.00|-15|1|40|-1","","","","0.00005573","","","0.0006","0.0002","","","0.0004","5.573e-05","T","0.388","T","0.204","B","0.004","B","0.013","","","N","1","N","-0.55","T","5.52","N","-2.08","0.034","T","-0.909","T","0.003","T","0.004","0.011","T","0.010","9.057","0.464","3.46","0.943","3.509"
"chr14","105413040","105413040","T>C","","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:NM_138420:exon7:c.A8748G:p.I2916M","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:ENST00000333244.6_1:exon7:c.A8748G:p.I2916M","AHNAK2:ENST00000333244.5:c.8748A>G:p.(Ile2916Met)","0.32195944","","","","","","","","","","","","","","","","ENSG00000185567","AHNAK2","HGNC:20125","AHNAK2","113146","ENSG00000185567","uc010axc.2","0.016233365275246874","","1.0","","1285","0/1","Het","71","61,10","0.859154929577465","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a large nucleoprotein. The encoded protein has a tripartite domain structure with a relatively short N-terminus and a long C-terminus, separated by a large body of repeats. The N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain is thought to function in the formation of stable homodimers. The encoded protein may play a role in calcium signaling by associating with calcium channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]","AHNAK nucleoprotein 2","regulation of RNA splicing(GO:0043484)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|T-tubule(GO:0030315)|sarcolemma(GO:0042383)","protein binding(GO:0005515)","","","","","","","SpliceAI>C|AHNAK2|0.00|0.00|0.00|0.00|11|-2|-45|-3","","","","0.00007235","","","0.0003","0.0009","","","7.235e-05","0","D","0.007","D","0.004","B","0.003","B","0.006","","","N","1","N","0.255","T","5.11","N","-1.14","0.119","T","-0.911","T","0.004","T","0.005","0.017","T","0.008","0.744","-0.195","4.12","-1.636","1.290"
"chr14","105415607","105415607","C>G","","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:NM_138420:exon7:c.G6181C:p.V2061L","AHNAK2","exonic","nonsynonymous SNV","","AHNAK2:ENST00000333244.6_1:exon7:c.G6181C:p.V2061L","AHNAK2:ENST00000333244.5:c.6181G>C:p.(Val2061Leu)","0.07252464","","","","","","","","","","","","","","","","ENSG00000185567","AHNAK2","HGNC:20125","AHNAK2","113146","ENSG00000185567","uc010axc.2","0.016233365275246874","","1.0","","1286","0/1","Het","121","110,11","0.909090909090909","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a large nucleoprotein. The encoded protein has a tripartite domain structure with a relatively short N-terminus and a long C-terminus, separated by a large body of repeats. The N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain is thought to function in the formation of stable homodimers. The encoded protein may play a role in calcium signaling by associating with calcium channel proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]","AHNAK nucleoprotein 2","regulation of RNA splicing(GO:0043484)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|plasma membrane(GO:0005886)|T-tubule(GO:0030315)|sarcolemma(GO:0042383)","protein binding(GO:0005515)","","","","","","","SpliceAI>G|AHNAK2|0.00|0.00|0.00|0.00|-13|42|28|-38","","","","0.0036","0.0032","0.001","0.0036","","","","0.0002","0.0006","T","1.0","T","0.718","P","0.567","B","0.184","","","N","1","N","0.095","T","6.0","N","0.28","0.051","T","-0.921","T","0.001","","","0.022","T","0.020","0.001","-1.838","4.25","-3.079","2.922"
"chr4","190881969","190881969","G>A","","FRG1","exonic","nonsynonymous SNV","","FRG1:NM_004477:exon7:c.G604A:p.V202I","FRG1","exonic","nonsynonymous SNV","","FRG1:ENST00000226798.9_1:exon7:c.G604A:p.V202I","FRG1:ENST00000226798.4:c.604G>A:p.(Val202Ile)","0.999968","0.0","0.9999679923057556","0.016228671566118","0.0","0.9984862804412842","0.016012843702088","","","","","","","","","","ENSG00000109536","FRG1","HGNC:3954","FRG1","2483","ENSG00000109536","uc003izs.4","0.01622867156611803","","0.9999679923057556","ORPHA:269 Facioscapulohumeral dystrophy-autosomal_dominant","1288","0/1","Het","133","75,58","0.56390977443609","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Facioscapulohumeral muscular dystrophy 1(158900)","Elevated circulating creatine kinase concentration(HP:0003236)|Exudative retinal detachment(HP:0012231)|Intellectual disability(HP:0001249)|Autosomal dominant inheritance(HP:0000006)|Sensorineural hearing impairment(HP:0000407)|Restrictive ventilatory defect(HP:0002091)|Childhood onset(HP:0011463)|Scapular winging(HP:0003691)|Tongue atrophy(HP:0012473)|Abdominal wall muscle weakness(HP:0009023)|Shoulder girdle muscle atrophy(HP:0003724)|Shoulder girdle muscle weakness(HP:0003547)|Retinal telangiectasia(HP:0007763)|Beevor's sign(HP:0030664)|Calf muscle hypertrophy(HP:0008981)|External ophthalmoplegia(HP:0000544)|Dysphagia(HP:0002015)|Slowly progressive(HP:0003677)|Scapulohumeral muscular dystrophy(HP:0008970)|Facial palsy(HP:0010628)|Seizure(HP:0001250)|Abnormal retinal vascular morphology(HP:0008046)|Abnormality of cardiovascular system morphology(HP:0030680)|Abnormal eyelash morphology(HP:0000499)|Palpebral edema(HP:0100540)|Mask-like facies(HP:0000298)|Skeletal muscle atrophy(HP:0003202)|Sensorineural hearing impairment(HP:0000407)|Hyperlordosis(HP:0003307)|EMG abnormality(HP:0003457)|Elevated circulating creatine kinase concentration(HP:0003236)","This gene maps to a location 100 kb centromeric of the repeat units on chromosome 4q35 which are deleted in facioscapulohumeral muscular dystrophy (FSHD). It is evolutionarily conserved and has related sequences on multiple human chromosomes but DNA sequence analysis did not reveal any homology to known genes. In vivo studies demonstrate the encoded protein is localized to the nucleolus. [provided by RefSeq, Jul 2008]","FSHD region gene 1","mRNA splicing, via spliceosome(GO:0000398)|rRNA processing(GO:0006364)|muscle organ development(GO:0007517)","nucleolus(GO:0005730)|Cajal body(GO:0015030)|Z disc(GO:0030018)|striated muscle dense body(GO:0055120)|catalytic step 2 spliceosome(GO:0071013)|catalytic step 2 spliceosome(GO:0071013)","RNA binding(GO:0003723)|protein binding(GO:0005515)|actin filament binding(GO:0051015)","muscular dystrophy(DOID:9884)","","","","","","",".;.","","","","","","","","","","","","T","0.155","T","0.297","B","0.034","B","0.038","N","0.000","D","1.000","","","T","1.54","N","0.16","0.205","T","-1.085","T","0.065","T","0.006","0.226","D","0.685","19.90","2.021","4.04","5.754","8.111"
"chr4","190874255","190874255","A>T","","FRG1","exonic","nonsynonymous SNV","","FRG1:NM_004477:exon4:c.A292T:p.T98S","FRG1","exonic","nonsynonymous SNV","","FRG1:ENST00000226798.9_1:exon4:c.A292T:p.T98S","FRG1:ENST00000226798.4:c.292A>T:p.(Thr98Ser)","0.99700457","","","","0.0","0.9984862804412842","0.016012843702088","","","","","","","","","","ENSG00000109536","FRG1","HGNC:3954","FRG1","2483","ENSG00000109536","uc003izs.4","0.01622867156611803","","0.9999679923057556","ORPHA:269 Facioscapulohumeral dystrophy-autosomal_dominant","1289","0/1","Het","590","496,94","0.840677966101695","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Facioscapulohumeral muscular dystrophy 1(158900)","Elevated circulating creatine kinase concentration(HP:0003236)|Exudative retinal detachment(HP:0012231)|Intellectual disability(HP:0001249)|Autosomal dominant inheritance(HP:0000006)|Sensorineural hearing impairment(HP:0000407)|Restrictive ventilatory defect(HP:0002091)|Childhood onset(HP:0011463)|Scapular winging(HP:0003691)|Tongue atrophy(HP:0012473)|Abdominal wall muscle weakness(HP:0009023)|Shoulder girdle muscle atrophy(HP:0003724)|Shoulder girdle muscle weakness(HP:0003547)|Retinal telangiectasia(HP:0007763)|Beevor's sign(HP:0030664)|Calf muscle hypertrophy(HP:0008981)|External ophthalmoplegia(HP:0000544)|Dysphagia(HP:0002015)|Slowly progressive(HP:0003677)|Scapulohumeral muscular dystrophy(HP:0008970)|Facial palsy(HP:0010628)|Seizure(HP:0001250)|Abnormal retinal vascular morphology(HP:0008046)|Abnormality of cardiovascular system morphology(HP:0030680)|Abnormal eyelash morphology(HP:0000499)|Palpebral edema(HP:0100540)|Mask-like facies(HP:0000298)|Skeletal muscle atrophy(HP:0003202)|Sensorineural hearing impairment(HP:0000407)|Hyperlordosis(HP:0003307)|EMG abnormality(HP:0003457)|Elevated circulating creatine kinase concentration(HP:0003236)","This gene maps to a location 100 kb centromeric of the repeat units on chromosome 4q35 which are deleted in facioscapulohumeral muscular dystrophy (FSHD). It is evolutionarily conserved and has related sequences on multiple human chromosomes but DNA sequence analysis did not reveal any homology to known genes. In vivo studies demonstrate the encoded protein is localized to the nucleolus. [provided by RefSeq, Jul 2008]","FSHD region gene 1","mRNA splicing, via spliceosome(GO:0000398)|rRNA processing(GO:0006364)|muscle organ development(GO:0007517)","nucleolus(GO:0005730)|Cajal body(GO:0015030)|Z disc(GO:0030018)|striated muscle dense body(GO:0055120)|catalytic step 2 spliceosome(GO:0071013)|catalytic step 2 spliceosome(GO:0071013)","RNA binding(GO:0003723)|protein binding(GO:0005515)|actin filament binding(GO:0051015)","muscular dystrophy(DOID:9884)","","","","","","",".;.","","","0.00006401","","","0.0006","0.0015","","","6.401e-05","0","D","0.046","T","0.119","B","0.043","B","0.083","D","0.000","D","1.000","","","T","1.8","D","-2.93","0.729","T","-1.073","T","0.058","T","0.014","0.252","T","0.072","22.7","2.566","3.71","4.531","11.050"
"chr4","190876196","190876196","G>A","","FRG1","exonic","nonsynonymous SNV","","FRG1:NM_004477:exon5:c.G322A:p.A108T","FRG1","exonic","nonsynonymous SNV","","FRG1:ENST00000226798.9_1:exon5:c.G322A:p.A108T","FRG1:ENST00000226798.4:c.322G>A:p.(Ala108Thr)","0.99583757","","","","","","","","","","","","","","","","ENSG00000109536","FRG1","HGNC:3954","FRG1","2483","ENSG00000109536","uc003izs.4","0.01622867156611803","","0.9999679923057556","ORPHA:269 Facioscapulohumeral dystrophy-autosomal_dominant","1290","0/1","Het","336","299,37","0.889880952380952","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Facioscapulohumeral muscular dystrophy 1(158900)","Elevated circulating creatine kinase concentration(HP:0003236)|Exudative retinal detachment(HP:0012231)|Intellectual disability(HP:0001249)|Autosomal dominant inheritance(HP:0000006)|Sensorineural hearing impairment(HP:0000407)|Restrictive ventilatory defect(HP:0002091)|Childhood onset(HP:0011463)|Scapular winging(HP:0003691)|Tongue atrophy(HP:0012473)|Abdominal wall muscle weakness(HP:0009023)|Shoulder girdle muscle atrophy(HP:0003724)|Shoulder girdle muscle weakness(HP:0003547)|Retinal telangiectasia(HP:0007763)|Beevor's sign(HP:0030664)|Calf muscle hypertrophy(HP:0008981)|External ophthalmoplegia(HP:0000544)|Dysphagia(HP:0002015)|Slowly progressive(HP:0003677)|Scapulohumeral muscular dystrophy(HP:0008970)|Facial palsy(HP:0010628)|Seizure(HP:0001250)|Abnormal retinal vascular morphology(HP:0008046)|Abnormality of cardiovascular system morphology(HP:0030680)|Abnormal eyelash morphology(HP:0000499)|Palpebral edema(HP:0100540)|Mask-like facies(HP:0000298)|Skeletal muscle atrophy(HP:0003202)|Sensorineural hearing impairment(HP:0000407)|Hyperlordosis(HP:0003307)|EMG abnormality(HP:0003457)|Elevated circulating creatine kinase concentration(HP:0003236)","This gene maps to a location 100 kb centromeric of the repeat units on chromosome 4q35 which are deleted in facioscapulohumeral muscular dystrophy (FSHD). It is evolutionarily conserved and has related sequences on multiple human chromosomes but DNA sequence analysis did not reveal any homology to known genes. In vivo studies demonstrate the encoded protein is localized to the nucleolus. [provided by RefSeq, Jul 2008]","FSHD region gene 1","mRNA splicing, via spliceosome(GO:0000398)|rRNA processing(GO:0006364)|muscle organ development(GO:0007517)","nucleolus(GO:0005730)|Cajal body(GO:0015030)|Z disc(GO:0030018)|striated muscle dense body(GO:0055120)|catalytic step 2 spliceosome(GO:0071013)|catalytic step 2 spliceosome(GO:0071013)","RNA binding(GO:0003723)|protein binding(GO:0005515)|actin filament binding(GO:0051015)","muscular dystrophy(DOID:9884)","","","","","","",".;.","","","0.00001994","","","0.0001","0.","","","1.994e-05","0","D","0.038","T","0.07","P","0.744","B","0.241","D","0.000","D","1","","","T","1.87","D","-2.74","0.806","T","-0.790","T","0.170","T","0.013","0.283","D","0.892","23.9","3.124","4.04","7.763","14.145"
"chr4","190881933","190881933","A>G","","FRG1","exonic","nonsynonymous SNV","","FRG1:NM_004477:exon7:c.A568G:p.K190E","FRG1","exonic","nonsynonymous SNV","","FRG1:ENST00000226798.9_1:exon7:c.A568G:p.K190E","FRG1:ENST00000226798.4:c.568A>G:p.(Lys190Glu)","0.575598","","","","","","","","","","","","","","","","ENSG00000109536","FRG1","HGNC:3954","FRG1","2483","ENSG00000109536","uc003izs.4","0.01622867156611803","","0.9999679923057556","ORPHA:269 Facioscapulohumeral dystrophy-autosomal_dominant","1297","0/1","Het","144","75,69","0.520833333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Facioscapulohumeral muscular dystrophy 1(158900)","Elevated circulating creatine kinase concentration(HP:0003236)|Exudative retinal detachment(HP:0012231)|Intellectual disability(HP:0001249)|Autosomal dominant inheritance(HP:0000006)|Sensorineural hearing impairment(HP:0000407)|Restrictive ventilatory defect(HP:0002091)|Childhood onset(HP:0011463)|Scapular winging(HP:0003691)|Tongue atrophy(HP:0012473)|Abdominal wall muscle weakness(HP:0009023)|Shoulder girdle muscle atrophy(HP:0003724)|Shoulder girdle muscle weakness(HP:0003547)|Retinal telangiectasia(HP:0007763)|Beevor's sign(HP:0030664)|Calf muscle hypertrophy(HP:0008981)|External ophthalmoplegia(HP:0000544)|Dysphagia(HP:0002015)|Slowly progressive(HP:0003677)|Scapulohumeral muscular dystrophy(HP:0008970)|Facial palsy(HP:0010628)|Seizure(HP:0001250)|Abnormal retinal vascular morphology(HP:0008046)|Abnormality of cardiovascular system morphology(HP:0030680)|Abnormal eyelash morphology(HP:0000499)|Palpebral edema(HP:0100540)|Mask-like facies(HP:0000298)|Skeletal muscle atrophy(HP:0003202)|Sensorineural hearing impairment(HP:0000407)|Hyperlordosis(HP:0003307)|EMG abnormality(HP:0003457)|Elevated circulating creatine kinase concentration(HP:0003236)","This gene maps to a location 100 kb centromeric of the repeat units on chromosome 4q35 which are deleted in facioscapulohumeral muscular dystrophy (FSHD). It is evolutionarily conserved and has related sequences on multiple human chromosomes but DNA sequence analysis did not reveal any homology to known genes. In vivo studies demonstrate the encoded protein is localized to the nucleolus. [provided by RefSeq, Jul 2008]","FSHD region gene 1","mRNA splicing, via spliceosome(GO:0000398)|rRNA processing(GO:0006364)|muscle organ development(GO:0007517)","nucleolus(GO:0005730)|Cajal body(GO:0015030)|Z disc(GO:0030018)|striated muscle dense body(GO:0055120)|catalytic step 2 spliceosome(GO:0071013)|catalytic step 2 spliceosome(GO:0071013)","RNA binding(GO:0003723)|protein binding(GO:0005515)|actin filament binding(GO:0051015)","muscular dystrophy(DOID:9884)","","","","","","",".;.","","Score=766;Name=V$EVI1_01","","","","","","","","","","T","0.961","T","0.914","B","0.034","B","0.034","D","0.000","D","0.576","","","T","1.47","N","-0.7","0.168","T","-1.030","T","0.049","T","0.006","0.180","D","0.578","20.5","2.078","4.04","2.753","11.310"
"chr6","168720112","168720112","C>T","","DACT2","exonic","nonsynonymous SNV","","DACT2:NM_001286351:exon1:c.G202A:p.E68K,DACT2:NM_214462:exon1:c.G202A:p.E68K","DACT2","exonic","nonsynonymous SNV","","DACT2:ENST00000366795.4_1:exon1:c.G202A:p.E68K,DACT2:ENST00000366796.7_1:exon1:c.G202A:p.E68K","DACT2:ENST00000366795.3:c.202G>A:p.(Glu68Lys)","0.99996","0.0","0.9999600052833556","0.016227500532093","","","","","","","","","","","","","ENSG00000164488","DACT2","HGNC:21231","DACT2","168002","ENSG00000164488","uc003qwq.5","0.01622750053209302","","0.9999600052833557","","1325","0/1","Het","12","7,5","0.583333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","dishevelled binding antagonist of beta catenin 2","epithelial cell morphogenesis(GO:0003382)|negative regulation of cell adhesion(GO:0007162)|skin development(GO:0043588)|inner medullary collecting duct development(GO:0072061)|negative regulation of nodal signaling pathway(GO:1900108)|negative regulation of nodal signaling pathway(GO:1900108)","cytoplasm(GO:0005737)","protein kinase C binding(GO:0005080)|beta-catenin binding(GO:0008013)|transcription factor binding(GO:0008134)|protein kinase A binding(GO:0051018)|delta-catenin binding(GO:0070097)","","","Wp vitamin d receptor pathway","","","","",".;.","","Score=847;Name=V$AP4_01","","","","","","","","","","D","0.003","D","0.0","D","1.0","D","0.997","U","0.005","D","1.000","M","2.24","T","0.61","N","-2.47","0.309","T","-0.647","T","0.207","D","0.325","0.206","D","0.938","23.4","2.917","3.27","4.163","11.651"
"chr19","45649651","45649651","T>C","","PPP1R37","exonic","nonsynonymous SNV","","PPP1R37:NM_019121:exon12:c.T1997C:p.L666P","PPP1R37","exonic","nonsynonymous SNV","","PPP1R37:ENST00000221462.9_1:exon12:c.T1997C:p.L666P","PPP1R37:ENST00000221462.4:c.1997T>C:p.(Leu666Pro)","0.9999488","0.0","0.999948799610138","0.0162258577289228","","","","","","","","","","","","","ENSG00000104866","PPP1R37","HGNC:27607","PPP1R37","284352","ENSG00000104866","uc021uvs.2","0.016225857728922814","","0.9999487996101379","","1379","0/1","Het","36","17,19","0.472222222222222","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","protein phosphatase 1 regulatory subunit 37","negative regulation of catalytic activity(GO:0043086)","","protein phosphatase inhibitor activity(GO:0004864)|protein binding(GO:0005515)","","","","","","","","","","","","","","","","","","","","D","0.0","D","0.041","","","","","N","0.046","D","1.000","M","2.045","T","-0.25","N","-2.24","0.489","T","-0.446","T","0.334","D","0.260","0.372","D","0.904","25.2","3.560","5.27","1.341","8.199"
"chr11","93494680","93494680","G>A","","C11orf54","splicing","","NM_001286067:exon10:c.775-1G>A;NM_001286068:exon9:c.775-1G>A;NM_001286071:exon8:c.598-1G>A;NM_001286070:exon8:c.718-1G>A;NM_001286069:exon9:c.775-1G>A;NM_014039:exon8:c.625-1G>A","","C11orf54","splicing","","ENST00000528288.5_1:exon8:c.625-1G>A;ENST00000540113.5_1:exon8:c.718-1G>A;ENST00000617482.4_1:exon8:c.598-1G>A;ENST00000331239.8_1:exon9:c.775-1G>A;ENST00000528099.5_1:exon10:c.775-1G>A;ENST00000354421.8_1:exon9:c.775-1G>A","","C11orf54:ENST00000331239.4:c.775-1G>A:p.?","0.9999488","0.0","0.999948799610138","0.0162258577289228","","","","","","","","","","","","","ENSG00000182919","C11orf54","HGNC:30204","C11orf54","28970","ENSG00000182919","uc001peh.5","0.016225857728922814","","0.9999487996101379","","1380","0/1","Het","20","14,6","0.7","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","chromosome 11 open reading frame 54","","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nuclear body(GO:0016604)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)|zinc ion binding(GO:0008270)|zinc ion binding(GO:0008270)|hydrolase activity, acting on ester bonds(GO:0016788)|hydrolase activity, acting on ester bonds(GO:0016788)","","","","","","","",".;.;.;.;.;.;.","","","","","","","","","","","","","","","","","","","","","","D","1","","","","","","","","","","","","","","","","","35","6.109","5.17","7.716","18.669"
"chr9","67927076","67927076","G>A","","ANKRD20A1;ANKRD20A3","splicing","","NM_032250:exon1:c.203+1G>A;NM_001012419:exon1:c.203+1G>A","","ANKRD20A1","splicing","","ENST00000377477.2:exon1:c.203+1G>A","","ANKRD20A1:ENST00000377477.2:c.203+1G>A:p.?","0.99989766","0.0","0.9998976588249208","0.016218362331328","0.0","0.997448831796646","0.0158634108576405","","","","","","","","","","ENSG00000196774","ANKRD20A1","HGNC:23665","ANKRD20A1","84210","ENSG00000260691","uc004aeu.4","0.016218362331328","","0.9998976588249207","","1381","0/1","Het","279","247,32","0.885304659498208","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","","","","","","","","","","","",".;.","","","","","","","","","","","","","","","","","","","","","","N","0.520","","","","","","","","","","","","","","","","","23.3","2.868","1.23","1.286","5.982"
"chr9","67927062","67927062","G>A","","ANKRD20A1;ANKRD20A3","exonic","nonsynonymous SNV","","ANKRD20A3:NM_001012419:exon1:c.G190A:p.D64N,ANKRD20A1:NM_032250:exon1:c.G190A:p.D64N","ANKRD20A1","exonic","nonsynonymous SNV","","ANKRD20A1:ENST00000377477.2:exon1:c.G190A:p.D64N","ANKRD20A1:ENST00000377477.2:c.190G>A:p.(Asp64Asn)","0.995","","","","0.0","0.997448831796646","0.0158634108576405","","","","","","","","","","ENSG00000196774","ANKRD20A1","HGNC:23665","ANKRD20A1","84210","ENSG00000260691","uc004aeu.4","0.016218362331328","","0.9998976588249207","","1382","0/1","Het","291","259,32","0.890034364261168","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","","","","","","","","","","","","Ankyrin","","","","","","","","","","","","","","D","0.015","D","0.999","D","0.995","","","N","1","L","1.3","","","","","0.141","T","-0.908","T","0.254","T","0.001","0.154","D","0.768","19.40","1.958","1.23","1.926","5.982"
"chrX","55172708","55172708","T>G","","FAM104B","exonic","nonsynonymous SNV","","FAM104B:NM_001166699:exon3:c.A160C:p.I54L,FAM104B:NM_001166700:exon3:c.A160C:p.I54L,FAM104B:NM_001166701:exon3:c.A157C:p.I53L,FAM104B:NM_001166702:exon3:c.A148C:p.I50L,FAM104B:NM_001166703:exon3:c.A154C:p.I52L,FAM104B:NM_138362:exon3:c.A157C:p.I53L","FAM104B","exonic","nonsynonymous SNV","","FAM104B:ENST00000332132.8_1:exon3:c.A160C:p.I54L,FAM104B:ENST00000358460.8_1:exon3:c.A157C:p.I53L,FAM104B:ENST00000425133.2_1:exon3:c.A160C:p.I54L,FAM104B:ENST00000477847.6_1:exon3:c.A148C:p.I50L,FAM104B:ENST00000489298.1_1:exon3:c.A154C:p.I52L","FAM104B:ENST00000332132.4:c.160A>C:p.(Ile54Leu)","0.9997171","","","","","","","0.0","0.999717116355896","0.0161919285281168","0.0","0.999717116355896","0.0161919285281168","","","","ENSG00000182518","FAM104B","HGNC:25085","FAM104B","90736","ENSG00000182518","uc004duh.3","0.01619192852811684","","0.999717116355896","","1383","0/1","Het","254","61,193","0.240157480314961","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","family with sequence similarity 104 member B","","","","","","","","","","",".;.;.;.;.","","","0.000005458","","","0.","0.","","","5.458e-06","0","D","0.0","T","0.051","B","0.105","B","0.068","U","0.153","N","1","M","1.955","T","0.27","N","-1.83","0.551","T","-0.863","T","0.155","T","0.012","0.098","T","0.225","8.808","0.439","1.59","0.742","4.529"
"chrX","55172716","55172716","C>T","","FAM104B","exonic","nonsynonymous SNV","","FAM104B:NM_001166699:exon3:c.G152A:p.S51N,FAM104B:NM_001166700:exon3:c.G152A:p.S51N,FAM104B:NM_001166701:exon3:c.G149A:p.S50N,FAM104B:NM_001166702:exon3:c.G140A:p.S47N,FAM104B:NM_001166703:exon3:c.G146A:p.S49N,FAM104B:NM_138362:exon3:c.G149A:p.S50N","FAM104B","exonic","nonsynonymous SNV","","FAM104B:ENST00000332132.8_1:exon3:c.G152A:p.S51N,FAM104B:ENST00000358460.8_1:exon3:c.G149A:p.S50N,FAM104B:ENST00000425133.2_1:exon3:c.G152A:p.S51N,FAM104B:ENST00000477847.6_1:exon3:c.G140A:p.S47N,FAM104B:ENST00000489298.1_1:exon3:c.G146A:p.S49N","FAM104B:ENST00000332132.4:c.152G>A:p.(Ser51Asn)","0.993","","","","","","","","","","","","","","","","ENSG00000182518","FAM104B","HGNC:25085","FAM104B","90736","ENSG00000182518","uc004duh.3","0.01619192852811684","","0.999717116355896","","1384","0/1","Het","243","162,81","0.666666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","family with sequence similarity 104 member B","","","","","","","","","","",".;.;.;.;.","","","","","","","","","","","","D","0.032","T","0.093","B","0.393","B","0.383","U","0.060","N","1","L","1.89","T","0.58","N","-1.28","0.403","T","-0.992","T","0.137","T","0.011","0.056","T","0.244","9.175","0.476","1.6","0.332","4.875"
"chrX","55172687","55172687","T>C","","FAM104B","exonic","nonsynonymous SNV","","FAM104B:NM_001166699:exon3:c.A181G:p.S61G,FAM104B:NM_001166700:exon3:c.A181G:p.S61G,FAM104B:NM_001166701:exon3:c.A178G:p.S60G,FAM104B:NM_001166702:exon3:c.A169G:p.S57G,FAM104B:NM_001166703:exon3:c.A175G:p.S59G,FAM104B:NM_138362:exon3:c.A178G:p.S60G","FAM104B","exonic","nonsynonymous SNV","","FAM104B:ENST00000332132.8_1:exon3:c.A181G:p.S61G,FAM104B:ENST00000358460.8_1:exon3:c.A178G:p.S60G,FAM104B:ENST00000425133.2_1:exon3:c.A181G:p.S61G,FAM104B:ENST00000477847.6_1:exon3:c.A169G:p.S57G,FAM104B:ENST00000489298.1_1:exon3:c.A175G:p.S59G","FAM104B:ENST00000332132.4:c.181A>G:p.(Ser61Gly)","0.986","","","","","","","","","","","","","","","","ENSG00000182518","FAM104B","HGNC:25085","FAM104B","90736","ENSG00000182518","uc004duh.3","0.01619192852811684","","0.999717116355896","","1385","0/1","Het","232","72,160","0.310344827586207","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","family with sequence similarity 104 member B","","","","","","","","","","",".;.;.;.;.","","","0","","","0.","0.","","","","","D","0.014","T","0.115","B","0.18","B","0.013","N","0.023","N","1","L","1.125","T","0.62","D","-3.25","0.165","T","-1.046","T","0.083","T","0.004","0.075","T","0.063","8.760","0.434","1.59","0.342","4.198"
"chrX","55172537","55172537","G>A","","FAM104B","exonic","stopgain","","FAM104B:NM_001166700:exon3:c.C331T:p.R111X,FAM104B:NM_001166701:exon3:c.C328T:p.R110X,FAM104B:NM_001166702:exon3:c.C319T:p.R107X,FAM104B:NM_001166703:exon3:c.C325T:p.R109X","FAM104B","exonic","stopgain","","FAM104B:ENST00000425133.2_1:exon3:c.C331T:p.R111X,FAM104B:ENST00000477847.6_1:exon3:c.C319T:p.R107X,FAM104B:ENST00000489298.1_1:exon3:c.C325T:p.R109X","FAM104B:ENST00000425133.2:c.331C>T:p.(Arg111*)","0.9299332","","","","","","","","","","","","","","","","ENSG00000182518","FAM104B","HGNC:25085","FAM104B","90736","ENSG00000182518","uc004duh.3","0.01619192852811684","","0.999717116355896","","1386","0/1","Het","164","31,133","0.189024390243902","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","family with sequence similarity 104 member B","","","","","","","","","","",".;.;.","","","0.00003419","","","0.0005","0.","","","3.419e-05","0","","","","","","","","","","","N","0.985","","","","","","","0.121","","","","","","","","","","33","4.881","1.59","1.269","4.504"
"chrX","55172659","55172659","A>G","","FAM104B","exonic","nonsynonymous SNV","","FAM104B:NM_001166699:exon3:c.T209C:p.I70T,FAM104B:NM_001166700:exon3:c.T209C:p.I70T,FAM104B:NM_001166701:exon3:c.T206C:p.I69T,FAM104B:NM_001166702:exon3:c.T197C:p.I66T,FAM104B:NM_001166703:exon3:c.T203C:p.I68T,FAM104B:NM_138362:exon3:c.T206C:p.I69T","FAM104B","exonic","nonsynonymous SNV","","FAM104B:ENST00000332132.8_1:exon3:c.T209C:p.I70T,FAM104B:ENST00000358460.8_1:exon3:c.T206C:p.I69T,FAM104B:ENST00000425133.2_1:exon3:c.T209C:p.I70T,FAM104B:ENST00000477847.6_1:exon3:c.T197C:p.I66T,FAM104B:ENST00000489298.1_1:exon3:c.T203C:p.I68T","FAM104B:ENST00000332132.4:c.209T>C:p.(Ile70Thr)","0.677","","","","","","","","","","","","","","","","ENSG00000182518","FAM104B","HGNC:25085","FAM104B","90736","ENSG00000182518","uc004duh.3","0.01619192852811684","","0.999717116355896","","1391","0/1","Het","243","184,59","0.757201646090535","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","family with sequence similarity 104 member B","","","","","","","","","","",".;.;.;.;.","","","","","","","","","","","","T","0.403","T","0.268","B","0.393","B","0.291","N","0.039","N","1","N","0.64","T","0.95","N","-0.72","0.2","T","-0.952","T","0.090","T","0.004","0.021","T","0.069","6.440","0.242","1.6","-0.230","4.189"
"chrX","55172645","55172645","C>T","","FAM104B","exonic","nonsynonymous SNV","","FAM104B:NM_001166699:exon3:c.G223A:p.D75N,FAM104B:NM_001166700:exon3:c.G223A:p.D75N,FAM104B:NM_001166701:exon3:c.G220A:p.D74N,FAM104B:NM_001166702:exon3:c.G211A:p.D71N,FAM104B:NM_001166703:exon3:c.G217A:p.D73N,FAM104B:NM_138362:exon3:c.G220A:p.D74N","FAM104B","exonic","nonsynonymous SNV","","FAM104B:ENST00000332132.8_1:exon3:c.G223A:p.D75N,FAM104B:ENST00000358460.8_1:exon3:c.G220A:p.D74N,FAM104B:ENST00000425133.2_1:exon3:c.G223A:p.D75N,FAM104B:ENST00000477847.6_1:exon3:c.G211A:p.D71N,FAM104B:ENST00000489298.1_1:exon3:c.G217A:p.D73N","FAM104B:ENST00000332132.4:c.223G>A:p.(Asp75Asn)","0.3187686","","","","","","","","","","","","","","","","ENSG00000182518","FAM104B","HGNC:25085","FAM104B","90736","ENSG00000182518","uc004duh.3","0.01619192852811684","","0.999717116355896","","1393","0/1","Het","269","78,191","0.28996282527881","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","family with sequence similarity 104 member B","","","","","","","","","","",".;.;.;.;.","","","0.00001119","0.0013","","0.0001","","","","1.119e-05","0","T","0.675","T","1.0","B","0.003","B","0.0","N","0.171","P","1","N","-0.49","T","1.04","N","0.87","0.132","T","-1.045","T","0.035","T","0.003","0.012","T","0.005","1.300","-0.112","1.59","0.059","4.225"
"chr15","81294838","81294838","G>C","","MESDC1","exonic","nonsynonymous SNV","","MESDC1:NM_022566:exon1:c.G226C:p.E76Q","TLNRD1","exonic","nonsynonymous SNV","","TLNRD1:ENST00000267984.4_1:exon1:c.G226C:p.E76Q","TLNRD1:ENST00000267984.2:c.226G>C:p.(Glu76Gln)","0.9996918","0.0","0.9996917843818665","0.0161882229838772","","","","","","","","","","","","","ENSG00000140406","TLNRD1","HGNC:13519","TLNRD1","59274","ENSG00000140406","uc002bfz.4","0.016188222983877246","","0.9996917843818665","","1395","0/1","Het","122","58,64","0.475409836065574","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that is regulated by micro RNA MiR-574-3, and is thought to have an oncogenic function in human bladder cancer. A similar gene in mouse is located in a chromosomal region critical for differentiation of mesoderm, which affects embryo patterning and the formation of heart, muscle, blood, skeleton and the urogenital system. The mouse gene is expressed in early development, and in the adult. [provided by RefSeq, Nov 2016]","talin rod domain containing 1","","stress fiber(GO:0001725)","actin binding(GO:0003779)|actin binding(GO:0003779)|protein binding(GO:0005515)|identical protein binding(GO:0042802)","","","","","","","","","","Score=747;Name=V$STAT3_01","0.000006608","","","0.","0.","","","6.608e-06","0","T","0.24","T","0.096","P","0.742","B","0.318","U","0.000","D","1.000","","","T","3.15","N","-0.55","0.353","T","-0.947","T","0.021","D","0.041","0.149","D","0.650","22.9","2.681","4.15","9.267","16.799"
"chr17","62135281","62135281","C>T","","ERN1","exonic","nonsynonymous SNV","","ERN1:NM_001433:exon12:c.G1279A:p.A427T","ERN1","exonic","nonsynonymous SNV","","ERN1:ENST00000433197.4_1:exon12:c.G1279A:p.A427T,ERN1:ENST00000680433.1_1:exon12:c.G1279A:p.A427T","ERN1:ENST00000433197.3:c.1279G>A:p.(Ala427Thr)","0.43323436","0.5001634861400817","0.4332343637943268","0.0161360208977723","","","","","","","","","","","","","ENSG00000178607","ERN1","HGNC:3449","ERN1","2081","ENSG00000178607","uc002jdz.3","0.016136020897772323","0.5001634861400817","0.4332343637943268","","1396","0/1","Het","118","65,53","0.550847457627119","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes the transmembrane protein kinase inositol-requiring enzyme 1. The encoded protein contains two functional catalytic domains, a serine/threonine-protein kinase domain and an endoribonuclease domain. This protein functions as a sensor of unfolded proteins in the endoplasmic reticulum (ER) and triggers an intracellular signaling pathway termed the unfolded protein response (UPR). The UPR is an ER stress response that is conserved from yeast to mammals and activates genes involved in degrading misfolded proteins, regulating protein synthesis and activating molecular chaperones. This protein specifically mediates the splicing and activation of the stress response transcription factor X-box binding protein 1. [provided by RefSeq, Aug 2017]","endoplasmic reticulum to nucleus signaling 1","endothelial cell proliferation(GO:0001935)|mRNA cleavage(GO:0006379)|mRNA catabolic process(GO:0006402)|protein phosphorylation(GO:0006468)|regulation of macroautophagy(GO:0016241)|positive regulation of RNA splicing(GO:0033120)|cellular response to unfolded protein(GO:0034620)|cellular response to unfolded protein(GO:0034620)|response to endoplasmic reticulum stress(GO:0034976)|cellular response to vascular endothelial growth factor stimulus(GO:0035924)|peptidyl-serine autophosphorylation(GO:0036289)|IRE1-mediated unfolded protein response(GO:0036498)|IRE1-mediated unfolded protein response(GO:0036498)|IRE1-mediated unfolded protein response(GO:0036498)|positive regulation of JUN kinase activity(GO:0043507)|protein autophosphorylation(GO:0046777)|regulation of cell cycle(GO:0051726)|mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054)|mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054)|mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054)|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059)|cellular response to hydrogen peroxide(GO:0070301)|cellular response to glucose stimulus(GO:0071333)|RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502)|mRNA cleavage involved in mRNA processing(GO:0098787)|positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103)|insulin metabolic process(GO:1901142)|positive regulation of vascular associated smooth muscle cell proliferation(GO:1904707)|peptidyl-serine trans-autophosphorylation(GO:1990579)","nuclear inner membrane(GO:0005637)|cytoplasm(GO:0005737)|mitochondrion(GO:0005739)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum membrane(GO:0005789)|integral component of endoplasmic reticulum membrane(GO:0030176)|Ire1 complex(GO:1990332)|AIP1-IRE1 complex(GO:1990597)|IRE1-TRAF2-ASK1 complex(GO:1990604)|IRE1-TRAF2-ASK1 complex(GO:1990604)|IRE1-RACK1-PP2A complex(GO:1990630)","magnesium ion binding(GO:0000287)|endoribonuclease activity(GO:0004521)|endoribonuclease activity(GO:0004521)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|platelet-derived growth factor receptor binding(GO:0005161)|protein binding(GO:0005515)|ATP binding(GO:0005524)|enzyme binding(GO:0019899)|Hsp70 protein binding(GO:0030544)|identical protein binding(GO:0042802)|protein homodimerization activity(GO:0042803)|protein homodimerization activity(GO:0042803)|ADP binding(GO:0043531)|unfolded protein binding(GO:0051082)|Hsp90 protein binding(GO:0051879)|protein serine kinase activity(GO:0106310)","epilepsy(DOID:1826)|hepatitis B(DOID:2043)|hepatitis(DOID:2237)","Alzheimers disease","Wp alzheimers disease|Wp corticotropinreleasing hormone signaling pathway|Wp photodynamic therapyinduced unfolded protein response|Wp apoptosisrelated network due to altered notch3 in ovarian cancer|Wp vegfavegfr2 signaling pathway|Wp nonalcoholic fatty liver disease|Wp unfolded protein response|Wp endoplasmic reticulum stress response in coronavirus infection","Ire1alpha activates chaperones|Unfolded protein response upr","","Unfolded protein response","SpliceAI>T|ERN1|0.00|0.00|0.00|0.00|-24|3|-9|-47","","","","0.00008697","","","0.0001","0.","0.0001","","8.697e-05","5.735e-05","T","0.563","T","0.58","B","0.006","B","0.002","N","0.956","N","1","L","1.155","T","2.3","N","-0.02","0.13","T","-0.949","T","0.024","T","0.007","0.015","T","0.022","6.625","0.255","5.13","-0.005","5.213"
"chr5","140201733","140201733","A>G","","PCDHA5","exonic","nonsynonymous SNV","","PCDHA5:NM_018908:exon1:c.A373G:p.I125V,PCDHA5:NM_031501:exon1:c.A373G:p.I125V","PCDHA5","exonic","nonsynonymous SNV","","PCDHA5:ENST00000529619.5_1:exon1:c.A373G:p.I125V,PCDHA5:ENST00000529859.2_1:exon1:c.A373G:p.I125V,PCDHA5:ENST00000614258.1_1:exon1:c.A373G:p.I125V","PCDHA5:ENST00000378126.3:c.373A>G:p.(Ile125Val)","0.99921304","0.0","0.9992130398750304","0.0161183491855628","","","","","","","","","","","","","ENSG00000204965","PCDHA5","HGNC:8671","PCDHA5","56143","ENSG00000204965","uc003lhl.2","0.016118349185562868","","0.9992130398750305","","1397","0/1","Het","46","28,18","0.608695652173913","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene is a member of the protocadherin alpha gene cluster, one of three related gene clusters tandemly linked on chromosome five that demonstrate an unusual genomic organization similar to that of B-cell and T-cell receptor gene clusters. The alpha gene cluster is composed of 15 cadherin superfamily genes related to the mouse CNR genes and consists of 13 highly similar and 2 more distantly related coding sequences. The tandem array of 15 N-terminal exons, or variable exons, are followed by downstream C-terminal exons, or constant exons, which are shared by all genes in the cluster. The large, uninterrupted N-terminal exons each encode six cadherin ectodomains while the C-terminal exons encode the cytoplasmic domain. These neural cadherin-like cell adhesion proteins are integral plasma membrane proteins that most likely play a critical role in the establishment and function of specific cell-cell connections in the brain. Alternative splicing has been observed and additional variants have been suggested but their full-length nature has yet to be determined. [provided by RefSeq, Jul 2008]","protocadherin alpha 5","cell adhesion(GO:0007155)|homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156)|nervous system development(GO:0007399)","integral component of plasma membrane(GO:0005887)","calcium ion binding(GO:0005509)","","","","","","","",".;.;Cadherin-like","","","0.00005437","","","0.","0.0001","","","3.976e-06","5.437e-05","T","0.261","T","0.184","B","0.015","B","0.01","","","D","1","L","1.19","T","0.66","N","-0.79","0.076","T","-1.011","T","0.098","T","0.009","0.017","T","0.033","14.86","1.237","4.01","2.034","7.993"
"chr9","69423792","69423792","A>T","","ANKRD20A4","exonic","nonsynonymous SNV","","ANKRD20A4:NM_001098805:exon15:c.A2088T:p.Q696H","ANKRD20A4P","exonic","nonsynonymous SNV","","ANKRD20A4P:ENST00000357336.3_1:exon15:c.A2088T:p.Q696H","ANKRD20A4P:ENST00000357336.3:c.2088A>T:p.(Gln696His)","0.9990597","0.0","0.9990596771240234","0.0160960283602768","0.0","0.9905298352241516","0.0149013174354382","","","","","","","","","","ENSG00000172014","ANKRD20A4P","HGNC:31982","ANKRD20A4P","728747","ENSG00000172014","uc004afn.4","0.01609602836027686","","0.9990596771240234","","1398","0/1","Het","30","8,22","0.266666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 20 family member A4, pseudogene","","","","","","","","","","","CCDC144C-like,","","","0.000006627","","","","","","","6.627e-06","0","D","0.0","T","0.117","B","0.002","B","0.001","","","N","1.000","M","2.09","T","1.87","D","-3.51","0.394","T","-0.980","T","0.050","T","0.004","0.081","T","0.097","4.986","0.144","2.26","-0.036","4.628"
"chr9","69423703","69423703","A>C","","ANKRD20A4","exonic","nonsynonymous SNV","","ANKRD20A4:NM_001098805:exon15:c.A1999C:p.T667P","ANKRD20A4P","exonic","nonsynonymous SNV","","ANKRD20A4P:ENST00000357336.3_1:exon15:c.A1999C:p.T667P","ANKRD20A4P:ENST00000357336.3:c.1999A>C:p.(Thr667Pro)","0.982","","","","0.0","0.9905298352241516","0.0149013174354382","","","","","","","","","","ENSG00000172014","ANKRD20A4P","HGNC:31982","ANKRD20A4P","728747","ENSG00000172014","uc004afn.4","0.01609602836027686","","0.9990596771240234","","1399","0/1","Het","54","45,9","0.833333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 20 family member A4, pseudogene","","","","","","","","","","SpliceAI>C|ANKRD20A4|0.00|0.00|0.00|0.00|28|4|36|-43","CCDC144C-like,","","","","","","","","","","","","D","0.018","D","0.043","B","0.074","B","0.009","","","N","1.000","L","1.445","T","2.28","D","-2.52","0.153","T","-1.014","T","0.033","T","0.003","0.019","T","0.090","13.80","1.056","2.26","0.291","5.752"
"chr9","69423550","69423550","G>T","","ANKRD20A4","exonic","nonsynonymous SNV","","ANKRD20A4:NM_001098805:exon15:c.G1846T:p.A616S","ANKRD20A4P","exonic","nonsynonymous SNV","","ANKRD20A4P:ENST00000357336.3_1:exon15:c.G1846T:p.A616S","ANKRD20A4P:ENST00000357336.3:c.1846G>T:p.(Ala616Ser)","0.904","","","","","","","","","","","","","","","","ENSG00000172014","ANKRD20A4P","HGNC:31982","ANKRD20A4P","728747","ENSG00000172014","uc004afn.4","0.01609602836027686","","0.9990596771240234","","1400","0/1","Het","122","107,15","0.877049180327869","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 20 family member A4, pseudogene","","","","","","","","","","","CCDC144C-like,","","","","","","","","","","","","T","0.096","D","0.012","D","0.989","P","0.662","","","N","1.000","M","2.75","T","1.11","N","-1.98","0.194","T","-0.931","T","0.161","T","0.005","0.082","D","0.743","21.2","2.168","2.26","1.878","4.958"
"chr9","69391111","69391111","G>A","","ANKRD20A4","exonic","nonsynonymous SNV","","ANKRD20A4:NM_001098805:exon5:c.G619A:p.V207I","ANKRD20A4P","exonic","nonsynonymous SNV","","ANKRD20A4P:ENST00000357336.3_1:exon5:c.G619A:p.V207I","ANKRD20A4P:ENST00000357336.3:c.619G>A:p.(Val207Ile)","0.49134853","","","","","","","","","","","","","","","","ENSG00000172014","ANKRD20A4P","HGNC:31982","ANKRD20A4P","728747","ENSG00000172014","uc004afn.4","0.01609602836027686","","0.9990596771240234","","1401","0/1","Het","126","115,11","0.912698412698413","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 20 family member A4, pseudogene","","","","","","","","","","","Ankyrin","","","","","","","","","","","","T","0.451","T","0.188","B","0.032","B","0.013","","","N","1","L","1.915","T","-0.31","N","-0.58","0.189","T","-1.010","T","0.152","T","0.009","0.070","T","0.098","0.104","-0.478","1.52","0.583","4.221"
"chr9","69391114","69391114","T>C","","ANKRD20A4","exonic","nonsynonymous SNV","","ANKRD20A4:NM_001098805:exon5:c.T622C:p.Y208H","ANKRD20A4P","exonic","nonsynonymous SNV","","ANKRD20A4P:ENST00000357336.3_1:exon5:c.T622C:p.Y208H","ANKRD20A4P:ENST00000357336.3:c.622T>C:p.(Tyr208His)","0.39951056","","","","","","","","","","","","","","","","ENSG00000172014","ANKRD20A4P","HGNC:31982","ANKRD20A4P","728747","ENSG00000172014","uc004afn.4","0.01609602836027686","","0.9990596771240234","","1402","0/1","Het","121","110,11","0.909090909090909","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 20 family member A4, pseudogene","","","","","","","","","","","Ankyrin","","","","","","","","","","","","T","0.545","T","0.541","B","0.0","B","0.0","","","N","1","N","-0.18","T","-0.1","N","0.37","0.071","T","-1.016","T","0.112","T","0.007","0.097","T","0.042","1.931","-0.051","1.52","0.054","2.244"
"chr9","69423755","69423755","G>C","","ANKRD20A4","exonic","nonsynonymous SNV","","ANKRD20A4:NM_001098805:exon15:c.G2051C:p.S684T","ANKRD20A4P","exonic","nonsynonymous SNV","","ANKRD20A4P:ENST00000357336.3_1:exon15:c.G2051C:p.S684T","ANKRD20A4P:ENST00000357336.3:c.2051G>C:p.(Ser684Thr)","0.288","","","","","","","","","","","","","","","","ENSG00000172014","ANKRD20A4P","HGNC:31982","ANKRD20A4P","728747","ENSG00000172014","uc004afn.4","0.01609602836027686","","0.9990596771240234","","1403","0/1","Het","26","10,16","0.384615384615385","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 20 family member A4, pseudogene","","","","","","","","","","","CCDC144C-like,","","","0","","","","","","","0","0","T","0.712","T","1.0","B","0.0","B","0.0","","","N","1","N","-1.02","T","2.17","N","0.15","0.069","T","-0.977","T","0.015","T","0.002","0.016","T","0.056","1.420","-0.099","2.26","1.044","2.061"
"chr9","69423700","69423700","G>A","","ANKRD20A4","exonic","nonsynonymous SNV","","ANKRD20A4:NM_001098805:exon15:c.G1996A:p.E666K","ANKRD20A4P","exonic","nonsynonymous SNV","","ANKRD20A4P:ENST00000357336.3_1:exon15:c.G1996A:p.E666K","ANKRD20A4P:ENST00000357336.3:c.1996G>A:p.(Glu666Lys)","0","","","","","","","","","","","","","","","","ENSG00000172014","ANKRD20A4P","HGNC:31982","ANKRD20A4P","728747","ENSG00000172014","uc004afn.4","0.01609602836027686","","0.9990596771240234","","1413","0/1","Het","56","47,9","0.839285714285714","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 20 family member A4, pseudogene","","","","","","","","","","","CCDC144C-like,","","","","","","","","","","","","T","1.0","T","1.0","B","0.0","B","0.0","","","N","1.000","N","-1.59","T","1.97","N","2.29","0.082","T","-0.954","T","0.013","T","0.002","0.025","T","0.045","11.57","0.752","2.26","1.035","5.629"
"chr17","7386114","7386114","A>G","","SLC35G6","exonic","nonsynonymous SNV","","SLC35G6:NM_001102614:exon2:c.A811G:p.S271G","SLC35G6","exonic","nonsynonymous SNV","","SLC35G6:ENST00000412468.3_1:exon2:c.A811G:p.S271G","SLC35G6:ENST00000412468.2:c.811A>G:p.(Ser271Gly)","0.998347","0.0","0.998346984386444","0.0159926994692862","0.0","0.7042787075042725","0.0010903471957037","","","","","","","","","","ENSG00000259224","SLC35G6","HGNC:31351","SLC35G6","643664","ENSG00000259224","uc010cmj.2","0.015992699469286224","","0.9983469843864441","","1414","0/1","Het","542","497,45","0.916974169741697","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","solute carrier family 35 member G6","","integral component of membrane(GO:0016021)","","","","","","","","SpliceAI>G|SLC35G6|0.00|0.00|0.00|0.00|18|-35|-46|-4","","","","0.0049","","","0.0042","0.0049","","","0.0001","0","T","0.605","T","0.406","B","0.0","B","0.001","","","D","1","L","1.7","T","0.67","N","-1.33","0.177","T","-1.017","T","0.089","D","0.050","0.045","T","0.048","13.02","0.941","4.06","0.893","4.559"
"chr12","6939829","6939829","C>T","","P3H3","exonic","unknown","","UNKNOWN","P3H3","exonic","unknown","","UNKNOWN","P3H3:ENST00000251761.8:c.325C>T:p.(Arg109Trp)","0.9982672","0.0","0.9982671737670898","0.0159811689303861","","","","","","","","","","","","","ENSG00000110811","P3H3","HGNC:19318","P3H3","10536","ENSG00000110811","","0.01598116893038611","","0.9982671737670898","","1416","0/1","Het","113","68,45","0.601769911504425","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene belongs to the leprecan family of proteoglycans, which function as collagen prolyl hydroxylases that are required for proper collagen biosynthesis, folding and assembly. This protein, like other family members, is thought to reside in the endoplasmic reticulum. Epigenetic inactivation of this gene is associated with breast and other cancers, suggesting that it may function as a tumor suppressor. [provided by RefSeq, Aug 2013]","prolyl 3-hydroxylase 3","negative regulation of cell population proliferation(GO:0008285)|peptidyl-lysine hydroxylation(GO:0017185)|peptidyl-proline hydroxylation(GO:0019511)|collagen metabolic process(GO:0032963)|collagen biosynthetic process(GO:0032964)","endoplasmic reticulum(GO:0005783)|catalytic complex(GO:1902494)","iron ion binding(GO:0005506)|procollagen-proline 3-dioxygenase activity(GO:0019797)|L-ascorbic acid binding(GO:0031418)","","","","Extracellular matrix organization|Collagen formation|Collagen biosynthesis and modifying enzymes","","","SpliceAI>T|P3H3|0.00|0.04|0.00|0.00|-19|-26|-26|-13","","","","0.000008104","","","0.","0.0001","","","8.104e-06","5.583e-05","","","D","0.001","D","1.0","D","0.981","D","0.000","D","0.995","","","","","","","0.892","T","-0.552","T","0.247","D","0.122","0.450","D","0.981","24.2","3.250","4.76","2.102","12.112"
"chr11","130060579","130060579","G>A","","ST14","exonic","nonsynonymous SNV","","ST14:NM_021978:exon7:c.G865A:p.A289T","ST14","exonic","nonsynonymous SNV","","ST14:ENST00000278742.6_1:exon7:c.G865A:p.A289T","ST14:ENST00000278742.5:c.865G>A:p.(Ala289Thr)","0.71463585","0.2500130630141939","0.7146358489990234","0.0158862605493978","","","","","","","","","","","","","ENSG00000149418","ST14","HGNC:11344","ST14","6768","ENSG00000149418","uc001qfw.4","0.01588626054939782","0.2500130630141939","0.7146358489990234","OMIM:602400 Ichthyosis, congenital, autosomal recessive 11-autosomal_recessive;ORPHA:91132 Ichthyosis-hypotrichosis syndrome-autosomal_recessive","1421","0/1","Het","111","52,59","0.468468468468468","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Ichthyosis, congenital, autosomal recessive 11(602400)","Curly hair(HP:0002212)|Autosomal recessive inheritance(HP:0000007)|Photophobia(HP:0000613)|Congenital ichthyosiform erythroderma(HP:0007431)|Sparse and thin eyebrow(HP:0000535)|Photophobia(HP:0000613)|Sparse hair(HP:0008070)|Corneal opacity(HP:0007957)|Hypohidrosis(HP:0000966)|Sparse hair(HP:0008070)|Blepharitis(HP:0000498)|Hyperkeratosis(HP:0000962)|Pili torti(HP:0003777)|Brittle hair(HP:0002299)|Sparse hair(HP:0008070)|Ichthyosis(HP:0008064)","The protein encoded by this gene is an epithelial-derived, integral membrane serine protease. This protease forms a complex with the Kunitz-type serine protease inhibitor, HAI-1, and is found to be activated by sphingosine 1-phosphate. This protease has been shown to cleave and activate hepatocyte growth factor/scattering factor, and urokinase plasminogen activator, which suggest the function of this protease as an epithelial membrane activator for other proteases and latent growth factors. The expression of this protease has been associated with breast, colon, prostate, and ovarian tumors, which implicates its role in cancer invasion, and metastasis. [provided by RefSeq, Jul 2008]","ST14 transmembrane serine protease matriptase","neural tube closure(GO:0001843)|proteolysis(GO:0006508)|keratinocyte differentiation(GO:0030216)|keratinocyte differentiation(GO:0030216)|epithelial cell morphogenesis involved in placental branching(GO:0060672)","extracellular space(GO:0005615)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|basolateral plasma membrane(GO:0016323)|extrinsic component of plasma membrane(GO:0019897)","serine-type endopeptidase activity(GO:0004252)|serine-type peptidase activity(GO:0008236)","cancer(DOID:162)|squamous cell carcinoma(DOID:1749)|pancreatic ductal adenocarcinoma(DOID:3498)|renal cell carcinoma(DOID:4450)|hypotrichosis(DOID:4535)","","","Developmental biology|Keratinization|Formation of the cornified envelope","","Estrogen response late|P53 pathway","","CUB","","","0.00001549","","","0.","","","","1.549e-05","0","T","0.285","T","0.183","B","0.065","B","0.063","N","0.036","N","1","L","0.995","T","2.23","N","-1.29","0.121","T","-1.032","T","0.031","T","0.007","0.029","T","0.158","8.782","0.437","5.55","0.730","10.009"
"chr3","194349230","194349230","T>C","","TMEM44","exonic","nonsynonymous SNV","","TMEM44:NM_001011655:exon2:c.A146G:p.Y49C,TMEM44:NM_001166305:exon2:c.A146G:p.Y49C,TMEM44:NM_001166306:exon2:c.A146G:p.Y49C,TMEM44:NM_138399:exon2:c.A146G:p.Y49C","TMEM44","exonic","nonsynonymous SNV","","TMEM44:ENST00000347147.9_1:exon2:c.A146G:p.Y49C,TMEM44:ENST00000381975.7_1:exon2:c.A146G:p.Y49C,TMEM44:ENST00000392432.6_1:exon2:c.A146G:p.Y49C,TMEM44:ENST00000473092.5_1:exon2:c.A146G:p.Y49C","TMEM44:ENST00000273580.7:c.146A>G:p.(Tyr49Cys)","0.99748087","0.0","0.9974808692932128","0.0158680049029979","","","","","","","","","","","","","ENSG00000145014","TMEM44","HGNC:25120","TMEM44","93109","ENSG00000145014","uc011bsv.3","0.015868004902997977","","0.9974808692932129","","1422","0/1","Het","61","34,27","0.557377049180328","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","transmembrane protein 44","","integral component of membrane(GO:0016021)","","","","","","","","",".;.;.;.","","Score=908;Name=V$OCT1_06","0.00005458","","","","","","","4.014e-06","5.458e-05","D","0.007","D","0.0","D","1.0","D","0.999","D","0.000","D","0.988","L","1.04","T","1.54","D","-5.04","0.607","T","-0.679","T","0.217","D","0.033","0.323","D","0.982","24.2","3.240","5.23","1.528","11.521"
"chr7","1784444","1784444","G>A","","ELFN1","exonic","nonsynonymous SNV","","ELFN1:NM_001128636:exon2:c.G212A:p.R71H","ELFN1","exonic","nonsynonymous SNV","","ELFN1:ENST00000561626.3_1:exon2:c.G212A:p.R71H,ELFN1:ENST00000424383.4_1:exon3:c.G212A:p.R71H","ELFN1:ENST00000424383.2:c.212G>A:p.(Arg71His)","0.9972986","0.0","0.9972985982894896","0.0158418854403648","","","","","","","","","","","","","ENSG00000225968","ELFN1","HGNC:33154","ELFN1","392617","ENSG00000225968","uc064aye.1","0.015841885440364897","","0.9972985982894897","","1423","0/1","Het","325","176,149","0.541538461538462","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","extracellular leucine rich repeat and fibronectin type III domain containing 1","negative regulation of catalytic activity(GO:0043086)|synapse organization(GO:0050808)","extracellular space(GO:0005615)|integral component of membrane(GO:0016021)|dendrite(GO:0030425)|extracellular matrix(GO:0031012)|excitatory synapse(GO:0060076)","protein phosphatase inhibitor activity(GO:0004864)","","","","","","","",".;.","","Score=959;Name=V$GATA2_01","0.00000575","","","0.","0.","","","5.75e-06","0","D","0.001","D","0.003","D","0.989","P","0.563","","","D","0.904","L","1.02","T","0.62","N","-2.23","0.235","","","","","D","0.386","","","","26.1","3.761","4.21","5.745","3.153"
"chr16","24762086","24762086","G>C","","TNRC6A","exonic","nonsynonymous SNV","","TNRC6A:NM_014494:exon3:c.G93C:p.K31N","TNRC6A","exonic","nonsynonymous SNV","","TNRC6A:ENST00000315183.11_1:exon3:c.G93C:p.K31N,TNRC6A:ENST00000395799.8_1:exon3:c.G93C:p.K31N","TNRC6A:ENST00000315183.7:c.93G>C:p.(Lys31Asn)","0.99689794","0.0","0.9968979358673096","0.015784619058236","","","","","","","","","","","","","ENSG00000090905","TNRC6A","HGNC:11969","TNRC6A","27327","ENSG00000090905","uc002dmm.4","0.01578461905823604","","0.9968979358673096","OMIM:618074 ?Epilepsy, familial adult myoclonic, 6-autosomal_dominant","1424","0/1","Het","38","19,19","0.5","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Epilepsy, familial adult myoclonic, 6(618074)","Myoclonic tremor(HP:0033054)|Adult onset(HP:0003581)|Autosomal dominant inheritance(HP:0000006)","This gene encodes a member of the trinucleotide repeat containing 6 protein family. The protein functions in post-transcriptional gene silencing through the RNA interference (RNAi) and microRNA pathways. The protein associates with messenger RNAs and Argonaute proteins in cytoplasmic bodies known as GW-bodies or P-bodies. Inhibiting expression of this gene delocalizes other GW-body proteins and impairs RNAi and microRNA-induced gene silencing. [provided by RefSeq, Jul 2008]","trinucleotide repeat containing adaptor 6A","cellular response to starvation(GO:0009267)|gene silencing by miRNA(GO:0035195)|gene silencing by miRNA(GO:0035195)|miRNA mediated inhibition of translation(GO:0035278)|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213)","P-body(GO:0000932)|P-body(GO:0000932)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|Golgi apparatus(GO:0005794)|cytosol(GO:0005829)|RISC complex(GO:0016442)|intracellular membrane-bounded organelle(GO:0043231)","RNA binding(GO:0003723)|protein binding(GO:0005515)","cancer(DOID:162)","","","Signaling by notch|Pre notch expression and processing|Signaling by wnt|Gene silencing by rna|Oxidative stress induced senescence|Cellular senescence|Oncogene induced senescence|Transcriptional regulation by tp53|Beta catenin independent wnt signaling|Ca2 pathway|Transcriptional regulation by small rnas|Tp53 regulates metabolic genes|Mapk family signaling cascades|Mapk6 mapk4 signaling|Pten regulation|Rna polymerase ii transcription|Transcriptional regulation by ventx|Transcriptional regulation by runx1|Regulation of runx1 expression and activity|Runx1 regulates genes involved in megakaryocyte differentiation and platelet function|Esr mediated signaling|Regulation of pten mrna translation|Competing endogenous rnas cernas regulate pten translation|Cellular responses to external stimuli|Transcriptional regulation by mecp2|Intracellular signaling by second messengers|Signaling by nuclear receptors|Estrogen dependent gene expression|Regulation of mecp2 expression and activity|Nr1h2 and nr1h3 mediated signaling|Nr1h3 nr1h2 regulate gene expression linked to cholesterol transport and efflux","","","",".;.","Name=GA-rich","Score=809;Name=V$EVI1_03","","","","","","","","","","D","0.004","D","0.012","B","0.319","B","0.104","D","0.001","N","0.818","L","1.22","T","2.09","N","-1.65","0.455","T","-1.114","T","0.044","T","0.007","0.043","D","0.800","24.0","3.164","4.99","5.067","13.968"
"chr16","22087020","22087020","->TGATCCTTTTCTGTATGGCTGCCCTAATATTTCCAATAGGATTTTACATCAAT","","C16orf52","exonic","stopgain","","C16orf52:NM_001164579:exon2:c.319_320insTGATCCTTTTCTGTATGGCTGCCCTAATATTTCCAATAGGATTTTACATCAAT:p.E125*","MOSMO","exonic","stopgain","","MOSMO:ENST00000542527.7_1:exon2:c.319_320insTGATCCTTTTCTGTATGGCTGCCCTAATATTTCCAATAGGATTTTACATCAAT:p.E125*,MOSMO:ENST00000562695.1_1:exon2:c.319_320insTGATCCTTTTCTGTATGGCTGCCCTAATATTTCCAATAGGATTTTACATCAAT:p.S107Mfs*39,MOSMO:ENST00000567004.1_1:exon2:c.265_266insTGATCCTTTTCTGTATGGCTGCCCTAATATTTCCAATAGGATTTTACATCAAT:p.S89Mfs*39,MOSMO:ENST00000569656.5_1:exon2:c.319_320insTGATCCTTTTCTGTATGGCTGCCCTAATATTTCCAATAGGATTTTACATCAAT:p.K107Mfs*39","MOSMO:ENST00000562695.1:c.319_320insTGATCCTTTTCTGTATGGCTGCCCTAATATTTCCAATAGGATTTTACATCAAT:p.(Ser107Metfs*39)","0.9963485","0.0","0.99634850025177","0.0157064196960854","","","","","","","","","","","","","ENSG00000185716","MOSMO","HGNC:27087","MOSMO","730094","ENSG00000185716","uc002dkd.3","0.01570641969608544","","0.99634850025177","","1425","0/1","Het","101","82,19","0.811881188118812","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","modulator of smoothened","cell differentiation(GO:0030154)|regulation of protein stability(GO:0031647)|regulation of neuron differentiation(GO:0045664)|negative regulation of smoothened signaling pathway(GO:0045879)|negative regulation of smoothened signaling pathway(GO:0045879)","Golgi apparatus(GO:0005794)|Golgi apparatus(GO:0005794)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|ciliary membrane(GO:0060170)|ciliary membrane(GO:0060170)","","","","","","","","","","","Score=768;Name=V$STAT5A_02","0.0001","","","","","","","0.0001","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr19","42827820","42827820","C>G","","TMEM145","exonic","nonsynonymous SNV","","TMEM145:NM_173633:exon14:c.C1280G:p.P427R","TMEM145","exonic","nonsynonymous SNV","","TMEM145:ENST00000301204.8_1:exon14:c.C1280G:p.P427R,TMEM145:ENST00000673187.1_1:exon14:c.C1322G:p.P441R,TMEM145:ENST00000673205.1_1:exon14:c.C1280G:p.P427R","TMEM145:ENST00000301204.3:c.1280C>G:p.(Pro427Arg)","0.9959623","0.0","0.9959623217582704","0.0156516844505952","","","","","","","","","","","","","ENSG00000167619","TMEM145","HGNC:26912","TMEM145","284339","ENSG00000167619","uc002otk.2","0.015651684450595296","","0.9959623217582703","","1426","0/1","Het","182","98,84","0.538461538461538","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","transmembrane protein 145","G protein-coupled receptor signaling pathway(GO:0007186)|response to pheromone(GO:0019236)","integral component of membrane(GO:0016021)","","","","","","","","","","","","0.00005441","","","0.","0.0001","","","3.979e-06","5.441e-05","T","0.428","D","0.035","D","0.99","P","0.675","N","0.045","D","0.998","L","1.15","T","0.93","N","-1.49","0.399","T","-1.069","T","0.114","T","0.017","0.124","T","0.337","21.4","2.200","4.83","1.277","9.448"
"chr16","28509412","28509412","C>T","","APOBR","exonic","nonsynonymous SNV","","APOBR:NM_018690:exon3:c.C2966T:p.P989L","APOBR","exonic","nonsynonymous SNV","","APOBR:ENST00000564831.6_1:exon3:c.C2966T:p.P989L,APOBR:ENST00000431282.2_1:exon4:c.C2939T:p.P980L","APOBR:ENST00000328423.5:c.2939C>T:p.(Pro980Leu)","0.9956722","0.0","0.9956722259521484","0.015610691052455","","","","","","","","","","","","","ENSG00000184730","APOBR","HGNC:24087","APOBR","55911","ENSG00000184730","uc002dqb.2","0.015610691052455066","","0.9956722259521484","","1427","0/1","Het","227","118,109","0.519823788546256","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Apolipoprotein B48 receptor is a macrophage receptor that binds to the apolipoprotein B48 of dietary triglyceride (TG)-rich lipoproteins. This receptor may provide essential lipids, lipid-soluble vitamins and other nutrients to reticuloendothelial cells. If overwhelmed with elevated plasma triglyceride, the apolipoprotein B48 receptor may contribute to foam cell formation, endothelial dysfunction, and atherothrombogenesis. [provided by RefSeq, Jul 2008]","apolipoprotein B receptor","triglyceride metabolic process(GO:0006641)|lipid transport(GO:0006869)|endocytosis(GO:0006897)|cholesterol metabolic process(GO:0008203)","plasma membrane(GO:0005886)|membrane(GO:0016020)|very-low-density lipoprotein particle(GO:0034361)|low-density lipoprotein particle(GO:0034362)|chylomicron(GO:0042627)","very-low-density lipoprotein particle receptor activity(GO:0030229)","atherosclerosis(DOID:1936)","","","Plasma lipoprotein assembly remodeling and clearance|Transport of small molecules|Plasma lipoprotein clearance|Vldl clearance","","","SpliceAI>T|APOBR|0.01|0.02|0.00|0.00|-10|31|-10|31",".;.","","","0.00002477","","","0.","0.0002","","","2.477e-05","0.0003","D","0.0","D","0.01","D","1.0","D","1.0","","","D","1.000","L","1.735","T","-0.22","D","-5.93","0.501","T","-0.314","T","0.350","D","0.221","0.278","D","0.531","23.3","2.893","4.63","2.642","12.997"
"chr19","55377348","55377348","G>C","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.G1038C:p.W346C,KIR3DL2:NM_006737:exon7:c.G1089C:p.W363C","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.G1038C:p.W346C,KIR3DL2:ENST00000326321.7_1:exon7:c.G1089C:p.W363C","KIR3DL2:ENST00000270442.5:c.1038G>C:p.(Trp346Cys)","0.995","0.0","0.9950000047683716","0.0155161052507706","0.0","0.9939999878406524","0.0153764393342043","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1428","0/1","Het","106","85,21","0.80188679245283","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","","","","","","","","","","D","0.011","T","0.055","D","0.999","D","0.995","U","0.005","N","1.000","M","2.65","T","7.12","D","-8.3","0.417","T","-0.938","T","0.005","T","5.45E-4","0.087","D","0.919","21.5","2.211","0.792","0.848","4.875"
"chr19","55377325","55377325","C>T","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.C1015T:p.L339F,KIR3DL2:NM_006737:exon7:c.C1066T:p.L356F","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.C1015T:p.L339F,KIR3DL2:ENST00000326321.7_1:exon7:c.C1066T:p.L356F","KIR3DL2:ENST00000270442.5:c.1015C>T:p.(Leu339Phe)","0.993","","","","0.0","0.9939999878406524","0.0153764393342043","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1429","0/1","Het","102","82,20","0.803921568627451","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","Name=CT-rich","","","","","","","","","","","T","0.749","T","0.137","D","0.999","D","0.993","U","0.959","N","1","L","1.67","T","6.68","N","-0.57","0.144","T","-0.940","T","0.004","T","6.53E-4","0.046","T","0.150","6.278","0.230","0.792","-0.403","2.405"
"chr19","55367083","55367083","A>G","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon5:c.A665G:p.E222G,KIR3DL2:NM_006737:exon5:c.A665G:p.E222G","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon5:c.A665G:p.E222G,KIR3DL2:ENST00000326321.7_1:exon5:c.A665G:p.E222G","KIR3DL2:ENST00000270442.5:c.665A>G:p.(Glu222Gly)","0.99","","","","","","","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1430","0/1","Het","145","131,14","0.903448275862069","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","","","","","","","","","","T","0.118","T","0.271","D","0.999","D","0.99","U","0.407","N","1","N","0.38","T","5.81","N","-1.77","0.087","T","-0.864","T","0.005","T","0.001","0.018","T","0.048","18.02","1.777","0.993","-0.810","4.242"
"chr19","55377343","55377343","C>T","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.C1033T:p.R345C,KIR3DL2:NM_006737:exon7:c.C1084T:p.R362C","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.C1033T:p.R345C,KIR3DL2:ENST00000326321.7_1:exon7:c.C1084T:p.R362C","KIR3DL2:ENST00000270442.5:c.1033C>T:p.(Arg345Cys)","0.98164225","","","","","","","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1431","0/1","Het","106","86,20","0.811320754716981","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","0.00001195","","","0.","0.","","","1.195e-05","0","D","0.049","D","0.045","D","0.998","P","0.724","U","0.003","N","1","M","2.18","T","7.01","D","-3.01","0.177","T","-0.926","T","0.005","T","7.08E-4","0.076","T","0.077","18.07","1.783","0.792","-0.462","4.875"
"chr19","55377302","55377302","T>C","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.T992C:p.V331A,KIR3DL2:NM_006737:exon7:c.T1043C:p.V348A","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.T992C:p.V331A,KIR3DL2:ENST00000326321.7_1:exon7:c.T1043C:p.V348A","KIR3DL2:ENST00000270442.5:c.992T>C:p.(Val331Ala)","0.966","","","","","","","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1432","0/1","Het","101","84,17","0.831683168316832","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","Name=CT-rich","","","","","","","","","","","T","0.162","T","0.986","D","0.98","D","0.966","N","0.029","N","1","N","0.395","T","7.27","N","-0.92","0.126","T","-0.917","T","0.002","T","4.01E-4","0.065","T","0.139","0.183","-0.399","0.792","-0.401","5.878"
"chr19","55377265","55377265","T>C","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.T955C:p.C319R,KIR3DL2:NM_006737:exon7:c.T1006C:p.C336R","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.T955C:p.C319R,KIR3DL2:ENST00000326321.7_1:exon7:c.T1006C:p.C336R","KIR3DL2:ENST00000270442.5:c.955T>C:p.(Cys319Arg)","0.866","","","","","","","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1433","0/1","Het","83","68,15","0.819277108433735","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","","","","","","","","","","T","0.134","T","0.451","B","0.0","B","0.0","","","N","1.000","N","-1.04","T","7.31","N","0.16","0.083","T","-0.976","T","0.001","T","0.001","0.009","T","0.059","6.833","0.271","0.609","-1.665",""
"chr19","55377280","55377280","G>A","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.G970A:p.V324I,KIR3DL2:NM_006737:exon7:c.G1021A:p.V341I","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.G970A:p.V324I,KIR3DL2:ENST00000326321.7_1:exon7:c.G1021A:p.V341I","KIR3DL2:ENST00000270442.5:c.970G>A:p.(Val324Ile)","0.848","","","","","","","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1434","0/1","Het","87","72,15","0.827586206896552","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","SpliceAI>A|KIR3DL2|0.00|0.00|0.00|0.00|-30|-10|-3|-21",".;.","","","","","","","","","","","","T","0.164","T","0.419","B","0.002","B","0.01","","","N","1","L","1.11","T","7.18","N","-0.21","0.072","T","-0.975","T","0.001","T","5.53E-4","0.008","T","0.082","0.009","-0.805","0.792","-0.835","3.986"
"chr19","55377875","55377875","C>G","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon7:c.C1105G:p.Q369E,KIR3DL2:NM_006737:exon8:c.C1156G:p.Q386E","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon7:c.C1105G:p.Q369E,KIR3DL2:ENST00000326321.7_1:exon8:c.C1156G:p.Q386E","KIR3DL2:ENST00000270442.5:c.1105C>G:p.(Gln369Glu)","0.6","","","","","","","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1435","0/1","Het","167","143,24","0.856287425149701","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","","","","","","","","","","T","1.0","T","1.0","B","0.0","B","0.0","","","N","1","N","-1.08","T","7.15","N","1.42","0.047","T","-0.988","T","0.000","T","4.87E-4","0.019","T","0.048","0.010","-0.790","1.05","0.363","6.644"
"chr19","55377319","55377319","C>A","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.C1009A:p.L337I,KIR3DL2:NM_006737:exon7:c.C1060A:p.L354I","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.C1009A:p.L337I,KIR3DL2:ENST00000326321.7_1:exon7:c.C1060A:p.L354I","KIR3DL2:ENST00000270442.5:c.1009C>A:p.(Leu337Ile)","0.491","","","","","","","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1436","0/1","Het","99","79,20","0.797979797979798","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","Name=CT-rich","","","","","","","","","","","T","0.509","T","1.0","B","0.01","B","0.009","N","0.026","N","1","N","-0.22","T","6.79","N","1.13","0.193","T","-0.867","T","0.001","T","7.73E-4","0.013","T","0.241","0.001","-1.449","0.756","-0.986","6.404"
"chr19","55377340","55377340","T>C","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.T1030C:p.Y344H,KIR3DL2:NM_006737:exon7:c.T1081C:p.Y361H","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.T1030C:p.Y344H,KIR3DL2:ENST00000326321.7_1:exon7:c.T1081C:p.Y361H","KIR3DL2:ENST00000270442.5:c.1030T>C:p.(Tyr344His)","0.0039967652","","","","","","","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1437","0/1","Het","105","83,22","0.79047619047619","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","","","0.000007961","","","","","","","7.961e-06","0","T","1.0","T","0.639","B","0.001","B","0.004","N","0.001","N","1","N","-1.885","T","7.23","N","2.95","0.108","T","-0.904","T","0.000","T","9.29E-4","0.052","T","0.056","0.064","-0.545","0.792","-0.520","4.953"
"chr19","55377307","55377307","T>A","","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:NM_001242867:exon6:c.T997A:p.F333I,KIR3DL2:NM_006737:exon7:c.T1048A:p.F350I","KIR3DL2","exonic","nonsynonymous SNV","","KIR3DL2:ENST00000270442.5_1:exon6:c.T997A:p.F333I,KIR3DL2:ENST00000326321.7_1:exon7:c.T1048A:p.F350I","KIR3DL2:ENST00000270442.5:c.997T>A:p.(Phe333Ile)","0.0009997969","","","","","","","","","","","","","","","","ENSG00000240403","KIR3DL2","HGNC:6339","KIR3DL2","3812","ENSG00000240403","uc002qho.5","0.015516105250770688","","0.9950000047683716","","1438","0/1","Het","104","87,17","0.836538461538462","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2","cellular defense response(GO:0006968)|negative regulation of neuron death(GO:1901215)","plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)","protein binding(GO:0005515)|MHC class Ib protein binding(GO:0023029)","dermatomyositis(DOID:10223)|pre-eclampsia(DOID:10591)|childhood type dermatomyositis(DOID:14203)|syndrome(DOID:225)|schizophrenia(DOID:5419)|spondylitis(DOID:6590)|ankylosing spondylitis(DOID:7147)|cancer(DOID:162)|disease(DOID:4)|Sezary's disease(DOID:8541)","Antigen processing and presentation|Natural killer cell mediated cytotoxicity|Graft versus host disease","","Adaptive immune system|Immunoregulatory interactions between a lymphoid and a non lymphoid cell","","","",".;.","Name=CT-rich","","0.000003977","","","0.","0.","","","3.977e-06","0","T","1.0","T","1.0","B","0.0","B","0.001","N","0.521","N","1","N","-2.095","T","7.34","N","2.41","0.177","T","-0.951","T","0.000","T","5.53E-4","0.025","T","0.102","0.464","-0.265","0.792","-3.473","1.833"
"chr1","49201966","49201966","->T","","BEND5","exonic","frameshift insertion","","BEND5:NM_001302082:exon5:c.545dupA:p.K183Efs*6,BEND5:NM_024603:exon5:c.1052dupA:p.K352Efs*6","BEND5","exonic","frameshift insertion","","BEND5:ENST00000371833.4_1:exon5:c.1052dupA:p.K352Efs*6","BEND5:ENST00000371833.3:c.1052dup:p.(Lys352Glufs*6)","0.99462295","0.0","0.9946229457855223","0.0154632978148526","","","","","","","","","","","","","ENSG00000162373","BEND5","HGNC:25668","BEND5","79656","ENSG00000162373","uc001crx.5","0.015463297814852615","","0.9946229457855225","","1439","0/1","Het","125","108,17","0.864","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","BEN domain containing 5","negative regulation of transcription, DNA-templated(GO:0045892)|negative regulation of transcription, DNA-templated(GO:0045892)","Golgi apparatus(GO:0005794)","DNA binding(GO:0003677)|protein binding(GO:0005515)","","","","","","","SpliceAI>CT|AGBL4|0.00|0.00|0.00|0.00|46|30|0|1>CT|BEND5|0.00|0.00|0.00|0.00|46|30|0|1","","","Score=756;Name=V$PAX4_04","0.00002496","","","0.0008","0.0005","","","2.496e-05","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chrX","37027738","37027738","C>T","","FAM47C","exonic","nonsynonymous SNV","","FAM47C:NM_001013736:exon1:c.C1255T:p.P419S","FAM47C","exonic","nonsynonymous SNV","","FAM47C:ENST00000358047.5_1:exon1:c.C1255T:p.P419S","FAM47C:ENST00000358047.3:c.1255C>T:p.(Pro419Ser)","0.994","","","","","","","0.0","0.9940000176429749","0.0153764434780069","0.0","0.9940000176429749","0.0153764434780069","","","","ENSG00000198173","FAM47C","HGNC:25301","FAM47C","442444","ENSG00000198173","uc004ddl.3","0.015376443478006992","","0.9940000176429749","","1440","0/1","Het","205","114,91","0.55609756097561","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a product belonging to a family of proteins with unknown function. The coding sequence of this family member includes several tandemly repeated regions. [provided by RefSeq, Sep 2011]","family with sequence similarity 47 member C","","","","","","","","","","","","","","","","","","","","","","","T","0.489","T","0.141","D","1.0","D","0.994","","","N","1.000","L","1.13","T","1.97","N","-1.08","0.068","T","-1.022","T","0.113","T","0.002","0.072","T","0.230","14.62","1.193","1.23","0.286","8.239"
"chr2","86393732","86393732","T>C","","IMMT","exonic","nonsynonymous SNV","","IMMT:NM_001100169:exon7:c.A688G:p.T230A,IMMT:NM_001100170:exon7:c.A658G:p.T220A,IMMT:NM_006839:exon7:c.A691G:p.T231A","IMMT","exonic","nonsynonymous SNV","","IMMT:ENST00000409051.6_1:exon6:c.A550G:p.T184A,IMMT:ENST00000254636.9_1:exon7:c.A394G:p.T132A,IMMT:ENST00000410111.8_1:exon7:c.A691G:p.T231A,IMMT:ENST00000442664.6_1:exon7:c.A688G:p.T230A,IMMT:ENST00000449247.6_1:exon7:c.A658G:p.T220A,IMMT:ENST00000620815.4_1:exon7:c.A655G:p.T219A","IMMT:ENST00000254636.5:c.394A>G:p.(Thr132Ala)","0.99375165","0.0","0.9937516450881958","0.0153419471707163","","","","","","","","","","","","","ENSG00000132305","IMMT","HGNC:6047","IMMT","10989","ENSG00000132305","uc002sqz.4","0.01534194717071635","","0.9937516450881958","","1441","0/1","Het","76","43,33","0.565789473684211","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","inner membrane mitochondrial protein","inner mitochondrial membrane organization(GO:0007007)|cristae formation(GO:0042407)|cristae formation(GO:0042407)|mitochondrial calcium ion homeostasis(GO:0051560)","SAM complex(GO:0001401)|mitochondrion(GO:0005739)|mitochondrion(GO:0005739)|mitochondrial inner membrane(GO:0005743)|mitochondrial intermembrane space(GO:0005758)|membrane(GO:0016020)|MICOS complex(GO:0061617)|MICOS complex(GO:0061617)|MICOS complex(GO:0061617)|MIB complex(GO:0140275)","RNA binding(GO:0003723)|protein binding(GO:0005515)","syndrome(DOID:225)","","","Mitochondrial biogenesis|Organelle biogenesis and maintenance|Cristae formation","","Adipogenesis|Mtorc1 signaling|Oxidative phosphorylation","",".;.;.;.;.;.","","","0.00003225","0.0002","0.001","0.","0.0004","","","3.225e-05","0.0004","T","0.171","T","0.642","B","0.324","B","0.273","D","0.000","D","0.999","","","T","1.53","N","-1.73","0.434","T","-1.060","T","0.106","T","0.015","0.181","T","0.159","23.0","2.719","5.36","2.499","14.643"
"chr1","1159283","1159283","G>A","","SDF4","exonic","nonsynonymous SNV","","SDF4:NM_016176:exon3:c.C392T:p.T131M,SDF4:NM_016547:exon3:c.C392T:p.T131M","SDF4","exonic","nonsynonymous SNV","","SDF4:ENST00000263741.12_1:exon3:c.C371T:p.T124M,SDF4:ENST00000360001.12_1:exon3:c.C371T:p.T124M,SDF4:ENST00000660930.1_1:exon3:c.C392T:p.T131M","SDF4:ENST00000263741.7:c.392C>T:p.(Thr131Met)","0.9934424","0.0","0.9934424161911012","0.0152991050217575","","","","","","","","","","","","","ENSG00000078808","SDF4","HGNC:24188","SDF4","51150","ENSG00000078808","uc001adi.5","0.015299105021757542","","0.9934424161911011","","1442","0/1","Het","71","36,35","0.507042253521127","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a stromal cell derived factor that is a member of the CREC protein family. The encoded protein contains six EF-hand motifs and calcium-binding motifs. This protein localizes to the Golgi lumen and may be involved in regulating calcium dependent cellular activities. [provided by RefSeq, Sep 2011]","stromal cell derived factor 4","UV protection(GO:0009650)|calcium-ion regulated exocytosis(GO:0017156)|calcium-ion regulated exocytosis(GO:0017156)|cerebellum development(GO:0021549)|fat cell differentiation(GO:0045444)|response to ethanol(GO:0045471)|zymogen granule exocytosis(GO:0070625)|maintenance of synapse structure(GO:0099558)","cytoplasm(GO:0005737)|late endosome(GO:0005770)|endoplasmic reticulum(GO:0005783)|Golgi apparatus(GO:0005794)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|membrane(GO:0016020)|bleb(GO:0032059)|extracellular exosome(GO:0070062)","calcium ion binding(GO:0005509)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|identical protein binding(GO:0042802)","","","","","","","","EF-hand","","","0.00002817","","","0.","0.","","","2.817e-05","0","D","0.019","D","0.003","P","0.518","B","0.228","D","0.000","D","1","L","1.725","T","-0.56","N","-1.34","0.835","T","-0.179","T","0.401","D","0.169","0.289","T","0.465","22.2","2.347","4.24","9.480","16.001"
"chr9","69200747","69200747","G>T","","FOXD4L6","exonic","nonsynonymous SNV","","FOXD4L6:NM_001085476:exon1:c.C866A:p.A289D","FOXD4L6","exonic","nonsynonymous SNV","","FOXD4L6:ENST00000377473.1:exon1:c.C866A:p.A289D","FOXD4L6:ENST00000377473.1:c.866C>A:p.(Ala289Asp)","0.52746946","","","","0.5033130892552435","0.422734722495079","0.0151554786487035","","","","","","","","","","ENSG00000204793","FOXD4L6","HGNC:31986","FOXD4L6","653404","ENSG00000273514","uc004afi.3","0.015155478648703561","0.5033130892552435","0.42273472249507904","","1445","0/1","Het","58","46,12","0.793103448275862","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","forkhead box D4 like 6","regulation of transcription by RNA polymerase II(GO:0006357)|anatomical structure morphogenesis(GO:0009653)|cell differentiation(GO:0030154)","chromatin(GO:0000785)|nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|protein binding(GO:0005515)","","","","","","","SpliceAI>T|FOXD4L6|0.00|0.00|0.00|0.00|16|-34|7|-24","","","","0.0002","","","","","","","0.0002","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr12","51385452","51385452","G>A","","SLC11A2","exonic","nonsynonymous SNV","","SLC11A2:NM_001174130:exon13:c.C1339T:p.P447S,SLC11A2:NM_000617:exon14:c.C1351T:p.P451S,SLC11A2:NM_001174125:exon14:c.C1438T:p.P480S,SLC11A2:NM_001174126:exon14:c.C1351T:p.P451S,SLC11A2:NM_001174127:exon14:c.C1351T:p.P451S,SLC11A2:NM_001174128:exon14:c.C1351T:p.P451S,SLC11A2:NM_001174129:exon14:c.C1351T:p.P451S","SLC11A2","exonic","nonsynonymous SNV","","SLC11A2:ENST00000545993.7_1:exon13:c.C1339T:p.P447S,SLC11A2:ENST00000262052.9_1:exon14:c.C1351T:p.P451S,SLC11A2:ENST00000394904.9_1:exon14:c.C1438T:p.P480S,SLC11A2:ENST00000541174.6_1:exon14:c.C1351T:p.P451S,SLC11A2:ENST00000546743.5_1:exon14:c.C1114T:p.P372S,SLC11A2:ENST00000547198.5_1:exon14:c.C1351T:p.P451S,SLC11A2:ENST00000547688.7_1:exon14:c.C1438T:p.P480S,SLC11A2:ENST00000644495.1_1:exon14:c.C1351T:p.P451S,SLC11A2:ENST00000643884.1_1:exon15:c.C1387T:p.P463S","SLC11A2:ENST00000262051.7:c.1351C>T:p.(Pro451Ser)","0.991394","0.0","0.9913939833641052","0.0150182642484999","","","","","","","","","","","","","ENSG00000110911","SLC11A2","HGNC:10908","SLC11A2","4891","ENSG00000110911","uc001rxi.4","0.015018264248499941","","0.9913939833641052","OMIM:206100 Anemia, hypochromic microcytic, with iron overload 1-autosomal_recessive","1446","0/1","Het","63","33,30","0.523809523809524","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Anemia, hypochromic microcytic, with iron overload 1(206100)","Decreased mean corpuscular volume(HP:0025066)|Abnormality of the liver(HP:0001392)|Autosomal recessive inheritance(HP:0000007)|Abnormality of metabolism/homeostasis(HP:0001939)|Hypochromia(HP:0032231)","This gene encodes a member of the solute carrier family 11 protein family. The product of this gene transports divalent metals and is involved in iron absorption. Mutations in this gene are associated with hypochromic microcytic anemia with iron overload. A related solute carrier family 11 protein gene is located on chromosome 2. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Apr 2010]","solute carrier family 11 member 2","response to hypoxia(GO:0001666)|heme biosynthetic process(GO:0006783)|cobalt ion transport(GO:0006824)|copper ion transport(GO:0006825)|iron ion transport(GO:0006826)|manganese ion transport(GO:0006828)|cellular iron ion homeostasis(GO:0006879)|learning or memory(GO:0007611)|response to iron ion(GO:0010039)|lead ion transport(GO:0015692)|iron import into cell(GO:0033212)|iron import into cell(GO:0033212)|iron ion transmembrane transport(GO:0034755)|copper ion transmembrane transport(GO:0035434)|nickel cation transmembrane transport(GO:0035444)|dendrite morphogenesis(GO:0048813)|erythrocyte development(GO:0048821)|multicellular organismal iron ion homeostasis(GO:0060586)|multicellular organismal iron ion homeostasis(GO:0060586)|cadmium ion transmembrane transport(GO:0070574)|manganese ion transmembrane transport(GO:0071421)|proton transmembrane transport(GO:1902600)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|mitochondrion(GO:0005739)|mitochondrial outer membrane(GO:0005741)|lysosomal membrane(GO:0005765)|lysosomal membrane(GO:0005765)|lysosomal membrane(GO:0005765)|early endosome(GO:0005769)|early endosome(GO:0005769)|vacuole(GO:0005773)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|integral component of plasma membrane(GO:0005887)|integral component of plasma membrane(GO:0005887)|integral component of plasma membrane(GO:0005887)|cell surface(GO:0009986)|membrane(GO:0016020)|apical plasma membrane(GO:0016324)|cytoplasmic vesicle(GO:0031410)|brush border membrane(GO:0031526)|late endosome membrane(GO:0031902)|late endosome membrane(GO:0031902)|apical part of cell(GO:0045177)|apical part of cell(GO:0045177)|basal part of cell(GO:0045178)|perinuclear region of cytoplasm(GO:0048471)|recycling endosome(GO:0055037)|recycling endosome(GO:0055037)|paraferritin complex(GO:0070826)|extracellular vesicle(GO:1903561)|extracellular vesicle(GO:1903561)","copper ion transmembrane transporter activity(GO:0005375)|iron ion transmembrane transporter activity(GO:0005381)|iron ion transmembrane transporter activity(GO:0005381)|manganese ion transmembrane transporter activity(GO:0005384)|manganese ion transmembrane transporter activity(GO:0005384)|protein binding(GO:0005515)|cadmium ion transmembrane transporter activity(GO:0015086)|cadmium ion transmembrane transporter activity(GO:0015086)|cobalt ion transmembrane transporter activity(GO:0015087)|ferrous iron transmembrane transporter activity(GO:0015093)|ferrous iron transmembrane transporter activity(GO:0015093)|ferrous iron transmembrane transporter activity(GO:0015093)|ferrous iron transmembrane transporter activity(GO:0015093)|lead ion transmembrane transporter activity(GO:0015094)|lead ion transmembrane transporter activity(GO:0015094)|nickel cation transmembrane transporter activity(GO:0015099)|solute:proton symporter activity(GO:0015295)|cadmium ion binding(GO:0046870)|cadmium ion binding(GO:0046870)|transition metal ion transmembrane transporter activity(GO:0046915)","Alzheimer's disease(DOID:10652)|microcytic anemia(DOID:11252)|syndrome(DOID:225)|lateral sclerosis(DOID:230)|hemochromatosis(DOID:2352)|anemia(DOID:2355)|amyotrophic lateral sclerosis(DOID:332)|kidney disease(DOID:557)","Lysosome","Wp copper homeostasis|Wp iron metabolism in placenta|Wp hereditary leiomyomatosis and renal cell carcinoma pathway|Wp ferroptosis","Transport of small molecules|Transport of bile salts and organic acids metal ions and amine compounds|Slc mediated transmembrane transport|Metal ion slc transporters|Slc transporter disorders|Disorders of transmembrane transporters|Iron uptake and transport","","Inflammatory response|Heme metabolism","",".;.;.;.;.;.;.;.;.;.;.","","Score=841;Name=V$HNF4_01_B","0.0000439","0.0002","0.001","0.","0.0006","","","4.39e-05","0.0006","D","0.0","D","0.001","D","1.0","D","0.998","D","0.000","D","1","M","2.795","D","-2.0","D","-7.8","0.981","D","0.786","D","0.807","D","0.102","0.914","D","0.656","25.0","3.491","5.51","9.399","18.536"
"chr6","152651397","152651397","G>A","SYNE1:23345","SYNE1","exonic","nonsynonymous SNV","","SYNE1:NM_033071:exon77:c.C14210T:p.T4737M,SYNE1:NM_182961:exon78:c.C14423T:p.T4808M","SYNE1","exonic","nonsynonymous SNV","","SYNE1:ENST00000423061.6_1:exon77:c.C14210T:p.T4737M,SYNE1:ENST00000367255.10_1:exon78:c.C14423T:p.T4808M","SYNE1:ENST00000265368.4:c.14423C>T:p.(Thr4808Met)","0.9913374","0.0","0.9913374185562134","0.0150105816574797","","","","","","","","","","","","","ENSG00000131018","SYNE1","HGNC:17089","SYNE1","23345","ENSG00000131018","uc003qou.4","0.0150105816574797","","0.9913374185562134","OMIM:610743 Spinocerebellar ataxia, autosomal recessive 8-autosomal_recessive;OMIM:612998 Emery-Dreifuss muscular dystrophy 4, autosomal dominant-autosomal_dominant;OMIM:618484 Arthrogryposis multiplex congenita 3, myogenic type-autosomal_recessive;ORPHA:88644 Autosomal recessive ataxia, Beauce type-autosomal_recessive;ORPHA:98853 Autosomal dominant Emery-Dreifuss muscular dystrophy-autosomal_dominant","1447","0/1","Het","146","78,68","0.534246575342466","Uncertain_significance","False","Intellectual_disability|Autosomal_recessive_ataxia,_Beauce_type|Emery-Dreifuss_muscular_dystrophy_4,_autosomal_dominant|not_provided","Human_Phenotype_Ontology:HP:0000730,Human_Phenotype_Ontology:HP:0001249,Human_Phenotype_Ontology:HP:0001267,Human_Phenotype_Ontology:HP:0001286,Human_Phenotype_Ontology:HP:0002122,Human_Phenotype_Ontology:HP:0002192,Human_Phenotype_Ontology:HP:0002316,Human_Phenotype_Ontology:HP:0002382,Human_Phenotype_Ontology:HP:0002386,Human_Phenotype_Ontology:HP:0002402,Human_Phenotype_Ontology:HP:0002458,Human_Phenotype_Ontology:HP:0002482,Human_Phenotype_Ontology:HP:0002499,Human_Phenotype_Ontology:HP:0002543,Human_Phenotype_Ontology:HP:0003767,Human_Phenotype_Ontology:HP:0006833,Human_Phenotype_Ontology:HP:0007154,Human_Phenotype_Ontology:HP:0007176,Human_Phenotype_Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756,SNOMED_CT:228156007|MONDO:MONDO:0012549,MedGen:C1853116,OMIM:610743,Orphanet:ORPHA88644|MONDO:MONDO:0013071,MedGen:C2751807,OMIM:612998|MedGen:CN517202","NC_000006.11:g.152651397G>A","criteria_provided,_multiple_submitters,_no_conflicts","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Spinocerebellar ataxia, autosomal recessive 8(610743)|Dreifuss muscular dystrophy 4, autosomal dominant(612998)|Arthrogryposis multiplex congenita 3, myogenic type(618484)","Cerebellar atrophy(HP:0001272)|Pes cavus(HP:0001761)|Scoliosis(HP:0002650)|Fasciculations(HP:0002380)|Ptosis(HP:0000508)|EMG: neuropathic changes(HP:0003445)|Chronic axonal neuropathy(HP:0007267)|Intellectual disability(HP:0001249)|Gait disturbance(HP:0001288)|Ankle clonus(HP:0011448)|Short attention span(HP:0000736)|Decreased fetal movement(HP:0001558)|Motor polyneuropathy(HP:0007178)|Reduced tendon reflexes(HP:0001315)|Clumsiness(HP:0002312)|Atrophy/Degeneration affecting the brainstem(HP:0007366)|Lower limb spasticity(HP:0002061)|Impaired vibratory sensation(HP:0002495)|Dysmetria(HP:0001310)|Abnormal cerebral white matter morphology(HP:0002500)|Skeletal muscle atrophy(HP:0003202)|Impaired smooth pursuit(HP:0007772)|Ophthalmoparesis(HP:0000597)|Babinski sign(HP:0003487)|Dysarthria(HP:0001260)|Polyneuropathy(HP:0001271)|Kyphosis(HP:0002808)|Strabismus(HP:0000486)|Sensory axonal neuropathy(HP:0003390)|Neonatal hypotonia(HP:0001319)|Arm dystonia(HP:0031960)|Urinary incontinence(HP:0000020)|Abnormality of the respiratory system(HP:0002086)|Lower limb muscle weakness(HP:0007340)|Motor delay(HP:0001270)|Square-wave jerks(HP:0025402)|Gait ataxia(HP:0002066)|Slowly progressive(HP:0003677)|Pes cavus(HP:0001761)|Adult onset(HP:0003581)|Dysarthria(HP:0001260)|Autosomal recessive inheritance(HP:0000007)|Peripheral axonal neuropathy(HP:0003477)|Kyphosis(HP:0002808)|Ptosis(HP:0000508)|Cerebellar atrophy(HP:0001272)|Nystagmus(HP:0000639)|Limb ataxia(HP:0002070)|Dysmetria(HP:0001310)|Spasticity(HP:0001257)|Scoliosis(HP:0002650)|Strabismus(HP:0000486)|Atrioventricular block(HP:0001678)|Scoliosis(HP:0002650)|Toe walking(HP:0040083)|Elbow flexion contracture(HP:0002987)|Waddling gait(HP:0002515)|Increased LDL cholesterol concentration(HP:0003141)|EMG: myopathic abnormalities(HP:0003458)|Hypertrophic cardiomyopathy(HP:0001639)|Rimmed vacuoles(HP:0003805)|Reduced tendon reflexes(HP:0001315)|Elevated circulating creatine kinase concentration(HP:0003236)|Proximal muscle weakness in upper limbs(HP:0008997)|Respiratory insufficiency due to muscle weakness(HP:0002747)|Type 1 muscle fiber atrophy(HP:0011807)|Dilated cardiomyopathy(HP:0001644)|Myotonia(HP:0002486)|Hypotonia(HP:0001252)|Achilles tendon contracture(HP:0001771)|Hyperlordosis(HP:0003307)|Proximal muscle weakness in lower limbs(HP:0008994)|Sprengel anomaly(HP:0000912)|Decreased cervical spine flexion due to contractures of posterior cervical muscles(HP:0004631)|Ichthyosis(HP:0008064)|Ptosis(HP:0000508)|Obesity(HP:0001513)|Lipodystrophy(HP:0009125)|Kyphosis(HP:0002808)|Proximal lower limb amyotrophy(HP:0008956)|Vocal cord paralysis(HP:0001605)|Absent muscle fiber emerin(HP:0030117)|Pectus excavatum(HP:0000767)|Ventricular escape rhythm(HP:0005155)|Hypertriglyceridemia(HP:0002155)|Scapular winging(HP:0003691)|Joint stiffness(HP:0001387)|Back pain(HP:0003418)|Limb-girdle muscular dystrophy(HP:0006785)|Spinal rigidity(HP:0003306)|Supraventricular arrhythmia(HP:0005115)|Proximal upper limb amyotrophy(HP:0008948)|Sudden cardiac death(HP:0001645)|Muscular dystrophy(HP:0003560)|Ventricular septal hypertrophy(HP:0005144)|Childhood onset(HP:0011463)|Autosomal dominant inheritance(HP:0000006)|Elevated circulating creatine kinase concentration(HP:0003236)|Proximal muscle weakness(HP:0003701)|Proximal amyotrophy(HP:0007126)|Neck muscle weakness(HP:0000467)|Kyphosis(HP:0002808)|Gowers sign(HP:0003391)|Strabismus(HP:0000486)|Arthrogryposis multiplex congenita(HP:0002804)|Cryptorchidism(HP:0000028)|Scoliosis(HP:0002650)|Talipes equinovarus(HP:0001762)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Adducted thumb(HP:0001181)|Autosomal recessive inheritance(HP:0000007)|Generalized hypotonia(HP:0001290)|Weakness of facial musculature(HP:0030319)|Hyporeflexia(HP:0001265)|Small for gestational age(HP:0001518)|Delayed gross motor development(HP:0002194)|Decreased fetal movement(HP:0001558)|Congenital onset(HP:0003577)|Progressive(HP:0003676)|Hypermetropia(HP:0000540)|Restrictive ventilatory defect(HP:0002091)","This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]","spectrin repeat containing nuclear envelope protein 1","nucleus organization(GO:0006997)|Golgi organization(GO:0007030)|spermatogenesis(GO:0007283)|muscle cell differentiation(GO:0042692)|nuclear matrix anchoring at nuclear membrane(GO:0090292)","P-body(GO:0000932)|nucleus(GO:0005634)|nuclear envelope(GO:0005635)|nuclear outer membrane(GO:0005640)|nucleoplasm(GO:0005654)|nucleolus(GO:0005730)|cytoplasm(GO:0005737)|Golgi apparatus(GO:0005794)|cytoskeleton(GO:0005856)|integral component of membrane(GO:0016021)|sarcomere(GO:0030017)|nuclear membrane(GO:0031965)|meiotic nuclear membrane microtubule tethering complex(GO:0034993)|postsynaptic membrane(GO:0045211)","RNA binding(GO:0003723)|actin binding(GO:0003779)|protein binding(GO:0005515)|lamin binding(GO:0005521)|enzyme binding(GO:0019899)|protein homodimerization activity(GO:0042803)|actin filament binding(GO:0051015)|cytoskeleton-nuclear membrane anchor activity(GO:0140444)","cancer(DOID:162)|muscular dystrophy(DOID:9884)","","Wp envelope proteins and their potential roles in edmd physiopathology","Meiotic synapsis|Reproduction|Meiosis|Cell cycle","","Uv response dn","",".;.;.","","","0.00007556","","","0.0001","0.0003","0.0001","0.0001","7.556e-05","0.0005","T","0.064","T","0.085","P","0.734","B","0.074","D","0.000","D","1.000","M","1.98","T","0.62","N","-1.98","0.256","T","-1.018","T","0.073","T","0.021","0.116","T","0.139","22.3","2.381","5.84","7.826","15.296"
"chr14","100125925","100125925","C>G","","HHIPL1","exonic","nonsynonymous SNV","","HHIPL1:NM_001127258:exon4:c.C1207G:p.R403G,HHIPL1:NM_032425:exon4:c.C1207G:p.R403G","HHIPL1","exonic","nonsynonymous SNV","","HHIPL1:ENST00000330710.10_1:exon4:c.C1207G:p.R403G,HHIPL1:ENST00000357223.2_1:exon4:c.C1207G:p.R403G","HHIPL1:ENST00000330710.5:c.1207C>G:p.(Arg403Gly)","0.9910459","0.0","0.9910458922386168","0.0149710480969203","","","","","","","","","","","","","ENSG00000182218","HHIPL1","HGNC:19710","HHIPL1","84439","ENSG00000182218","uc010avs.4","0.014971048096920386","","0.9910458922386169","","1448","0/1","Het","93","51,42","0.548387096774194","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that belongs to the glucose/sorbosone dehydrogenase family. The encoded protein also contains a domain that binds folate and reduced folic acid derivatives. [provided by RefSeq, Jul 2016]","HHIP like 1","endocytosis(GO:0006897)|biological_process(GO:0008150)","cellular_component(GO:0005575)|extracellular region(GO:0005576)|membrane(GO:0016020)","molecular_function(GO:0003674)|catalytic activity(GO:0003824)|scavenger receptor activity(GO:0005044)","","","","","","","","Glucose/Sorbosone","","","","","","","","","","","","D","0.004","D","0.016","D","1.0","D","0.997","D","0.000","D","1.000","M","2.605","T","2.8","D","-6.31","0.895","T","-1.010","T","0.099","D","0.363","0.374","D","0.980","23.3","2.877","4.87","2.398","8.325"
"chr19","14200695","14200695","G>A","","SAMD1","exonic","nonsynonymous SNV","","SAMD1:NM_138352:exon1:c.C538T:p.R180C","SAMD1","exonic","nonsynonymous SNV","","SAMD1:ENST00000533683.7_1:exon1:c.C538T:p.R180C","SAMD1:ENST00000533683.2:c.538C>T:p.(Arg180Cys)","0.99035126","0.0","0.9903512597084044","0.0148772625252827","","","","","","","","","","","","","ENSG00000141858","SAMD1","HGNC:17958","SAMD1","90378","ENSG00000141858","uc060ulq.1","0.01487726252528278","","0.9903512597084045","","1450","0/1","Het","12","3,9","0.25","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","sterile alpha motif domain containing 1","negative regulation of transcription, DNA-templated(GO:0045892)","extracellular region(GO:0005576)|nucleus(GO:0005634)|cytoplasm(GO:0005737)","chromatin binding(GO:0003682)|histone binding(GO:0042393)","","","","","","","","","","","0.00008504","0.0004","","0.0005","0.","","","8.504e-05","0","D","0.0","D","0.002","B","0.046","B","0.005","U","0.137","D","0.995","","","T","0.51","N","-1.89","0.198","T","-0.987","T","0.100","D","0.310","0.090","T","0.174","22.8","2.634","2.64","1.317","10.684"
"chr7","101989093","101989093","C>G","","SPDYE6","exonic","nonsynonymous SNV","","SPDYE6:NM_001146210:exon6:c.G780C:p.E260D","SPDYE6","exonic","nonsynonymous SNV","","SPDYE6:ENST00000563237.3_1:exon6:c.G780C:p.E260D","SPDYE6:ENST00000331921.6:n.1201G>C:","0.98738456","0.0","0.987384557723999","0.0144831856078987","","","","","","","","","","","","","ENSG00000166667","SPDYE6","HGNC:35465","SPDYE6","729597","ENSG00000260097","uc033abc.2","0.014483185607898718","","0.987384557723999","","1456","0/1","Het","876","773,103","0.882420091324201","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a cell cycle regulatory protein which plays an important role in cell cycle progression by binding and activating cyclin-dependent kinases. The encoded protein belongs to a family of cyclin-dependent kinase regulators that contain a speedy box domain which is required for cyclin-dependent kinase activation. [provided by RefSeq, Jul 2017]","speedy/RINGO cell cycle regulator family member E6","","","protein binding(GO:0005515)|protein kinase binding(GO:0019901)","","","","","","","","","","","0.00001278","","","","","","","1.278e-05","0.0001","","","D","0.0","D","0.998","D","0.996","","","","","M","3.065","","","","","0.35","","","","","","","","","","5.403","0.171","0.453","-0.028",""
"chr11","14913577","14913577","A>G","","CYP2R1","exonic","nonsynonymous SNV","","CYP2R1:NM_024514:exon1:c.T175C:p.S59P","CYP2R1","exonic","nonsynonymous SNV","","CYP2R1:ENST00000334636.10_1:exon1:c.T175C:p.S59P","CYP2R1:ENST00000334636.5:c.175T>C:p.(Ser59Pro)","0.7030755","0.2505643331678584","0.7030755281448364","0.0143900390147461","","","","","","","","","","","","","ENSG00000186104","CYP2R1","HGNC:20580","CYP2R1","120227","ENSG00000186104","uc001mlr.4","0.014390039014746173","0.2505643331678584","0.7030755281448364","OMIM:600081 Rickets due to defect in vitamin D 25-hydroxylation deficiency-autosomal_recessive;ORPHA:289157 Hypocalcemic vitamin D-dependent rickets-autosomal_recessive","1457","0/1","Het","30","15,15","0.5","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Deficient rickets, type 1b(600081)","Enlargement of the ankles(HP:0003029)|Wide cranial sutures(HP:0010537)|Irritability(HP:0000737)|Femoral bowing(HP:0002980)|Hypophosphatemia(HP:0002148)|Short stature(HP:0004322)|Rachitic rosary(HP:0000897)|Delayed epiphyseal ossification(HP:0002663)|Genu varum(HP:0002970)|Tibial bowing(HP:0002982)|Tetany(HP:0001281)|Motor delay(HP:0001270)|Secondary hyperparathyroidism(HP:0000867)|Protuberant abdomen(HP:0001538)|Failure to thrive(HP:0001508)|Elevated circulating parathyroid hormone level(HP:0003165)|Enlargement of the costochondral junction(HP:0000920)|Enamel hypoplasia(HP:0006297)|Subperiosteal bone resorption(HP:0003106)|Postnatal growth retardation(HP:0008897)|Increased susceptibility to fractures(HP:0002659)|Thin bony cortex(HP:0002753)|Delayed eruption of teeth(HP:0000684)|Irregular, rachitic-like metaphyses(HP:0005042)|Difficulty walking(HP:0002355)|Deformed rib cage(HP:0000886)|Bone pain(HP:0002653)|Generalized hypotonia(HP:0001290)|Low serum calcitriol(HP:0012052)|Sparse bone trabeculae(HP:0002752)|Rickets(HP:0002748)|Hypocalcemic seizures(HP:0002199)|Frontal bossing(HP:0002007)|Enlargement of the wrists(HP:0003020)|Osteomalacia(HP:0002749)|Muscle weakness(HP:0001324)|Flat occiput(HP:0005469)|Elevated alkaline phosphatase of bone origin(HP:0010639)|Generalized aminoaciduria(HP:0002909)|Generalized hypotonia(HP:0001290)|Difficulty standing(HP:0003698)|Enlargement of the ankles(HP:0003029)|Hypotonia(HP:0001252)|Deformed rib cage(HP:0000886)|Metaphyseal irregularity(HP:0003025)|Bulging of the costochondral junction(HP:0000893)|Tibial bowing(HP:0002982)|Elevated circulating alkaline phosphatase concentration(HP:0003155)|Widely patent fontanelles and sutures(HP:0004492)|Thin bony cortex(HP:0002753)|Infantile onset(HP:0003593)|Failure to thrive(HP:0001508)|Recurrent fractures(HP:0002757)|Hypophosphatemia(HP:0002148)|Muscle weakness(HP:0001324)|Flat occiput(HP:0005469)|Femoral bowing(HP:0002980)|Bowing of the legs(HP:0002979)|Autosomal recessive inheritance(HP:0000007)|Fibular bowing(HP:0010502)|Growth delay(HP:0001510)|Frontal bossing(HP:0002007)|Sparse bone trabeculae(HP:0002752)|Rickets(HP:0002748)|Bone pain(HP:0002653)|Enlargement of the costochondral junction(HP:0000920)|Enlargement of the wrists(HP:0003020)|Difficulty walking(HP:0002355)|Delayed epiphyseal ossification(HP:0002663)|Bulging epiphyses(HP:0003013)","This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is a microsomal vitamin D hydroxylase that converts vitamin D into the active ligand for the vitamin D receptor. A mutation in this gene has been associated with selective 25-hydroxyvitamin D deficiency. [provided by RefSeq, Jul 2008]","cytochrome P450 family 2 subfamily R member 1","organic acid metabolic process(GO:0006082)|vitamin metabolic process(GO:0006766)|xenobiotic metabolic process(GO:0006805)|response to cesium ion(GO:0010164)|response to ionizing radiation(GO:0010212)|calcitriol biosynthetic process from calciol(GO:0036378)|vitamin D metabolic process(GO:0042359)","cytoplasm(GO:0005737)|endoplasmic reticulum membrane(GO:0005789)|intracellular membrane-bounded organelle(GO:0043231)","iron ion binding(GO:0005506)|steroid hydroxylase activity(GO:0008395)|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712)|heme binding(GO:0020037)|heme binding(GO:0020037)|vitamin D3 25-hydroxylase activity(GO:0030343)|vitamin D3 25-hydroxylase activity(GO:0030343)|protein homodimerization activity(GO:0042803)|D3 vitamins binding(GO:1902271)","rickets(DOID:10609)|syndrome(DOID:225)|diabetes mellitus(DOID:9351)","","Wp vitamin d metabolism|Wp metapathway biotransformation phase i and ii|Wp oxidation by cytochrome p450","Vitamin d calciferol metabolism|Biological oxidations|Cytochrome p450 arranged by substrate type|Vitamins|Phase i functionalization of compounds|Metabolism of lipids|Metabolic disorders of biological oxidation enzymes|Diseases of metabolism|Metabolism of steroids","","","","","","","0.000008062","0.0002","0.001","","","","","8.062e-06","0.0001","T","0.295","T","0.274","B","0.002","B","0.006","N","0.028","N","1","N","-0.14","T","-0.4","N","0.28","0.052","T","-1.003","T","0.117","T","0.009","0.058","T","0.052","12.48","0.868","5.12","0.434","7.820"
"chrX","24228952","24228952","T>C","","ZFX","exonic","nonsynonymous SNV","","ZFX:NM_001178086:exon6:c.T1190C:p.I397T,ZFX:NM_001178084:exon8:c.T1877C:p.I626T,ZFX:NM_003410:exon10:c.T1877C:p.I626T,ZFX:NM_001178085:exon11:c.T1877C:p.I626T","ZFX","exonic","nonsynonymous SNV","","ZFX:ENST00000338565.3_1:exon6:c.T1727C:p.I576T,ZFX:ENST00000539115.5_1:exon6:c.T1190C:p.I397T,ZFX:ENST00000379188.7_1:exon9:c.T1994C:p.I665T,ZFX:ENST00000304543.10_1:exon10:c.T1877C:p.I626T,ZFX:ENST00000379177.5_1:exon11:c.T1877C:p.I626T","ZFX:ENST00000304543.5:c.1877T>C:p.(Ile626Thr)","0.4204329","","","","","","","","","","0.5000069367069955","0.4204328954219818","0.0143489295134708","","","","ENSG00000005889","ZFX","HGNC:12869","ZFX","7543","ENSG00000005889","uc004dbd.3","0.014348929513470884","0.5000069367069955","0.4204328954219818","","1458","0/1","Het","141","70,71","0.49645390070922","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene on the X chromosome is structurally similar to a related gene on the Y chromosome. It encodes a member of the krueppel C2H2-type zinc-finger protein family. The full-length protein contains an acidic transcriptional activation domain (AD), a nuclear localization sequence (NLS) and a DNA binding domain (DBD) consisting of 13 C2H2-type zinc fingers. Studies in mouse embryonic and adult hematopoietic stem cells showed that this gene was required as a transcriptional regulator for self-renewal of both stem cell types, but it was dispensable for growth and differentiation of their progeny. Multiple alternatively spliced transcript variants encoding different isoforms have been identified, but the full-length nature of some variants has not been determined. [provided by RefSeq, May 2010]","zinc finger protein X-linked","ovarian follicle development(GO:0001541)|regulation of transcription by RNA polymerase II(GO:0006357)|spermatogenesis(GO:0007283)|fertilization(GO:0009566)|post-embryonic development(GO:0009791)|multicellular organism growth(GO:0035264)|oocyte development(GO:0048599)|homeostasis of number of cells(GO:0048872)|parental behavior(GO:0060746)","nucleoplasm(GO:0005654)|chromosome(GO:0005694)|nucleolus(GO:0005730)","chromatin insulator sequence binding(GO:0043035)|metal ion binding(GO:0046872)","","","Wp hematopoietic stem cell gene regulation by gabp alphabeta complex","","","","",".;.;Zinc","","","0.0025","0.0003","0.001","0.0002","0.0024","","","0.0002","0.0025","T","0.671","T","0.518","B","0.009","B","0.027","N","0.019","N","0.970","N","0.085","T","2.44","N","0.19","0.074","T","-1.035","T","0.026","T","0.003","0.035","T","0.049","17.53","1.708","5.11","3.866","10.147"
"chr1","15708597","15708597","G>A","","FHAD1","exonic","nonsynonymous SNV","","FHAD1:NM_052929:exon30:c.G4030A:p.E1344K","FHAD1","exonic","nonsynonymous SNV","","FHAD1:ENST00000375998.8_1:exon29:c.G4030A:p.E1344K,FHAD1:ENST00000358897.8_1:exon30:c.G4030A:p.E1344K,FHAD1:ENST00000683790.1_1:exon31:c.G4096A:p.E1366K","FHAD1:ENST00000314740.8:c.1789G>A:p.(Glu597Lys)","0.9854456","0.0","0.9854456186294556","0.0142312060848693","","","","","","","","","","","","","ENSG00000142621","FHAD1","HGNC:29408","FHAD1","114827","ENSG00000142621","uc001awb.2","0.0142312060848693","","0.9854456186294556","","1459","0/1","Het","73","48,25","0.657534246575342","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","forkhead associated phosphopeptide binding domain 1","","","","","","","","","","",".;.;.;.","","","0.00003789","0.0002","0.001","","","","","3.789e-05","0.0005","D","0.011","D","0.0","D","1.0","D","0.994","","","N","0.869","M","2.815","T","0.28","N","-1.82","0.245","T","-0.256","T","0.360","D","0.063","0.200","T","0.444","24.9","3.468","5.8","3.702","12.758"
"chr8","10480644","10480644","C>G","","RP1L1","exonic","nonsynonymous SNV","","RP1L1:NM_178857:exon2:c.G68C:p.R23P","RP1L1","exonic","nonsynonymous SNV","","RP1L1:ENST00000382483.4_1:exon2:c.G68C:p.R23P","RP1L1:ENST00000382483.3:c.68G>C:p.(Arg23Pro)","0.98424405","0.0","0.9842440485954284","0.0140772267033517","0.0","0.9286220371723176","0.0084941963888159","","","","","","","","","","ENSG00000183638","RP1L1","HGNC:15946","RP1L1","94137","ENSG00000183638","uc003wtc.4","0.014077226703351799","","0.9842440485954285","OMIM:613587 Occult macular dystrophy-autosomal_dominant;OMIM:618826 Retinitis pigmentosa 88-autosomal_recessive;ORPHA:791 Retinitis pigmentosa-autosomal_recessive","1461","0/1","Het","114","44,70","0.385964912280702","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Occult macular dystrophy(613587)|Retinitis pigmentosa 88(618826)","Autosomal recessive inheritance(HP:0000007)|Bone spicule pigmentation of the retina(HP:0007737)|Reduced visual acuity(HP:0007663)|Optic disc pallor(HP:0000543)|Exotropia(HP:0000577)|Reduced visual acuity(HP:0007663)|Macular degeneration(HP:0000608)|Attenuation of retinal blood vessels(HP:0007843)|Neonatal onset(HP:0003623)|Cystoid macular edema(HP:0011505)|Nyctalopia(HP:0000662)|Atypical scarring of skin(HP:0000987)|Sensorineural hearing impairment(HP:0000407)|Keratoconus(HP:0000563)|Glaucoma(HP:0000501)|Obesity(HP:0001513)|Blindness(HP:0000618)|Hyperinsulinemia(HP:0000842)|Anteverted nares(HP:0000463)|Abnormal retinal vascular morphology(HP:0008046)|Abnormal testis morphology(HP:0000035)|Hyperreflexia(HP:0001347)|Ophthalmoplegia(HP:0000602)|Abnormal electroretinogram(HP:0000512)|Hypoplasia of penis(HP:0008736)|Nystagmus(HP:0000639)|Progressive night blindness(HP:0007675)|Type II diabetes mellitus(HP:0005978)|Optic atrophy(HP:0000648)|Intellectual disability(HP:0001249)|Conductive hearing impairment(HP:0000405)|Photophobia(HP:0000613)|Cataract(HP:0000518)|Hypogonadism(HP:0000135)|Abnormality of retinal pigmentation(HP:0007703)|Wide nasal bridge(HP:0000431)|Abnormal multifocal electroretinogram(HP:0030468)|Autosomal dominant inheritance(HP:0000006)|Macular dystrophy(HP:0007754)|Slow decrease in visual acuity(HP:0007924)","This gene encodes a member of the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, and two C-terminal large repetitive regions, both of which contain a high percentage of glutamine and glutamic acid residues. This protein is a retinal-specific protein. Its exact length varies among individuals due to the presence of a 16aa repeat in the first C-terminal repetitive region. The 16aa repeat is encoded by the highly polymorphic 48-bp repeat, and 1-6 copies of the 16aa repeat have been identified in normal individuals. The current reference sequence shown here has a single copy of the 16aa repeat. This protein and the RP1 protein, another retinal-specific protein, play essential and synergistic roles in affecting photosensitivity and outer segment morphogenesis of rod photoreceptors. Mutations in this gene cause occult macular dystrophy (OMD). [provided by RefSeq, Sep 2010]","RP1 like 1","visual perception(GO:0007601)|axoneme assembly(GO:0035082)|intracellular signal transduction(GO:0035556)|photoreceptor cell development(GO:0042461)|photoreceptor cell development(GO:0042461)|photoreceptor cell maintenance(GO:0045494)|photoreceptor cell maintenance(GO:0045494)|retina development in camera-type eye(GO:0060041)","photoreceptor outer segment(GO:0001750)|microtubule(GO:0005874)|axoneme(GO:0005930)|axoneme(GO:0005930)|photoreceptor connecting cilium(GO:0032391)","","retinitis pigmentosa(DOID:10584)|retinitis(DOID:3612)","","Wp ciliopathies","","","","","","","","0.0001","","","0.0001","0.","","","0.0001","0","D","0.006","D","0.01","","","","","","","N","1","M","2.505","T","3.21","D","-4.0","0.542","T","-1.086","T","0.051","D","0.034","0.050","T","0.165","22.0","2.296","4.5","2.251","6.657"
"chr8","10467637","10467637","T>C","RP1L1:94137","RP1L1","exonic","nonsynonymous SNV","","RP1L1:NM_178857:exon4:c.A3971G:p.E1324G","RP1L1","exonic","nonsynonymous SNV","","RP1L1:ENST00000382483.4_1:exon4:c.A3971G:p.E1324G","RP1L1:ENST00000382483.3:c.3971A>G:p.(Glu1324Gly)","0.873","","","","0.0","0.9286220371723176","0.0084941963888159","","","","","","","","","","ENSG00000183638","RP1L1","HGNC:15946","RP1L1","94137","ENSG00000183638","uc003wtc.4","0.014077226703351799","","0.9842440485954285","OMIM:613587 Occult macular dystrophy-autosomal_dominant;OMIM:618826 Retinitis pigmentosa 88-autosomal_recessive;ORPHA:791 Retinitis pigmentosa-autosomal_recessive","1462","0/1","Het","267","145,122","0.543071161048689","Conflicting_interpretations_of_pathogenicity","True","Occult_macular_dystrophy|Retinitis_pigmentosa_88|not_specified|not_provided","Human_Phenotype_Ontology:HP:0030636,MONDO:MONDO:0013316,MedGen:C3150833,OMIM:613587,Orphanet:ORPHA247834|MONDO:MONDO:0032940,MedGen:C5394208,OMIM:618826|MedGen:CN169374|MedGen:CN517202","NC_000008.10:g.10467637T>C","criteria_provided,_conflicting_interpretations","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Occult macular dystrophy(613587)|Retinitis pigmentosa 88(618826)","Autosomal recessive inheritance(HP:0000007)|Bone spicule pigmentation of the retina(HP:0007737)|Reduced visual acuity(HP:0007663)|Optic disc pallor(HP:0000543)|Exotropia(HP:0000577)|Reduced visual acuity(HP:0007663)|Macular degeneration(HP:0000608)|Attenuation of retinal blood vessels(HP:0007843)|Neonatal onset(HP:0003623)|Cystoid macular edema(HP:0011505)|Nyctalopia(HP:0000662)|Atypical scarring of skin(HP:0000987)|Sensorineural hearing impairment(HP:0000407)|Keratoconus(HP:0000563)|Glaucoma(HP:0000501)|Obesity(HP:0001513)|Blindness(HP:0000618)|Hyperinsulinemia(HP:0000842)|Anteverted nares(HP:0000463)|Abnormal retinal vascular morphology(HP:0008046)|Abnormal testis morphology(HP:0000035)|Hyperreflexia(HP:0001347)|Ophthalmoplegia(HP:0000602)|Abnormal electroretinogram(HP:0000512)|Hypoplasia of penis(HP:0008736)|Nystagmus(HP:0000639)|Progressive night blindness(HP:0007675)|Type II diabetes mellitus(HP:0005978)|Optic atrophy(HP:0000648)|Intellectual disability(HP:0001249)|Conductive hearing impairment(HP:0000405)|Photophobia(HP:0000613)|Cataract(HP:0000518)|Hypogonadism(HP:0000135)|Abnormality of retinal pigmentation(HP:0007703)|Wide nasal bridge(HP:0000431)|Abnormal multifocal electroretinogram(HP:0030468)|Autosomal dominant inheritance(HP:0000006)|Macular dystrophy(HP:0007754)|Slow decrease in visual acuity(HP:0007924)","This gene encodes a member of the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, and two C-terminal large repetitive regions, both of which contain a high percentage of glutamine and glutamic acid residues. This protein is a retinal-specific protein. Its exact length varies among individuals due to the presence of a 16aa repeat in the first C-terminal repetitive region. The 16aa repeat is encoded by the highly polymorphic 48-bp repeat, and 1-6 copies of the 16aa repeat have been identified in normal individuals. The current reference sequence shown here has a single copy of the 16aa repeat. This protein and the RP1 protein, another retinal-specific protein, play essential and synergistic roles in affecting photosensitivity and outer segment morphogenesis of rod photoreceptors. Mutations in this gene cause occult macular dystrophy (OMD). [provided by RefSeq, Sep 2010]","RP1 like 1","visual perception(GO:0007601)|axoneme assembly(GO:0035082)|intracellular signal transduction(GO:0035556)|photoreceptor cell development(GO:0042461)|photoreceptor cell development(GO:0042461)|photoreceptor cell maintenance(GO:0045494)|photoreceptor cell maintenance(GO:0045494)|retina development in camera-type eye(GO:0060041)","photoreceptor outer segment(GO:0001750)|microtubule(GO:0005874)|axoneme(GO:0005930)|axoneme(GO:0005930)|photoreceptor connecting cilium(GO:0032391)","","retinitis pigmentosa(DOID:10584)|retinitis(DOID:3612)","","Wp ciliopathies","","","","SpliceAI>C|RP1L1|0.00|0.00|0.00|0.00|-27|39|14|9","","Name=CT-rich","","","","","","","","","","","T","0.127","T","0.086","","","","","","","P","1","N","0.55","T","2.94","N","-1.26","0.059","T","-0.960","T","0.013","","","0.034","T","0.043","0.007","-0.840","1.91","-0.294","7.767"
"chr15","75500578","75500578","C>T","","C15orf39","exonic","nonsynonymous SNV","","C15orf39:NM_015492:exon2:c.C2189T:p.A730V","C15orf39","exonic","nonsynonymous SNV","","C15orf39:ENST00000567617.1_1:exon1:c.C2189T:p.A730V,C15orf39:ENST00000360639.6_1:exon2:c.C2189T:p.A730V,C15orf39:ENST00000394987.5_1:exon2:c.C2189T:p.A730V","C15orf39:ENST00000360639.2:c.2189C>T:p.(Ala730Val)","0.97894984","0.0","0.9789498448371888","0.0134181155616459","","","","","","","","","","","","","ENSG00000167173","C15orf39","HGNC:24497","C15orf39","56905","ENSG00000167173","uc002azp.4","0.013418115561645984","","0.9789498448371887","","1466","0/1","Het","167","89,78","0.532934131736527","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","chromosome 15 open reading frame 39","","cytosol(GO:0005829)","","","","Wp vegfavegfr2 signaling pathway","","","","",".;.;.","Name=(CCCCAG)n","","","","","","","","","","","D","0.021","T","0.285","B","0.004","B","0.008","N","0.242","N","1","N","0.75","T","1.64","N","-0.61","0.143","T","-1.043","T","0.058","D","0.028","0.033","T","0.086","10.88","0.667","3.69","0.869","3.866"
"chr15","32688688","32688688","G>C","","GOLGA8K","exonic","nonsynonymous SNV","","GOLGA8K:NM_001282493:exon12:c.C931G:p.L311V","GOLGA8K","exonic","nonsynonymous SNV","","GOLGA8K:ENST00000512626.2_1:exon12:c.C931G:p.L311V","GOLGA8K:ENST00000512626.2:c.931C>G:p.(Leu311Val)","0.97190094","0.0","0.9719009399414062","0.0125875894702817","","","","","","","","","","","","","ENSG00000249931","GOLGA8K","HGNC:38652","GOLGA8K","653125","ENSG00000249931","uc032byu.2","0.012587589470281787","","0.9719009399414062","","1473","0/1","Het","30","18,12","0.6","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","golgin A8 family member K","Golgi organization(GO:0007030)|spindle assembly(GO:0051225)","Golgi cis cisterna(GO:0000137)|cis-Golgi network(GO:0005801)|Golgi cisterna membrane(GO:0032580)","","","","Wp 15q133 copy number variation syndrome","","","","SpliceAI>C|GOLGA8K|0.00|0.00|0.00|0.00|36|-28|1|-44","","","","0","","","","","","","0","0","D","0.024","D","0.041","","","","","","","D","0.506","","","","","N","-2.43","0.205","T","-0.517","T","0.222","D","0.072","0.112","D","0.576","16.25","1.496","1.66","1.946","9.336"
"chr4","87687597","87687597","T>C","","PTPN13","exonic","nonsynonymous SNV","","PTPN13:NM_080684:exon24:c.T3683C:p.L1228P,PTPN13:NM_006264:exon26:c.T4199C:p.L1400P,PTPN13:NM_080683:exon27:c.T4256C:p.L1419P,PTPN13:NM_080685:exon27:c.T4271C:p.L1424P","PTPN13","exonic","nonsynonymous SNV","","PTPN13:ENST00000316707.10_1:exon24:c.T3683C:p.L1228P,PTPN13:ENST00000427191.6_1:exon26:c.T4199C:p.L1400P,PTPN13:ENST00000511467.1_1:exon26:c.T4271C:p.L1424P,PTPN13:ENST00000411767.7_1:exon27:c.T4256C:p.L1419P,PTPN13:ENST00000436978.5_1:exon27:c.T4271C:p.L1424P","PTPN13:ENST00000316707.6:c.3683T>C:p.(Leu1228Pro)","0.9575727","","","","0.0","0.9653489291667938","0.011861220557705","","","","","","","","","","ENSG00000163629","PTPN13","HGNC:9646","PTPN13","5783","ENSG00000163629","uc003hpz.4","0.011861220557705013","","0.9653489291667938","","1479","0/1","Het","75","46,29","0.613333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP is a large intracellular protein. It has a catalytic PTP domain at its C-terminus and two major structural domains: a region with five PDZ domains and a FERM domain that binds to plasma membrane and cytoskeletal elements. This PTP was found to interact with, and dephosphorylate, Fas receptor and IkappaBalpha through the PDZ domains. This suggests it has a role in Fas mediated programmed cell death. This PTP was also shown to interact with GTPase-activating protein, and thus may function as a regulator of Rho signaling pathways. Four alternatively spliced transcript variants, which encode distinct proteins, have been reported. [provided by RefSeq, Oct 2008]","protein tyrosine phosphatase non-receptor type 13","negative regulation of protein phosphorylation(GO:0001933)|protein dephosphorylation(GO:0006470)|regulation of phosphatidylinositol 3-kinase signaling(GO:0014066)|peptidyl-tyrosine dephosphorylation(GO:0035335)|peptidyl-tyrosine dephosphorylation(GO:0035335)","fibrillar center(GO:0001650)|nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|cytoplasm(GO:0005737)|cytoplasm(GO:0005737)|cytosol(GO:0005829)|cytoskeleton(GO:0005856)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|lamellipodium(GO:0030027)|neuron projection(GO:0043005)|cell body(GO:0044297)|extracellular exosome(GO:0070062)","protein tyrosine phosphatase activity(GO:0004725)|protein tyrosine phosphatase activity(GO:0004725)|protein tyrosine phosphatase activity(GO:0004725)|protein binding(GO:0005515)|phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312)|phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312)","colon carcinoma(DOID:1520)|cancer(DOID:162)|squamous cell carcinoma(DOID:1749)|head and neck squamous cell carcinoma(DOID:5520)|primary biliary cholangitis(DOID:12236)|rheumatoid arthritis(DOID:7148)","","Wp ectoderm differentiation|Wp apoptosis modulation and signaling","Cytokine signaling in immune system|Pi metabolism|Phospholipid metabolism|Synthesis of pips at the plasma membrane|Interleukin 1 family signaling|Signaling by interleukins|Metabolism of lipids|Interleukin 37 signaling|Rho gtpase cycle|Rnd3 gtpase cycle|Rnd2 gtpase cycle|Rnd1 gtpase cycle|Signaling by rho gtpases miro gtpases and rhobtb3","Fas pathway","","",".;.;.;PDZ","","Score=772;Name=V$AHRARNT_02","0.0027","","","0.0002","0.0027","","","0.0001","0.0018","D","0.001","D","0.003","D","1.0","D","0.996","N","0.002","D","1","H","3.945","T","1.21","D","-5.9","0.96","T","-0.110","T","0.342","D","0.071","0.506","T","0.482","29.0","4.145","5.55","7.264","15.706"
"chr19","55450929","55450929","C>T","","NLRP7","exonic","nonsynonymous SNV","","NLRP7:NM_001127255:exon4:c.G1258A:p.A420T,NLRP7:NM_139176:exon4:c.G1258A:p.A420T,NLRP7:NM_206828:exon4:c.G1258A:p.A420T","NLRP7","exonic","nonsynonymous SNV","","NLRP7:ENST00000328092.9_1:exon3:c.G1258A:p.A420T,NLRP7:ENST00000590030.5_1:exon3:c.G1258A:p.A420T,NLRP7:ENST00000340844.6_1:exon4:c.G1258A:p.A420T,NLRP7:ENST00000592784.5_1:exon4:c.G1258A:p.A420T,NLRP7:ENST00000588756.5_1:exon6:c.G1258A:p.A420T","NLRP7:ENST00000328092.5:c.1258G>A:p.(Ala420Thr)","0.9645727","0.0","0.9645727276802064","0.0117779609681858","","","","","","","","","","","","","ENSG00000167634","NLRP7","HGNC:22947","NLRP7","199713","ENSG00000167634","uc061ctx.1","0.011777960968185864","","0.9645727276802063","OMIM:231090 Hydatidiform mole, recurrent, 1-autosomal_recessive","1484","0/1","Het","175","96,79","0.548571428571429","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Hydatidiform mole, recurrent, 1(231090)","Hydatidiform mole(HP:0032192)|Autosomal recessive inheritance(HP:0000007)|Abnormality of the genitourinary system(HP:0000119)","This gene encodes a member of the NACHT, leucine rich repeat, and PYD containing (NLRP) protein family. It has an N-terminal pyrin domain, followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. NLRP proteins are implicated in the activation of proinflammatory caspases through multiprotein complexes called inflammasomes. This gene may act as a feedback regulator of caspase-1-dependent interleukin 1-beta secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]","NLR family pyrin domain containing 7","negative regulation of endopeptidase activity(GO:0010951)|negative regulation of protein processing(GO:0010955)|negative regulation of interleukin-1 beta production(GO:0032691)|cellular response to lipopolysaccharide(GO:0071222)|cellular response to interleukin-1(GO:0071347)|negative regulation of cytokine production involved in inflammatory response(GO:1900016)|negative regulation of aspartic-type peptidase activity(GO:1905246)","cellular_component(GO:0005575)","ATP binding(GO:0005524)|aspartic-type endopeptidase inhibitor activity(GO:0019828)|interleukin-1 binding(GO:0019966)|caspase binding(GO:0089720)","cancer(DOID:162)","","Wp nucleotidebinding oligomerization domain nod pathway","","","","",".;.;.;.;.","","","0.00003245","","","0.","0.0004","","","3.245e-05","0.0004","D","0.027","T","0.078","D","0.999","P","0.799","N","0.377","N","1","M","2.56","T","-0.88","D","-3.56","0.123","T","-0.567","T","0.462","T","0.025","0.176","T","0.448","17.55","1.710","2.06","1.012","6.67"
"chr2","98128313","98128313","G>A","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.C3008T:p.T1003M","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.C3008T:p.T1003M,ANKRD36B:ENST00000359901.8_1:exon39:c.C3008T:p.T1003M,ANKRD36B:ENST00000438709.6_1:exon40:c.C2045T:p.T682M","AC159540.14:ENST00000448261.1::","0.9643911","0.0","0.9643911123275756","0.011758563435833","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1485","0/1","Het","109","20,89","0.18348623853211","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","0.00004468","","","","","","","4.468e-05","0","","","T","0.065","D","1.0","D","0.967","","","","","L","1.76","","","","","0.254","","","","","","","","","","7.477","0.321","1.4","2.576","8.752"
"chr2","98128196","98128196","T>C","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.A3125G:p.Y1042C","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.A3125G:p.Y1042C,ANKRD36B:ENST00000359901.8_1:exon39:c.A3125G:p.Y1042C,ANKRD36B:ENST00000438709.6_1:exon40:c.A2162G:p.Y721C","AC159540.14:ENST00000448261.1::","0.893","","","","0.0","0.8930000066757202","0.0061386820486887","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1486","1/1","Hom","177","6,171","0.0338983050847458","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","SpliceAI>C|ANKRD36B|0.00|0.00|0.00|0.00|46|49|-26|30","CCDC144C-like,","","","0","","","","","","","0","0","","","D","0.013","D","0.996","P","0.893","","","","","M","2.365","","","","","0.22","","","","","","","","","","6.976","0.282","1.54","1.347","3.736"
"chr2","98128139","98128139","C>T","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.G3182A:p.R1061K","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.G3182A:p.R1061K,ANKRD36B:ENST00000359901.8_1:exon39:c.G3182A:p.R1061K,ANKRD36B:ENST00000438709.6_1:exon40:c.G2219A:p.R740K","AC159540.14:ENST00000448261.1::","0.52","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1491","0/1","Het","72","62,10","0.861111111111111","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","T","0.475","P","0.886","P","0.483","","","","","L","1.885","","","","","0.079","","","","","","","","","","9.753","0.538","1.54","-0.329","2.246"
"chr2","98128128","98128128","G>A","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.C3193T:p.L1065F","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.C3193T:p.L1065F,ANKRD36B:ENST00000359901.8_1:exon39:c.C3193T:p.L1065F,ANKRD36B:ENST00000438709.6_1:exon40:c.C2230T:p.L744F","AC159540.14:ENST00000448261.1::","0.515","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1492","0/1","Het","55","36,19","0.654545454545455","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","T","0.132","P","0.956","B","0.3","","","","","M","2.075","","","","","0.127","","","","","","","","","","9.701","0.532","1.54","1.966","3.666"
"chr2","98128449","98128449","T>A","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.A2872T:p.R958W","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.A2872T:p.R958W,ANKRD36B:ENST00000359901.8_1:exon39:c.A2872T:p.R958W,ANKRD36B:ENST00000438709.6_1:exon40:c.A1909T:p.R637W","AC159540.14:ENST00000448261.1::","0.509","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1493","0/1","Het","65","31,34","0.476923076923077","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","D","0.001","P","0.582","B","0.083","","","","","M","2.095","","","","","0.202","","","","","","","","","","9.542","0.515","1.4","0.850","3.205"
"chr2","98128364","98128364","T>C","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.A2957G:p.H986R","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.A2957G:p.H986R,ANKRD36B:ENST00000359901.8_1:exon39:c.A2957G:p.H986R,ANKRD36B:ENST00000438709.6_1:exon40:c.A1994G:p.H665R","AC159540.14:ENST00000448261.1::","0.48769075","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1496","0/1","Het","54","9,45","0.166666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","0.0000159","","","","","","","1.59e-05","0.0001","","","T","0.753","B","0.237","B","0.019","","","","","N","0.69","","","","","0.122","","","","","","","","","","9.488","0.509","1.4","0.961","3.561"
"chr2","98128402","98128402","C>A","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.G2919T:p.K973N","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.G2919T:p.K973N,ANKRD36B:ENST00000359901.8_1:exon39:c.G2919T:p.K973N,ANKRD36B:ENST00000438709.6_1:exon40:c.G1956T:p.K652N","AC159540.14:ENST00000448261.1::","0.469","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1497","0/1","Het","50","12,38","0.24","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","T","0.149","B","0.053","B","0.006","","","","","L","0.855","","","","","0.145","","","","","","","","","","11.03","0.685","1.4","1.209","3.487"
"chr2","98128421","98128421","T>C","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.A2900G:p.K967R","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.A2900G:p.K967R,ANKRD36B:ENST00000359901.8_1:exon39:c.A2900G:p.K967R,ANKRD36B:ENST00000438709.6_1:exon40:c.A1937G:p.K646R","AC159540.14:ENST00000448261.1::","0.391","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1500","0/1","Het","58","23,35","0.396551724137931","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","D","0.006","B","0.047","B","0.01","","","","","L","1.635","","","","","0.111","","","","","","","","","","9.811","0.544","1.4","0.667","4.107"
"chr2","98128073","98128073","G>A","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.C3248T:p.S1083F","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.C3248T:p.S1083F,ANKRD36B:ENST00000359901.8_1:exon39:c.C3248T:p.S1083F,ANKRD36B:ENST00000438709.6_1:exon40:c.C2285T:p.S762F","AC159540.14:ENST00000448261.1::","0.277","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1501","0/1","Het","6","2,4","0.333333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","T","0.077","B","0.004","B","0.001","","","","","N","0.55","","","","","0.192","","","","","","","","","","1.114","-0.135","1.4","0.047","3.589"
"chr2","98128014","98128014","T>C","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.A3307G:p.K1103E","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.A3307G:p.K1103E,ANKRD36B:ENST00000359901.8_1:exon39:c.A3307G:p.K1103E,ANKRD36B:ENST00000438709.6_1:exon40:c.A2344G:p.K782E","AC159540.14:ENST00000448261.1::","0.258","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1502","1/1","Hom","4","0,4","0","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","T","1.0","B","0.0","B","0.0","","","","","N","-0.91","","","","","0.173","","","","","","","","","","6.422","0.241","1.4","1.772","6.082"
"chr2","98128194","98128194","G>C","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.C3127G:p.R1043G","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.C3127G:p.R1043G,ANKRD36B:ENST00000359901.8_1:exon39:c.C3127G:p.R1043G,ANKRD36B:ENST00000438709.6_1:exon40:c.C2164G:p.R722G","AC159540.14:ENST00000448261.1::","0.209","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1503","1/1","Hom","176","6,170","0.0340909090909091","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","SpliceAI>C|ANKRD36B|0.00|0.00|0.00|0.00|0|-8|0|-3","CCDC144C-like,","","","0","","","","","","","0","0","","","T","0.206","P","0.56","B","0.057","","","","","M","2.595","","","","","0.336","","","","","","","","","","1.066","-0.141","1.54","3.319","6.247"
"chr2","98127993","98127993","C>T","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.G3328A:p.G1110R","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.G3328A:p.G1110R,ANKRD36B:ENST00000359901.8_1:exon39:c.G3328A:p.G1110R,ANKRD36B:ENST00000438709.6_1:exon40:c.G2365A:p.G789R","AC159540.14:ENST00000448261.1::","0.179","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1504","1/1","Hom","3","0,3","0","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","T","0.916","B","0.0","B","0.0","","","","","N","-2.075","","","","","0.112","","","","","","","","","","5.254","0.161","1.4","1.228","4.937"
"chr2","98128143","98128143","T>C","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.A3178G:p.K1060E","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.A3178G:p.K1060E,ANKRD36B:ENST00000359901.8_1:exon39:c.A3178G:p.K1060E,ANKRD36B:ENST00000438709.6_1:exon40:c.A2215G:p.K739E","AC159540.14:ENST00000448261.1::","0.163","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1505","1/1","Hom","86","3,83","0.0348837209302326","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","T","0.541","B","0.0","B","0.0","","","","","L","1.835","","","","","0.139","","","","","","","","","","6.279","0.230","1.54","0.848","6.861"
"chr2","98128256","98128256","C>T","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.G3065A:p.R1022H","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.G3065A:p.R1022H,ANKRD36B:ENST00000359901.8_1:exon39:c.G3065A:p.R1022H,ANKRD36B:ENST00000438709.6_1:exon40:c.G2102A:p.R701H","AC159540.14:ENST00000448261.1::","0.115676895","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1506","1/1","Hom","198","6,192","0.0303030303030303","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","0.00009373","","","","","","","9.373e-05","0","","","D","0.034","D","0.987","B","0.094","","","","","N","0.145","","","","","0.043","","","","","","","","","","1.653","-0.075","1.4","-0.877","5.519"
"chr2","98128515","98128515","C>T","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.G2806A:p.V936I","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.G2806A:p.V936I,ANKRD36B:ENST00000359901.8_1:exon39:c.G2806A:p.V936I,ANKRD36B:ENST00000438709.6_1:exon40:c.G1843A:p.V615I","AC159540.14:ENST00000448261.1::","0.061","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1507","0/1","Het","131","59,72","0.450381679389313","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","",".;.;.","","","","","","","","","","","","","","T","0.612","B","0.003","B","0.001","","","","","N","0","","","","","0.1","","","","","","","","","","6.855","0.273","1.4","-0.086","8.123"
"chr2","98128099","98128099","A>C","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.T3222G:p.C1074W","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.T3222G:p.C1074W,ANKRD36B:ENST00000359901.8_1:exon39:c.T3222G:p.C1074W,ANKRD36B:ENST00000438709.6_1:exon40:c.T2259G:p.C753W","AC159540.14:ENST00000448261.1::","0.056","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1508","0/1","Het","12","2,10","0.166666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","CCDC144C-like,","","","","","","","","","","","","","","T","0.194","B","0.0","B","0.0","","","","","N","-1.935","","","","","0.377","","","","","","","","","","1.261","-0.116","1.54","2.408","5.230"
"chr2","98128070","98128071","TG>-","","ANKRD36B","exonic","frameshift deletion","","ANKRD36B:NM_025190:exon39:c.3250_3251del:p.H1084Cfs*10","ANKRD36B","exonic","frameshift deletion","","ANKRD36B:ENST00000258459.11_1:exon39:c.3250_3251del:p.H1084Cfs*10,ANKRD36B:ENST00000359901.8_1:exon39:c.3250_3251del:p.H1084Cfs*10,ANKRD36B:ENST00000438709.6_1:exon40:c.2287_2288del:p.H763Cfs*10","AC159540.14:ENST00000448261.1::","0.033","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1509","0/1","Het","6","2,4","0.333333333333333","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","98128172","98128172","C>A","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.G3149T:p.R1050L","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.G3149T:p.R1050L,ANKRD36B:ENST00000359901.8_1:exon39:c.G3149T:p.R1050L,ANKRD36B:ENST00000438709.6_1:exon40:c.G2186T:p.R729L","AC159540.14:ENST00000448261.1::","0.03096794","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1510","1/1","Hom","159","6,153","0.0377358490566038","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","SpliceAI>A|ANKRD36B|0.00|0.00|0.00|0.00|-19|14|19|-2","CCDC144C-like,","","","0.00001499","","","","","","","1.499e-05","0","","","T","0.456","B","0.0","B","0.0","","","","","N","-1.62","","","","","0.146","","","","","","","","","","0.221","-0.373","1.52","1.316","3.453"
"chr2","98128098","98128098","G>A","","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:NM_025190:exon39:c.C3223T:p.R1075C","ANKRD36B","exonic","nonsynonymous SNV","","ANKRD36B:ENST00000258459.11_1:exon39:c.C3223T:p.R1075C,ANKRD36B:ENST00000359901.8_1:exon39:c.C3223T:p.R1075C,ANKRD36B:ENST00000438709.6_1:exon40:c.C2260T:p.R754C","AC159540.14:ENST00000448261.1::","0.026","","","","","","","","","","","","","","","","ENSG00000235833","AC159540.14","","","","ENSG00000235833","","0.011758563435833062","","0.9643911123275757","","1511","0/1","Het","12","2,10","0.166666666666667","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36B","","","protein binding(GO:0005515)","","","","","","","SpliceAI>A|ANKRD36B|0.00|0.00|0.00|0.00|-12|18|13|-11","CCDC144C-like,","","","","","","","","","","","","","","T","0.198","B","0.0","B","0.0","","","","","N","-1.385","","","","","0.105","","","","","","","","","","3.977","0.083","1.54","0.606","5.828"
"chr21","11098704","11098723","ACTCCAGCCGCCATCTTACT>-","","BAGE2;BAGE3","exonic","startloss","","BAGE3:NM_182481:exon1:c.1_14del:p.M1?,BAGE2:NM_182482:exon1:c.1_14del:p.M1?","AL078471.5;AP003900.6","intergenic","","dist=68985;dist=71044","","BAGE2:ENST00000470054.1:n.203_222del:","0.8","","","","","","","","","","","","","","","","ENSG00000187172","BAGE2","HGNC:15723","BAGE2","85319","ENSG00000187172","","0.011611028069988738","","0.9629999995231628","","1525","0/1","Het","348","287,61","0.824712643678161","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","","","","","","","","","","","","","Name=REP522","","0.0001","","","0.0001","0.","","","0","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","179399634","179399634","C>T","TTN:7273|TTN-AS1:100506866","TTN","exonic","nonsynonymous SNV","","TTN:NM_003319:exon186:c.G74513A:p.R24838H,TTN:NM_133432:exon187:c.G74888A:p.R24963H,TTN:NM_133437:exon187:c.G75089A:p.R25030H,TTN:NM_133378:exon307:c.G94004A:p.R31335H,TTN:NM_001256850:exon308:c.G96785A:p.R32262H,TTN:NM_001267550:exon358:c.G101708A:p.R33903H","TTN","exonic","nonsynonymous SNV","","TTN:ENST00000342175.11_1:exon186:c.G75089A:p.R25030H,TTN:ENST00000359218.10_1:exon186:c.G74888A:p.R24963H,TTN:ENST00000460472.6_1:exon186:c.G74513A:p.R24838H,TTN:ENST00000342992.10_1:exon307:c.G94004A:p.R31335H,TTN:ENST00000591111.5_1:exon308:c.G96785A:p.R32262H,TTN:ENST00000589042.5_1:exon358:c.G101708A:p.R33903H","TTN:ENST00000342175.6:c.75089G>A:p.(Arg25030His)","0.97141397","","","","0.0","0.9613966345787048","0.0114432504669261","","","","","","","","","","ENSG00000155657","TTN","HGNC:12403","TTN","7273","ENSG00000155657","uc031rqc.3","0.011443250466926158","","0.9613966345787048","OMIM:600334 Tibial muscular dystrophy, tardive-autosomal_dominant;OMIM:603689 Myopathy, myofibrillar, 9, with early respiratory failure-autosomal_dominant;OMIM:604145 Cardiomyopathy, dilated, 1G-autosomal_dominant;OMIM:608807 Muscular dystrophy, limb-girdle, autosomal recessive 10-autosomal_recessive;OMIM:611705 Salih myopathy-autosomal_recessive;OMIM:613765 Cardiomyopathy, familial hypertrophic, 9-autosomal_dominant;ORPHA:154 Familial isolated dilated cardiomyopathy-autosomal_dominant;ORPHA:169186 Autosomal recessive centronuclear myopathy-autosomal_recessive;ORPHA:178464 Hereditary myopathy with early respiratory failure-autosomal_dominant;ORPHA:324604 Classic multiminicore myopathy-unknown;ORPHA:609 Tibial muscular dystrophy-autosomal_dominant","1564","0/1","Het","112","68,44","0.607142857142857","Conflicting_interpretations_of_pathogenicity","True","Dilated_cardiomyopathy_1G|Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J|not_provided","MONDO:MONDO:0011400,MedGen:C1858763,OMIM:604145|MONDO:MONDO:0012127,MedGen:C1837342,OMIM:608807,Orphanet:ORPHA140922|MedGen:CN517202","NC_000002.11:g.179399634C>T","criteria_provided,_conflicting_interpretations","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Tibial muscular dystrophy, tardive(600334)|Myopathy, myofibrillar, 9, with early respiratory failure(603689)|Cardiomyopathy, dilated, 1g(604145)|Girdle, autosomal recessive 10(608807)|Salih myopathy(611705)|Cardiomyopathy, familial hypertrophic, 9(613765)","Respiratory failure(HP:0002878)|Myofibrillar myopathy(HP:0003715)|Diaphragmatic weakness(HP:0009113)|Nocturnal hypoventilation(HP:0002877)|Shoulder girdle muscle weakness(HP:0003547)|Difficulty walking(HP:0002355)|Scapular winging(HP:0003691)|Pelvic girdle muscle weakness(HP:0003749)|Muscle fiber splitting(HP:0003555)|Neck flexor weakness(HP:0003722)|Reduced vital capacity(HP:0002792)|Adult onset(HP:0003581)|Slowly progressive(HP:0003677)|Quadriceps muscle weakness(HP:0003731)|Calf muscle hypertrophy(HP:0008981)|Autosomal dominant inheritance(HP:0000006)|Adult onset(HP:0003581)|Achilles tendon contracture(HP:0001771)|Elevated circulating creatine kinase concentration(HP:0003236)|Increased variability in muscle fiber diameter(HP:0003557)|Foot dorsiflexor weakness(HP:0009027)|Frequent falls(HP:0002359)|Rimmed vacuoles(HP:0003805)|Increased muscle lipid content(HP:0009058)|Clumsiness(HP:0002312)|Quadriceps muscle weakness(HP:0003731)|EMG: myopathic abnormalities(HP:0003458)|Increased variability in muscle fiber diameter(HP:0003557)|Rimmed vacuoles(HP:0003805)|Distal upper limb muscle weakness(HP:0008959)|Steppage gait(HP:0003376)|Peroneal muscle atrophy(HP:0009049)|Difficulty walking(HP:0002355)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Mildly elevated creatine kinase(HP:0008180)|Ankle weakness(HP:0031374)|Foot dorsiflexor weakness(HP:0009027)|Autosomal dominant inheritance(HP:0000006)|Hypertrophic cardiomyopathy(HP:0001639)|Skeletal muscle atrophy(HP:0003202)|Proximal muscle weakness(HP:0003701)|Elevated circulating creatine kinase concentration(HP:0003236)|Muscular dystrophy(HP:0003560)|Progressive(HP:0003676)|Variable expressivity(HP:0003828)|Distal muscle weakness(HP:0002460)|Autosomal recessive inheritance(HP:0000007)|EMG: myopathic abnormalities(HP:0003458)|Childhood onset(HP:0011463)|Elevated circulating creatine kinase concentration(HP:0003236)|Dilated cardiomyopathy(HP:0001644)|Generalized muscle weakness(HP:0003324)|Infantile onset(HP:0003593)|Arrhythmia(HP:0011675)|Mitochondrial depletion(HP:0030059)|Myopathy(HP:0003198)|Ptosis(HP:0000508)|Motor delay(HP:0001270)|Autosomal recessive inheritance(HP:0000007)|Elevated circulating creatine kinase concentration(HP:0003236)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Congenital onset(HP:0003577)|Scoliosis(HP:0002650)|Facial palsy(HP:0010628)|Sudden death(HP:0001699)|Calf muscle hypertrophy(HP:0008981)|Flexion contracture(HP:0001371)|Respiratory insufficiency(HP:0002093)|Protruding ear(HP:0000411)|Dysphonia(HP:0001618)|EMG: decremental response of compound muscle action potential to repetitive nerve stimulation(HP:0003403)|Bifid uvula(HP:0000193)|Pes cavus(HP:0001761)|Narrow mouth(HP:0000160)|Hyperlordosis(HP:0003307)|Hip contracture(HP:0003273)|Type 1 muscle fiber predominance(HP:0003803)|Intellectual disability, mild(HP:0001256)|Long face(HP:0000276)|Dysarthria(HP:0001260)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Generalized amyotrophy(HP:0003700)|High palate(HP:0000218)|Abnormal heart valve morphology(HP:0001654)|Talipes equinovarus(HP:0001762)|Motor delay(HP:0001270)|Difficulty climbing stairs(HP:0003551)|Retrognathia(HP:0000278)|Difficulty running(HP:0009046)|Long fingers(HP:0100807)|Ophthalmoplegia(HP:0000602)|Waddling gait(HP:0002515)|Areflexia(HP:0001284)|Left ventricular hypertrophy(HP:0001712)|Generalized hypotonia(HP:0001290)|Delayed speech and language development(HP:0000750)|Scapular winging(HP:0003691)|Progressive muscle weakness(HP:0003323)|Facial diplegia(HP:0001349)|Gowers sign(HP:0003391)|Right ventricular failure(HP:0001708)|Limited neck flexion(HP:0005991)|Pes planus(HP:0001763)|Spinal rigidity(HP:0003306)|Multiple joint contractures(HP:0002828)|Increased muscle lipid content(HP:0009058)|Mitral valve prolapse(HP:0001634)|Intermittent episodes of respiratory insufficiency due to muscle weakness(HP:0004889)|Failure to thrive(HP:0001508)|Restrictive ventilatory defect(HP:0002091)|Right ventricular hypertrophy(HP:0001667)|Weakness of facial musculature(HP:0030319)|Short stature(HP:0004322)|Muscle fiber atrophy(HP:0100295)|High palate(HP:0000218)|Delayed gross motor development(HP:0002194)|High pitched voice(HP:0001620)|Poor head control(HP:0002421)|Congenital muscular dystrophy(HP:0003741)|Microretrognathia(HP:0000308)|Nocturnal hypoventilation(HP:0002877)|Axial muscle weakness(HP:0003327)|Generalized hypotonia(HP:0001290)|Mandibular prognathia(HP:0000303)|Hip dysplasia(HP:0001385)|Generalized amyotrophy(HP:0003700)|Congestive heart failure(HP:0001635)|Scoliosis(HP:0002650)|Dilated cardiomyopathy(HP:0001644)|Atrial fibrillation(HP:0005110)|Autosomal dominant inheritance(HP:0000006)|Congestive heart failure(HP:0001635)|Reduced ejection fraction(HP:0012664)|Premature atrial contractions(HP:0006699)|Atrioventricular block(HP:0001678)|Ventricular tachycardia(HP:0004756)|Falls(HP:0002527)|Neck flexor weakness(HP:0003722)|Muscle fiber hypertrophy(HP:0100293)|Restrictive ventilatory defect(HP:0002091)|Type 1 muscle fiber predominance(HP:0003803)|Necrotizing myopathy(HP:0008978)|EMG: myopathic abnormalities(HP:0003458)|Tibialis muscle weakness(HP:0008963)|Elevated circulating creatine kinase concentration(HP:0003236)|Proximal muscle weakness(HP:0003701)|Limited hip movement(HP:0008800)|Internally nucleated skeletal muscle fibers(HP:0031237)|Muscle fiber splitting(HP:0003555)|Respiratory insufficiency due to muscle weakness(HP:0002747)|Skeletal muscle atrophy(HP:0003202)|Foot dorsiflexor weakness(HP:0009027)|Increased variability in muscle fiber diameter(HP:0003557)|Reduced vital capacity(HP:0002792)|Calf muscle hypertrophy(HP:0008981)|Orthopnea(HP:0012764)|Rimmed vacuoles(HP:0003805)|Rimmed vacuoles(HP:0003805)|Muscular dystrophy(HP:0003560)|Incomplete penetrance(HP:0003829)|Adult onset(HP:0003581)|Steppage gait(HP:0003376)|Slowly progressive(HP:0003677)|Autosomal dominant inheritance(HP:0000006)|EMG: myopathic abnormalities(HP:0003458)|Palmoplantar keratoderma(HP:0000982)|Elevated circulating creatine kinase concentration(HP:0003236)|Lipoatrophy(HP:0100578)|Abnormality of neutrophils(HP:0001874)|Myopathy(HP:0003198)|EMG abnormality(HP:0003457)|Dilated cardiomyopathy(HP:0001644)|Sensorineural hearing impairment(HP:0000407)","This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]","titin","cardiac muscle hypertrophy(GO:0003300)|muscle contraction(GO:0006936)|muscle contraction(GO:0006936)|striated muscle contraction(GO:0006941)|mitotic chromosome condensation(GO:0007076)|positive regulation of gene expression(GO:0010628)|positive regulation of gene expression(GO:0010628)|protein kinase A signaling(GO:0010737)|peptidyl-tyrosine phosphorylation(GO:0018108)|skeletal muscle thin filament assembly(GO:0030240)|skeletal muscle myosin thick filament assembly(GO:0030241)|detection of muscle stretch(GO:0035995)|detection of muscle stretch(GO:0035995)|sarcomere organization(GO:0045214)|regulation of protein kinase activity(GO:0045859)|sarcomerogenesis(GO:0048769)|positive regulation of protein secretion(GO:0050714)|positive regulation of protein secretion(GO:0050714)|regulation of catalytic activity(GO:0050790)|response to calcium ion(GO:0051592)|cardiac myofibril assembly(GO:0055003)|cardiac muscle tissue morphogenesis(GO:0055008)|cardiac muscle cell development(GO:0055013)|cardiac muscle contraction(GO:0060048)","condensed nuclear chromosome(GO:0000794)|extracellular region(GO:0005576)|cytosol(GO:0005829)|Z disc(GO:0030018)|I band(GO:0031674)|extracellular exosome(GO:0070062)","protease binding(GO:0002020)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein tyrosine kinase activity(GO:0004713)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|calmodulin binding(GO:0005516)|calmodulin binding(GO:0005516)|ATP binding(GO:0005524)|structural constituent of muscle(GO:0008307)|structural constituent of muscle(GO:0008307)|enzyme binding(GO:0019899)|protein kinase binding(GO:0019901)|telethonin binding(GO:0031433)|telethonin binding(GO:0031433)|identical protein binding(GO:0042802)|actinin binding(GO:0042805)|actinin binding(GO:0042805)|protein self-association(GO:0043621)|actin filament binding(GO:0051015)|muscle alpha-actinin binding(GO:0051371)|structural molecule activity conferring elasticity(GO:0097493)|structural molecule activity conferring elasticity(GO:0097493)|protein serine kinase activity(GO:0106310)","heart disease(DOID:114)|distal myopathy(DOID:11720)|dilated cardiomyopathy(DOID:12930)|thymoma(DOID:3275)|myopathy(DOID:423)|myasthenia gravis(DOID:437)|muscular dystrophy(DOID:9884)","Hypertrophic cardiomyopathy hcm|Dilated cardiomyopathy","Wp striated muscle contraction pathway","Hemostasis|Striated muscle contraction|Muscle contraction|Platelet activation signaling and aggregation|Response to elevated platelet cytosolic ca2","","","SpliceAI>T|TTN|0.00|0.00|0.00|0.00|-2|-46|2|-40",".;.;Protein","","","0.003","0.0006","0.003","0.0002","0.0018","","","0.0002","0.0020","D","0.0","","","D","1.0","D","0.999","","","D","1.000","L","1.13","T","-0.13","D","-3.54","0.276","T","-0.450","T","0.251","T","0.016","0.447","T","0.195","24.5","3.341","5.95","7.905","20.392"
"chr2","179640551","179640551","T>C","TTN:7273","TTN","exonic","nonsynonymous SNV","","TTN:NM_003319:exon27:c.A5902G:p.T1968A,TTN:NM_133432:exon27:c.A5902G:p.T1968A,TTN:NM_133437:exon27:c.A5902G:p.T1968A,TTN:NM_001256850:exon28:c.A6040G:p.T2014A,TTN:NM_001267550:exon28:c.A6040G:p.T2014A,TTN:NM_133378:exon28:c.A6040G:p.T2014A,TTN:NM_133379:exon28:c.A6040G:p.T2014A","TTN","exonic","nonsynonymous SNV","","TTN:ENST00000342175.11_1:exon26:c.A5902G:p.T1968A,TTN:ENST00000359218.10_1:exon26:c.A5902G:p.T1968A,TTN:ENST00000460472.6_1:exon27:c.A5902G:p.T1968A,TTN:ENST00000342992.10_1:exon28:c.A6040G:p.T2014A,TTN:ENST00000360870.10_1:exon28:c.A6040G:p.T2014A,TTN:ENST00000589042.5_1:exon28:c.A6040G:p.T2014A,TTN:ENST00000591111.5_1:exon28:c.A6040G:p.T2014A","TTN:ENST00000342175.6:c.5902A>G:p.(Thr1968Ala)","0.9513793","","","","0.0","0.9613966345787048","0.0114432504669261","","","","","","","","","","ENSG00000155657","TTN","HGNC:12403","TTN","7273","ENSG00000155657","uc031rqc.3","0.011443250466926158","","0.9613966345787048","OMIM:600334 Tibial muscular dystrophy, tardive-autosomal_dominant;OMIM:603689 Myopathy, myofibrillar, 9, with early respiratory failure-autosomal_dominant;OMIM:604145 Cardiomyopathy, dilated, 1G-autosomal_dominant;OMIM:608807 Muscular dystrophy, limb-girdle, autosomal recessive 10-autosomal_recessive;OMIM:611705 Salih myopathy-autosomal_recessive;OMIM:613765 Cardiomyopathy, familial hypertrophic, 9-autosomal_dominant;ORPHA:154 Familial isolated dilated cardiomyopathy-autosomal_dominant;ORPHA:169186 Autosomal recessive centronuclear myopathy-autosomal_recessive;ORPHA:178464 Hereditary myopathy with early respiratory failure-autosomal_dominant;ORPHA:324604 Classic multiminicore myopathy-unknown;ORPHA:609 Tibial muscular dystrophy-autosomal_dominant","1565","0/1","Het","118","58,60","0.491525423728814","Likely_benign","False","Dilated_cardiomyopathy_1G|Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J|not_provided","MONDO:MONDO:0011400,MedGen:C1858763,OMIM:604145|MONDO:MONDO:0012127,MedGen:C1837342,OMIM:608807,Orphanet:ORPHA140922|MedGen:CN517202","NC_000002.11:g.179640551T>C","criteria_provided,_multiple_submitters,_no_conflicts","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Tibial muscular dystrophy, tardive(600334)|Myopathy, myofibrillar, 9, with early respiratory failure(603689)|Cardiomyopathy, dilated, 1g(604145)|Girdle, autosomal recessive 10(608807)|Salih myopathy(611705)|Cardiomyopathy, familial hypertrophic, 9(613765)","Respiratory failure(HP:0002878)|Myofibrillar myopathy(HP:0003715)|Diaphragmatic weakness(HP:0009113)|Nocturnal hypoventilation(HP:0002877)|Shoulder girdle muscle weakness(HP:0003547)|Difficulty walking(HP:0002355)|Scapular winging(HP:0003691)|Pelvic girdle muscle weakness(HP:0003749)|Muscle fiber splitting(HP:0003555)|Neck flexor weakness(HP:0003722)|Reduced vital capacity(HP:0002792)|Adult onset(HP:0003581)|Slowly progressive(HP:0003677)|Quadriceps muscle weakness(HP:0003731)|Calf muscle hypertrophy(HP:0008981)|Autosomal dominant inheritance(HP:0000006)|Adult onset(HP:0003581)|Achilles tendon contracture(HP:0001771)|Elevated circulating creatine kinase concentration(HP:0003236)|Increased variability in muscle fiber diameter(HP:0003557)|Foot dorsiflexor weakness(HP:0009027)|Frequent falls(HP:0002359)|Rimmed vacuoles(HP:0003805)|Increased muscle lipid content(HP:0009058)|Clumsiness(HP:0002312)|Quadriceps muscle weakness(HP:0003731)|EMG: myopathic abnormalities(HP:0003458)|Increased variability in muscle fiber diameter(HP:0003557)|Rimmed vacuoles(HP:0003805)|Distal upper limb muscle weakness(HP:0008959)|Steppage gait(HP:0003376)|Peroneal muscle atrophy(HP:0009049)|Difficulty walking(HP:0002355)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Mildly elevated creatine kinase(HP:0008180)|Ankle weakness(HP:0031374)|Foot dorsiflexor weakness(HP:0009027)|Autosomal dominant inheritance(HP:0000006)|Hypertrophic cardiomyopathy(HP:0001639)|Skeletal muscle atrophy(HP:0003202)|Proximal muscle weakness(HP:0003701)|Elevated circulating creatine kinase concentration(HP:0003236)|Muscular dystrophy(HP:0003560)|Progressive(HP:0003676)|Variable expressivity(HP:0003828)|Distal muscle weakness(HP:0002460)|Autosomal recessive inheritance(HP:0000007)|EMG: myopathic abnormalities(HP:0003458)|Childhood onset(HP:0011463)|Elevated circulating creatine kinase concentration(HP:0003236)|Dilated cardiomyopathy(HP:0001644)|Generalized muscle weakness(HP:0003324)|Infantile onset(HP:0003593)|Arrhythmia(HP:0011675)|Mitochondrial depletion(HP:0030059)|Myopathy(HP:0003198)|Ptosis(HP:0000508)|Motor delay(HP:0001270)|Autosomal recessive inheritance(HP:0000007)|Elevated circulating creatine kinase concentration(HP:0003236)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Congenital onset(HP:0003577)|Scoliosis(HP:0002650)|Facial palsy(HP:0010628)|Sudden death(HP:0001699)|Calf muscle hypertrophy(HP:0008981)|Flexion contracture(HP:0001371)|Respiratory insufficiency(HP:0002093)|Protruding ear(HP:0000411)|Dysphonia(HP:0001618)|EMG: decremental response of compound muscle action potential to repetitive nerve stimulation(HP:0003403)|Bifid uvula(HP:0000193)|Pes cavus(HP:0001761)|Narrow mouth(HP:0000160)|Hyperlordosis(HP:0003307)|Hip contracture(HP:0003273)|Type 1 muscle fiber predominance(HP:0003803)|Intellectual disability, mild(HP:0001256)|Long face(HP:0000276)|Dysarthria(HP:0001260)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Generalized amyotrophy(HP:0003700)|High palate(HP:0000218)|Abnormal heart valve morphology(HP:0001654)|Talipes equinovarus(HP:0001762)|Motor delay(HP:0001270)|Difficulty climbing stairs(HP:0003551)|Retrognathia(HP:0000278)|Difficulty running(HP:0009046)|Long fingers(HP:0100807)|Ophthalmoplegia(HP:0000602)|Waddling gait(HP:0002515)|Areflexia(HP:0001284)|Left ventricular hypertrophy(HP:0001712)|Generalized hypotonia(HP:0001290)|Delayed speech and language development(HP:0000750)|Scapular winging(HP:0003691)|Progressive muscle weakness(HP:0003323)|Facial diplegia(HP:0001349)|Gowers sign(HP:0003391)|Right ventricular failure(HP:0001708)|Limited neck flexion(HP:0005991)|Pes planus(HP:0001763)|Spinal rigidity(HP:0003306)|Multiple joint contractures(HP:0002828)|Increased muscle lipid content(HP:0009058)|Mitral valve prolapse(HP:0001634)|Intermittent episodes of respiratory insufficiency due to muscle weakness(HP:0004889)|Failure to thrive(HP:0001508)|Restrictive ventilatory defect(HP:0002091)|Right ventricular hypertrophy(HP:0001667)|Weakness of facial musculature(HP:0030319)|Short stature(HP:0004322)|Muscle fiber atrophy(HP:0100295)|High palate(HP:0000218)|Delayed gross motor development(HP:0002194)|High pitched voice(HP:0001620)|Poor head control(HP:0002421)|Congenital muscular dystrophy(HP:0003741)|Microretrognathia(HP:0000308)|Nocturnal hypoventilation(HP:0002877)|Axial muscle weakness(HP:0003327)|Generalized hypotonia(HP:0001290)|Mandibular prognathia(HP:0000303)|Hip dysplasia(HP:0001385)|Generalized amyotrophy(HP:0003700)|Congestive heart failure(HP:0001635)|Scoliosis(HP:0002650)|Dilated cardiomyopathy(HP:0001644)|Atrial fibrillation(HP:0005110)|Autosomal dominant inheritance(HP:0000006)|Congestive heart failure(HP:0001635)|Reduced ejection fraction(HP:0012664)|Premature atrial contractions(HP:0006699)|Atrioventricular block(HP:0001678)|Ventricular tachycardia(HP:0004756)|Falls(HP:0002527)|Neck flexor weakness(HP:0003722)|Muscle fiber hypertrophy(HP:0100293)|Restrictive ventilatory defect(HP:0002091)|Type 1 muscle fiber predominance(HP:0003803)|Necrotizing myopathy(HP:0008978)|EMG: myopathic abnormalities(HP:0003458)|Tibialis muscle weakness(HP:0008963)|Elevated circulating creatine kinase concentration(HP:0003236)|Proximal muscle weakness(HP:0003701)|Limited hip movement(HP:0008800)|Internally nucleated skeletal muscle fibers(HP:0031237)|Muscle fiber splitting(HP:0003555)|Respiratory insufficiency due to muscle weakness(HP:0002747)|Skeletal muscle atrophy(HP:0003202)|Foot dorsiflexor weakness(HP:0009027)|Increased variability in muscle fiber diameter(HP:0003557)|Reduced vital capacity(HP:0002792)|Calf muscle hypertrophy(HP:0008981)|Orthopnea(HP:0012764)|Rimmed vacuoles(HP:0003805)|Rimmed vacuoles(HP:0003805)|Muscular dystrophy(HP:0003560)|Incomplete penetrance(HP:0003829)|Adult onset(HP:0003581)|Steppage gait(HP:0003376)|Slowly progressive(HP:0003677)|Autosomal dominant inheritance(HP:0000006)|EMG: myopathic abnormalities(HP:0003458)|Palmoplantar keratoderma(HP:0000982)|Elevated circulating creatine kinase concentration(HP:0003236)|Lipoatrophy(HP:0100578)|Abnormality of neutrophils(HP:0001874)|Myopathy(HP:0003198)|EMG abnormality(HP:0003457)|Dilated cardiomyopathy(HP:0001644)|Sensorineural hearing impairment(HP:0000407)","This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]","titin","cardiac muscle hypertrophy(GO:0003300)|muscle contraction(GO:0006936)|muscle contraction(GO:0006936)|striated muscle contraction(GO:0006941)|mitotic chromosome condensation(GO:0007076)|positive regulation of gene expression(GO:0010628)|positive regulation of gene expression(GO:0010628)|protein kinase A signaling(GO:0010737)|peptidyl-tyrosine phosphorylation(GO:0018108)|skeletal muscle thin filament assembly(GO:0030240)|skeletal muscle myosin thick filament assembly(GO:0030241)|detection of muscle stretch(GO:0035995)|detection of muscle stretch(GO:0035995)|sarcomere organization(GO:0045214)|regulation of protein kinase activity(GO:0045859)|sarcomerogenesis(GO:0048769)|positive regulation of protein secretion(GO:0050714)|positive regulation of protein secretion(GO:0050714)|regulation of catalytic activity(GO:0050790)|response to calcium ion(GO:0051592)|cardiac myofibril assembly(GO:0055003)|cardiac muscle tissue morphogenesis(GO:0055008)|cardiac muscle cell development(GO:0055013)|cardiac muscle contraction(GO:0060048)","condensed nuclear chromosome(GO:0000794)|extracellular region(GO:0005576)|cytosol(GO:0005829)|Z disc(GO:0030018)|I band(GO:0031674)|extracellular exosome(GO:0070062)","protease binding(GO:0002020)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein tyrosine kinase activity(GO:0004713)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|calmodulin binding(GO:0005516)|calmodulin binding(GO:0005516)|ATP binding(GO:0005524)|structural constituent of muscle(GO:0008307)|structural constituent of muscle(GO:0008307)|enzyme binding(GO:0019899)|protein kinase binding(GO:0019901)|telethonin binding(GO:0031433)|telethonin binding(GO:0031433)|identical protein binding(GO:0042802)|actinin binding(GO:0042805)|actinin binding(GO:0042805)|protein self-association(GO:0043621)|actin filament binding(GO:0051015)|muscle alpha-actinin binding(GO:0051371)|structural molecule activity conferring elasticity(GO:0097493)|structural molecule activity conferring elasticity(GO:0097493)|protein serine kinase activity(GO:0106310)","heart disease(DOID:114)|distal myopathy(DOID:11720)|dilated cardiomyopathy(DOID:12930)|thymoma(DOID:3275)|myopathy(DOID:423)|myasthenia gravis(DOID:437)|muscular dystrophy(DOID:9884)","Hypertrophic cardiomyopathy hcm|Dilated cardiomyopathy","Wp striated muscle contraction pathway","Hemostasis|Striated muscle contraction|Muscle contraction|Platelet activation signaling and aggregation|Response to elevated platelet cytosolic ca2","","","",".;.;.;.;.;.;.;.","","","0.003","0.0006","0.003","0.0001","0.0019","","","0.0002","0.0021","T","0.195","D","0.003","P","0.702","B","0.217","","","D","0.979","","","T","0.01","D","-3.31","0.385","T","-0.775","T","0.177","T","0.021","0.153","T","0.105","19.52","1.972","5.12","5.120","14.921"
"chr2","179583077","179583077","A>C","TTN:7273","TTN","exonic","nonsynonymous SNV","","TTN:NM_133378:exon82:c.T21024G:p.D7008E,TTN:NM_001256850:exon83:c.T23805G:p.D7935E,TTN:NM_001267550:exon85:c.T24756G:p.D8252E","TTN","exonic","nonsynonymous SNV","","TTN:ENST00000342992.10_1:exon82:c.T21024G:p.D7008E,TTN:ENST00000591111.5_1:exon83:c.T23805G:p.D7935E,TTN:ENST00000589042.5_1:exon85:c.T24756G:p.D8252E","TTN:ENST00000342992.6:c.21024T>G:p.(Asp7008Glu)","0.9500603","","","","","","","","","","","","","","","","ENSG00000155657","TTN","HGNC:12403","TTN","7273","ENSG00000155657","uc031rqc.3","0.011443250466926158","","0.9613966345787048","OMIM:600334 Tibial muscular dystrophy, tardive-autosomal_dominant;OMIM:603689 Myopathy, myofibrillar, 9, with early respiratory failure-autosomal_dominant;OMIM:604145 Cardiomyopathy, dilated, 1G-autosomal_dominant;OMIM:608807 Muscular dystrophy, limb-girdle, autosomal recessive 10-autosomal_recessive;OMIM:611705 Salih myopathy-autosomal_recessive;OMIM:613765 Cardiomyopathy, familial hypertrophic, 9-autosomal_dominant;ORPHA:154 Familial isolated dilated cardiomyopathy-autosomal_dominant;ORPHA:169186 Autosomal recessive centronuclear myopathy-autosomal_recessive;ORPHA:178464 Hereditary myopathy with early respiratory failure-autosomal_dominant;ORPHA:324604 Classic multiminicore myopathy-unknown;ORPHA:609 Tibial muscular dystrophy-autosomal_dominant","1566","0/1","Het","96","55,41","0.572916666666667","Conflicting_interpretations_of_pathogenicity","True","Tibial_muscular_dystrophy|Myopathy,_myofibrillar,_9,_with_early_respiratory_failure|Dilated_cardiomyopathy_1G|Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J|Early-onset_myopathy_with_fatal_cardiomyopathy|not_provided","MONDO:MONDO:0010870,MedGen:C1838244,OMIM:600334,Orphanet:ORPHA609|MONDO:MONDO:0011362,MedGen:C1863599,OMIM:603689,Orphanet:ORPHA178464|MONDO:MONDO:0011400,MedGen:C1858763,OMIM:604145|MONDO:MONDO:0012127,MedGen:C1837342,OMIM:608807,Orphanet:ORPHA140922|MONDO:MONDO:0012714,MedGen:C2673677,OMIM:611705,Orphanet:ORPHA289377|MedGen:CN517202","NC_000002.11:g.179583077A>C","criteria_provided,_conflicting_interpretations","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 1 ; BP7: 0","Tibial muscular dystrophy, tardive(600334)|Myopathy, myofibrillar, 9, with early respiratory failure(603689)|Cardiomyopathy, dilated, 1g(604145)|Girdle, autosomal recessive 10(608807)|Salih myopathy(611705)|Cardiomyopathy, familial hypertrophic, 9(613765)","Respiratory failure(HP:0002878)|Myofibrillar myopathy(HP:0003715)|Diaphragmatic weakness(HP:0009113)|Nocturnal hypoventilation(HP:0002877)|Shoulder girdle muscle weakness(HP:0003547)|Difficulty walking(HP:0002355)|Scapular winging(HP:0003691)|Pelvic girdle muscle weakness(HP:0003749)|Muscle fiber splitting(HP:0003555)|Neck flexor weakness(HP:0003722)|Reduced vital capacity(HP:0002792)|Adult onset(HP:0003581)|Slowly progressive(HP:0003677)|Quadriceps muscle weakness(HP:0003731)|Calf muscle hypertrophy(HP:0008981)|Autosomal dominant inheritance(HP:0000006)|Adult onset(HP:0003581)|Achilles tendon contracture(HP:0001771)|Elevated circulating creatine kinase concentration(HP:0003236)|Increased variability in muscle fiber diameter(HP:0003557)|Foot dorsiflexor weakness(HP:0009027)|Frequent falls(HP:0002359)|Rimmed vacuoles(HP:0003805)|Increased muscle lipid content(HP:0009058)|Clumsiness(HP:0002312)|Quadriceps muscle weakness(HP:0003731)|EMG: myopathic abnormalities(HP:0003458)|Increased variability in muscle fiber diameter(HP:0003557)|Rimmed vacuoles(HP:0003805)|Distal upper limb muscle weakness(HP:0008959)|Steppage gait(HP:0003376)|Peroneal muscle atrophy(HP:0009049)|Difficulty walking(HP:0002355)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Mildly elevated creatine kinase(HP:0008180)|Ankle weakness(HP:0031374)|Foot dorsiflexor weakness(HP:0009027)|Autosomal dominant inheritance(HP:0000006)|Hypertrophic cardiomyopathy(HP:0001639)|Skeletal muscle atrophy(HP:0003202)|Proximal muscle weakness(HP:0003701)|Elevated circulating creatine kinase concentration(HP:0003236)|Muscular dystrophy(HP:0003560)|Progressive(HP:0003676)|Variable expressivity(HP:0003828)|Distal muscle weakness(HP:0002460)|Autosomal recessive inheritance(HP:0000007)|EMG: myopathic abnormalities(HP:0003458)|Childhood onset(HP:0011463)|Elevated circulating creatine kinase concentration(HP:0003236)|Dilated cardiomyopathy(HP:0001644)|Generalized muscle weakness(HP:0003324)|Infantile onset(HP:0003593)|Arrhythmia(HP:0011675)|Mitochondrial depletion(HP:0030059)|Myopathy(HP:0003198)|Ptosis(HP:0000508)|Motor delay(HP:0001270)|Autosomal recessive inheritance(HP:0000007)|Elevated circulating creatine kinase concentration(HP:0003236)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Congenital onset(HP:0003577)|Scoliosis(HP:0002650)|Facial palsy(HP:0010628)|Sudden death(HP:0001699)|Calf muscle hypertrophy(HP:0008981)|Flexion contracture(HP:0001371)|Respiratory insufficiency(HP:0002093)|Protruding ear(HP:0000411)|Dysphonia(HP:0001618)|EMG: decremental response of compound muscle action potential to repetitive nerve stimulation(HP:0003403)|Bifid uvula(HP:0000193)|Pes cavus(HP:0001761)|Narrow mouth(HP:0000160)|Hyperlordosis(HP:0003307)|Hip contracture(HP:0003273)|Type 1 muscle fiber predominance(HP:0003803)|Intellectual disability, mild(HP:0001256)|Long face(HP:0000276)|Dysarthria(HP:0001260)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Generalized amyotrophy(HP:0003700)|High palate(HP:0000218)|Abnormal heart valve morphology(HP:0001654)|Talipes equinovarus(HP:0001762)|Motor delay(HP:0001270)|Difficulty climbing stairs(HP:0003551)|Retrognathia(HP:0000278)|Difficulty running(HP:0009046)|Long fingers(HP:0100807)|Ophthalmoplegia(HP:0000602)|Waddling gait(HP:0002515)|Areflexia(HP:0001284)|Left ventricular hypertrophy(HP:0001712)|Generalized hypotonia(HP:0001290)|Delayed speech and language development(HP:0000750)|Scapular winging(HP:0003691)|Progressive muscle weakness(HP:0003323)|Facial diplegia(HP:0001349)|Gowers sign(HP:0003391)|Right ventricular failure(HP:0001708)|Limited neck flexion(HP:0005991)|Pes planus(HP:0001763)|Spinal rigidity(HP:0003306)|Multiple joint contractures(HP:0002828)|Increased muscle lipid content(HP:0009058)|Mitral valve prolapse(HP:0001634)|Intermittent episodes of respiratory insufficiency due to muscle weakness(HP:0004889)|Failure to thrive(HP:0001508)|Restrictive ventilatory defect(HP:0002091)|Right ventricular hypertrophy(HP:0001667)|Weakness of facial musculature(HP:0030319)|Short stature(HP:0004322)|Muscle fiber atrophy(HP:0100295)|High palate(HP:0000218)|Delayed gross motor development(HP:0002194)|High pitched voice(HP:0001620)|Poor head control(HP:0002421)|Congenital muscular dystrophy(HP:0003741)|Microretrognathia(HP:0000308)|Nocturnal hypoventilation(HP:0002877)|Axial muscle weakness(HP:0003327)|Generalized hypotonia(HP:0001290)|Mandibular prognathia(HP:0000303)|Hip dysplasia(HP:0001385)|Generalized amyotrophy(HP:0003700)|Congestive heart failure(HP:0001635)|Scoliosis(HP:0002650)|Dilated cardiomyopathy(HP:0001644)|Atrial fibrillation(HP:0005110)|Autosomal dominant inheritance(HP:0000006)|Congestive heart failure(HP:0001635)|Reduced ejection fraction(HP:0012664)|Premature atrial contractions(HP:0006699)|Atrioventricular block(HP:0001678)|Ventricular tachycardia(HP:0004756)|Falls(HP:0002527)|Neck flexor weakness(HP:0003722)|Muscle fiber hypertrophy(HP:0100293)|Restrictive ventilatory defect(HP:0002091)|Type 1 muscle fiber predominance(HP:0003803)|Necrotizing myopathy(HP:0008978)|EMG: myopathic abnormalities(HP:0003458)|Tibialis muscle weakness(HP:0008963)|Elevated circulating creatine kinase concentration(HP:0003236)|Proximal muscle weakness(HP:0003701)|Limited hip movement(HP:0008800)|Internally nucleated skeletal muscle fibers(HP:0031237)|Muscle fiber splitting(HP:0003555)|Respiratory insufficiency due to muscle weakness(HP:0002747)|Skeletal muscle atrophy(HP:0003202)|Foot dorsiflexor weakness(HP:0009027)|Increased variability in muscle fiber diameter(HP:0003557)|Reduced vital capacity(HP:0002792)|Calf muscle hypertrophy(HP:0008981)|Orthopnea(HP:0012764)|Rimmed vacuoles(HP:0003805)|Rimmed vacuoles(HP:0003805)|Muscular dystrophy(HP:0003560)|Incomplete penetrance(HP:0003829)|Adult onset(HP:0003581)|Steppage gait(HP:0003376)|Slowly progressive(HP:0003677)|Autosomal dominant inheritance(HP:0000006)|EMG: myopathic abnormalities(HP:0003458)|Palmoplantar keratoderma(HP:0000982)|Elevated circulating creatine kinase concentration(HP:0003236)|Lipoatrophy(HP:0100578)|Abnormality of neutrophils(HP:0001874)|Myopathy(HP:0003198)|EMG abnormality(HP:0003457)|Dilated cardiomyopathy(HP:0001644)|Sensorineural hearing impairment(HP:0000407)","This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]","titin","cardiac muscle hypertrophy(GO:0003300)|muscle contraction(GO:0006936)|muscle contraction(GO:0006936)|striated muscle contraction(GO:0006941)|mitotic chromosome condensation(GO:0007076)|positive regulation of gene expression(GO:0010628)|positive regulation of gene expression(GO:0010628)|protein kinase A signaling(GO:0010737)|peptidyl-tyrosine phosphorylation(GO:0018108)|skeletal muscle thin filament assembly(GO:0030240)|skeletal muscle myosin thick filament assembly(GO:0030241)|detection of muscle stretch(GO:0035995)|detection of muscle stretch(GO:0035995)|sarcomere organization(GO:0045214)|regulation of protein kinase activity(GO:0045859)|sarcomerogenesis(GO:0048769)|positive regulation of protein secretion(GO:0050714)|positive regulation of protein secretion(GO:0050714)|regulation of catalytic activity(GO:0050790)|response to calcium ion(GO:0051592)|cardiac myofibril assembly(GO:0055003)|cardiac muscle tissue morphogenesis(GO:0055008)|cardiac muscle cell development(GO:0055013)|cardiac muscle contraction(GO:0060048)","condensed nuclear chromosome(GO:0000794)|extracellular region(GO:0005576)|cytosol(GO:0005829)|Z disc(GO:0030018)|I band(GO:0031674)|extracellular exosome(GO:0070062)","protease binding(GO:0002020)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein tyrosine kinase activity(GO:0004713)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|calmodulin binding(GO:0005516)|calmodulin binding(GO:0005516)|ATP binding(GO:0005524)|structural constituent of muscle(GO:0008307)|structural constituent of muscle(GO:0008307)|enzyme binding(GO:0019899)|protein kinase binding(GO:0019901)|telethonin binding(GO:0031433)|telethonin binding(GO:0031433)|identical protein binding(GO:0042802)|actinin binding(GO:0042805)|actinin binding(GO:0042805)|protein self-association(GO:0043621)|actin filament binding(GO:0051015)|muscle alpha-actinin binding(GO:0051371)|structural molecule activity conferring elasticity(GO:0097493)|structural molecule activity conferring elasticity(GO:0097493)|protein serine kinase activity(GO:0106310)","heart disease(DOID:114)|distal myopathy(DOID:11720)|dilated cardiomyopathy(DOID:12930)|thymoma(DOID:3275)|myopathy(DOID:423)|myasthenia gravis(DOID:437)|muscular dystrophy(DOID:9884)","Hypertrophic cardiomyopathy hcm|Dilated cardiomyopathy","Wp striated muscle contraction pathway","Hemostasis|Striated muscle contraction|Muscle contraction|Platelet activation signaling and aggregation|Response to elevated platelet cytosolic ca2","","","",".;Immunoglobulin","","","0.0019","","","0.0001","0.0019","","","0.0001","0.0019","T","0.934","","","P","0.543","B","0.287","","","D","1.000","","","T","-0.22","N","-1.51","0.286","T","-0.597","T","0.247","T","0.017","0.110","T","0.052","14.19","1.119","6.16","-0.131","12.842"
"chr2","179650715","179650715","C>T","TTN:7273","TTN","exonic","nonsynonymous SNV","","TTN:NM_003319:exon13:c.G2092A:p.A698T,TTN:NM_133432:exon13:c.G2092A:p.A698T,TTN:NM_133437:exon13:c.G2092A:p.A698T,TTN:NM_001256850:exon14:c.G2230A:p.A744T,TTN:NM_001267550:exon14:c.G2230A:p.A744T,TTN:NM_133378:exon14:c.G2230A:p.A744T,TTN:NM_133379:exon14:c.G2230A:p.A744T","TTN","exonic","nonsynonymous SNV","","TTN:ENST00000342175.11_1:exon12:c.G2092A:p.A698T,TTN:ENST00000359218.10_1:exon12:c.G2092A:p.A698T,TTN:ENST00000460472.6_1:exon13:c.G2092A:p.A698T,TTN:ENST00000342992.10_1:exon14:c.G2230A:p.A744T,TTN:ENST00000360870.10_1:exon14:c.G2230A:p.A744T,TTN:ENST00000589042.5_1:exon14:c.G2230A:p.A744T,TTN:ENST00000591111.5_1:exon14:c.G2230A:p.A744T","TTN:ENST00000342175.6:c.2092G>A:p.(Ala698Thr)","0.099983394","","","","","","","","","","","","","","","","ENSG00000155657","TTN","HGNC:12403","TTN","7273","ENSG00000155657","uc031rqc.3","0.011443250466926158","","0.9613966345787048","OMIM:600334 Tibial muscular dystrophy, tardive-autosomal_dominant;OMIM:603689 Myopathy, myofibrillar, 9, with early respiratory failure-autosomal_dominant;OMIM:604145 Cardiomyopathy, dilated, 1G-autosomal_dominant;OMIM:608807 Muscular dystrophy, limb-girdle, autosomal recessive 10-autosomal_recessive;OMIM:611705 Salih myopathy-autosomal_recessive;OMIM:613765 Cardiomyopathy, familial hypertrophic, 9-autosomal_dominant;ORPHA:154 Familial isolated dilated cardiomyopathy-autosomal_dominant;ORPHA:169186 Autosomal recessive centronuclear myopathy-autosomal_recessive;ORPHA:178464 Hereditary myopathy with early respiratory failure-autosomal_dominant;ORPHA:324604 Classic multiminicore myopathy-unknown;ORPHA:609 Tibial muscular dystrophy-autosomal_dominant","1567","0/1","Het","161","94,67","0.583850931677019","Conflicting_interpretations_of_pathogenicity","True","Dilated_cardiomyopathy_1G|Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J|not_specified|not_provided","MONDO:MONDO:0011400,MedGen:C1858763,OMIM:604145|MONDO:MONDO:0012127,MedGen:C1837342,OMIM:608807,Orphanet:ORPHA140922|MedGen:CN169374|MedGen:CN517202","NC_000002.11:g.179650715C>T","criteria_provided,_conflicting_interpretations","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 1 ; BP7: 0","Tibial muscular dystrophy, tardive(600334)|Myopathy, myofibrillar, 9, with early respiratory failure(603689)|Cardiomyopathy, dilated, 1g(604145)|Girdle, autosomal recessive 10(608807)|Salih myopathy(611705)|Cardiomyopathy, familial hypertrophic, 9(613765)","Respiratory failure(HP:0002878)|Myofibrillar myopathy(HP:0003715)|Diaphragmatic weakness(HP:0009113)|Nocturnal hypoventilation(HP:0002877)|Shoulder girdle muscle weakness(HP:0003547)|Difficulty walking(HP:0002355)|Scapular winging(HP:0003691)|Pelvic girdle muscle weakness(HP:0003749)|Muscle fiber splitting(HP:0003555)|Neck flexor weakness(HP:0003722)|Reduced vital capacity(HP:0002792)|Adult onset(HP:0003581)|Slowly progressive(HP:0003677)|Quadriceps muscle weakness(HP:0003731)|Calf muscle hypertrophy(HP:0008981)|Autosomal dominant inheritance(HP:0000006)|Adult onset(HP:0003581)|Achilles tendon contracture(HP:0001771)|Elevated circulating creatine kinase concentration(HP:0003236)|Increased variability in muscle fiber diameter(HP:0003557)|Foot dorsiflexor weakness(HP:0009027)|Frequent falls(HP:0002359)|Rimmed vacuoles(HP:0003805)|Increased muscle lipid content(HP:0009058)|Clumsiness(HP:0002312)|Quadriceps muscle weakness(HP:0003731)|EMG: myopathic abnormalities(HP:0003458)|Increased variability in muscle fiber diameter(HP:0003557)|Rimmed vacuoles(HP:0003805)|Distal upper limb muscle weakness(HP:0008959)|Steppage gait(HP:0003376)|Peroneal muscle atrophy(HP:0009049)|Difficulty walking(HP:0002355)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Mildly elevated creatine kinase(HP:0008180)|Ankle weakness(HP:0031374)|Foot dorsiflexor weakness(HP:0009027)|Autosomal dominant inheritance(HP:0000006)|Hypertrophic cardiomyopathy(HP:0001639)|Skeletal muscle atrophy(HP:0003202)|Proximal muscle weakness(HP:0003701)|Elevated circulating creatine kinase concentration(HP:0003236)|Muscular dystrophy(HP:0003560)|Progressive(HP:0003676)|Variable expressivity(HP:0003828)|Distal muscle weakness(HP:0002460)|Autosomal recessive inheritance(HP:0000007)|EMG: myopathic abnormalities(HP:0003458)|Childhood onset(HP:0011463)|Elevated circulating creatine kinase concentration(HP:0003236)|Dilated cardiomyopathy(HP:0001644)|Generalized muscle weakness(HP:0003324)|Infantile onset(HP:0003593)|Arrhythmia(HP:0011675)|Mitochondrial depletion(HP:0030059)|Myopathy(HP:0003198)|Ptosis(HP:0000508)|Motor delay(HP:0001270)|Autosomal recessive inheritance(HP:0000007)|Elevated circulating creatine kinase concentration(HP:0003236)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Congenital onset(HP:0003577)|Scoliosis(HP:0002650)|Facial palsy(HP:0010628)|Sudden death(HP:0001699)|Calf muscle hypertrophy(HP:0008981)|Flexion contracture(HP:0001371)|Respiratory insufficiency(HP:0002093)|Protruding ear(HP:0000411)|Dysphonia(HP:0001618)|EMG: decremental response of compound muscle action potential to repetitive nerve stimulation(HP:0003403)|Bifid uvula(HP:0000193)|Pes cavus(HP:0001761)|Narrow mouth(HP:0000160)|Hyperlordosis(HP:0003307)|Hip contracture(HP:0003273)|Type 1 muscle fiber predominance(HP:0003803)|Intellectual disability, mild(HP:0001256)|Long face(HP:0000276)|Dysarthria(HP:0001260)|Centrally nucleated skeletal muscle fibers(HP:0003687)|Generalized amyotrophy(HP:0003700)|High palate(HP:0000218)|Abnormal heart valve morphology(HP:0001654)|Talipes equinovarus(HP:0001762)|Motor delay(HP:0001270)|Difficulty climbing stairs(HP:0003551)|Retrognathia(HP:0000278)|Difficulty running(HP:0009046)|Long fingers(HP:0100807)|Ophthalmoplegia(HP:0000602)|Waddling gait(HP:0002515)|Areflexia(HP:0001284)|Left ventricular hypertrophy(HP:0001712)|Generalized hypotonia(HP:0001290)|Delayed speech and language development(HP:0000750)|Scapular winging(HP:0003691)|Progressive muscle weakness(HP:0003323)|Facial diplegia(HP:0001349)|Gowers sign(HP:0003391)|Right ventricular failure(HP:0001708)|Limited neck flexion(HP:0005991)|Pes planus(HP:0001763)|Spinal rigidity(HP:0003306)|Multiple joint contractures(HP:0002828)|Increased muscle lipid content(HP:0009058)|Mitral valve prolapse(HP:0001634)|Intermittent episodes of respiratory insufficiency due to muscle weakness(HP:0004889)|Failure to thrive(HP:0001508)|Restrictive ventilatory defect(HP:0002091)|Right ventricular hypertrophy(HP:0001667)|Weakness of facial musculature(HP:0030319)|Short stature(HP:0004322)|Muscle fiber atrophy(HP:0100295)|High palate(HP:0000218)|Delayed gross motor development(HP:0002194)|High pitched voice(HP:0001620)|Poor head control(HP:0002421)|Congenital muscular dystrophy(HP:0003741)|Microretrognathia(HP:0000308)|Nocturnal hypoventilation(HP:0002877)|Axial muscle weakness(HP:0003327)|Generalized hypotonia(HP:0001290)|Mandibular prognathia(HP:0000303)|Hip dysplasia(HP:0001385)|Generalized amyotrophy(HP:0003700)|Congestive heart failure(HP:0001635)|Scoliosis(HP:0002650)|Dilated cardiomyopathy(HP:0001644)|Atrial fibrillation(HP:0005110)|Autosomal dominant inheritance(HP:0000006)|Congestive heart failure(HP:0001635)|Reduced ejection fraction(HP:0012664)|Premature atrial contractions(HP:0006699)|Atrioventricular block(HP:0001678)|Ventricular tachycardia(HP:0004756)|Falls(HP:0002527)|Neck flexor weakness(HP:0003722)|Muscle fiber hypertrophy(HP:0100293)|Restrictive ventilatory defect(HP:0002091)|Type 1 muscle fiber predominance(HP:0003803)|Necrotizing myopathy(HP:0008978)|EMG: myopathic abnormalities(HP:0003458)|Tibialis muscle weakness(HP:0008963)|Elevated circulating creatine kinase concentration(HP:0003236)|Proximal muscle weakness(HP:0003701)|Limited hip movement(HP:0008800)|Internally nucleated skeletal muscle fibers(HP:0031237)|Muscle fiber splitting(HP:0003555)|Respiratory insufficiency due to muscle weakness(HP:0002747)|Skeletal muscle atrophy(HP:0003202)|Foot dorsiflexor weakness(HP:0009027)|Increased variability in muscle fiber diameter(HP:0003557)|Reduced vital capacity(HP:0002792)|Calf muscle hypertrophy(HP:0008981)|Orthopnea(HP:0012764)|Rimmed vacuoles(HP:0003805)|Rimmed vacuoles(HP:0003805)|Muscular dystrophy(HP:0003560)|Incomplete penetrance(HP:0003829)|Adult onset(HP:0003581)|Steppage gait(HP:0003376)|Slowly progressive(HP:0003677)|Autosomal dominant inheritance(HP:0000006)|EMG: myopathic abnormalities(HP:0003458)|Palmoplantar keratoderma(HP:0000982)|Elevated circulating creatine kinase concentration(HP:0003236)|Lipoatrophy(HP:0100578)|Abnormality of neutrophils(HP:0001874)|Myopathy(HP:0003198)|EMG abnormality(HP:0003457)|Dilated cardiomyopathy(HP:0001644)|Sensorineural hearing impairment(HP:0000407)","This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]","titin","cardiac muscle hypertrophy(GO:0003300)|muscle contraction(GO:0006936)|muscle contraction(GO:0006936)|striated muscle contraction(GO:0006941)|mitotic chromosome condensation(GO:0007076)|positive regulation of gene expression(GO:0010628)|positive regulation of gene expression(GO:0010628)|protein kinase A signaling(GO:0010737)|peptidyl-tyrosine phosphorylation(GO:0018108)|skeletal muscle thin filament assembly(GO:0030240)|skeletal muscle myosin thick filament assembly(GO:0030241)|detection of muscle stretch(GO:0035995)|detection of muscle stretch(GO:0035995)|sarcomere organization(GO:0045214)|regulation of protein kinase activity(GO:0045859)|sarcomerogenesis(GO:0048769)|positive regulation of protein secretion(GO:0050714)|positive regulation of protein secretion(GO:0050714)|regulation of catalytic activity(GO:0050790)|response to calcium ion(GO:0051592)|cardiac myofibril assembly(GO:0055003)|cardiac muscle tissue morphogenesis(GO:0055008)|cardiac muscle cell development(GO:0055013)|cardiac muscle contraction(GO:0060048)","condensed nuclear chromosome(GO:0000794)|extracellular region(GO:0005576)|cytosol(GO:0005829)|Z disc(GO:0030018)|I band(GO:0031674)|extracellular exosome(GO:0070062)","protease binding(GO:0002020)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein tyrosine kinase activity(GO:0004713)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|calmodulin binding(GO:0005516)|calmodulin binding(GO:0005516)|ATP binding(GO:0005524)|structural constituent of muscle(GO:0008307)|structural constituent of muscle(GO:0008307)|enzyme binding(GO:0019899)|protein kinase binding(GO:0019901)|telethonin binding(GO:0031433)|telethonin binding(GO:0031433)|identical protein binding(GO:0042802)|actinin binding(GO:0042805)|actinin binding(GO:0042805)|protein self-association(GO:0043621)|actin filament binding(GO:0051015)|muscle alpha-actinin binding(GO:0051371)|structural molecule activity conferring elasticity(GO:0097493)|structural molecule activity conferring elasticity(GO:0097493)|protein serine kinase activity(GO:0106310)","heart disease(DOID:114)|distal myopathy(DOID:11720)|dilated cardiomyopathy(DOID:12930)|thymoma(DOID:3275)|myopathy(DOID:423)|myasthenia gravis(DOID:437)|muscular dystrophy(DOID:9884)","Hypertrophic cardiomyopathy hcm|Dilated cardiomyopathy","Wp striated muscle contraction pathway","Hemostasis|Striated muscle contraction|Muscle contraction|Platelet activation signaling and aggregation|Response to elevated platelet cytosolic ca2","","","SpliceAI>T|TTN|0.00|0.00|0.06|0.00|-6|39|-5|-8",".;.;.;.;.;.;.;.","","","0.006","0.0012","0.006","0.0004","0.0037","","","0.0004","0.0041","T","0.893","T","1.0","B","0.0","B","0.0","","","N","1","","","T","0.1","N","0.26","0.042","T","-1.023","T","0.056","T","0.019","0.087","T","0.003","6.659","0.258","6.17","0.050","11.759"
"chr18","14513678","14513678","T>G","","POTEC","exonic","nonsynonymous SNV","","POTEC:NM_001137671:exon10:c.A1516C:p.K506Q","POTEC","exonic","nonsynonymous SNV","","POTEC:ENST00000358970.10_1:exon10:c.A1516C:p.K506Q","POTEC:ENST00000358970.5:c.1516A>C:p.(Lys506Gln)","0.939","0.0","0.9390000104904176","0.0093356783006561","0.0","0.8620498478412628","0.0046269117782607","","","","","","","","","","ENSG00000183206","POTEC","HGNC:33894","POTEC","388468","ENSG00000183206","uc010dln.4","0.009335678300656196","","0.9390000104904175","","1637","0/1","Het","176","132,44","0.75","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","POTE ankyrin domain family member C","","","","","","","","","","","","","","","","","","","","","","","T","0.061","T","0.267","P","0.455","B","0.137","","","N","1","M","2.35","T","1.38","N","0.11","0.36","T","-1.046","T","0.060","T","9.61E-4","0.021","T","0.115","12.33","0.848","1.53","1.060","4.177"
"chr18","14533084","14533084","T>C","","POTEC","exonic","nonsynonymous SNV","","POTEC:NM_001137671:exon5:c.A1031G:p.Y344C","POTEC","exonic","nonsynonymous SNV","","POTEC:ENST00000358970.10_1:exon5:c.A1031G:p.Y344C,POTEC:ENST00000620346.1_1:exon5:c.A1031G:p.Y344C","POTEC:ENST00000358970.5:c.1031A>G:p.(Tyr344Cys)","0.7850997","","","","0.0","0.8620498478412628","0.0046269117782607","","","","","","","","","","ENSG00000183206","POTEC","HGNC:33894","POTEC","388468","ENSG00000183206","uc010dln.4","0.009335678300656196","","0.9390000104904175","","1638","0/1","Het","89","50,39","0.561797752808989","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","POTE ankyrin domain family member C","","","","","","","","","","SpliceAI>C|POTEC|0.00|0.00|0.01|0.01|27|3|-24|3","Ankyrin","","","0.0096","","","0.0007","0.0089","","","0.0007","0.0096","D","0.007","T","0.09","D","1.0","D","0.998","","","N","1","M","2.15","T","0.51","D","-5.75","0.64","T","-0.883","T","0.267","T","0.004","0.203","T","0.273","18.52","1.843","1.09","3.608","4.425"
"chr21","14982886","14982886","G>A","","POTED","exonic","nonsynonymous SNV","","POTED:NM_174981:exon1:c.G337A:p.G113S","POTED","exonic","nonsynonymous SNV","","POTED:ENST00000299443.6_1:exon1:c.G337A:p.G113S,POTED:ENST00000620442.4_1:exon1:c.G337A:p.G113S","POTED:ENST00000299443.5:c.337G>A:p.(Gly113Ser)","0.9307485","","","","0.0","0.9307485222816468","0.0086602612208643","","","","","","","","","","ENSG00000166351","POTED","HGNC:23822","POTED","317754","ENSG00000166351","uc002yjb.1","0.008660261220864376","","0.9307485222816467","","1648","1/1","Hom","202","9,193","0.0445544554455446","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","POTE ankyrin domain family member D","","plasma membrane(GO:0005886)","","","","","","","","SpliceAI>A|POTED|0.00|0.00|0.00|0.00|-7|41|-7|-42",".;.","","","0.00006251","","","","","","","6.251e-05","0","T","0.153","D","0.043","D","1.0","D","0.937","","","N","1","L","1.15","T","1.66","N","-1.24","0.08","T","-0.997","T","0.095","T","0.003","0.029","T","0.037","11.94","0.799","0.418","-1.777",""
"chr21","15013735","15013735","A>G","","POTED","exonic","nonsynonymous SNV","","POTED:NM_174981:exon11:c.A1603G:p.M535V","POTED","exonic","nonsynonymous SNV","","POTED:ENST00000299443.6_1:exon11:c.A1603G:p.M535V","POTED:ENST00000299443.5:c.1603A>G:p.(Met535Val)","0.78499997","","","","","","","","","","","","","","","","ENSG00000166351","POTED","HGNC:23822","POTED","317754","ENSG00000166351","uc002yjb.1","0.008660261220864376","","0.9307485222816467","","1650","1/1","Hom","189","9,180","0.0476190476190476","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","POTE ankyrin domain family member D","","plasma membrane(GO:0005886)","","","","","","","","","CCDC144C-like,","","","","","","","","","","","","T","0.215","T","0.265","B","0.053","B","0.007","","","N","1.000","L","1.295","T","2.51","N","-0.92","0.112","T","-0.946","T","0.021","T","9.25E-4","0.056","T","0.062","10.84","0.662","2.1","1.579","3.884"
"chr21","14982952","14982952","A>G","","POTED","exonic","nonsynonymous SNV","","POTED:NM_174981:exon1:c.A403G:p.I135V","POTED","exonic","nonsynonymous SNV","","POTED:ENST00000299443.6_1:exon1:c.A403G:p.I135V,POTED:ENST00000620442.4_1:exon1:c.A403G:p.I135V","POTED:ENST00000299443.5:c.403A>G:p.(Ile135Val)","0.58958405","","","","","","","","","","","","","","","","ENSG00000166351","POTED","HGNC:23822","POTED","317754","ENSG00000166351","uc002yjb.1","0.008660261220864376","","0.9307485222816467","","1651","1/1","Hom","157","5,152","0.0318471337579618","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","POTE ankyrin domain family member D","","plasma membrane(GO:0005886)","","","","","","","","SpliceAI>G|POTED|0.00|0.00|0.00|0.01|45|32|45|-8",".;.","","","0.0003","","","","","","","0.0003","0","T","1.0","T","1.0","B","0.0","B","0.0","","","P","1","L","0.955","T","0.69","N","0.21","0.013","T","-1.046","T","0.001","T","0.002","0.027","T","0.023","0.001","-1.214","1.29","-2.318","5.628"
"chr21","14982577","14982577","A>G","","POTED","exonic","nonsynonymous SNV","","POTED:NM_174981:exon1:c.A28G:p.T10A","POTED","exonic","nonsynonymous SNV","","POTED:ENST00000299443.6_1:exon1:c.A28G:p.T10A,POTED:ENST00000620442.4_1:exon1:c.A28G:p.T10A","POTED:ENST00000299443.5:c.28A>G:p.(Thr10Ala)","0.2737986","","","","","","","","","","","","","","","","ENSG00000166351","POTED","HGNC:23822","POTED","317754","ENSG00000166351","uc002yjb.1","0.008660261220864376","","0.9307485222816467","","1652","0/1","Het","245","193,52","0.787755102040816","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","POTE ankyrin domain family member D","","plasma membrane(GO:0005886)","","","","","","","","SpliceAI>G|POTED|0.00|0.00|0.00|0.00|35|18|45|-16",".;.","","","","","","","","","","","","T","1.0","T","1.0","B","0.0","B","0.0","","","N","1","N","-1.87","T","2.21","N","0.84","0.035","T","-0.994","T","0.010","T","5.66E-4","0.010","T","0.054","0.008","-0.823","0.447","-2.359",""
"chr21","14982586","14982586","A>G","","POTED","exonic","nonsynonymous SNV","","POTED:NM_174981:exon1:c.A37G:p.T13A","POTED","exonic","nonsynonymous SNV","","POTED:ENST00000299443.6_1:exon1:c.A37G:p.T13A,POTED:ENST00000620442.4_1:exon1:c.A37G:p.T13A","POTED:ENST00000299443.5:c.37A>G:p.(Thr13Ala)","0.100000024","","","","","","","","","","","","","","","","ENSG00000166351","POTED","HGNC:23822","POTED","317754","ENSG00000166351","uc002yjb.1","0.008660261220864376","","0.9307485222816467","","1653","0/1","Het","258","194,64","0.751937984496124","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","POTE ankyrin domain family member D","","plasma membrane(GO:0005886)","","","","","","","","SpliceAI>G|POTED|0.00|0.00|0.00|0.00|-36|26|36|-25",".;.","","","","","","","","","","","","T","0.9","T","0.744","B","0.0","B","0.0","","","N","1","N","-0.755","T","1.85","N","0.36","0.016","T","-1.004","T","0.018","T","9.02E-4","0.010","T","0.044","0.001","-1.775","0.447","-6.406",""
"chr2","97911776","97911776","T>C","","ANKRD36","exonic","nonsynonymous SNV","","ANKRD36:NM_001164315:exon71:c.T5452C:p.C1818R","ANKRD36","exonic","nonsynonymous SNV","","ANKRD36:ENST00000420699.9_1:exon71:c.T5374C:p.C1792R,ANKRD36:ENST00000461153.7_1:exon71:c.T5374C:p.C1792R,ANKRD36:ENST00000652721.1_1:exon71:c.T5374C:p.C1792R","ANKRD36:ENST00000357042.4:c.193T>C:p.(Cys65Arg)","0.903","","","","0.0","0.902999997138977","0.0067251739603374","","","","","","","","","","ENSG00000135976","ANKRD36","HGNC:24079","ANKRD36","375248","ENSG00000135976","uc010yva.3","0.006725173960337417","","0.902999997138977","","1705","1/1","Hom","3","0,3","0","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36","","","","","","","","","","",".;CCDC144C-like,","","","","","","","","","","","","T","0.097","D","0.013","B","0.099","B","0.01","","","N","1","M","2.25","T","2.64","D","-2.67","0.251","T","-1.041","T","0.063","T","0.001","0.066","T","0.127","0.830","-0.178","1.4","0.556","4.893"
"chr2","97779551","97779551","A>T","","ANKRD36","exonic","nonsynonymous SNV","","ANKRD36:NM_001164315:exon1:c.A75T:p.Q25H","ANKRD36","exonic","nonsynonymous SNV","","ANKRD36:ENST00000420699.9_1:exon1:c.A75T:p.Q25H,ANKRD36:ENST00000461153.7_1:exon1:c.A75T:p.Q25H,ANKRD36:ENST00000620383.1_1:exon1:c.A75T:p.Q25H,ANKRD36:ENST00000652721.1_1:exon1:c.A75T:p.Q25H","ANKRD36:ENST00000420699.2:c.75A>T:p.(Gln25His)","0.6127579","","","","","","","","","","","","","","","","ENSG00000135976","ANKRD36","HGNC:24079","ANKRD36","375248","ENSG00000135976","uc010yva.3","0.006725173960337417","","0.902999997138977","","1706","0/1","Het","29","22,7","0.758620689655172","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36","","","","","","","","","","SpliceAI>T|ANKRD36|0.00|0.00|0.00|0.00|28|0|14|-1",".;.;.;.","","","0.00004424","0.0026","0.012","0.0001","0.0011","","","4.424e-05","0.0002","T","0.334","T","0.227","P","0.627","B","0.074","","","N","1","L","1.24","T","0.64","N","-0.48","0.09","T","-1.076","T","0.070","","","0.021","T","0.027","1.135","-0.132","0.74","-1.549","4.168"
"chr2","97779555","97779555","C>T","","ANKRD36","exonic","nonsynonymous SNV","","ANKRD36:NM_001164315:exon1:c.C79T:p.P27S","ANKRD36","exonic","nonsynonymous SNV","","ANKRD36:ENST00000420699.9_1:exon1:c.C79T:p.P27S,ANKRD36:ENST00000461153.7_1:exon1:c.C79T:p.P27S,ANKRD36:ENST00000620383.1_1:exon1:c.C79T:p.P27S,ANKRD36:ENST00000652721.1_1:exon1:c.C79T:p.P27S","ANKRD36:ENST00000420699.2:c.79C>T:p.(Pro27Ser)","0.54990596","","","","","","","","","","","","","","","","ENSG00000135976","ANKRD36","HGNC:24079","ANKRD36","375248","ENSG00000135976","uc010yva.3","0.006725173960337417","","0.902999997138977","","1707","0/1","Het","30","22,8","0.733333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 36","","","","","","","","","","SpliceAI>T|ANKRD36|0.00|0.00|0.06|0.00|0|24|48|-5",".;.;.;.","","","0.00006034","0.0032","0.015","0.0001","0.0016","","","6.034e-05","0.0005","T","0.393","T","0.433","B","0.001","B","0.0","","","N","1","N","0","T","0.62","N","-0.17","0.071","T","-1.056","T","0.045","","","0.023","T","0.008","0.349","-0.307","0.74","-1.151","3.692"
"chrX","152101490","152101490","G>A","","ZNF185","exonic","nonsynonymous SNV","","ZNF185:NM_001178113:exon6:c.G430A:p.V144I,ZNF185:NM_001178110:exon12:c.G916A:p.V306I,ZNF185:NM_001178107:exon13:c.G1006A:p.V336I,ZNF185:NM_001178109:exon13:c.G1006A:p.V336I,ZNF185:NM_001178106:exon14:c.G1093A:p.V365I,ZNF185:NM_001178108:exon14:c.G1096A:p.V366I,ZNF185:NM_007150:exon14:c.G1093A:p.V365I","ZNF185","exonic","nonsynonymous SNV","","ZNF185:ENST00000318529.12_1:exon6:c.G430A:p.V144I,ZNF185:ENST00000318504.11_1:exon12:c.G916A:p.V306I,ZNF185:ENST00000539731.5_1:exon13:c.G1006A:p.V336I,ZNF185:ENST00000370268.8_1:exon14:c.G1093A:p.V365I,ZNF185:ENST00000370270.6_1:exon14:c.G1093A:p.V365I,ZNF185:ENST00000449285.6_1:exon14:c.G1096A:p.V366I,ZNF185:ENST00000535861.5_1:exon14:c.G1093A:p.V365I","ZNF185:ENST00000318504.7:c.916G>A:p.(Val306Ile)","0.89778197","","","","","","","","","","0.0","0.8977819681167603","0.0064125123394521","","","","ENSG00000147394","ZNF185","HGNC:12976","ZNF185","7739","ENSG00000147394","uc010ntv.3","0.006412512339452156","","0.8977819681167603","","1711","0/1","Het","93","45,48","0.483870967741935","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Zinc-finger proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation, and apoptosis. This gene encodes a LIM-domain zinc finger protein. The LIM domain is composed of two contiguous zinc finger domains, separated by a two-amino acid residue hydrophobic linker. The LIM domain mediates protein:protein interactions. Multiple alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, May 2010]","zinc finger protein 185 with LIM domain","","cytoplasm(GO:0005737)|focal adhesion(GO:0005925)|actin cytoskeleton(GO:0015629)","protein binding(GO:0005515)|zinc ion binding(GO:0008270)|actin filament binding(GO:0051015)","","","","","","Estrogen response early","",".;.;.;.;.;.;.","","","0.0022","","","0.0002","0.0022","","","0.0001","0.0015","T","0.145","T","0.174","B","0.11","B","0.059","U","0.945","N","1","N","0.345","T","0.77","N","-0.59","0.087","T","-1.033","T","0.074","T","0.017","0.025","T","0.022","7.590","0.330","3.19","0.606","5.277"
"chr7","100174621","100174621","G>A","","LRCH4","exonic","nonsynonymous SNV","","LRCH4:NM_001289934:exon13:c.C1372T:p.P458S,LRCH4:NM_002319:exon13:c.C1372T:p.P458S","LRCH4","exonic","nonsynonymous SNV","","LRCH4:ENST00000310300.11_1:exon13:c.C1372T:p.P458S","LRCH4:ENST00000310300.6:c.1372C>T:p.(Pro458Ser)","0.89622015","0.0","0.8962201476097107","0.0063217685147102","0.0","0.8261257410049438","0.003330993363976","","","","","","","","","","ENSG00000077454","LRCH4","HGNC:6691","LRCH4","4034","ENSG00000077454","uc003uvj.4","0.006321768514710277","","0.8962201476097107","","1716","0/1","Het","217","109,108","0.502304147465438","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that contains leucine-rich repeats (LRR) at its amino terminus and that is known to be involved in ligand binding. The carboxyl terminus may act as a membrane anchor. Identified structural elements suggest that the encoded protein resembles a receptor. [provided by RefSeq, Jul 2008]","leucine rich repeats and calponin homology domain containing 4","nervous system development(GO:0007399)","PML body(GO:0016605)|PML body(GO:0016605)","protein binding(GO:0005515)","","","","","","","",".;.","","","0.001","0.0002","0.001","","","","","","","T","0.329","T","0.712","B","0.01","B","0.003","N","0.121","N","1","L","0.805","T","1.48","N","-0.31","0.173","T","-1.056","T","0.049","T","0.010","0.014","T","0.082","1.468","-0.093","4.03","0.046","3.009"
"chr7","100172813","100172813","A>G","","LRCH4","exonic","nonsynonymous SNV","","LRCH4:NM_002319:exon18:c.T1969C:p.S657P","LRCH4","exonic","nonsynonymous SNV","","LRCH4:ENST00000310300.11_1:exon18:c.T1969C:p.S657P,LRCH4:ENST00000619071.4_1:exon18:c.T346C:p.S116P","LRCH4:ENST00000310300.6:c.1969T>C:p.(Ser657Pro)","0.75603133","","","","0.0","0.8261257410049438","0.003330993363976","","","","","","","","","","ENSG00000077454","LRCH4","HGNC:6691","LRCH4","4034","ENSG00000077454","uc003uvj.4","0.006321768514710277","","0.8962201476097107","","1717","0/1","Het","126","63,63","0.5","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that contains leucine-rich repeats (LRR) at its amino terminus and that is known to be involved in ligand binding. The carboxyl terminus may act as a membrane anchor. Identified structural elements suggest that the encoded protein resembles a receptor. [provided by RefSeq, Jul 2008]","leucine rich repeats and calponin homology domain containing 4","nervous system development(GO:0007399)","PML body(GO:0016605)|PML body(GO:0016605)","protein binding(GO:0005515)","","","","","","","SpliceAI>G|LRCH4|0.00|0.00|0.00|0.00|24|1|37|-3",".;.;.","","","0.002","0.0006","0.002","0.0009","0.001","0.0001","0.0001","0.0008","0.0003","T","0.211","T","0.268","B","0.0","B","0.001","N","0.102","D","0.779","N","0.745","T","1.39","N","-0.1","0.149","T","-1.085","T","0.066","T","0.010","0.013","T","0.013","16.60","1.558","4.24","-0.519","2.991"
"chr19","58018149","58018149","G>C","","ZNF773","exonic","nonsynonymous SNV","","ZNF773:NM_001304334:exon4:c.G683C:p.S228T,ZNF773:NM_198542:exon4:c.G686C:p.S229T","ZNF773","exonic","nonsynonymous SNV","","ZNF773:ENST00000282292.9_1:exon4:c.G686C:p.S229T,ZNF773:ENST00000598770.5_1:exon4:c.G683C:p.S228T","ZNF773:ENST00000282292.4:c.686G>C:p.(Ser229Thr)","0.3092639","0.500004442349109","0.3092639148235321","0.0052169704625304","","","","","","","","","","","","","ENSG00000152439","ZNF773","HGNC:30487","ZNF773","374928","ENSG00000152439","uc002qox.4","0.00521697046253044","0.500004442349109","0.3092639148235321","","1832","0/1","Het","11","8,3","0.727272727272727","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 773","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|protein binding(GO:0005515)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","",".;Zinc","","","0.00001193","","","0.","0.0001","","","1.193e-05","0.0002","T","0.69","T","0.417","B","0.007","B","0.005","","","N","1","N","0.18","T","3.21","N","-1.14","0.058","T","-0.924","T","0.011","T","0.001","0.038","T","0.010","14.32","1.141","1.18","-1.264","6.528"
"chr16","74425559","74425573","CCTCTTCCACCCTCT>-","","NPIPB15","exonic","nonframeshift deletion","","NPIPB15:NM_001306094:exon7:c.913_927del:p.P310_S314del","NPIPB15","exonic","nonframeshift deletion","","NPIPB15:ENST00000429990.1_1:exon7:c.913_927del:p.P310_S314del","NPIPB15:ENST00000429990.1:c.927_941del:p.(Pro310_Ser314del)","0.85","0.0","0.8500000238418579","0.0041442058628768","","","","","","","","","","","","","ENSG00000196436","NPIPB15","HGNC:34409","NPIPB15","440348","ENSG00000196436","","0.0041442058628768106","","0.8500000238418579","","1928","0/1","Het","291","260,31","0.893470790378007","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","nuclear pore complex interacting protein family member B15","","extracellular region(GO:0005576)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)","","","","","","","","","","","","0.0093","","","0.0093","0.","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr9","35906583","35906583","->CCACCACCACCA","","HRCT1","exonic","nonframeshift insertion","","HRCT1:NM_001039792:exon1:c.299_300insCCACCACCACCA:p.H105_P106insHHHH","HRCT1","exonic","nonframeshift insertion","","HRCT1:ENST00000354323.3_1:exon1:c.299_300insCCACCACCACCA:p.H105_P106insHHHH","HRCT1:ENST00000354323.2:c.305_316dup:p.(His102_His105dup)","0.85","0.0","0.8500000238418579","0.0041442058628768","","","","","","","","","","","","","ENSG00000196196","HRCT1","HGNC:33872","HRCT1","646962","ENSG00000196196","uc003zyr.1","0.0041442058628768106","","0.8500000238418579","","1929","0/1","Het","64","34,30","0.53125","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","histidine rich carboxyl terminus 1","","integral component of membrane(GO:0016021)","","","","","","","","SpliceAI>TCCACCACCACCA|HRCT1|0.00|0.00|0.00|0.01|0|8|-25|-47","","Name=(CCA)n","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr15","23685922","23685922","->CCGCATCTTCTCCTCCTGCTT","GOLGA6L2:283685","GOLGA6L2","exonic","nonframeshift insertion","","GOLGA6L2:NM_001304388:exon8:c.1699_1700insAAGCAGGAGGAGAAGATGCGG:p.A566_G567insEAGGEDA","GOLGA6L2","exonic","nonframeshift insertion","","GOLGA6L2:ENST00000567107.6_1:exon8:c.1699_1700insAAGCAGGAGGAGAAGATGCGG:p.A566_G567insEAGGEDA","GOLGA6L2:ENST00000567107.1:c.1699_1700insAAGCAGGAGGAGAAGATGCGG:p.(Ala566_Gly567insGluAlaGlyGlyGluAspAla)","0.85","0.0","0.8500000238418579","0.0041442058628768","","","","","","","","","","","","","ENSG00000174450","GOLGA6L2","HGNC:26695","GOLGA6L2","283685","ENSG00000174450","uc059gss.1","0.0041442058628768106","","0.8500000238418579","","1930","0/1","Het","53","27,26","0.509433962264151","Uncertain_significance","False","not_provided","MedGen:CN517202","NC_000015.9:g.23685942_23685943insTCCGCATCTTCTCCTCCTGCT","no_assertion_criteria_provided","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","golgin A6 family like 2","","","","","","","","","","SpliceAI>CCCGCATCTTCTCCTCCTGCTT|GOLGA6L2|0.00|0.00|0.00|0.00|0|42|-16|26","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chrX","54011405","54011407","CTC>-","","PHF8","exonic","nonframeshift deletion","","PHF8:NM_001184897:exon17:c.2080_2082del:p.E694del,PHF8:NM_001184896:exon18:c.2491_2493del:p.E831del,PHF8:NM_015107:exon18:c.2383_2385del:p.E795del,PHF8:NM_001184898:exon19:c.2332_2334del:p.E778del","PHF8","exonic","nonframeshift deletion","","PHF8:ENST00000338946.10_1:exon17:c.2080_2082del:p.E694del,PHF8:ENST00000338154.11_1:exon18:c.2383_2385del:p.E795del,PHF8:ENST00000357988.9_1:exon18:c.2491_2493del:p.E831del,PHF8:ENST00000322659.12_1:exon19:c.2332_2334del:p.E778del","PHF8:ENST00000322659.8:c.2332_2334del:p.(Glu778del)","0.84895754","","","","","","","0.0","0.8489575386047363","0.0041048807097425","0.0","0.8489575386047363","0.0041048807097425","","","","ENSG00000172943","PHF8","HGNC:20672","PHF8","23133","ENSG00000172943","uc004dst.4","0.004104880709742521","","0.8489575386047363","OMIM:300263 Intellectual developmental disorder, X-linked, syndromic, Siderius type-x_recessive;ORPHA:85287 X-linked intellectual disability, Siderius type-x_recessive","1931","0/1","Het","132","120,12","0.909090909090909","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Linked, syndromic, siderius type(300263)","Broad nasal tip(HP:0000455)|Large hands(HP:0001176)|Cryptorchidism(HP:0000028)|Scoliosis(HP:0002650)|Intellectual disability, mild(HP:0001256)|Synophrys(HP:0000664)|Low posterior hairline(HP:0002162)|Decreased testicular size(HP:0008734)|Cleft upper lip(HP:0000204)|Long face(HP:0000276)|Preaxial hand polydactyly(HP:0001177)|Cleft palate(HP:0000175)|Long face(HP:0000276)|Low posterior hairline(HP:0002162)|Cleft lip(HP:0410030)|Upslanted palpebral fissure(HP:0000582)|Microcephaly(HP:0000252)|Arachnodactyly(HP:0001166)|X-linked recessive inheritance(HP:0001419)|Pes planus(HP:0001763)|Broad nasal tip(HP:0000455)|Synophrys(HP:0000664)|Cleft lip(HP:0410030)|Cleft palate(HP:0000175)|Long toe(HP:0010511)|Thoracic kyphosis(HP:0002942)|Large hands(HP:0001176)|Sloping forehead(HP:0000340)|Delayed speech and language development(HP:0000750)|Prominent supraorbital ridges(HP:0000336)|Intellectual disability, mild(HP:0001256)|Nasal speech(HP:0001611)","The protein encoded by this gene is a histone lysine demethylase that preferentially acts on histones in the monomethyl or dimethyl states. The encoded protein requires Fe(2+) ion, 2-oxoglutarate, and oxygen for its catalytic activity. The protein has an N-terminal PHD finger and a central Jumonji C domain. This gene is thought to function as a transcription activator. Defects in this gene are a cause of syndromic X-linked Siderius type intellectual disability (MRXSSD) and over-expression of this gene is associated with several forms of cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]","PHD finger protein 8","G1/S transition of mitotic cell cycle(GO:0000082)|regulation of transcription by RNA polymerase II(GO:0006357)|protein demethylation(GO:0006482)|brain development(GO:0007420)|histone H3-K9 demethylation(GO:0033169)|histone H4-K20 demethylation(GO:0035574)|positive regulation of transcription, DNA-templated(GO:0045893)|positive regulation of transcription, DNA-templated(GO:0045893)|positive regulation of transcription by RNA polymerase I(GO:0045943)|negative regulation of ribosomal DNA heterochromatin assembly(GO:0061188)|histone H3-K36 demethylation(GO:0070544)|histone H3-K27 demethylation(GO:0071557)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|nucleolus(GO:0005730)|nuclear membrane(GO:0031965)","chromatin binding(GO:0003682)|transcription coregulator activity(GO:0003712)|iron ion binding(GO:0005506)|protein binding(GO:0005515)|zinc ion binding(GO:0008270)|2-oxoglutarate-dependent dioxygenase activity(GO:0016706)|histone demethylase activity(GO:0032452)|histone demethylase activity(GO:0032452)|histone demethylase activity(GO:0032452)|histone H3-methyl-lysine-9 demethylase activity(GO:0032454)|methylated histone binding(GO:0035064)|histone H4-methyl-lysine-20 demethylase activity(GO:0035575)|histone H3-methyl-lysine-36 demethylase activity(GO:0051864)|histone H3-tri/di-methyl-lysine-27 demethylase activity(GO:0071558)","intellectual disability(DOID:1059)|autistic disorder(DOID:12849)|syndrome(DOID:225)","","Wp ectoderm differentiation","Cell cycle|Condensation of prophase chromosomes|Hdms demethylate histones|Chromatin modifying enzymes|Mitotic prophase|M phase|Cell cycle mitotic","","","SpliceAI>T|PHF8|0.00|0.00|0.00|0.00|12|6|-34|7","","","","0.00005066","","","0.0009","0.0012","","","5.066e-05","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr6","30994888","30994889","CA>-","","MUC22","exonic","frameshift deletion","","MUC22:NM_001198815:exon3:c.1680_1681del:p.I561Rfs*3","MUC22","exonic","frameshift deletion","","MUC22:ENST00000561890.1_1:exon2:c.1680_1681del:p.I561Rfs*3","MUC22:ENST00000561890.1:c.1680_1681del:p.(Ile561Argfs*3)","0.94669455","","","","0.0","0.8321327269077301","0.0035192527417773","","","","","","","","","","ENSG00000261272","MUC22","HGNC:39755","MUC22","100507679","ENSG00000261272","uc063mxr.1","0.0035192527417773124","","0.8321327269077301","","1953","0/1","Het","62","56,6","0.903225806451613","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","mucin 22","","integral component of membrane(GO:0016021)","","","","","","","","","","","","0.0021","","","0.0015","0.","","","0.0021","0.0002","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr6","30994878","30994878","T>C","","MUC22","exonic","nonsynonymous SNV","","MUC22:NM_001198815:exon3:c.T1670C:p.M557T","MUC22","exonic","nonsynonymous SNV","","MUC22:ENST00000561890.1_1:exon2:c.T1670C:p.M557T","MUC22:ENST00000561890.1:c.1670T>C:p.(Met557Thr)","0.3100422","","","","","","","","","","","","","","","","ENSG00000261272","MUC22","HGNC:39755","MUC22","100507679","ENSG00000261272","uc063mxr.1","0.0035192527417773124","","0.8321327269077301","","1957","0/1","Het","61","55,6","0.901639344262295","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","mucin 22","","integral component of membrane(GO:0016021)","","","","","","","","SpliceAI>C|MUC22|0.00|0.00|0.00|0.00|-45|15|31|15","","","","0.0043","","","0.0019","0.","","","0.0043","0.0035","T","0.642","T","1.0","","","","","","","N","1","N","0.695","T","2.63","N","0.54","0.118","","","","","","","","","","0.004","-0.923","2.83","-0.576","10.810"
"chr22","20378697","20378697","G>A","","TMEM191B","exonic","nonsynonymous SNV","","TMEM191B:NM_001242313:exon3:c.G434A:p.R145K","TMEM191B","exonic","nonsynonymous SNV","","TMEM191B:ENST00000612978.5_1:exon3:c.G434A:p.R145K","PI4KAP1:ENST00000430523.3::","0.9007745","","","","","","","","","","","","","","","","ENSG00000215513","PI4KAP1","HGNC:33576","PI4KAP1","728233","ENSG00000274602","","0.0030922068661373477","","0.8180000185966492","","2079","0/1","Het","34","26,8","0.764705882352941","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","transmembrane protein 191B","","integral component of membrane(GO:0016021)","","","","","","","","","","","","0.0016","","","","","","","0.0001","0.0016","","","T","0.065","","","","","","","","","","","","","","","0.169","","","","","","","","","","11.08","0.691","1.63","0.265","2.673"
"chr1","3328445","3328445","G>A","PRDM16:63976","PRDM16","exonic","nonsynonymous SNV","","PRDM16:NM_022114:exon9:c.G1684A:p.V562I,PRDM16:NM_199454:exon9:c.G1684A:p.V562I","PRDM16","exonic","nonsynonymous SNV","","PRDM16:ENST00000270722.10_1:exon9:c.G1684A:p.V562I,PRDM16:ENST00000378391.6_1:exon9:c.G1684A:p.V562I,PRDM16:ENST00000511072.5_1:exon9:c.G1687A:p.V563I,PRDM16:ENST00000514189.5_1:exon9:c.G1687A:p.V563I","PRDM16:ENST00000270722.5:c.1684G>A:p.(Val562Ile)","0.5112074","","","","0.2500169103132066","0.5332037806510925","0.0030411174046","","","","","","","","","","ENSG00000142611","PRDM16","HGNC:14000","PRDM16","63976","ENSG00000142611","uc001akf.4","0.003041117404600013","0.2500169103132066","0.5332037806510925","OMIM:615373 Left ventricular noncompaction 8-autosomal_dominant;ORPHA:154 Familial isolated dilated cardiomyopathy-autosomal_dominant;ORPHA:1606 1p36 deletion syndrome-polygenic","2081","0/1","Het","142","68,74","0.47887323943662","Benign/Likely_benign","False","Left_ventricular_noncompaction_8|not_specified|not_provided","MONDO:MONDO:0014152,MedGen:C3809288,OMIM:615373|MedGen:CN169374|MedGen:CN517202","NC_000001.10:g.3328445G>A","criteria_provided,_multiple_submitters,_no_conflicts","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 1 ; BP7: 0","Left ventricular noncompaction 8(615373)","Agenesis of corpus callosum(HP:0001274)|Abnormal cardiac septum morphology(HP:0001671)|Cerebral cortical atrophy(HP:0002120)|Depressed nasal ridge(HP:0000457)|Hypoplasia of penis(HP:0008736)|Annular pancreas(HP:0001734)|Microcephaly(HP:0000252)|Hypospadias(HP:0000047)|Delayed cranial suture closure(HP:0000270)|Long philtrum(HP:0000343)|Short stature(HP:0004322)|Strabismus(HP:0000486)|Frontal bossing(HP:0002007)|Brachydactyly(HP:0001156)|Hepatic steatosis(HP:0001397)|Abnormal intestine morphology(HP:0002242)|Global developmental delay(HP:0001263)|Cranial nerve paralysis(HP:0006824)|Horizontal eyebrow(HP:0011228)|Telangiectasia(HP:0001009)|Constipation(HP:0002019)|Clinodactyly of the 5th finger(HP:0004209)|Depressed nasal bridge(HP:0005280)|Foot polydactyly(HP:0001829)|Camptodactyly of finger(HP:0100490)|Optic atrophy(HP:0000648)|Obesity(HP:0001513)|Poor speech(HP:0002465)|Spinal canal stenosis(HP:0003416)|Low-set, posteriorly rotated ears(HP:0000368)|Abnormality of the spleen(HP:0001743)|Kyphosis(HP:0002808)|Pointed chin(HP:0000307)|Pyloric stenosis(HP:0002021)|Ventriculomegaly(HP:0002119)|Myopathy(HP:0003198)|11 pairs of ribs(HP:0000878)|Cataract(HP:0000518)|Abnormality of the neck(HP:0000464)|Hemiplegia/hemiparesis(HP:0004374)|Absent speech(HP:0001344)|Hypotonia(HP:0001252)|Self-injurious behavior(HP:0100716)|Scoliosis(HP:0002650)|Joint stiffness(HP:0001387)|Conductive hearing impairment(HP:0000405)|Seizure(HP:0001250)|Hydronephrosis(HP:0000126)|Gait disturbance(HP:0001288)|Failure to thrive(HP:0001508)|Brachycephaly(HP:0000248)|Dilated cardiomyopathy(HP:0001644)|Abnormality of the anus(HP:0004378)|Ocular albinism(HP:0001107)|Generalized hirsutism(HP:0002230)|Tetralogy of Fallot(HP:0001636)|Gastroesophageal reflux(HP:0002020)|Abnormal blistering of the skin(HP:0008066)|Renal cyst(HP:0000107)|Epicanthus(HP:0000286)|Patent ductus arteriosus(HP:0001643)|Lower limb asymmetry(HP:0100559)|Short foot(HP:0001773)|Feeding difficulties in infancy(HP:0008872)|Narrow mouth(HP:0000160)|Deeply set eye(HP:0000490)|Intellectual disability(HP:0001249)|Aortic arch aneurysm(HP:0005113)|Hip dysplasia(HP:0001385)|Wide nasal bridge(HP:0000431)|Abnormality of female external genitalia(HP:0000055)|Neuroblastoma(HP:0003006)|Midface retrusion(HP:0011800)|EEG abnormality(HP:0002353)|Bifid ribs(HP:0000892)|Hypothyroidism(HP:0000821)|High hypermetropia(HP:0008499)|Rib fusion(HP:0000902)|Cryptorchidism(HP:0000028)|Microtia(HP:0008551)|Sensorineural hearing impairment(HP:0000407)|Macule(HP:0012733)|Autism(HP:0000717)|Abnormal heart valve morphology(HP:0001654)|Dysphagia(HP:0002015)|Stereotypy(HP:0000733)|Hypogonadism(HP:0000135)|Visual impairment(HP:0000505)|Nystagmus(HP:0000639)|Polyphagia(HP:0002591)|Autosomal dominant inheritance(HP:0000006)|Left ventricular noncompaction(HP:0030682)|Abnormal left ventricle morphology(HP:0001711)|Dilated cardiomyopathy(HP:0001644)|Mitral regurgitation(HP:0001653)|Congestive heart failure(HP:0001635)|Abnormal left ventricular function(HP:0005162)|Arrhythmia(HP:0011675)|Palmoplantar keratoderma(HP:0000982)|Elevated circulating creatine kinase concentration(HP:0003236)|Lipoatrophy(HP:0100578)|Abnormality of neutrophils(HP:0001874)|Myopathy(HP:0003198)|EMG abnormality(HP:0003457)|Dilated cardiomyopathy(HP:0001644)|Sensorineural hearing impairment(HP:0000407)","The reciprocal translocation t(1;3)(p36;q21) occurs in a subset of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). This gene is located near the 1p36.3 breakpoint and has been shown to be specifically expressed in the t(1:3)(p36,q21)-positive MDS/AML. The protein encoded by this gene is a zinc finger transcription factor and contains an N-terminal PR domain. The translocation results in the overexpression of a truncated version of this protein that lacks the PR domain, which may play an important role in the pathogenesis of MDS and AML. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]","PR/SET domain 16","negative regulation of transcription by RNA polymerase II(GO:0000122)|regulation of transcription by RNA polymerase II(GO:0006357)|negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512)|negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512)|regulation of cellular respiration(GO:0043457)|negative regulation of transcription, DNA-templated(GO:0045892)|negative regulation of transcription, DNA-templated(GO:0045892)|positive regulation of transcription, DNA-templated(GO:0045893)|positive regulation of transcription, DNA-templated(GO:0045893)|positive regulation of transcription by RNA polymerase II(GO:0045944)|brown fat cell differentiation(GO:0050873)|histone H3-K9 methylation(GO:0051567)|heterochromatin organization(GO:0070828)|positive regulation of cold-induced thermogenesis(GO:0120162)","nucleus(GO:0005634)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|cytosol(GO:0005829)|cytosol(GO:0005829)|aggresome(GO:0016235)|transcription repressor complex(GO:0017053)","transcription cis-regulatory region binding(GO:0000976)|RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription repressor activity, RNA polymerase II-specific(GO:0001227)|DNA-binding transcription activator activity, RNA polymerase II-specific(GO:0001228)|transcription coregulator activity(GO:0003712)|transcription coactivator activity(GO:0003713)|protein binding(GO:0005515)|histone-lysine N-methyltransferase activity(GO:0018024)|sequence-specific DNA binding(GO:0043565)|metal ion binding(GO:0046872)|histone methyltransferase activity (H3-K9 specific)(GO:0046974)|DNA-binding transcription factor binding(GO:0140297)","leukemia(DOID:1240)|syndrome(DOID:225)|chronic granulomatous disease(DOID:3265)|T-cell lymphoblastic leukemia/lymphoma(DOID:715)|acute myeloid leukemia(DOID:9119)|myeloid leukemia(DOID:8692)","","Wp fto obesity variant mechanism|Wp differentiation of white and brown adipocyte|Wp thermogenesis|Wp thyroid hormones production and their peripheral downstream signalling effects","Pkmts methylate histone lysines|Chromatin modifying enzymes","","","SpliceAI>A|PRDM16|0.00|0.00|0.00|0.00|5|-45|5|-1",".;.;.;.;.","","","0.0032","0.0032","0.002","0.0006","0.0025","0.0013","0.0001","0.0005","0.0024","T","0.434","T","0.553","P","0.889","B","0.236","U","0.015","N","0.971","L","1.75","T","3.47","N","-0.23","0.072","T","-0.989","T","0.011","T","0.010","0.058","T","0.006","13.13","0.957","5.33","3.508","9.224"
"chr7","99084932","99084932","G>A","","ZNF789","exonic","nonsynonymous SNV","","ZNF789:NM_213603:exon5:c.G1099A:p.E367K","ZNF789","exonic","nonsynonymous SNV","","ZNF789:ENST00000331410.10_1:exon5:c.G1099A:p.E367K","ZNF789:ENST00000331410.5:c.1099G>A:p.(Glu367Lys)","0.81406","0.0","0.8140599727630615","0.002982644419384","","","","","","","","","","","","","ENSG00000198556","ZNF789","HGNC:27801","ZNF789","285989","ENSG00000198556","uc003uqq.2","0.0029826444193840934","","0.8140599727630615","","2085","0/1","Het","85","38,47","0.447058823529412","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 789","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|protein binding(GO:0005515)|metal ion binding(GO:0046872)","","","","","","","","Zinc","","","","","","","","","","","","T","1.0","T","1.0","B","0.0","B","0.001","","","D","0.814","N","-1.97","T","3.19","N","2.91","0.115","T","-0.884","T","0.005","T","0.008","0.059","T","0.030","4.352","0.105","2.89","1.172","7.774"
"chr19","55239223","55239223","G>A","","KIR3DL3","exonic","nonsynonymous SNV","","KIR3DL3:NM_153443:exon4:c.G502A:p.V168I","KIR3DL3","exonic","unknown","","UNKNOWN","KIR3DL3:ENST00000291860.1:c.502G>A:p.(Val168Ile)","0.806","","","","0.0","0.8059999942779541","0.0027704279800939","","","","","","","","","","ENSG00000242019","KIR3DL3","HGNC:16312","KIR3DL3","115653","ENSG00000242019","uc032ieo.2","0.0027704279800939095","","0.8059999942779541","","2091","1/1","Hom","244","8,236","0.0327868852459016","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several """"framework"""" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the """"framework"""" loci that is present on all haplotypes. [provided by RefSeq, Jul 2008]","killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3","","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)","protein binding(GO:0005515)","pre-eclampsia(DOID:10591)","Antigen processing and presentation","","","","","","Immunoglobulin","","","","","","","","","","","","T","0.194","T","0.546","","","","","U","0.000","N","1","","","T","4.08","N","-0.29","0.072","T","-0.943","T","0.006","T","9.02E-4","0.011","T","0.145","0.001","-1.157","1.38","-2.684","2.603"
"chr5","54439387","54439387","T>C","","CDC20B","exonic","nonsynonymous SNV","","CDC20B:NM_001145734:exon4:c.A440G:p.H147R,CDC20B:NM_001170402:exon4:c.A440G:p.H147R,CDC20B:NM_152623:exon4:c.A440G:p.H147R","CDC20B","exonic","nonsynonymous SNV","","CDC20B:ENST00000296733.5_1:exon4:c.A440G:p.H147R,CDC20B:ENST00000322374.10_1:exon4:c.A440G:p.H147R,CDC20B:ENST00000381375.7_1:exon4:c.A440G:p.H147R","CDC20B:ENST00000296733.1:c.440A>G:p.(His147Arg)","0.80450994","0.0","0.8045099377632141","0.0027328774686086","","","","","","","","","","","","","ENSG00000164287","CDC20B","HGNC:24222","CDC20B","166979","ENSG00000164287","uc003jpn.3","0.002732877468608697","","0.8045099377632141","","2093","0/1","Het","42","23,19","0.547619047619048","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","cell division cycle 20B","anaphase-promoting complex-dependent catabolic process(GO:0031145)|positive regulation of ubiquitin protein ligase activity(GO:1904668)|positive regulation of anaphase-promoting complex-dependent catabolic process(GO:1905786)","anaphase-promoting complex(GO:0005680)","protein binding(GO:0005515)|anaphase-promoting complex binding(GO:0010997)|ubiquitin ligase activator activity(GO:1990757)","","","Wp mirna regulation of dna damage response","","","","",".;.;.","","","0.000003989","","","","","","","3.989e-06","0","T","0.203","T","0.665","B","0.004","B","0.004","N","0.578","N","1","L","1.825","T","1.19","N","-0.66","0.082","T","-1.029","T","0.098","T","0.003","0.030","T","0.057","0.022","-0.685","4.65","-0.258","0.862"
"chr9","72349175","72349177","AAA>-","","PTAR1","splicing","","NM_001099666:exon4:r.spl","","PTAR1","splicing","","ENST00000377200.9_1:exon2:r.spl;ENST00000340434.5_1:exon4:r.spl","","PTAR1:ENST00000340434.4:c.324-7_324-5del:p.?","0.8","0.0","0.800000011920929","0.0026222891432373","","","","","","","","","","","","","ENSG00000188647","PTAR1","HGNC:30449","PTAR1","375743","ENSG00000188647","uc004ahi.4","0.0026222891432373043","","0.800000011920929","","2101","0/1","Het","5","2,3","0.4","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","protein prenyltransferase alpha subunit repeat containing 1","protein prenylation(GO:0018342)","cytoplasm(GO:0005737)","protein prenyltransferase activity(GO:0008318)","","","","","","","","","Name=(A)n","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr7","86556237","86556239","AAA>-","","KIAA1324L","splicing","","NM_001291990:exon9:r.spl;NM_001291991:exon8:r.spl;NM_001142749:exon9:r.spl;NM_152748:exon8:r.spl","","ELAPOR2","splicing","","ENST00000450689.7_1:exon9:r.spl;ENST00000444627.5_1:exon9:r.spl;ENST00000416314.5_1:exon8:r.spl","","ELAPOR2:ENST00000297222.6:c.370-7_370-5del:p.?","0.8","0.0","0.800000011920929","0.0026222891432373","","","","","","","","","","","","","ENSG00000164659","ELAPOR2","HGNC:21945","ELAPOR2","222223","ENSG00000164659","uc011kha.4","0.0026222891432373043","","0.800000011920929","","2105","0/1","Het","7","3,4","0.428571428571429","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","endosome-lysosome associated apoptosis and autophagy regulator family member 2","positive regulation of BMP signaling pathway(GO:0030513)|positive regulation of BMP signaling pathway(GO:0030513)|positive regulation of epidermis development(GO:0045684)|negative regulation of nervous system development(GO:0051961)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)","BMP receptor binding(GO:0070700)","","","","","","","SpliceAI>C|KIAA1324L|0.00|0.04|0.00|0.00|-4|-10|4|-14","","Name=(A)n","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr11","1619423","1619423","T>C","","KRTAP5-2","exonic","nonsynonymous SNV","","KRTAP5-2:NM_001004325:exon1:c.A58G:p.S20G","KRTAP5-2","exonic","nonsynonymous SNV","","KRTAP5-2:ENST00000412090.2_1:exon1:c.A58G:p.S20G","KRTAP5-2:ENST00000412090.1:c.58A>G:p.(Ser20Gly)","0.0047391267","","","","","","","","","","","","","","","","ENSG00000205867","KRTAP5-2","HGNC:23597","KRTAP5-2","440021","ENSG00000205867","uc001ltv.3","0.002354887957221395","","0.7882595062255859","","2131","0/1","Het","70","57,13","0.814285714285714","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","keratin associated protein 5-2","","cytosol(GO:0005829)|keratin filament(GO:0045095)","protein binding(GO:0005515)","","","","Developmental biology|Keratinization","","","SpliceAI>C|KRTAP5-2|0.00|0.00|0.00|0.00|-8|-2|-9|-3","","","","0.0026","","","0.0026","","","","0.0009","0","","","T","0.277","B","0.049","B","0.005","","","N","1","N","0.135","T","5.7","N","-2.28","0.175","T","-0.930","T","0.002","T","0.010","0.015","T","0.010","9.337","0.493","1.51","-2.072","2.384"
"chr11","1619459","1619459","T>C","","KRTAP5-2","exonic","nonsynonymous SNV","","KRTAP5-2:NM_001004325:exon1:c.A22G:p.R8G","KRTAP5-2","exonic","nonsynonymous SNV","","KRTAP5-2:ENST00000412090.2_1:exon1:c.A22G:p.R8G","KRTAP5-2:ENST00000412090.1:c.22A>G:p.(Arg8Gly)","0","","","","","","","","","","","","","","","","ENSG00000205867","KRTAP5-2","HGNC:23597","KRTAP5-2","440021","ENSG00000205867","uc001ltv.3","0.002354887957221395","","0.7882595062255859","","2132","0/1","Het","81","69,12","0.851851851851852","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","keratin associated protein 5-2","","cytosol(GO:0005829)|keratin filament(GO:0045095)","protein binding(GO:0005515)","","","","Developmental biology|Keratinization","","","","","","","0.00003202","0.0004","","0.0001","0.","","","3.202e-05","0","","","T","1.0","B","0.0","B","0.0","","","N","1","N","-3.235","T","6.03","N","0.59","0.205","T","-0.949","T","0.000","D","0.028","0.057","T","0.021","13.76","1.049","3.67","0.037","3.746"
"chr11","104878038","104878038","C>T","","CASP5","exonic","nonsynonymous SNV","","CASP5:NM_001136109:exon2:c.G31A:p.V11I,CASP5:NM_001136112:exon3:c.G244A:p.V82I,CASP5:NM_004347:exon3:c.G205A:p.V69I","CASP5","exonic","nonsynonymous SNV","","CASP5:ENST00000444749.6_1:exon2:c.G31A:p.V11I,CASP5:ENST00000260315.8_1:exon3:c.G205A:p.V69I,CASP5:ENST00000393141.6_1:exon3:c.G244A:p.V82I,CASP5:ENST00000526056.5_1:exon3:c.G244A:p.V82I","CASP5:ENST00000260315.3:c.205G>A:p.(Val69Ile)","0.7678821","0.0","0.7678821086883545","0.0019537546871814","","","","","","","","","","","","","ENSG00000137757","CASP5","HGNC:1506","CASP5","838","ENSG00000137757","uc010rva.2","0.0019537546871814747","","0.7678821086883545","","2160","0/1","Het","61","29,32","0.475409836065574","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. Overexpression of the active form of this enzyme induces apoptosis in fibroblasts. Max, a central component of the Myc/Max/Mad transcription regulation network important for cell growth, differentiation, and apoptosis, is cleaved by this protein; this process requires Fas-mediated dephosphorylation of Max. The expression of this gene is regulated by interferon-gamma and lipopolysaccharide. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]","caspase 5","proteolysis(GO:0006508)|apoptotic process(GO:0006915)|activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919)|substantia nigra development(GO:0021762)|regulation of apoptotic process(GO:0042981)|regulation of inflammatory response(GO:0050727)|cellular response to mechanical stimulus(GO:0071260)|apoptotic signaling pathway(GO:0097190)","cytoplasm(GO:0005737)|cytosol(GO:0005829)|NLRP1 inflammasome complex(GO:0072558)|NLRP1 inflammasome complex(GO:0072558)","cysteine-type endopeptidase activity(GO:0004197)|protein binding(GO:0005515)|cysteine-type peptidase activity(GO:0008234)|cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153)|cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199)|cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200)","cancer(DOID:162)|bladder carcinoma(DOID:4007)|lung cancer(DOID:1324)|disease(DOID:4)","Nod like receptor signaling pathway","Wp nucleotidebinding oligomerization domain nod pathway|Wp vitamin d receptor pathway","Regulated necrosis|Programmed cell death|Pyroptosis","","Complement","",".;CARD","","Score=949;Name=V$NKX22_01","","","","","","","","","","T","0.885","T","0.663","B","0.0","B","0.0","N","0.132","N","1","N","0","T","1.97","N","0.33","0.046","T","-1.027","T","0.019","T","0.001","0.012","T","0.044","0.003","-1.000","4.12","-0.437","1.216"
"chr4","44697642","44697642","C>T","GUF1:60558","GUF1","exonic","nonsynonymous SNV","","GUF1:NM_021927:exon15:c.C1726T:p.H576Y","GUF1","exonic","nonsynonymous SNV","","GUF1:ENST00000281543.6_1:exon15:c.C1726T:p.H576Y","GUF1:ENST00000281543.5:c.1726C>T:p.(His576Tyr)","0.0009539315","","","","0.5000087298240032","0.1954769585863687","0.0018410784112038","","","","","","","","","","ENSG00000151806","GUF1","HGNC:25799","GUF1","60558","ENSG00000151806","uc003gww.5","0.0018410784112038634","0.5000087298240032","0.1954769585863687","OMIM:617065 ?Developmental and epileptic encephalopathy 40-autosomal_recessive;ORPHA:3451 Infantile spasms syndrome-autosomal_recessive","2164","0/1","Het","58","26,32","0.448275862068966","Likely_benign","False","not_provided","MedGen:CN517202","NC_000004.11:g.44697642C>T","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Developmental and epileptic encephalopathy 40(617065)","Myoclonus(HP:0001336)|Infantile spasms(HP:0012469)|Hypsarrhythmia(HP:0002521)|Abnormality of skin morphology(HP:0011121)|Developmental regression(HP:0002376)|Seizure(HP:0001250)|Myoclonus(HP:0001336)|Epileptic encephalopathy(HP:0200134)|Intellectual disability, profound(HP:0002187)|Hypsarrhythmia(HP:0002521)|Spasticity(HP:0001257)|Cerebral cortical atrophy(HP:0002120)|Choreoathetosis(HP:0001266)|Autosomal recessive inheritance(HP:0000007)","This gene encodes a GTPase that triggers back-translocation of the elongating ribosome during mitochondrial protein synthesis. The protein contains a highly conserved C-terminal domain not found in other GTPases that facilitates tRNA binding. The encoded protein is thought to prevent misincorporation of amino acids in stressful, suboptimal conditions. An allelic variant in this gene has been associated with early infantile epileptic encephalopathy-40. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]","GTP binding elongation factor GUF1","translation(GO:0006412)|positive regulation of translation(GO:0045727)|positive regulation of translation(GO:0045727)","mitochondrion(GO:0005739)|mitochondrial inner membrane(GO:0005743)|mitochondrial matrix(GO:0005759)","GTPase activity(GO:0003924)|GTP binding(GO:0005525)|ribosome binding(GO:0043022)|ribosome binding(GO:0043022)|mitochondrial ribosome binding(GO:0097177)","","","","","","","","GTP-binding","","","0.003","0.0002","0.001","0.0002","0.0026","","","0.0002","0.0030","T","1.0","T","1.0","B","0.0","B","0.001","N","0.011","N","1","N","-2.185","T","-0.29","N","-0.4","0.203","T","-0.929","T","0.051","T","0.006","0.049","T","0.017","0.418","-0.280","5.74","-0.135","9.503"
"chr14","94933567","94933567","T>A","","SERPINA9","exonic","nonsynonymous SNV","","SERPINA9:NM_001284275:exon3:c.A727T:p.M243L,SERPINA9:NM_175739:exon3:c.A835T:p.M279L,SERPINA9:NM_001042518:exon4:c.A535T:p.M179L,SERPINA9:NM_001284276:exon4:c.A388T:p.M130L","SERPINA9","exonic","nonsynonymous SNV","","SERPINA9:ENST00000337425.10_1:exon3:c.A835T:p.M279L,SERPINA9:ENST00000380365.7_1:exon3:c.A781T:p.M261L,SERPINA9:ENST00000448305.6_1:exon3:c.A541T:p.M181L,SERPINA9:ENST00000546329.2_1:exon3:c.A541T:p.M181L,SERPINA9:ENST00000674397.2_1:exon3:c.A781T:p.M261L,SERPINA9:ENST00000298845.12_1:exon4:c.A481T:p.M161L,SERPINA9:ENST00000424550.6_1:exon4:c.A388T:p.M130L,SERPINA9:ENST00000674164.1_1:exon4:c.A535T:p.M179L","SERPINA9:ENST00000298845.7:c.535A>T:p.(Met179Leu)","0.7598444","0.0","0.7598444223403931","0.0018149818223247","","","","","","","","","","","","","ENSG00000170054","SERPINA9","HGNC:15995","SERPINA9","327657","ENSG00000170054","uc001ydf.4","0.0018149818223247062","","0.7598444223403931","","2166","0/1","Het","80","30,50","0.375","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","serpin family A member 9","negative regulation of endopeptidase activity(GO:0010951)","extracellular space(GO:0005615)|cytoplasm(GO:0005737)|membrane(GO:0016020)","serine-type endopeptidase inhibitor activity(GO:0004867)|serine-type endopeptidase inhibitor activity(GO:0004867)","","","","","","","",".;.;.;.;Serpin","","","","","","","","","","","","T","0.533","T","0.364","P","0.706","B","0.445","N","0.003","N","0.927","N","0.005","T","-1.03","N","-0.94","0.145","T","-0.728","T","0.264","D","0.031","0.167","T","0.272","15.76","1.408","3.89","0.566","10.085"
"chr19","55598675","55598675","G>T","","EPS8L1","exonic","nonsynonymous SNV","","EPS8L1:NM_017729:exon14:c.G1576T:p.V526L,EPS8L1:NM_133180:exon19:c.G1957T:p.V653L","EPS8L1","exonic","nonsynonymous SNV","","EPS8L1:ENST00000588359.5_1:exon8:c.G1015T:p.V339L,EPS8L1:ENST00000245618.5_1:exon14:c.G1576T:p.V526L,EPS8L1:ENST00000540810.5_1:exon17:c.G1765T:p.V589L,EPS8L1:ENST00000201647.11_1:exon19:c.G1957T:p.V653L","EPS8L1:ENST00000201647.6:c.1957G>T:p.(Val653Leu)","0.9669244","","","","0.0","0.7556354701519012","0.0017462839196256","","","","","","","","","","ENSG00000131037","EPS8L1","HGNC:21295","EPS8L1","54869","ENSG00000131037","uc002qis.5","0.001746283919625659","","0.7556354701519012","","2168","0/1","Het","33","21,12","0.636363636363636","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that is related to epidermal growth factor receptor pathway substrate 8 (EPS8), a substrate for the epidermal growth factor receptor. The function of this protein is unknown. At least two alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]","EPS8 like 1","Rho protein signal transduction(GO:0007266)|Rho protein signal transduction(GO:0007266)|regulation of Rho protein signal transduction(GO:0035023)|regulation of Rho protein signal transduction(GO:0035023)|regulation of catalytic activity(GO:0050790)|positive regulation of ruffle assembly(GO:1900029)|positive regulation of ruffle assembly(GO:1900029)","cytosol(GO:0005829)|plasma membrane(GO:0005886)|ruffle membrane(GO:0032587)|ruffle membrane(GO:0032587)|protein-containing complex(GO:0032991)|extracellular exosome(GO:0070062)","actin binding(GO:0003779)|actin binding(GO:0003779)|guanyl-nucleotide exchange factor activity(GO:0005085)|protein binding(GO:0005515)|T cell receptor binding(GO:0042608)|cadherin binding(GO:0045296)","","","Wp fragile x syndrome","","","","",".;.;.;.","","","0.00006167","","","0.0002","0.0022","","","6.167e-05","0.0008","D","0.005","D","0.015","D","0.972","P","0.837","N","0.009","D","1.000","M","3.28","T","1.85","D","-2.54","0.554","T","-0.838","T","0.159","D","0.038","0.154","T","0.470","24.5","3.353","4.02","2.981","9.969"
"chr19","55597526","55597526","G>A","","EPS8L1","exonic","nonsynonymous SNV","","EPS8L1:NM_017729:exon11:c.G1235A:p.R412Q,EPS8L1:NM_133180:exon16:c.G1616A:p.R539Q","EPS8L1","exonic","nonsynonymous SNV","","EPS8L1:ENST00000588359.5_1:exon5:c.G674A:p.R225Q,EPS8L1:ENST00000245618.5_1:exon11:c.G1235A:p.R412Q,EPS8L1:ENST00000540810.5_1:exon14:c.G1424A:p.R475Q,EPS8L1:ENST00000201647.11_1:exon16:c.G1616A:p.R539Q","EPS8L1:ENST00000201647.6:c.1616G>A:p.(Arg539Gln)","0.5443465","","","","0.0","0.7556354701519012","0.0017462839196256","","","","","","","","","","ENSG00000131037","EPS8L1","HGNC:21295","EPS8L1","54869","ENSG00000131037","uc002qis.5","0.001746283919625659","","0.7556354701519012","","2169","0/1","Het","141","80,61","0.567375886524823","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that is related to epidermal growth factor receptor pathway substrate 8 (EPS8), a substrate for the epidermal growth factor receptor. The function of this protein is unknown. At least two alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]","EPS8 like 1","Rho protein signal transduction(GO:0007266)|Rho protein signal transduction(GO:0007266)|regulation of Rho protein signal transduction(GO:0035023)|regulation of Rho protein signal transduction(GO:0035023)|regulation of catalytic activity(GO:0050790)|positive regulation of ruffle assembly(GO:1900029)|positive regulation of ruffle assembly(GO:1900029)","cytosol(GO:0005829)|plasma membrane(GO:0005886)|ruffle membrane(GO:0032587)|ruffle membrane(GO:0032587)|protein-containing complex(GO:0032991)|extracellular exosome(GO:0070062)","actin binding(GO:0003779)|actin binding(GO:0003779)|guanyl-nucleotide exchange factor activity(GO:0005085)|protein binding(GO:0005515)|T cell receptor binding(GO:0042608)|cadherin binding(GO:0045296)","","","Wp fragile x syndrome","","","","SpliceAI>A|EPS8L1|0.00|0.00|0.00|0.00|2|13|2|34",".;.;.;.","","","0.002","0.001","0.002","0.0009","0.0014","0.0001","","0.0007","0.0010","T","0.387","T","0.509","B","0.005","B","0.001","N","0.032","N","1","N","0.165","T","1.58","N","-0.61","0.109","T","-1.033","T","0.028","T","0.003","0.006","T","0.008","3.316","0.043","4.03","-3.800","2.006"
"chr1","11810230","11810230","A>G","","AGTRAP","exonic","nonsynonymous SNV","","AGTRAP:NM_001040194:exon5:c.A440G:p.Q147R,AGTRAP:NM_020350:exon5:c.A461G:p.Q154R","AGTRAP","exonic","nonsynonymous SNV","","AGTRAP:ENST00000510878.1_1:exon4:c.A355G:p.K119E,AGTRAP:ENST00000314340.10_1:exon5:c.A461G:p.Q154R,AGTRAP:ENST00000376629.8_1:exon5:c.A440G:p.Q147R","AGTRAP:ENST00000314340.5:c.461A>G:p.(Gln154Arg)","0.18285587","0.5000041806893023","0.182855874300003","0.0016398358744562","","","","","","","","","","","","","ENSG00000177674","AGTRAP","HGNC:13539","AGTRAP","57085","ENSG00000177674","uc001asv.4","0.0016398358744562018","0.5000041806893023","0.18285587430000305","","2184","0/1","Het","96","56,40","0.583333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a transmembrane protein localized to the plasma membrane and perinuclear vesicular structures. The gene product interacts with the angiotensin II type I receptor and negatively regulates angiotensin II signaling. Alternative splicing of this gene generates multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]","angiotensin II receptor associated protein","response to hypoxia(GO:0001666)|regulation of blood pressure(GO:0008217)|angiotensin-activated signaling pathway(GO:0038166)","Golgi membrane(GO:0000139)|endoplasmic reticulum membrane(GO:0005789)|Golgi apparatus(GO:0005794)|plasma membrane(GO:0005886)|cell cortex(GO:0005938)|integral component of membrane(GO:0016021)|cytoplasmic vesicle membrane(GO:0030659)|intracellular membrane-bounded organelle(GO:0043231)","angiotensin type II receptor activity(GO:0004945)|protein binding(GO:0005515)","","","","Diseases of signal transduction by growth factor receptors and second messengers|Signaling by braf and raf fusions|Oncogenic mapk signaling","","","",".;.","","","0.00005446","","","","","","","4.007e-06","5.446e-05","T","0.817","T","0.756","B","0.144","B","0.06","U","0.408","N","1","L","1.39","T","0.93","N","-1.24","0.049","T","-1.011","T","0.072","T","0.008","0.070","T","0.077","5.782","0.196","5.0","0.294","12.778"
"chr15","83447635","83447635","C>T","","FSD2","exonic","nonsynonymous SNV","","FSD2:NM_001007122:exon6:c.G994A:p.G332R,FSD2:NM_001281806:exon6:c.G994A:p.G332R,FSD2:NM_001281805:exon7:c.G994A:p.G332R","FSD2","exonic","nonsynonymous SNV","","FSD2:ENST00000334574.12_1:exon6:c.G994A:p.G332R,FSD2:ENST00000541889.1_1:exon6:c.G994A:p.G332R","FSD2:ENST00000334574.8:c.994G>A:p.(Gly332Arg)","0.7482725","0.0","0.7482724785804749","0.0016322899837416","","","","","","","","","","","","","ENSG00000186628","FSD2","HGNC:18024","FSD2","123722","ENSG00000186628","uc002bjd.4","0.0016322899837416225","","0.7482724785804749","","2185","0/1","Het","71","42,29","0.591549295774648","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a protein that belongs to the FN3/SPRY family of proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]","fibronectin type III and SPRY domain containing 2","","nucleus(GO:0005634)|sarcoplasmic reticulum(GO:0016529)|perinuclear region of cytoplasm(GO:0048471)","protein binding(GO:0005515)","","","","","","","",".;.","","Score=957;Name=V$NFKAPPAB_01","0.0000281","0.0002","0.001","0.","0.0002","0.0002","","2.81e-05","0.0001","T","0.514","T","0.118","B","0.028","B","0.005","N","0.001","D","0.754","L","1.87","T","0.5","N","-0.18","0.107","T","-0.895","T","0.132","T","0.025","0.054","T","0.057","15.67","1.390","5.8","2.020","9.311"
"chr16","28354289","28354290","GC>-","","NPIPB6","exonic","frameshift deletion","","NPIPB6:NM_001282524:exon7:c.916_917del:p.A306Sfs*13","NPIPB6","exonic","frameshift deletion","","NPIPB6:ENST00000532254.1_1:exon7:c.916_917del:p.A306Sfs*13,NPIPB6:ENST00000533640.5_1:exon7:c.862_863del:p.A288Sfs*13","NPIPB6:ENST00000532254.1:c.916_917del:p.(Ala306Serfs*13)","0.80455047","","","","0.0","0.7473235428333282","0.0016181495523144","","","","","","","","","","ENSG00000198156","NPIPB6","HGNC:37454","NPIPB6","728741","ENSG00000198156","","0.0016181495523144931","","0.7473235428333282","","2186","0/1","Het","34","32,2","0.941176470588235","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","nuclear pore complex interacting protein family member B6","","nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)","","","","","","","","","","","","0.0011","","","0.0009","0.0006","","","0.0011","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr16","28354287","28354287","->GAC","","NPIPB6","exonic","nonframeshift insertion","","NPIPB6:NM_001282524:exon7:c.918_919insGTC:p.A306_P307insV","NPIPB6","exonic","nonframeshift insertion","","NPIPB6:ENST00000532254.1_1:exon7:c.918_919insGTC:p.A306_P307insV,NPIPB6:ENST00000533640.5_1:exon7:c.864_865insGTC:p.A288_P289insV","NPIPB6:ENST00000532254.1:c.918_919insGTC:p.(Ala306_Pro307insVal)","0.6900966","","","","0.0","0.7473235428333282","0.0016181495523144","","","","","","","","","","ENSG00000198156","NPIPB6","HGNC:37454","NPIPB6","728741","ENSG00000198156","","0.0016181495523144931","","0.7473235428333282","","2187","0/1","Het","37","32,5","0.864864864864865","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","nuclear pore complex interacting protein family member B6","","nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)","","","","","","","","","","","","0.0013","","","0.0004","0.","","","0.0013","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","171627343","171627343","G>C","","ERICH2","exonic","nonsynonymous SNV","","ERICH2:NM_001290030:exon1:c.G152C:p.R51P,ERICH2:NM_001290031:exon1:c.G152C:p.R51P","AC007405.4;AC007405.6","upstream","","dist=280","","EIF2S2P4:ENST00000543391.1::","0.78679836","","","","0.0","0.7440623939037323","0.001570479863779","","","","","","","","","","ENSG00000128692","EIF2S2P4","HGNC:37626","EIF2S2P4","728350","ENSG00000128692","","0.001570479863779052","","0.7440623939037323","","2191","0/1","Het","28","21,7","0.75","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","glutamate rich 2","","","protein binding(GO:0005515)","","","","","","","","","Name=(CCCCG)n","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","171627348","171627348","G>C","","ERICH2","exonic","nonsynonymous SNV","","ERICH2:NM_001290030:exon1:c.G157C:p.A53P,ERICH2:NM_001290031:exon1:c.G157C:p.A53P","AC007405.4;AC007405.6","upstream","","dist=275","","EIF2S2P4:ENST00000543391.1::","0.70132643","","","","0.0","0.7440623939037323","0.001570479863779","","","","","","","","","","ENSG00000128692","EIF2S2P4","HGNC:37626","EIF2S2P4","728350","ENSG00000128692","","0.001570479863779052","","0.7440623939037323","","2192","0/1","Het","28","21,7","0.75","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","glutamate rich 2","","","protein binding(GO:0005515)","","","","","","","","","Name=(CCCCG)n","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr2","171627361","171627363","GGA>-","","ERICH2","exonic","nonframeshift deletion","","ERICH2:NM_001290030:exon1:c.170_172del:p.R57_T58delinsP,ERICH2:NM_001290031:exon1:c.170_172del:p.R57_T58delinsP","AC007405.4;AC007405.6","upstream","","dist=260","","EIF2S2P4:ENST00000543391.1::","0.5850144","","","","","","","","","","","","","","","","ENSG00000128692","EIF2S2P4","HGNC:37626","EIF2S2P4","728350","ENSG00000128692","","0.001570479863779052","","0.7440623939037323","","2194","0/1","Het","32","27,5","0.84375","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","glutamate rich 2","","","protein binding(GO:0005515)","","","","","","","","","Name=(CCCCG)n","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr1","60456370","60456370","G>A","","C1orf87","exonic","nonsynonymous SNV","","C1orf87:NM_152377:exon12:c.C1616T:p.A539V","C1orf87","exonic","nonsynonymous SNV","","C1orf87:ENST00000450089.6_1:exon8:c.C929T:p.A310V,C1orf87:ENST00000371201.3_1:exon12:c.C1616T:p.A539V","C1orf87:ENST00000371201.3:c.1616C>T:p.(Ala539Val)","0.72385967","0.0","0.7238596677780151","0.0013048775498956","","","","","","","","","","","","","ENSG00000162598","C1orf87","HGNC:28547","C1orf87","127795","ENSG00000162598","uc001czs.3","0.0013048775498956378","","0.7238596677780151","","2237","0/1","Het","98","64,34","0.653061224489796","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","chromosome 1 open reading frame 87","","","","","","","","","","",".;.","","","0.00005437","","","0.","0.0001","","","3.979e-06","5.437e-05","T","0.275","D","0.035","P","0.932","P","0.582","N","0.002","N","0.967","M","2.3","T","2.27","N","-1.84","0.205","T","-1.030","T","0.080","T","0.005","0.081","D","0.896","22.9","2.667","4.89","4.325","4.331"
"chr17","79353580","79353580","->GGGTGGGAAGTGACGTGTCATGGGTGAACAGCAGTGGA","","LOC100130370","exonic","stopgain","","LOC100130370:NM_001272086:exon3:c.204_205insTCCACTGCTGTTCACCCATGACACGTCACTTCCCACCC:p.A69Sfs*7","RP11-1055B8.3","ncRNA_exonic","","","","TMEM105:ENST00000332900.1::","0.099","","","","0.0","0.4069999866187572","7.117345522895552e-05","","","","","","","","","","ENSG00000185332","TMEM105","HGNC:26794","TMEM105","284186","ENSG00000185332","uc002kad.4","0.0012030324747440762","","0.7149999737739563","","2248","0/1","Het","79","52,27","0.658227848101266","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","uncharacterized LOC100130370","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr21","33840145","33840145","T>C","","EVA1C","exonic","nonsynonymous SNV","","EVA1C:NM_001286556:exon4:c.T623C:p.L208P,EVA1C:NM_058187:exon4:c.T623C:p.L208P","EVA1C","exonic","nonsynonymous SNV","","EVA1C:ENST00000300255.7_1:exon4:c.T623C:p.L208P,EVA1C:ENST00000382699.7_1:exon4:c.T623C:p.L208P,EVA1C:ENST00000401402.7_1:exon4:c.T623C:p.L208P","EVA1C:ENST00000300255.2:c.623T>C:p.(Leu208Pro)","0.71099997","0.0","0.7109999656677246","0.0011596909066331","","","","","","","","","","","","","ENSG00000166979","EVA1C","HGNC:13239","EVA1C","59271","ENSG00000166979","uc002ypr.3","0.0011596909066331836","","0.7109999656677246","","2268","0/1","Het","47","29,18","0.617021276595745","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","eva-1 homolog C","biological_process(GO:0008150)","extracellular region(GO:0005576)|extracellular region(GO:0005576)|integral component of membrane(GO:0016021)","heparin binding(GO:0008201)|heparin binding(GO:0008201)|carbohydrate binding(GO:0030246)","","","","","","","","D-galactoside/L-rhamnose","","Score=831;Name=V$HEN1_02","","","","","","","","","","T","0.363","T","0.294","B","0.004","B","0.015","N","0.029","N","0.999","L","1.28","T","2.21","N","-1.06","0.408","T","-1.018","T","0.018","T","0.006","0.076","T","0.156","13.89","1.070","5.61","0.648","2.274"
"chr19","40512079","40512079","C>T","","ZNF546","exonic","nonsynonymous SNV","","ZNF546:NM_001297763:exon4:c.C83T:p.T28I,ZNF546:NM_178544:exon4:c.C161T:p.T54I","ZNF546","exonic","nonsynonymous SNV","","ZNF546:ENST00000347077.9_1:exon4:c.C161T:p.T54I,ZNF546:ENST00000600094.5_1:exon4:c.C83T:p.T28I","ZNF546:ENST00000347077.4:c.161C>T:p.(Thr54Ile)","0.6939681","0.0","0.6939681172370911","0.0009919368674389546","","","","","","","","","","","","","ENSG00000187187","ZNF546","HGNC:28671","ZNF546","339327","ENSG00000187187","uc002oms.3","0.0009919368674389546","","0.6939681172370911","","2294","0/1","Het","40","27,13","0.675","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 546","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","",".;.;.;.;.","","","0.000016","","","0.","0.0002","","","1.6e-05","0.0002","T","0.3","T","0.116","B","0.148","B","0.035","","","N","0.996","N","0","T","5.9","N","-0.72","0.237","T","-0.944","T","0.011","T","0.003","0.010","T","0.217","15.29","1.319","2.71","0.162","6.394"
"chr6","57512794","57512796","ATT>-","","PRIM2","splicing","","NM_000947:exon14:r.spl;NM_000947:exon15:r.spl","","PRIM2","intronic","","","","PRIM2:ENST00000607273.1:c.*581_*583del:p.(=)","0.385","","","","","","","","","","","","","","","","ENSG00000146143","PRIM2","HGNC:9370","PRIM2","5558","ENSG00000146143","uc032wzb.2","0.0009741859107167353","","0.6919999718666077","","2305","0/1","Het","32","14,18","0.4375","Uncertain_significance","False","not_provided","MedGen:CN517202","NC_000006.11:g.57512794_57512796del","no_assertion_criteria_provided","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes the 58 kilodalton subunit of DNA primase, an enzyme that plays a key role in the replication of DNA. The encoded protein forms a heterodimer with a 49 kilodalton subunit. This heterodimer functions as a DNA-directed RNA polymerase to synthesize small RNA primers that are used to create Okazaki fragments on the lagging strand of the DNA. Alternative splicing of this gene results in multiple transcript variants. This gene has a related pseudogene, which is also present on chromosome 6. [provided by RefSeq, Apr 2014]","DNA primase subunit 2","DNA replication, synthesis of RNA primer(GO:0006269)|DNA replication, synthesis of RNA primer(GO:0006269)|positive regulation of DNA primase activity(GO:1903934)","nucleoplasm(GO:0005654)|alpha DNA polymerase:primase complex(GO:0005658)|alpha DNA polymerase:primase complex(GO:0005658)","DNA binding(GO:0003677)|protein binding(GO:0005515)|metal ion binding(GO:0046872)|4 iron, 4 sulfur cluster binding(GO:0051539)|DNA/RNA hybrid binding(GO:0071667)","","Purine metabolism|Pyrimidine metabolism|Dna replication","Wp dna replication|Wp pyrimidine metabolism|Wp g1 to s cell cycle control","Inhibition of replication initiation of damaged dna by rb1 e2f1|E2f mediated regulation of dna replication|Telomere maintenance|Cell cycle|Polymerase switching on the c strand of the telomere|Telomere c strand lagging strand synthesis|Telomere c strand synthesis initiation|Extension of telomeres|Mitotic g1 phase and g1 s transition|Dna replication initiation|Activation of the pre replicative complex|Dna replication pre initiation|Polymerase switching|Processive synthesis on the lagging strand|Lagging strand synthesis|Dna strand elongation|S phase|Cell cycle mitotic|Dna replication|Chromosome maintenance|Diseases of programmed cell death","","G2m checkpoint|E2f targets","","","Name=AluJo","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","49337917","49337917","G>A","","USP4","exonic","nonsynonymous SNV","","USP4:NM_199443:exon10:c.C1354T:p.H452Y,USP4:NM_003363:exon11:c.C1495T:p.H499Y","USP4","exonic","nonsynonymous SNV","","USP4:ENST00000351842.8_1:exon10:c.C1354T:p.H452Y,USP4:ENST00000265560.9_1:exon11:c.C1495T:p.H499Y","USP4:ENST00000265560.4:c.1495C>T:p.(His499Tyr)","0.116894096","0.5017205137992278","0.1168940961360931","0.0009115447287069795","","","","","","","","","","","","","ENSG00000114316","USP4","HGNC:12627","USP4","7375","ENSG00000114316","uc003cwq.3","0.0009115447287069795","0.5017205137992278","0.11689409613609314","","2319","0/1","Het","37","23,14","0.621621621621622","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The protein encoded by this gene is a protease that deubiquitinates target proteins such as ADORA2A and TRIM21. The encoded protein shuttles between the nucleus and cytoplasm and is involved in maintaining operational fidelity in the endoplasmic reticulum. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]","ubiquitin specific peptidase 4","spliceosomal tri-snRNP complex assembly(GO:0000244)|ubiquitin-dependent protein catabolic process(GO:0006511)|protein deubiquitination(GO:0016579)|protein deubiquitination(GO:0016579)|protein deubiquitination(GO:0016579)|negative regulation of protein ubiquitination(GO:0031397)|regulation of protein stability(GO:0031647)|protein localization to cell surface(GO:0034394)","nucleus(GO:0005634)|nucleus(GO:0005634)|cytoplasm(GO:0005737)|lysosome(GO:0005764)|cytosol(GO:0005829)|cytosol(GO:0005829)|plasma membrane(GO:0005886)","thiol-dependent deubiquitinase(GO:0004843)|thiol-dependent deubiquitinase(GO:0004843)|protein binding(GO:0005515)|adenosine receptor binding(GO:0031685)|identical protein binding(GO:0042802)|metal ion binding(GO:0046872)","","","","Tnfr1 induced proapoptotic signaling|Regulation of tnfr1 signaling|Tnfr1 induced nfkappab signaling pathway|Deubiquitination|Ub specific processing proteases|Post translational protein modification|Death receptor signalling|Tnf signaling","","","","Peptidase","","Score=680;Name=V$PPARG_02","0.00001591","","","","","","","1.591e-05","0","T","0.883","T","0.496","B","0.001","B","0.003","N","0.038","N","0.997","L","1.595","T","2.03","N","-1.06","0.206","T","-1.063","T","0.121","T","0.006","0.078","T","0.092","16.76","1.585","5.83","3.445","6.491"
"chr3","186440260","186440260","G>A","","KNG1","exonic","nonsynonymous SNV","","KNG1:NM_000893:exon3:c.G341A:p.R114K,KNG1:NM_001102416:exon3:c.G341A:p.R114K,KNG1:NM_001166451:exon3:c.G341A:p.R114K","KNG1","exonic","nonsynonymous SNV","","KNG1:ENST00000287611.8_1:exon3:c.G341A:p.R114K,KNG1:ENST00000447445.1_1:exon3:c.G341A:p.R114K,KNG1:ENST00000644859.2_1:exon3:c.G341A:p.R114K","KNG1:ENST00000265023.4:c.341G>A:p.(Arg114Lys)","0.67163926","0.0","0.6716392636299133","0.0008081756643511539","","","","","","","","","","","","","ENSG00000113889","KNG1","HGNC:6383","KNG1","3827","ENSG00000113889","uc003fqr.4","0.0008081756643511539","","0.6716392636299133","OMIM:619363 Angioedema, hereditary, 6-autosomal_dominant","2327","0/1","Het","42","31,11","0.738095238095238","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","High molecular weight kininogen deficiency(228960)|Angioedema, hereditary, 6(619363)","Facial edema(HP:0000282)|Edema of the dorsum of hands(HP:0007514)|Young adult onset(HP:0011462)|Swollen lip(HP:0031244)|Autosomal dominant inheritance(HP:0000006)|Angioedema(HP:0100665)|Middle age onset(HP:0003596)","This gene uses alternative splicing to generate two different proteins- high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK). HMWK is essential for blood coagulation and assembly of the kallikrein-kinin system. Also, bradykinin, a peptide causing numerous physiological effects, is released from HMWK. Bradykinin also functions as an antimicrobial peptide with antibacterial and antifungal activity. In contrast to HMWK, LMWK is not involved in blood coagulation. Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reduces or depletes angiotensin converting enzyme 2 (ACE2), which results in an increase in levels of des-Arg(9)-bradykinin, a bioactive metabolite of bradykinin that is associated with lung injury and inflammation. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2020]","kininogen 1","inflammatory response(GO:0006954)|negative regulation of cell adhesion(GO:0007162)|positive regulation of cytosolic calcium ion concentration(GO:0007204)|positive regulation of cytosolic calcium ion concentration(GO:0007204)|blood coagulation(GO:0007596)|negative regulation of endopeptidase activity(GO:0010951)|negative regulation of blood coagulation(GO:0030195)|negative regulation of blood coagulation(GO:0030195)|vasodilation(GO:0042311)|positive regulation of apoptotic process(GO:0043065)|negative regulation of proteolysis(GO:0045861)","extracellular region(GO:0005576)|extracellular region(GO:0005576)|extracellular region(GO:0005576)|extracellular region(GO:0005576)|extracellular space(GO:0005615)|endoplasmic reticulum lumen(GO:0005788)|plasma membrane(GO:0005886)|platelet alpha granule lumen(GO:0031093)|collagen-containing extracellular matrix(GO:0062023)|extracellular exosome(GO:0070062)|blood microparticle(GO:0072562)","endopeptidase inhibitor activity(GO:0004866)|cysteine-type endopeptidase inhibitor activity(GO:0004869)|cysteine-type endopeptidase inhibitor activity(GO:0004869)|signaling receptor binding(GO:0005102)|protein binding(GO:0005515)|heparin binding(GO:0008201)|zinc ion binding(GO:0008270)","hypertension(DOID:10763)|essential hypertension(DOID:10825)|listeriosis(DOID:11573)|cancer(DOID:162)|chondrosarcoma(DOID:3371)|disease(DOID:4)|adenocarcinoma(DOID:299)","Complement and coagulation cascades","Wp complement and coagulation cascades|Wp ace inhibitor pathway|Wp vitamin d receptor pathway|Wp cells and molecules involved in local acute inflammatory response|Wp ras and bradykinin pathways in covid19","Hemostasis|Intrinsic pathway of fibrin clot formation|Formation of fibrin clot clotting cascade|Signaling by gpcr|Class a 1 rhodopsin like receptors|Peptide ligand binding receptors|Regulation of insulin like growth factor igf transport and uptake by insulin like growth factor binding proteins igfbps|G alpha q signalling events|G alpha i signalling events|Gpcr ligand binding|Post translational protein modification|Platelet activation signaling and aggregation|Response to elevated platelet cytosolic ca2","Lair pathway|No1 pathway|Biopeptides pathway|Intrinsic pathway","","",".;Cystatin","","","0.00001592","","","0.","0.0005","","","1.592e-05","0.0002","T","0.337","T","0.215","P","0.801","B","0.19","N","0.448","N","1","L","1.555","T","1.79","N","-1.15","0.104","T","-1.034","T","0.041","T","0.004","0.038","T","0.147","8.631","0.422","4.67","-0.037","7.209"
"chr22","21822454","21822454","G>A","","TMEM191C","exonic","nonsynonymous SNV","","TMEM191C:NM_001207052:exon3:c.G434A:p.R145K","TMEM191C","exonic","nonsynonymous SNV","","TMEM191C:ENST00000432134.8_1:exon3:c.G293A:p.R98K,TMEM191C:ENST00000536718.3_1:exon3:c.G293A:p.R98K,TMEM191C:ENST00000621561.5_1:exon3:c.G293A:p.R98K","PI4KAP2:ENST00000450651.1::","0.8723358","","","","0.0","0.6405536830425262","0.0006075874440789597","","","","","","","","","","ENSG00000183506","PI4KAP2","HGNC:33577","PI4KAP2","375133","ENSG00000183506","","0.0006075874440789597","","0.6405536830425262","","2379","0/1","Het","69","37,32","0.536231884057971","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","transmembrane protein 191C","","integral component of membrane(GO:0016021)","","","","","","","","",".;.","","","0.0028","0.0004","0.002","","","","","0.0002","0.0028","","","","","","","","","","","","","","","","","","","","","","","","","","","","","11.47","0.739","3.0","-0.131","7.231"
"chr1","152324836","152324836","C>G","","FLG2","exonic","nonsynonymous SNV","","FLG2:NM_001014342:exon3:c.G5426C:p.S1809T","FLG2","exonic","nonsynonymous SNV","","FLG2:ENST00000388718.5_1:exon3:c.G5426C:p.S1809T","FLG2:ENST00000388718.5:c.5426G>C:p.(Ser1809Thr)","0.63693124","0.0","0.6369312405586243","0.0005877185418656208","","","","","","","","","","","","","ENSG00000143520","FLG2","HGNC:33276","FLG2","388698","ENSG00000143520","uc001ezw.5","0.0005877185418656208","","0.6369312405586243","OMIM:618084 Peeling skin syndrome 6-autosomal_recessive","2383","0/1","Het","39","24,15","0.615384615384615","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Peeling skin syndrome 6(618084)","Orthokeratosis(HP:0040162)|Autosomal recessive inheritance(HP:0000007)|Pruritus(HP:0000989)|Parakeratosis(HP:0001036)","The filaggrin-like protein encoded by this gene is upregulated by calcium, proteolyzed by calpain 1, and is involved in epithelial homeostasis. The encoded protein is required for proper cornification in skin, with defects in this gene being associated with skin diseases. This protein also has a function in skin barrier protection. In fact, in addition to providing a physical barrier, C-terminal fragments of this protein display antimicrobial activity against P. aeruginosa and E. coli. [provided by RefSeq, Jul 2020]","filaggrin 2","cell adhesion(GO:0007155)|epidermis morphogenesis(GO:0048730)|establishment of skin barrier(GO:0061436)|establishment of skin barrier(GO:0061436)","cornified envelope(GO:0001533)|extracellular region(GO:0005576)|nucleus(GO:0005634)|cytoplasm(GO:0005737)|keratohyalin granule(GO:0036457)|tertiary granule lumen(GO:1904724)","structural molecule activity(GO:0005198)|calcium ion binding(GO:0005509)|transition metal ion binding(GO:0046914)","","","","Innate immune system|Neutrophil degranulation","","","","","","","","","","","","","","","","T","0.363","T","0.671","B","0.033","B","0.007","","","N","1","L","1.87","T","1.32","N","-0.95","0.06","T","-0.951","T","0.019","T","0.002","0.030","T","0.064","1.788","-0.063","3.49","-1.057","8.77"
"chr22","18923848","18923848","->CCCGC","","PRODH","splicing","","NM_016335:exon2:UTR5","","PRODH","splicing","","ENST00000610940.4_1:exon2:UTR5","","PRODH:ENST00000357068.6:c.-53_-49dup:p.(=)","0.622","","","","0.0","0.621999979019165","0.000512447161800961","","","","","","","","","","ENSG00000100033","PRODH","HGNC:9453","PRODH","5625","ENSG00000100033","uc002zok.5","0.000512447161800961","","0.621999979019165","OMIM:239500 Hyperprolinemia, type I-autosomal_recessive;OMIM:600850 Schizophrenia, susceptibility to, 4-autosomal_dominant;ORPHA:419 Hyperprolinemia type 1-autosomal_recessive","2398","1/1","Hom","12","0,12","0","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Hyperprolinemia, type i(239500)|Schizophrenia 4(600850)","Prolinuria(HP:0003137)|Hyperprolinemia(HP:0008358)|Intellectual disability(HP:0001249)|Seizure(HP:0001250)|Schizophrenia(HP:0100753)|Global developmental delay(HP:0001263)|Intellectual disability(HP:0001249)|Stereotypy(HP:0000733)|Hypotonia(HP:0001252)|Status epilepticus(HP:0002133)|Generalized hypotonia(HP:0001290)|Delayed speech and language development(HP:0000750)|Autosomal recessive inheritance(HP:0000007)|Hyperglycinuria(HP:0003108)|Hyperprolinemia(HP:0008358)|Autistic behavior(HP:0000729)|Ataxia(HP:0001251)|EEG abnormality(HP:0002353)|Hyperactivity(HP:0000752)|Hydroxyprolinuria(HP:0003080)|Aggressive behavior(HP:0000718)|Schizophrenia(HP:0100753)|Autosomal dominant inheritance(HP:0000006)|Abnormality of metabolism/homeostasis(HP:0001939)|Schizophrenia(HP:0100753)|Seizure(HP:0001250)|Nephropathy(HP:0000112)|Hyperprolinemia(HP:0008358)|Proteinuria(HP:0000093)|Prolinuria(HP:0003137)","This gene encodes a mitochondrial protein that catalyzes the first step in proline degradation. Mutations in this gene are associated with hyperprolinemia type 1 and susceptibility to schizophrenia 4 (SCZD4). This gene is located on chromosome 22q11.21, a region which has also been associated with the contiguous gene deletion syndromes, DiGeorge and CATCH22. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2010]","proline dehydrogenase 1","proline metabolic process(GO:0006560)|proline catabolic process(GO:0006562)|intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631)|proline catabolic process to glutamate(GO:0010133)|proline catabolic process to glutamate(GO:0010133)|positive regulation of cell death(GO:0010942)|4-hydroxyproline catabolic process(GO:0019470)","nucleoplasm(GO:0005654)|mitochondrion(GO:0005739)|mitochondrion(GO:0005739)|mitochondrial inner membrane(GO:0005743)|mitochondrial matrix(GO:0005759)|intracellular membrane-bounded organelle(GO:0043231)","proline dehydrogenase activity(GO:0004657)|proline dehydrogenase activity(GO:0004657)|proline dehydrogenase activity(GO:0004657)|FAD binding(GO:0071949)|FAD binding(GO:0071949)","intellectual disability(DOID:1059)|cancer(DOID:162)|epilepsy(DOID:1826)|schizophrenia(DOID:5419)","Arginine and proline metabolism","Wp 22q112 copy number variation syndrome","Metabolism of amino acids and derivatives","","Kras signaling dn","SpliceAI>TCCCGC|PRODH|0.00|0.00|0.00|0.00|-20|-38|-31|-27","","","","0","","","","","","","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr9","39888542","39888542","T>C","","SPATA31A1","exonic","nonsynonymous SNV","","SPATA31A1:NM_001085452:exon4:c.T1571C:p.L524P","SPATA31A2","exonic","nonsynonymous SNV","","SPATA31A2:ENST00000456183.2:exon4:c.T1529C:p.L510P","SPATA31A2:ENST00000456183.2:c.1529T>C:p.(Leu510Pro)","0.6","","","","0.0","0.6000000238418579","0.0004187390569624058","","","","","","","","","","ENSG00000204848","SPATA31A2","","","642265","ENSG00000204848","","0.0004187390569624058","","0.6000000238418579","","2417","1/1","Hom","4","0,4","0","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","SPATA31 subfamily A member 1","spermatogenesis(GO:0007283)|cell differentiation(GO:0030154)","integral component of membrane(GO:0016021)","","","","","","","","","","","","0","","","","","","","0","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr1","247274889","247274889","C>A","","C1orf229","exonic","nonsynonymous SNV","","C1orf229:NM_207401:exon1:c.G638T:p.W213L","C1orf229","ncRNA_exonic","","","","LINC02897:ENST00000408893.2:c.638G>T:p.(Trp213Leu)","0.6","0.0","0.6000000238418579","0.0004187390569624058","","","","","","","","","","","","","ENSG00000221953","LINC02897","HGNC:33759","LINC02897","388759","ENSG00000221953","uc001icg.2","0.0004187390569624058","","0.6000000238418579","","2418","0/1","Het","19","7,12","0.368421052631579","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","long intergenic non-protein coding RNA 2897","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr18","72343286","72343286","G>C","","ZNF407","exonic","nonsynonymous SNV","","ZNF407:NM_001146189:exon1:c.G311C:p.G104A,ZNF407:NM_001146190:exon1:c.G311C:p.G104A,ZNF407:NM_017757:exon1:c.G311C:p.G104A","ZNF407","exonic","nonsynonymous SNV","","ZNF407:ENST00000309902.10_1:exon1:c.G311C:p.G104A,ZNF407:ENST00000577538.5_1:exon1:c.G311C:p.G104A,ZNF407:ENST00000299687.10_1:exon2:c.G311C:p.G104A,ZNF407:ENST00000582337.5_1:exon2:c.G311C:p.G104A","ZNF407:ENST00000299687.5:c.311G>C:p.(Gly104Ala)","0.59975624","0.0","0.5997562408447266","0.00041780300013643086","0.0","0.423904612660408","8.312594350622222e-05","","","","","","","","","","ENSG00000215421","ZNF407","HGNC:19904","ZNF407","55628","ENSG00000215421","uc002llw.3","0.00041780300013643086","","0.5997562408447266","","2431","0/1","Het","115","60,55","0.521739130434783","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies(619557)","","This gene encodes a zinc finger protein whose exact function is not known. It may be involved in transcriptional regulation. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]","zinc finger protein 407","regulation of gene expression(GO:0010468)|positive regulation of transcription by RNA polymerase II(GO:0045944)","nucleus(GO:0005634)","DNA binding(GO:0003677)|zinc ion binding(GO:0008270)","","","","","","","",".;.;.;.","","","0.000008025","","","0.","0.","","","8.025e-06","0","T","1.0","T","1.0","B","0.0","B","0.0","N","0.744","N","1","N","0","T","3.53","N","0.45","0.022","T","-0.902","T","0.007","T","0.008","0.147","T","0.033","0.001","-2.094","5.16","-4.822","2.930"
"chr19","7934244","7934244","G>C","","PRR36","exonic","unknown","","UNKNOWN","PRR36","exonic","unknown","","UNKNOWN","CTD-3193O13.9:ENST00000539422.1:c.3716C>G:p.(Pro1239Arg)","0.59974086","0.0","0.5997408628463745","0.0004177440232113671","","","","","","","","","","","","","ENSG00000183248","CTD-3193O13.9","","","80164","ENSG00000183248","","0.0004177440232113671","","0.5997408628463745","","2433","0/1","Het","43","18,25","0.418604651162791","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a large protein of unknown function that contains internal regions of low complexity sequence. Alternative splicing results in multiple transcript variants. The transcript structure of the protein-coding variant at this locus is conserved between human and mouse. [provided by RefSeq, Oct 2013]","proline rich 36","","","","","","","","","","","","","","0","","","","","","","0","0","","","D","0.007","","","","","","","N","1","","","","","","","0.144","T","-1.061","T","0.091","D","0.493","0.126","D","0.811","20.2","2.047","4.12","2.781","7.825"
"chr1","145298363","145298363","C>T","","NBPF10","exonic","nonsynonymous SNV","","NBPF10:NM_001039703:exon5:c.C775T:p.P259S,NBPF10:NM_001302371:exon5:c.C775T:p.P259S","CH17-159N18.5;NBPF10","intronic","","","","NBPF10:ENST00000342960.5:c.775C>T:p.(Pro259Ser)","0.5990628","0.0","0.5990628004074097","0.00041515180850441934","0.0","0.5983478426933289","0.0004124359570716742","","","","","","","","","","ENSG00000163386","NBPF10","HGNC:31992","NBPF10","100132406","ENSG00000271425","uc057kcv.1","0.00041515180850441944","","0.5990628004074097","","2435","0/1","Het","61","41,20","0.672131147540984","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]","NBPF member 10","","cytoplasm(GO:0005737)","RNA binding(GO:0003723)","","","","","","","SpliceAI>T|NBPF10|0.00|0.00|0.01|0.00|3|-43|3|6>T|RP11-458D21.5|0.00|0.00|0.01|0.00|3|-43|3|6","Neuroblastoma","","","0.00002637","","","0.0001","0.","","","2.637e-05","0","","","T","0.269","","","","","","","N","1","","","","","","","0.194","T","-0.900","T","0.005","T","5.37E-4","0.033","T","0.026","15.83","1.420","1.11","1.364","5.737"
"chr1","145298247","145298247","C>T","","NBPF10","exonic","nonsynonymous SNV","","NBPF10:NM_001039703:exon5:c.C659T:p.S220F,NBPF10:NM_001302371:exon5:c.C659T:p.S220F","CH17-159N18.5;NBPF10","intronic","","","","NBPF10:ENST00000342960.5:c.659C>T:p.(Ser220Phe)","0.5976329","","","","0.0","0.5983478426933289","0.0004124359570716742","","","","","","","","","","ENSG00000163386","NBPF10","HGNC:31992","NBPF10","100132406","ENSG00000271425","uc057kcv.1","0.00041515180850441944","","0.5990628004074097","","2436","0/1","Het","462","392,70","0.848484848484849","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]","NBPF member 10","","cytoplasm(GO:0005737)","RNA binding(GO:0003723)","","","","","","","SpliceAI>T|NBPF10|0.02|0.00|0.00|0.00|-17|5|-17|0>T|RP11-458D21.5|0.02|0.00|0.00|0.00|-17|5|-17|0","Neuroblastoma","","","0.00003377","","","0.0001","0.","","","3.377e-05","0","","","D","0.024","","","","","","","N","1","","","","","","","0.12","T","-1.029","T","0.032","T","4.64E-4","0.045","T","0.288","11.35","0.724","1.18","-1.453","5.048"
"chr1","145368473","145368473","G>C","","NBPF9","exonic","unknown","","UNKNOWN","CH17-159N18.5;LINC01719","intergenic","","dist=3093;dist=4594","","NBPF10:ENST00000342960.5:c.10451G>C:p.(Arg3484Pro)","0.588648","","","","","","","","","","","","","","","","ENSG00000163386","NBPF10","HGNC:31992","NBPF10","100132406","ENSG00000271425","uc057kcv.1","0.00041515180850441944","","0.5990628004074097","","2437","0/1","Het","345","303,42","0.878260869565217","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. [provided by RefSeq, Apr 2013]","NBPF member 9","","cytoplasm(GO:0005737)","","","","","","","","SpliceAI>C|NBPF10|0.00|0.00|0.00|0.00|-23|-32|48|-1","","","","0.00005685","","","0.0001","","","","0.0002","5.685e-05","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr18","2608826","2608826","G>A","","NDC80","exonic","nonsynonymous SNV","","NDC80:NM_006101:exon15:c.G1685A:p.R562Q","NDC80","exonic","nonsynonymous SNV","","NDC80:ENST00000261597.9_1:exon15:c.G1685A:p.R562Q","NDC80:ENST00000261597.4:c.1685G>A:p.(Arg562Gln)","0.02875041","0.502548310207203","0.0287504103034734","0.000409424612994978","","","","","","","","","","","","","ENSG00000080986","NDC80","HGNC:16909","NDC80","10403","ENSG00000080986","uc002kli.3","0.000409424612994978","0.502548310207203","0.028750410303473473","","2441","0/1","Het","49","30,19","0.612244897959184","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a component of the NDC80 kinetochore complex. The encoded protein consists of an N-terminal microtubule binding domain and a C-terminal coiled-coiled domain that interacts with other components of the complex. This protein functions to organize and stabilize microtubule-kinetochore interactions and is required for proper chromosome segregation. [provided by RefSeq, Oct 2011]","NDC80 kinetochore complex component","mitotic sister chromatid segregation(GO:0000070)|establishment of mitotic spindle orientation(GO:0000132)|mitotic cell cycle(GO:0000278)|mitotic spindle organization(GO:0007052)|chromosome segregation(GO:0007059)|attachment of spindle microtubules to kinetochore(GO:0008608)|centrosome duplication(GO:0051298)|cell division(GO:0051301)|metaphase plate congression(GO:0051310)|metaphase plate congression(GO:0051310)|attachment of mitotic spindle microtubules to kinetochore(GO:0051315)|attachment of mitotic spindle microtubules to kinetochore(GO:0051315)|kinetochore organization(GO:0051383)|positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267)|positive regulation of protein localization to kinetochore(GO:1905342)","chromosome, centromeric region(GO:0000775)|kinetochore(GO:0000776)|outer kinetochore(GO:0000940)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|centrosome(GO:0005813)|cytosol(GO:0005829)|membrane(GO:0016020)|Ndc80 complex(GO:0031262)|Ndc80 complex(GO:0031262)","protein binding(GO:0005515)|identical protein binding(GO:0042802)","cancer(DOID:162)|embryoma(DOID:4766)","","","Cell cycle|Rho gtpase effectors|Separation of sister chromatids|Resolution of sister chromatid cohesion|Mitotic metaphase and anaphase|Rho gtpases activate formins|Mitotic prometaphase|M phase|Cell cycle mitotic|Mitotic spindle checkpoint|Cell cycle checkpoints|Signaling by rho gtpases miro gtpases and rhobtb3","","Mitotic spindle|G2m checkpoint","","","","","0.00007182","","","0.0001","0.0002","","","7.182e-05","0.0005","T","0.971","T","1.0","B","0.009","B","0.002","D","0.000","N","0.680","L","0.955","T","0.76","N","0.92","0.252","T","-1.046","T","0.066","T","0.008","0.058","T","0.056","19.81","2.010","5.38","2.794","11.256"
"chr12","102158191","102158191","G>A","GNPTAB:79158","GNPTAB","exonic","nonsynonymous SNV","","GNPTAB:NM_024312:exon13:c.C2504T:p.P835L","GNPTAB","exonic","nonsynonymous SNV","","GNPTAB:ENST00000299314.12_1:exon13:c.C2504T:p.P835L","GNPTAB:ENST00000299314.7:c.2504C>T:p.(Pro835Leu)","0","0.2638110464169185","0.0","2.6299260435078936e-05","","","","","","","","","","","","","ENSG00000111670","GNPTAB","HGNC:29670","GNPTAB","79158","ENSG00000111670","uc001tit.4","0.00040803198375784997","0.527622092833837","","OMIM:252500 Mucolipidosis II alpha/beta-autosomal_recessive;OMIM:252600 Mucolipidosis III alpha/beta-autosomal_recessive;ORPHA:576 Mucolipidosis type II-autosomal_recessive","2442","0/1","Het","280","174,106","0.621428571428571","Likely_benign","False","Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy","MONDO:MONDO:0009650,MedGen:C2673377,OMIM:252500,Orphanet:ORPHA576|MONDO:MONDO:0018931,MedGen:C0033788,OMIM:252600,Orphanet:ORPHA423461,SNOMED_CT:65764006","NC_000012.11:g.102158191G>A","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Mucolipidosis ii alpha/beta(252500)|Mucolipidosis iii alpha/beta(252600)","Short ribs(HP:0000773)|Specific learning disability(HP:0001328)|Deficiency of N-acetylglucosamine-1-phosphotransferase(HP:0003264)|Constrictive median neuropathy(HP:0012185)|Coarse facial features(HP:0000280)|Increased serum beta-hexosaminidase(HP:0003333)|Irregular carpal bones(HP:0004236)|Split hand(HP:0001171)|Scoliosis(HP:0002650)|Aortic regurgitation(HP:0001659)|Increased serum iduronate sulfatase level(HP:0003538)|Intellectual disability(HP:0001249)|Craniosynostosis(HP:0001363)|Carpal bone hypoplasia(HP:0001498)|Short long bone(HP:0003026)|Thickened skin(HP:0001072)|Soft tissue swelling of interphalangeal joints(HP:0006162)|Broad ribs(HP:0000885)|Short stature(HP:0004322)|Retinal degeneration(HP:0000546)|Mandibular prognathia(HP:0000303)|Dysostosis multiplex(HP:0000943)|Shallow acetabular fossae(HP:0003182)|Hyperopic astigmatism(HP:0000484)|Autosomal recessive inheritance(HP:0000007)|Opacification of the corneal stroma(HP:0007759)|Retinopathy(HP:0000488)|J-shaped sella turcica(HP:0002680)|Hypoplasia of the odontoid process(HP:0003311)|Mucopolysacchariduria(HP:0008155)|Carpal bone hypoplasia(HP:0001498)|Hip dislocation(HP:0002827)|Anteverted nares(HP:0000463)|Death in childhood(HP:0003819)|Depressed nasal bridge(HP:0005280)|Macroglossia(HP:0000158)|Talipes equinovarus(HP:0001762)|Megalocornea(HP:0000485)|Thoracolumbar kyphoscoliosis(HP:0003423)|Wide intermamillary distance(HP:0006610)|Coarse facial features(HP:0000280)|Progressive alveolar ridge hypertropy(HP:0009092)|Osteopenia(HP:0000938)|Hoarse voice(HP:0001609)|Narrow forehead(HP:0000341)|Thickened calvaria(HP:0002684)|Short long bone(HP:0003026)|Beaking of vertebral bodies T12-L3(HP:0004562)|Recurrent pneumonia(HP:0006532)|Global developmental delay(HP:0001263)|Severe global developmental delay(HP:0011344)|Cavernous hemangioma(HP:0001048)|Opacification of the corneal stroma(HP:0007759)|Epicanthus(HP:0000286)|Sparse and thin eyebrow(HP:0000535)|Umbilical hernia(HP:0001537)|Recurrent bronchitis(HP:0002837)|Pathologic fracture(HP:0002756)|Flared iliac wing(HP:0002869)|Split hand(HP:0001171)|Increased serum iduronate sulfatase level(HP:0003538)|Diastasis recti(HP:0001540)|Large sella turcica(HP:0002690)|Hypoplastic scapulae(HP:0000882)|Ovoid vertebral bodies(HP:0003300)|Metaphyseal widening(HP:0003016)|Lower thoracic interpediculate narrowness(HP:0008470)|Failure to thrive(HP:0001508)|Severe postnatal growth retardation(HP:0008850)|High forehead(HP:0000348)|Deficiency of N-acetylglucosamine-1-phosphotransferase(HP:0003264)|Protuberant abdomen(HP:0001538)|Hepatomegaly(HP:0002240)|Flat acetabular roof(HP:0003180)|Autosomal recessive inheritance(HP:0000007)|Splenomegaly(HP:0001744)|Cardiomegaly(HP:0001640)|Myelopathy(HP:0002196)|Palpebral edema(HP:0100540)|Long philtrum(HP:0000343)|Increased serum beta-hexosaminidase(HP:0003333)|Atlantoaxial dislocation(HP:0003414)|Hypertrophic cardiomyopathy(HP:0001639)|Abnormal rib cage morphology(HP:0001547)|Neonatal hypotonia(HP:0001319)|Varus deformity of humeral neck(HP:0006362)|Heart murmur(HP:0030148)|Recurrent otitis media(HP:0000403)|Bullet-shaped phalanges of the hand(HP:0009769)|Aortic regurgitation(HP:0001659)|Congestive heart failure(HP:0001635)|Inguinal hernia(HP:0000023)|Abnormal aortic valve morphology(HP:0001646)|Thickened skin(HP:0001072)|Shallow orbits(HP:0000586)|Aortic regurgitation(HP:0001659)|Weight loss(HP:0001824)|Depressed nasal bridge(HP:0005280)|Abnormal mitral valve morphology(HP:0001633)|Cardiomyopathy(HP:0001638)|Gastrostomy tube feeding in infancy(HP:0011471)|Respiratory failure requiring assisted ventilation(HP:0004887)|Gingival overgrowth(HP:0000212)|Sensorineural hearing impairment(HP:0000407)|Recurrent respiratory infections(HP:0002205)|Poor speech(HP:0002465)|Limited shoulder movement(HP:0006467)|Motor delay(HP:0001270)|Restricted chest movement(HP:0006596)|Inguinal hernia(HP:0000023)|Hoarse voice(HP:0001609)|Cognitive impairment(HP:0100543)|Craniosynostosis(HP:0001363)|Talipes equinovarus(HP:0001762)|Pulmonary insufficiency(HP:0010444)|Obstructive sleep apnea(HP:0002870)|Epicanthus(HP:0000286)|Restrictive ventilatory defect(HP:0002091)|Patent foramen ovale(HP:0001655)|Expressive language delay(HP:0002474)|Postnatal growth retardation(HP:0008897)|Narrow chest(HP:0000774)|Telangiectases of the cheeks(HP:0007421)|Knee flexion contracture(HP:0006380)|Oligohydramnios(HP:0001562)|Conductive hearing impairment(HP:0000405)|Abnormality of long bone morphology(HP:0011314)|Protuberant abdomen(HP:0001538)|Dry hair(HP:0011359)|Hepatosplenomegaly(HP:0001433)|Hip contracture(HP:0003273)|Flat face(HP:0012368)|Hip dislocation(HP:0002827)|Prominent metopic ridge(HP:0005487)|White hair(HP:0011364)|Abnormality of the thoracic cavity(HP:0045027)|Limited wrist movement(HP:0006248)|Splenomegaly(HP:0001744)|Stridor(HP:0010307)|Short stature(HP:0004322)|Otitis media(HP:0000388)|Decreased movement range in interphalangeal joints(HP:0006203)|Fine hair(HP:0002213)|Kyphosis(HP:0002808)|Appendicular hypotonia(HP:0012389)|Left ventricular hypertrophy(HP:0001712)|Inability to walk(HP:0002540)|Mitral regurgitation(HP:0001653)|Muscular hypotonia of the trunk(HP:0008936)|Coarse facial features(HP:0000280)|Umbilical hernia(HP:0001537)|Diastasis recti(HP:0001540)","This gene encodes two of three subunit types of the membrane-bound enzyme N-acetylglucosamine-1-phosphotransferase, a heterohexameric complex composed of two alpha, two beta, and two gamma subunits. The encoded protein is proteolytically cleaved at the Lys928-Asp929 bond to yield mature alpha and beta polypeptides while the gamma subunits are the product of a distinct gene (GeneID 84572). In the Golgi apparatus, the heterohexameric complex catalyzes the first step in the synthesis of mannose 6-phosphate recognition markers on certain oligosaccharides of newly synthesized lysosomal enzymes. These recognition markers are essential for appropriate trafficking of lysosomal enzymes. Mutations in this gene have been associated with both mucolipidosis II and mucolipidosis IIIA.[provided by RefSeq, May 2010]","N-acetylglucosamine-1-phosphate transferase subunits alpha and beta","lysosome organization(GO:0007040)|N-glycan processing to lysosome(GO:0016256)|N-glycan processing to lysosome(GO:0016256)|secretion of lysosomal enzymes(GO:0033299)|carbohydrate phosphorylation(GO:0046835)|carbohydrate phosphorylation(GO:0046835)","Golgi membrane(GO:0000139)|Golgi apparatus(GO:0005794)|Golgi apparatus(GO:0005794)|integral component of membrane(GO:0016021)","UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976)|UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976)|UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)","glycoproteinosis(DOID:3343)|disease(DOID:4)","Lysosome","","","","","","","","","0.00005186","0.0002","0.001","0.","0.0006","","","5.186e-05","0.0007","T","1.0","T","0.365","B","0.0","B","0.0","N","0.383","N","1","N","-1.23","D","-3.79","N","-0.12","0.096","T","-0.291","T","0.396","T","0.019","0.214","T","0.008","0.075","-0.523","5.48","-0.201","6.267"
"chr19","40433068","40433068","C>A","","FCGBP","exonic","nonsynonymous SNV","","FCGBP:NM_003890:exon2:c.G1201T:p.A401S","FCGBP","exonic","unknown","","UNKNOWN","FCGBP:ENST00000221347.6:c.1201G>T:p.(Ala401Ser)","0.59482986","0.0","0.5948298573493958","0.0003993289612429525","","","","","","","","","","","","","ENSG00000090920","FCGBP","HGNC:13572","FCGBP","8857","ENSG00000275395","uc060ynu.1","0.00039932896124295254","","0.5948298573493958","","2448","0/1","Het","145","83,62","0.572413793103448","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","Fc gamma binding protein","","extracellular space(GO:0005615)|extracellular matrix(GO:0031012)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)","","","","","","","","IgGFc-binding","","","0.00001386","","","0.","0.0002","","","1.386e-05","0.0002","","","","","","","","","N","0.746","N","1","","","","","","","","T","-0.973","T","0.027","T","0.003","0.060","T","0.021","1.431","-0.097","4.36","-0.402","10.098"
"chr1","16902844","16902844","G>T","","NBPF1","exonic","unknown","","UNKNOWN","NBPF1","exonic","nonsynonymous SNV","","NBPF1:ENST00000430580.6_1:exon19:c.C2037A:p.D679E,NBPF1:ENST00000432949.5_1:exon19:c.C2037A:p.D679E","NBPF1:ENST00000287968.8:c.132C>A:p.(Asp44Glu)","0.5932018","0.0","0.5932018160820007","0.0003934050906551429","0.0","0.5926679372787476","0.0003914816834201596","","","","","","","","","","ENSG00000219481","NBPF1","HGNC:26088","NBPF1","55672","ENSG00000219481","uc001ayw.5","0.00039340509065514284","","0.5932018160820007","","2449","0/1","Het","654","564,90","0.862385321100917","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. [provided by RefSeq, Apr 2013]","NBPF member 1","","cytoplasm(GO:0005737)","protein binding(GO:0005515)","","","","","","","SpliceAI>T|NBPF1|0.00|0.00|0.00|0.00|-4|26|1|26",".;.","","","0.00006192","","","0.012","0.018","","","0.0004","6.192e-05","","","T","0.964","","","","","","","","","","","","","","","0.168","","","","","","","","","","10.23","0.590","0.672","0.442","3.058"
"chr1","16918468","16918468","T>A","","NBPF1","exonic","unknown","","UNKNOWN","NBPF1","exonic","nonsynonymous SNV","","NBPF1:ENST00000430580.6_1:exon7:c.A49T:p.I17F,NBPF1:ENST00000432949.5_1:exon7:c.A49T:p.I17F","NBPF1:ENST00000430580.2:c.49A>T:p.(Ile17Phe)","0.59213406","","","","0.0","0.5926679372787476","0.0003914816834201596","","","","","","","","","","ENSG00000219481","NBPF1","HGNC:26088","NBPF1","55672","ENSG00000219481","uc001ayw.5","0.00039340509065514284","","0.5932018160820007","","2450","0/1","Het","411","343,68","0.834549878345499","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. [provided by RefSeq, Apr 2013]","NBPF member 1","","cytoplasm(GO:0005737)","protein binding(GO:0005515)","","","","","","","",".;.","","","0.00001999","","","0.0001","","","","1.999e-05","0.0003","","","T","0.264","","","","","","","","","","","","","","","0.173","","","","","T","0.001","","","","9.712","0.533","0.566","-0.695",""
"chrX","110987953","110987953","->ACC","ALG13:79868","ALG13","exonic","nonframeshift insertion","","ALG13:NM_001099922:exon24:c.2753_2754insACC:p.P945_A946insP,ALG13:NM_001257231:exon24:c.2519_2520insACC:p.P867_A868insP","ALG13","exonic","nonframeshift insertion","","ALG13:ENST00000394780.8_1:exon24:c.2753_2754insACC:p.P945_A946insP,ALG13:ENST00000610588.4_1:exon24:c.2519_2520insACC:p.P867_A868insP","ALG13:ENST00000394780.3:c.2796_2798dup:p.(Pro945dup)","0.1498399","","","","","","","","","","0.3911647507719955","0.1498398929834365","0.0003911364070068866","","","","ENSG00000101901","ALG13","HGNC:30881","ALG13","79868","ENSG00000101901","uc011msy.3","0.0003911364070068866","0.39116475077199553","0.14983989298343658","OMIM:300884 ?Congenital disorder of glycosylation, type Is-x_dominant;OMIM:300884 Developmental and epileptic encephalopathy 36-x_dominant;ORPHA:324422 ALG13-CDG-x_dominant;ORPHA:777 X-linked non-syndromic intellectual disability-x_recessive","2458","0/1","Het","29","14,15","0.482758620689655","Conflicting_interpretations_of_pathogenicity","True","Developmental_and_epileptic_encephalopathy,_36|not_provided","MONDO:MONDO:0010472,MedGen:C3550904,OMIM:300884,Orphanet:ORPHA324422|MedGen:CN517202","NC_000023.10:g.110987954ACC[16]","criteria_provided,_conflicting_interpretations","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Developmental and epileptic encephalopathy 36(300884)","Hepatomegaly(HP:0002240)|X-linked recessive inheritance(HP:0001419)|Cerebral atrophy(HP:0002059)|Infantile onset(HP:0003593)|Intellectual disability, severe(HP:0010864)|Hydrocephalus(HP:0000238)|Optic atrophy(HP:0000648)|Abnormality of extrapyramidal motor function(HP:0002071)|Recurrent infections(HP:0002719)|Anteverted nares(HP:0000463)|Abnormal facial shape(HP:0001999)|X-linked dominant inheritance(HP:0001423)|Type I transferrin isoform profile(HP:0003642)|Flexion contracture(HP:0001371)|Delayed myelination(HP:0012448)|Seizure(HP:0001250)|Microcephaly(HP:0000252)|Hypsarrhythmia(HP:0002521)|Low-set ears(HP:0000369)|Global developmental delay(HP:0001263)|Poor eye contact(HP:0000817)|Hypertelorism(HP:0000316)|Horizontal nystagmus(HP:0000666)|Generalized hypotonia(HP:0001290)|Abnormal pyramidal sign(HP:0007256)|Long philtrum(HP:0000343)|Hypertelorism(HP:0000316)|Global brain atrophy(HP:0002283)|Cognitive impairment(HP:0100543)|Poor head control(HP:0002421)|Anteverted nares(HP:0000463)|Infantile spasms(HP:0012469)|Short chin(HP:0000331)|Clumsiness(HP:0002312)|Autism(HP:0000717)|Decreased body weight(HP:0004325)|Delayed speech and language development(HP:0000750)|Abnormal lateral ventricle morphology(HP:0030047)|Adducted thumb(HP:0001181)|Poor eye contact(HP:0000817)|Hypsarrhythmia(HP:0002521)|Nystagmus(HP:0000639)|Generalized hypotonia(HP:0001290)|Thick lower lip vermilion(HP:0000179)|Pyloric stenosis(HP:0002021)|Drooling(HP:0002307)|Midface retrusion(HP:0011800)|Meckel diverticulum(HP:0002245)|Babinski sign(HP:0003487)|Moderate sensorineural hearing impairment(HP:0008504)|Mild neurosensory hearing impairment(HP:0008587)|Urinary incontinence(HP:0000020)|Global developmental delay(HP:0001263)|Generalized non-motor (absence) seizure(HP:0002121)|Clinodactyly of the 2nd toe(HP:0005824)|Intellectual disability, moderate(HP:0002342)|Delayed eruption of teeth(HP:0000684)|Autistic behavior(HP:0000729)|2-3 toe syndactyly(HP:0004691)|Periorbital fullness(HP:0000629)|Delayed speech and language development(HP:0000750)|Bilateral tonic-clonic seizure(HP:0002069)|Poor speech(HP:0002465)|Attention deficit hyperactivity disorder(HP:0007018)|Depressed nasal bridge(HP:0005280)|Broad nasal tip(HP:0000455)|Pes planus(HP:0001763)|Macrocephaly(HP:0000256)|Obesity(HP:0001513)|Intellectual disability, profound(HP:0002187)|Shortening of all distal phalanges of the fingers(HP:0006118)|Widened subarachnoid space(HP:0012704)|Small for gestational age(HP:0001518)|Long palpebral fissure(HP:0000637)|Long philtrum(HP:0000343)|Thin upper lip vermilion(HP:0000219)|Intellectual disability, severe(HP:0010864)|Downslanted palpebral fissures(HP:0000494)|Facial palsy(HP:0010628)","The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]","ALG13 UDP-N-acetylglucosaminyltransferase subunit","proteolysis(GO:0006508)","endoplasmic reticulum membrane(GO:0005789)","RNA binding(GO:0003723)|N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577)|thiol-dependent deubiquitinase(GO:0004843)","","N glycan biosynthesis","Wp glycosylation and related congenital defects","Diseases associated with n glycosylation of proteins|Diseases of glycosylation|Biosynthesis of the n glycan precursor dolichol lipid linked oligosaccharide llo and transfer to a nascent protein|Asparagine n linked glycosylation|Diseases of metabolism|Post translational protein modification","","","","","","","0.0023","","","0.","0.","","","0.0015","0.0023","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr6","136913602","136913602","A>G","","MAP3K5","exonic","nonsynonymous SNV","","MAP3K5:NM_005923:exon22:c.T3029C:p.V1010A","MAP3K5","exonic","nonsynonymous SNV","","MAP3K5:ENST00000359015.5_1:exon22:c.T3029C:p.V1010A","MAP3K5:ENST00000355845.4:c.770T>C:p.(Val257Ala)","0.14395645","","","","","","","","","","","","","","","","ENSG00000197442","MAP3K5","HGNC:6857","MAP3K5","4217","ENSG00000197442","uc003qhc.4","0.00035066831769319564","0.5130411135032773","","","2580","0/1","Het","101","65,36","0.643564356435644","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 1 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Mitogen-activated protein kinase (MAPK) signaling cascades include MAPK or extracellular signal-regulated kinase (ERK), MAPK kinase (MKK or MEK), and MAPK kinase kinase (MAPKKK or MEKK). MAPKK kinase/MEKK phosphorylates and activates its downstream protein kinase, MAPK kinase/MEK, which in turn activates MAPK. The kinases of these signaling cascades are highly conserved, and homologs exist in yeast, Drosophila, and mammalian cells. MAPKKK5 contains 1,374 amino acids with all 11 kinase subdomains. Northern blot analysis shows that MAPKKK5 transcript is abundantly expressed in human heart and pancreas. The MAPKKK5 protein phosphorylates and activates MKK4 (aliases SERK1, MAPKK4) in vitro, and activates c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) during transient expression in COS and 293 cells; MAPKKK5 does not activate MAPK/ERK. [provided by RefSeq, Jul 2008]","mitogen-activated protein kinase kinase kinase 5","MAPK cascade(GO:0000165)|response to ischemia(GO:0002931)|protein phosphorylation(GO:0006468)|JNK cascade(GO:0007254)|intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631)|intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631)|positive regulation of cardiac muscle cell apoptotic process(GO:0010666)|cellular response to stress(GO:0033554)|cellular response to amino acid starvation(GO:0034198)|response to endoplasmic reticulum stress(GO:0034976)|wound healing(GO:0042060)|positive regulation of apoptotic process(GO:0043065)|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280)|positive regulation of JUN kinase activity(GO:0043507)|innate immune response(GO:0045087)|positive regulation of protein kinase activity(GO:0045860)|positive regulation of transcription, DNA-templated(GO:0045893)|positive regulation of JNK cascade(GO:0046330)|stress-activated MAPK cascade(GO:0051403)|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059)|cellular response to hydrogen peroxide(GO:0070301)|cellular response to tumor necrosis factor(GO:0071356)|endothelial cell apoptotic process(GO:0072577)|cellular senescence(GO:0090398)|apoptotic signaling pathway(GO:0097190)|positive regulation of p38MAPK cascade(GO:1900745)|positive regulation of neuron death(GO:1901216)|positive regulation of neuron death(GO:1901216)|positive regulation of vascular associated smooth muscle cell proliferation(GO:1904707)","cytoplasm(GO:0005737)|cytosol(GO:0005829)|external side of plasma membrane(GO:0009897)|protein-containing complex(GO:0032991)|protein kinase complex(GO:1902911)|IRE1-TRAF2-ASK1 complex(GO:1990604)","magnesium ion binding(GO:0000287)|protein kinase activity(GO:0004672)|protein kinase activity(GO:0004672)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|MAP kinase kinase kinase activity(GO:0004709)|MAP kinase kinase kinase activity(GO:0004709)|protein binding(GO:0005515)|ATP binding(GO:0005524)|protein phosphatase binding(GO:0019903)|protein domain specific binding(GO:0019904)|identical protein binding(GO:0042802)|protein homodimerization activity(GO:0042803)|protein serine kinase activity(GO:0106310)","Japanese encephalitis(DOID:10844)|cancer(DOID:162)|osteosarcoma(DOID:3347)|rheumatoid arthritis(DOID:7148)|retinoblastoma(DOID:768)|influenza(DOID:8469)|arthritis(DOID:848)|diabetes mellitus(DOID:9351)|encephalitis(DOID:9588)|obesity(DOID:9970)|leukemia(DOID:1240)|disease(DOID:4)|pancreatic cancer(DOID:1793)|Parkinson's disease(DOID:14330)","Mapk signaling pathway|Neurotrophin signaling pathway|Amyotrophic lateral sclerosis als","Wp angiopoietin like protein 8 regulatory pathway|Wp amyotrophic lateral sclerosis als|Wp photodynamic therapyinduced ap1 survival signaling|Wp corticotropinreleasing hormone signaling pathway|Wp insulin signaling|Wp atm signaling network in development and disease|Wp 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression|Wp mapk signaling pathway|Wp integrated cancer pathway|Wp p38 mapk signaling pathway|Wp tnf alpha signaling pathway|Wp apoptosis modulation and signaling|Wp vegfavegfr2 signaling pathway|Wp thermogenesis|Wp nonalcoholic fatty liver disease|Wp regucalcin in proximal tubule epithelial kidney cells","Oxidative stress induced senescence|Cellular senescence|Cellular responses to external stimuli","Hivnef pathway|Keratinocyte pathway|Mapk pathway|P38mapk pathway|41bb pathway","","SpliceAI>G|MAP3K5|0.00|0.00|0.01|0.00|26|-27|-49|2","","","","0.0049","0.0002","0.001","0.0004","0.0049","","","0.0004","0.0049","T","0.775","T","0.894","B","0.0","B","0.001","N","0.042","N","1.000","N","0.345","T","-0.31","N","-0.17","0.217","T","-0.959","T","0.052","T","0.007","0.040","T","0.008","11.12","0.696","5.97","0.619","9.964"
"chr20","34599150","34599150","G>T","","CNBD2","exonic","nonsynonymous SNV","","CNBD2:NM_001207076:exon10:c.G1240T:p.V414L,CNBD2:NM_080834:exon10:c.G1240T:p.V414L","CNBD2","exonic","nonsynonymous SNV","","CNBD2:ENST00000349339.5_1:exon10:c.G1240T:p.V414L,CNBD2:ENST00000373973.7_1:exon10:c.G1240T:p.V414L,CNBD2:ENST00000538900.1_1:exon10:c.G1240T:p.V414L","CNBD2:ENST00000349339.1:c.1240G>T:p.(Val414Leu)","0.9254574","","","","","","","","","","","","","","","","ENSG00000149646","CNBD2","HGNC:16145","CNBD2","140894","ENSG00000149646","uc002xer.1","0.0003159997872989119","0.5030229450203478","","","2615","0/1","Het","93","55,38","0.591397849462366","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","cyclic nucleotide binding domain containing 2","spermatogenesis(GO:0007283)","cytosol(GO:0005829)","cAMP binding(GO:0030552)","","","","","","","",".;.;.","","","0.00007651","0.0004","0.002","0.0001","0.0014","","","7.651e-05","0.0010","T","0.158","D","0.043","B","0.012","B","0.006","N","0.350","N","1.000","L","0.895","T","1.03","N","-0.94","0.132","T","-0.995","T","0.082","T","0.005","0.024","T","0.006","7.401","0.315","4.83","-0.259","5.538"
"chr1","102433146","102433146","->AAAAAAAAAAAAAAAAAA","","OLFM3","splicing","","NM_001288823:exon2:UTR5","","OLFM3","intronic","","","","OLFM3:ENST00000370103.4:c.69+29157_69+29158insTTTTTTTTTTTTTTTTTT:p.(=)","0.003","0.5000050917979024","0.003000000026077","0.00031479608163462056","","","","","","","","","","","","","ENSG00000118733","OLFM3","HGNC:17990","OLFM3","118427","ENSG00000118733","uc001dug.4","0.00031479608163462056","0.5000050917979024","0.003000000026077032","","2618","0/1","Het","12","5,7","0.416666666666667","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","olfactomedin 3","eye photoreceptor cell development(GO:0042462)","extracellular space(GO:0005615)|Golgi apparatus(GO:0005794)|AMPA glutamate receptor complex(GO:0032281)|synapse(GO:0045202)","protein binding(GO:0005515)","","","","","","","","","Name=MLT1J","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr17","7750555","7750555","G>T","","KDM6B","exonic","nonsynonymous SNV","","KDM6B:NM_001080424:exon10:c.G1042T:p.G348C","KDM6B","exonic","nonsynonymous SNV","","KDM6B:ENST00000254846.9_1:exon10:c.G1042T:p.G348C,KDM6B:ENST00000448097.7_1:exon11:c.G1042T:p.G348C","KDM6B:ENST00000254846.5:c.1042G>T:p.(Gly348Cys)","0.98205256","","","","","","","","","","","","","","","","ENSG00000132510","KDM6B","HGNC:29012","KDM6B","23135","ENSG00000132510","uc002giw.2","0.0003113582405625754","0.5015989206731319","","OMIM:618505 Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities-autosomal_dominant","2626","0/1","Het","84","45,39","0.535714285714286","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities(618505)","Hemangioma(HP:0001028)|Joint hypermobility(HP:0001382)|Wide nasal bridge(HP:0000431)|Pectus excavatum(HP:0000767)|Telecanthus(HP:0000506)|Dolichocephaly(HP:0000268)|Generalized hypotonia(HP:0001290)|Prominent forehead(HP:0011220)|Hypoplastic nipples(HP:0002557)|Cryptorchidism(HP:0000028)|Wide mouth(HP:0000154)|Abnormality of the dentition(HP:0000164)|Seizure(HP:0001250)|Cafe-au-lait spot(HP:0000957)|Mandibular prognathia(HP:0000303)|Macrotia(HP:0000400)|Depressed nasal bridge(HP:0005280)|Exotropia(HP:0000577)|Full cheeks(HP:0000293)|Autistic behavior(HP:0000729)|Speech apraxia(HP:0011098)|Autosomal dominant inheritance(HP:0000006)|Epicanthus(HP:0000286)|Round face(HP:0000311)|Hyperactivity(HP:0000752)|Global developmental delay(HP:0001263)|Clinodactyly of the 5th finger(HP:0004209)|Thick vermilion border(HP:0012471)|Esotropia(HP:0000565)","The protein encoded by this gene is a lysine-specific demethylase that specifically demethylates di- or tri-methylated lysine 27 of histone H3 (H3K27me2 or H3K27me3). H3K27 trimethylation is a repressive epigenetic mark controlling chromatin organization and gene silencing. This protein can also demethylate non-histone proteins such as retinoblastoma protein. Through its demethylation actvity this gene influences cellular differentiation and development, tumorigenesis, inflammatory diseases, and neurodegenerative diseases. This protein has two classical nuclear localization signals at its N-terminus. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Feb 2017]","lysine demethylase 6B","inflammatory response to antigenic stimulus(GO:0002437)|chromatin remodeling(GO:0006338)|heart development(GO:0007507)|regulation of gene expression(GO:0010468)|response to activity(GO:0014823)|hippocampus development(GO:0021766)|cell fate commitment(GO:0045165)|endothelial cell differentiation(GO:0045446)|positive regulation of transcription by RNA polymerase II(GO:0045944)|mesodermal cell differentiation(GO:0048333)|cardiac muscle cell differentiation(GO:0055007)|response to fungicide(GO:0060992)|cellular response to hydrogen peroxide(GO:0070301)|histone H3-K27 demethylation(GO:0071557)|histone H3-K27 demethylation(GO:0071557)|positive regulation of cold-induced thermogenesis(GO:0120162)","nucleus(GO:0005634)|nucleoplasm(GO:0005654)|MLL3/4 complex(GO:0044666)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|protein binding(GO:0005515)|beta-catenin binding(GO:0008013)|chromatin DNA binding(GO:0031490)|histone demethylase activity(GO:0032452)|metal ion binding(GO:0046872)|dioxygenase activity(GO:0051213)|histone H3-tri/di-methyl-lysine-27 demethylase activity(GO:0071558)|histone H3-tri/di-methyl-lysine-27 demethylase activity(GO:0071558)","cancer(DOID:162)","","Wp pathways affected in adenoid cystic carcinoma|Wp vitamin dsensitive calcium signaling in depression","Oxidative stress induced senescence|Cellular senescence|Hdms demethylate histones|Chromatin modifying enzymes|Cellular responses to external stimuli","","Tnfa signaling via nfkb","SpliceAI>T|KDM6B|0.00|0.00|0.00|0.00|32|50|9|0",".;.;.","","Score=786;Name=V$PAX5_01","0.0000633","","","0.","0.0006","","","6.33e-05","0.0008","D","0.0","D","0.002","D","1.0","D","0.975","N","0.078","D","0.982","L","0.895","T","2.83","N","-0.93","0.695","T","-0.996","T","0.038","T","0.018","0.147","T","0.274","27.0","3.918","4.71","7.638","14.968"
"chr9","140773612","140773612","->ACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT","","CACNA1B","splicing","","NM_000718:exon2:c.390+1->ACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT;NM_001243812:exon2:c.390+1->ACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT","","CACNA1B","splicing","","ENST00000371372.6_1:exon2:c.390+1->ACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT;ENST00000277549.9_1:exon2:c.390+1->ACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT;ENST00000277551.6_1:exon2:c.390+1->ACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT;ENST00000371363.5_1:exon2:c.390+1->ACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT;ENST00000371355.8_1:exon2:c.390+1->ACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT;ENST00000371357.5_1:exon2:c.390+1->ACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT","","CACNA1B:ENST00000277549.5:c.-2035+1_-2035+2insACGACACGGAGCCCTATTTCATCGGGATCTTTTGCTTCGAGGCAGGGATCAAAATCATCGCTCTGGGCTT:p.(=)","0.87975574","","","","","","","","","","","","","","","","ENSG00000148408","CACNA1B","HGNC:1389","CACNA1B","774","ENSG00000148408","uc064xnz.1","0.00030648134011543717","0.5000796423628344","","OMIM:618497 Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements-autosomal_recessive;ORPHA:442835 Non-specific early-onset epileptic encephalopathy-autosomal_dominant_and_recessive","2646","0/1","Het","214","154,60","0.719626168224299","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements(618497)","Choreoathetosis(HP:0001266)|Cerebral visual impairment(HP:0100704)|Global developmental delay(HP:0001263)|Dystonia(HP:0001332)|Seizure(HP:0001250)|Epileptic encephalopathy(HP:0200134)|Secondary microcephaly(HP:0005484)|Hyperkinetic movements(HP:0002487)|Hypotonia(HP:0001252)|Recurrent respiratory infections(HP:0002205)|Cerebral atrophy(HP:0002059)|Strabismus(HP:0000486)|Autosomal recessive inheritance(HP:0000007)|Absent speech(HP:0001344)|Myoclonus(HP:0001336)|Nystagmus(HP:0000639)|Inability to walk(HP:0002540)|Developmental regression(HP:0002376)|Rigidity(HP:0002063)|Ptosis(HP:0000508)|Mental deterioration(HP:0001268)|Myoclonus(HP:0001336)|Generalized hypotonia(HP:0001290)|Tremor(HP:0001337)|Encephalopathy(HP:0001298)|Optic atrophy(HP:0000648)|Global developmental delay(HP:0001263)|Hypsarrhythmia(HP:0002521)|Hyporeflexia(HP:0001265)|Gastroesophageal reflux(HP:0002020)|Microcephaly(HP:0000252)|Impulsivity(HP:0100710)|Intellectual disability(HP:0001249)|Poor head control(HP:0002421)|Abnormal corpus callosum morphology(HP:0001273)|Feeding difficulties(HP:0011968)|Status epilepticus(HP:0002133)|Downslanted palpebral fissures(HP:0000494)|Attention deficit hyperactivity disorder(HP:0007018)|Limb hypertonia(HP:0002509)|Developmental regression(HP:0002376)|Dyskinesia(HP:0100660)|Abnormal myelination(HP:0012447)|Short stature(HP:0004322)|Abnormality of vision(HP:0000504)|Failure to thrive(HP:0001508)|Retinal degeneration(HP:0000546)|Unsteady gait(HP:0002317)|Ataxia(HP:0001251)|Spasticity(HP:0001257)|Autism(HP:0000717)|Cerebral atrophy(HP:0002059)|High forehead(HP:0000348)|Delayed speech and language development(HP:0000750)|Nystagmus(HP:0000639)|Decreased fetal movement(HP:0001558)|EEG with multifocal slow activity(HP:0010844)|Hypodontia(HP:0000668)|Difficulty walking(HP:0002355)","The protein encoded by this gene is the pore-forming subunit of an N-type voltage-dependent calcium channel, which controls neurotransmitter release from neurons. The encoded protein forms a complex with alpha-2, beta, and delta subunits to form the high-voltage activated channel. This channel is sensitive to omega-conotoxin-GVIA and omega-agatoxin-IIIA but insensitive to dihydropyridines. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]","calcium voltage-gated channel subunit alpha1 B","calcium ion transport(GO:0006816)|chemical synaptic transmission(GO:0007268)|regulation of ion transmembrane transport(GO:0034765)|modulation of chemical synaptic transmission(GO:0050804)|calcium ion import(GO:0070509)|calcium ion transmembrane transport(GO:0070588)|response to amyloid-beta(GO:1904645)","plasma membrane(GO:0005886)|voltage-gated calcium channel complex(GO:0005891)|synapse(GO:0045202)","amyloid-beta binding(GO:0001540)|voltage-gated calcium channel activity(GO:0005245)|calcium ion binding(GO:0005509)|protein binding(GO:0005515)|ATP binding(GO:0005524)|protein C-terminus binding(GO:0008022)|high voltage-gated calcium channel activity(GO:0008331)","cerebral infarction(DOID:3526)","Taste transduction|Mapk signaling pathway|Calcium signaling pathway|Type ii diabetes mellitus","Wp calcium regulation in the cardiac cell|Wp synaptic vesicle pathway|Wp mapk signaling pathway","Presynaptic depolarization and calcium channel opening|Transmission across chemical synapses|Neuronal system","","Peroxisome","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr1","197072871","197072871","C>T","ASPM:259266","ASPM","exonic","nonsynonymous SNV","","ASPM:NM_018136:exon18:c.G5510A:p.G1837D","ASPM","exonic","nonsynonymous SNV","","ASPM:ENST00000367409.9_1:exon18:c.G5510A:p.G1837D,ASPM:ENST00000680265.1_1:exon18:c.G5510A:p.G1837D,ASPM:ENST00000680710.1_1:exon18:c.G5510A:p.G1837D","ASPM:ENST00000367409.4:c.5510G>A:p.(Gly1837Asp)","0.85723114","","","","","","","","","","","","","","","","ENSG00000066279","ASPM","HGNC:19048","ASPM","259266","ENSG00000066279","uc001gtu.4","0.0003064116620817139","0.5000577612045163","","OMIM:608716 Microcephaly 5, primary, autosomal recessive-autosomal_recessive;ORPHA:2512 Autosomal recessive primary microcephaly-autosomal_recessive","2652","0/1","Het","56","29,27","0.517857142857143","Conflicting_interpretations_of_pathogenicity","True","Microcephaly_5,_primary,_autosomal_recessive|not_provided","MONDO:MONDO:0012106,MedGen:C1837501,OMIM:608716|MedGen:CN517202","NC_000001.10:g.197072871C>T","criteria_provided,_conflicting_interpretations","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 1 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Microcephaly 5, primary, autosomal recessive(608716)","Proptosis(HP:0000520)|Simplified gyral pattern(HP:0009879)|Autosomal recessive inheritance(HP:0000007)|Ventriculomegaly(HP:0002119)|Small cerebral cortex(HP:0002472)|Narrow forehead(HP:0000341)|Cortical dysplasia(HP:0002539)|Intellectual disability(HP:0001249)|Sloping forehead(HP:0000340)|Motor delay(HP:0001270)|Delayed speech and language development(HP:0000750)|Seizure(HP:0001250)|Hypoplasia of the corpus callosum(HP:0002079)|Congenital onset(HP:0003577)|Short stature(HP:0004322)|Attention deficit hyperactivity disorder(HP:0007018)|Agenesis of corpus callosum(HP:0001274)|Cerebellar hypoplasia(HP:0001321)|Microcephaly(HP:0000252)|Hearing impairment(HP:0000365)|Highly arched eyebrow(HP:0002553)|Unilateral renal agenesis(HP:0000122)|Thin upper lip vermilion(HP:0000219)|Abnormal cortical bone morphology(HP:0003103)|Short stature(HP:0004322)|Upslanted palpebral fissure(HP:0000582)|Ventriculomegaly(HP:0002119)|Global developmental delay(HP:0001263)|Agenesis of corpus callosum(HP:0001274)|Hyperreflexia(HP:0001347)|Hypoplasia of the frontal lobes(HP:0007333)|Vesicoureteral reflux(HP:0000076)|Gray matter heterotopia(HP:0002282)|Microcephaly(HP:0000252)|Sloping forehead(HP:0000340)|Intellectual disability, severe(HP:0010864)|Pachygyria(HP:0001302)","This gene is the human ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is essential for normal mitotic spindle function in embryonic neuroblasts. Studies in mouse also suggest a role of this gene in mitotic spindle regulation, with a preferential role in regulating neurogenesis. Mutations in this gene are associated with microcephaly primary type 5. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011]","assembly factor for spindle microtubules","neuron migration(GO:0001764)|positive regulation of neuroblast proliferation(GO:0002052)|spindle organization(GO:0007051)|spermatogenesis(GO:0007283)|male gonad development(GO:0008584)|forebrain neuroblast division(GO:0021873)|cerebral cortex development(GO:0021987)|negative regulation of neuron differentiation(GO:0045665)|negative regulation of asymmetric cell division(GO:0045769)|oogenesis(GO:0048477)|developmental growth(GO:0048589)|regulation of meiotic cell cycle(GO:0051445)|spindle localization(GO:0051653)|maintenance of centrosome location(GO:0051661)|positive regulation of canonical Wnt signaling pathway(GO:0090263)|meiotic spindle assembly(GO:0090306)|neuronal stem cell population maintenance(GO:0097150)","nucleus(GO:0005634)|cytoplasm(GO:0005737)|centrosome(GO:0005813)|apical plasma membrane(GO:0016324)|midbody(GO:0030496)|microtubule minus-end(GO:0036449)|meiotic spindle(GO:0072687)|mitotic spindle pole(GO:0097431)","calmodulin binding(GO:0005516)","microcephaly(DOID:10907)|Angelman syndrome(DOID:1932)|syndrome(DOID:225)|hereditary breast ovarian cancer syndrome(DOID:5683)|hepatocellular carcinoma(DOID:684)","","","","","","SpliceAI>T|ASPM|0.00|0.00|0.00|0.00|-50|0|-13|-12","IQ","","","0.0072","0.001","0.005","0.0005","0.0072","","","0.0005","0.0066","D","0.022","D","0.019","D","0.997","D","0.991","N","0.001","D","1","H","3.915","T","-0.86","D","-3.95","0.713","D","0.452","D","0.603","D","0.068","0.600","T","0.210","25.1","3.541","5.58","1.582","14.091"
"chr16","3024565","3024565","G>A","","PKMYT1","exonic","nonsynonymous SNV","","PKMYT1:NM_001258450:exon5:c.C758T:p.P253L,PKMYT1:NM_001258451:exon5:c.C938T:p.P313L,PKMYT1:NM_004203:exon5:c.C965T:p.P322L,PKMYT1:NM_182687:exon5:c.C965T:p.P322L","PKMYT1","exonic","nonsynonymous SNV","","PKMYT1:ENST00000262300.13_1:exon5:c.C965T:p.P322L,PKMYT1:ENST00000431515.6_1:exon5:c.C965T:p.P322L,PKMYT1:ENST00000440027.6_1:exon5:c.C965T:p.P322L,PKMYT1:ENST00000573944.5_1:exon5:c.C938T:p.P313L,PKMYT1:ENST00000574385.5_1:exon5:c.C938T:p.P313L,PKMYT1:ENST00000574730.5_1:exon5:c.C758T:p.P253L","PKMYT1:ENST00000262300.8:c.965C>T:p.(Pro322Leu)","0.9550972","","","","","","","","","","","","","","","","ENSG00000127564","PKMYT1","HGNC:29650","PKMYT1","9088","ENSG00000127564","uc059psg.1","0.0003064036637496349","0.5000552491510462","","","2654","0/1","Het","85","40,45","0.470588235294118","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","This gene encodes a member of the serine/threonine protein kinase family. The encoded protein is a membrane-associated kinase that negatively regulates the G2/M transition of the cell cycle by phosphorylating and inactivating cyclin-dependent kinase 1. The activity of the encoded protein is regulated by polo-like kinase 1. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]","protein kinase, membrane associated tyrosine/threonine 1","regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079)|G2/M transition of mitotic cell cycle(GO:0000086)|mitotic cell cycle(GO:0000278)|protein phosphorylation(GO:0006468)|regulation of mitotic nuclear division(GO:0007088)|meiotic cell cycle(GO:0051321)","Golgi membrane(GO:0000139)|nucleus(GO:0005634)|nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)|nucleolus(GO:0005730)|endoplasmic reticulum(GO:0005783)|endoplasmic reticulum membrane(GO:0005789)|Golgi apparatus(GO:0005794)|cytosol(GO:0005829)|membrane(GO:0016020)","protein kinase activity(GO:0004672)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein serine/threonine kinase activity(GO:0004674)|protein binding(GO:0005515)|ATP binding(GO:0005524)|kinase activity(GO:0016301)|metal ion binding(GO:0046872)|protein serine kinase activity(GO:0106310)","","Cell cycle|Oocyte meiosis|Progesterone mediated oocyte maturation","Wp cell cycle","Polo like kinase mediated events|Cell cycle|Mitotic g2 g2 m phases|Cyclin a b1 b2 associated events during g2 m transition|Cell cycle mitotic|G2 m dna replication checkpoint|G2 m checkpoints|Cell cycle checkpoints","","","","Protein","","","0.00006092","0.0006","0.003","0.0002","","","","6.092e-05","0.0008","D","0.018","T","0.051","P","0.826","B","0.368","N","0.001","D","0.999","L","1.335","T","-0.2","D","-3.14","0.396","T","-0.701","T","0.176","D","0.029","0.105","T","0.226","23.6","3.026","5.24","2.152","11.388"
"chr2","198948882","198948882","G>T","","PLCL1","exonic","nonsynonymous SNV","","PLCL1:NM_006226:exon2:c.G641T:p.W214L","PLCL1","exonic","nonsynonymous SNV","","PLCL1:ENST00000437704.3_1:exon1:c.G410T:p.W137L,PLCL1:ENST00000428675.6_1:exon2:c.G641T:p.W214L","PLCL1:ENST00000428675.1:c.641G>T:p.(Trp214Leu)","0.933432","","","","","","","","","","","","","","","","ENSG00000115896","PLCL1","HGNC:9063","PLCL1","5334","ENSG00000115896","uc010fsp.4","0.00030633457632615955","0.5000335479853675","","","2659","0/1","Het","138","73,65","0.528985507246377","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","phospholipase C like 1 (inactive)","lipid metabolic process(GO:0006629)|gamma-aminobutyric acid signaling pathway(GO:0007214)|regulation of synaptic transmission, GABAergic(GO:0032228)|regulation of peptidyl-serine phosphorylation(GO:0033135)|intracellular signal transduction(GO:0035556)|phosphatidylinositol-mediated signaling(GO:0048015)|negative regulation of cold-induced thermogenesis(GO:0120163)|positive regulation of receptor binding(GO:1900122)","cytoplasm(GO:0005737)|plasma membrane(GO:0005886)","phosphatidylinositol phospholipase C activity(GO:0004435)|phospholipase C activity(GO:0004629)|GABA receptor binding(GO:0050811)|inositol 1,4,5 trisphosphate binding(GO:0070679)","disease(DOID:4)","","Wp gpr40 pathway","","","Uv response up","SpliceAI>T|PLCL1|0.00|0.00|0.00|0.00|32|0|32|-45","Pleckstrin","","Score=862;Name=V$TAL1ALPHAE47_01","0.005","0.001","0.005","0.0003","0.0031","","","0.0003","0.0038","D","0.0","D","0.0","D","1.0","D","1.0","D","0.000","D","1","H","3.54","D","-3.67","D","-11.89","0.918","D","0.908","D","0.916","D","0.493","0.902","T","0.393","30","4.271","5.67","9.989","20.142"
"chr3","45267443","45267443","G>C","","TMEM158","exonic","nonsynonymous SNV","","TMEM158:NM_015444:exon1:c.C77G:p.P26R","TMEM158","exonic","nonsynonymous SNV","","TMEM158:ENST00000503771.2_1:exon1:c.C77G:p.P26R","TMEM158:ENST00000503771.1:c.77C>G:p.(Pro26Arg)","0.8593397","","","","","","","","","","","","","","","","ENSG00000249992","TMEM158","HGNC:30293","TMEM158","25907","ENSG00000249992","uc011baf.3","0.0003062763244377958","0.5000152465854626","","","2672","0/1","Het","28","9,19","0.321428571428571","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","Constitutive activation of the Ras pathway triggers an irreversible proliferation arrest reminiscent of replicative senescence. Transcription of this gene is upregulated in response to activation of the Ras pathway, but not under other conditions that induce senescence. The encoded protein is similar to a rat cell surface receptor proposed to function in a neuronal survival pathway. An allelic polymorphism in this gene results in both functional and non-functional (frameshifted) alleles; the reference genome represents the functional allele. [provided by RefSeq, Jul 2015]","transmembrane protein 158","","integral component of membrane(GO:0016021)","peptide binding(GO:0042277)","cancer(DOID:162)","","","","","Kras signaling up","SpliceAI>C|TMEM158|0.00|0.00|0.00|0.00|0|-33|2|-13","","","Score=817;Name=V$HEN1_01","","","","","","","","","","D","0.01","T","0.266","B","0.161","B","0.042","","","N","0.955","N","0.55","","","N","-1.41","0.169","T","-1.037","T","0.041","D","0.046","0.018","T","0.121","11.96","0.801","1.99","1.975","5.983"
"chr12","11214001","11214001","C>G","","TAS2R46","exonic","nonsynonymous SNV","","TAS2R46:NM_176887:exon1:c.G893C:p.R298T","TAS2R46","exonic","nonsynonymous SNV","","TAS2R46:ENST00000533467.1_1:exon1:c.G893C:p.R298T","TAS2R46:ENST00000533467.1:c.893G>C:p.(Arg298Thr)","0.2990149","","","","","","","","","","","","","","","","ENSG00000226761","TAS2R46","HGNC:18877","TAS2R46","259292","ENSG00000226761","uc001qzp.1","0.00030626506806203627","0.5000117096906251","","","2673","0/1","Het","52","45,7","0.865384615384615","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","TAS2R46 belongs to the large TAS2R receptor family. TAS2Rs are expressed on the surface of taste receptor cells and mediate the perception of bitterness through a G protein-coupled second messenger pathway (Conte et al., 2002 [PubMed 12584440]). For further information on TAS2Rs, see MIM 604791.[supplied by OMIM, Sep 2009]","taste 2 receptor member 46","detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580)|detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580)|G protein-coupled receptor signaling pathway(GO:0007186)","plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)|integral component of membrane(GO:0016021)|ciliary membrane(GO:0060170)","G protein-coupled receptor activity(GO:0004930)|bitter taste receptor activity(GO:0033038)|bitter taste receptor activity(GO:0033038)","","Taste transduction","","Signaling by gpcr|G alpha i signalling events|Class c 3 metabotropic glutamate pheromone receptors|Gpcr ligand binding","","","SpliceAI>G|PRH1-PRR4|0.03|0.00|0.00|0.00|15|-1|-7|0>G|TAS2R46|0.11|0.06|0.00|0.13|15|-38|-7|0","","","","","","","","","","","","","T","0.114","T","0.109","P","0.482","P","0.461","","","N","1","M","2.27","T","1.16","D","-3.2","0.176","T","-0.958","T","0.075","T","0.003","0.049","T","0.369","12.14","0.824","2.54","-3.580","3.716"
"chr7","103029784","103029784","T>C","","SLC26A5","exonic","nonsynonymous SNV","","SLC26A5:NM_198999:exon13:c.A1399G:p.I467V,SLC26A5:NM_206883:exon13:c.A1399G:p.I467V,SLC26A5:NM_206884:exon13:c.A1399G:p.I467V","SLC26A5","exonic","nonsynonymous SNV","","SLC26A5:ENST00000393727.5_1:exon11:c.A1399G:p.I467V,SLC26A5:ENST00000393729.5_1:exon11:c.A1288G:p.I430V,SLC26A5:ENST00000306312.8_1:exon13:c.A1399G:p.I467V,SLC26A5:ENST00000339444.10_1:exon13:c.A1399G:p.I467V,SLC26A5:ENST00000354356.8_1:exon13:c.A1399G:p.I467V,SLC26A5:ENST00000393735.6_1:exon13:c.A1399G:p.I467V","SLC26A5:ENST00000306312.3:c.1399A>G:p.(Ile467Val)","0.97250545","","","","","","","","","","","","","","","","ENSG00000170615","SLC26A5","HGNC:9359","SLC26A5","375611","ENSG00000170615","uc003vbz.4","0.00030623614389534815","0.5000026207576411","","OMIM:613865 ?Deafness, autosomal recessive 61-autosomal_recessive","2675","0/1","Het","27","14,13","0.518518518518518","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Deafness, autosomal recessive 61(613865)","Sensorineural hearing impairment(HP:0000407)|Autosomal recessive inheritance(HP:0000007)","This gene encodes a member of the SLC26A/SulP transporter family. The protein functions as a molecular motor in motile outer hair cells (OHCs) of the cochlea, inducing changes in cell length that act to amplify sound levels. The transmembrane protein is an incomplete anion transporter, and does not allow anions to cross the cell membrane but instead undergoes a conformational change in response to changes in intracellular Cl- levels that results in a change in cell length. The protein functions at microsecond rates, which is several orders of magnitude faster than conventional molecular motor proteins. Mutations in this gene are potential candidates for causing neurosensory deafness. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]","solute carrier family 26 member 5","response to ischemia(GO:0002931)|sensory perception of sound(GO:0007605)|regulation of cell shape(GO:0008360)|response to xenobiotic stimulus(GO:0009410)|response to salicylic acid(GO:0009751)|response to auditory stimulus(GO:0010996)|bicarbonate transport(GO:0015701)|fructose transmembrane transport(GO:0015755)|oxalate transport(GO:0019532)|negative regulation of ion transmembrane transport(GO:0034766)|response to potassium ion(GO:0035864)|regulation of membrane potential(GO:0042391)|positive regulation of cell size(GO:0045793)|cochlea development(GO:0090102)|response to thyroid hormone(GO:0097066)|response to salt(GO:1902074)|sulfate transmembrane transport(GO:1902358)|chloride transmembrane transport(GO:1902476)|positive regulation of cell motility(GO:2000147)","cytoplasm(GO:0005737)|integral component of plasma membrane(GO:0005887)|basolateral plasma membrane(GO:0016323)|lateral plasma membrane(GO:0016328)|lateral wall of outer hair cell(GO:0120249)","secondary active sulfate transmembrane transporter activity(GO:0008271)|bicarbonate transmembrane transporter activity(GO:0015106)|chloride transmembrane transporter activity(GO:0015108)|sulfate transmembrane transporter activity(GO:0015116)|anion:anion antiporter activity(GO:0015301)|oxalate transmembrane transporter activity(GO:0019531)|spectrin binding(GO:0030507)|identical protein binding(GO:0042802)","","","","Sensory processing of sound|Sensory processing of sound by outer hair cells of the cochlea|Sensory perception","","","",".;.;SLC26A/SulP","","","0.00008748","","","0.0001","0.0015","","","8.748e-05","0.0012","T","0.511","T","0.921","B","0.177","B","0.142","D","0.000","D","0.993","N","0.545","D","-3.16","N","-0.1","0.283","T","-0.003","D","0.627","D","0.059","0.384","T","0.073","17.29","1.671","4.7","4.695","10.312"
"chr3","51990378","51990378","G>C","","GPR62","exonic","nonsynonymous SNV","","GPR62:NM_080865:exon1:c.G710C:p.G237A","GPR62","exonic","nonsynonymous SNV","","GPR62:ENST00000322241.6_1:exon1:c.G710C:p.G237A","GPR62:ENST00000322241.4:c.710G>C:p.(Gly237Ala)","0.8348935","","","","","","","","","","","","","","","","ENSG00000180929","GPR62","HGNC:13301","GPR62","118442","ENSG00000180929","uc003dca.4","0.00030623353823615806","0.5000018019309209","","","2676","0/1","Het","56","26,30","0.464285714285714","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","G protein-coupled receptor 62","G protein-coupled receptor signaling pathway(GO:0007186)|G protein-coupled receptor signaling pathway(GO:0007186)|positive regulation of cAMP-mediated signaling(GO:0043950)|inositol phosphate-mediated signaling(GO:0048016)","endosome(GO:0005768)|endosome(GO:0005768)|plasma membrane(GO:0005886)|plasma membrane(GO:0005886)|endosome membrane(GO:0010008)|integral component of membrane(GO:0016021)|receptor complex(GO:0043235)|receptor complex(GO:0043235)","G protein-coupled receptor activity(GO:0004930)|protein binding(GO:0005515)|identical protein binding(GO:0042802)|arrestin family protein binding(GO:1990763)","","","Wp gpcrs other","","","","SpliceAI>C|GPR62|0.00|0.00|0.00|0.00|-44|45|-2|-1","GPCR,","","Score=766;Name=V$YY1_02","0.00008029","","","0.0001","0.0007","","","8.029e-05","0.0009","T","0.089","D","0.0","B","0.31","B","0.123","U","0.004","N","0.841","L","1.18","T","-0.54","D","-2.57","0.156","T","-0.882","T","0.208","D","0.251","0.096","T","0.101","20.2","2.050","4.7","4.607","11.690"
"chr6","147105797","147105797","A>G","","ADGB","exonic","nonsynonymous SNV","","ADGB:NM_024694:exon31:c.A4079G:p.Y1360C","ADGB","exonic","nonsynonymous SNV","","ADGB:ENST00000397944.8_1:exon31:c.A4079G:p.Y1360C,ADGB:ENST00000681847.1_1:exon31:c.A4079G:p.Y1360C","ADGB:ENST00000367488.1:c.248A>G:p.(Tyr83Cys)","0.8691068","","","","","","","","","","","","","","","","ENSG00000118492","ADGB","HGNC:21212","ADGB","79747","ENSG00000118492","uc010khx.4","0.00030623138196932603","0.5000011243201925","","","2677","0/1","Het","73","48,25","0.657534246575342","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","androglobin","proteolysis(GO:0006508)","","calcium-dependent cysteine-type endopeptidase activity(GO:0004198)|oxygen binding(GO:0019825)|heme binding(GO:0020037)","","","","","","","SpliceAI>G|ADGB|0.00|0.02|0.02|0.00|12|-43|12|13",".;.;.","","","0.0064","0.0004","0.002","0.0002","0.0064","","","0.0003","0.0045","D","0.033","T","0.071","D","1.0","D","0.983","","","N","0.911","M","2.215","T","1.18","D","-5.43","0.555","T","-0.881","T","0.128","D","0.034","0.213","T","0.236","26.1","3.770","5.48","2.957","5.068"
"chr3","124739825","124739825","T>C","","HEG1","exonic","nonsynonymous SNV","","HEG1:NM_020733:exon4:c.A1063G:p.K355E","HEG1","exonic","nonsynonymous SNV","","HEG1:ENST00000311127.9_1:exon4:c.A1063G:p.K355E","HEG1:ENST00000311127.4:c.1063A>G:p.(Lys355Glu)","0","0.5000010252547327","0.0","0.0003062310667282962","","","","","","","","","","","","","ENSG00000173706","HEG1","HGNC:29227","HEG1","57493","ENSG00000173706","uc003ehs.4","0.0003062310667282962","0.5000010252547327","","","2678","0/1","Het","142","69,73","0.485915492957746","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","heart development protein with EGF like domains 1","vasculogenesis(GO:0001570)|in utero embryonic development(GO:0001701)|endothelial cell morphogenesis(GO:0001886)|lymph vessel development(GO:0001945)|lymph circulation(GO:0003017)|cardiac atrium morphogenesis(GO:0003209)|ventricular trabecula myocardium morphogenesis(GO:0003222)|ventricular septum development(GO:0003281)|cell-cell junction assembly(GO:0007043)|heart development(GO:0007507)|post-embryonic development(GO:0009791)|lung development(GO:0030324)|negative regulation of Rho protein signal transduction(GO:0035024)|multicellular organism growth(GO:0035264)|venous blood vessel morphogenesis(GO:0048845)|regulation of body fluid levels(GO:0050878)|cardiac muscle tissue growth(GO:0055017)|pericardium development(GO:0060039)|positive regulation of fibroblast growth factor production(GO:0090271)|protein localization to cell junction(GO:1902414)|negative regulation of membrane permeability(GO:1905709)|negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299)","extracellular region(GO:0005576)|cell-cell junction(GO:0005911)|external side of plasma membrane(GO:0009897)|integral component of membrane(GO:0016021)","calcium ion binding(GO:0005509)|protein binding(GO:0005515)","","","","","","","","","","","0.00004014","","","0.","0.0001","","","4.014e-05","0.0005","T","1.0","T","0.927","B","0.0","B","0.0","","","N","1","N","-0.2","T","0.75","N","0.61","0.078","T","-0.990","T","0.034","T","0.003","0.047","T","0.009","3.824","0.074","5.02","0.239","4.394"
"chr15","56959031","56959031","T>C","","ZNF280D","exonic","nonsynonymous SNV","","ZNF280D:NM_001002843:exon14:c.A1660G:p.T554A,ZNF280D:NM_001288588:exon15:c.A1699G:p.T567A,ZNF280D:NM_017661:exon15:c.A1699G:p.T567A","RP11-566D24.2;ZNF280D","exonic","nonsynonymous SNV","","ZNF280D:ENST00000559237.5_1:exon14:c.A1660G:p.T554A,ZNF280D:ENST00000267807.12_1:exon15:c.A1699G:p.T567A,RP11-566D24.2:ENST00000559000.6_1:exon20:c.A1660G:p.T554A","ZNF280D:ENST00000267807.7:c.1699A>G:p.(Thr567Ala)","0.3680659","","","","","","","","","","","","","","","","ENSG00000137871","ZNF280D","HGNC:25953","ZNF280D","54816","ENSG00000137871","uc002adu.5","0.00030623072081655103","0.500000916550789","","","2679","0/1","Het","101","51,50","0.504950495049505","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","zinc finger protein 280D","regulation of transcription, DNA-templated(GO:0006355)|regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|metal ion binding(GO:0046872)","","","","","","","",".;.;.","","","0.00002393","","","0.","0.0003","0.0001","0.0001","2.393e-05","0.0001","T","0.626","T","0.655","B","0.001","B","0.008","N","0.382","N","1","L","1.21","T","4.0","N","-0.02","0.028","T","-0.939","T","0.008","T","0.005","0.031","T","0.018","8.592","0.418","4.58","-0.182","1.657"
"chr22","23917253","23917253","C>T","IGLL1:3543","IGLL1","exonic","nonsynonymous SNV","","IGLL1:NM_020070:exon2:c.G223A:p.G75S","IGLL1","exonic","nonsynonymous SNV","","IGLL1:ENST00000330377.3_1:exon2:c.G223A:p.G75S","IGLL1:ENST00000330377.2:c.223G>A:p.(Gly75Ser)","0.8936711","","","","","","","","","","","","","","","","ENSG00000128322","IGLL1","HGNC:5870","IGLL1","3543","ENSG00000128322","uc002zxd.4","0.0003062301256873358","0.5000007295291198","","OMIM:613500 Agammaglobulinemia 2-autosomal_recessive;ORPHA:33110 Autosomal agammaglobulinemia-autosomal_recessive","2680","0/1","Het","172","102,70","0.593023255813954","Likely_benign","False","Agammaglobulinemia_2,_autosomal_recessive","MONDO:MONDO:0013287,MedGen:C3150750,OMIM:613500","NC_000022.10:g.23917253C>T","criteria_provided,_single_submitter","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Agammaglobulinemia 2, autosomal recessive(613500)","Diarrhea(HP:0002014)|External ear malformation(HP:0008572)|Chronic otitis media(HP:0000389)|Skin rash(HP:0000988)|Conjunctivitis(HP:0000509)|Fever(HP:0001945)|Hepatitis(HP:0012115)|Immunodeficiency(HP:0002721)|Recurrent respiratory infections(HP:0002205)|Arthritis(HP:0001369)|Verrucae(HP:0200043)|Bronchiectasis(HP:0002110)|Osteomyelitis(HP:0002754)|Cough(HP:0012735)|Sepsis(HP:0100806)|Epicanthus(HP:0000286)|Fatigue(HP:0012378)|Neutropenia(HP:0001875)|Dehydration(HP:0001944)|Recurrent skin infections(HP:0001581)|Malabsorption(HP:0002024)|High palate(HP:0000218)|Failure to thrive(HP:0001508)|Sinusitis(HP:0000246)|Agammaglobulinemia(HP:0004432)|Cellulitis(HP:0100658)|Hypertelorism(HP:0000316)|Meningitis(HP:0001287)|Meningitis(HP:0001287)|Agammaglobulinemia(HP:0004432)|Autosomal recessive inheritance(HP:0000007)|Recurrent pneumonia(HP:0006532)|Recurrent bacterial infections(HP:0002718)|Infantile onset(HP:0003593)","The preB cell receptor is found on the surface of proB and preB cells, where it is involved in transduction of signals for cellular proliferation, differentiation from the proB cell to the preB cell stage, allelic exclusion at the Ig heavy chain gene locus, and promotion of Ig light chain gene rearrangements. The preB cell receptor is composed of a membrane-bound Ig mu heavy chain in association with a heterodimeric surrogate light chain. This gene encodes one of the surrogate light chain subunits and is a member of the immunoglobulin gene superfamily. This gene does not undergo rearrangement. Mutations in this gene can result in B cell deficiency and agammaglobulinemia, an autosomal recessive disease in which few or no gamma globulins or antibodies are made. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]","immunoglobulin lambda like polypeptide 1","phagocytosis, recognition(GO:0006910)|phagocytosis, engulfment(GO:0006911)|immune response(GO:0006955)|complement activation, classical pathway(GO:0006958)|defense response to bacterium(GO:0042742)|innate immune response(GO:0045087)|B cell receptor signaling pathway(GO:0050853)|positive regulation of B cell activation(GO:0050871)","extracellular region(GO:0005576)|endoplasmic reticulum(GO:0005783)|external side of plasma membrane(GO:0009897)|membrane(GO:0016020)|immunoglobulin complex, circulating(GO:0042571)","antigen binding(GO:0003823)|protein binding(GO:0005515)|immunoglobulin receptor binding(GO:0034987)","","Primary immunodeficiency","Wp pathogenesis of sarscov2 mediated by nsp9nsp10 complex","Hemostasis|Cell surface interactions at the vascular wall","","","SpliceAI>T|IGLL1|0.00|0.02|0.00|0.00|16|19|-19|16",".;.","","","0.0059","0.0008","0.004","0.0004","0.0046","","","0.0005","0.0059","T","0.143","T","0.071","P","0.46","B","0.021","","","D","1.000","N","0.11","T","6.86","N","-1.44","0.147","T","-0.900","T","0.002","T","0.014","0.082","T","0.025","11.53","0.747","1.58","0.074","7.441"
"chr5","35779419","35779419","G>A","","SPEF2","exonic","nonsynonymous SNV","","SPEF2:NM_024867:exon30:c.G4418A:p.R1473Q","SPEF2","exonic","nonsynonymous SNV","","SPEF2:ENST00000356031.8_1:exon30:c.G4418A:p.R1473Q,SPEF2:ENST00000440995.6_1:exon30:c.G4403A:p.R1468Q,SPEF2:ENST00000637569.1_1:exon30:c.G4418A:p.R1473Q","SPEF2:ENST00000356031.3:c.4418G>A:p.(Arg1473Gln)","0.96265537","","","","","","","","","","","","","","","","ENSG00000152582","SPEF2","HGNC:26293","SPEF2","79925","ENSG00000152582","uc003jjo.4","0.00030622930941316695","0.5000004730111982","","OMIM:618751 Spermatogenic failure 43-autosomal_recessive;ORPHA:244 Primary ciliary dyskinesia-autosomal_dominant_and_recessive","2682","0/1","Het","94","47,47","0.5","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Spermatogenic failure 43(618751)","Anomalous pulmonary venous return(HP:0010772)|Abnormal sperm motility(HP:0012206)|Hydrocephalus(HP:0000238)|Airway obstruction(HP:0006536)|Atelectasis(HP:0100750)|Productive cough(HP:0031245)|Polysplenia(HP:0001748)|Recurrent sinopulmonary infections(HP:0005425)|Neonatal respiratory distress(HP:0002643)|Abnormal inferior vena cava morphology(HP:0025576)|Rod-cone dystrophy(HP:0000510)|Transposition of the great arteries(HP:0001669)|Situs inversus totalis(HP:0001696)|Delayed speech and language development(HP:0000750)|Wheezing(HP:0030828)|Ventriculomegaly(HP:0002119)|Intestinal malrotation(HP:0002566)|Chronic sinusitis(HP:0011109)|Persistent left superior vena cava(HP:0005301)|Male infertility(HP:0003251)|Atrial situs ambiguous(HP:0011539)|Bronchiectasis(HP:0002110)|Nasal polyposis(HP:0100582)|Female infertility(HP:0008222)|Recurrent otitis media(HP:0000403)|Recurrent mycobacterial infections(HP:0011274)|Lithoptysis(HP:0032543)|Conductive hearing impairment(HP:0000405)|Chronic otitis media(HP:0000389)|Chronic rhinitis(HP:0002257)|Nasal congestion(HP:0001742)|Ectopic pregnancy(HP:0031456)|Peribronchovascular interstitial thickening(HP:0025177)|Clubbing(HP:0001217)|Double outlet right ventricle(HP:0001719)|Pulmonary situs ambiguus(HP:0011617)|Respiratory failure(HP:0002878)|Asplenia(HP:0001746)|Coiled sperm flagella(HP:0032560)|Absent sperm axoneme central pair complex(HP:0033525)|Male infertility(HP:0003251)|Absent sperm flagella(HP:0032558)|Autosomal recessive inheritance(HP:0000007)|Reduced sperm motility(HP:0012207)","","sperm flagellar 2","epithelial cilium movement involved in extracellular fluid movement(GO:0003351)|spermatogenesis(GO:0007283)|sperm axoneme assembly(GO:0007288)|sperm axoneme assembly(GO:0007288)|sperm axoneme assembly(GO:0007288)|skeletal system morphogenesis(GO:0048705)|brain morphogenesis(GO:0048854)|respiratory system development(GO:0060541)","manchette(GO:0002177)|manchette(GO:0002177)|extracellular region(GO:0005576)|cytoplasm(GO:0005737)|Golgi apparatus(GO:0005794)|sperm flagellum(GO:0036126)|sperm midpiece(GO:0097225)|sperm midpiece(GO:0097225)","molecular_function(GO:0003674)","","","","","","","SpliceAI>A|SPEF2|0.00|0.00|0.00|0.00|3|-48|-34|29",".;.;.","","","0.003","0.0006","0.003","0.0003","0.0024","0.0003","","0.0002","0.0019","T","0.292","T","0.16","D","0.977","B","0.243","N","0.339","D","1.000","M","2.34","T","-0.3","N","-0.8","0.102","T","-0.942","T","0.146","T","0.020","0.155","T","0.029","20.1","2.040","5.5","0.598","6.781"
"chr19","35175077","35175089","AAAAAAAAAAAAA>-","","ZNF302","exonic","nonframeshift deletion","","ZNF302:NM_001289188:exon5:c.398_410del:p.*133*,ZNF302:NM_001289189:exon5:c.398_410del:p.*133*,ZNF302:NM_001289190:exon5:c.395_407del:p.*132*,ZNF302:NM_001289191:exon5:c.395_407del:p.*132*,ZNF302:NM_001289192:exon5:c.395_407del:p.*132*,ZNF302:NM_018675:exon5:c.395_407del:p.*132*","ZNF302","exonic","nonframeshift deletion","","ZNF302:ENST00000505365.2_1:exon5:c.395_407del:p.*132*,ZNF302:ENST00000507959.5_1:exon5:c.398_410del:p.*133*","ZNF302:ENST00000423823.2:c.215-80_215-68del:p.(=)","0.563","0.0","0.5630000233650208","0.000298141324318348","","","","","","","","","","","","","ENSG00000089335","ZNF302","HGNC:13848","ZNF302","55900","ENSG00000089335","uc002nvq.3","0.000298141324318348","","0.5630000233650208","","2686","0/1","Het","8","5,3","0.625","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","This gene encodes a member of the zinc-finger protein family. The encoded protein contains seven C2H2-type zinc fingers and a KRAB domain, but its function has yet to be determined. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2014]","zinc finger protein 302","regulation of transcription by RNA polymerase II(GO:0006357)","nucleus(GO:0005634)","RNA polymerase II cis-regulatory region sequence-specific DNA binding(GO:0000978)|DNA-binding transcription factor activity, RNA polymerase II-specific(GO:0000981)|protein binding(GO:0005515)|metal ion binding(GO:0046872)","","","","Rna polymerase ii transcription","","","SpliceAI>T|ZNF302|0.00|0.00|0.00|0.00|-17|47|49|-2","","Name=(A)n","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr1","228362991","228362991","G>A","","IBA57","exonic","nonsynonymous SNV","","IBA57:NM_001010867:exon3:c.G848A:p.R283Q,IBA57:NM_001310327:exon3:c.G269A:p.R90Q","IBA57","exonic","nonsynonymous SNV","","IBA57:ENST00000366711.4_1:exon3:c.G848A:p.R283Q","IBA57:ENST00000366711.3:c.848G>A:p.(Arg283Gln)","0.27788493","0.250015277933926","0.2778849303722381","0.0002923398175754458","","","","","","","","","","","","","ENSG00000181873","IBA57","HGNC:27302","IBA57","200205","ENSG00000181873","uc001hsl.5","0.0002923398175754458","0.250015277933926","0.27788493037223816","OMIM:615330 Multiple mitochondrial dysfunctions syndrome 3-autosomal_recessive;OMIM:616451 ?Spastic paraplegia 74, autosomal recessive-autosomal_recessive;ORPHA:468661 Autosomal recessive spastic paraplegia type 74-autosomal_recessive","2687","0/1","Het","294","166,128","0.564625850340136","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 1 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Multiple mitochondrial dysfunctions syndrome 3(615330)|Spastic paraplegia 74, autosomal recessive(616451)","Slowly progressive(HP:0003677)|Optic atrophy(HP:0000648)|Distal sensory impairment(HP:0002936)|Hyperreflexia(HP:0001347)|Babinski sign(HP:0003487)|Autosomal recessive inheritance(HP:0000007)|Areflexia(HP:0001284)|Visual field defect(HP:0001123)|Spastic paraplegia(HP:0001258)|Peripheral axonal neuropathy(HP:0003477)|Optic atrophy(HP:0000648)|Autosomal recessive inheritance(HP:0000007)|Recurrent fever(HP:0001954)|Lactic acidosis(HP:0003128)|Developmental regression(HP:0002376)|Visual impairment(HP:0000505)|Severe muscular hypotonia(HP:0006829)|Encephalopathy(HP:0001298)|Cognitive impairment(HP:0100543)|High palate(HP:0000218)|Congenital onset(HP:0003577)|Retrognathia(HP:0000278)|Metabolic acidosis(HP:0001942)|Nystagmus(HP:0000639)|Wide intermamillary distance(HP:0006610)|Arthrogryposis multiplex congenita(HP:0002804)|Hypoplasia of the corpus callosum(HP:0002079)|Edema(HP:0000969)|Intrauterine growth retardation(HP:0001511)|Spastic tetraplegia(HP:0002510)|Respiratory failure(HP:0002878)|Irritability(HP:0000737)|Polyhydramnios(HP:0001561)|Feeding difficulties(HP:0011968)|Seizure(HP:0001250)|Leukodystrophy(HP:0002415)|Microcephaly(HP:0000252)|Cerebral atrophy(HP:0002059)|Abnormality of mitochondrial metabolism(HP:0003287)|Progressive(HP:0003676)|Polymicrogyria(HP:0002126)|Variable expressivity(HP:0003828)|Distal amyotrophy(HP:0003693)|Decreased Achilles reflex(HP:0009072)|Cerebellar atrophy(HP:0001272)|EMG: neuropathic changes(HP:0003445)|Hypoplasia of the corpus callosum(HP:0002079)|Distal peripheral sensory neuropathy(HP:0007067)|Distal lower limb muscle weakness(HP:0009053)|Peripheral axonal neuropathy(HP:0003477)|Progressive spastic paraplegia(HP:0007020)|Pes cavus(HP:0001761)|Visual field defect(HP:0001123)|Cerebral white matter atrophy(HP:0012762)|Babinski sign(HP:0003487)|Decreased activity of mitochondrial complex I(HP:0011923)|Difficulty walking(HP:0002355)|Hyperactive patellar reflex(HP:0007083)|Decreased activity of mitochondrial complex II(HP:0008314)|Optic atrophy(HP:0000648)","The protein encoded by this gene localizes to the mitochondrion and is part of the iron-sulfur cluster assembly pathway. The encoded protein functions late in the biosynthesis of mitochondrial 4Fe-4S proteins. Defects in this gene have been associated with autosomal recessive spastic paraplegia-74 and with multiple mitochondrial dysfunctions syndrome-3. Two transcript variants encoding different isoforms have been found for this gene. The smaller isoform is not likely to be localized to the mitochondrion since it lacks the amino-terminal transit peptide. [provided by RefSeq, Jul 2015]","iron-sulfur cluster assembly factor IBA57","heme biosynthetic process(GO:0006783)|iron-sulfur cluster assembly(GO:0016226)","mitochondrion(GO:0005739)|mitochondrial matrix(GO:0005759)","RNA binding(GO:0003723)|protein binding(GO:0005515)|transferase activity(GO:0016740)","","","","","","","","Glycine","","","0.00001198","","","0.","0.","","","1.198e-05","0","T","0.722","T","0.673","B","0.028","B","0.022","N","0.250","N","1","N","0.235","T","1.01","N","-0.22","0.022","T","-0.992","T","0.039","T","0.004","0.036","T","0.024","1.283","-0.114","5.08","-0.807","10.108"
"chr16","15457557","15457589","GTGAGCAGACACACTCGGGAGGTGTCTTGAGAT>-","","NPIPA5","exonic","nonframeshift deletion","","NPIPA5:NM_001277325:exon8:c.980_1012del:p.N327_L338delinsI","NPIPA5","exonic","nonframeshift deletion","","NPIPA5:ENST00000360151.9_1:exon8:c.980_1012del:p.N327_L338delinsI","NPIPA5:ENST00000360151.4:c.980_1012del:p.(Asn327_Leu338delinsIle)","0.5876265","","","","0.0","0.5375361740589142","0.00023598650809230216","","","","","","","","","","ENSG00000183793","NPIPA5","HGNC:41980","NPIPA5","100288332","ENSG00000183793","","0.00023598650809230216","","0.5375361740589142","","2732","0/1","Het","9","4,5","0.444444444444444","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","nuclear pore complex interacting protein family member A5","","nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)","","","","","","","","SpliceAI>A|NPIPA5|0.00|0.00|0.00|0.00|-17|13|-36|15","","","","0.00006362","","","","","","","6.362e-05","0.0004","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr16","15457592","15457629","TCATCCGCTGAGGGTGGAGCTGAGGGTGGAAGGGGAGT>-","","NPIPA5","exonic","stopgain","","NPIPA5:NM_001277325:exon8:c.940_977del:p.T314*","NPIPA5","exonic","stopgain","","NPIPA5:ENST00000360151.9_1:exon8:c.940_977del:p.T314*","NPIPA5:ENST00000360151.4:c.940_977del:p.(Thr314fs)","0.48744583","","","","0.0","0.5375361740589142","0.00023598650809230216","","","","","","","","","","ENSG00000183793","NPIPA5","HGNC:41980","NPIPA5","100288332","ENSG00000183793","","0.00023598650809230216","","0.5375361740589142","","2733","0/1","Het","9","4,5","0.444444444444444","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","nuclear pore complex interacting protein family member A5","","nucleoplasm(GO:0005654)|nucleoplasm(GO:0005654)","","","","","","","","SpliceAI>A|NPIPA5|0.00|0.00|0.00|0.00|-10|19|-1|-20","","","","0.00006365","","","","","","","6.365e-05","0.0004","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr3","175165119","175165119","C>A","","NAALADL2","exonic","nonsynonymous SNV","","NAALADL2:NM_207015:exon6:c.C1193A:p.T398N","NAALADL2","exonic","nonsynonymous SNV","","NAALADL2:ENST00000454872.6_1:exon6:c.C1193A:p.T398N","NAALADL2:ENST00000454872.1:c.1193C>A:p.(Thr398Asn)","0.5039742","0.0","0.503974199295044","0.00017340162445095717","","","","","","","","","","","","","ENSG00000177694","NAALADL2","HGNC:23219","NAALADL2","254827","ENSG00000177694","uc003fit.4","0.00017340162445095717","","0.503974199295044","","2763","0/1","Het","59","24,35","0.406779661016949","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","N-acetylated alpha-linked acidic dipeptidase like 2","proteolysis(GO:0006508)|response to bacterium(GO:0009617)","nucleoplasm(GO:0005654)|integral component of membrane(GO:0016021)","protein binding(GO:0005515)|metalloexopeptidase activity(GO:0008235)","","","","","","","","","","","0","","","","","","","0","0","T","0.496","T","0.558","B","0.003","B","0.001","N","0.862","N","1","L","1.87","T","0.97","N","-0.69","0.049","T","-1.018","T","0.065","T","0.008","0.038","T","0.026","8.275","0.389","5.71","-0.398","1.442"
"chr21","47531486","47531486","G>C","","COL6A2","exonic","nonsynonymous SNV","","COL6A2:NM_001849:exon2:c.G96C:p.E32D,COL6A2:NM_058174:exon2:c.G96C:p.E32D,COL6A2:NM_058175:exon2:c.G96C:p.E32D","COL6A2","exonic","nonsynonymous SNV","","COL6A2:ENST00000397763.5_1:exon1:c.G96C:p.E32D,COL6A2:ENST00000409416.6_1:exon1:c.G96C:p.E32D,COL6A2:ENST00000300527.9_1:exon2:c.G96C:p.E32D,COL6A2:ENST00000310645.9_1:exon2:c.G96C:p.E32D","COL6A2:ENST00000300527.4:c.96G>C:p.(Glu32Asp)","0.50193834","0.0","0.5019383430480957","0.00017019021572047194","","","","","","","","","","","","","ENSG00000142173","COL6A2","HGNC:2212","COL6A2","1292","ENSG00000142173","uc002zia.2","0.00017019021572047194","","0.5019383430480957","OMIM:158810 Bethlem myopathy 1-autosomal_dominant_and_recessive;OMIM:254090 Ullrich congenital muscular dystrophy 1-autosomal_dominant_and_recessive;OMIM:255600 ?Myosclerosis, congenital-autosomal_recessive;ORPHA:610 Bethlem myopathy-autosomal_dominant_and_recessive;ORPHA:75840 Congenital muscular dystrophy, Ullrich type-autosomal_dominant_and_recessive","2766","0/1","Het","63","45,18","0.714285714285714","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Bethlem myopathy 1(158810)|Ullrich congenital muscular dystrophy 1(254090)|Myosclerosis, autosomal recessive(255600)","Autosomal dominant inheritance(HP:0000006)|Round face(HP:0000311)|Nocturnal hypoventilation(HP:0002877)|Progressive(HP:0003676)|Slender build(HP:0001533)|Variable expressivity(HP:0003828)|Increased variability in muscle fiber diameter(HP:0003557)|Autosomal recessive inheritance(HP:0000007)|Hyperhidrosis(HP:0000975)|Motor delay(HP:0001270)|Hyperextensibility at wrists(HP:0005072)|Infantile onset(HP:0003593)|Facial palsy(HP:0010628)|High palate(HP:0000218)|Mildly elevated creatine kinase(HP:0008180)|Proximal muscle weakness(HP:0003701)|Muscle fiber necrosis(HP:0003713)|Reduced muscle collagen VI(HP:0030095)|Failure to thrive(HP:0001508)|Protruding ear(HP:0000411)|Congenital muscular dystrophy(HP:0003741)|Recurrent lower respiratory tract infections(HP:0002783)|Increased laxity of fingers(HP:0006149)|Hip dislocation(HP:0002827)|Spinal rigidity(HP:0003306)|Distal joint laxity(HP:0020152)|Flexion contracture(HP:0001371)|Kyphosis(HP:0002808)|Neonatal hypotonia(HP:0001319)|Follicular hyperkeratosis(HP:0007502)|Respiratory insufficiency due to muscle weakness(HP:0002747)|Feeding difficulties in infancy(HP:0008872)|Talipes equinovarus(HP:0001762)|Scoliosis(HP:0002650)|Distal joint laxity(HP:0020152)|Type 1 muscle fiber predominance(HP:0003803)|Increased laxity of ankles(HP:0006460)|Torticollis(HP:0000473)|Generalized amyotrophy(HP:0003700)|Slender finger(HP:0001238)|Esotropia(HP:0000565)|Scoliosis(HP:0002650)|Elbow flexion contracture(HP:0002987)|Elevated circulating creatine kinase concentration(HP:0003236)|Increased endomysial connective tissue(HP:0100297)|Respiratory failure(HP:0002878)|Adducted thumb(HP:0001181)|Torticollis(HP:0000473)|Hyperextensibility at wrists(HP:0005072)|Spinal rigidity(HP:0003306)|Long toe(HP:0010511)|Short neck(HP:0000470)|Pes valgus(HP:0008081)|Generalized hypotonia(HP:0001290)|Frequent falls(HP:0002359)|Increased laxity of fingers(HP:0006149)|Increased variability in muscle fiber diameter(HP:0003557)|Micrognathia(HP:0000347)|EMG: myopathic abnormalities(HP:0003458)|Decreased fetal movement(HP:0001558)|Hip dislocation(HP:0002827)|Diaphragmatic weakness(HP:0009113)|Generalized muscle weakness(HP:0003324)|Generalized amyotrophy(HP:0003700)|Knee flexion contracture(HP:0006380)|Kyphosis(HP:0002808)|Abnormal palate morphology(HP:0000174)|Restricted neck movement due to contractures(HP:0005997)|Achilles tendon contracture(HP:0001771)|Reduced forced vital capacity(HP:0032341)|Elevated circulating creatine kinase concentration(HP:0003236)|Lumbar hyperlordosis(HP:0002938)|Progressive(HP:0003676)|Decreased pulmonary function(HP:0005952)|Short stature(HP:0004322)|Facial palsy(HP:0010628)|Spinal rigidity(HP:0003306)|Proximal muscle weakness(HP:0003701)|Distal muscle weakness(HP:0002460)|Skeletal muscle atrophy(HP:0003202)|Thoracolumbar scoliosis(HP:0002944)|Increased connective tissue(HP:0009025)|Autosomal recessive inheritance(HP:0000007)|Juvenile onset(HP:0003621)|Quadriceps muscle weakness(HP:0003731)|EMG: myopathic abnormalities(HP:0003458)|Rimmed vacuoles(HP:0003805)|Keratosis pilaris(HP:0032152)|Neck muscle weakness(HP:0000467)|Ankle flexion contracture(HP:0006466)|Scapular winging(HP:0003691)|Distal muscle weakness(HP:0002460)|Reduced muscle collagen VI(HP:0030095)|Axial muscle weakness(HP:0003327)|Waddling gait(HP:0002515)|Spinal rigidity(HP:0003306)|Achilles tendon contracture(HP:0001771)|Progressive proximal muscle weakness(HP:0009073)|Joint hypermobility(HP:0001382)|Scoliosis(HP:0002650)|Gowers sign(HP:0003391)|Muscular dystrophy(HP:0003560)|Foot dorsiflexor weakness(HP:0009027)|Increased muscle lipid content(HP:0009058)|Curved toe phalanx(HP:0010176)|Hyperkeratosis(HP:0000962)|Hypoventilation(HP:0002791)|Generalized amyotrophy(HP:0003700)|Reduced maximal expiratory pressure(HP:0012497)|Multiple joint contractures(HP:0002828)|Limb-girdle muscle weakness(HP:0003325)|Lumbar hyperlordosis(HP:0002938)|Elevated circulating creatine kinase concentration(HP:0003236)|Cigarette-paper scars(HP:0001073)|Camptodactyly of finger(HP:0100490)|Elbow flexion contracture(HP:0002987)|Wrist flexion contracture(HP:0001239)|Difficulty walking(HP:0002355)|Respiratory insufficiency due to muscle weakness(HP:0002747)|Torticollis(HP:0000473)|Ankle flexion contracture(HP:0006466)|Autosomal dominant inheritance(HP:0000006)|Distal muscle weakness(HP:0002460)|Variable expressivity(HP:0003828)|Decreased fetal movement(HP:0001558)|Autosomal recessive inheritance(HP:0000007)|Elevated circulating creatine kinase concentration(HP:0003236)|Neonatal hypotonia(HP:0001319)|Abnormality of the cardiovascular system(HP:0001626)|Camptodactyly of finger(HP:0100490)|Congenital muscular torticollis(HP:0005988)|Proximal muscle weakness(HP:0003701)|Motor delay(HP:0001270)|Myopathy(HP:0003198)|Slowly progressive(HP:0003677)|Skeletal muscle atrophy(HP:0003202)|Elbow flexion contracture(HP:0002987)|Limb-girdle muscle weakness(HP:0003325)","This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]","collagen type VI alpha 2 chain","cell adhesion(GO:0007155)|response to glucose(GO:0009749)","extracellular region(GO:0005576)|extracellular region(GO:0005576)|extracellular region(GO:0005576)|collagen trimer(GO:0005581)|extracellular space(GO:0005615)|extracellular space(GO:0005615)|endoplasmic reticulum lumen(GO:0005788)|protein-containing complex(GO:0032991)|sarcolemma(GO:0042383)|collagen-containing extracellular matrix(GO:0062023)|collagen-containing extracellular matrix(GO:0062023)|collagen-containing extracellular matrix(GO:0062023)|collagen-containing extracellular matrix(GO:0062023)|extracellular exosome(GO:0070062)|extracellular vesicle(GO:1903561)","protein binding(GO:0005515)|collagen binding(GO:0005518)|extracellular matrix structural constituent conferring tensile strength(GO:0030020)|extracellular matrix structural constituent conferring tensile strength(GO:0030020)|extracellular matrix structural constituent conferring tensile strength(GO:0030020)","syndrome(DOID:225)|myopathy(DOID:423)|muscular dystrophy(DOID:9884)","Focal adhesion|Ecm receptor interaction","Wp focal adhesion|Wp mirna targets in ecm and membrane receptors|Wp focal adhesionpi3kaktmtorsignaling pathway|Wp pi3kakt signaling pathway","Developmental biology|Collagen degradation|Degradation of the extracellular matrix|Extracellular matrix organization|Collagen formation|Collagen biosynthesis and modifying enzymes|Signaling by pdgf|Assembly of collagen fibrils and other multimeric structures|Integrin cell surface interactions|Ecm proteoglycans|Ncam signaling for neurite out growth|Ncam1 interactions|Collagen chain trimerization|Signaling by receptor tyrosine kinases|Nervous system development","","Myogenesis|Epithelial mesenchymal transition","",".;.;.;.;.","","","0.000004013","","","","","","","4.013e-06","0","T","0.516","T","0.226","B","0.0","B","0.001","N","0.860","N","1","N","0.145","T","-1.09","N","-0.29","0.09","T","-0.961","T","0.175","D","0.063","0.128","T","0.021","0.051","-0.574","4.16","-2.730","7.816"
"chr1","149378229","149378237","ACCAGTCTA>-","","FCGR1C;FCGR1C","ncRNA_exonic;splicing","","","","CR812485.1;H3-2","intergenic","","dist=54807;dist=18726","","H2BP2:ENST00000609585.1:n.425-8377_425-8369del:","0.426","","","","0.0","0.4259999990463257","8.474094226950879e-05","","","","","","","","","","ENSG00000240929","H2BP2","HGNC:20654","H2BP2","338391","ENSG00000234571","","8.474094226950879e-05","","0.4259999990463257","","2845","1/1","Hom","5","0,5","0","","","","","","","","PVS1: . ; PS1: . ; PS2: . ; PS3: . ; PS4: . ; PM1: . ; PM2: . ; PM3: . ; PM4: . ; PM5: . ; PM6: . ; PP1: . ; PP2: . ; PP3: . ; PP4: . ; PP5: . ; BA1: . ; BS1: . ; BS2: . ; BS3: . ; BS4: . ; BP1: . ; BP2: . ; BP3: . ; BP4: . ; BP5: . ; BP6: . ; BP7: .","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr7","100550515","100550515","T>A","","MUC3A","exonic","nonsynonymous SNV","","MUC3A:NM_005960:exon2:c.T1096A:p.S366T","MUC3A","upstream","","dist=735","","MUC3A:ENST00000319509.7::","0.414","0.0","0.414000004529953","7.589888833090653e-05","","","","","","","","","","","","","ENSG00000169894","MUC3A","HGNC:7513","MUC3A","4584","ENSG00000169894","uc033aad.2","7.589888833090653e-05","","0.414000004529953","","2850","0/1","Het","213","195,18","0.915492957746479","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The mucin genes encode epithelial glycoproteins, some of which are secreted and some membrane bound. Each of the genes contains at least one large domain of tandemly repeated sequence that encodes the peptide sequence rich in serine and/or threonine residues, which carries most of the O-linked glycosylation (Gendler and Spicer, 1995 [PubMed 7778880]).[supplied by OMIM, Aug 2008]","mucin 3A, cell surface associated","","extracellular region(GO:0005576)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|integral component of membrane(GO:0016021)","extracellular matrix structural constituent(GO:0005201)|extracellular matrix constituent, lubricant activity(GO:0030197)","laryngitis(DOID:3437)|arthritis(DOID:848)|cancer(DOID:162)|clear cell renal cell carcinoma(DOID:4467)","","","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","",".;.","","","","","","","","","","","","","","T","0.497","","","","","","","","","","","","","","","0.029","","","","","","","","","","4.573","0.119","2.29","-2.010","2.911"
"chr11","1268488","1268488","C>T","","MUC5B","exonic","nonsynonymous SNV","","MUC5B:NM_002458:exon31:c.C10378T:p.P3460S","MUC5B","exonic","nonsynonymous SNV","","MUC5B:ENST00000529681.5_1:exon31:c.C10378T:p.P3460S","MUC5B:ENST00000447027.1:c.10387C>T:p.(Pro3463Ser)","0.29776886","","","","","","","","","","","","","","","","ENSG00000117983","MUC5B","HGNC:7516","MUC5B","727897","ENSG00000117983","uc001lta.4","3.35202890001209e-05","0.2871519542705951","","OMIM:178500 Pulmonary fibrosis, idiopathic, susceptibility to-autosomal_dominant;ORPHA:2032 Idiopathic pulmonary fibrosis-autosomal_dominant","2919","0/1","Het","466","413,53","0.886266094420601","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","Interstitial lung disease 2(178500)","Crackles(HP:0030830)|Clubbing of fingers(HP:0100759)|Gastroesophageal reflux(HP:0002020)|Bronchiectasis(HP:0002110)|Honeycomb lung(HP:0025175)|Pulmonary insufficiency(HP:0010444)|Ground-glass opacification(HP:0025179)|Reticular pattern on pulmonary HRCT(HP:0025390)|Exertional dyspnea(HP:0002875)|Cough(HP:0012735)|Pulmonary fibrosis(HP:0002206)|Exertional dyspnea(HP:0002875)|Decreased DLCO(HP:0045051)|Usual interstitial pneumonia(HP:0031950)|Clubbing of fingers(HP:0100759)|Cirrhosis(HP:0001394)|Autosomal dominant inheritance(HP:0000006)|Pulmonary fibrosis(HP:0002206)|Cough(HP:0012735)|Pulmonary arterial hypertension(HP:0002092)|Increased circulating antibody level(HP:0010702)|Dyspnea(HP:0002094)|Elevated bronchoalveolar lavage fluid neutrophil proportion(HP:0032977)|Alveolar cell carcinoma(HP:0006519)","This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]","mucin 5B, oligomeric mucus/gel-forming","","extracellular space(GO:0005615)|extracellular space(GO:0005615)|Golgi lumen(GO:0005796)|plasma membrane(GO:0005886)|extracellular matrix(GO:0031012)|intracellular membrane-bounded organelle(GO:0043231)|extracellular exosome(GO:0070062)","protein binding(GO:0005515)","otitis media(DOID:10754)|cancer(DOID:162)|chronic obstructive pulmonary disease(DOID:3083)|pulmonary fibrosis(DOID:3770)|pneumonia(DOID:552)","","Wp lung fibrosis","Innate immune system|Diseases of glycosylation|Diseases associated with o glycosylation of proteins|Defective galnt3 causes familial hyperphosphatemic tumoral calcinosis hftc|Defective c1galt1c1 causes tn polyagglutination syndrome tnps|O linked glycosylation|Dectin 2 family|C type lectin receptors clrs|Diseases of metabolism|Post translational protein modification|O linked glycosylation of mucins|Termination of o glycan biosynthesis","","","SpliceAI>T|MUC5B|0.00|0.00|0.00|0.00|11|20|11|20","","","","0.0009","","","0.0003","0.0009","","","0.0001","0.0008","T","0.581","","","","","","","","","N","1","L","0.805","T","1.99","N","-1.97","0.023","T","-1.045","T","0.047","T","0.001","0.022","T","0.019","5.613","0.185","2.39","-2.570","5.778"
"chr1","13634750","13634750","T>C","","PRAMEF10;PRAMEF33P","exonic","unknown","","UNKNOWN","PRAMEF21;PRAMEF15","intergenic","","dist=107807;dist=7223","","XX-FW84067D5.2:ENST00000447851.1:n.896T>C:","0.00451088","","","","","","","","","","","","","","","","ENSG00000224581","XX-FW84067D5.2","","","","ENSG00000224581","","","","","","3046","0/1","Het","57","48,9","0.842105263157895","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","1.992","-0.046","0.822","-2.667","3.759"
"chr22","29075636","29075636","G>T","","TTC28","exonic","nonsynonymous SNV","","TTC28:NM_001145418:exon1:c.C76A:p.P26T","TTC28","exonic","nonsynonymous SNV","","TTC28:ENST00000397906.6_1:exon1:c.C76A:p.P26T","TTC28:ENST00000397906.2:c.76C>A:p.(Pro26Thr)","0.3730044","","","","","","","","","","","","","","","","ENSG00000100154","TTC28","HGNC:29179","TTC28","23331","ENSG00000100154","uc003adp.4","","","","","3048","0/1","Het","27","23,4","0.851851851851852","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","tetratricopeptide repeat domain 28","cell cycle(GO:0007049)|regulation of mitotic cell cycle(GO:0007346)|cell division(GO:0051301)","spindle pole(GO:0000922)|cytoplasm(GO:0005737)|microtubule organizing center(GO:0005815)|midbody(GO:0030496)","kinase binding(GO:0019900)","","","","","","","SpliceAI>T|TTC28|0.00|0.00|0.00|0.00|-4|19|-30|-34","","","","0.0043","","","0.0001","0.","","","0.0006","0.0043","T","0.147","T","0.149","B","0.124","B","0.014","","","N","0.976","N","0","D","-2.68","N","0.31","0.274","T","-0.662","T","0.417","D","0.643","0.447","T","0.013","16.32","1.510","2.36","0.156","4.997"
"chr1","153085095","153085095","A>G","","SPRR2F","exonic","nonsynonymous SNV","","SPRR2F:NM_001014450:exon2:c.T115C:p.S39P","SPRR2F","exonic","nonsynonymous SNV","","SPRR2F:ENST00000468739.2_1:exon2:c.T115C:p.S39P","SPRR2F:ENST00000468739.1:c.115T>C:p.(Ser39Pro)","0","0.0","0.0","0.0","","","","","","","","","","","","","ENSG00000244094","SPRR2F","HGNC:11266","SPRR2F","6705","ENSG00000244094","uc001fbi.4","","","","","3053","0/1","Het","7","2,5","0.285714285714286","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","small proline rich protein 2F","epidermis development(GO:0008544)|keratinocyte differentiation(GO:0030216)|keratinization(GO:0031424)","cornified envelope(GO:0001533)|cornified envelope(GO:0001533)|cytosol(GO:0005829)","","","","","Developmental biology|Keratinization|Formation of the cornified envelope","","","","","","","0.00003186","0.0002","","0.","0.","","","3.186e-05","0","","","T","1.0","B","0.0","B","0.0","N","0.063","N","1","","","T","2.52","N","1.83","0.202","T","-0.961","T","0.008","T","0.002","0.058","T","0.011","3.532","0.056","3.96","0.464","3.996"
"chr19","43999748","43999748","G>A","","PHLDB3","exonic","nonsynonymous SNV","","PHLDB3:NM_198850:exon7:c.C850T:p.R284W","PHLDB3","exonic","nonsynonymous SNV","","PHLDB3:ENST00000292140.9_1:exon7:c.C850T:p.R284W","PHLDB3:ENST00000292140.5:c.850C>T:p.(Arg284Trp)","0.70123494","","","","","","","","","","","","","","","","ENSG00000176531","PHLDB3","HGNC:30499","PHLDB3","653583","ENSG00000176531","uc002own.5","","","","","3065","0/1","Het","164","84,80","0.51219512195122","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","pleckstrin homology like domain family B member 3","","","enzyme binding(GO:0019899)","","","","","","","SpliceAI>A|PHLDB3|0.00|0.08|0.00|0.00|-39|24|38|-2",".;.","","","0.0095","0.0012","0.006","0.0007","0.0095","","","0.0005","0.0069","D","0.031","T","0.188","B","0.0","B","0.0","","","N","1.000","N","0.345","T","0.9","N","-1.93","0.197","T","-1.053","T","0.046","T","0.007","0.068","T","0.062","23.1","2.778","4.66","3.492","9.372"
"chr10","81471597","81471597","C>G","","NUTM2B","exonic","nonsynonymous SNV","","NUTM2B:NM_001278495:exon7:c.C1993G:p.Q665E","NUTM2B","exonic","nonsynonymous SNV","","NUTM2B:ENST00000429828.5_1:exon7:c.C1993G:p.Q665E","NUTM2B:ENST00000429828.1:c.1993C>G:p.(Gln665Glu)","0","0.0","0.0","0.0","","","","","","","","","","","","","ENSG00000188199","NUTM2B","HGNC:23445","NUTM2B","729262","ENSG00000188199","uc031wmo.1","","","","","3068","0/1","Het","60","50,10","0.833333333333333","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","NUT family member 2B","","","","","","","","","","SpliceAI>G|NUTM2B|0.03|0.00|0.00|0.00|-38|5|-45|5","Nuclear","","","0.00006908","","","","","","","6.908e-05","0.0001","T","1.0","T","1.0","","","","","N","0.009","N","1","","","T","2.78","N","-0.56","0.052","T","-0.981","T","0.011","T","0.001","0.043","T","0.022","0.012","-0.760","1.38","-0.221","3.959"
"chr1","144816621","144816621","A>G","","NBPF8;NBPF9","exonic","unknown","","UNKNOWN","NBPF9","exonic","nonsynonymous SNV","","NBPF9:ENST00000338347.4:exon5:c.A754G:p.T252A,NBPF9:ENST00000440491.2:exon5:c.A754G:p.T252A","NBPF9:ENST00000338347.4:c.754A>G:p.(Thr252Ala)","0.40492746","","","","","","","","","","","","","","","","ENSG00000168614","NBPF9","HGNC:31991","NBPF9","400818","ENSG00000269713","uc057kjy.1","","","","","3069","0/1","Het","340","288,52","0.847058823529412","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","","","","","","","","","","","SpliceAI>G|NBPF9|0.00|0.00|0.00|0.00|1|-48|-48|41","","","","0.000003987","","","","","","","3.987e-06","0","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"chr1","148346627","148346627","C>G","","NBPF14;NBPF8;NBPF9","exonic","nonsynonymous SNV","","NBPF8:NM_001037501:exon1:c.G130C:p.V44L,NBPF14:NM_015383:exon1:c.G130C:p.V44L,NBPF9:NM_001277444:exon2:c.G130C:p.V44L","NBPF20","exonic","nonsynonymous SNV","","NBPF20:ENST00000414710.2:exon1:c.G130C:p.V44L,NBPF20:ENST00000369202.1:exon2:c.G130C:p.V44L","NBPF20:ENST00000369202.1:c.130G>C:p.(Val44Leu)","0.103011996","","","","","","","","","","","","","","","","ENSG00000203832","NBPF20","HGNC:32000","NBPF20","100288142","ENSG00000162825","uc031usp.2","","","","","3070","0/1","Het","148","126,22","0.851351351351351","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","","","","","","","","","","","SpliceAI>G|NBPF20|0.00|0.00|0.00|0.00|-33|48|-40|-45",".;.","","","0.003","0.0012","0.003","0.0003","0.0001","","","0.0002","0","","","D","0.033","","","","","","","","","","","","","","","0.153","T","-0.910","T","0.003","T","0.002","0.035","T","0.002","0.005","-0.889","0.521","-3.677",""
"chr8","2026918","2026918","C>T","","MYOM2","exonic","stopgain","","MYOM2:NM_003970:exon12:c.C1366T:p.R456X","MYOM2","exonic","unknown","","UNKNOWN","MYOM2:ENST00000262113.4:c.1366C>T:p.(Arg456*)","0.98224074","","","","","","","","","","","","","","","","ENSG00000036448","MYOM2","HGNC:7614","MYOM2","9172","ENSG00000036448","uc033azy.2","","","","","3071","0/1","Het","109","61,48","0.559633027522936","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 1 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","The giant protein titin, together with its associated proteins, interconnects the major structure of sarcomeres, the M bands and Z discs. The C-terminal end of the titin string extends into the M line, where it binds tightly to M-band constituents of apparent molecular masses of 190 kD and 165 kD. The predicted MYOM2 protein contains 1,465 amino acids. Like MYOM1, MYOM2 has a unique N-terminal domain followed by 12 repeat domains with strong homology to either fibronectin type III or immunoglobulin C2 domains. Protein sequence comparisons suggested that the MYOM2 protein and bovine M protein are identical. [provided by RefSeq, Jul 2008]","myomesin 2","extraocular skeletal muscle development(GO:0002074)|muscle contraction(GO:0006936)|sarcomere organization(GO:0045214)","mitochondrion(GO:0005739)|M band(GO:0031430)|myosin filament(GO:0032982)","protein binding(GO:0005515)|structural constituent of muscle(GO:0008307)|kinase binding(GO:0019900)|actin filament binding(GO:0051015)","","","","","","Myogenesis","SpliceAI>T|MYOM2|0.00|0.02|0.00|0.00|20|-29|-37|2","","","","0.001","0.0002","0.001","0.0004","0.001","0.0002","0.0003","0.0005","0.0007","","","","","","","","","D","0.000","A","1","","","","","","","0.215","","","","","","","","","","42","8.360","4.71","4.549","18.037"
"chr6","56919602","56919602","C>T","","KIAA1586","exonic","nonsynonymous SNV","","KIAA1586:NM_001286274:exon3:c.C2224T:p.R742W,KIAA1586:NM_001286275:exon4:c.C2104T:p.R702W,KIAA1586:NM_001286276:exon4:c.C2104T:p.R702W,KIAA1586:NM_020931:exon4:c.C2305T:p.R769W","KIAA1586","exonic","nonsynonymous SNV","","KIAA1586:ENST00000545356.5_1:exon3:c.C2224T:p.R742W,KIAA1586:ENST00000370733.5_1:exon4:c.C2305T:p.R769W","KIAA1586:ENST00000370733.4:c.2305C>T:p.(Arg769Trp)","0.60611206","","","","","","","","","","","","","","","","ENSG00000168116","KIAA1586","HGNC:21360","KIAA1586","57691","ENSG00000168116","uc003pdj.5","","","","","3073","0/1","Het","84","51,33","0.607142857142857","","","","","","","Likely benign","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 1 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","KIAA1586","protein sumoylation(GO:0016925)|protein sumoylation(GO:0016925)|protein sumoylation(GO:0016925)","","SUMO ligase activity(GO:0061665)|SUMO ligase activity(GO:0061665)","","","","","","","SpliceAI>T|KIAA1586|0.00|0.00|0.00|0.00|8|-22|8|31",".;.","Name=MER63D","","0.0096","0.0018","0.006","0.0006","0.0062","","","0.0009","0.0096","D","0.002","D","0.002","B","0.003","B","0.002","","","N","0.998","N","0.695","T","1.25","N","-2.18","0.303","T","-0.979","T","0.014","T","0.004","0.092","T","0.071","22.5","2.496","2.4","-1.372","2.273"
"chr17","76481027","76481027","C>T","","DNAH17","exonic","nonsynonymous SNV","","DNAH17:NM_173628:exon48:c.G7572A:p.M2524I","DNAH17","exonic","nonsynonymous SNV","","DNAH17:ENST00000389840.7_1:exon48:c.G7572A:p.M2524I","DNAH17:ENST00000389840.5:c.7530G>A:p.(Met2510Ile)","0.92813283","","","","","","","","","","","","","","","","ENSG00000187775","DNAH17","HGNC:2946","DNAH17","8632","ENSG00000187775","uc010dhp.2","","","","OMIM:618643 Spermatogenic failure 39-autosomal_recessive","3084","0/1","Het","107","63,44","0.588785046728972","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 1 ; PM2: 0 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 0 ; BP5: 0 ; BP6: 0 ; BP7: 0","Spermatogenic failure 39(618643)","Reduced sperm motility(HP:0012207)|Oligospermia(HP:0000798)|Male infertility(HP:0003251)|Coiled sperm flagella(HP:0032560)|Reduced sperm motility(HP:0012207)|Autosomal recessive inheritance(HP:0000007)|Short sperm flagella(HP:0032559)|Tapered sperm head(HP:0032562)|Absent sperm flagella(HP:0032558)","Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. DNAH17 is a heavy chain associated with axonemal dynein (Milisav and Affara, 1998 [PubMed 9545504]).[supplied by OMIM, Mar 2008]","dynein axonemal heavy chain 17","cilium movement(GO:0003341)|microtubule-based movement(GO:0007018)|outer dynein arm assembly(GO:0036158)|cilium-dependent cell motility(GO:0060285)","axonemal dynein complex(GO:0005858)|microtubule(GO:0005874)|axoneme(GO:0005930)|axoneme(GO:0005930)|dynein complex(GO:0030286)|motile cilium(GO:0031514)|sperm flagellum(GO:0036126)|outer dynein arm(GO:0036157)","microtubule motor activity(GO:0003777)|ATP binding(GO:0005524)|minus-end-directed microtubule motor activity(GO:0008569)|dynein intermediate chain binding(GO:0045505)|dynein light intermediate chain binding(GO:0051959)","","","","","","","SpliceAI>T|DNAH17|0.00|0.00|0.00|0.02|-13|34|3|-20",".;.","","Score=943;Name=V$P53_02","0.0033","0.0004","0.002","0.0002","0.0033","","","0.0002","0.0023","","","","","","","","","","","D","0.981","","","T","1.59","","","0.743","T","-1.074","T","0.097","T","0.012","0.116","T","0.117","23.7","3.077","4.96","4.881","18.212"
"chr18","12127835","12127835","G>A","","ANKRD62","exonic","nonsynonymous SNV","","ANKRD62:NM_001277333:exon14:c.G2651A:p.R884H","ANKRD62","exonic","nonsynonymous SNV","","ANKRD62:ENST00000587848.3_1:exon14:c.G2651A:p.R884H","ANKRD62:ENST00000314074.8:c.2609G>A:p.(Arg870His)","0","0.0","0.0","0.0","","","","","","","","","","","","","ENSG00000181626","ANKRD62","HGNC:35241","ANKRD62","342850","ENSG00000181626","uc031rhk.2","","","","","3091","0/1","Het","93","49,44","0.526881720430108","","","","","","","Uncertain significance","PVS1: 0 ; PS1: 0 ; PS2: 0 ; PS3: 0 ; PS4: 0 ; PM1: 0 ; PM2: 1 ; PM3: 0 ; PM4: 0 ; PM5: 0 ; PM6: 0 ; PP1: 0 ; PP2: 0 ; PP3: 0 ; PP4: 0 ; PP5: 0 ; BA1: 0 ; BS1: 0 ; BS2: 0 ; BS3: 0 ; BS4: 0 ; BP1: 0 ; BP2: 0 ; BP3: 0 ; BP4: 1 ; BP5: 0 ; BP6: 0 ; BP7: 0","","","","ankyrin repeat domain 62","","","","","","","","","","SpliceAI>A|ANKRD62|0.00|0.00|0.00|0.00|15|-27|-33|-1","","","","0.0000383","","","","","","","3.83e-05","0","","","T","0.679","B","0.002","B","0.0","","","N","1","N","-0.46","","","","","0.091","T","-0.972","T","0.188","T","0.009","0.080","T","0.030","8.521","0.411","2.0","1.112","4.352"
